Citrus Sinensis ID: 017591
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 369 | 2.2.26 [Sep-21-2011] | |||||||
| Q9XID3 | 829 | G-type lectin S-receptor- | yes | no | 0.815 | 0.363 | 0.467 | 1e-70 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.813 | 0.365 | 0.453 | 2e-69 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.799 | 0.338 | 0.473 | 3e-66 | |
| Q9FID6 | 813 | Probable receptor-like pr | no | no | 0.802 | 0.364 | 0.412 | 1e-64 | |
| Q9FID5 | 806 | Probable receptor-like pr | no | no | 0.783 | 0.358 | 0.427 | 5e-64 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.785 | 0.350 | 0.456 | 6e-64 | |
| Q3ECH2 | 892 | Probable receptor-like pr | no | no | 0.796 | 0.329 | 0.398 | 6e-61 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.780 | 0.278 | 0.437 | 6e-61 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.756 | 0.350 | 0.471 | 8e-61 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.777 | 0.329 | 0.427 | 5e-59 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 267 bits (682), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 145/310 (46%), Positives = 189/310 (60%), Gaps = 9/310 (2%)
Query: 5 LRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRV 64
L + A PV+FT ++L T ++ KLGAGGFG VY+G N +A K L+ ++
Sbjct: 463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGI--EQG 520
Query: 65 EAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFT--DTEVLKWE 122
E QF E+ TI T+H+NLVRL GFC LVYEFM NGSLD +LFT + L WE
Sbjct: 521 EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWE 580
Query: 123 KLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182
+IA+GTA+GI YLHEEC I+H DIKP NIL+D F+AKV+DFGLAKL NP++
Sbjct: 581 YRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY 640
Query: 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQ 242
+ S RGT GY APE+L N PIT K DVYS+GM+L E++ ++N F
Sbjct: 641 NMSSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIW 699
Query: 243 VWDEYEKGELAAKVLGCGIEEN---DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299
++E+EKG A +L + E+ D E+ RM + WC+Q+ P RP M VV+MLEG
Sbjct: 700 AYEEFEKGNTKA-ILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG 758
Query: 300 GVEIVAPPKP 309
EI P P
Sbjct: 759 ITEIKNPLCP 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (671), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 141/311 (45%), Positives = 198/311 (63%), Gaps = 11/311 (3%)
Query: 2 EKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLN 61
+ FL +++ P+RF + L S TNN+S KLG GGFG VY+G P+G ++A K L+
Sbjct: 470 DNFLENLS-GMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQ 528
Query: 62 KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTE---V 118
+ E F AE+ IG +H++LVRL GFC + L YEF+ GSL++++F + +
Sbjct: 529 GKKE--FRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVL 586
Query: 119 LKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178
L W+ +IA+GTA+G+AYLHE+C+ RI+H DIKP NILLD F+AKV+DFGLAKL E
Sbjct: 587 LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTRE 646
Query: 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW 238
+H T+ RGT GY APE+ + NY I++K DVYS+GM+L E+IG RKN +
Sbjct: 647 QSHVFTT-MRGTRGYLAPEW-ITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCH 704
Query: 239 FPKQVWDEYEKGELAAKVLG--CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296
FP + + E+G+L V G ++ D E +R ALWC+Q+ + RP MS VV+M
Sbjct: 705 FPSFAFKKMEEGKLMDIVDGKMKNVDVTD-ERVQRAMKTALWCIQEDMQTRPSMSKVVQM 763
Query: 297 LEGGVEIVAPP 307
LEG +V PP
Sbjct: 764 LEGVFPVVQPP 774
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (643), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 144/304 (47%), Positives = 183/304 (60%), Gaps = 9/304 (2%)
Query: 11 EKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMA 70
+ PV FT L + TNN+S LG+GGFG VYKG +A K L L+ E +F+
Sbjct: 515 DSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHG-EREFIT 573
Query: 71 EIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTE---VLKWEKLLDI 127
E+ TIG +H+NLVRL G+C + + LVYE+M NGSLDK++F+ + +L W +I
Sbjct: 574 EVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEI 633
Query: 128 AIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187
A+ TA+GIAY HE+C RIIH DIKP NILLD F KV+DFGLAK+ E++H T
Sbjct: 634 AVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTM-I 692
Query: 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF-PKQVWDE 246
RGT GY APE+ + N PIT K DVYS+GMLL EI+G R+N D S D D+F P + E
Sbjct: 693 RGTRGYLAPEW-VSNRPITVKADVYSYGMLLLEIVGGRRNL-DMSYDAEDFFYPGWAYKE 750
Query: 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV-EIVA 305
G V + EE + VA WC+QD RP M VVK+LEG EI
Sbjct: 751 LTNGTSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINL 810
Query: 306 PPKP 309
PP P
Sbjct: 811 PPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 125/303 (41%), Positives = 189/303 (62%), Gaps = 7/303 (2%)
Query: 15 RFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGT 74
++ +L T ++S +G GGFG VY+G NG +A K+LK K F+ E+ +
Sbjct: 485 QYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDL--KGNGDDFINEVTS 542
Query: 75 IGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVL-KWEKLLDIAIGTAR 133
+ +T H+N+V L GFCY+ +K A++ EF+E+GSLD+++ + + L IA+G AR
Sbjct: 543 MSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPNVTTLYGIALGIAR 602
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
G+ YLH C RI+H+DIKP NILLD F KVADFGLAKLC + S RGT GY
Sbjct: 603 GLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGY 662
Query: 194 SAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKNAQDCSSD-TLDWFPKQVWDEYEKGE 251
APE + R Y I+ K DVYS+GML+ ++IG R + + + + +FP ++ + E G+
Sbjct: 663 IAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGD 722
Query: 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIV-APPKPF 310
++G I E D + ++M +V+LWC++ CP RPPM+ VV+M+EG ++ + PPKP
Sbjct: 723 -QTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKPS 781
Query: 311 RYL 313
R++
Sbjct: 782 RHI 784
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 5e-64, Method: Compositional matrix adjust.
Identities = 129/302 (42%), Positives = 185/302 (61%), Gaps = 13/302 (4%)
Query: 16 FTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTI 75
+T +L T ++S +G GGFG VY G NG K+A K+LK K F+ E+ ++
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDL--KGSAEDFINEVASM 545
Query: 76 GRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK-WEKLLDIAIGTARG 134
+T H+N+V L GFC++ +K A+VYEF+ENGSLD+++ + + + L IA+G ARG
Sbjct: 546 SQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTLYGIALGIARG 605
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYS 194
+ YLH C RI+H+DIKP NILLD KV+DFGLAKLC + S RGT GY
Sbjct: 606 LEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYI 665
Query: 195 APEFLLRNY-PITQKCDVYSFGMLLFEIIGRR-----KNAQDCSSDTLDWFPKQVWDEYE 248
APE R Y ++ K DVYSFGML+ ++IG R + +S T +FP ++ + E
Sbjct: 666 APEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASST--YFPDWIYKDLE 723
Query: 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIV-APP 307
GE + G I + ++E A++M +V LWC+Q CP RP M+ VV+M+EG ++ + PP
Sbjct: 724 DGE-QTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPP 782
Query: 308 KP 309
KP
Sbjct: 783 KP 784
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 244 bits (624), Expect = 6e-64, Method: Compositional matrix adjust.
Identities = 137/300 (45%), Positives = 183/300 (61%), Gaps = 10/300 (3%)
Query: 16 FTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTI 75
F+ +L + T N+S KLG GGFG V+KG P+ IA K L+ + E QF E+ TI
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGI--SQGEKQFRTEVVTI 540
Query: 76 GRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTE----VLKWEKLLDIAIGT 131
G H+NLVRL GFC + +K LVY++M NGSLD +LF + VL W+ IA+GT
Sbjct: 541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP 191
ARG+AYLH+EC IIH DIKP NILLD++F KVADFGLAKL + + T+ RGT
Sbjct: 601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTT-MRGTR 659
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251
GY APE+ + IT K DVYS+GM+LFE++ R+N + ++ + +FP K
Sbjct: 660 GYLAPEW-ISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDG 718
Query: 252 LAAKVLGCGIEEN--DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVAPPKP 309
++ +E + D EE R VA WC+QD RP MS VV++LEG +E+ PP P
Sbjct: 719 DIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 234 bits (598), Expect = 6e-61, Method: Compositional matrix adjust.
Identities = 123/309 (39%), Positives = 187/309 (60%), Gaps = 15/309 (4%)
Query: 15 RFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGT 74
+T ++ T +++ +G GGFG+VY G + +A K+LK E F+ E+ +
Sbjct: 545 HYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGE-DFINEVAS 603
Query: 75 IGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGTAR 133
+ +T H+N+V L GFC + ++ A++YEF+ NGSLDK++ + V L + L IA+G AR
Sbjct: 604 MSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSSVNLDLKTLYGIALGVAR 663
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
G+ YLH C RI+H+DIKP N+LLD KV+DFGLAKLC + + S RGT GY
Sbjct: 664 GLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGY 723
Query: 194 SAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKNA---QDCSSD-TLDWFPKQVWDEYE 248
APE + R Y ++ K DVYS+GML+ E+IG RK Q+ SD + +FP+ ++ + E
Sbjct: 724 IAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSIYFPEWIYKDLE 783
Query: 249 KGELA-------AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301
K + ++ GI + E A +M++V LWC+Q P RPPM+ VV+M+EG +
Sbjct: 784 KANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSL 843
Query: 302 EIV-APPKP 309
+ + PP+P
Sbjct: 844 DALEVPPRP 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 234 bits (598), Expect = 6e-61, Method: Compositional matrix adjust.
Identities = 129/295 (43%), Positives = 183/295 (62%), Gaps = 7/295 (2%)
Query: 12 KPVRFTLEQLCSFTNNY--STKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFM 69
KP FT +L S T ++ S KLG GGFG VYKG+ +G ++A K+L +++ + QF+
Sbjct: 677 KPYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVG-SRQGKGQFV 735
Query: 70 AEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIA 128
AEI I H NLV+LYG CY+ LVYE++ NGSLD+ LF + + L W +I
Sbjct: 736 AEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLHLDWSTRYEIC 795
Query: 129 IGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188
+G ARG+ YLHEE RI+H D+K +NILLD+K KV+DFGLAKL + + TH ST
Sbjct: 796 LGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTR-VA 854
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYE 248
GT GY APE+ +R + +T+K DVY+FG++ E++ R N+ + D + + W+ +E
Sbjct: 855 GTIGYLAPEYAMRGH-LTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHE 913
Query: 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEI 303
KG +++ + E + EE +RM +AL C Q RPPMS VV ML G VE+
Sbjct: 914 KGR-EVELIDHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEV 967
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 234 bits (597), Expect = 8e-61, Method: Compositional matrix adjust.
Identities = 139/295 (47%), Positives = 180/295 (61%), Gaps = 16/295 (5%)
Query: 16 FTLEQLCSFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGT 74
F+ ++L S TN +S K+G GGFG V+KG P + +A K L+ + E++F AE+ T
Sbjct: 451 FSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSG--ESEFRAEVCT 508
Query: 75 IGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLF-TDTEVLKWEKLLDIAIGTAR 133
IG H+NLVRL GFC + LVY++M GSL YL T ++L WE IA+GTA+
Sbjct: 509 IGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAK 568
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
GIAYLHE C IIH DIKP NILLD+ ++AKV+DFGLAKL + + + RGT GY
Sbjct: 569 GIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSR-VLATMRGTWGY 627
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD---------WFPKQVW 244
APE+ + PIT K DVYSFGM L E+IG R+N +SDTL +FP
Sbjct: 628 VAPEW-ISGLPITTKADVYSFGMTLLELIGGRRNVI-VNSDTLGEKETEPEKWFFPPWAA 685
Query: 245 DEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299
E +G + + V E + EE RM+ VA+WC+QD E RP M VVKMLEG
Sbjct: 686 REIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 228 bits (581), Expect = 5e-59, Method: Compositional matrix adjust.
Identities = 136/318 (42%), Positives = 186/318 (58%), Gaps = 31/318 (9%)
Query: 13 PVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAK-ILKTCLNKRVEAQFMAE 71
P +F E+L T N+ ++G+GGFG VYKG P+ IA K I L+ R E F E
Sbjct: 502 PQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQE--FCTE 559
Query: 72 IGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIG 130
I IG H NLV+L GFC + LVYE+M +GSL+K LF+ + VL+W++ DIA+G
Sbjct: 560 IAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALG 619
Query: 131 TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGT 190
TARG+AYLH C+Q+IIH D+KP NILL F K++DFGL+KL N E + T+ RGT
Sbjct: 620 TARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTT-MRGT 678
Query: 191 PGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKN------AQDCSSDT--------- 235
GY APE+ + N I++K DVYS+GM+L E++ RKN + + D
Sbjct: 679 RGYLAPEW-ITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSSTTT 737
Query: 236 ----LDWFPKQVWDEYEKG---ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARP 288
L +FP D +E+G ELA L + +EAE++ +AL CV + P RP
Sbjct: 738 TSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTS---QEAEKLVRIALCCVHEEPALRP 794
Query: 289 PMSAVVKMLEGGVEIVAP 306
M+AVV M EG + + P
Sbjct: 795 TMAAVVGMFEGSIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 369 | ||||||
| 225429784 | 361 | PREDICTED: G-type lectin S-receptor-like | 0.959 | 0.980 | 0.699 | 1e-154 | |
| 359476316 | 361 | PREDICTED: G-type lectin S-receptor-like | 0.959 | 0.980 | 0.690 | 1e-151 | |
| 296081766 | 543 | unnamed protein product [Vitis vinifera] | 0.959 | 0.651 | 0.690 | 1e-151 | |
| 449532913 | 358 | PREDICTED: G-type lectin S-receptor-like | 0.951 | 0.980 | 0.657 | 1e-136 | |
| 449437068 | 436 | PREDICTED: G-type lectin S-receptor-like | 0.951 | 0.805 | 0.654 | 1e-135 | |
| 449437350 | 363 | PREDICTED: G-type lectin S-receptor-like | 0.948 | 0.964 | 0.632 | 1e-130 | |
| 449437352 | 452 | PREDICTED: G-type lectin S-receptor-like | 0.948 | 0.774 | 0.610 | 1e-128 | |
| 449528245 | 486 | PREDICTED: G-type lectin S-receptor-like | 0.970 | 0.736 | 0.601 | 1e-127 | |
| 449437348 | 452 | PREDICTED: probable receptor-like protei | 0.951 | 0.776 | 0.613 | 1e-125 | |
| 356556192 | 414 | PREDICTED: G-type lectin S-receptor-like | 0.845 | 0.753 | 0.613 | 1e-111 |
| >gi|225429784|ref|XP_002282725.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1420), Expect = e-154, Method: Compositional matrix adjust.
Identities = 251/359 (69%), Positives = 302/359 (84%), Gaps = 5/359 (1%)
Query: 1 MEKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL 60
MEKF +++AREKPVRFT +QLCSFT+NY+T LG+GGFG+VYKGQFPNGVKIA K+L
Sbjct: 1 MEKFFQELAREKPVRFTAQQLCSFTDNYTTTLGSGGFGMVYKGQFPNGVKIAVKVLNRSP 60
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK 120
+++ E QFMAE+GTIGRTYHINLVRLYGFCYDQ +ALVYE++ENGSLDKYLF++ + ++
Sbjct: 61 DRQAEEQFMAEVGTIGRTYHINLVRLYGFCYDQFMSALVYEYLENGSLDKYLFSEAQEVE 120
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
WEKL IA+GTA+GIAYLHEEC +RIIHYDIKP NILLDA F KVADFGLAKLCN + T
Sbjct: 121 WEKLHHIAVGTAKGIAYLHEECVERIIHYDIKPGNILLDANFFPKVADFGLAKLCNRDGT 180
Query: 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240
H + SGYRGTPGYSAPEFLL+N+PIT KCDVYSFGMLLFEI+GRR+NA+ S++++DWFP
Sbjct: 181 HLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLFEIVGRRRNAKVGSNESMDWFP 240
Query: 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300
K W+EYEKG+LAA + CGIEE DRE+AERMSMVALWCVQD P++RPPMSAVVKMLEGG
Sbjct: 241 KHTWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWCVQDSPDSRPPMSAVVKMLEGG 300
Query: 301 VEIVAPPKPFRYLYSIGMDALKSPCRIVNGSSHLASEGTQGQGGESFWYQESSPIIAKY 359
VE++ PPKPF YLYS+GM+ + SS+ SE T S WY+E++PI+AKY
Sbjct: 301 VEVMPPPKPFHYLYSVGMNVFQQANETGTNSSYATSEETS-----SIWYKETTPIMAKY 354
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476316|ref|XP_003631817.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1391), Expect = e-151, Method: Compositional matrix adjust.
Identities = 248/359 (69%), Positives = 300/359 (83%), Gaps = 5/359 (1%)
Query: 1 MEKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL 60
ME+F ++IA+EKPVRFT +QLCSFT NYST LG+GGFGVVYKGQF NGVKIA K+L
Sbjct: 1 MERFFQEIAKEKPVRFTAQQLCSFTANYSTTLGSGGFGVVYKGQFLNGVKIAVKVLNRSP 60
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK 120
+++ QFMAE+GTIGRTYH+NLVRLYGFC+DQ +ALVYE++ENGSLDKYLF++ ++
Sbjct: 61 DRQAGEQFMAEVGTIGRTYHMNLVRLYGFCHDQFMSALVYEYLENGSLDKYLFSEAREIE 120
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
WEKL IA+GTA+GIAYLHEEC QRIIHYDIKP N+LLDA F KVADFGLAKLCN +NT
Sbjct: 121 WEKLHHIAVGTAKGIAYLHEECVQRIIHYDIKPGNVLLDANFFPKVADFGLAKLCNRDNT 180
Query: 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240
H + SGYRGTPGYSAPEFLL+N+PIT KCDVYSFGMLLFEI+GRR+NA+ S++++DWFP
Sbjct: 181 HLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLFEIVGRRRNAKIGSNESMDWFP 240
Query: 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300
K VW+EYEKG+LAA + CGIEE DRE+AERMSMVALWCVQD P++RP MSAVVKMLEGG
Sbjct: 241 KHVWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWCVQDSPDSRPLMSAVVKMLEGG 300
Query: 301 VEIVAPPKPFRYLYSIGMDALKSPCRIVNGSSHLASEGTQGQGGESFWYQESSPIIAKY 359
VE++ PPKPF YLYS+G++ L+ SS+ S+ T S WY+E++PI+AKY
Sbjct: 301 VEVMPPPKPFHYLYSVGINVLQQANETGTSSSYATSKETN-----SIWYKETTPIMAKY 354
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081766|emb|CBI20771.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 539 bits (1389), Expect = e-151, Method: Compositional matrix adjust.
Identities = 248/359 (69%), Positives = 300/359 (83%), Gaps = 5/359 (1%)
Query: 1 MEKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL 60
ME+F ++IA+EKPVRFT +QLCSFT NYST LG+GGFGVVYKGQF NGVKIA K+L
Sbjct: 59 MERFFQEIAKEKPVRFTAQQLCSFTANYSTTLGSGGFGVVYKGQFLNGVKIAVKVLNRSP 118
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK 120
+++ QFMAE+GTIGRTYH+NLVRLYGFC+DQ +ALVYE++ENGSLDKYLF++ ++
Sbjct: 119 DRQAGEQFMAEVGTIGRTYHMNLVRLYGFCHDQFMSALVYEYLENGSLDKYLFSEAREIE 178
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
WEKL IA+GTA+GIAYLHEEC QRIIHYDIKP N+LLDA F KVADFGLAKLCN +NT
Sbjct: 179 WEKLHHIAVGTAKGIAYLHEECVQRIIHYDIKPGNVLLDANFFPKVADFGLAKLCNRDNT 238
Query: 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240
H + SGYRGTPGYSAPEFLL+N+PIT KCDVYSFGMLLFEI+GRR+NA+ S++++DWFP
Sbjct: 239 HLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLFEIVGRRRNAKIGSNESMDWFP 298
Query: 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300
K VW+EYEKG+LAA + CGIEE DRE+AERMSMVALWCVQD P++RP MSAVVKMLEGG
Sbjct: 299 KHVWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWCVQDSPDSRPLMSAVVKMLEGG 358
Query: 301 VEIVAPPKPFRYLYSIGMDALKSPCRIVNGSSHLASEGTQGQGGESFWYQESSPIIAKY 359
VE++ PPKPF YLYS+G++ L+ SS+ S+ T S WY+E++PI+AKY
Sbjct: 359 VEVMPPPKPFHYLYSVGINVLQQANETGTSSSYATSKETN-----SIWYKETTPIMAKY 412
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449532913|ref|XP_004173422.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 491 bits (1263), Expect = e-136, Method: Compositional matrix adjust.
Identities = 236/359 (65%), Positives = 277/359 (77%), Gaps = 8/359 (2%)
Query: 1 MEKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL 60
MEKF+R++A E+PVRFT +QL FT+NYST LG+GGFG VYKGQFPNGVKIA K+LK
Sbjct: 1 MEKFIREMAEERPVRFTPQQLYCFTSNYSTPLGSGGFGSVYKGQFPNGVKIAVKVLKRNA 60
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK 120
+++ E QFMAE+GTIGRTYHINLVRLYGFCYDQ ALV+E+MENGSLDKYLF + +
Sbjct: 61 DRQAEEQFMAEVGTIGRTYHINLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDID 120
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
W KL D+AIGTA+G+AYLHEEC QRIIHYDIKPANILLDA FS KV DFGLAKLCN + T
Sbjct: 121 WRKLHDVAIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDIT 180
Query: 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240
H S +GYRGTPGYSAPEFL NYPIT KCDVYSFGM+LFEI+GR++NA S DW P
Sbjct: 181 HMSLTGYRGTPGYSAPEFLFFNYPITHKCDVYSFGMVLFEIVGRKRNAGVTDSGNPDWLP 240
Query: 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300
+ VWD YEKG+L L CGIEE+++E A RM VALWCVQD P+ RPPMS VV+MLEGG
Sbjct: 241 QHVWDNYEKGKLEELTLMCGIEEDNKERANRMCEVALWCVQDSPDNRPPMSTVVRMLEGG 300
Query: 301 VEIVAPPKPFRYLYSIGMDALKSPCRIVNGSSHLASEGTQGQGGESFWYQESSPIIAKY 359
VEI+ PPKPF YL S A ++ + N S + S G S WY++ +PI+ KY
Sbjct: 301 VEIMPPPKPFLYLQST---AKRNAQQTSNSSDYSTSNEESG----SVWYKD-TPIMKKY 351
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437068|ref|XP_004136314.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 489 bits (1258), Expect = e-135, Method: Compositional matrix adjust.
Identities = 235/359 (65%), Positives = 276/359 (76%), Gaps = 8/359 (2%)
Query: 1 MEKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL 60
MEKF+R++A E+PVR T +QL FT+NYST LG+GGFG VYKGQFPNGVKIA K+LK
Sbjct: 79 MEKFIREMAEERPVRLTPQQLYCFTSNYSTPLGSGGFGSVYKGQFPNGVKIAVKVLKRNA 138
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK 120
+++ E QFMAE+GTIGRTYHINLVRLYGFCYDQ ALV+E+MENGSLDKYLF + +
Sbjct: 139 DRQAEEQFMAEVGTIGRTYHINLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDID 198
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
W KL D+AIGTA+G+AYLHEEC QRIIHYDIKPANILLDA FS KV DFGLAKLCN + T
Sbjct: 199 WRKLHDVAIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDIT 258
Query: 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240
H S +GYRGTPGYSAPEFL NYPIT KCDVYSFGM+LFEI+GR++NA S DW P
Sbjct: 259 HMSLTGYRGTPGYSAPEFLFFNYPITHKCDVYSFGMVLFEIVGRKRNAGVTDSGNPDWLP 318
Query: 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300
+ VWD YEKG+L L CGIEE+++E A RM VALWCVQD P+ RPPMS VV+MLEGG
Sbjct: 319 QHVWDNYEKGKLEELTLMCGIEEDNKERANRMCEVALWCVQDSPDNRPPMSTVVRMLEGG 378
Query: 301 VEIVAPPKPFRYLYSIGMDALKSPCRIVNGSSHLASEGTQGQGGESFWYQESSPIIAKY 359
VEI+ PPKPF YL S A ++ + N S + S G S WY++ +PI+ KY
Sbjct: 379 VEIMPPPKPFLYLQST---AKRNAQQTSNSSDYSTSNEESG----SVWYKD-TPIMKKY 429
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437350|ref|XP_004136455.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1211), Expect = e-130, Method: Compositional matrix adjust.
Identities = 231/365 (63%), Positives = 273/365 (74%), Gaps = 15/365 (4%)
Query: 1 MEKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL 60
MEKF R IA EKPVRFT +QL +FT+NYST+LG+GGFG VYKG+FPNGV IA K+LK
Sbjct: 1 MEKFFRKIAEEKPVRFTADQLYTFTSNYSTRLGSGGFGEVYKGKFPNGVNIAVKVLKRGS 60
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK 120
+KR E QFMAE+G+I RTYHINLVRLYGFCYD +ALV+E++ NGSLDKYLF + ++
Sbjct: 61 DKRAEEQFMAEVGSICRTYHINLVRLYGFCYDHFMSALVFEYLVNGSLDKYLFGKRKEIE 120
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
W KL DIAIGTA+G+AYLHEEC QRIIHYDIKPANILLDA FS KV DFGLAKLCN ++T
Sbjct: 121 WRKLHDIAIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDST 180
Query: 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240
H S SGYRGTPGYSAPEFLL NYP+T KCDVYSFGM+LFEIIGR+ NA S DWFP
Sbjct: 181 HISFSGYRGTPGYSAPEFLLVNYPLTHKCDVYSFGMVLFEIIGRKSNAGTTVSGNPDWFP 240
Query: 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300
+ VWD YE G+L ++GCGI E DRE A R VALWCVQD P+ RP MS VV+MLEGG
Sbjct: 241 QHVWDAYENGKLEELIIGCGIGEEDREMASRACEVALWCVQDSPDGRPTMSVVVRMLEGG 300
Query: 301 VEIVAPPKPFRYLYSIGMDALKSPCRIVN------GSSHLASEGTQGQGGESFWYQESSP 354
VEI+ P KPF+YL +P R N + +S + + S WY++++
Sbjct: 301 VEIMPPAKPFQYL---------NPIRTGNSSTSSQQTGSNSSGSSTSRDSNSQWYKKTTT 351
Query: 355 IIAKY 359
I+ KY
Sbjct: 352 IMRKY 356
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437352|ref|XP_004136456.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1196), Expect = e-128, Method: Compositional matrix adjust.
Identities = 223/365 (61%), Positives = 270/365 (73%), Gaps = 15/365 (4%)
Query: 1 MEKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL 60
MEKF++++A+EKP+RFT +QL FT NYST LGAG F VYKG+FPNGVKIA K+L
Sbjct: 90 MEKFIQELAKEKPIRFTAQQLYIFTRNYSTILGAGAFSTVYKGEFPNGVKIAVKVLNRNS 149
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK 120
+K+ E QFMAE+GTIG+TYH +LVRLYGFCYDQ ALV+E+MENGSLDKYLF + +
Sbjct: 150 DKQAEQQFMAEVGTIGKTYHRHLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDVD 209
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
W KL D+AIGTA+G+ YLHEEC +RIIHYDIKPANILLDA FS KV DFGLAKLC+ + T
Sbjct: 210 WGKLHDVAIGTAKGLTYLHEECQERIIHYDIKPANILLDANFSPKVCDFGLAKLCHRDRT 269
Query: 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240
H S +GYRGTPGYSAPEF L NYPIT KCDVYSFGMLLFEI+GR+KNA S LDWFP
Sbjct: 270 HISLTGYRGTPGYSAPEFFLNNYPITHKCDVYSFGMLLFEIVGRKKNATVTPSGNLDWFP 329
Query: 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300
+ VWD+Y+K EL CGIEE D+E RM VALWC+QD P+ RPPMS VVKMLEG
Sbjct: 330 RHVWDKYKKRELEEISQICGIEEKDKESVSRMCKVALWCIQDSPDERPPMSVVVKMLEGD 389
Query: 301 VEIVAPPKPFRYLYSIGMDALKSPCRIVNGSSHL------ASEGTQGQGGESFWYQESSP 354
VEI+AP PF++ +P + N +L ++ T + S WY++++P
Sbjct: 390 VEIMAPSNPFKF---------SNPTPVGNNKPNLLQSSSSSNYSTSSEEIHSSWYKKATP 440
Query: 355 IIAKY 359
I+ KY
Sbjct: 441 IMKKY 445
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449528245|ref|XP_004171116.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 461 bits (1185), Expect = e-127, Method: Compositional matrix adjust.
Identities = 225/374 (60%), Positives = 275/374 (73%), Gaps = 16/374 (4%)
Query: 1 MEKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL 60
MEKF++++A+EKP+RFT +QL FT NYST LGAG F VYKG+FPNGVKIA K+L
Sbjct: 90 MEKFIQELAKEKPMRFTAQQLYIFTRNYSTILGAGAFSTVYKGEFPNGVKIAVKVLNRNS 149
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK 120
+K+ E QFMAE+GTIG+TYH +LVRLYGFCYDQ ALV+E+MENGSLDKYLF + +
Sbjct: 150 DKQAEQQFMAEVGTIGKTYHRHLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDVD 209
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
W KL D+AIGTA+G+ YLHEEC +RIIHYDIKPANILLDA FS KV DFGLAKLC+ + T
Sbjct: 210 WGKLHDVAIGTAKGLTYLHEECQERIIHYDIKPANILLDANFSPKVCDFGLAKLCHRDRT 269
Query: 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240
H S +G RGTPGYSAPEF L NYPIT KCDVYSFGMLLFEI+GR+KNA S LDWFP
Sbjct: 270 HISLTGCRGTPGYSAPEFFLNNYPITHKCDVYSFGMLLFEIVGRKKNATVTPSGNLDWFP 329
Query: 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300
+ VWD+Y+K EL CGIEE D+E RM VALWC+QD P+ RPPMS VVKMLEG
Sbjct: 330 RHVWDKYKKRELEEISQICGIEEKDKESVSRMCKVALWCIQDSPDERPPMSVVVKMLEGD 389
Query: 301 VEIVAPPKPFRYLYSIGMDALKSPCRIVNGSSHL------ASEGTQGQGGESFWYQESSP 354
VEI+AP PF++ +P + N +L ++ T + S WY++++P
Sbjct: 390 VEIMAPSNPFKF---------SNPTPVGNNKPNLLQSSSSSNYSTSSEEIHSSWYKKATP 440
Query: 355 IIAKYGASGFAVSS 368
I+ K +SGF+ +S
Sbjct: 441 IMKKM-SSGFSPTS 453
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437348|ref|XP_004136454.1| PREDICTED: probable receptor-like protein kinase At5g39020-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 455 bits (1170), Expect = e-125, Method: Compositional matrix adjust.
Identities = 221/360 (61%), Positives = 270/360 (75%), Gaps = 9/360 (2%)
Query: 1 MEKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL 60
MEK LR IA E P+RFT QL +FT+NYST+LG+GGFG VYKGQFPNG+KIA KILK
Sbjct: 93 MEKILRGIAEESPIRFTALQLNAFTSNYSTRLGSGGFGDVYKGQFPNGLKIAVKILKKNS 152
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTE-VL 119
NK+ E QFMAEI TIGRT H NL+RLYGFCYD+T +ALV EFMENGSLD++L+ T+ L
Sbjct: 153 NKKAENQFMAEIETIGRTRHRNLLRLYGFCYDETMSALVLEFMENGSLDRFLYGKTKNEL 212
Query: 120 KWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179
WEKLL+IAIGT RGIAY+HEEC ++IIHYDIKPANILLD FS K+ DFGLA LCN +N
Sbjct: 213 DWEKLLEIAIGTGRGIAYMHEECERKIIHYDIKPANILLDENFSPKIGDFGLANLCNKDN 272
Query: 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF 239
THDS + YRGTPGYSAPE L N+P+T KCDVYSFGM+LFE++GRRKNA ++DWF
Sbjct: 273 THDSLTEYRGTPGYSAPELLRFNFPVTYKCDVYSFGMVLFEMVGRRKNAAVSPLGSIDWF 332
Query: 240 PKQVWDEYEKGELAAKVLGCGIEEND--REEAERMSMVALWCVQDCPEARPPMSAVVKML 297
P QVW+ +EKGEL +EE+ + + +RM +VALWCVQD PE RPPMSAVV+ML
Sbjct: 333 PIQVWERFEKGELVNMSGDYDVEEDGERKMKVDRMCVVALWCVQDSPEDRPPMSAVVRML 392
Query: 298 EGGVEIVAPPKPFRYLYSIGMDALKSPCRIVNGSSHLA----SEGTQGQGGESFWYQESS 353
EG VEI+ PPKPF+Y++ I D+ S + S ++ S + +G WY+ +S
Sbjct: 393 EGSVEIMPPPKPFQYMFPIPTDS--STVTVAMDSEQMSFGSTSSYSMSKGTLPIWYKAAS 450
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556192|ref|XP_003546410.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1051), Expect = e-111, Method: Compositional matrix adjust.
Identities = 192/313 (61%), Positives = 239/313 (76%), Gaps = 1/313 (0%)
Query: 1 MEKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL 60
++KFL D+ REKP+RFT +QL T+NYS LG+GGFG VYKG F NG +A K+L+
Sbjct: 50 IDKFLNDMEREKPIRFTDQQLRIATDNYSNLLGSGGFGTVYKGIFTNGTMVAVKVLRGSS 109
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK 120
+K++E QFMAE+GTIGR +H NLVRLYGFC+++ ALVYE+M NGSLDKYLF + + L
Sbjct: 110 DKKIEEQFMAEVGTIGRIHHFNLVRLYGFCFEKNLIALVYEYMGNGSLDKYLFHEKKTLG 169
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
+EKL +IA+GTARGIAYLHEEC QRIIHYDIKP NILLD F+ KVADFGLAKLCN +NT
Sbjct: 170 YEKLHEIAVGTARGIAYLHEECRQRIIHYDIKPGNILLDRNFNPKVADFGLAKLCNKDNT 229
Query: 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240
H + +G RGTPGY+APE + +PIT KCDVYSFGMLLFEIIGRR+N +++ +WFP
Sbjct: 230 HITMTGGRGTPGYAAPELWM-PFPITHKCDVYSFGMLLFEIIGRRRNLDIKRAESQEWFP 288
Query: 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300
VW ++ +L ++ CGIEE +E AERM +ALWCVQ PE RP MS VVKMLEG
Sbjct: 289 IWVWKRFDTAQLGELIIVCGIEEKSKEIAERMIKIALWCVQYRPELRPIMSVVVKMLEGS 348
Query: 301 VEIVAPPKPFRYL 313
+E+ P PF++L
Sbjct: 349 LEVPEPGNPFQHL 361
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 369 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.813 | 0.361 | 0.472 | 2.2e-66 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.813 | 0.365 | 0.459 | 7.4e-66 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.799 | 0.443 | 0.422 | 6.7e-65 | |
| TAIR|locus:2020583 | 799 | AT1G70250 [Arabidopsis thalian | 0.813 | 0.375 | 0.443 | 2.3e-64 | |
| TAIR|locus:2019688 | 674 | AT1G66930 [Arabidopsis thalian | 0.823 | 0.451 | 0.412 | 4.2e-63 | |
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.813 | 0.351 | 0.419 | 5.4e-63 | |
| TAIR|locus:2177142 | 813 | AT5G39020 [Arabidopsis thalian | 0.799 | 0.362 | 0.417 | 3.4e-61 | |
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.796 | 0.441 | 0.414 | 5.5e-61 | |
| TAIR|locus:2177152 | 806 | AT5G39030 [Arabidopsis thalian | 0.799 | 0.366 | 0.427 | 7.1e-61 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.783 | 0.349 | 0.465 | 1.2e-60 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 2.2e-66, P = 2.2e-66
Identities = 147/311 (47%), Positives = 192/311 (61%)
Query: 5 LRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRV 64
L + A PV+FT ++L T ++ KLGAGGFG VY+G N +A K L+ ++
Sbjct: 463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGI--EQG 520
Query: 65 EAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFT-DT-EVLKWE 122
E QF E+ TI T+H+NLVRL GFC LVYEFM NGSLD +LFT D+ + L WE
Sbjct: 521 EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWE 580
Query: 123 KLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182
+IA+GTA+GI YLHEEC I+H DIKP NIL+D F+AKV+DFGLAKL NP++
Sbjct: 581 YRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY 640
Query: 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQ 242
+ S RGT GY APE+L N PIT K DVYS+GM+L E++ ++N F
Sbjct: 641 NMSSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIW 699
Query: 243 VWDEYEKGELAAKVLGCGIEEN---DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299
++E+EKG A +L + E+ D E+ RM + WC+Q+ P RP M VV+MLEG
Sbjct: 700 AYEEFEKGNTKA-ILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG 758
Query: 300 GVEIVAP--PK 308
EI P PK
Sbjct: 759 ITEIKNPLCPK 769
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 670 (240.9 bits), Expect = 7.4e-66, P = 7.4e-66
Identities = 143/311 (45%), Positives = 199/311 (63%)
Query: 2 EKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLN 61
+ FL +++ P+RF + L S TNN+S KLG GGFG VY+G P+G ++A K L+
Sbjct: 470 DNFLENLSG-MPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQ 528
Query: 62 KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFT--DTEVL 119
+ E F AE+ IG +H++LVRL GFC + L YEF+ GSL++++F D +VL
Sbjct: 529 GKKE--FRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVL 586
Query: 120 -KWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178
W+ +IA+GTA+G+AYLHE+C+ RI+H DIKP NILLD F+AKV+DFGLAKL E
Sbjct: 587 LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTRE 646
Query: 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW 238
+H T+ RGT GY APE++ NY I++K DVYS+GM+L E+IG RKN +
Sbjct: 647 QSHVFTT-MRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCH 704
Query: 239 FPKQVWDEYEKGELAAKVLGC--GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296
FP + + E+G+L V G ++ D E +R ALWC+Q+ + RP MS VV+M
Sbjct: 705 FPSFAFKKMEEGKLMDIVDGKMKNVDVTD-ERVQRAMKTALWCIQEDMQTRPSMSKVVQM 763
Query: 297 LEGGVEIVAPP 307
LEG +V PP
Sbjct: 764 LEGVFPVVQPP 774
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 661 (237.7 bits), Expect = 6.7e-65, P = 6.7e-65
Identities = 129/305 (42%), Positives = 197/305 (64%)
Query: 15 RFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIG 73
R++ ++ TN+++ LG GGFG VYKG+ + G +A KILK E F+ E+
Sbjct: 320 RYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGEE--FINEVA 377
Query: 74 TIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGTA 132
++ RT H+N+V L GFCY++ K A++YEFM NGSLDKY+ + ++WE+L D+A+G +
Sbjct: 378 SMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYISANMSTKMEWERLYDVAVGIS 437
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
RG+ YLH C RI+H+DIKP NIL+D K++DFGLAKLC + + S RGT G
Sbjct: 438 RGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRGTFG 497
Query: 193 YSAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRR---KNAQDCSSDTLDWFPKQVWDEYE 248
Y APE +N+ ++ K DVYS+GM++ E+IG + K S++ +FP+ V+ ++E
Sbjct: 498 YIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWVYKDFE 557
Query: 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIV-APP 307
KGE+ ++ G I + + + A+++ +VALWC+Q P RPPM V++MLEG +E + PP
Sbjct: 558 KGEIT-RIFGDSITDEEEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEALQVPP 616
Query: 308 KPFRY 312
P +
Sbjct: 617 NPLLF 621
|
|
| TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 656 (236.0 bits), Expect = 2.3e-64, P = 2.3e-64
Identities = 137/309 (44%), Positives = 195/309 (63%)
Query: 15 RFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVK-IAAKILKTCLNKRVEAQFMAEIG 73
RF+ Q+ T ++ LG GGFG VYKG+ P+G + +A KILK N+ E F+ EI
Sbjct: 448 RFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPDGSRDVAVKILKES-NEDGE-DFINEIA 505
Query: 74 TIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGTA 132
++ RT H N+V L GFCY+ K A++YE M NGSLDK++ + ++W+ L +IA+G +
Sbjct: 506 SMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFISKNMSAKMEWKTLYNIAVGVS 565
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
G+ YLH C RI+H+DIKP NIL+D K++DFGLAKLC + S RGT G
Sbjct: 566 HGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHARGTIG 625
Query: 193 YSAPEFLLRNYP-ITQKCDVYSFGMLLFEIIGRRK--NAQDC-SSDTLDWFPKQVWDEYE 248
Y APE +N+ ++ K DVYS+GM++ E+IG R AQ+ SS+T +FP ++ + E
Sbjct: 626 YIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGARNIGRAQNAGSSNTSMYFPDWIYKDLE 685
Query: 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVA-PP 307
KGE+ + + EE D + ++M +V LWC+Q P RPPMS VV+MLEG +E + PP
Sbjct: 686 KGEIMSFLADQITEEEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEGSLEALQIPP 745
Query: 308 KPFRYLYSI 316
KP L +I
Sbjct: 746 KPLLCLPAI 754
|
|
| TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 644 (231.8 bits), Expect = 4.2e-63, P = 4.2e-63
Identities = 129/313 (41%), Positives = 197/313 (62%)
Query: 13 PVR-FTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAE 71
P++ +T Q+ T +++ +G GGFG+VY+G +G +A K+LK E F+ E
Sbjct: 332 PLKHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSE-DFINE 390
Query: 72 IGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIG 130
+ ++ +T H+N+V L GFC + ++ A++YEF+ENGSLDK++ T V L L IA+G
Sbjct: 391 VSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEKTSVILDLTALYGIALG 450
Query: 131 TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGT 190
ARG+ YLH C RI+H+DIKP N+LLD S KV+DFGLAKLC + + S RGT
Sbjct: 451 VARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGT 510
Query: 191 PGYSAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKN---AQDCSSDTLDWFPKQVWDE 246
GY APE + R Y ++ K DVYS+GML+FE+IG RK Q+ ++ + +FP+ ++ +
Sbjct: 511 IGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEWIYKD 570
Query: 247 YEKGELA-AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIV- 304
EK + + + GI + E A++M++V LWC+Q P RPPM+ VV+M+EG ++ +
Sbjct: 571 LEKADNGDLEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALE 630
Query: 305 APPKPFRYLYSIG 317
PP+P +G
Sbjct: 631 VPPRPVLQQIHVG 643
|
|
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 643 (231.4 bits), Expect = 5.4e-63, P = 5.4e-63
Identities = 131/312 (41%), Positives = 200/312 (64%)
Query: 15 RFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPN--GVKIAAKILKTCLNKRVEAQFMAEI 72
R++ E++ TN++ +G GGFG VYKG+ P+ G IA KILK +K +F+ E+
Sbjct: 508 RYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASGRDIALKILKE--SKGNGEEFINEL 565
Query: 73 GTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGT 131
++ R H+N+V L+GFCY+ ++ A++YEFM NGSLDK++ + ++W+ L +IA+G
Sbjct: 566 VSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKFISENMSTKIEWKTLYNIAVGV 625
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP 191
ARG+ YLH C +I+H+DIKP NIL+D K++DFGLAKLC + + S RGT
Sbjct: 626 ARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDARGTV 685
Query: 192 GYSAPEFLLRNYP-ITQKCDVYSFGMLLFEIIG--RRKNAQDCSSDTLD-WFPKQVWDEY 247
GY APE +NY ++ K DVYS+GM++ E+IG +R+ + ++D +FP V+++
Sbjct: 686 GYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATKREEVETSATDKSSMYFPDWVYEDL 745
Query: 248 EKGELAAKVLGCGIEENDREE-AERMSMVALWCVQDCPEARPPMSAVVKMLEGG-VEIV- 304
E+ E + IEE + E+ +RM++V LWC+Q P RPPM VV+MLEG +E +
Sbjct: 746 ERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGSRLEALQ 805
Query: 305 APPKPFRYLYSI 316
PPKP L+ +
Sbjct: 806 VPPKPLLNLHVV 817
|
|
| TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 626 (225.4 bits), Expect = 3.4e-61, P = 3.4e-61
Identities = 127/304 (41%), Positives = 189/304 (62%)
Query: 15 RFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGT 74
++ +L T ++S +G GGFG VY+G NG +A K+LK K F+ E+ +
Sbjct: 485 QYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDL--KGNGDDFINEVTS 542
Query: 75 IGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVL-KWEKLLDIAIGTAR 133
+ +T H+N+V L GFCY+ +K A++ EF+E+GSLD+++ + + L IA+G AR
Sbjct: 543 MSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPNVTTLYGIALGIAR 602
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
G+ YLH C RI+H+DIKP NILLD F KVADFGLAKLC + S RGT GY
Sbjct: 603 GLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGY 662
Query: 194 SAPEFLLRNYP-ITQKCDVYSFGMLLFEIIGRRKNAQD--CSSDTLDWFPKQVWDEYEKG 250
APE + R Y I+ K DVYS+GML+ ++IG R + C+ T +FP ++ + E G
Sbjct: 663 IAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTA-YFPDWIYKDLENG 721
Query: 251 ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVA-PPKP 309
+ ++G I E D + ++M +V+LWC++ CP RPPM+ VV+M+EG ++ + PPKP
Sbjct: 722 D-QTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKP 780
Query: 310 FRYL 313
R++
Sbjct: 781 SRHI 784
|
|
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 624 (224.7 bits), Expect = 5.5e-61, P = 5.5e-61
Identities = 126/304 (41%), Positives = 191/304 (62%)
Query: 13 PVR-FTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAE 71
P++ ++ Q+ S T +++ +G GGFG VY+G +G +A K+LK + F+ E
Sbjct: 334 PLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKESQGNGED--FINE 391
Query: 72 IGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIG 130
+ ++ +T H+N+V L GFC + K A++YEFMENGSLDK++ + + + W +L IA+G
Sbjct: 392 VASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSKKSSTMDWRELYGIALG 451
Query: 131 TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGT 190
ARG+ YLH C RI+H+DIKP N+LLD S KV+DFGLAKLC + + S RGT
Sbjct: 452 VARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESILSLMDTRGT 511
Query: 191 PGYSAPEFLLRNYP-ITQKCDVYSFGMLLFEIIGRRK--NAQDCSSDTLD-WFPKQVWDE 246
GY APE R Y ++ K DVYS+GML+ +IIG R + +D +S T +FP+ ++ +
Sbjct: 512 IGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDTTSSTSSMYFPEWIYRD 571
Query: 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIV-A 305
EK K + I + E A++M++V LWC+Q P RP M+ VV+M+EG ++ +
Sbjct: 572 LEKAH-NGKSIETAISNEEDEIAKKMTLVGLWCIQPWPLDRPAMNRVVEMMEGNLDALEV 630
Query: 306 PPKP 309
PP+P
Sbjct: 631 PPRP 634
|
|
| TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 623 (224.4 bits), Expect = 7.1e-61, P = 7.1e-61
Identities = 130/304 (42%), Positives = 189/304 (62%)
Query: 16 FTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTI 75
+T +L T ++S +G GGFG VY G NG K+A K+LK L E F+ E+ ++
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKD-LKGSAE-DFINEVASM 545
Query: 76 GRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK-WEKLLDIAIGTARG 134
+T H+N+V L GFC++ +K A+VYEF+ENGSLD+++ + + + L IA+G ARG
Sbjct: 546 SQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTLYGIALGIARG 605
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYS 194
+ YLH C RI+H+DIKP NILLD KV+DFGLAKLC + S RGT GY
Sbjct: 606 LEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYI 665
Query: 195 APEFLLRNYP-ITQKCDVYSFGMLLFEIIGRR-KNAQDC--SSDTLDWFPKQVWDEYEKG 250
APE R Y ++ K DVYSFGML+ ++IG R K + S+ + +FP ++ + E G
Sbjct: 666 APEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDG 725
Query: 251 ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVA-PPKP 309
E + G I + ++E A++M +V LWC+Q CP RP M+ VV+M+EG ++ + PPKP
Sbjct: 726 E-QTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP 784
Query: 310 FRYL 313
++
Sbjct: 785 SMHI 788
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 621 (223.7 bits), Expect = 1.2e-60, P = 1.2e-60
Identities = 140/301 (46%), Positives = 187/301 (62%)
Query: 16 FTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTI 75
F+ +L + T N+S KLG GGFG V+KG P+ IA K L+ + E QF E+ TI
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGI--SQGEKQFRTEVVTI 540
Query: 76 GRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTD-TE---VLKWEKLLDIAIGT 131
G H+NLVRL GFC + +K LVY++M NGSLD +LF + E VL W+ IA+GT
Sbjct: 541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP 191
ARG+AYLH+EC IIH DIKP NILLD++F KVADFGLAKL + + T+ RGT
Sbjct: 601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTT-MRGTR 659
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEK-G 250
GY APE++ IT K DVYS+GM+LFE++ R+N + ++ + +FP K G
Sbjct: 660 GYLAPEWI-SGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDG 718
Query: 251 ELAAKVLGCGIEEN--DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVAPPK 308
++ + V +E + D EE R VA WC+QD RP MS VV++LEG +E+ PP
Sbjct: 719 DIRSLV-DPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPF 777
Query: 309 P 309
P
Sbjct: 778 P 778
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 369 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-45 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-42 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-32 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-05 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 6e-54
Identities = 73/192 (38%), Positives = 106/192 (55%), Gaps = 7/192 (3%)
Query: 32 LGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
LG GGFG VY + G K+A KI+K + + + + EI + + H N+V+LYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
D+ LV E+ E GSL L + L +++L I + G+ YLH IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 151 IKPANILLDAK-FSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
+KP NILLD+ K+ADFGL+KL + + T GTP Y APE LL ++K
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 210 DVYSFGMLLFEI 221
D++S G++L+E+
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-51
Identities = 86/263 (32%), Positives = 124/263 (47%), Gaps = 24/263 (9%)
Query: 31 KLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQ-FMAEIGTIGRTYHINLVRLYG 88
KLG+G FG VYK + G +A KILK K + Q EI + R H N+VRL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
D+ LV E+ E G L YL L ++ IA+ RG+ YLH IIH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHS---NGIIH 121
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+KP NILLD K+ADFGLAK ++ + + GTP Y APE LL K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 209 CDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268
DV+S G++L+E++ + P + ++ +L ++LG +E ++ +
Sbjct: 180 VDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRRILGPPLEFDEPKW 226
Query: 269 AERMSM---VALWCVQDCPEARP 288
+ + C+ P RP
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-46
Identities = 79/276 (28%), Positives = 124/276 (44%), Gaps = 33/276 (11%)
Query: 31 KLGAGGFGVVYKGQ-----FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
KLG G FG VYKG+ V++A K LK +++ +F+ E + + H N+V+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
L G C ++ +V E+ME G L YL + L LL A+ ARG+ YL +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES---KN 122
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG---YRGTPGYSAPEFLLRN 202
IH D+ N L+ K++DFGL++ ++ + G R + APE L
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPESLKEG 178
Query: 203 -YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261
+ T K DV+SFG+LL+EI ++V + + G + C
Sbjct: 179 KF--TSKSDVWSFGVLLWEIF------TLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC-- 228
Query: 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297
+ + L C + PE RP S +V++L
Sbjct: 229 -------PPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 6e-46
Identities = 80/279 (28%), Positives = 119/279 (42%), Gaps = 38/279 (13%)
Query: 31 KLGAGGFGVVYKGQ-----FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
KLG G FG VYKG V++A K LK +++ +F+ E + + H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYL-FTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
L G C ++ +V E+M G L YL + L LL A+ ARG+ YL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---K 122
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYS-----APEFL 199
IH D+ N L+ K++DFGL++ Y+ G APE L
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRD------LYDDDYYKVKGGKLPIRWMAPESL 176
Query: 200 LRN-YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258
+ T K DV+SFG+LL+EI +V + +KG K
Sbjct: 177 KEGKF--TSKSDVWSFGVLLWEIF------TLGEEPYPGMSNAEVLEYLKKGYRLPKPPN 228
Query: 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297
C + + L C + PE RP S +V++L
Sbjct: 229 C---------PPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-45
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 31 KLGAGGFGVVYKG-----QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
KLG G FG VYKG K+A K LK ++ +F+ E + + H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
L G C +V E+M G L +L E L + LL +A+ A+G+ YL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---KN 122
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPI 205
+H D+ N L+ K++DFGL++ ++ + G + + APE L++
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE-SLKDGKF 181
Query: 206 TQKCDVYSFGMLLFEII 222
T K DV+SFG+LL+EI
Sbjct: 182 TSKSDVWSFGVLLWEIF 198
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 8e-45
Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G FG VY + G +A K++K K+ + + EI + + H N+VRLY
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 90 CYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
D+ K LV E+ E G L L ++ E + YLH +
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF------YLRQILSALEYLHS---K 116
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYP 204
I+H D+KP NILLD K+ADFGLA+ +P + + GTP Y APE +L
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPE-VLLGKG 172
Query: 205 ITQKCDVYSFGMLLFEII 222
+ D++S G++L+E++
Sbjct: 173 YGKAVDIWSLGVILYELL 190
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 84/292 (28%), Positives = 124/292 (42%), Gaps = 55/292 (18%)
Query: 31 KLGAGGFGVVYKGQF----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
KLG G FG VYKG+ ++A K LK ++ F+ E + + H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYL--------FTDTEVLKWEKLLDIAIGTARGIAYL 138
G C ++ LV E+ME G L YL + L + LL AI A+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYS---- 194
++ +H D+ N L+ K++DFGL++ ++ + T G
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD-----YYRKKTGGKLPIRW 173
Query: 195 -APE-FLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL------DWFPKQVWDE 246
APE + T K DV+SFG+LL+EI TL ++V +
Sbjct: 174 MAPESLKDGIF--TSKSDVWSFGVLLWEIF------------TLGATPYPGLSNEEVLEY 219
Query: 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
KG K C + + + L C Q PE RP S +V+ LE
Sbjct: 220 LRKGYRLPKPEYCP---------DELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 6e-35
Identities = 69/193 (35%), Positives = 102/193 (52%), Gaps = 8/193 (4%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLGAG FG V+ G + K+A K LK EA F+ E + + H LV+LY C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEA-FLQEAQIMKKLRHDKLVQLYAVC 70
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
++ +V E+M GSL +L + L+ +L+D+A A G+AYL + IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D+ NIL+ K+ADFGLA+L ++ + + G + ++APE T K
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYG-RFTIKS 185
Query: 210 DVYSFGMLLFEII 222
DV+SFG+LL EI+
Sbjct: 186 DVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 7e-33
Identities = 71/197 (36%), Positives = 105/197 (53%), Gaps = 12/197 (6%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLG+G FG V++G + N V++A KILK+ + + F E+ + R H +L+ L+ C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 91 YDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
++ E ME GSL +L + + +VL L+D+A A G+AYL E Q IH
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHR 128
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPE--NTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
D+ NIL+ KVADFGLA+L + + D Y+ T APE +
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAASHGT-FST 183
Query: 208 KCDVYSFGMLLFEIIGR 224
K DV+SFG+LL+E+
Sbjct: 184 KSDVWSFGILLYEMFTY 200
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 61/191 (31%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
K+G GGFG VYK + G ++A K++K +K + + + EI + + H N+V+ YG
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKL-ESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ + +V EF GSL L + + L ++ + +G+ YLH + IIH
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHR 122
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
DIK ANILL + K+ DFGL+ + ++ GTP + APE + P K
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGK-PYDYKA 178
Query: 210 DVYSFGMLLFE 220
D++S G+ E
Sbjct: 179 DIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 67/202 (33%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 31 KLGAGGFGVVYKGQFP-NGVKIAAK--ILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
LG G FG VY G +A K L + +EA EI + H N+VR Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA-LEREIRILSSLQHPNIVRYY 65
Query: 88 GFCYDQTKAAL-VY-EFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHE 140
G D+ K L ++ E++ GSL L + + K+ I G+AYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY--TRQIL----EGLAYLHS 119
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
I+H DIK ANIL+D+ K+ADFG AK T + T RGTP + APE ++
Sbjct: 120 ---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE-VI 175
Query: 201 RNYPITQKCDVYSFGMLLFEII 222
R + D++S G + E+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMA 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 71/193 (36%), Positives = 104/193 (53%), Gaps = 8/193 (4%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLGAG FG V++G + N +A K LK F+AE + + H L++LY C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ +V E M+ GSL +YL LK +L+D+A A G+AYL Q IH
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHR 127
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D+ N+L+ KVADFGLA++ E+ +++ G + ++APE L N + K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIK-EDIYEAREGAKFPIKWTAPEAALYN-RFSIKS 185
Query: 210 DVYSFGMLLFEII 222
DV+SFG+LL EI+
Sbjct: 186 DVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-31
Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 13/195 (6%)
Query: 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G GVVYK + P G A K + ++ Q + E+ T+ +V+ YG
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKW-EKLL-DIAIGTARGIAYLHEECNQRI 146
Y + + ++V E+M+ GSL L +V K E +L IA +G+ YLH + I
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT--KRHI 121
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE-FLLRNYPI 205
IH DIKP+N+L+++K K+ADFG++K ENT D + + GT Y +PE +Y
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 206 TQKCDVYSFGMLLFE 220
D++S G+ L E
Sbjct: 180 --AADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 24/271 (8%)
Query: 28 YSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
++G+G FG+V+ G + K+A K ++ E F+ E + + H LV+LY
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G C +++ LV+EFME+G L YL E LL + + G+AYL +I
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE-FLLRNYPIT 206
H D+ N L+ KV+DFG+ + ++ + S++G + +S+PE F Y +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVFSFSKY--S 179
Query: 207 QKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266
K DV+SFG+L++E+ K + S++ +V + G K R
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETINAGFRLYK---------PR 224
Query: 267 EEAERMSMVALWCVQDCPEARPPMSAVVKML 297
++ + + C ++ PE RP S ++ L
Sbjct: 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 3e-30
Identities = 72/204 (35%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEA--QFMAEIGTIGRTYH-INLVRLY 87
KLG G FG VY + + +A K+L L + + +F+ EI + H N+V+LY
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 88 GFCYDQTKAALVYEFMENGSLDKYL--FTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
F D+ LV E+++ GSL+ L L + L I + YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 146 IIHYDIKPANILLDAK-FSAKVADFGLAKLCNPENTHDS----TSGYRGTPGYSAPEFLL 200
IIH DIKP NILLD K+ DFGLAKL + S S GTPGY APE LL
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 201 RNY--PITQKCDVYSFGMLLFEII 222
+ D++S G+ L+E++
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELL 205
|
Length = 384 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY 91
LG+G FGVV+ G++ + +A K+++ E F+ E + + H NLV+LYG C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 92 DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDI 151
Q +V E+M NG L YL L E LLD+ + YL IH D+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 152 KPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDV 211
N L+ KV+DFGLA+ ++ + S+ G + ++ PE + + K DV
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDV 184
Query: 212 YSFGMLLFEII-------GRRKNAQ 229
+SFG+L++E+ R N++
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 67/191 (35%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY 91
+G G FG V G + G K+A K LK + F+AE + H NLV+L G
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKD--DSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 92 DQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
+V E+M GSL YL + V+ + L A+ G+ YL E + +H D
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127
Query: 151 IKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCD 210
+ N+L+ AKV+DFGLAK E + SG + ++APE LR + K D
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQDSG-KLPVKWTAPE-ALREKKFSTKSD 181
Query: 211 VYSFGMLLFEI 221
V+SFG+LL+EI
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 74/194 (38%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLGAG FG V+ G + K+A K LK F+AE + + H LVRLY
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
Q ++ E+MENGSL +L T + L KL+D+A A G+A++ + IH
Sbjct: 71 -TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHR 126
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY-PITQK 208
D++ ANIL+ K+ADFGLA+L +N + + G + ++APE + NY T K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI--NYGTFTIK 183
Query: 209 CDVYSFGMLLFEII 222
DV+SFG+LL EI+
Sbjct: 184 SDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 63/197 (31%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 32 LGAGGFGVVYKG--QFPNG--VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
+G G FG V +G + P + +A K LK + + F+ E +G+ H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G ++ E+MENGSLDK+L + +L+ + G A G+ YL E +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YV 128
Query: 148 HYDIKPANILLDAKFSAKVADFGLAK-LCNPENTHDSTSGYRGTPGYSAPEFL-LRNYPI 205
H D+ NIL+++ KV+DFGL++ L + E T+ T G + ++APE + R +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT-TKGGKIPIRWTAPEAIAYRKF-- 185
Query: 206 TQKCDVYSFGMLLFEII 222
T DV+SFG++++E++
Sbjct: 186 TSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 9e-29
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
++G G FG VY + +G K + + ++++ + E+ + + H N+++ Y
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 89 FCYDQTKAALVYEFMENGSLDKYL---------FTDTEVLKWEKLLDIAIGTARGIAYLH 139
++ K +V E+ + G L + + F + ++L W + + + + YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW--FVQLCLA----LKYLH 120
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFL 199
++I+H DIKP NI L + K+ DFG++K+ + +T D GTP Y +PE L
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STVDLAKTVVGTPYYLSPE-L 174
Query: 200 LRNYPITQKCDVYSFGMLLFE 220
+N P K D++S G +L+E
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 83/299 (27%), Positives = 133/299 (44%), Gaps = 52/299 (17%)
Query: 32 LGAGGFGVVYKGQF-PNG--VKI--AAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
LG+G FG VYKG + P G VKI A K+L+ + + + + E + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G C L+ + M G L Y+ + + + LL+ + A+G++YL E +R+
Sbjct: 75 LGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRL 130
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE-FLLRNYPI 205
+H D+ N+L+ K+ DFGLAKL + + G + + A E L R Y
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY-- 188
Query: 206 TQKCDVYSFGMLLFEII--GRR----KNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259
T K DV+S+G+ ++E++ G + A + + D EKGE + C
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVE------------IPDLLEKGERLPQPPIC 236
Query: 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVV----KMLEGGVEIVAPPKPFRYLY 314
I+ M +V W + E+RP ++ KM P RYL
Sbjct: 237 TID-------VYMVLVKCWMIDA--ESRPTFKELINEFSKMAR---------DPQRYLV 277
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 66/200 (33%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+LGAG GVV K P G +A K ++ +N+ ++ Q + E+ + + +V YG
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKW---EKLLDIAIGTARGIAYLHEECNQRI 146
Y+ ++ E+M+ GSLDK L EV L IA+ +G+ YLHE +I
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHE--KHKI 122
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN-YPI 205
IH D+KP+NIL++++ K+ DFG++ + + + GT Y APE + N Y +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGNDYSV 178
Query: 206 TQKCDVYSFGMLLFEI-IGR 224
K D++S G+ L E+ GR
Sbjct: 179 --KSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 67/205 (32%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 29 STKLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQ---FMAEIGTIGRTYHINLV 84
+G G FGVVYKG G +A K + L K E M EI + H N+V
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQIS--LEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKW-EKLLDIAIGTARGIAYL 138
+ G ++ E+ ENGSL + + F ++ V + ++L +G+AYL
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-------QGLAYL 115
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLA-KLCNPENTHDSTSGYRGTPGYSAPE 197
HE Q +IH DIK ANIL K+ADFG+A KL + + D S GTP + APE
Sbjct: 116 HE---QGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDAS-VVGTPYWMAPE 169
Query: 198 FLLRNYPITQKCDVYSFGMLLFEII 222
++ + D++S G + E++
Sbjct: 170 -VIEMSGASTASDIWSLGCTVIELL 193
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 28 YSTKLGAGGFGVVYKGQFPN-----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN 82
+ +LG G FG V ++ G ++A K L ++ + F EI + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 83 LVRLYGFCYDQTKAA--LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHE 140
+V+ G C + L+ E++ +GSL YL + + ++LL + +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG- 126
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYS-----A 195
+QR IH D+ NIL++++ K++DFGLAK+ D Y PG S A
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP----EDKDYYYVKEPGESPIFWYA 180
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFEI 221
PE LR + DV+SFG+ L+E+
Sbjct: 181 PE-CLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 69/194 (35%), Positives = 106/194 (54%), Gaps = 10/194 (5%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLGAG FG V+ G + N K+A K LK V+A F+ E + H LVRLY
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQA-FLEEANLMKTLQHDKLVRLYAVV 70
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ ++ E+M GSL +L +D + KL+D + A G+AY+ + IH
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY-PITQK 208
D++ AN+L+ K+ADFGLA++ +N + + G + ++APE + N+ T K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAI--NFGSFTIK 184
Query: 209 CDVYSFGMLLFEII 222
DV+SFG+LL+EI+
Sbjct: 185 SDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 31 KLGAGGFGVVYKGQFPNGVKI-AAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+LG G G V K + N I A K + T N ++ Q + E+ +V+ YG
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 90 CYD--QTKAALVYEFMENGSLDKYLFTDTEVLKW-----EK-LLDIAIGTARGIAYLHEE 141
D + + E+ E GSLD +V K EK L IA +G++YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVLKGLSYLHS- 123
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
++IIH DIKP+NILL K K+ DFG++ E + + GT Y APE ++
Sbjct: 124 --RKIIHRDIKPSNILLTRKGQVKLCDFGVSG----ELVNSLAGTFTGTSFYMAPE-RIQ 176
Query: 202 NYPITQKCDVYSFGMLLFEIIGRR 225
P + DV+S G+ L E+ R
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 30/204 (14%)
Query: 32 LGAGGFGVVYKGQFPN-GVKIAAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG V + + G A K+LK + ++ + E + R H +V+L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 89 FCY-DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYLH 139
+ + + K LV E+ G L +L K + AR + YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---------SKEGRFSEERARFYAAEIVLALEYLH 110
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAK-LCNPENTHDSTSGYRGTPGYSAPEF 198
+ II+ D+KP NILLDA K+ DFGLAK L + T+ + GTP Y APE
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELS---SEGSRTNTFCGTPEYLAPEV 164
Query: 199 LLRNYPITQKCDVYSFGMLLFEII 222
LL + D +S G+LL+E++
Sbjct: 165 LLGK-GYGKAVDWWSLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGF 89
K+G G FG VYKG ++A K ++ L ++ +F+ E I + Y H N+V+L G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQE-AEILKQYDHPNIVKLIGV 60
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
C + +V E + GSL +L L +KLL +++ A G+ YL + IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP-GYSAPEFLLRNY-PITQ 207
D+ N L+ K++DFG+++ + + G + P ++APE L NY T
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEAL--NYGRYTS 174
Query: 208 KCDVYSFGMLLFEI 221
+ DV+S+G+LL+E
Sbjct: 175 ESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 40/213 (18%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILK----------TCLNKRVEAQFMAEIGTIGRTY 79
KLG G +GVVYK + G +A K ++ T L R EI +
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL--R-------EISLLKELK 56
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLH 139
H N+V+L + + K LV+E+ + L KYL L + I RG+AY H
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN---PENTHDSTSGYRGTPGYSAP 196
RI+H D+KP NIL++ K+ADFGLA+ TH+ T Y AP
Sbjct: 116 S---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TLWYRAP 167
Query: 197 EFLL--RNY--PITQKCDVYSFGMLLFEIIGRR 225
E LL ++Y + D++S G + E+I +
Sbjct: 168 EILLGSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 65/198 (32%), Positives = 110/198 (55%), Gaps = 13/198 (6%)
Query: 32 LGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
+GAG FG V++G V +A K LK ++ F++E +G+ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G A ++ E+MENG+LDKYL +L+ + G A G+ YL + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYV 129
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLC--NPENTHDSTSGYRGTPGYSAPEFL-LRNYP 204
H D+ NIL+++ KV+DFGL+++ +PE T+ +TSG + ++APE + R +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY-TTSGGKIPIRWTAPEAIAYRKF- 187
Query: 205 ITQKCDVYSFGMLLFEII 222
T DV+SFG++++E++
Sbjct: 188 -TSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-23
Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 22/268 (8%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+LG G FGVV G++ +A K++K E +F+ E + + H LV+LYG C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
Q +V E+M NG L YL + + +LL++ G+AYL +++ IH D
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125
Query: 151 IKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCD 210
+ N L+D + KV+DFGL++ ++ + S+ G + +S PE LL + K D
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLLY-SKFSSKSD 183
Query: 211 VYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAE 270
V++FG+L++E+ K ++ + E KV +E
Sbjct: 184 VWAFGVLMWEVYS---------------LGKMPYERFNNSETVEKVSQGLRLYRPHLASE 228
Query: 271 RMSMVALWCVQDCPEARPPMSAVVKMLE 298
++ + C + E RP ++ +E
Sbjct: 229 KVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 80/270 (29%), Positives = 131/270 (48%), Gaps = 26/270 (9%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLGAG FG V+ + K+A K +K + VEA F+AE + H LV+L+
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEA-FLAEANVMKTLQHDKLVKLHAVV 70
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ ++ EFM GSL +L +D KL+D + A G+A++ + + IH
Sbjct: 71 -TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 126
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY-PITQK 208
D++ ANIL+ A K+ADFGLA++ +N + + G + ++APE + N+ T K
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAI--NFGSFTIK 183
Query: 209 CDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268
DV+SFG+LL EI+ + S+ +V E+G + C E +
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALERGYRMPRPENCPEELYN--- 234
Query: 269 AERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ + C ++ PE RP + +L+
Sbjct: 235 ------IMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-23
Identities = 64/192 (33%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+LG+G FGVV+ G++ +K+A K + E F+ E + + H LV+LYG C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
Q +V EFMENG L YL L + LL + G+ YL IH D
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRD 125
Query: 151 IKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE-FLLRNYPITQKC 209
+ N L+ + KV+DFG+ + ++ + S+SG + +S PE F Y + K
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKY--SSKS 182
Query: 210 DVYSFGMLLFEI 221
DV+SFG+L++E+
Sbjct: 183 DVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-23
Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 13/195 (6%)
Query: 32 LGAGGFGVVYKG--QFPNG--VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
LG G FG V KG +G V++A K LK + +F+ E + + H +VRL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G C + LV E G L KYL E+ L ++A A G+AYL + +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREI-PVSDLKELAHQVAMGMAYLES---KHFV 117
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENT-HDSTSGYRGTPGYSAPEFLLRNYPI- 205
H D+ N+LL + AK++DFG+++ + + +T+ R + APE + NY
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI--NYGKF 175
Query: 206 TQKCDVYSFGMLLFE 220
+ K DV+S+G+ L+E
Sbjct: 176 SSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 6e-23
Identities = 86/300 (28%), Positives = 136/300 (45%), Gaps = 34/300 (11%)
Query: 32 LGAGGFGVVYKGQF-PNG----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
LG+G FG VYKG + P G + +A KIL + +FM E + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G C T LV + M +G L Y+ + + + LL+ + A+G+ YL E +R+
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 130
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPIT 206
+H D+ N+L+ + K+ DFGLA+L + + G + + A E + T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE-CIHYRKFT 189
Query: 207 QKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP-KQVWDEYEKGELAAKVLGCGIEEND 265
+ DV+S+G+ ++E++ D P +++ D EKGE + C I+
Sbjct: 190 HQSDVWSYGVTIWELM-------TFGGKPYDGIPTREIPDLLEKGERLPQPPICTID--- 239
Query: 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVAPPK-PFRYLYSIGMDALKSP 324
M MV W + ++RP K E E + P RYL G D +K P
Sbjct: 240 ----VYMVMVKCWMID--ADSRP------KFKELAAEFSRMARDPQRYLVIQGDDRMKLP 287
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 7e-23
Identities = 82/269 (30%), Positives = 128/269 (47%), Gaps = 24/269 (8%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLG G FG V+ G + K+A K LK F+ E + + H LV+LY
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 91 YDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
++ +V E+M GSL +L + LK L+D+A A G+AY+ E N IH
Sbjct: 71 SEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMN--YIHR 126
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D++ ANIL+ K+ADFGLA+L +N + + G + ++APE L T K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG-RFTIKS 184
Query: 210 DVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEA 269
DV+SFG+LL E++ + + ++ ++V ++ E+G C I ++
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYRMPCPQDCPISLHE---- 234
Query: 270 ERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ L C + PE RP + LE
Sbjct: 235 -----LMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-23
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 9/193 (4%)
Query: 31 KLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G +G VY+G + + +A K LK VE +F+ E + H NLV+L G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 90 CYDQTKAALVYEFMENGSLDKYLF-TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
C + ++ EFM G+L YL + + + LL +A + + YL + + IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 127
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+ N L+ KVADFGL++L +T+ + +G + ++APE L N + K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYN-KFSIK 185
Query: 209 CDVYSFGMLLFEI 221
DV++FG+LL+EI
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 66/211 (31%), Positives = 94/211 (44%), Gaps = 29/211 (13%)
Query: 31 KLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMA-EIGTIGRTYHINLVRLYG 88
K+G G FG VY G +A K ++ N + +A E+ + H NLV+ YG
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 89 FCYDQTKAALVYEFME---NGSLDKYLFTDTEVLKWEKLLDIAIGTA------RGIAYLH 139
+ K VY FME G+L+ E+L+ ++LD + G+AYLH
Sbjct: 67 VEVHREK---VYIFMEYCSGGTLE-------ELLEHGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT--HDSTSGYRGTPGYSAPE 197
I+H DIKPANI LD K+ DFG A T + GTP Y APE
Sbjct: 117 S---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 198 FLLRNYPITQ--KCDVYSFGMLLFEII-GRR 225
+ D++S G ++ E+ G+R
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 32 LGAGGFGVVYKG-QFPNGVKIAAKILKTCLN----KRVEAQFMAEIGTIGRTYHINLVRL 86
LG+G FG VY+G +G A K + + + Q EI + + H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYL-----FTDTEV-LKWEKLLDIAIGTARGIAYLHE 140
G ++ + E + GSL K L F + + L ++L G+ YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------GLEYLH- 119
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
++ +H DIK ANIL+D K+ADFG+AK ++G+P + APE +
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIA 174
Query: 201 RNYPITQKCDVYSFGMLLFEI 221
+ D++S G + E+
Sbjct: 175 QQGGYGLAADIWSLGCTVLEM 195
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 11 EKPVRFTLEQLCS------FTNNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKR 63
E+ ++ L+ + S N K+G G G VYK G ++A K ++ L K+
Sbjct: 1 EEELKAALKDIVSEGDPRELYKNLE-KIGEGASGEVYKATDRATGKEVAIKKMR--LRKQ 57
Query: 64 VEAQFMAEIGTIGRTYHINLVRLYGFCY-DQTKAALVYEFMENGSLDKYLFTDTEVLKW- 121
+ + EI + H N+V Y Y + +V E+M+ GSL T+++
Sbjct: 58 NKELIINEILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSL-------TDIITQN 109
Query: 122 -EKLLDIAIG-----TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC 175
++ + I +G+ YLH +Q +IH DIK NILL S K+ADFG A
Sbjct: 110 FVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166
Query: 176 NPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
E + GTP + APE + R K D++S G++ E+
Sbjct: 167 TKE--KSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-22
Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 32 LGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
LG G FG VYK Q G+ AAKI++ + +E FM EI + H N+V LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMVEIDILSECKHPNIVGLYEAY 71
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
+ + K ++ EF + G+LD + L ++ + + +LH + ++IH D
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128
Query: 151 IKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYRGTPGYSAPEFLL----RNYPI 205
+K NILL K+ADFG+ AK + D+ + GTP + APE + ++ P
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACETFKDNPY 185
Query: 206 TQKCDVYSFGMLLFEIIGRR 225
K D++S G+ L E+
Sbjct: 186 DYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-22
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 19/202 (9%)
Query: 32 LGAGGFGVVYKGQF-PNGVK---IAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
+GAG FG V +G+ G + +A K LK+ ++ F++E +G+ H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G ++ EFMENG+LD +L + +L+ + G A G+ YL E +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYV 128
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPEFL-L 200
H D+ NIL+++ KV+DFGL++ ++T D T Y + G ++APE +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLE-DDTSDPT--YTSSLGGKIPIRWTAPEAIAY 185
Query: 201 RNYPITQKCDVYSFGMLLFEII 222
R + T DV+S+G++++E++
Sbjct: 186 RKF--TSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G +GVVYK + +I A KI ++ + + EI + H N+++L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
+ LV+EFM+ L K + L + +G+A+ H I+H
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILH 121
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPEN---THDSTSGYRGTPGYSAPEFLLRNYPI 205
D+KP N+L++ + K+ADFGLA+ TH Y T Y APE LL +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH-----YVVTRWYRAPELLLGDKGY 176
Query: 206 TQKCDVYSFGMLLFEIIGRR 225
+ D++S G + E++ RR
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G G FG V K + + KI +I + ++ + Q ++E+ + H N+VR Y
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 89 FCYDQTKAALVYEFMEN------GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLH--E 140
D++ +Y ME L + + + ++ E + I + H
Sbjct: 67 RIIDRSNQ-TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
+ ++H D+KPANI LDA + K+ DFGLAK+ + Y GTP Y +PE L
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG--HDSSFAKTYVGTPYYMSPEQLN 183
Query: 201 RNYPITQKCDVYSFGMLLFEI 221
+K D++S G L++E+
Sbjct: 184 HM-SYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 31 KLGAGGFGVVYKGQF--PNG--VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
KLG G FGVV +G++ G + +A K LK+ + F+ E + H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEK--------LLDIAIGTARGIAYL 138
YG +V E GSL + L+ + L D A+ A G+ YL
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSL-------LDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP-GYSAPE 197
+R IH D+ NILL + K+ DFGL + H + P + APE
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 198 FLLRNYPITQKCDVYSFGMLLFEI 221
LR + DV+ FG+ L+E+
Sbjct: 171 -SLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 31 KLGAGGFGVVYKG-QFPNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G FGVV+K + + A K I + +N+R + + E + + ++R Y
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTD-----TEVLKWEKLLDIAIGTARGIAYLHEECN 143
D+ K +V E+ ENG L K L E W + I +G +A+LH +
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLH---S 119
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY 203
++I+H DIK N+ LDA + K+ D G+AKL + +T GTP Y +PE L +
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE-LCEDK 176
Query: 204 PITQKCDVYSFGMLLFE 220
P +K DV++ G++L+E
Sbjct: 177 PYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 31 KLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMA---EIGTIGRTYHINLVRL 86
KLG G +G VYK G +A K++ VE EI + + +V+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV------PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
YG + T +V E+ GS+ + + L E++ I T +G+ YLH + +
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKK 120
Query: 147 IHYDIKPANILLDAKFSAKVADFGLA-KLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPI 205
IH DIK NILL+ + AK+ADFG++ +L +T + GTP + APE +
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQL---TDTMAKRNTVIGTPFWMAPEVIQEI-GY 176
Query: 206 TQKCDVYSFGMLLFEI 221
K D++S G+ E+
Sbjct: 177 NNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-21
Identities = 63/193 (32%), Positives = 102/193 (52%), Gaps = 17/193 (8%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQ-FMAEIGTIGRTYHINLVRLYGF 89
+G G FG V +G++ G K+A K +K V AQ F+ E + + +H NLVRL G
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIKC----DVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVL-KWEKLLDIAIGTARGIAYLHEECNQRIIH 148
+V E M G+L +L T L +LL ++ A G+ YL +++++H
Sbjct: 68 ILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+ NIL+ AKV+DFGLA++ +S + ++APE L++ + K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV-GSMGVDNSKLPVK----WTAPE-ALKHKKFSSK 177
Query: 209 CDVYSFGMLLFEI 221
DV+S+G+LL+E+
Sbjct: 178 SDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 43/221 (19%)
Query: 32 LGAGGFGVVYKGQF--PN---GVKIAAKILKTCLNKRVEAQFMAEIGTIGR-TYHINLVR 85
+G G F V + N +KI K K E + R H +++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK--VKYVKIEKEVLTRLNGHPGIIK 66
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFT----DTEVLKW--EKLLDIAIGTARGIAYLH 139
LY D+ V E+ NG L +Y+ D + ++ ++L + YLH
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA-------LEYLH 119
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG------------- 186
++ IIH D+KP NILLD K+ DFG AK+ +P ++ +S G
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 187 -----YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
+ GT Y +PE LL P + D+++ G ++++++
Sbjct: 177 RRFASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQML 216
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-21
Identities = 84/273 (30%), Positives = 129/273 (47%), Gaps = 32/273 (11%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLG G FG V+ G + K+A K LK + F+ E + + H LV LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 91 YDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
++ +V EFM GSL +L D + LK +L+D+A A G+AY+ E N IH
Sbjct: 71 SEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI-ERMN--YIHR 126
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D++ ANIL+ K+ADFGLA+L +N + + G + ++APE L T K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGR-FTIKS 184
Query: 210 DVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP----KQVWDEYEKGELAAKVLGCGIEEND 265
DV+SFG+LL E++ + + +P ++V ++ E+G GC
Sbjct: 185 DVWSFGILLTELVTKGRVP----------YPGMVNREVLEQVERGYRMPCPQGC------ 228
Query: 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E + + C + P+ RP + LE
Sbjct: 229 ---PESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-21
Identities = 67/192 (34%), Positives = 102/192 (53%), Gaps = 9/192 (4%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLG G FG V+ G + ++A K LK F+ E + + H LV+LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
++ +V E+M GSL +L + + L+ +L+D+A A G+AY+ E N +H
Sbjct: 71 SEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHR 126
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D++ ANIL+ KVADFGLA+L +N + + G + ++APE L T K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGR-FTIKS 184
Query: 210 DVYSFGMLLFEI 221
DV+SFG+LL E+
Sbjct: 185 DVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-21
Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 32/272 (11%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY 91
LG G FG V+KG + +A K K L + ++ +F++E + + H N+V+L G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 92 DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDI 151
+ +V E + G +L + LK ++L+ A+ A G+AYL ++ IH D+
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDL 119
Query: 152 KPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP-GYSAPEFLLRNY-PITQKC 209
N L+ K++DFG+++ ++ S+SG + P ++APE L NY + +
Sbjct: 120 AARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEAL--NYGRYSSES 175
Query: 210 DVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP----KQVWDEYEKGELAAKVLGCGIEEND 265
DV+S+G+LL+E S + +P +Q ++ EKG + C
Sbjct: 176 DVWSYGILLWETF----------SLGVCPYPGMTNQQAREQVEKGYRMSCPQKC------ 219
Query: 266 REEAERMSMVALWCVQDCPEARPPMSAVVKML 297
+ + V C PE RP S + K L
Sbjct: 220 ---PDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 80/304 (26%), Positives = 133/304 (43%), Gaps = 42/304 (13%)
Query: 32 LGAGGFGVVYKGQF-PNG----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
LG+G FG VYKG + P G + +A K L+ + + + + E + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G C T L+ + M G L Y+ + + + LL+ + A+G+ YL E +R+
Sbjct: 75 LGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRL 130
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL-RNYPI 205
+H D+ N+L+ K+ DFGLAKL + G + + A E +L R Y
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY-- 188
Query: 206 TQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP-KQVWDEYEKGELAAKVLGCGIEEN 264
T + DV+S+G+ ++E++ S D P ++ EKGE + C I+
Sbjct: 189 THQSDVWSYGVTVWELM-------TFGSKPYDGIPASEISSILEKGERLPQPPICTID-- 239
Query: 265 DREEAERMSMVALWCVQDCPEARPPMSAVV----KMLEGGVEIVAPPKPFRYLYSIGMDA 320
M MV W + ++RP ++ KM P RYL G +
Sbjct: 240 -----VYMIMVKCWMID--ADSRPKFRELIIEFSKMAR---------DPQRYLVIQGDER 283
Query: 321 LKSP 324
+ P
Sbjct: 284 MHLP 287
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G + VYKG+ G +A K + + + + EI + H N+VRL+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTE--VLKWEKLLDIAIGTARGIAYLHEECNQRII 147
+ + K LV+E+M+ L KY+ T L + +GIA+ HE R++
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVL 122
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCN-PENTHDS---TSGYRGTPGYSAPEFLLRNY 203
H D+KP N+L++ + K+ADFGLA+ P NT + T YR AP+ LL +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYR------APDVLLGSR 176
Query: 204 PITQKCDVYSFGMLLFEII 222
+ D++S G ++ E+I
Sbjct: 177 TYSTSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 4e-20
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 34/206 (16%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKT-------CLNKRVEAQFMAEIGTIGRTYHIN 82
+LG G FG VY + G +A K +K C+N R E + + ++ H N
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKL-----NEHPN 59
Query: 83 LVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC 142
+V+L + + V+E+ME + + I +G+A++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAK---LCNPENTHDSTSGYRGTPGYSAPEFL 199
H D+KP N+L+ K+ADFGLA+ P + ST YR APE L
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYR------APEIL 170
Query: 200 LR----NYPITQKCDVYSFGMLLFEI 221
LR + P+ D+++ G ++ E+
Sbjct: 171 LRSTSYSSPV----DIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-20
Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 36/281 (12%)
Query: 32 LGAGGFGVVYKGQFPN-GVKIAA--KILKTCLNKRVEAQ--------FMAEIGTIGRT-Y 79
LG+G FG VYK + N G + A +I + + ++E+ I
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTE---VLKWEKLLDIAIGTARGIA 136
H N+VR Y + + +V + +E L ++ + E E++ +I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAP 196
YLH+E +RI+H D+ P NI+L + DFGLAK PE+ S GT YS P
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GTILYSCP 182
Query: 197 EFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256
E +++N P +K DV++FG +L+++ S++ L K V YE
Sbjct: 183 E-IVKNEPYGEKADVWAFGCILYQMC--TLQPPFYSTNMLSLATKIVEAVYEP------- 232
Query: 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297
+ +E ++ V C+ EARP + V M+
Sbjct: 233 ------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 65/206 (31%), Positives = 93/206 (45%), Gaps = 30/206 (14%)
Query: 33 GAGGFGVVYKGQF-PNGVKIAAKIL--KTCLNKRVEAQFMAEIGTIGRTYHINLVRL-YG 88
G G FG V Q A K + + C+ K + E + H LV L Y
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
F D+ LV + + G L +L F++ +V W + +I + + YLH
Sbjct: 69 FQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW--ICEIVLA----LEYLHS--- 118
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR-- 201
+ IIH DIKP NILLD + + DF +A P+ STS GTPGY APE L R
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQG 175
Query: 202 -NYPITQKCDVYSFGMLLFE-IIGRR 225
+ + D +S G+ +E + G+R
Sbjct: 176 YSVAV----DWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-20
Identities = 59/193 (30%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
++G G FG V+ G+ + +A K + L ++A+F+ E + + H N+VRL G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
C + +V E ++ G +L T+ LK ++L+ + A G+ YL + IH
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP-GYSAPEFLLRNY-PITQ 207
D+ N L+ K K++DFG+++ + + ST G + P ++APE L NY +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEAL--NYGRYSS 175
Query: 208 KCDVYSFGMLLFE 220
+ DV+SFG+LL+E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-20
Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 33/272 (12%)
Query: 32 LGAGGFGVVYKGQF-PNG----VKIAAKILKTCLNKRVEAQFMAE---IGTIGRTYHINL 83
LG+G FG VYKG + P+G + +A K+L+ + + + + E + +G Y +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY---V 71
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
RL G C T LV + M G L Y+ + + + + LL+ + A+G++YL E
Sbjct: 72 CRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE--- 127
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY 203
R++H D+ N+L+ + K+ DFGLA+L + + T G + + A E +L
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR- 186
Query: 204 PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP-KQVWDEYEKGELAAKVLGCGIE 262
T + DV+S+G+ ++E++ + D P +++ D EKGE + C I+
Sbjct: 187 RFTHQSDVWSYGVTVWELM-------TFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239
Query: 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVV 294
M MV W + E RP +V
Sbjct: 240 -------VYMIMVKCWMID--SECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-19
Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 10/197 (5%)
Query: 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
++LGAG GVV K Q P+G+ +A K++ + + Q + E+ + +V YG
Sbjct: 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
Y + ++ E M+ GSLD+ L + + + E L ++I RG+AYL E+ +I+H
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMH 127
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+KP+NIL++++ K+ DFG++ + + + GT Y +PE L + Q
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 209 CDVYSFGMLLFEI-IGR 224
D++S G+ L E+ IGR
Sbjct: 184 -DIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 66/192 (34%), Positives = 97/192 (50%), Gaps = 15/192 (7%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY 91
+G G FG V G + G K+A K +K N F+AE + + H NLV+L G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 92 DQTKAA-LVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
++ +V E+M GSL YL + VL + LL ++ + YL E N +H
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EANN-FVHR 126
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D+ N+L+ AKV+DFGL K +T D+ + ++APE LR + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTG---KLPVKWTAPE-ALREKKFSTKS 180
Query: 210 DVYSFGMLLFEI 221
DV+SFG+LL+EI
Sbjct: 181 DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 65/220 (29%), Positives = 96/220 (43%), Gaps = 51/220 (23%)
Query: 31 KLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRV----------EAQFMAEIGTIGRTY 79
KLG G + VVYK + G +A K +K K E + + E+
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL------K 60
Query: 80 HINLVRLYG-FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIG-------- 130
H N++ L F + LV+EFME TD E + +K + +
Sbjct: 61 HPNIIGLLDVFGHKSN-INLVFEFME---------TDLEKVIKDKSIVLTPADIKSYMLM 110
Query: 131 TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC-NPEN--THDSTSGY 187
T RG+ YLH + I+H D+KP N+L+ + K+ADFGLA+ +P TH
Sbjct: 111 TLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--- 164
Query: 188 RGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
T Y APE L R+Y D++S G + E++ R
Sbjct: 165 --TRWYRAPELLFGARHY--GVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-19
Identities = 59/198 (29%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 32 LGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
+GAG FG V G+ + +A K LK ++ F++E +G+ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G +V E+MENGSLD +L +L+ + G A G+ YL + +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYV 128
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLC--NPENTHDSTSGYRGTPGYSAPEFL-LRNYP 204
H D+ NIL+++ KV+DFGL+++ +PE + +T G + ++APE + R +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIRWTAPEAIAYRKF- 186
Query: 205 ITQKCDVYSFGMLLFEII 222
T DV+S+G++++E++
Sbjct: 187 -TSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 48/273 (17%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
++G+G G VYK P G A K++ V Q EI + H N+V+ +
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 90 CYDQT-KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
+D + ++ EFM+ GSL+ T + + L D+A GIAYLH + I+H
Sbjct: 141 -FDHNGEIQVLLEFMDGGSLE-----GTHIADEQFLADVARQILSGIAYLHR---RHIVH 191
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
DIKP+N+L+++ + K+ADFG++++ T D + GT Y +PE + N +
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSPERI--NTDLNHG 247
Query: 209 C------DVYSFGMLLFEI-IGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261
D++S G+ + E +GR FP V +G+ A+ L C I
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR--------------FPFGVG---RQGDWAS--LMCAI 288
Query: 262 EENDREEA------ERMSMVALWCVQDCPEARP 288
+ EA E ++ C+Q P R
Sbjct: 289 CMSQPPEAPATASREFRHFISC-CLQREPAKRW 320
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+LG G FG VYK Q GV AAK++ T + +E +M EI + H N+V+L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDA 70
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
Y + ++ EF G++D + L ++ + T + YLHE +IIH
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHR 127
Query: 150 DIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYRGTPGYSAPEFLL----RNYP 204
D+K NIL K+ADFG+ AK DS + GTP + APE ++ ++ P
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS---FIGTPYWMAPEVVMCETSKDRP 184
Query: 205 ITQKCDVYSFGMLLFEI 221
K DV+S G+ L E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+LG G FG VYK + G AAK+++T + +E +M EI + H +V+L G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYMVEIEILATCNHPYIVKLLGA 77
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
Y K ++ EF G++D + L ++ I + YLH + +IIH
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHR 134
Query: 150 DIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYRGTPGYSAPEFL----LRNYP 204
D+K N+LL K+ADFG+ AK DS + GTP + APE + +++ P
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS---FIGTPYWMAPEVVMCETMKDTP 191
Query: 205 ITQKCDVYSFGMLLFEI 221
K D++S G+ L E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-19
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 32 LGAGGFGVVYKGQFPN-------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
LG+G FG VY+G + +++A K L+ + + +F+ E + H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEKLLDIAIGTARGIAYL 138
+L G C ++ E ME G L YL +L ++LLDI + A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 139 HEECNQRIIHYDIKPANILL-----DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP-G 192
+ IH D+ N L+ DA K+ DFGLA+ ++ + G P
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY-KSDYYRKEGEGLLPVR 178
Query: 193 YSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
+ APE LL T + DV+SFG+L++EI+
Sbjct: 179 WMAPESLLDGK-FTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 41/218 (18%)
Query: 32 LGAGGFGVVYKGQFPNGVK------IAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G FG V+ G+ + +A K LK + F E + H N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFT-------------DTEVLKWEKLLDIAIGTA 132
YG C + +V+E+ME+G L+K+L + L +LL IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD--STSGYR-- 188
G+ YL +Q +H D+ N L+ K+ DFG+++ D +T YR
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVYTTDYYRVG 181
Query: 189 GTP----GYSAPEFLL-RNYPITQKCDVYSFGMLLFEI 221
G + PE ++ R + T + DV+SFG++L+EI
Sbjct: 182 GHTMLPIRWMPPESIMYRKF--TTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-19
Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 32 LGAGGFGVVYKGQF----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRL 86
+G G FG VY G + A K L + QF+ E G I + + H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKE-GIIMKDFSHPNVLSL 61
Query: 87 YGFCYDQTKAALV-YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
G C + LV +M++G L ++ ++T + L+ + A+G+ YL +++
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKK 118
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAK-LCNPE--NTHDSTSGYRGTPGYSAPEFLLRN 202
+H D+ N +LD F+ KVADFGLA+ + + E + H+ T G + + A E L+
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT-GAKLPVKWMALES-LQT 176
Query: 203 YPITQKCDVYSFGMLLFEIIGR 224
T K DV+SFG+LL+E++ R
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTR 198
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
KLG G +G VYK + + A K + ++++ + EI + H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEV---LKWEKLLDIAIGTARGIAYLHEECNQR 145
D K +V E+ G L K + + + +++ I I RG+ LHE Q+
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QK 123
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPI 205
I+H D+K ANILL A K+ D G++K+ GTP Y APE + + P
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPE-VWKGRPY 178
Query: 206 TQKCDVYSFGMLLFEI 221
+ K D++S G LL+E+
Sbjct: 179 SYKSDIWSLGCLLYEM 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 80/302 (26%), Positives = 130/302 (43%), Gaps = 54/302 (17%)
Query: 16 FTLEQLCSFTNNYSTKLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGT 74
T+ + S + + G G YKG+ NG++ K + V + +EI
Sbjct: 683 ITINDILSSLKEENV-ISRGKKGASYKGKSIKNGMQFVVKEIN-----DVNSIPSSEIAD 736
Query: 75 IGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARG 134
+G+ H N+V+L G C + A L++E++E +L + L L WE+ IAIG A+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKA 792
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYS 194
+ +LH C+ ++ ++ P I++D K + L L + +S Y
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYV 845
Query: 195 APEFLLRNYPITQKCDVYSFGMLLFEII-GR-----------------RKNAQDCSSDTL 236
APE IT+K D+Y FG++L E++ G+ R DC D
Sbjct: 846 APETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM- 903
Query: 237 DWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296
W D +G+++ N E E M++ AL C P ARP + V+K
Sbjct: 904 -WI-----DPSIRGDVSV---------NQNEIVEVMNL-ALHCTATDPTARPCANDVLKT 947
Query: 297 LE 298
LE
Sbjct: 948 LE 949
|
Length = 968 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 62/202 (30%), Positives = 107/202 (52%), Gaps = 22/202 (10%)
Query: 32 LGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH-INLVRLYGF 89
+G G FG V K G +A K +++ ++++ + + + ++ + R+ +V+ YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKW---EKLL-DIAIGTARGIAYLHEECNQR 145
+ + + E M+ SLDK+ EVLK E++L IA+ T + + YL EE
Sbjct: 72 LFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK-- 128
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLA-KLCNP-ENTHDSTSGYRGTPGYSAPEFLLRN- 202
IIH D+KP+NILLD + K+ DFG++ +L + T D+ G Y APE + +
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA-----GCRPYMAPERIDPSA 183
Query: 203 ---YPITQKCDVYSFGMLLFEI 221
Y + + DV+S G+ L+E+
Sbjct: 184 RDGYDV--RSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 68/217 (31%), Positives = 95/217 (43%), Gaps = 43/217 (19%)
Query: 32 LGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G FG VY+G + +++A K L +++ E+ F+ E + + H N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEKLLDIAIGTARGIAYLH 139
L G +++ ++ E M G L +L L + LL A A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 140 EECNQRIIHYDIKPANILLDAKFS---AKVADFGLAKLCNPENTHD--STSGYRG----- 189
E IH DI N LL K AK+ADFG+A+ D S YR
Sbjct: 134 E---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--------DIYRASYYRKGGRAM 182
Query: 190 -----TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
P PE L T K DV+SFG+LL+EI
Sbjct: 183 LPIKWMP----PEAFLDGI-FTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 63/198 (31%), Positives = 91/198 (45%), Gaps = 19/198 (9%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
++G+G +G VYK + G +A K++K E EI + H N+V +G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIVAYFGS 68
Query: 90 CYDQTKAALVYEFMENGSL-DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
+ K +V E+ GSL D Y T L ++ + T +G+AYLHE IH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYLHE---TGKIH 124
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR----GTPGYSAPEFLL--RN 202
DIK ANILL K+ADFG++ +T R GTP + APE R
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 203 YPITQKCDVYSFGMLLFE 220
KCD+++ G+ E
Sbjct: 179 GGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 30 TKLGAGGFGVVYKG---QFPNGV---KIAAKILKTCLNKR------VEAQFMAEIGTIGR 77
+LG G FG+VY+G G ++A K + + R EA M E
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF----N 67
Query: 78 TYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFT---DTE------VLKWEKLLDIA 128
+H+ VRL G +V E M G L YL + + E +K + +A
Sbjct: 68 CHHV--VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 129 IGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188
A G+AYL ++ +H D+ N ++ + K+ DFG+ + + +
Sbjct: 126 AEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
+ APE L++ T K DV+SFG++L+E+
Sbjct: 183 LPVRWMAPE-SLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 29/264 (10%)
Query: 32 LGAGGFGVVYKGQF-PNG--VKIAAKILKTCLNKRVEAQFMA---EIGTIGRTYHINLVR 85
LG+G FG V+KG + P G +KI I KT ++ F + +G H +VR
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAI-KTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
L G C LV + GSL ++ + L ++LL+ + A+G+ YL E R
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HR 129
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE-FLLRNYP 204
++H ++ NILL + ++ADFG+A L P++ S ++ + A E L Y
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY- 188
Query: 205 ITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264
T + DV+S+G+ ++E++ A+ + P +V D EKGE A+ C I+
Sbjct: 189 -THQSDVWSYGVTVWEMMSY--GAEPYAG----MRPHEVPDLLEKGERLAQPQICTID-- 239
Query: 265 DREEAERMSMVALWCVQDCPEARP 288
M MV W + + RP
Sbjct: 240 -----VYMVMVKCWMIDE--NVRP 256
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 62/269 (23%), Positives = 112/269 (41%), Gaps = 25/269 (9%)
Query: 32 LGAGGFG--VVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
LG G FG +Y+ + + + ++ T L+++ + EI + H N++ Y
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 90 CYDQTKAALVYEFMENGSL-DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
D + E+ G+L DK + ++ + E +L ++Y+H+ I+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILH 124
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
DIK NI L K+ DFG++K+ E + T GTP Y +PE L + K
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPE-LCQGVKYNFK 181
Query: 209 CDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268
D+++ G +L+E++ TL K+ +D L K++
Sbjct: 182 SDIWALGCVLYELL------------TL----KRTFDATNPLNLVVKIVQGNYTPVVSVY 225
Query: 269 AERMSMVALWCVQDCPEARPPMSAVVKML 297
+ + + +Q PE RP V+
Sbjct: 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQF----MAEIGTIGRTYHINLVRL 86
++G G +G VYK + ++ A LK + + F + EI + + H N+VRL
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVA--LKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 87 YGFCYDQTKAA--LVYEFME---NGSLD--KYLFTDTEVLKWEKLLDIAIGTARGIAYLH 139
+ K + +V+E+M+ G LD + FT++++ + K L G+ YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL------LEGLQYLH 117
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG-----YRGTPGYS 194
+ I+H DIK +NIL++ K+ADFGLA+ N+ D T+ YR
Sbjct: 118 ---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR------ 168
Query: 195 APEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
PE LL Y + D++S G +L E+ +
Sbjct: 169 PPELLLGATRY--GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 31 KLGAGGFGVVYK-GQFPNGVKIAAKILKTCLNKR---VEAQFMAEIGTIGRTYHINLVRL 86
++G G G+V+K G +A K K L + + Q + EI + H +V+L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALK--KVALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEKLLDIAIGTARGIAYLHE 140
+ LV E+M L + L + +V + ++L +G+AY+H
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML------LKGVAYMHA 117
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
I+H D+KPAN+L+ A K+ADFGLA+L + E S T Y APE L
Sbjct: 118 N---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE-EPRLYSHQVATRWYRAPELLY 173
Query: 201 --RNYPITQKCDVYSFGMLLFEIIG 223
R Y D+++ G + E++
Sbjct: 174 GARKY--DPGVDLWAVGCIFAELLN 196
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 78/285 (27%), Positives = 137/285 (48%), Gaps = 36/285 (12%)
Query: 30 TKLGAGGFGVVYK-GQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
++LGAG GVV+K P+G+ +A K++ + + Q + E+ + +V YG
Sbjct: 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLL-DIAIGTARGIAYLHEECNQRII 147
Y + ++ E M+ GSLD+ L + E++L ++I +G+ YL E+ +I+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLREK--HKIM 126
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
H D+KP+NIL++++ K+ DFG++ + + + GT Y +PE L + Q
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 208 KCDVYSFGMLLFEI-IGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN-- 264
D++S G+ L E+ IGR +P D E + GC +E +
Sbjct: 183 S-DIWSMGLSLVEMAIGR--------------YPIPPPDAKE----LELMFGCPVEGDPA 223
Query: 265 DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVAPPKP 309
+ E + R P++RPPM A+ ++L+ IV P P
Sbjct: 224 ESETSPRPRPPGRPLSSYGPDSRPPM-AIFELLD---YIVNEPPP 264
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 73/236 (30%), Positives = 99/236 (41%), Gaps = 47/236 (19%)
Query: 22 CSFTNNY--STKLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQF----MAEIGT 74
CS +Y KLG G FG VYK Q G +A LK L + F + EI
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVA---LKKILMHNEKDGFPITALREIKI 60
Query: 75 IGRTYHINLVRLYGFCYDQTKAA--------LVYEFME---NGSLDKYLFTDTEV---LK 120
+ + H N+V L ++ + +V +M+ +G L+ TE
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL---CNP 177
+LL+ GI YLHE I+H DIK ANIL+D + K+ADFGLA+ P
Sbjct: 121 MLQLLE-------GINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 178 ENTHDSTSGYRG------TPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
G R T Y PE LL R Y T D++ G + E+ RR
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY--TTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 7e-18
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 32 LGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGT---IGRTYHIN 82
LG G FG V K + +A K+LK ++ + ++E+ IG+ H N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 83 LVRLYGFCYDQTKAALVYEFMENGSLDKYL---------------FTDTEVLKWEKLLDI 127
++ L G C + +V E+ +G+L +L E L + L+
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 128 AIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187
A ARG+ +L +++ IH D+ N+L+ K+ADFGLA+ + + + T+
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
R + APE L Q DV+SFG+LL+EI
Sbjct: 195 RLPVKWMAPEALFDRVYTHQS-DVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 8e-18
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 28 YSTKLGAGGFGVVYKGQF--PNGVK----IAAKILKTCLNKRVEAQFMAEIGTIGRTYHI 81
+ +LG G FG VYKG+ PN +A K LK +V+ +F E + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYLF------------TDTEV---LKWEKLLD 126
N+V L G C + +++E++ +G L ++L D V L L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 127 IAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186
IAI A G+ YL + +H D+ N L+ + K++DFGL++ + D
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI---YSAD---- 178
Query: 187 YRGTPGYS-------APEFLLRNYPITQKCDVYSFGMLLFEI 221
Y S PE +L T + D++SFG++L+EI
Sbjct: 179 YYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 8e-18
Identities = 76/281 (27%), Positives = 122/281 (43%), Gaps = 42/281 (14%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQ-----FMAEIGTIGRTYHINLVR 85
LG G F Y+ + G +A K + N E + EI + R H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 86 LYGFCYDQTKAALVYEFMENGS----LDKY-LFTDTEVLKW-EKLLDIAIGTARGIAYLH 139
+ G + + L E+M GS L KY F + ++ + E+LL RG++YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL-------RGLSYLH 120
Query: 140 EECNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPENTH-DSTSG-YRGTPGYSAP 196
E +IIH D+K AN+L+D+ ++ADFG A + T G GT + AP
Sbjct: 121 E---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 197 EFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256
E +LR + CDV+S G ++ E+ ++ W ++ + L K+
Sbjct: 178 E-VLRGEQYGRSCDVWSVGCVIIEM----------ATAKPPWNAEKHSNHL---ALIFKI 223
Query: 257 LGCGIEENDREEAERMSM--VALWCVQDCPEARPPMSAVVK 295
E + V L C++ PE RPP ++K
Sbjct: 224 -ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 9e-18
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 31 KLGAGGFGVVYKGQ--FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G +GVVYK + N KI ++ V + + EI + H N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAI-GTARGIAYLHEECNQRII 147
+ + + LV+E+++ L K++ + + K +L+ + RGIAY H + R++
Sbjct: 69 VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVL 124
Query: 148 HYDIKPANILLDAKFSA-KVADFGLAKLCN-PEN--THDSTSGYRGTPGYSAPEFLLRNY 203
H D+KP N+L+D + +A K+ADFGLA+ P TH+ T Y APE LL +
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-----TLWYRAPEILLGSR 179
Query: 204 PITQKCDVYSFGMLLFEIIGRR 225
+ D++S G + E++ ++
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 9e-18
Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G +GVVYK + ++ A KI + V + + EI + H N+V+L
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-FTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
+ + K LV+EF+ + L K++ + + + +G+A+ H + R++
Sbjct: 67 VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVL 122
Query: 148 HYDIKPANILLDAKFSAKVADFGLAK---LCNPENTHDSTSGYRGTPGYSAPEFLLRNYP 204
H D+KP N+L++ + + K+ADFGLA+ + TH+ T Y APE LL
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEILLGCKY 177
Query: 205 ITQKCDVYSFGMLLFEIIGRR 225
+ D++S G + E++ RR
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 28 YSTKLGAGGFGVVYKGQFPNGVKI-AAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
Y LG G G VYK +I A K++ + ++ Q M+E+ + + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
YG + + + ++ EFM+ GSLD Y VL IA+ +G+ YL + +I
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKI 116
Query: 147 IHYDIKPANILLDAKFSAKVADFGLA-KLCNPENTHDSTSGYRGTPGYSAPEFLL-RNYP 204
+H D+KP+N+L++ + K+ DFG++ +L N Y GT Y APE + Y
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-----SIAKTYVGTNAYMAPERISGEQYG 171
Query: 205 ITQKCDVYSFGMLLFEI-IGR 224
I DV+S G+ E+ +GR
Sbjct: 172 IHS--DVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 64/212 (30%), Positives = 92/212 (43%), Gaps = 38/212 (17%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKI--LKTCL----NKRVEAQFMAEIGTIGRTYHINL 83
+G G VVY PN K+A K L+ C R E Q M++ H N+
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC------NHPNV 61
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKW---EKLLDIAI------GTARG 134
V+ Y + LV ++ GSL +++K LD AI +G
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSL-------LDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR----GT 190
+ YLH IH DIK NILL S K+ADFG++ + + D T R GT
Sbjct: 115 LEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVS--ASLADGGDRTRKVRKTFVGT 169
Query: 191 PGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
P + APE + + + K D++SFG+ E+
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G +GVVYKG+ +I A KI + V + + EI + H N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFT-------DTEVLKWEKLLDIAIGTARGIAYLHEE 141
+++ L++EF+ L KYL + D E++K L I +GI + H
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVK-SYLYQIL----QGILFCHS- 119
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN-PEN--THDSTSGYRGTPGYSAPEF 198
+R++H D+KP N+L+D K K+ADFGLA+ P TH+ T Y APE
Sbjct: 120 --RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWYRAPEV 172
Query: 199 LLRNYPITQKCDVYSFGMLLFEIIGRR 225
LL + + D++S G + E+ ++
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 31 KLGAGGFGVVYKGQF--PNGVKI--AAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+G G FG VY+G + P KI A K K C + V +F+ E + + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G + +V E G L YL + L L+ + + +AYL ++R
Sbjct: 73 IGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRF 128
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY-PI 205
+H DI N+L+ + K+ DFGL++ E+ + ++ G + + APE + N+
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-KLPIKWMAPESI--NFRRF 185
Query: 206 TQKCDVYSFGMLLFEII 222
T DV+ FG+ ++EI+
Sbjct: 186 TSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAA-KILKTCLNKRVEAQFMA-EIGT---IGRTYHINLVRL 86
+G G +G VYK + N + A K ++ L++ EI + H N+VRL
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 87 YGFCY-----DQTKAALVYEFMENGSLDKYLFTDTE-VLKWEKLLDIAIGTARGIAYLHE 140
C+ + K LV+E ++ L YL + L E + D+ RG+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH- 124
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS---TSGYRGTPGYSAPE 197
+ RI+H D+KP NIL+ + K+ADFGLA++ + E S T YR APE
Sbjct: 125 --SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR------APE 176
Query: 198 FLLRNYPITQKCDVYSFGMLLFEIIGRR 225
LL++ T D++S G + E+ RR
Sbjct: 177 VLLQSSYAT-PVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 71/298 (23%), Positives = 124/298 (41%), Gaps = 48/298 (16%)
Query: 30 TKLGAGGFGVVYKGQ------FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL 83
LG G FG V K +A K+LK + ++E + + H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYL-----------------------FTDTEVLK 120
++LYG C L+ E+ + GSL +L D L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
L+ A +RG+ YL E +++H D+ N+L+ K++DFGL++ E++
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240
+ S R + A E L ++ T + DV+SFG+LL+EI+ N + P
Sbjct: 183 YVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA------P 235
Query: 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+++++ + G + C +E M + L C + P+ RP + + K LE
Sbjct: 236 ERLFNLLKTGYRMERPENC---------SEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 24/204 (11%)
Query: 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+LGAG GVV K P+G+ +A K++ + + Q + E+ + +V YG
Sbjct: 7 GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKW-----EKLL-DIAIGTARGIAYLHEEC 142
Y + ++ E M+ GSLD+ VLK E +L I+I RG+ YL E+
Sbjct: 67 AFYSDGEISICMEHMDGGSLDQ-------VLKKAGRIPENILGKISIAVLRGLTYLREK- 118
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS-TSGYRGTPGYSAPEFLLR 201
+I+H D+KP+NIL++++ K+ DFG++ DS + + GT Y +PE L
Sbjct: 119 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLIDSMANSFVGTRSYMSPERLQG 172
Query: 202 NYPITQKCDVYSFGMLLFEI-IGR 224
+ T + D++S G+ L E+ IGR
Sbjct: 173 TH-YTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 32 LGAGGFGVVYKGQF--PNGV--KIAAKILKTCLNKRVEAQ-FMAEIGTIGRTYHINLVRL 86
LG G FG V +GQ +G K+A K +K ++ E + F++E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 87 YGFCYDQT------KAALVYEFMENGSLDKYLF-----TDTEVLKWEKLLDIAIGTARGI 135
G C++ + K ++ FM++G L +L E L + LL + A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSA 195
YL N+ IH D+ N +L + VADFGL+K + + + + A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFEIIGR 224
E L T K DV++FG+ ++EI R
Sbjct: 184 IESLADRV-YTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 32 LGAGGFGVVYKG-QFPNGVKIAAKILKTC-----LNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G FG VY G ++A K + K V A EI + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNA-LECEIQLLKNLQHERIVQ 68
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHE 140
YG D ++ E+M GS+ L T+T K+ + + G+ YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLH- 121
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR---GTPGYSAPE 197
+ I+H DIK ANIL D+ + K+ DFG +K + S +G + GTP + +PE
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASK--RLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 198 FLL-RNYPITQKCDVYSFGMLLFEII 222
+ Y +K DV+S G + E++
Sbjct: 178 VISGEGY--GRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-17
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAAK--ILKTCLNKRVEAQF---MAEIGTIGRTYHINLVRL 86
LG G +G VY G G IA K L T E ++ E+ + H+N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEK-LLDIAIGTARGIAYLHE 140
G C D ++ EF+ GS+ L + K+ K +LD G+AYLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-------GVAYLHN 120
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS----GYRGTPGYSAP 196
C ++H DIK N++L K+ DFG A+ H + S GTP + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 197 EFLLRNYPITQKCDVYSFGMLLFEI 221
E ++ +K D++S G +FE+
Sbjct: 178 E-VINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 5e-17
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 38/209 (18%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G G +G+V K + +I A K L++ +K V+ M EI + + H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 89 FCYDQTKAALVYEFMENGSLD---------------KYLFTDTEVLKWEKLLDIAIGTAR 133
+ + LV+EF+++ LD KYLF ++L R
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF---QIL-------------R 111
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
GI + H + IIH DIKP NIL+ K+ DFG A+ + + Y T Y
Sbjct: 112 GIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWY 166
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEII 222
APE L+ + + D+++ G L+ E++
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 5e-17
Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 33/210 (15%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G +GVVYK + +I A KI ++ V + + EI + H N+VRL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFT------DTEVLKWEKLLDIAIGTARGIAYLHEEC 142
+ + K LV+EF+ + L KY+ + D ++K L + +GIAY H
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIK--SYLYQLL---QGIAYCH--- 116
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN-P--ENTHDSTSGYRGTPGYSAPEFL 199
+ R++H D+KP N+L+D + + K+ADFGLA+ P TH+ T Y APE L
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEIL 171
Query: 200 L--RNY--PITQKCDVYSFGMLLFEIIGRR 225
L R Y P+ D++S G + E++ RR
Sbjct: 172 LGSRQYSTPV----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 67/206 (32%), Positives = 93/206 (45%), Gaps = 36/206 (17%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAA-KILKTCLNKRVEAQFMAEIGTIGRTY--HINLVRLYG 88
+G G +G VYK + ++ A KI+ ++ E + E + R Y H N+ YG
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK--EEYNIL-RKYSNHPNIATFYG 70
Query: 89 FCYDQTKAA-------LVYEFMENGS---LDKYLFTDTEVLKWEKLLDIAIGTARGIAYL 138
+ + LV E GS L K L + LK E + I T RG+AYL
Sbjct: 71 -AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL 129
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYR----GTPGY 193
HE ++IH DIK NILL K+ DFG+ A+L DST G R GTP +
Sbjct: 130 HE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-------DSTLGRRNTFIGTPYW 179
Query: 194 SAPEFLL----RNYPITQKCDVYSFG 215
APE + + + DV+S G
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 5e-17
Identities = 67/205 (32%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 32 LGAGGFGVVYKGQF-PN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
LG G FG V + P G +A K LK ++ + + EI + YH N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 87 YGFCYDQTKAA--LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
G C +Q L+ E++ GSL YL L +LL A G+AYLH +Q
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEF-----L 199
IH D+ N+LLD K+ DFGLAK PE H+ YR +P F
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEG-HEY---YRVREDGDSPVFWYAVEC 181
Query: 200 LRNYPITQKCDVYSFGMLLFEIIGR 224
L+ + DV+SFG+ L+E++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 8e-17
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 28 YSTKLGAGGFGVVYKGQFP-----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN 82
+ +LG G FG V ++ G +A K L+ + + F EI + H N
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-DFEREIEILKSLQHDN 66
Query: 83 LVRLYGFCYDQTKAA--LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHE 140
+V+ G CY + LV E++ GSL YL E L KLL A +G+ YL
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL--CNPENTHDSTSGYRGT-PGYS--- 194
+R +H D+ NIL++++ K+ DFGL K+ + E Y+ PG S
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY-------YKVREPGESPIF 176
Query: 195 --APEFLLRNYPITQKCDVYSFGMLLFEI 221
APE L + + DV+SFG++L+E+
Sbjct: 177 WYAPESLTES-KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 30 TKLGAGGFGVVYKG--QFPNGVK-IAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVR 85
+LG+G FG V KG + K +A KILK N ++ + + E + + + +VR
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
+ G C + LV E E G L+K+L + V + + ++ + G+ YL EE N
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQKNKHV-TEKNITELVHQVSMGMKYL-EETN-- 115
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAK-LCNPENTHDSTSGYRGTPGYSAPEFLLRNYP 204
+H D+ N+LL + AK++DFGL+K L EN + + + + + APE + Y
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE-CMNYYK 174
Query: 205 ITQKCDVYSFGMLLFE 220
+ K DV+SFG+L++E
Sbjct: 175 FSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 10/216 (4%)
Query: 26 NNYST--KLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTYHI 81
N Y +G G +GVV K + +I A K ++ ++ V+ + E+ + + H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
N+V L + + LV+E++E L+ L L + + + IAY H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCHS- 118
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
IIH DIKP NIL+ K+ DFG A+ T Y T Y APE L+
Sbjct: 119 --HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYRAPELLVG 175
Query: 202 NYPITQKCDVYSFGMLLFEII-GRRKNAQDCSSDTL 236
+ + DV++ G ++ E++ G D D L
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 1e-16
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 53/214 (24%)
Query: 32 LGAGGFGVVYKGQF-PNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG V + +G A KIL + + + E + H LV LYG
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYL------------FTDTEVLKWEKLLDIAIGTARGIA 136
D + LV E++ G L +L F +V+ +A+
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV-------LALE------ 115
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK--------LCNPENTHDSTSGYR 188
YLH + I++ D+KP N+LLD+ K+ DFG AK LC
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC------------- 159
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
GTP Y APE ++ + + D ++ G+L++E++
Sbjct: 160 GTPEYLAPE-IILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 25 TNNYS--TKLGAGGFGVVYKGQ-FPNGVKIAAKILKT--CLNKRVEAQFMAEIGTIGRTY 79
N+ K+G G F VVYK +G +A K ++ ++ + + EI + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSL---------DKYLFTDTEVLKWEKLLDIAIG 130
H N+++ + + +V E + G L K L + + W+ + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI--WKYFVQLC-- 116
Query: 131 TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGT 190
+ ++H +RI+H DIKPAN+ + A K+ D GL + + + T + GT
Sbjct: 117 --SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGT 169
Query: 191 PGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
P Y +PE + K D++S G LL+E+
Sbjct: 170 PYYMSPE-RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 13/193 (6%)
Query: 32 LGAGGFGVVYK-GQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
LGAG G V K P G +A K++ V Q + E+ + +V YG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
++ + EFM+ GSLD+ ++ + E L IA+ G+ YL+ RI+H D
Sbjct: 73 LNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRD 129
Query: 151 IKPANILLDAKFSAKVADFGLA-KLCNP-ENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
IKP+NIL++++ K+ DFG++ +L N +T + GT Y +PE ++ T K
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGELINSIADT------FVGTSTYMSPE-RIQGGKYTVK 182
Query: 209 CDVYSFGMLLFEI 221
DV+S G+ + E+
Sbjct: 183 SDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 58/225 (25%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTY--------- 79
KLG G +G+V+K ++ A KI N +AQ RT+
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQ---------RTFREIMFLQEL 63
Query: 80 --HINLVRLYGFCYDQTKAA------LVYEFMENGSLDKYLFTD-TEVLKWEKLLD---- 126
H N+V+L + KA LV+E+ME TD V++ L D
Sbjct: 64 GDHPNIVKLL----NVIKAENDKDIYLVFEYME---------TDLHAVIRANILEDVHKR 110
Query: 127 -IAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK-LCNPENTHDST 184
I + + Y+H + +IH D+KP+NILL++ K+ADFGLA+ L E ++
Sbjct: 111 YIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 185 --SGYRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
+ Y T Y APE LL Y T+ D++S G +L E++ +
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRY--TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 22/201 (10%)
Query: 31 KLGAGGFGVVY--KGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G FG +Y K + + + +I T + + + E+ + + H N+V +
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 89 FCYDQTKAALVYEFMENGSLDK-------YLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
+ + +V E+ + G L K LF++ ++L W + I++G + ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG----LKHIHD- 119
Query: 142 CNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
++I+H DIK NI L AK+ DFG+A+ N ++ + GTP Y +PE +
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPE-IC 174
Query: 201 RNYPITQKCDVYSFGMLLFEI 221
+N P K D++S G +L+E+
Sbjct: 175 QNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 8/96 (8%)
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST-SGYRGTP 191
RG+ YLH N +IH D+KP+NIL+++ K+ DFGLA+ +P+ + Y T
Sbjct: 114 RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 192 GYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
Y APE LL Y T+ D++S G + E++ R+
Sbjct: 171 WYRAPELLLSSSRY--TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 32 LGAGGFGVVYKG-------QFPN-GVKIAAKILKTCLNKRVEAQFMAEI---GTIGRTYH 80
LG G FG V + P+ V +A K+LK + A ++E+ IG+ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYL-----------FTDTEV----LKWEKLL 125
N++ L G C + ++ E+ G+L ++L F T+V L ++ L+
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 126 DIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185
A ARG+ YL ++R IH D+ N+L+ K+ADFGLA+ + + + TS
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 186 GYRGTPGYSAPEFLL-RNYPITQKCDVYSFGMLLFEI 221
R + APE L R Y T + DV+SFG+L++EI
Sbjct: 195 NGRLPVKWMAPEALFDRVY--THQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 22/187 (11%)
Query: 48 GVKIAAKILKT--CLNKRVEAQFMAEIGTIGRTYHINLVRLY--GFCYDQTKAALVYEFM 103
G ++A K+L+T + A+F E R YH N+V L G A V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61
Query: 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL---DA 160
+L + L D L + + + +A H NQ I+H D+KP NI++
Sbjct: 62 PGRTLREVLAADG-ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGV 117
Query: 161 KFSAKVADFGLAKLCNPENTHDS-------TSGYRGTPGYSAPEFLLRNYPITQKCDVYS 213
+ AKV DFG+ L D+ T+ GTP Y APE LR P+T D+Y+
Sbjct: 118 RPHAKVLDFGIGTLL--PGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYA 174
Query: 214 FGMLLFE 220
+G++ E
Sbjct: 175 WGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 32 LGAGGFGVVYKGQF-------PNGV-KIAAKILKTCLNKRVEAQFMAEI---GTIGRTYH 80
LG G FG V + PN V K+A K+LK+ ++ + ++E+ IG+ H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--H 83
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYL---------------FTDTEVLKWEKLL 125
N++ L G C ++ E+ G+L +YL E L ++ L+
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 126 DIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185
A ARG+ YL +++ IH D+ N+L+ K+ADFGLA+ + + + T+
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 186 GYRGTPGYSAPEFLL-RNYPITQKCDVYSFGMLLFEI 221
R + APE L R Y T + DV+SFG+LL+EI
Sbjct: 201 NGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 47/212 (22%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILK--------TCLNKRVEAQFMAEIGTIGRTYHI 81
+G G FG VYK +A K++ + + E QF+++ R+ +I
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ--EIQFLSQC----RSPYI 61
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTA-----RGIA 136
+ YG +K ++ E+ GS ++LK KL + I G+
Sbjct: 62 --TKYYGSFLKGSKLWIIMEYCGGGSC-------LDLLKPGKLDETYIAFILREVLLGLE 112
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA-KLCNPENTHDSTSGYRGTPGYSA 195
YLHE + IH DIK ANILL + K+ADFG++ +L +T + + GTP + A
Sbjct: 113 YLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQL---TSTMSKRNTFVGTPFWMA 166
Query: 196 PEFLLRNYPITQ-----KCDVYSFGMLLFEII 222
PE I Q K D++S G+ E+
Sbjct: 167 PEV------IKQSGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 24/202 (11%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR-TYHINLVRLYG 88
K+G G F V K Q G A K +K + + EI + R + H N++RL
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 89 FCYDQT--KAALVYEFMENGSLD-----KYLFTDTEVLKW-EKLLDIAIGTARGIAYLHE 140
+D+ + ALV+E M+ + K + V + +LL + + ++H
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLL-------KSLDHMHR 118
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
I H DIKP NIL+ K+ADFG C + + Y T Y APE LL
Sbjct: 119 ---NGIFHRDIKPENILIKDD-ILKLADFGS---CRGIYSKPPYTEYISTRWYRAPECLL 171
Query: 201 RNYPITQKCDVYSFGMLLFEII 222
+ K D+++ G + FEI+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 37/207 (17%)
Query: 32 LGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRV------EAQFMAEIGTIGRTYHINLV 84
LG GGFG V + A K C+ KR + +E + H +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALK----CVKKRHIVETGQQEHIFSEKEILEECNHPFIV 56
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIA 136
+LY D+ ++ E+ G L +T +L+ L D TAR
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGEL----WT---ILRDRGLFDEY--TARFYIACVVLAFE 107
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK-LCNPENTHDSTSGYRGTPGYSA 195
YLH N+ II+ D+KP N+LLD+ K+ DFG AK L + + T + GTP Y A
Sbjct: 108 YLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT----FCGTPEYVA 160
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFEII 222
PE +L N D +S G+LL+E++
Sbjct: 161 PEIIL-NKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 32 LGAGGFGVVYKGQFPNG---VKIAAKILKTCLNKRVEAQ-FMAEIGTIGRTYHINLVRLY 87
LG G FG V +GQ +K+A K +K + R E + F++E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 88 GFCYDQTKA------ALVYEFMENGSLDKYLF----TDTEV-LKWEKLLDIAIGTARGIA 136
G C ++ ++ FM++G L +L D L + L+ A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAP 196
YL ++ IH D+ N +L+ + VADFGL+K + + + + A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 197 EFLL-RNYPITQKCDVYSFGMLLFEIIGR 224
E L R Y T K DV+SFG+ ++EI R
Sbjct: 184 ESLADRVY--TTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 32 LGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH-INLVRLYGF 89
LG G +GVV K + P G +A K ++ +N + + + + ++ R+ V YG
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 90 CYDQTKAALVYEFMENGSLDKY---LFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
+ + + E M+ SLDK+ ++ + + L IA+ + + YLH + + +
Sbjct: 69 LFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--V 125
Query: 147 IHYDIKPANILLDAKFSAKVADFG--------LAKLCNPENTHDSTSGYRGTPGYSAPEF 198
IH D+KP+N+L++ K+ DFG +AK T D+ G Y APE
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK------TIDA-----GCKPYMAPER 174
Query: 199 L-----LRNYPITQKCDVYSFGMLLFEI-IGR 224
+ + Y + K DV+S G+ + E+ GR
Sbjct: 175 INPELNQKGYDV--KSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 5e-15
Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 43/227 (18%)
Query: 28 YSTKLGAGGFGVVYKGQFPNGVK------IAAKILKTCLNKRVEAQFMAEIGTIGRTYHI 81
Y +G G FG V++ + P + +A K+LK + ++A F E + H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYL------------FTDTEV---------LK 120
N+V+L G C L++E+M G L+++L + + L
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
+ L IA A G+AYL E ++ +H D+ N L+ K+ADFGL++ N
Sbjct: 129 CTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR-----NI 180
Query: 181 HDSTSGYRGTPG------YSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
+ S Y+ + + PE + N T+ DV+++G++L+EI
Sbjct: 181 Y-SADYYKASENDAIPIRWMPPESIFYNRYTTES-DVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 32 LGAGGFGVVY--------KGQFPNGVKIAAKILKTCLNKRVEAQFMAEI---GTIGRTYH 80
LG G FG V K + V +A K+LK ++ + ++E+ IG+ H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFT---------------DTEVLKWEKLL 125
N++ L G C ++ E+ G+L +YL E + ++ L+
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 126 DIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185
ARG+ YL +Q+ IH D+ N+L+ K+ADFGLA+ N + + T+
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 186 GYRGTPGYSAPEFLL-RNYPITQKCDVYSFGMLLFEI 221
R + APE L R Y T + DV+SFG+L++EI
Sbjct: 198 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-15
Identities = 52/195 (26%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 32 LGAGGFGVVYKG--QFPNG--VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
LG G FG + +G + P+ + +A L+ + + F+AE T+G+ H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G +V E+M NG+LD +L L +L+ + G A G+ YL E +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYV 129
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
H + +L+++ K++ F + E + + SG + ++APE ++ + +
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSG-KSPVLWAAPE-AIQYHHFSS 187
Query: 208 KCDVYSFGMLLFEII 222
DV+SFG++++E++
Sbjct: 188 ASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 31/211 (14%)
Query: 31 KLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQ-FMAEIGTIGRTYHINLVRLYG 88
+G G +G+V P GVK+A K + + + Q + EI + R H N++ +
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 89 F----CYDQTKAA-LVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAI-----GTARGIAY 137
++ +V E ME TD +++K + L + I RG+ Y
Sbjct: 71 IIRPPSFESFNDVYIVQELME---------TDLYKLIKTQHLSNDHIQYFLYQILRGLKY 121
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG---YRGTPGYS 194
+H N ++H D+KP+N+LL+ K+ DFGLA++ +PE HD T Y T Y
Sbjct: 122 IHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE--HDHTGFLTEYVATRWYR 176
Query: 195 APEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
APE +L + T+ D++S G +L E++ R
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 69/229 (30%), Positives = 101/229 (44%), Gaps = 29/229 (12%)
Query: 12 KPVRFTLEQLCSFTNNYST--KLGAGGFGVVYK-GQFPNGVKIAAKILKTC--LNKRVEA 66
LE L T+ + +G G +G VYK +G A KIL +++ +EA
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67
Query: 67 QFMAEIGTIGRTY--HINLVRLYGFCYDQTKAA-----LVYEFMENGS---LDKYLFTDT 116
++ I ++ H N+V+ YG Y K LV E GS L K L
Sbjct: 68 EY-----NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 117 EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176
+ L + I G G+ +LH N RIIH D+K NILL + K+ DFG++
Sbjct: 123 QRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 177 PENTHDSTSGYRGTPGYSAPEFLL----RNYPITQKCDVYSFGMLLFEI 221
+TS GTP + APE + +Y +CDV+S G+ E+
Sbjct: 180 STRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 70/199 (35%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 32 LGAGGFG-VVYKGQFPNGVKIAAKIL--KTCLNKRVEAQFMAEIGTIGRTY-HINLVRL- 86
+G G FG V+ + +G A K+L KT L K+ + MAE + + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 87 YGFCYDQT--KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
Y F QT K V +++ G L +L + L+ + A A I YLH +
Sbjct: 63 YSF---QTAEKLYFVLDYVNGGELFFHLQRERCFLE-PRARFYAAEVASAIGYLH---SL 115
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKL-CNPENTHDSTSGYRGTPGYSAPEFLLRNY 203
II+ D+KP NILLD++ + DFGL K PE T TS + GTP Y APE +LR
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET---TSTFCGTPEYLAPE-VLRKE 171
Query: 204 PITQKCDVYSFGMLLFEII 222
P + D + G +L+E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRV-EAQFMAEIGTIGRTYHINLVRL-Y 87
LG GGFG V Q K+ A K+ K L KR E + E + + +V L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
F + LV M G L +++ + + A G+ +LH+ RI
Sbjct: 61 AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPIT 206
++ D+KP N+LLD + +++D GLA G GTPGY APE +L+
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPE-VLQGEVYD 172
Query: 207 QKCDVYSFGMLLFEIIGRR 225
D ++ G L+E+I R
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 7e-15
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQ-FMAEIGTIGRTYHINLVRL-Y 87
LG GGFG V Q K+ A K+ K L KR + M E + + + +V L Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 88 GFCYDQTKA--ALVYEFMENGSLDKYLFTDTEV---LKWEKLLDIAIGTARGIAYLHEEC 142
F QTK LV M G L +++ E + G+ +LH+
Sbjct: 61 AF---QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-- 115
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
+RII+ D+KP N+LLD + +++D GLA ++ T GY GTPG+ APE LL+
Sbjct: 116 -RRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPE-LLQG 171
Query: 203 YPITQKCDVYSFGMLLFEIIGRR 225
D ++ G+ L+E+I R
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 43/289 (14%)
Query: 31 KLGAGGFGVVYKGQFPN------GVKIAAKILKT-CLNKRVEAQFMAEIGTIGRTYHINL 83
+LG G FG V+ + N + +A K LK L R + Q AE+ T H ++
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT--NLQHEHI 69
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYL---------FTDTEVLK------WEKLLDIA 128
V+ YG C D +V+E+M++G L+K+L D + + ++L IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 129 IGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188
A G+ YL +Q +H D+ N L+ A K+ DFG+++ + + G+
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-RVGGHT 185
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYE 248
P P + T + DV+SFG++L+EI + KQ W +
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------YGKQPWFQLS 230
Query: 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297
E+ + + E R + + + L C Q P+ R + + K+L
Sbjct: 231 NTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 30 TKLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEA--QFMAEIGTIGRTYHINLVRL 86
++G G FG VY + +A K + + E + E+ + + H N +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE- 79
Query: 87 YGFCY-DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
Y CY + A LV E+ GS L + L+ ++ I G +G+AYLH
Sbjct: 80 YKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER-- 136
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR---- 201
IH DIK NILL + K+ADFG A L +P N+ + GTP + APE +L
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVILAMDEG 189
Query: 202 NYPITQKCDVYSFGMLLFEIIGRR 225
Y K DV+S G+ E+ R+
Sbjct: 190 QY--DGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 52/194 (26%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 31 KLGAGGFGVVYKGQF---PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
+LG+G FG V KG + + +A K+LK K V + M E + + + +VR+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G C + LV E G L+K+L + + ++++ + G+ YL + +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFV 117
Query: 148 HYDIKPANILLDAKFSAKVADFGLAK-LCNPENTHDSTSGYRGTPGYSAPEFLLRNYPIT 206
H D+ N+LL + AK++DFGL+K L ++ + + S + + APE + +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-RKFS 176
Query: 207 QKCDVYSFGMLLFE 220
+ DV+S+G+ ++E
Sbjct: 177 SRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 47/230 (20%)
Query: 27 NYSTKLGAGGFGVVY------------KGQFPNGVK-----IAAKILKTCLNKRVEAQFM 69
N+ KLG G FG V+ K N +A K+L+ + F+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 70 AEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYL-----FTDTEV-----L 119
E+ + R N+ RL G C ++ E+MENG L+++L T L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 120 KWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179
+ LL +A A G+ YL E N +H D+ N L+ ++ K+ADFG+++ N
Sbjct: 128 SFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR-----N 179
Query: 180 THDSTSGY---RGTP----GYSAPE-FLLRNYPITQKCDVYSFGMLLFEI 221
+ +S Y +G + A E LL + T K DV++FG+ L+EI
Sbjct: 180 LY--SSDYYRVQGRAPLPIRWMAWESVLLGKF--TTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 32 LGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHI---NLVRLY 87
+G G +G VY+G P G +A KI+ + E+ + + N+ + Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIG-----TARGIAYLHEEC 142
G + ++ E+ E GS+ ++K + + I + Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-------RTLMKAGPIAEKYISVIIREVLVALKYIHKV- 120
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
+IH DIK ANIL+ + K+ DFG+A L N ++ ST + GTP + APE +
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEG 176
Query: 203 YPITQKCDVYSFGMLLFEII 222
K D++S G+ ++E+
Sbjct: 177 KYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 32 LGAGGFGVVYK------GQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLV 84
LGAG FG V + + +K+A K+LK + M+E+ + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGTARGIAYLHEECN 143
L G C ++ E+ G L +L E L E LL + A+G+A+L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---AS 159
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP----GYSAPEFL 199
+ IH D+ N+LL K+ DFGLA+ + +DS +G + APE +
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 200 LRNYPITQKCDVYSFGMLLFEI 221
T + DV+S+G+LL+EI
Sbjct: 216 FNCV-YTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 32 LGAGGFGVV----YKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
LG G FG V Y + N G ++A K LK A EI + YH N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 87 YGFCYDQTKAA--LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
G C + L+ EF+ +GSL +YL + + ++ L A+ +G+ YL ++
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY-SAPEFLLRNY 203
+ +H D+ N+L++++ K+ DFGL K + + + +P + APE L+++
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS- 187
Query: 204 PITQKCDVYSFGMLLFEII 222
DV+SFG+ L+E++
Sbjct: 188 KFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 31 KLGAGGFGVV----------YKGQFPNG-----VKIAAKILKTCLNKRVEAQFMAEIGTI 75
KLG G FG V + G+ V +A K+L+ + K F+ EI +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 76 GRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYL--------FT---DTEVLKWEKL 124
R + N++RL G C ++ E+MENG L+++L FT + + L
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 125 LDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184
L +A+ A G+ YL + +H D+ N L+ ++ K+ADFG+++ N + S
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-----NLY-SG 182
Query: 185 SGYRGTPGYSAP-------EFLLRNYPITQKCDVYSFGMLLFEI 221
YR P LL + T DV++FG+ L+E+
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKF--TTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 31 KLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+LG G +G VYK P GV +A K ++ L++ Q + E+ + + +V YG
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 90 CYDQTKAALVYEFMENGSLDKYL--FTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
+ + + E+M+ GSLDK TE + + L I +G+ +L EE N II
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPI-- 205
H D+KP N+L++ K+ DFG++ N + T+ G Y APE + P
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTN--IGCQSYMAPERIKSGGPNQN 181
Query: 206 ---TQKCDVYSFGMLLFEI 221
T + DV+S G+ + E+
Sbjct: 182 PTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 32/209 (15%)
Query: 32 LGAGGFGVVY---KGQFPNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRL 86
+ G +G V+ K G A K++K + K Q + E + + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 87 -YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLD---IAIGTAR---GIAYLH 139
Y F + LV E++ G L +L+ LD I A + YLH
Sbjct: 59 YYSFQGKK-NLYLVMEYLPGGDLAS-------LLENVGSLDEDVARIYIAEIVLALEYLH 110
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL------CNPENTHDSTSGYRGTPGY 193
+ IIH D+KP NIL+D+ K+ DFGL+K+ N + GTP Y
Sbjct: 111 ---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEII 222
APE +L ++ D +S G +L+E +
Sbjct: 168 IAPEVILGQ-GHSKTVDWWSLGCILYEFL 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 61/228 (26%), Positives = 89/228 (39%), Gaps = 49/228 (21%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILKTC--LNKRVEAQFMAE--IGTIGRTYHINLVRL 86
+G G FG V+ + + ++ A K+L+ + + A AE I + I V+L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI--VKL 66
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
Y D+ LV E+M G L L F + ++ A + L
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFY--------IAELVLALDSV 117
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAK--------------LCNPENTHDSTSGY 187
IH DIKP NIL+DA K+ADFGL K N +
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 188 R-------------GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
R GTP Y APE L +CD +S G++L+E++
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 28/219 (12%)
Query: 32 LGAGGFGVVYKGQFPNG--------VKIAAKILKTCLNKRVEAQFMA-EIGTIGRTYHIN 82
+G+G FG VY G + V++ + + KR +A EI + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 83 LVRLYGFCYDQTKAALVYEFMENGS----LDKY-LFTDTEVLKWEKLLDIAIGTARGIAY 137
+V+ G D + E++ GS L+ Y F +T V + + +G+ Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR------QILKGLNY 121
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR----GTPGY 193
LH N+ IIH DIK ANIL+D K K++DFG++K + T+G R G+ +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCS 232
APE +++ T+K D++S G L+ E++ + DC+
Sbjct: 179 MAPE-VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 31 KLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKR-VEAQFMAEIGTIGRTY---HINLVR 85
++G G +G VYK + P+ G +A K ++ N+ + + E+ + R H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 86 LYGFCYD-----QTKAALVYEFMENGSLDKYLF-TDTEVLKWEKLLDIAIGTARGIAYLH 139
L C +TK LV+E ++ L YL L E + D+ RG+ +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFL 199
C I+H D+KP NIL+ + K+ADFGLA++ + + + T Y APE L
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAPEVL 179
Query: 200 LRNYPITQKCDVYSFGMLLFEIIGRR 225
L++ T D++S G + E+ R+
Sbjct: 180 LQSTYAT-PVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 32 LGAGGFGVVYKGQFP-NGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLY 87
+G G FG V + +G+K+ A K+LK ++ F E+ + + +H N++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 88 GFCYDQTKAALVYEFMENGSL------DKYLFTD---------TEVLKWEKLLDIAIGTA 132
G C ++ + E+ G+L + L TD L ++LL A A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
G+ YL E ++ IH D+ N+L+ ++K+ADFGL++ E + + R
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVR 183
Query: 193 YSAPEFLLRNYPI-TQKCDVYSFGMLLFEII---GRRKNAQDCSSDTLDWFPKQVWDEYE 248
+ A E L NY + T K DV+SFG+LL+EI+ G C+ +++++
Sbjct: 184 WMAIESL--NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---------ELYEKLP 232
Query: 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV----KMLEG 299
+G K C D E E M C +D P RPP + + +MLE
Sbjct: 233 QGYRMEKPRNC-----DDEVYELMRQ----CWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 21/200 (10%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKIL--KTCLNKRVEAQFMAEIGTIGRTY-HINLVRL- 86
+G G FG V + K A K+L K L K+ + MAE + + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 87 YGFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
Y F QT L V +++ G L +L + + A A + YLH
Sbjct: 63 YSF---QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---L 115
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT--HDSTSGYRGTPGYSAPEFLLRN 202
II+ D+KP NILLD++ + DFGL K E +TS + GTP Y APE +LR
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPE-VLRK 170
Query: 203 YPITQKCDVYSFGMLLFEII 222
P + D + G +L+E++
Sbjct: 171 QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 64/249 (25%), Positives = 98/249 (39%), Gaps = 42/249 (16%)
Query: 31 KLGAGGFGVVYKGQFPN-GVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLY 87
+G GG G VY P ++A K ++ L N ++ +F+ E H +V +Y
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDT---EVLKWE--------KLLDIAIGTARGIA 136
C D ++E +L K L E L E L I I
Sbjct: 69 SICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKV-ADFGLAKLCNPENTHDSTSGYR------- 188
Y+H ++ ++H D+KP NILL F V D+G A E
Sbjct: 128 YVH---SKGVLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 189 ---------GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-----RRKNAQDCSSD 234
GTP Y APE LL P ++ D+Y+ G++L++++ RRK + S
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242
Query: 235 TLDWFPKQV 243
+ P +V
Sbjct: 243 DVILSPIEV 251
|
Length = 932 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 41/231 (17%)
Query: 28 YSTKLGAGGFGVVY-----------KGQFPNGVK------IAAKILKTCLNKRVEAQFMA 70
+ KLG G FG V+ QFP V+ +A KIL+ NK F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 71 EIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYL----FTDTE--------- 117
E+ + R N++RL G C D+ ++ E+MENG L+++L D E
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 118 -----VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA 172
+ + LL +A+ A G+ YL + +H D+ N L+ + K+ADFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 173 KLCNPENTHDSTSGYRGTP-GYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
+ + + G P + A E +L T DV++FG+ L+EI+
Sbjct: 186 RNLYAGDYY-RIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 81/294 (27%), Positives = 133/294 (45%), Gaps = 53/294 (18%)
Query: 32 LGAGGFGVVYKGQF-PNGVKIAAKI--LKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLY 87
+G G FG V K + +G+++ A I +K +K F E+ + + +H N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 88 GFCYDQTKAALVYEFMENGSL------DKYLFTD---------TEVLKWEKLLDIAIGTA 132
G C + L E+ +G+L + L TD L ++LL A A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
RG+ YL + ++ IH D+ NIL+ + AK+ADFGL++ E T G R
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG-RLPVR 188
Query: 193 YSAPEFLLRNYPI-TQKCDVYSFGMLLFEII---GRRKNAQDCSSDTLDWFPKQVWDEYE 248
+ A E L NY + T DV+S+G+LL+EI+ G C+ +++++
Sbjct: 189 WMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------ELYEKLP 237
Query: 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV----KMLE 298
+G K L C D E + M C ++ P RP + ++ +MLE
Sbjct: 238 QGYRLEKPLNC-----DDEVYDLMRQ----CWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 66/203 (32%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 32 LGAGGFGVVYKGQF-PNGVKIAAKILK---TCLNKRVEAQFMAE---IGTIGRTYHINLV 84
LG G FG V ++ G A K LK VE+ M E T H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVES-LMCEKRIFETANSERHPFLV 65
Query: 85 RLYGFCYDQTK--AALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC 142
L+ C+ QT+ V E+ G L + T+V + + A G+ YLHE
Sbjct: 66 NLFA-CF-QTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQYLHE-- 119
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT--HDSTSGYRGTPGYSAPEFLL 200
+I++ D+K N+LLD + K+ADFGL K E D TS + GTP + APE L
Sbjct: 120 -NKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 201 -RNYPITQKCDVYSFGMLLFEII 222
+Y T+ D + G+L++E++
Sbjct: 175 ETSY--TRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 34/217 (15%)
Query: 32 LGAGGFGVVY--------KGQFPNGVKIAAKILKTCLNKRVEAQFMAEI---GTIGRTYH 80
LG G FG V K + V +A K+LK + + ++E+ IG+ H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--H 77
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFT----------DT-----EVLKWEKLL 125
N++ L G C ++ E+ G+L +YL DT E L ++ L+
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 126 DIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185
A ARG+ YL +Q+ IH D+ N+L+ K+ADFGLA+ + + + T+
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 186 GYRGTPGYSAPEFLL-RNYPITQKCDVYSFGMLLFEI 221
R + APE L R Y T + DV+SFG+LL+EI
Sbjct: 195 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 57/193 (29%), Positives = 97/193 (50%), Gaps = 10/193 (5%)
Query: 31 KLGAGGFGVV-YKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
K+G G G+V + G ++A K + +R E F E+ + +H N+V +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDMYNS 87
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ +V EF+E G+L + T T + E++ + + R ++YLH NQ +IH
Sbjct: 88 YLVGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIATVCLSVLRALSYLH---NQGVIHR 142
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
DIK +ILL + K++DFG + E + GTP + APE + R P +
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISR-LPYGTEV 199
Query: 210 DVYSFGMLLFEII 222
D++S G+++ E+I
Sbjct: 200 DIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 34/214 (15%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAE---IGTIGRTY------- 79
++G G +G V+K + NG + A KRV Q E + TI
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVAL-------KRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 80 --HINLVRLYGFCY-----DQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGT 131
H N+VRL+ C +TK LV+E ++ L YL E + E + D+
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP 191
RG+ +LH + R++H D+KP NIL+ + K+ADFGLA++ + + + + T
Sbjct: 120 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTL 173
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
Y APE LL++ T D++S G + E+ R+
Sbjct: 174 WYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 78/294 (26%), Positives = 133/294 (45%), Gaps = 53/294 (18%)
Query: 32 LGAGGFGVVYKGQFP-NGVKI--AAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLY 87
+G G FG V K + +G+++ A K +K +K F E+ + + +H N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 88 GFCYDQTKAALVYEFMENGSL------DKYLFTD---------TEVLKWEKLLDIAIGTA 132
G C + L E+ +G+L + L TD L ++LL A A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
RG+ YL + ++ IH D+ NIL+ + AK+ADFGL++ + + + R
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 193 YSAPEFLLRNYPI-TQKCDVYSFGMLLFEII---GRRKNAQDCSSDTLDWFPKQVWDEYE 248
+ A E L NY + T DV+S+G+LL+EI+ G C+ +++++
Sbjct: 177 WMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------ELYEKLP 225
Query: 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV----KMLE 298
+G K L C D E + M C ++ P RP + ++ +MLE
Sbjct: 226 QGYRLEKPLNC-----DDEVYDLMRQ----CWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 11/194 (5%)
Query: 32 LGAGGFGVVY--KGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+G G FG+V+ + + + I +I + K E + H N++ Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
+ +V E+ G+L +Y+ +L + +L + + ++H + I+H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILH 124
Query: 149 YDIKPANILLDA-KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
D+K NILLD K K+ DFG++K+ ++ GTP Y +PE L P Q
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPE-LCEGKPYNQ 180
Query: 208 KCDVYSFGMLLFEI 221
K D+++ G +L+E+
Sbjct: 181 KSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 37/99 (37%), Positives = 57/99 (57%), Gaps = 16/99 (16%)
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN----THDSTSGYR 188
RG+ YLH + I+H DIKP N+L+++ K+ DFGLA++ P+ T + + Y
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 189 GTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
Y APE L+ R+Y T D++S G + E++GRR
Sbjct: 170 ----YRAPEILMGSRHY--TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 65/287 (22%), Positives = 116/287 (40%), Gaps = 40/287 (13%)
Query: 31 KLGAGGFGVVYKGQFPN------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
+LG G FG V+ + N + +A K LK + F E + H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIV 70
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYLFTD-------------TEVLKWEKLLDIAIGT 131
+ YG C + +V+E+M++G L+K+L E L ++L IA
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE-LTQSQMLHIAQQI 129
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP 191
A G+ YL +Q +H D+ N L+ K+ DFG+++ + + G+ P
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY-RVGGHTMLP 185
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251
P + T + DV+S G++L+EI + KQ W + E
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT---------------YGKQPWYQLSNNE 230
Query: 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ + + + R + + + L C Q P R + + +L+
Sbjct: 231 VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQF---MAEIGTIGRTYHINLVRLY 87
++G G FG VY + ++ A + K+ ++ + E+ + + H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G + A LV E+ GS L + L+ ++ I G +G+AYLH +I
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR--NYPI 205
H DIK NILL K+ADFG A +P N+ + GTP + APE +L
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEGQY 197
Query: 206 TQKCDVYSFGMLLFEIIGRR 225
K DV+S G+ E+ R+
Sbjct: 198 DGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 31 KLGAGGFGVVYKGQFPNGVK----IAAKILKTCLNKRVEA--QFMAEIGTIGRTYHINLV 84
++G G FG VY F V+ +A K + + E + E+ + R H N +
Sbjct: 32 EIGHGSFGAVY---FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSI 88
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
G + A LV E+ GS L + L+ ++ I G +G+AYLH +
Sbjct: 89 EYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SH 144
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR--N 202
+IH DIK NILL K+ADFG A + +P N+ + GTP + APE +L
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDE 198
Query: 203 YPITQKCDVYSFGMLLFEIIGRR 225
K DV+S G+ E+ R+
Sbjct: 199 GQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G + V+KG+ +A K ++ + + E+ + H N+V L+
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ + LV+E++++ L +YL ++ + RG++Y H+ ++I+H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHR 127
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCN-PENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+KP N+L++ K K+ADFGLA+ + P T+ S T Y P+ LL + +
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTY---SNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 209 CDVYSFGMLLFEIIGRR 225
D++ G +L+E+ R
Sbjct: 185 IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 32 LGAGGFGVVYKG-QFPNGVKIAAK---ILKTCLNKRVEAQ------FMAEIGTIGRTYHI 81
+G G +G VY G +A K + T + Q +EI T+ H+
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGS----LDKYLFTDTEVLKWEKLLDIAIGTARGIAY 137
N+V+ GF + ++ E++ GS L Y + +++++ G+AY
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-----FTEQVLEGLAY 123
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE 197
LH ++ I+H D+K N+L+DA K++DFG++K + +D +G+ + APE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 198 FL-LRNYPITQKCDVYSFGMLLFEII-GRR 225
+ + + K D++S G ++ E+ GRR
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 43/220 (19%)
Query: 31 KLGAGGFGVVYKGQ----FPNGVK--IAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINL 83
+LG G FG V+ + P K +A K LK + R + Q AE+ T+ + HI
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI-- 69
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYLFT---DTEVLKWEK-----------LLDIAI 129
VR YG C + +V+E+M +G L+++L + D ++L + +L IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 130 GTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG 189
A G+ YL + +H D+ N L+ K+ DFG+++ ST YR
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY------STDYYR- 179
Query: 190 TPG-------YSAPEFLL-RNYPITQKCDVYSFGMLLFEI 221
G + PE +L R + T + D++SFG++L+EI
Sbjct: 180 VGGRTMLPIRWMPPESILYRKF--TTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK-LCNPENTHDS-TSGYRGT 190
RG+ Y+H +IH D+KP+N+L++ ++ DFG+A+ L + H + Y T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 191 PGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
Y APE LL T D++S G + E++GRR
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 28/204 (13%)
Query: 32 LGAGGFGVVY---KGQFPN-GVKIAAKIL-KTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
LG G FG V+ K P+ G A K+L K L R + E + H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 87 -YGFCYDQT--KAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDIAIGTARGIAYL 138
Y F QT K L+ +F+ G L + +FT+ +V + L ++A+ + +L
Sbjct: 64 HYAF---QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALA----LDHL 114
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEF 198
H + II+ D+KP NILLD + K+ DFGL+K + + GT Y APE
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEV 169
Query: 199 LLRNYPITQKCDVYSFGMLLFEII 222
+ R TQ D +SFG+L+FE++
Sbjct: 170 VNRRGH-TQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKT--CLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
K+G G F VY+ +GV +A K ++ ++ + A + EI + + H N+++ Y
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 88 GFCYDQTKAALVYEFMENGSLDKYL--FTDTEVLKWEKLL-DIAIGTARGIAYLHEECNQ 144
+ + +V E + G L + + F + L EK + + + ++H ++
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SR 125
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYP 204
R++H DIKPAN+ + A K+ D GL + + + T + GTP Y +PE + N
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN-G 182
Query: 205 ITQKCDVYSFGMLLFEI 221
K D++S G LL+E+
Sbjct: 183 YNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 11/201 (5%)
Query: 23 SFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HI 81
++ +N+ K+G G G+V + K+ A + K L K+ + + I R Y H
Sbjct: 20 TYLDNF-IKIGEGSTGIVCIATVKSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHE 77
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
N+V +Y + +V EF+E G+L + T T + E++ + + + ++ LH
Sbjct: 78 NVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLKALSVLHA- 134
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
Q +IH DIK +ILL K++DFG + E + GTP + APE + R
Sbjct: 135 --QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISR 190
Query: 202 NYPITQKCDVYSFGMLLFEII 222
P + D++S G+++ E++
Sbjct: 191 -LPYGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIA---AKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
++G G FG V G+ G+ A K L+ + F+ E+ H N+++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEK----LLDIAIGTARGIAYLHEECN 143
G C + LV EF G L YL ++ ++ L +A A G+ +LH+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFL---- 199
IH D+ N L A S K+ D+GLA PE+ + + + + APE +
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 200 --LRNYPITQKCDVYSFGMLLFEI 221
L T+K +++S G+ ++E+
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 41/287 (14%)
Query: 30 TKLGAGGFGVVYKGQFPNGVK------IAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL 83
T LG G FG V+ + + + K L+ ++ ++++F E+ + H N+
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYLFTD---TEVLKWEKL-----LDIAIGTARGI 135
VRL G C + ++ E+ + G L ++L E LK L + + A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK-LCNPENTHDSTSGYRGT--P- 191
+L N R +H D+ N L+ ++ KV+ L+K + N E R P
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK-----LRNALIPL 182
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251
+ APE + + + K DV+SFG+L++E+ + F +E
Sbjct: 183 RWLAPEAVQED-DFSTKSDVWSFGVLMWEVF----------TQGELPFYGLSDEEVLNR- 230
Query: 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
L A L + E ++ M W V P+ RP S +V L
Sbjct: 231 LQAGKLELPVPEGCPSRLYKL-MTRCWAVN--PKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 28/203 (13%)
Query: 30 TKLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLY 87
K+G G G+V G ++A K + +R E F E+ I R Y H N+V +Y
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEV-VIMRDYQHPNIVEMY 82
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTA-----RGIAYLHEEC 142
+ +V EF+E G+L T+++ ++ + I T + +++LH
Sbjct: 83 SSYLVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIATVCLAVLKALSFLH--- 132
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR---GTPGYSAPEFL 199
Q +IH DIK +ILL + K++DFG C + GTP + APE +
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFG---FCA--QVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 200 LRNYPITQKCDVYSFGMLLFEII 222
R P + D++S G+++ E++
Sbjct: 188 SRL-PYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G + VYKG+ +A K ++ + + E+ + H N+V L+
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ + LV+E+++ L +YL + + RG+ Y H ++++H
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHR 128
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCN-PENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+KP N+L++ + K+ADFGLA+ + P T+ S T Y P+ LL + + +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTY---SNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 209 CDVYSFGMLLFEIIGRR 225
D++ G + +E+ R
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 9/194 (4%)
Query: 31 KLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G + VYKG NG +A K++ + V + E + H N+V L+
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ + V+E+M L +Y+ L + RG+AY+H Q I+H
Sbjct: 72 IHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHR 127
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCN-PENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+KP N+L+ K+ADFGLA+ + P T+ S T Y P+ LL +
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEV---VTLWYRPPDVLLGATDYSSA 184
Query: 209 CDVYSFGMLLFEII 222
D++ G + E++
Sbjct: 185 LDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 7e-13
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 21/198 (10%)
Query: 31 KLGAGGFGVVYKGQFPNGVK--IAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
++G G FG VYKG N K +A KI+ + EI + + + R YG
Sbjct: 11 RIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTA-----RGIAYLHEECN 143
TK ++ E++ GS ++LK L + I T +G+ YLH E
Sbjct: 70 SYLKGTKLWIIMEYLGGGSA-------LDLLKPGPLEETYIATILREILKGLDYLHSE-- 120
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY 203
R IH DIK AN+LL + K+ADFG+A +T + + GTP + APE +++
Sbjct: 121 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE-VIKQS 176
Query: 204 PITQKCDVYSFGMLLFEI 221
K D++S G+ E+
Sbjct: 177 AYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
RG+ Y+H + ++H D+KP+N+LL+A K+ DFGLA+ + D + Y T
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--EKGDFMTEYVVTRW 173
Query: 193 YSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
Y APE LL T DV+S G + E++GR+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP---ENTHDSTSGYRG 189
G+ Y+H + ++H D+KP N+L++A K+ DFGLA+ + EN T Y
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT-EYVA 171
Query: 190 TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
T Y APE +L T+ DV+S G +L E++GR+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 38/211 (18%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK------------TCLNKRVEAQFMAEIGTIGRT 78
LG G FG V + ++ A K+LK T KRV A G+
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLAL-------AGK- 54
Query: 79 YHINLVRLYGFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIA 136
H L +L QTK L V E++ G L ++ + A G+
Sbjct: 55 -HPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQ 110
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK--LCNPENTHDSTSGYRGTPGYS 194
+LHE + II+ D+K N+LLD++ K+ADFG+ K + +TS + GTP Y
Sbjct: 111 FLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG----GVTTSTFCGTPDYI 163
Query: 195 APEFLLRNYPITQKCDVYSFGMLLFE-IIGR 224
APE +L P D ++ G+LL+E + G+
Sbjct: 164 APE-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 32 LGAGGFG-VVYKGQFPNGVKIAAKIL--KTCLNKRVEAQFMAEIGTIGRTY-HINLVRLY 87
+G G FG V+ + +G A K+L K LN++ + MAE + + H LV L+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
K V +F+ G L +L + + A A + YLH + I+
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINIV 118
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
+ D+KP NILLD++ + DFGL K D+T+ + GTP Y APE ++R P
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPE-VIRKQPYDN 175
Query: 208 KCDVYSFGMLLFEII 222
D + G +L+E++
Sbjct: 176 TVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 32 LGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVE-AQFMAEIGTIGRTYHINLVRL 86
LG G FG V + Q + K+A K+LK + + +F+ E + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 87 YGFC-YDQTKAAL-----VYEFMENGSLDKYLFT-----DTEVLKWEKLLDIAIGTARGI 135
G + K L + FM++G L +L + L + L+ I A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSA 195
YL ++ IH D+ N +L+ + VADFGL+K + + + + A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFEIIGR 224
E L N T DV++FG+ ++EI+ R
Sbjct: 184 LESLADNVYTTHS-DVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 49/231 (21%)
Query: 28 YSTKLGAGGFGVVY-------------------KGQFPNGVKIAAKILKTCLNKRVEAQF 68
+ KLG G FG V+ G P V +A K+L+ NK F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQP--VLVAVKMLREDANKNARNDF 66
Query: 69 MAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYL----------FTDTEV 118
+ EI + R N++RL C ++ E+MENG L+++L D
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 119 LKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178
+ + L+ +A A G+ YL + +H D+ N L+ ++ K+ADFG+++
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR----- 178
Query: 179 NTHDSTSGYRGTPGYSAP-------EFLLRNYPITQKCDVYSFGMLLFEII 222
N + S YR P LL + T DV++FG+ L+EI+
Sbjct: 179 NLY-SGDYYRIQGRAVLPIRWMSWESILLGKF--TTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 20/152 (13%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G +G V+K + +I A ++ ++ V + + EI + H N+VRLY
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLK--WEKLLDIAIGTARGIAYLHEE 141
+ K LV+E+ + L KY D E++K +LL +G+A+ H
Sbjct: 67 VLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL-------KGLAFCHS- 117
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173
++H D+KP N+L++ K+ADFGLA+
Sbjct: 118 --HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G + V+KG+ +A K ++ + + E+ + H N+V L+
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ LV+E+++ L +Y+ ++ + RG+AY H ++++H
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHR 128
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCN-PENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+KP N+L++ + K+ADFGLA+ + P T+ S T Y P+ LL + + +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTY---SNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 209 CDVYSFGMLLFEIIGRR 225
D++ G + FE+ R
Sbjct: 186 IDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 9/194 (4%)
Query: 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G + VYKG+ NG +A K+++ + + E + H N+V L+
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ + LV+E++ L +Y+ L E + RG++Y+H+ + I+H
Sbjct: 72 IHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHR 127
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCN-PENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+KP N+L+ K+ADFGLA+ + P +T+ S T Y P+ LL + +
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTY---SNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 209 CDVYSFGMLLFEII 222
D++ G + E+I
Sbjct: 185 LDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEA--QFMAEIGTIGRTYHINLVRLY 87
++G G FG VY + N +A K + + E + E+ + + H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G + A LV E+ GS L + L+ ++ + G +G+AYLH + +I
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMI 137
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR--NYPI 205
H D+K NILL K+ DFG A + P N + GTP + APE +L
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEGQY 191
Query: 206 TQKCDVYSFGMLLFEIIGRR 225
K DV+S G+ E+ R+
Sbjct: 192 DGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 22/201 (10%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL----- 86
+G GGFG VY + + K+ A CL+K+ E + ++LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAM---KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 87 -----YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
Y F + K + + M G L Y + V +++ A G+ ++H
Sbjct: 59 IVCMTYAF-HTPDKLCFILDLMNGGDL-HYHLSQHGVFSEKEMRFYATEIILGLEHMH-- 114
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
N+ +++ D+KPANILLD +++D GLA + + H S GT GY APE L +
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQK 169
Query: 202 NYPITQKCDVYSFGMLLFEII 222
D +S G +LF+++
Sbjct: 170 GTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 33/89 (37%), Positives = 54/89 (60%), Gaps = 1/89 (1%)
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE 197
+H ++ +IH DIK ANILL + K+ DFG +K+ + D + GTP Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 198 FLLRNYPITQKCDVYSFGMLLFEIIGRRK 226
+ R P ++K D++S G+LL+E++ ++
Sbjct: 216 -IWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 25/123 (20%)
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK--LCNPENTHDSTSGYRGTP 191
G+ LH+ + IIH DIKP N+L+D K+ DFGL++ L N + + GTP
Sbjct: 109 GVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK--------FVGTP 157
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLFEII-GRRK-NAQDCSSDTLDWFPKQVWDEYEK 249
Y APE +L + D +S G ++FE + G +A+ P V+D
Sbjct: 158 DYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAET---------PDAVFDNILS 207
Query: 250 GEL 252
+
Sbjct: 208 RRI 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 26 NNYSTKLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
N LG G +G+VY + V+IA K + + R EI H N+V
Sbjct: 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE-RDSRYVQPLHEEIALHSYLKHRNIV 68
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLD----IAIGTAR---GIAY 137
+ G + + E + GSL L + KW L D I T + G+ Y
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRS-----KWGPLKDNEQTIIFYTKQILEGLKY 123
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSA--KVADFGLAKL---CNPENTHDSTSGYRGTPG 192
LH+ +I+H DIK N+L++ +S K++DFG +K NP T + GT
Sbjct: 124 LHD---NQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP-----CTETFTGTLQ 174
Query: 193 YSAPEFL---LRNYPITQKCDVYSFGMLLFEI 221
Y APE + R Y D++S G + E+
Sbjct: 175 YMAPEVIDKGPRGY--GAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 31 KLGAGGFGVVY-----KGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
+LG G FG VY K +K+ +I LN Q E + + H +V+
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYL---------FTDTEVLKWEKLLDIAIGTARGIA 136
+ ++ ++ E+ E LD L ++ +V +W I G+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLLLGVH 120
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAP 196
Y+H+ +RI+H D+K NI L K+ DFG+++L + D + + GTP Y +P
Sbjct: 121 YMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYYMSP 174
Query: 197 EFLLRNYPITQKCDVYSFGMLLFEI 221
E L++ K D++S G +L+E+
Sbjct: 175 E-ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 46/215 (21%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKR---VEAQFMAEIGTIGRTYHINLVRL- 86
++G G +G+VY+ + +I A + K ++ + + EI + H N+V L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVA-LKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 87 --------------YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTA 132
+C +Q A+L+ F++++V K + +
Sbjct: 73 EVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTP-------FSESQV----KC--LMLQLL 118
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL----CNPENTHDSTSGYR 188
RG+ YLHE IIH D+K +N+LL K K+ADFGLA+ P T YR
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYR 175
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG 223
APE LL T D+++ G +L E++
Sbjct: 176 ------APELLLGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 45/139 (32%), Positives = 70/139 (50%), Gaps = 9/139 (6%)
Query: 98 LVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANI 156
+V F E G L L ++L ++++ + A + YLHE+ I+H D+K N+
Sbjct: 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNV 133
Query: 157 LLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGM 216
L KV D G+A++ EN D S GTP Y +PE L N P K DV++ G
Sbjct: 134 FLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPE-LFSNKPYNYKSDVWALGC 190
Query: 217 LLFEIIGRRK--NAQDCSS 233
++E+ + NA+D +S
Sbjct: 191 CVYEMATLKHAFNAKDMNS 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 56/192 (29%), Positives = 89/192 (46%), Gaps = 9/192 (4%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAA-KILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
K+G G FG V+KG K+ A KI+ + EI + + + + YG
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
TK ++ E++ GS L + L ++ I +G+ YLH E + IH
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE---KKIHR 125
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
DIK AN+LL K+ADFG+A +T + + GTP + APE +++ K
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE-VIKQSAYDSKA 182
Query: 210 DVYSFGMLLFEI 221
D++S G+ E+
Sbjct: 183 DIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 69/289 (23%), Positives = 129/289 (44%), Gaps = 46/289 (15%)
Query: 31 KLGAGGFGVVYKGQFPNGVK------IAAKILKTCLNKRVEAQFMAEIGTI-GRTYHINL 83
+LG G FG+VY+G + +K +A K + + R +F+ E + G T H ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HV 71
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYLFT---DTE------VLKWEKLLDIAIGTARG 134
VRL G +V E M +G L YL + + E ++++ +A A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG-- 192
+AYL+ ++ +H D+ N ++ F+ K+ DFG+ + + +++ +G G
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETDYYRKGGKGLL 183
Query: 193 ---YSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEK 249
+ APE L++ T D++SFG++L+EI +Q +
Sbjct: 184 PVRWMAPES-LKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSN 227
Query: 250 GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
++ V+ G + ER++ + C Q P+ RP +V +L+
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 7e-12
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 29 STKLGAGGFGVVYKGQFPNGVK------IAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN 82
S +LG G FG+VY+G VK +A K + + R +F+ E + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 83 LVRLYGFCYDQTKAALVYEFMENGSLDKYLFT---DTE------VLKWEKLLDIAIGTAR 133
+VRL G ++ E M G L YL + + E +K++ +A A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG- 192
G+AYL+ + +H D+ N ++ F+ K+ DFG+ + + +++ +G G
Sbjct: 131 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGL 182
Query: 193 ----YSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
+ +PE L++ T DV+SFG++L+EI
Sbjct: 183 LPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 47/218 (21%)
Query: 27 NYSTKLGAGGFGVVYKGQFPNGVKI-AAKILK------------TCLNKRVEA-----QF 68
N+ LG G FG V + ++ A KILK T + KRV A F
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 69 MAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDI- 127
+ ++ + +T + RLY V E++ G L ++ +V K+++ +
Sbjct: 63 LTQLHSCFQT----MDRLY----------FVMEYVNGGDL---MYHIQQVGKFKEPHAVF 105
Query: 128 -AIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH--DST 184
A A G+ +LH ++ II+ D+K N++LDA+ K+ADFG+ K EN +T
Sbjct: 106 YAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTT 158
Query: 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
+ GTP Y APE + P + D ++FG+LL+E++
Sbjct: 159 RTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKIL--KTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G G FG VY+ + + +I A K+L K + K+ A + E + RT + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 89 FCYD-QTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
+ QT + L V ++M G L +L + + IA + +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHK---YD 116
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPI 205
I++ D+KP NILLDA + DFGL+K +N +T+ + GT Y APE LL
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 206 TQKCDVYSFGMLLFEI 221
T+ D +S G+L+FE+
Sbjct: 175 TKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 29 STKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQF----MAEIGTIGRTYHINLV 84
K+G G FG V+K + +I A LK L + + F + EI + H N+V
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVA--LKKVLMENEKEGFPITALREIKILQLLKHENVV 74
Query: 85 RLYGFCYDQTKAA--------LVYEFMEN---GSLD--KYLFTDTEVLKWEKLLDIAIGT 131
L C + LV+EF E+ G L FT +E+ K K+L
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML------ 128
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG-- 189
G+ Y+H +I+H D+K ANIL+ K+ADFGLA+ + + + + Y
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFS-LSKNSKPNRYTNRV 184
Query: 190 -TPGYSAPEFLL--RNY--PITQKCDVYSFGMLLFE 220
T Y PE LL R+Y PI D++ G ++ E
Sbjct: 185 VTLWYRPPELLLGERDYGPPI----DMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 30 TKLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+ +G+G +G V G+++A K L + A+ RTY +RL
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---------RTYR--ELRLLK 71
Query: 89 FCYDQTKAALVYEFMENGSL----DKYLFTD------TEVLKWEKLLD-----IAIGTAR 133
+ L+ F SL D YL T ++K +KL D + R
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 131
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
G+ Y+H + IIH D+KP+N+ ++ K+ DFGLA+ +T D +GY T Y
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWY 183
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
APE +L Q D++S G ++ E++ R
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 15/197 (7%)
Query: 30 TKLGAGGFGVVYKGQFPNGVKIAA-KIL-KTCLNKRVEA-QFMAEIGTIGRTYHINLVRL 86
T++G GG+G V+ + + +I A K + K+ L K E + E + T LV+L
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
D L E++ G + L + VL + + LHE
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGY 122
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL-RNYPI 205
IH D+KP N L+DA K+ DFGL+K + G+P Y APE L + Y
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGYDF 177
Query: 206 TQKCDVYSFGMLLFEII 222
T D +S G +L+E +
Sbjct: 178 T--VDYWSLGCMLYEFL 192
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 10/194 (5%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
++G+G +G VYK + G A KI+K + EI + H N+V +G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-SLIQQEIFMVKECKHCNIVAYFGS 74
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ K + E+ GSL ++ T L ++ + T +G+AYLH + +H
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHR 130
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEF--LLRNYPITQ 207
DIK ANILL K+ADFG+A T + GTP + APE + +N Q
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 208 KCDVYSFGMLLFEI 221
CD+++ G+ E+
Sbjct: 189 LCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 23/199 (11%)
Query: 32 LGAGGFGVVYKGQFPNGVK-IAAKILKT--CLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G G FG V+ + A K++ + + E E + H ++RL+
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
+DQ ++ E++ G L YL F+++ L + + A+ YLH +
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL------EYLH---S 119
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY 203
+ I++ D+KP NILLD + K+ DFG AK D T GTP Y APE ++++
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE-VIQSK 173
Query: 204 PITQKCDVYSFGMLLFEII 222
+ D ++ G+L++E++
Sbjct: 174 GHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMA--EIGTIGRTYHINLVRLY 87
KLG G + VYKG+ G +A K ++ L A F A E + H N+V L+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
+ + LV+E+++ L +Y+ L + RG+AY H+ +R++
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVL 125
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCN-PENTHDS---TSGYRGTPGYSAPEFLLRNY 203
H D+KP N+L+ + K+ADFGLA+ + P T+ + T YR P+ LL +
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR------PPDVLLGST 179
Query: 204 PITQKCDVYSFGMLLFEII 222
+ D++ G + +E+
Sbjct: 180 EYSTSLDMWGVGCIFYEMA 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 10/194 (5%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAA-KILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
++G+G +G VYK + N ++AA K++K + EI + H N+V +G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGS 74
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ K + EF GSL ++ T L ++ ++ T +G+ YLH ++ +H
Sbjct: 75 YLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHR 130
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEF--LLRNYPITQ 207
DIK ANILL K+ADFG++ T + GTP + APE + R Q
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQ 188
Query: 208 KCDVYSFGMLLFEI 221
CD+++ G+ E+
Sbjct: 189 LCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 47/197 (23%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKT--CLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
K+G G F VY+ + +A K ++ ++ + + EI + + H N+++
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 88 GFCYDQTKAALVYEFMENGSLD---KYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
+ + +V E + G L KY ++ + + + ++H ++
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SR 125
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYP 204
R++H DIKPAN+ + A K+ D GL + + + T + GTP Y +PE + N
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN-G 182
Query: 205 ITQKCDVYSFGMLLFEI 221
K D++S G LL+E+
Sbjct: 183 YNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 32/199 (16%)
Query: 89 FCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWE--KLLDIAIGTARGIAYLHEECNQ 144
FC QTK L V E++ G L +F +++ + A G+ +LH +
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLH---KK 115
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKL-CNPENTHDSTSGYRGTPGYSAPEFLLRNY 203
II+ D+K N+LLD K+ADFG+ K N E S + GTP Y APE +L+
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---ASTFCGTPDYIAPE-ILKGQ 171
Query: 204 PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKGELAAK 255
+ D +SFG+LL+E++ + D L FP+ W E + +K
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--WISKEAKDCLSK 229
Query: 256 VLGCGIEENDREEAERMSM 274
+ +R+ +R+ +
Sbjct: 230 LF-------ERDPTKRLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 65/203 (32%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 32 LGAGGFGVVYKGQFP-NGVKIAAKILK---TCLNKRVEAQFMAEIGTIGRTY-HINLVRL 86
LG G FG V+ + A K LK ++ VE M E + + H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECT-MVEKRVLSLAWEHPFLTHL 61
Query: 87 YGFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
Y C QTK L V E++ G L + + A G+ +LH ++
Sbjct: 62 Y--CTFQTKENLFFVMEYLNGGDL-MFHIQSCHKFDLPRATFYAAEIICGLQFLH---SK 115
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT--HDSTSGYRGTPGYSAPEFLL-- 200
I++ D+K NILLD K+ADFG+ K EN T + GTP Y APE LL
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIAPEILLGQ 171
Query: 201 -RNYPITQKCDVYSFGMLLFEII 222
N + D +SFG+LL+E++
Sbjct: 172 KYNTSV----DWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 12/95 (12%)
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
RG+ Y+H + IIH D+KP+NI ++ K+ DFGLA+ + E T GY T
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-----GYVATRW 180
Query: 193 YSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
Y APE +L +Y Q D++S G ++ E++ +
Sbjct: 181 YRAPEIMLNWMHY--NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRV-EAQFMAEIGTIGRTYHINLVRLYG 88
LG GGFG V Q N K+ A K+ K L K+ E + E + + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 89 FCYD-QTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGTARGIAYLHEECNQRI 146
+ ++ +T LV M G L +++ E L+ E+++ + GI +LH I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPIT 206
++ D+KP N+LLD + + +++D GLA + + + + GT GY APE +L+ P +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGK--TITQRAGTNGYMAPE-ILKEEPYS 172
Query: 207 QKCDVYSFGMLLFEIIGRRKNAQD 230
D ++ G ++E++ R +D
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 32 LGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMA--EIGTIGRTYHINLVRLYG 88
+G G +G VYK + + G +A K ++ N++ A EI + + H N+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRL-DNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 89 FCYDQTKAA----------LVYEFMEN---GSLDKYL--FTDTEVLKWEK-LLDIAIGTA 132
D+ A LV+E+M++ G L+ L F++ + + K LL+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE------ 127
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
G+ Y H + +H DIK +NILL+ K K+ADFGLA+L N E + T+ T
Sbjct: 128 -GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLW 182
Query: 193 YSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
Y PE LL DV+S G +L E+ ++
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 30 TKLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
+K+G G +GVV+K + +I A K +++ + ++ + EI + + H NLV L
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
+ K LV+E+ ++ L++ L + + + I T + + + H+ I
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCI 122
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
H D+KP NIL+ + K+ DFG A++ D + Y T Y APE L+ +
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYTDYVATRWYRAPELLVGDTQYGP 180
Query: 208 KCDVYSFGMLLFEII 222
DV++ G + E++
Sbjct: 181 PVDVWAIGCVFAELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL----- 86
+G GGFG VY + + K+ A CL+K+ E + ++LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAM---KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 87 -----YGFCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIA 136
Y F + K + + + M G L +L F++ E+ + A G+
Sbjct: 59 IVCMSYAF-HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY------AAEIILGLE 111
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAP 196
++H N+ +++ D+KPANILLD +++D GLA + + H S GT GY AP
Sbjct: 112 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAP 164
Query: 197 EFLLRNYPITQKCDVYSFGMLLFEII 222
E L + D +S G +LF+++
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKIL--KTCLNKRVEAQFMAEIGTIGRTY-HINLVRLY 87
+G G FG V + K A K+L K L K+ E M+E + + H LV L+
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
K V +++ G L +L + L+ + A A + YLH + I+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLE-PRARFYAAEIASALGYLH---SLNIV 118
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENT--HDSTSGYRGTPGYSAPEFLLRNYPI 205
+ D+KP NILLD++ + DFGL K EN + +TS + GTP Y APE +L P
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPE-VLHKQPY 173
Query: 206 TQKCDVYSFGMLLFEII 222
+ D + G +L+E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 23 SFTNNYSTKLGAGGFGVV-YKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-H 80
S NY K+G G G+V + +G ++A K++ +R E F + I R Y H
Sbjct: 21 SLLENY-IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVV--IMRDYQH 77
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGTARGIAYLH 139
N+V +Y + ++ EF++ G+L + ++ L E++ + + + YLH
Sbjct: 78 QNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLH 134
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYRGTPGYSAPEF 198
+Q +IH DIK +ILL K++DFG A++ S GTP + APE
Sbjct: 135 ---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMAPEV 188
Query: 199 LLRNYPITQKCDVYSFGMLLFEII 222
+ R P + D++S G+++ E++
Sbjct: 189 ISRT-PYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 25/215 (11%)
Query: 28 YSTKLGAGGFGVVYKGQF-----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN 82
+ +LG FG +YKG + +A K LK N + +F E + +H N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 83 LVRLYGFCYDQTKAALVYEFMENGSLDKYLF----------------TDTEVLKWEKLLD 126
+V L G + +++E++ G L ++L T L L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 127 IAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186
IAI A G+ YL + +H D+ NIL+ + K++D GL++ + +
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
+ PE ++ + D++SFG++L+EI
Sbjct: 186 SLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 27 NYSTKLGAGGFGVVYKGQFPNG--VKIAAKILKTC---LNKRVEAQFMAEIGTIGRTYHI 81
N+ LG G FG V + N +A K + K+V+ F +E + H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHP 91
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
V LYG D++ LV EF+ G +L + D+ A I + E
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-----DVGCFYAAQIVLIFEY 146
Query: 142 CNQ-RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
I++ D+KP N+LLD K+ DFG AK+ + T GTP Y APE LL
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILL 201
Query: 201 RNYPITQKCDVYSFGMLLFEII 222
N + D ++ G+ ++EI+
Sbjct: 202 -NVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 41/131 (31%), Positives = 64/131 (48%), Gaps = 19/131 (14%)
Query: 98 LVYEFMENGSLDK-------YLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
+V E+ + G L + LF + +L+W + G+ ++HE +R++H D
Sbjct: 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHE---KRVLHRD 125
Query: 151 IKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCD 210
IK NI L K+ DFG A+L + T Y GTP Y PE + N P K D
Sbjct: 126 IKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPE-IWENMPYNNKSD 182
Query: 211 VYSFGMLLFEI 221
++S G +L+E+
Sbjct: 183 IWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 35 GGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQF----MAEIGTIGRTYHINLVRL---- 86
G +GVVY+ + +I A LK ++ + F + EI + + H N+V +
Sbjct: 16 GTYGVVYRARDKKTGEIVA--LKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVV 73
Query: 87 YGFCYDQTKAALVYEFMEN---GSLD--KYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
G + K +V E++E+ ++ K F +EV K L + + G+A+LH+
Sbjct: 74 VG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV----KCLMLQL--LSGVAHLHD- 124
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
I+H D+K +N+LL+ + K+ DFGLA+ T T Y APE LL
Sbjct: 125 --NWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TLWYRAPELLLG 180
Query: 202 NYPITQKCDVYSFGMLLFEIIGRR 225
+ D++S G + E++ ++
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 8/90 (8%)
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
RG+ Y+H + ++H D+KP+NIL++ K+ DFGLA++ +P+ T GY T
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT-----GYVSTRY 170
Query: 193 YSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
Y APE +L + D++S G + E++
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 80/277 (28%), Positives = 123/277 (44%), Gaps = 58/277 (20%)
Query: 27 NYSTKLGAGGFGVVYKGQFPNGVKI-AAKILK------------TCLNKRVEA-----QF 68
N+ LG G FG V + ++ A KILK T + KRV A F
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 69 MAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIA 128
+ ++ + +T + RLY V E++ G L Y K + A
Sbjct: 63 LTQLHSCFQT----MDRLY----------FVMEYVNGGDL-MYQIQQVGRFKEPHAVFYA 107
Query: 129 IGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD--STSG 186
A G+ +LH ++ II+ D+K N++LD++ K+ADFG+ K EN D +T
Sbjct: 108 AEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKT 160
Query: 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW-------- 238
+ GTP Y APE ++ P + D ++FG+LL+E++ + + D L
Sbjct: 161 FCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219
Query: 239 FPKQVWDEYE---KGELA---AKVLGCGIE-ENDREE 268
+PK + E KG + K LGCG E E D +E
Sbjct: 220 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 62/204 (30%), Positives = 89/204 (43%), Gaps = 33/204 (16%)
Query: 32 LGAGGFGVV----YKGQFPNGVKIAAKILKT--CLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G FG V +KG G A K LK L + E + H +V
Sbjct: 26 LGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFT----DTEVLKW---EKLLDIAIGTARGIAYL 138
+ D+ + + EF+ G L +L +V K+ E +L YL
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL--------AFEYL 134
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEF 198
H ++ II+ D+KP N+LLD K KV DFG AK D T GTP Y APE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPE- 185
Query: 199 LLRNYPITQKCDVYSFGMLLFEII 222
++++ + D ++ G+LL+E I
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 63/196 (32%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRV-EAQFMAEIGTIGRTYHINLVRLYG 88
LG GGFG V Q K+ A K+ K + KR E+ + E + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 89 FCYDQTKA-ALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGTARGIAYLHEECNQRI 146
+ Y+ A LV M G L +++ E + + + A G+ LH+E RI
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RI 123
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPIT 206
++ D+KP NILLD +++D GLA + PE + G GT GY APE +++N T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLA-VHVPEG--QTIKGRVGTVGYMAPE-VVKNERYT 179
Query: 207 QKCDVYSFGMLLFEII 222
D ++ G LL+E+I
Sbjct: 180 FSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAA-KILKTCLNKRVEAQFMAEIGTIGR-TYHINLVRLYGF 89
+G G +G VYKG+ ++AA K++ ++ E + EI + + ++H N+ YG
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE--EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 90 CYDQTKAA------LVYEFMENGSL-DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC 142
++ LV EF GS+ D T LK + + I RG+A+LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA-- 139
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYR----GTPGYSAPE 197
++IH DIK N+LL K+ DFG+ A+L D T G R GTP + APE
Sbjct: 140 -HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-------DRTVGRRNTFIGTPYWMAPE 191
Query: 198 FLL--RNYPIT--QKCDVYSFGMLLFEI 221
+ N T + D++S G+ E+
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 27/203 (13%)
Query: 31 KLGAGGFG--VVYKGQFPNGVKIAAK---ILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
K+G G FG ++ K + +G + K I K +R E++ E+ + H N+V+
Sbjct: 7 KIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESR--KEVAVLSNMKHPNIVQ 63
Query: 86 LYGFCYDQTKAALVYEFMENGSLDK-------YLFTDTEVLKWEKLLDIAIGTARGIAYL 138
+ +V ++ E G L K LF + ++L W + I + + ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--FVQICLA----LKHV 117
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEF 198
H+ ++I+H DIK NI L + K+ DFG+A++ N +T + GTP Y +PE
Sbjct: 118 HD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN--STVELARTCIGTPYYLSPE- 171
Query: 199 LLRNYPITQKCDVYSFGMLLFEI 221
+ N P K D+++ G +L+E+
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 45/221 (20%)
Query: 32 LGAGGFGVVYKG---QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G G+V+ V + +L + + + EI I R H N+V++Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDHDNIVKVYE 69
Query: 89 FCYD-----------QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLD------IAIGT 131
T+ VY E Y+ TD + + L
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQE------YMETDLANVLEQGPLSEEHARLFMYQL 123
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPENTHDSTSGYRG- 189
RG+ Y+H + ++H D+KPAN+ ++ + K+ DFGLA++ +P +H GY
Sbjct: 124 LRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH---KGYLSE 177
Query: 190 ---TPGYSAPEFLL--RNYPITQKCDVYSFGMLLFE-IIGR 224
T Y +P LL NY T+ D+++ G + E + G+
Sbjct: 178 GLVTKWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAA-KILKTCLNKRVEAQFMAEIGTIGR-TYHINLVRLYGF 89
+G G +G VYKG+ ++AA K++ ++ E + EI + + ++H N+ YG
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 90 CYDQTKAA------LVYEFMENGSL-DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC 142
+ LV EF GS+ D T LK E + I RG+++LH+
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-- 129
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYR----GTPGYSAPE 197
++IH DIK N+LL K+ DFG+ A+L D T G R GTP + APE
Sbjct: 130 -HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-------DRTVGRRNTFIGTPYWMAPE 181
Query: 198 FLL--RNYPITQ--KCDVYSFGMLLFEI 221
+ N T K D++S G+ E+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 31 KLGAGGFGVVYKGQFPNGVK--IAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
++G G FG V+KG N + +A KI+ + EI + + + + YG
Sbjct: 11 RIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTA-----RGIAYLHEECN 143
TK ++ E++ GS ++L+ + I T +G+ YLH E
Sbjct: 70 SYLKGTKLWIIMEYLGGGSA-------LDLLRAGPFDEFQIATMLKEILKGLDYLHSE-- 120
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY 203
+ IH DIK AN+LL + K+ADFG+A +T + + GTP + APE +++
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE-VIQQS 176
Query: 204 PITQKCDVYSFGMLLFEI 221
K D++S G+ E+
Sbjct: 177 AYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 52/224 (23%), Positives = 82/224 (36%), Gaps = 45/224 (20%)
Query: 32 LGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY----------- 79
LG G +G V K G +A K +K + +G G +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 80 --HINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEV--LKWEKLLDIAIG 130
H N++ L + LV + M L K T+++V + + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQIL------ 129
Query: 131 TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG- 189
G+ LH +H D+ PANI +++K K+ADFGLA+ D+ S
Sbjct: 130 --NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 190 -----------TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
T Y APE L+ D++S G + E++
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
|
Length = 335 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 33/77 (42%), Positives = 50/77 (64%), Gaps = 3/77 (3%)
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPI 205
+I+ D+KP NILLD + + DFGL KL N ++ D T+ + GTP Y APE LL +
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDD-DKTNTFCGTPEYLAPELLL-GHGY 170
Query: 206 TQKCDVYSFGMLLFEII 222
T+ D ++ G+LL+E++
Sbjct: 171 TKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 21/200 (10%)
Query: 32 LGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAE-----IGTIGRTYHINLVR 85
LG GGFG V Q G A K L+ K+ + + MA + + + +NL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 86 LYGFCYDQTKAAL--VYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEEC 142
Y +TK AL V M G L +++ + E+ L A G+ LH E
Sbjct: 68 AY-----ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE- 121
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
++ D+KP NILLD +++D GLA + PE +S G GT GY APE +L N
Sbjct: 122 --NTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEG--ESIRGRVGTVGYMAPE-VLNN 175
Query: 203 YPITQKCDVYSFGMLLFEII 222
T D + G L++E+I
Sbjct: 176 QRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 39/213 (18%)
Query: 32 LGAGGFGVVYKGQF-PNG----------VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH 80
LG G F +YKG V + K+L + + R F + + H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS--DHRDSLAFFETASLMSQLSH 60
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHE 140
+LV+LYG C + +V E+++ G LD +L + + LD+A A + YL +
Sbjct: 61 KHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG-------- 192
++++H ++ NIL+ A++ KL +P G T
Sbjct: 120 ---KKLVHGNVCGKNILV-ARYGLNEGYVPFIKLSDP--------GIPITVLSREERVER 167
Query: 193 --YSAPEFLLRNYP--ITQKCDVYSFGMLLFEI 221
+ APE +RN +T D +SFG L EI
Sbjct: 168 IPWIAPEC-IRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAAKI--LKTCLNKRV-----EAQFMAEIGTIGRTYHINLV 84
LG GGFG V Q V+ K+ K KR+ EA + E + + +V
Sbjct: 8 LGKGGFGEVCACQ----VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 85 RLYGFCYDQTKAAL--VYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEE 141
L + Y +TK AL V M G L +++ E+ + A G+ LH E
Sbjct: 64 SL-AYAY-ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
RI++ D+KP NILLD +++D GLA PE ++ G GT GY APE +++
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEG--ETIRGRVGTVGYMAPE-VVK 174
Query: 202 NYPITQKCDVYSFGMLLFEII 222
N T D + G L++E+I
Sbjct: 175 NERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 36/209 (17%)
Query: 32 LGAGGFGVVY---KGQFPNGVKI-AAKILKTCL---NKRVEAQFMAEIGTIGRTYHINLV 84
LG GG+G V+ K + KI A K+LK N++ A AE + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 85 RL-YGFCYDQT--KAALVYEFMENGSLDKYL------FTDTEVLKWEKLLDIAIGTARGI 135
L Y F QT K L+ E++ G L +L DT ++ +A+
Sbjct: 64 DLIYAF---QTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEIS-LALE----- 114
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS--TSGYRGTPGY 193
+LH+ Q II+ D+KP NILLDA+ K+ DFGL K E+ H+ T + GT Y
Sbjct: 115 -HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEII 222
APE L+R+ + D +S G L+++++
Sbjct: 167 MAPEILMRSGH-GKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 32 LGAGGFGVVYK-GQFPNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G G +G V+K NG K A KIL +++ +EA++ + H N+V+ YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI---LKALSDHPNVVKFYG 82
Query: 89 FCYDQTKAA-----LVYEFMENGS---LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHE 140
Y + LV E GS L K E ++ + I G+ +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH- 141
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYRGTPGYSAPEFL 199
+ IH D+K NILL + K+ DFG+ A+L + +++ GTP + APE +
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---GTPFWMAPEVI 196
Query: 200 LRNYPI----TQKCDVYSFGMLLFEI 221
+ +CDV+S G+ E+
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 51/172 (29%), Positives = 79/172 (45%), Gaps = 17/172 (9%)
Query: 57 KTCLNKRVEA---QFMAEIGTIGRTY-HINLVRLYG-FCYDQTKAALVYEFMENGSLDKY 111
KTC + ++A A I R H ++++L G F Y++ ++ + D Y
Sbjct: 115 KTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY----KTDLY 170
Query: 112 LF-TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFG 170
+ + +L I R I YLH RIIH DIK NI ++ + DFG
Sbjct: 171 CYLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG 227
Query: 171 LAKLCNPEN-THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
A C P + + G+ GT +APE L R+ P D++S G++LFE+
Sbjct: 228 AA--CFPVDINANKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 69/231 (29%), Positives = 105/231 (45%), Gaps = 29/231 (12%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRV-EAQFMAEIGTIGRTYHINLVRLYG 88
LG GGFG V Q K+ A K+ K + KR EA + E + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 89 FCYDQTKA-ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC----- 142
+ Y+ A LV M G L +++ + + R I Y E C
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYN---------MGNPGFDEQRAIFYAAELCCGLED 117
Query: 143 --NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
+RI++ D+KP NILLD + +++D GLA PE ++ G GT GY APE ++
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEG--ETVRGRVGTVGYMAPE-VI 173
Query: 201 RNYPITQKCDVYSFGMLLFEII-GR---RKNAQDCSSDTLDWFPKQVWDEY 247
N T D + G L++E+I G+ RK + + +D K+ +EY
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
G+ YLH QRIIH D+K NI ++ + D G A+ G GT
Sbjct: 168 EGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAF--LGLAGTVE 221
Query: 193 YSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
+APE L R+ K D++S G++LFE++
Sbjct: 222 TNAPEVLARD-KYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 18/200 (9%)
Query: 30 TKLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQ-FMAEIGTIGRTYHINLVRLY 87
++G+G +G V G K+A K L + A+ E+ + H N++ L
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIG-----TARGIAYLHEEC 142
T A EF + + Y+ TD + + L + + G+ Y+H
Sbjct: 81 DV---FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS-- 135
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
IIH D+KP N+ ++ K+ DFGLA+ + E T GY T Y APE +L
Sbjct: 136 -AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPEVILNW 189
Query: 203 YPITQKCDVYSFGMLLFEII 222
Q D++S G ++ E++
Sbjct: 190 MHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 79/281 (28%), Positives = 122/281 (43%), Gaps = 59/281 (20%)
Query: 25 TNNYSTKLGAGGFGVVYKGQFPNGVKI-AAKILK------------TCLNKRVEAQ---- 67
N+ LG G FG V + ++ A KILK T + KRV A
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 68 -FMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLD 126
F+ ++ + +T RLY V E++ G L Y K + +
Sbjct: 61 PFLTQLHSCFQTVD----RLY----------FVMEYVNGGDL-MYHIQQVGKFKEPQAVF 105
Query: 127 IAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD--ST 184
A + G+ +LH + II+ D+K N++LD++ K+ADFG+ K E+ D +T
Sbjct: 106 YAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTT 158
Query: 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW------ 238
+ GTP Y APE + P + D +++G+LL+E++ + D L
Sbjct: 159 RTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217
Query: 239 --FPKQVWDEYE---KG---ELAAKVLGCGIE-END-REEA 269
+PK + E KG + +K LGCG E E D RE A
Sbjct: 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHA 258
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 45/214 (21%)
Query: 30 TKLGAGGFGVV---YKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY------- 79
T +G+G +G V Y + K+A K L + A+ RTY
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHAR---------RTYRELRLLK 69
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTD------TEVLKWEKLLD-----IA 128
H+ + G T A + F E YL T+ ++K +KL D +
Sbjct: 70 HMKHENVIGLLDVFTPATSIENFNE-----VYLVTNLMGADLNNIVKCQKLSDEHVQFLI 124
Query: 129 IGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188
RG+ Y+H + IIH D+KP+N+ ++ ++ DFGLA+ D +GY
Sbjct: 125 YQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYV 176
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
T Y APE +L Q D++S G ++ E++
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 40/222 (18%)
Query: 27 NYSTKLGAGGFGVVYKGQ---FPNGVKIAAKILKTCLNKRVEAQFMA---EIGTIGRTYH 80
+G G +G VYK + +G + A K K ++ + EI + H
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD-KEQYTGISQSACREIALLRELKH 61
Query: 81 INLVRLYGFCYDQT--KAALVYEFMENGSLDKYLFTDTEVLKWE---KLLDIAIGTAR-- 133
N+V L + L++++ E+ +++K+ K + I +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLW--------QIIKFHRQAKRVSIPPSMVKSL 113
Query: 134 ------GIAYLHEECNQRIIHYDIKPANILLDAKFSA----KVADFGLAKLCN-PENTHD 182
G+ YLH ++H D+KPANIL+ + K+ D GLA+L N P
Sbjct: 114 LWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 183 STSGYRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEII 222
T Y APE LL R+Y T+ D+++ G + E++
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHY--TKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 32 LGAGGFGVV-YKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+G+G +G V G K+A K L + +++ A+ R Y +RL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL----YRPFQSELFAK-----RAYR--ELRLLKHM 71
Query: 91 YDQTKAALVYEFMENGSLDK----YL---FTDTE---VLKWEKLLD-----IAIGTARGI 135
+ L+ F + SLD+ YL F T+ ++K EKL + + +G+
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSA 195
Y+H IIH D+KP N+ ++ K+ DFGLA+ + E T GY T Y A
Sbjct: 132 KYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT-----GYVVTRWYRA 183
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFEII 222
PE +L TQ D++S G ++ E++
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 32 LGAGGFGVVYKGQFP-NGVKIAAKILK---TCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
LG G FG V + G A K LK ++ VE M E + + N +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECT-MVEKRVLALAWE-NPFLTH 60
Query: 88 GFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
+C QTK L V EF+ G L + D + A G+ +LH ++
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL-MFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKG 116
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH--DSTSGYRGTPGYSAPEFLLRNY 203
II+ D+K N++LD K+ADFG+ K EN + S + GTP Y APE +L+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRASTFCGTPDYIAPE-ILQGL 171
Query: 204 PITQKCDVYSFGMLLFEII 222
T D +SFG+LL+E++
Sbjct: 172 KYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 32 LGAGGFGVVYKG-QFPNGVKIAAKILK-----TCLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G FG VY G ++AAK ++ +K V A EI + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSA-LECEIQLLKNLQHERIVQ 68
Query: 86 LYGFCYDQTKAALV--YEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYL 138
YG D+ + L E+M GS+ L T++ K+ + + G++YL
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSYL 122
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR---GTPGYSA 195
H + I+H DIK ANIL D+ + K+ DFG +K + S +G R GTP + +
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASK--RLQTICMSGTGIRSVTGTPYWMS 177
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
PE ++ +K DV+S G + E++ +
Sbjct: 178 PE-VISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 32 LGAGGFGVVY----KGQFPNGVKIAAKILK--TCLNKRVEAQF-MAEIGTIGRTYHIN-L 83
LG G +G V+ G G A K+LK T + K A+ E + L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 84 VRL-YGFCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAY 137
V L Y F D TK L+ +++ G L +L FT++EV + + +A+ +
Sbjct: 68 VTLHYAFQTD-TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL------DH 120
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE 197
LH+ II+ DIK NILLD++ + DFGL+K E + + GT Y APE
Sbjct: 121 LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPE 176
Query: 198 FLLRNYPITQKC-DVYSFGMLLFEII 222
+ K D +S G+L FE++
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 35 GGFGVVYKGQF--PNGVKIAAKILKTCLNKRVEAQ---FMAEIGTIGRTYHINLVRLYGF 89
G FG ++ G K +KT + E Q + E + H N++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 90 CYDQTKAALV-YEFMENGSLDKYL-------FTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
C + + V Y +M G+L +L + + L ++L+ +AI A G++YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
+ +IH DI N ++D + K+ D L++ P + H + A E L+
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193
Query: 202 NYPITQKCDVYSFGMLLFEII 222
+ DV+SFG+LL+E++
Sbjct: 194 KE-YSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 62/236 (26%), Positives = 96/236 (40%), Gaps = 56/236 (23%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G G FG V Q + I A K L+ L K A AE + + +V+LY
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68
Query: 89 FCYDQTKAALVYEFMENGS----LDKY-LFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
D+ L+ E++ G L K FT+ E + +AI + + Y
Sbjct: 69 SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY------ 122
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAK-------------------------LCNPE 178
IH DIKP N+LLDAK K++DFGL + P
Sbjct: 123 ---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 179 NTHDSTSGYR-----------GTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEII 222
++ ++ GTP Y APE L+ Y ++CD +S G++++E++
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY--NKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 32 LGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHI-NLVRLYGF 89
+G+G G VYK +F G +A K ++ NK + + ++ + +++ +V+ YG+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ + E M LDK L + + L + + + + YL E +IH
Sbjct: 83 FITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHR 139
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFL-----LRNYP 204
D+KP+NILLDA + K+ DFG++ ++ G Y APE + Y
Sbjct: 140 DVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA---GCAAYMAPERIDPPDPNPKYD 196
Query: 205 ITQKCDVYSFGMLLFEI 221
I + DV+S G+ L E+
Sbjct: 197 I--RADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 26/201 (12%)
Query: 31 KLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
K+G G G VY G ++A K + + E + EI + H N+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL-IINEILVMRENKHPNIVNYLDS 84
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ----- 144
+ +V E++ GSL T+V+ E +D IA + EC Q
Sbjct: 85 YLVGDELWVVMEYLAGGSL-------TDVVT-ETCMDEGQ-----IAAVCRECLQALEFL 131
Query: 145 ---RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
++IH DIK NILL S K+ DFG PE + ST GTP + APE + R
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTR 189
Query: 202 NYPITQKCDVYSFGMLLFEII 222
K D++S G++ E++
Sbjct: 190 K-AYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 10/193 (5%)
Query: 31 KLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
K+G G G VY G ++A K + + E + EI + + N+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDS 84
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ +V E++ GSL + T+T + ++ + + + +LH + ++IH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD-VVTET-CMDEGQIAAVCRECLQALDFLH---SNQVIHR 139
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
DIK NILL S K+ DFG PE + ST GTP + APE + R K
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK-AYGPKV 196
Query: 210 DVYSFGMLLFEII 222
D++S G++ E++
Sbjct: 197 DIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 22/183 (12%)
Query: 50 KIAAKILKTCLNKRVEAQFM-AEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108
K+ AK + LN +A + +E+ + H +V+ + K L+ E+ G L
Sbjct: 95 KVVAKFVM--LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL 152
Query: 109 DKYL---------FTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD 159
+K + F + EV LL I A L E +++++H D+K ANI L
Sbjct: 153 NKQIKQRLKEHLPFQEYEV----GLLFYQIVLA-----LDEVHSRKMMHRDLKSANIFLM 203
Query: 160 AKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
K+ DFG +K + + D S + GTP Y APE R ++K D++S G++L+
Sbjct: 204 PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILY 262
Query: 220 EII 222
E++
Sbjct: 263 ELL 265
|
Length = 478 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 8/192 (4%)
Query: 32 LGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+G G +GVV K + +I A K + N+ V+ + E+ + N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ K LV+E++E L+ V EK+ + I + H+ I+H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHWCHK---NDIVHR 124
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
DIKP N+L+ K+ DFG A+ + E ++ + + Y T Y +PE LL P +
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLL-GAPYGKAV 182
Query: 210 DVYSFGMLLFEI 221
D++S G +L E+
Sbjct: 183 DMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 5e-09
Identities = 42/135 (31%), Positives = 62/135 (45%), Gaps = 14/135 (10%)
Query: 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARG---IAYLHEECNQ--------RII 147
+ F+++ + LF E L L D+ T IA + EC Q ++I
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVI 137
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
H DIK N+LL S K+ DFG PE + ST GTP + APE + R
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK-AYGP 194
Query: 208 KCDVYSFGMLLFEII 222
K D++S G++ E++
Sbjct: 195 KVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 10/91 (10%)
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH--DSTSGYRGTPGYS 194
+LHE + II+ D+K N+LLDA+ K+ D+G+ K E D+TS + GTP Y
Sbjct: 111 FLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYI 163
Query: 195 APEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
APE +LR D ++ G+L+FE++ R
Sbjct: 164 APE-ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 31 KLGAGGFGVVYKGQFPNGV---KIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
++G G FG V G+ +G ++ K L+ + + + +F+ E H NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFT----DTEVLKWEKLLDIAIGTARGIAYLHEECN 143
G C + T LV EF G L YL + + L +A A G+ +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP-GYSAPEFL--- 199
IH D+ N LL A + K+ D+GL+ + + T P + APE +
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 200 ---LRNYPITQKCDVYSFGMLLFEI 221
L T++ +V+S G+ ++E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 7/146 (4%)
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLH 139
H LV L+ +++ V E++ G L + L E + + + YLH
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH 113
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFL 199
E + II+ D+K N+LLD++ K+ D+G+ K D+TS + GTP Y APE +
Sbjct: 114 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE-I 167
Query: 200 LRNYPITQKCDVYSFGMLLFEIIGRR 225
LR D ++ G+L+FE++ R
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
GI +LH + IIH D+KP+NI++ + + K+ DFGLA+ T + Y T Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYY 183
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEII 222
APE +L + D++S G ++ E+I
Sbjct: 184 RAPEVIL-GMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 32 LGAGGFGVVYKG-QFPNGVKIAAKIL-----KTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G FG VY G ++A K + +K V A EI + H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKNLRHDRIVQ 68
Query: 86 LYGFCYD--QTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYL 138
YG D + K ++ E+M GS+ L T+ ++ + + +G++YL
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGVSYL 122
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR---GTPGYSA 195
H + I+H DIK ANIL D+ + K+ DFG +K + S +G + GTP + +
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASK--RIQTICMSGTGIKSVTGTPYWMS 177
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
PE ++ +K DV+S + E++ +
Sbjct: 178 PE-VISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 32 LGAGGFG-VVYKGQFPNGVKIAAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRL-Y 87
LG G FG V+ + G A KILK + K A + E + T H L L Y
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 88 GFCYDQTKAAL--VYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHE 140
F QT L V E+ G L +L F++ + + A+G YLH
Sbjct: 63 SF---QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHS 113
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH-DSTSGYRGTPGYSAPEFL 199
+++ D+K N++LD K+ DFG LC + + + GTP Y APE +
Sbjct: 114 ---CDVVYRDLKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTFCGTPEYLAPE-V 166
Query: 200 LRNYPITQKCDVYSFGMLLFEII-GR 224
L + + D + G++++E++ GR
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 31/211 (14%)
Query: 32 LGAGGFGVVYKG-QFPNGVKIAAKILK-----TCLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G FG VY G ++A K ++ +K V A EI + H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA-LECEIQLLKNLLHERIVQ 68
Query: 86 LYGFCYDQTKAAL--VYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYL 138
YG D + L E M GS+ L T+ K+ + + G++YL
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGVSYL 122
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK----LCNPENTHDSTSGYRGTPGYS 194
H + I+H DIK ANIL D+ + K+ DFG +K +C S + GTP +
Sbjct: 123 H---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GTPYWM 176
Query: 195 APEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
+PE ++ +K D++S G + E++ +
Sbjct: 177 SPE-VISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 67/261 (25%), Positives = 102/261 (39%), Gaps = 57/261 (21%)
Query: 32 LGAGGFGVVYKGQFPN-GVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G G FG V Q + G A KIL+ L K AE + + +V+++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
D+ L+ EF+ G + L + + E IA T I +H+ IH
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQ---LGFIH 124
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR-------------------- 188
DIKP N+LLD+K K++DFG LC T YR
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFG---LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 189 ----------------GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFE-IIGR----RKN 227
GTP Y APE ++ + CD +S G++++E +IG +
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 228 AQDCSSDTLDW-----FPKQV 243
Q+ ++W FP +V
Sbjct: 241 PQETYKKVMNWKETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKIL-KTCLNKRVEAQFMAEIGTIGRTYHIN---LVRL 86
+G G FG V + + ++ A K+L K + KR ++ F E I H N +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWIVQL 108
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVL-KWEKLLDIAIGTARGIAYLHEECNQR 145
+ D +V E+M G L L ++ ++ KW + + A + +H +
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLA--LDAIH---SMG 162
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN-THDSTSGYRGTPGYSAPEFLLR--- 201
IH D+KP N+LLD K+ADFG + T+ GTP Y +PE L
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQGG 220
Query: 202 NYPITQKCDVYSFGMLLFEII 222
+ ++CD +S G+ L+E++
Sbjct: 221 DGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 72/306 (23%), Positives = 115/306 (37%), Gaps = 93/306 (30%)
Query: 26 NNYST--KLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVE-AQFMAEIGTIGRTYH 80
++ T +G G FG V Q + KI A +LK+ + K+ + A AE + +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLD-----------IAI 129
+V LY D L+ EF+ G L T ++K++ + +AI
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLM------TMLIKYDTFSEDVTRFYMAECVLAI 114
Query: 130 GTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR- 188
+ + IH DIKP NIL+D K++DFGL+ HDS +
Sbjct: 115 EAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLST--GFHKQHDSAYYQKL 163
Query: 189 ----------------------------------------------GTPGYSAPE-FLLR 201
GTP Y APE FL +
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 202 NYPITQKCDVYSFGMLLFE-IIGR----RKNAQDCSSDTLDW-----FPKQVWDEYEKGE 251
Y Q+CD +S G ++FE +IG +N+ + ++W FP + E +
Sbjct: 224 GY--GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAED 281
Query: 252 LAAKVL 257
L +++
Sbjct: 282 LIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 64/244 (26%), Positives = 89/244 (36%), Gaps = 63/244 (25%)
Query: 32 LGAGGFG-VVYKGQFPNGVKIAAKIL--KTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG V + A K L K LN+ A AE + + +V+LY
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
D+ V +++ G + L F + + L +AI + + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF------ 122
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAK--------------------LCNPENTHDS 183
IH DIKP NIL+D K+ DFGL P + D
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 184 TSGYR-------------------------GTPGYSAPEFLLRNYPITQKCDVYSFGMLL 218
S R GTP Y APE LLR TQ CD +S G++L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVIL 238
Query: 219 FEII 222
FE++
Sbjct: 239 FEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 10/193 (5%)
Query: 31 KLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
K+G G G VY G ++A + + + E + EI + + N+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDS 85
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ +V E++ GSL + T+T + ++ + + + +LH + ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTD-VVTET-CMDEGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
DIK NILL S K+ DFG PE + ST GTP + APE + R K
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK-AYGPKV 197
Query: 210 DVYSFGMLLFEII 222
D++S G++ E+I
Sbjct: 198 DIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 59/198 (29%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKIL-KTCLNKRVEAQFMAEIGTIGRTYHIN-LVRLYG 88
+G G FG V + + K+ A K+L K + KR ++ F E I + +V+L+
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
D +V E+M G L + KW K TA + L + +IH
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIH 165
Query: 149 YDIKPANILLDAKFSAKVADFGLA-KLCNPENTHDSTSGYRGTPGYSAPEFLLR---NYP 204
D+KP N+LLD K+ADFG K+ T+ GTP Y +PE L +
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGY 223
Query: 205 ITQKCDVYSFGMLLFEII 222
++CD +S G+ LFE++
Sbjct: 224 YGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 83 LVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC 142
LV L+ ++ LV E++ G L + L E A + +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL-MFHMQRQRKLPEEHARFYAAEICIALNFLHE-- 114
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
+ II+ D+K N+LLDA K+ D+G+ K D+TS + GTP Y APE +LR
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPE-ILRG 170
Query: 203 YPITQKCDVYSFGMLLFEIIGRR 225
D ++ G+L+FE++ R
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 3e-08
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 34/155 (21%)
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLD------IAIGTAR 133
+ N ++LY L+ +++++G L F ++LK E L I
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----F---DLLKKEGKLSEAEVKKIIRQLVE 120
Query: 134 GIAYLHEECNQRIIHYDIKPANILLD-AKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
+ LH IIH DIK N+L D AK + D+GL K+ + +D T Y
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDY----- 172
Query: 193 YSAPEFLLRNYPITQKCDVYSF-----GMLLFEII 222
+S PE + D SF G+L +E++
Sbjct: 173 FS-PEKIKG-----HNYD-VSFDWWAVGVLTYELL 200
|
Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 69/259 (26%), Positives = 104/259 (40%), Gaps = 53/259 (20%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G G FG V Q + I A KIL+ L K A AE + +V+++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
D+ L+ EF+ G + L + + IA T I +H+ IH
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQ---LGFIH 124
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPEN--------THDSTSGYR------------ 188
DIKP N+LLDAK K++DFGL + TH+ S +
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 189 -------------GTPGYSAPE-FLLRNYPITQKCDVYSFGMLLFE-IIGR----RKNAQ 229
GTP Y APE F+ Y + CD +S G++++E +IG + Q
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGY--NKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 230 DCSSDTLDW-----FPKQV 243
+ ++W FP +V
Sbjct: 243 ETYRKVMNWKETLVFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 32 LGAGGFGVVYKGQFP-NGVKIAAKILKTCL---NKRVEAQFMAE--IGTIGRTYHINLVR 85
LG G FG V + +G A K+LK + + VE M E I ++ R H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECT-MTEKRILSLARN-HPFLTQ 60
Query: 86 LYGFCYDQTKAAL--VYEFMENGSL------------DKYLFTDTEVLKWEKLLDIAIGT 131
LY C QT L V EF+ G L + F E+
Sbjct: 61 LY--CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITS----------- 107
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD--STSGYRG 189
+ +LH+ + II+ D+K N+LLD + K+ADFG+ K E + +TS + G
Sbjct: 108 --ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCG 158
Query: 190 TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
TP Y APE +L+ D ++ G+LL+E++
Sbjct: 159 TPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 66/209 (31%), Positives = 94/209 (44%), Gaps = 33/209 (15%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKIL-KTCLNKRVE-AQFMAEIGTIGRTYHINLVRLYG 88
+G G FG V + + +I A KIL K + KR E A F E R +N G
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE-----RNVLVN-----G 58
Query: 89 FCYDQTKAALVYEFMENGSL----DKYLFTD--TEVLKWEKLL--DIA-IGTARGIAYLH 139
C Q L Y F + L D Y+ D T + K+E L D+A A + +H
Sbjct: 59 DC--QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFL 199
+H DIKP N+LLD ++ADFG N + T S+ GTP Y +PE L
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEIL 175
Query: 200 ------LRNYPITQKCDVYSFGMLLFEII 222
+ Y +CD +S G+ ++E++
Sbjct: 176 QAMEDGMGKY--GPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 39/120 (32%), Positives = 61/120 (50%), Gaps = 9/120 (7%)
Query: 109 DKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVA 167
D + + D + L E+ + I +AYLH + IIH D+K NI LD +A +
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLG 227
Query: 168 DFGLAKLCNPENTHDSTS--GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
DFG A C + D+ G+ GT ++PE L + P K D++S G++LFE+ +
Sbjct: 228 DFGAA--CKLDAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 20/195 (10%)
Query: 40 VYKGQFPNGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT--- 94
+YKG F N ++ + K K + EI + R N++++YGF D
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 95 -KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKP 153
+ +L+ E+ G L + L + + L ++ LD+AI +G+ L++ N+ + ++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 154 ANILLDAKFSAKVADFGLAK-LCNPENTHDSTSGYRGTPGYSAPEFLLRNY--PITQKCD 210
+ L+ + K+ GL K L +P + + Y +L + T K D
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF-------SYKMLNDIFSEYTIKDD 204
Query: 211 VYSFGMLLFEIIGRR 225
+YS G++L+EI +
Sbjct: 205 IYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 7e-08
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 32 LGAGGFG-VVYKGQFPNGVKIAAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRL-Y 87
LG G FG V+ + +G A KILK + K A + E + T H L L Y
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 88 GFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
F QTK L V E++ G L +L + V ++ + YLH + +
Sbjct: 63 SF---QTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGAEIVSALDYLH---SGK 115
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS--GYRGTPGYSAPEFLLRNY 203
I++ D+K N++LD K+ DFGL K E D+ + + GTP Y APE L N
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAPEVLEDN- 170
Query: 204 PITQKCDVYSFGMLLFEIIGRR 225
+ D + G++++E++ R
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFL--LRNYP 204
+H DIKP N+L+D K+ADFG A +S GTP Y APE L +
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDG 182
Query: 205 ITQ---KCDVYSFGMLLFEII-GRRKNAQDCSSDT 235
+CD +S G++ +E+I GR + S+ T
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT 217
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 32/220 (14%)
Query: 31 KLGAGGFGVVY--KGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G FG V+ K + I L +R ++Q + E+ + H N+VR
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 89 FCYDQT--KAALVYEFMENGSLDKYL---FTDTEVLKWEKLLDIAIGTARGIAYLHE--- 140
++ K ++ EF + G L + + + ++ ++DI +AY H
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 141 -ECNQRIIHYDIKPANIL-----------------LDAKFSAKVADFGLAKLCNPENTHD 182
+R++H D+KP NI L+ + AK+ DFGL+K E+
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH 199
Query: 183 STSGYRGTPGYSAPEFLL-RNYPITQKCDVYSFGMLLFEI 221
S GTP Y +PE LL K D+++ G +++E+
Sbjct: 200 SCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
|
Length = 1021 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKIL-KTCLNKRVEAQFMAEIGTIGRTYHIN-LVRLYG 88
+G G FG V + + K+ A K+L K + KR ++ F E I + +V+L+
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
D +V E+M G L + KW + TA + L + IH
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIH 165
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR---NYPI 205
D+KP N+LLD K+ADFG N E + GTP Y +PE L +
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 206 TQKCDVYSFGMLLFEII 222
++CD +S G+ L+E++
Sbjct: 225 GRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 45/148 (30%), Positives = 69/148 (46%), Gaps = 17/148 (11%)
Query: 35 GGFGVVYKGQFPNGVKI-AAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY 91
G FG VY G+ N K+ A K++K +NK + Q AE + + +V LY
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 92 DQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
LV E++ G + L F + +K+ I+ A + YLH I
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-----IS-EVALALDYLHR---HGI 125
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKL 174
IH D+KP N+L+ + K+ DFGL+K+
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 29/78 (37%), Positives = 46/78 (58%), Gaps = 5/78 (6%)
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKL-CNPENTHDSTSGYRGTPGYSAPEFLLRNYP 204
+I+ D+K NILLDA+ K+ADFG+ K T T+ + GTP Y APE +L+
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---TTTFCGTPDYIAPE-ILQELE 172
Query: 205 ITQKCDVYSFGMLLFEII 222
D ++ G+L++E++
Sbjct: 173 YGPSVDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 23/108 (21%)
Query: 131 TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR-- 188
T + YLH N I+H D+KP N+L+ + K+ DFGL+K+ T + G+
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 189 -----------GTPGYSAPEFLLRN---YPITQKCDVYSFGMLLFEII 222
GTP Y APE +LR P+ D ++ G++L+E +
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 36/154 (23%), Positives = 70/154 (45%), Gaps = 23/154 (14%)
Query: 31 KLGAGGFGVVYKGQF---PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY----HINL 83
++G G FG V + ++ K LK + + + +F+ + G Y H N+
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQ----GDPYRILQHPNI 57
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEKLLDIAIGTARGIAY 137
++ G C + LV+E+ E G L YL ++++L +++ A A G+ +
Sbjct: 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM---ACEIAAGVTH 114
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGL 171
+H+ +H D+ N L + + KV D+G+
Sbjct: 115 MHK---HNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 39/133 (29%), Positives = 48/133 (36%), Gaps = 53/133 (39%)
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC------------------- 175
I +H IH DIKP NIL+D K+ DFGL C
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL---CTGFRWTHDSKYYQKGDHHR 167
Query: 176 ----NPENTHDSTSGYR---------------------GTPGYSAPEFLLRN-YPITQKC 209
P R GTP Y APE LLR Y TQ C
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY--TQLC 225
Query: 210 DVYSFGMLLFEII 222
D +S G++L+E++
Sbjct: 226 DWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 32 LGAGGFG-VVYKGQFPNGVKIAAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRL-Y 87
LG G FG V+ + G A KILK + K A + E + + H L L Y
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
F + V E+ G L +L + V ++ + YLH E N ++
Sbjct: 63 SF-QTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VV 118
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS--GYRGTPGYSAPEFLLRNYPI 205
+ D+K N++LD K+ DFGL K E D + + GTP Y APE L N
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDN-DY 173
Query: 206 TQKCDVYSFGMLLFEIIGRR 225
+ D + G++++E++ R
Sbjct: 174 GRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 32 LGAGGFG-VVYKGQFPNGVKIAAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRL-Y 87
LG G FG V+ + G A KIL+ + K A + E + T H L L Y
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 88 GFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
F QT L V E+ G L +L + V E+ + YLH ++
Sbjct: 63 AF---QTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH---SRD 115
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST-SGYRGTPGYSAPEFLLRNYP 204
+++ DIK N++LD K+ DFG LC + +T + GTP Y APE L N
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTFCGTPEYLAPEVLEDN-D 171
Query: 205 ITQKCDVYSFGMLLFEIIGRR 225
+ D + G++++E++ R
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 117 EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176
+VL E L+ + A+G+ +L +++ IH D+ NILL K+ DFGLA+
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 177 PENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
+ + R + APE + Q DV+SFG+LL+EI
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQS-DVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 11/85 (12%)
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL---- 200
+H DIKP N+LLD ++ADFG + T S GTP Y +PE L
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEILQAMED 180
Query: 201 ---RNYPITQKCDVYSFGMLLFEII 222
R P +CD +S G+ ++E++
Sbjct: 181 GKGRYGP---ECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 4/103 (3%)
Query: 119 LKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178
L E L+ + ARG+ +L +++ IH D+ NILL K+ DFGLA+ +
Sbjct: 171 LTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227
Query: 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
+ R + APE + TQ DV+SFG+LL+EI
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQS-DVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 8e-07
Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 19/207 (9%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG-- 88
K+G G +G VYK + +G LK + EI + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYLHE 140
+ K L++++ E+ F +K + + G + GI YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 141 ECNQRIIHYDIKPANILL----DAKFSAKVADFGLAKLCN-PENTHDSTSGYRGTPGYSA 195
++H D+KPANIL+ + K+AD G A+L N P T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFEII 222
PE LL T+ D+++ G + E++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 4/130 (3%)
Query: 92 DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDI 151
D+ ++ +++ + L D L E LL + A+G+++L ++ IH D+
Sbjct: 184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDL 240
Query: 152 KPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDV 211
NILL K+ DFGLA+ ++ + R + APE + N T + DV
Sbjct: 241 AARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDV 299
Query: 212 YSFGMLLFEI 221
+S+G+LL+EI
Sbjct: 300 WSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 17 TLEQLCSFTNNYSTKLGA----GGFGVVYKGQ-FPNGVKIA-AKILKTCLNKRVEAQFMA 70
++ + + N S KLG G FGVVY+ K+A K+L+ K E M
Sbjct: 55 MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMK 114
Query: 71 EIGTIGRTYHINLVRLYGFCYDQTKAA--------LVYEFMENGSLDKYLFTDTEVLKWE 122
+ HIN++ L + Y + +V EF+ ++ KY+
Sbjct: 115 NLN------HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167
Query: 123 KLLDIAIGT---ARGIAYLHEECNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPE 178
L + + + R +AY+H ++ I H D+KP N+L+D + K+ DFG AK N
Sbjct: 168 PLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLL 222
Query: 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
S S Y + Y APE +L T D++S G ++ E+I
Sbjct: 223 AGQRSVS-YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 6/104 (5%)
Query: 119 LKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178
L E L+ + ARG+ +L +++ IH D+ NILL K+ DFGLA+ +
Sbjct: 170 LTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 226
Query: 179 NTHDSTSGYRGTPGYSAPEFLL-RNYPITQKCDVYSFGMLLFEI 221
+ R + APE + + Y T + DV+SFG+LL+EI
Sbjct: 227 PDYVRKGDARLPLKWMAPESIFDKVY--TTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 39/127 (30%), Positives = 61/127 (48%), Gaps = 13/127 (10%)
Query: 100 YEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL 158
Y+ + + L D +E L LL ARG+ +L ++ +H D+ N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 159 DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP----GYSAPEFLLRNYPITQKCDVYSF 214
K+ DFGLA+ + HDS +G+ + APE + N T DV+S+
Sbjct: 271 AQGKIVKICDFGLAR----DIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSY 325
Query: 215 GMLLFEI 221
G+LL+EI
Sbjct: 326 GILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 17/139 (12%)
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
Y YDQ + E D L ++ L + L+ + A G+ +L ++
Sbjct: 209 YESPYDQY----LPSAPERTRRDT-LINESPALSYMDLVGFSYQVANGMEFL---ASKNC 260
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP----GYSAPEFLLRN 202
+H D+ N+L+ K+ DFGLA+ + DS +G+ + APE + N
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLAR----DIMRDSNYISKGSTFLPLKWMAPESIFNN 316
Query: 203 YPITQKCDVYSFGMLLFEI 221
T DV+SFG+LL+EI
Sbjct: 317 L-YTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 17/206 (8%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG-- 88
K+G G +G VYK + +G LK + EI + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTE-------VLKWEKLLDIAIGTARGIAYLHEE 141
+ K L++++ E+ F L + + GI YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 142 CNQRIIHYDIKPANILL----DAKFSAKVADFGLAKLCN-PENTHDSTSGYRGTPGYSAP 196
++H D+KPANIL+ + K+AD G A+L N P T Y AP
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 197 EFLLRNYPITQKCDVYSFGMLLFEII 222
E LL T+ D+++ G + E++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 32 LGAGGFGVVY---KGQFPNGVKI-AAKILKTCLNKRVEAQFMAEIGTIGRTY--HIN--- 82
LG G +G V+ K + K+ A K+L+ V+ E R H+
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKA--ALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 83 -LVRLYGFCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIA 136
LV L+ + K L+ +++ G + +L F++ EV + + +A+
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL------E 119
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAP 196
+LH+ I++ DIK NILLD++ + DFGL+K E + T + GT Y AP
Sbjct: 120 HLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYMAP 175
Query: 197 EFLLRNYPITQKCDVYSFGMLLFEII 222
E + + D +S G+L+FE++
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 7/89 (7%)
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
GI +LH + IIH D+KP+NI++ + + K+ DFGLA+ T+ + Y T Y
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 188
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEII 222
APE +L + D++S G ++ E++
Sbjct: 189 RAPEVIL-GMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCL---NKRVEAQFMAEIGTIGRTYH-INLVRL 86
K+G G +G VYK + N K+ A + KT L + + + EI + I +VRL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVA-LKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 87 YGFCYDQTKAA-------LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTA------R 133
+ + LV+E++++ L K++ D+ + L + +
Sbjct: 67 --LDVEHVEEKNGKPSLYLVFEYLDS-DLKKFM--DSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 134 GIAYLHEECNQRIIHYDIKPANILLD-AKFSAKVADFGLAKLCN---PENTHDSTSGYRG 189
G+A+ H+ ++H D+KP N+L+D K K+AD GL + + TH+
Sbjct: 122 GVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----- 173
Query: 190 TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNA 228
T Y APE LL + + D++S G + E+ RK
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 22/204 (10%)
Query: 32 LGAGGFGVVYKG------------QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY 79
LG G F ++KG + +K+ K + EA M + +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASM-----MSQLS 57
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLH 139
H +LV YG C ++ +V E+++ GSLD YL + ++ L++A A + +L
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE 117
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP--ENTHDSTSGYRGTPGYSAPE 197
+ + + H ++ N+LL + K + KL +P T + PE
Sbjct: 118 D---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 198 FLLRNYPITQKCDVYSFGMLLFEI 221
+ ++ D +SFG L+EI
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 46/218 (21%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 25 TNNYSTKLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT 78
T + +LG FG VYKG +A K LK + +F E R
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65
Query: 79 YHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLF----------TDTE-----VLKWEK 123
H N+V L G + ++++ + + L ++L TD + L+
Sbjct: 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 124 LLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183
+ I A G+ +L + ++H D+ N+L+ K + K++D GL + + +
Sbjct: 126 FVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
+ +PE ++ + D++S+G++L+E+
Sbjct: 183 MGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 65/247 (26%), Positives = 89/247 (36%), Gaps = 69/247 (27%)
Query: 32 LGAGGFG-VVYKGQFPNGVKIAAKIL--KTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG V + A K L K L + A AE + + +VRLY
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
D+ V +++ G + L F + + L A+ + + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF------ 122
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN-THDST------------------ 184
IH DIKP NIL+D K+ DFGL C THDS
Sbjct: 123 ---IHRDIKPDNILIDRDGHIKLTDFGL---CTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 185 --------SGYR---------------------GTPGYSAPEFLLRNYPITQKCDVYSFG 215
G R GTP Y APE LLR TQ CD +S G
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVG 235
Query: 216 MLLFEII 222
++L+E++
Sbjct: 236 VILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 7e-06
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
GI +LH + IIH D+KP+NI++ + + K+ DFGLA+ T + Y T Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEII 222
APE +L + D++S G ++ E++
Sbjct: 185 RAPEVIL-GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 59/252 (23%), Positives = 89/252 (35%), Gaps = 74/252 (29%)
Query: 31 KLGAGGFGVVY----KGQFPNGVKIAAKIL-KTCLNKRVE-AQFMAEIGTIGRTYHINLV 84
LG G G V+ KG G A K+L K + KR + + + E + H L
Sbjct: 8 LLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 85 RLYGFCYDQTKAALVYEFMENGSL--------DKYL------FTDTEVLKWEKLLDIAIG 130
LY +T LV ++ G L K L F EVL +A+
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVL-------LAL- 116
Query: 131 TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT------HDST 184
YLH I++ D+KP NILL ++DF L+K + E +
Sbjct: 117 -----EYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 185 SGYR---------------------GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII- 222
GT Y APE ++ D ++ G+LL+E++
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLY 227
Query: 223 ------GRRKNA 228
G ++
Sbjct: 228 GTTPFKGSNRDE 239
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
GI +LH + IIH D+KP+NI++ + + K+ DFGLA+ T + Y T Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEII 222
APE +L + D++S G ++ E+I
Sbjct: 192 RAPEVIL-GMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 4/113 (3%)
Query: 115 DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174
D+ L + LL + A+G+ +L ++ IH D+ N+LL AK+ DFGLA+
Sbjct: 205 DSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD 261
Query: 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKN 227
++ + R + APE + + T + DV+S+G+LL+EI K+
Sbjct: 262 IMNDSNYVVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 4/86 (4%)
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYS 194
I Y+H E IIH DIK N+L++ + DFG A + G GT +
Sbjct: 273 IDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 195 APEFLLRNYPITQKCDVYSFGMLLFE 220
APE L + P T D++S G+++FE
Sbjct: 330 APEVLAGD-PYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 42/171 (24%), Positives = 76/171 (44%), Gaps = 20/171 (11%)
Query: 63 RVEAQFMAEIGTIGRTYHINLVRL--------YGFCYDQTKAALVYEFMENGSLDKYLFT 114
R Q EI +GR H N++++ + Q +Y FM + + D +
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD---WK 261
Query: 115 DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA-K 173
D +LK + + + A + Y+H ++++IH DIK NI L+ + DFG A
Sbjct: 262 DRPLLKQTRAIMKQLLCA--VEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 174 LCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGR 224
D G+ GT ++PE L + + D++S G++L +++
Sbjct: 317 FEKEREAFD--YGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 9/94 (9%)
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC-NPENTHDSTSGYRGTP 191
R + Y+H + H D+KP NIL +A K+ DFGLA++ N T + Y T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 192 GYSAPEF---LLRNYPITQKCDVYSFGMLLFEII 222
Y APE Y T D++S G + E++
Sbjct: 171 WYRAPELCGSFFSKY--TPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKIL-KTCLNKRVE-AQFMAEIGTIGRTYHINLVRLYG 88
+G G FG V + N K+ A KIL K + KR E A F E + + + L+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYL--FTDTEVLKWEKL----LDIAIGTARGIAYLHEEC 142
D+ LV ++ G L L F D + + IAI + + Y
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY----- 123
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL-- 200
+H DIKP NIL+D ++ADFG + T S+ GTP Y +PE L
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAM 178
Query: 201 -----RNYPITQKCDVYSFGMLLFEII 222
+ P +CD +S G+ ++E++
Sbjct: 179 EDGKGKYGP---ECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 36/211 (17%)
Query: 32 LGAGGFGVVY-----KGQFPNGVKIAAKILK---------TCLNKRVEAQFMAEIGTIGR 77
LG G +G V+ G +G A K+LK T + R E Q + I R
Sbjct: 8 LGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI----R 62
Query: 78 TYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTA 132
+ Y F D TK L+ +++ G L +L F + EV + + +A+
Sbjct: 63 QSPFLVTLHYAFQTD-TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL--- 118
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
+LH+ II+ DIK NILLD+ + DFGL+K + + + S + GT
Sbjct: 119 ---EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIE 171
Query: 193 YSAPEFLLRNYPITQKC-DVYSFGMLLFEII 222
Y AP+ + K D +S G+L++E++
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 2e-04
Identities = 33/143 (23%), Positives = 49/143 (34%), Gaps = 27/143 (18%)
Query: 39 VVYKGQFPNGVKIAAKILKTCLN------KRVEAQFMAEIGTIGRTYHI---------NL 83
VY +G +A KI +T + + Y NL
Sbjct: 12 DVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71
Query: 84 VRLY--GF-C---YDQTKAALVYEFMENGSLDKYLFTDTEVLK-WEKLLDIAIGTARGIA 136
RLY G D + LV EF+ + D +L+ E+L D + R
Sbjct: 72 KRLYEAGVPVPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMR-KL 130
Query: 137 YLHEECNQRIIHYDIKPANILLD 159
Y E ++H D+ NIL+D
Sbjct: 131 Y--REA--GLVHGDLSEYNILVD 149
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 44/186 (23%), Positives = 82/186 (44%), Gaps = 17/186 (9%)
Query: 43 GQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102
+ +K+ K+L ++ + F + + H ++V LYG C + +V EF
Sbjct: 27 YSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEF 85
Query: 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL---- 158
+E G LD ++ ++VL +A A ++YL + + ++H ++ NILL
Sbjct: 86 VEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREG 142
Query: 159 -DAKFSA--KVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFG 215
D + K++D G+ P P + APE + + ++ D +SFG
Sbjct: 143 IDGECGPFIKLSDPGI-----PITVLSRQECVERIP-WIAPECVEDSKNLSIAADKWSFG 196
Query: 216 MLLFEI 221
L+EI
Sbjct: 197 TTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 38/146 (26%), Positives = 61/146 (41%), Gaps = 20/146 (13%)
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSL----DKYLFTDTEVLK-WEKLLDIAIGTARGIA 136
N+V L+ + + LV + E G L K+L E +K W + +A+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAP 196
LH E I+ D+ P NILLD + ++ F ++ Y AP
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 197 EFLLRNYPITQKCDVYSFGMLLFEII 222
E + T+ CD +S G +LFE++
Sbjct: 152 E-VGGISEETEACDWWSLGAILFELL 176
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 40/151 (26%), Positives = 68/151 (45%), Gaps = 20/151 (13%)
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLH 139
HI+L ++G C ++ +V EF+E+G LD L + + + +A A ++YL
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE 134
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLA-------KLCNPENTHDSTSGYRGTP- 191
++ ++H ++ NILL A GLA KL +P + + S
Sbjct: 135 ---DKNLVHGNVCAKNILL--------ARLGLAEGTSPFIKLSDPGVSFTALSREERVER 183
Query: 192 -GYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
+ APE + ++ D +SFG L EI
Sbjct: 184 IPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.002
Identities = 29/151 (19%), Positives = 54/151 (35%), Gaps = 16/151 (10%)
Query: 31 KLGAGGFGVVYKGQFPNG---VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
L G VY + +KI K +R E + + + + ++
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVLKINPSREKGADRER-EVAILQLL----ARKGLPVPKVL 59
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
+ L+ E++E +LD+ + E + + A +A LH+ +
Sbjct: 60 ASGESDGWSYLLMEWIEGETLDE-----VSEEEKEDIAEQL---AELLAKLHQLPLLVLC 111
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPE 178
H D+ P NIL+D + D+ A P
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPPA 142
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 369 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.4 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.33 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.23 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.18 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.01 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.82 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.68 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.64 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.54 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.46 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.4 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.35 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.32 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.22 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.16 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.15 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.1 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.06 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.99 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.86 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.61 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.57 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.48 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.38 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.34 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.31 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.05 | |
| PLN02236 | 344 | choline kinase | 97.04 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.85 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.78 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.71 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.59 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.57 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.49 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.41 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.4 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.37 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.29 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.21 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.99 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.56 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.47 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.36 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.11 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.95 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-57 Score=418.48 Aligned_cols=285 Identities=42% Similarity=0.650 Sum_probs=244.6
Q ss_pred CcccCHHHHHHhhhccc--cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEE
Q 017591 13 PVRFTLEQLCSFTNNYS--TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90 (369)
Q Consensus 13 ~~~~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 90 (369)
...|++.||.+||++|+ +.||+|+||.||+|...++..||||.+....... ..+|.+|+.++.+++|||+|+++|||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45599999999999998 6999999999999999889999999887654433 56699999999999999999999999
Q ss_pred EeCC-ceEEEEeccCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEee
Q 017591 91 YDQT-KAALVYEFMENGSLDKYLFTDTE-VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVAD 168 (369)
Q Consensus 91 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 168 (369)
.+.+ ..+||||||++|+|.++++.... +++|.++++|+.++|+||+|||..+...|+||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 59999999999999999977666 899999999999999999999998877899999999999999999999999
Q ss_pred cCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhh
Q 017591 169 FGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYE 248 (369)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 248 (369)
||+|+............. .||.+|+|||++..+ ..+.|+|||||||+|+||+||+.+.+...+.....+..|.+..+.
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 999976543111111111 799999999999885 899999999999999999999999887654444446777777777
Q ss_pred hchhhhhhhcCCC-CCCCH-HHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 249 KGELAAKVLGCGI-EENDR-EEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 249 ~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+.+.+.++.... ..... .....+..++.+|++.+|.+||+|.+|+++|+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 7777666666544 34443 6788899999999999999999999999999654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=362.07 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=212.8
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc-eEEEEeccCCCC
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK-AALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~~~gs 107 (369)
..||+|.-|+||++++ ++++.+|+|++.....+....++.+|+++++..+||+||.+||.|..+.. ..|+||||++||
T Consensus 85 ~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGS 164 (364)
T KOG0581|consen 85 GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGS 164 (364)
T ss_pred hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCC
Confidence 4899999999999988 46899999999878888888999999999999999999999999999984 999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccC
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 187 (369)
|++++ ...+.+++..+.+++.++++||.|||+. ++||||||||+|||++..|.|||+|||.+..+-.. .....
T Consensus 165 Ld~~~-k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tf 237 (364)
T KOG0581|consen 165 LDDIL-KRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTF 237 (364)
T ss_pred HHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccc
Confidence 99999 4447799999999999999999999953 89999999999999999999999999999876433 23457
Q ss_pred CCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHH
Q 017591 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE 267 (369)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (369)
.||..|||||.++++ .|+.++||||||++++|+.+|+.|+.........+ -++...+.....+..+..
T Consensus 238 vGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~-----------~~Ll~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 238 VGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI-----------FELLCAIVDEPPPRLPEG 305 (364)
T ss_pred cccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH-----------HHHHHHHhcCCCCCCCcc
Confidence 799999999999886 89999999999999999999999998652221111 123333444444555554
Q ss_pred -HHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 268 -EAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 268 -~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+++++.+++..||++||.+||++.++++
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 8999999999999999999999999873
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=371.21 Aligned_cols=254 Identities=33% Similarity=0.494 Sum_probs=214.4
Q ss_pred ccccccCCceEEEEEEeCCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC-ceEEEEeccCCC
Q 017591 29 STKLGAGGFGVVYKGQFPNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-KAALVYEFMENG 106 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g 106 (369)
.+.||.|+||+||+|.+.....||+|++.... .......|.+|+.++.+++|||||+++|+|.+.. ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 35699999999999999555559999987532 2333678999999999999999999999999887 799999999999
Q ss_pred CHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhccCCC-eEeecCCCCceEecCCC-CeeEeecCCceecCCCCCccc
Q 017591 107 SLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQR-IIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 107 sL~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+|.++++. ....+++..++.++.|||.|+.|||+ ++ ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 99999977 47899999999999999999999999 88 99999999999999998 99999999998765322 23
Q ss_pred cccCCCCCCccccccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLR-NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~-~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.+...||..|||||++.+ ...++.|+||||||+++|||+||+.||........ .........++
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---------------~~~v~~~~~Rp 265 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---------------ASAVVVGGLRP 265 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---------------HHHHHhcCCCC
Confidence 334679999999999985 24799999999999999999999999986554211 11222334445
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
..+...+..+..|+.+||+.||..||++.+++..|+....
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 5566688899999999999999999999999999987633
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=372.68 Aligned_cols=246 Identities=23% Similarity=0.372 Sum_probs=209.5
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
|.-.+.||+|||+.||.+++ ..|+.||+|++.+. ........+.+|+++.+.|+|||||+++++|++.+..|||.|+
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence 33457899999999999998 77999999999753 2345567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
|+.++|..++ +..+++++.+++.++.||+.||.|||+ ++|+|||||..|+||+++.+|||+|||+|..+.....
T Consensus 100 C~~~sL~el~-Krrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-- 173 (592)
T KOG0575|consen 100 CHRGSLMELL-KRRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-- 173 (592)
T ss_pred cCCccHHHHH-HhcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc--
Confidence 9999999998 477899999999999999999999999 9999999999999999999999999999988753322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....+||+.|+|||++... ..+..+||||+||+||.||.|++||...... ..+..+... .-
T Consensus 174 rk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-------ety~~Ik~~----------~Y 235 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-------ETYNKIKLN----------EY 235 (592)
T ss_pred ccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHH-------HHHHHHHhc----------Cc
Confidence 23457899999999999865 6899999999999999999999999754321 112221111 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+...+....+||.++|+.||.+|||+++|+.
T Consensus 236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 234467788999999999999999999999983
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=360.38 Aligned_cols=255 Identities=27% Similarity=0.346 Sum_probs=208.1
Q ss_pred HHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccH------HHHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 017591 22 CSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNK------RVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT 94 (369)
Q Consensus 22 ~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 94 (369)
....+-..+.||+|+||.|-+|.. ++|+.||||++++.... .....+.+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 334444568999999999999976 56999999999754221 13345789999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC---CCeeEeecCC
Q 017591 95 KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGL 171 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~ 171 (369)
..|+||||++||.|.+.+. .++.+.+.....+++|++.|+.|||+ +||+||||||+|||+..+ -.+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999999984 45678888999999999999999999 999999999999999766 5699999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhh
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY--PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEK 249 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (369)
|+..+. ...+...+||+.|.|||++..++ .+..+.|+||+||+||-+|+|..||.+...+.. +.+.+..
T Consensus 326 AK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQI~~ 396 (475)
T KOG0615|consen 326 AKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQILK 396 (475)
T ss_pred hhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHHHhc
Confidence 998653 22345578999999999998653 344589999999999999999999986544321 1233333
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 250 GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
|.... .+......+++..+||.+||..||++||++.|+++
T Consensus 397 G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Ccccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 33221 23445677899999999999999999999999873
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-50 Score=366.65 Aligned_cols=259 Identities=30% Similarity=0.456 Sum_probs=220.5
Q ss_pred HHHHhhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEE
Q 017591 20 QLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 20 el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (369)
++..-..++.++||+|-||.||+|.+.....||+|.++... -....|.+|+.+|++|+|+|||+++++|..+...+||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 33334445668999999999999999777899999998642 2246788999999999999999999999998899999
Q ss_pred EeccCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 100 YEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+.|+|.++|.. .+..+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||+|+...++
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 999999999999975 56789999999999999999999999 99999999999999999999999999999954433
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
.........-+..|.|||.+..+ .++.|||||||||+||||+| |+.|+.... ..++...+.
T Consensus 357 -~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~ms----------------n~ev~~~le 418 (468)
T KOG0197|consen 357 -EYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMS----------------NEEVLELLE 418 (468)
T ss_pred -ceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCC----------------HHHHHHHHh
Confidence 33334445678889999999986 79999999999999999998 666655433 334455566
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.+.+.+.+..++..+.+|+..||+.+|++|||+..+...|+...
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 66666777788999999999999999999999999998888653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=341.44 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=211.2
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccc-cccHHHHHHHHHHHHHHhccCCCceeeEEe-EEEeCC-ceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKT-CLNKRVEAQFMAEIGTIGRTYHINLVRLYG-FCYDQT-KAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~-~~~lv~e 101 (369)
+.+.++||+|.||+||++.. .+|..+|.|.+.- ..+.....+...|+.+|++|+|||||++++ -+.+++ ..+||||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 34567999999999999966 6799999998863 345556678999999999999999999998 343444 4899999
Q ss_pred ccCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHhhccCC-CeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 102 FMENGSLDKYLF---TDTEVLKWEKLLDIAIGTARGIAYLHEECNQ-RIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 102 ~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
||.+|+|.+.+. +....+++..+|+++.|++.||.++|...++ -|.||||||.||+++.+|.|||+|||+++.+..
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 999999999984 3456899999999999999999999985544 389999999999999999999999999998764
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
... ......||+.||+||.+++. .++.||||||+||++|||+..+.||.+..- ..+..++.
T Consensus 181 ~~t--fA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~----------------~~L~~KI~ 241 (375)
T KOG0591|consen 181 KTT--FAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNL----------------LSLCKKIE 241 (375)
T ss_pred hhH--HHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccH----------------HHHHHHHH
Confidence 433 34457899999999999886 899999999999999999999999986522 12233444
Q ss_pred cCCCCCCC-HHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 258 GCGIEEND-REEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 258 ~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.+..+..+ ..++..+..|+..|+..||+.||+...++..+..
T Consensus 242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 55555555 7789999999999999999999996665555543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=347.42 Aligned_cols=199 Identities=31% Similarity=0.510 Sum_probs=176.9
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.++||.|+||+||+|+.+ ++..||||.+.... .+...+.+..|+.+|+.++|||||.+++++.+.+..+||||||.|
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 4577999999999999874 58999999887543 666677899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC------CCeeEeecCCceecCCCC
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK------FSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~------~~~kl~Dfg~~~~~~~~~ 179 (369)
|+|.+||+ ..+.+++..+..++.||+.||++||+ ++||||||||+||||+.. -.+||+|||+|+.+....
T Consensus 94 GDLs~yi~-~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~ 169 (429)
T KOG0595|consen 94 GDLSDYIR-RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS 169 (429)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence 99999994 44589999999999999999999999 999999999999999765 358999999999887433
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSD 234 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~ 234 (369)
.....+|++-|||||+++.. +|+.|+|+||+|+++|+|++|+.||......
T Consensus 170 ---~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 170 ---MAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred ---HHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 33457899999999999875 8999999999999999999999999865543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=337.39 Aligned_cols=253 Identities=27% Similarity=0.369 Sum_probs=206.3
Q ss_pred hccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC--ceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT--KAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 102 (369)
+...+.||+|+||.||++.+.+ |...|||......... ...+.+|+.+|.+++|||||+++|...... .+++.|||
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 3455789999999999998854 8999999887543322 667999999999999999999999754444 68999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-CCCeeEeecCCceecCC-CCC
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-KFSAKVADFGLAKLCNP-ENT 180 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~-~~~ 180 (369)
+++|+|.+++...++.+++..+..+.+|+++||+|||+ +|++|+||||+|||++. ++.+||+|||++..... ...
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999997666689999999999999999999999 99999999999999999 79999999999987653 112
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCC-CCCccCccccchhHHhhhchhhhhhhcC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDC-SSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
........||+.|||||++..+.....++|||||||++.||+||+.||... ... ..+.......
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~---------------~~~~~ig~~~ 239 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA---------------EALLLIGRED 239 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH---------------HHHHHHhccC
Confidence 223345789999999999986433446999999999999999999998653 110 0011111122
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHh
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L 297 (369)
..+..+...+....+++..|+..||.+|||+.++++.-
T Consensus 240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 34566777889999999999999999999999998644
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=332.59 Aligned_cols=238 Identities=26% Similarity=0.336 Sum_probs=202.8
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.++||+|+||.|+.++.+ +++.+|+|++++.. .....+...+|..+|..++||+||+++-.|.+.+++|||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 3589999999999999774 58999999998642 23346778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
||.|...| ++.+.+++..+.-|+..|+.||.|||+ +|||||||||+||||+.+|+++|+|||+++..-... ..+
T Consensus 109 GGeLf~hL-~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t 182 (357)
T KOG0598|consen 109 GGELFYHL-QREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DAT 182 (357)
T ss_pred CccHHHHH-HhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--Ccc
Confidence 99999999 566789999999999999999999999 999999999999999999999999999998532221 123
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
...+||+.|||||++.+. .++.++|.||||+++|||++|.+||...+.. +..+.+........
T Consensus 183 ~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~----------------~~~~~I~~~k~~~~ 245 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----------------KMYDKILKGKLPLP 245 (357)
T ss_pred ccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHH----------------HHHHHHhcCcCCCC
Confidence 447899999999999886 8999999999999999999999999754432 12233333333445
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC
Q 017591 265 DREEAERMSMVALWCVQDCPEARP 288 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RP 288 (369)
+...+....+++.++|..||++|.
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhc
Confidence 555788899999999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=323.35 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=206.0
Q ss_pred cccccCCceEEEEEEeCC-CcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 30 TKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
-++|+|+||+||++++++ |+.||||.+..+.+ +....-..+|+++|++++|+|+|.++++|.-.+..+||+|||+. +
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 479999999999999865 99999999876544 55666788999999999999999999999999999999999998 5
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccC
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 187 (369)
+.+-+......++.+.+.+|++|++.|+.|+|+ ++++||||||+|||++.+|.+||+|||.|+.+.. .....+..
T Consensus 87 vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDY 161 (396)
T KOG0593|consen 87 VLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDY 161 (396)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccchhhhh
Confidence 555565777789999999999999999999999 9999999999999999999999999999998763 22233456
Q ss_pred CCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------cccchhHHhhhch------hh
Q 017591 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------FPKQVWDEYEKGE------LA 253 (369)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~------~~ 253 (369)
..|..|+|||.+.+..+|....||||+||++.||++|.+-|.+.+.-..-+ +.......+.... +.
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 689999999999987899999999999999999999999998766532111 1110011111110 00
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
+.-.....+...+.....+.+++..||+.||++|++-++++
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 00001111222344556889999999999999999999887
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=342.01 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=203.1
Q ss_pred hccccccccCCceEEEEEEe------CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC-ceE
Q 017591 26 NNYSTKLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQT-KAA 97 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~ 97 (369)
+.+.++||+|+||.||+|.+ .++..||+|++...........+.+|+.++..+ +||||+++++++...+ ..+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 45668999999999999964 235789999988655555567899999999999 8999999999887644 578
Q ss_pred EEEeccCCCCHHHHhccCC-------------------------------------------------------------
Q 017591 98 LVYEFMENGSLDKYLFTDT------------------------------------------------------------- 116 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~------------------------------------------------------------- 116 (369)
+||||+++|+|.+++....
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 9999999999999985321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCcccc
Q 017591 117 EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAP 196 (369)
Q Consensus 117 ~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 196 (369)
.++++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...............++..|+||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 347889999999999999999999 99999999999999999999999999999865433222222334567889999
Q ss_pred ccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHH
Q 017591 197 EFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMV 275 (369)
Q Consensus 197 E~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 275 (369)
|++... .++.++|||||||++|||++ |..||....... ........+ .....+...+..+.+|
T Consensus 246 E~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~l 309 (338)
T cd05102 246 ESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDG---------TRMRAPENATPEIYRI 309 (338)
T ss_pred HHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcC---------CCCCCCCCCCHHHHHH
Confidence 988764 78999999999999999997 999987543221 111111111 1112233456779999
Q ss_pred HHhccccCCCCCCChHHHHHHhcCC
Q 017591 276 ALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 276 ~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+.+||+.||.+||++.+|++.|+..
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=339.97 Aligned_cols=266 Identities=23% Similarity=0.325 Sum_probs=217.3
Q ss_pred hhhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCC-ceEEEE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQT-KAALVY 100 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~ 100 (369)
.+|...++||.|+||.||+|+.+ .|..||||.+++......+.-=.+|+..|++++ ||||+++.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 45566789999999999999764 589999999887655555555678999999998 999999999999988 999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
|||+. +|.+++..++..|++..+..|++||++||+|+|. +|+.|||+||+|||+.....+||+|||+|+.+.+...
T Consensus 90 E~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred Hhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccCCC
Confidence 99987 9999998888999999999999999999999999 9999999999999999888999999999998765544
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc-----cccchhHHhhhchhhhh
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW-----FPKQVWDEYEKGELAAK 255 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 255 (369)
. +....|..|+|||++.+...|+.+.||||+|||++|+.+.++-|.+.+.....+ +....++.+..+.-...
T Consensus 166 Y---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 166 Y---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred c---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3 345689999999999887899999999999999999999999998766532111 11111222333332333
Q ss_pred hhcCCCC--------CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 256 VLGCGIE--------ENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 256 ~~~~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
.++..++ ...+..+.++.+++..|+.-||.+|||+.+.++.
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 3333222 2234477889999999999999999999998854
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=360.92 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=219.7
Q ss_pred cccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 28 YSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
|.+.||+|.||.||+|+.. +...||||.++.....+...+|++|++++..++|||||+++|+|.+++..++|+|
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence 5578999999999999753 3678999999987777788999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccC---------C----CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEee
Q 017591 102 FMENGSLDKYLFTD---------T----EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVAD 168 (369)
Q Consensus 102 ~~~~gsL~~~l~~~---------~----~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 168 (369)
||..|+|.+||..+ + .+++..+.+.|+.|||.|+.||-+ +.+|||||.++|+||.++..|||+|
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEecc
Confidence 99999999999532 1 238899999999999999999999 9999999999999999999999999
Q ss_pred cCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHh
Q 017591 169 FGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEY 247 (369)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 247 (369)
||+++...+.+.........-+++||+||.+..+ .+|++||||||||+|||+++ |+.|+.+...+
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------------- 712 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------------- 712 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchH-------------
Confidence 9999987666655554445568899999999986 89999999999999999997 77777654443
Q ss_pred hhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 248 EKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
++.+.+..+..-..+...+..+..|+..||+.+|.+||+++||-..|+....
T Consensus 713 ---EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 713 ---EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ---HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 3333344444445566778999999999999999999999999999987643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=326.34 Aligned_cols=261 Identities=22% Similarity=0.285 Sum_probs=209.7
Q ss_pred hhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
..|.+...||.|.-++||+|+. +.+..||||++.-..-......+.+|+..++.++||||++++..|..+..+++||+|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 3456678999999999999977 678999999998654444578899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC-C
Q 017591 103 MENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN-T 180 (369)
Q Consensus 103 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 180 (369)
|.+||+.+.+... ...+++..+..|++++++||.|||+ +|.||||||+.||||+.+|.|||+|||.+-.+.... .
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999543 4569999999999999999999999 999999999999999999999999999876654322 1
Q ss_pred cccc-ccCCCCCCccccccc-cccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 181 HDST-SGYRGTPGYSAPEFL-LRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 181 ~~~~-~~~~gt~~y~aPE~~-~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.... ....||++|||||++ +....|+.|+||||||++.+||.+|..||....+-.. .-.--++........
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-------Ll~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-------LLLTLQNDPPTLLTS 255 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-------HHHHhcCCCCCcccc
Confidence 1122 456899999999994 4445799999999999999999999999987654311 000011111100011
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
....+....+...+.+++..||+.||.+|||+++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 111122344566899999999999999999999988
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=333.55 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=204.2
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.|.+.||.|+|++|++|+.+ .++.+|||++.+.. ......-+..|-.+|.+| .||.|++++-.|.|+..+|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 35688999999999999874 59999999986531 122223466788888888 799999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc-
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH- 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 181 (369)
+++|.|.++| .+-+.|++.....++.+|+.||+|||+ +|||||||||+||||+++++++|+|||.|+.+......
T Consensus 156 A~nGdll~~i-~K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 156 APNGDLLDLI-KKYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred cCCCcHHHHH-HHhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 9999999999 455789999999999999999999999 99999999999999999999999999999988643222
Q ss_pred --------cc--cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 182 --------DS--TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 182 --------~~--~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
.. ...+.||..|.+||++..+ ..+..+|+|+||||||+|+.|++||...+.- .+++.
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------liFqk----- 298 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEY-------LIFQK----- 298 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHH-------HHHHH-----
Confidence 11 1447899999999999886 7899999999999999999999999765431 11121
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+... .-..++.+++.+.+|+.+.|..||.+|++..+|-+
T Consensus 299 ----I~~l-~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 299 ----IQAL-DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ----HHHh-cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 2211 12344556688999999999999999999988764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=306.36 Aligned_cols=264 Identities=24% Similarity=0.317 Sum_probs=209.5
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
|.-.++||+|.||+||+|++ ++|+.||+|.++... .+.......+|+..|+.++|+||+.++++|.+.+...||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 33457899999999999987 569999999987542 3334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+. +|+..+..+...++...+..|+.++++||+|+|+ +.|+||||||.|+|++.+|.+||+|||+++.+.+......
T Consensus 84 ~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 84 PT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred cc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 87 9999998888899999999999999999999999 9999999999999999999999999999999876554433
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCc-c-------CccccchhHHhhhchhhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDT-L-------DWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~ 255 (369)
. ..-|..|.|||.+.+...|+...||||.|||+.||+-|.+-|.+.+.-. . ..-....|..+..-.....
T Consensus 160 ~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 160 H--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred c--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 2 3678999999999998899999999999999999998877666544321 1 1111122222211110011
Q ss_pred hh---cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VL---GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ..............+.+|+..||..||.+|++++++++
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 10 01111123344566799999999999999999999874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=328.91 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=202.7
Q ss_pred hhccccccccCCceEEEEEEeCC-----------------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPN-----------------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 87 (369)
.+.+.++||+|+||.||+|.+.+ +..||+|++..........++.+|+.++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 44567899999999999997532 3479999988655555667899999999999999999999
Q ss_pred eEEEeCCceEEEEeccCCCCHHHHhccCC------------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEee
Q 017591 88 GFCYDQTKAALVYEFMENGSLDKYLFTDT------------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149 (369)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~ 149 (369)
+++.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+++||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcccc
Confidence 99999999999999999999999984321 247889999999999999999999 999999
Q ss_pred cCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc--CCCC
Q 017591 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG--RRKN 227 (369)
Q Consensus 150 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt--g~~p 227 (369)
||||+|||++.++.+||+|||+++...............++..|+|||++..+ .++.++|||||||++|||++ +..|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999876443332223334567899999988765 68999999999999999986 4556
Q ss_pred CCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 228 AQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
|........ ..... ..............+...+..+.+|+.+||+.||.+||++.+|.+.|+
T Consensus 242 ~~~~~~~~~-------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQV-------IENAG--EFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHH-------HHHHH--HHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 654332110 11100 000000000111122344577899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=335.02 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=205.1
Q ss_pred hhhccccccccCCceEEEEEEe-CCCcEEEEEEcccccc----HHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLN----KRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 97 (369)
..+.+.+.||+|+||.|+.|.. .++..||+|++..... ......+.+|+.+++.+. ||||+++++++...+..+
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 3455668899999999999976 4689999997765311 133556778999999999 999999999999999999
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC-CCeeEeecCCceecC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCN 176 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 176 (369)
+||||+.||.|.+++.. .+++.+..+..++.|++.|++|+|+ +||+||||||+|||++.+ +++||+|||++....
T Consensus 97 ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999966 7889999999999999999999999 999999999999999999 999999999999774
Q ss_pred CCCCccccccCCCCCCccccccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 177 PENTHDSTSGYRGTPGYSAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
.........+||+.|+|||++.+.. ....++||||+||+||.|++|+.||........ +..+..+..
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-------~~ki~~~~~--- 240 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-------YRKIRKGEF--- 240 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-------HHHHhcCCc---
Confidence 1112234468999999999998865 446899999999999999999999987433211 111211111
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 256 VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
.++.... +..+..|+.+||..||.+|+++.+|+
T Consensus 241 ----~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 ----KIPSYLL--SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----cCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1122211 78899999999999999999999998
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=321.73 Aligned_cols=257 Identities=24% Similarity=0.352 Sum_probs=207.3
Q ss_pred HhhhccccccccCCceEEEEEEeC----CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
...+.+.+.||+|+||.||+|.++ .+..||+|.++..........+.+|+.++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 344567789999999999999753 3679999998866555556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+++|+|.+++......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 999999999999996656689999999999999999999999 99999999999999999999999999987653222
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
... ......++..|+|||.+..+ .++.++|||||||++||+++ |..||....... ..+.. .
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~---------~ 222 (266)
T cd05064 161 AIY-TTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAV---------E 222 (266)
T ss_pred chh-cccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHH---------H
Confidence 111 11123356789999988764 78999999999999999875 999986543211 11111 1
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.......+...+..+.+++.+||+.+|.+||++.+|.+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 223 DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111223445677899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=331.18 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=207.5
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~ 105 (369)
++||+|.||.||+|++ .+|+.||+|.+.-+. .+.....+.+||.+|++|.||||+++.+...+. ...|||+|||+.
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 6899999999999987 569999999887543 445566788999999999999999999999877 689999999998
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+|..++...+-.|++.++..++.||+.||+|+|. +||.|||||.+|||||.+|.+||+|||+|+++....... .+
T Consensus 203 -DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T 277 (560)
T KOG0600|consen 203 -DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YT 277 (560)
T ss_pred -hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cc
Confidence 9999997777799999999999999999999999 999999999999999999999999999999876554433 45
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCc-cC-------ccccchhHHhhhchhhhh-h
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDT-LD-------WFPKQVWDEYEKGELAAK-V 256 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~-~ 256 (369)
...-|..|.|||.+.+...|+.+.|+||.||||.||+.|++.|++...-. +. ......|. ..++... .
T Consensus 278 ~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~---~~kLP~~~~ 354 (560)
T KOG0600|consen 278 SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP---VSKLPHATI 354 (560)
T ss_pred cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc---cccCCcccc
Confidence 56689999999999998899999999999999999999999988665421 10 00011111 0111000 0
Q ss_pred h------cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 257 L------GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 257 ~------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
. ...+.+.....+....+|+..+|..||.+|.|+.+++
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 0 0011122334567788999999999999999999987
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=336.87 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=202.7
Q ss_pred hccccccccCCceEEEEEEe------CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (369)
..+.++||+|+||.||+|.+ .++..||+|+++..........+.+|+.++..+ +||||+++++++.+.+..++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 34568999999999999963 236789999987554445556788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHhccCC--------------------------------------------------------------
Q 017591 99 VYEFMENGSLDKYLFTDT-------------------------------------------------------------- 116 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~-------------------------------------------------------------- 116 (369)
||||+++|+|.+++....
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 999999999999885321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 117 ------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 117 ------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
..+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++...........
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 247889999999999999999999 99999999999999999999999999999876543322222
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....++..|+|||.+... .++.++|||||||++|||++ |..||....... ..++....+ ....
T Consensus 274 ~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~---------~~~~ 337 (375)
T cd05104 274 GNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEG---------YRML 337 (375)
T ss_pred CCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhC---------ccCC
Confidence 233456789999988764 78999999999999999997 788886543221 111111111 1111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.+...+..+.+|+.+||+.||++||++.+|++.|+.
T Consensus 338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 222335679999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=323.72 Aligned_cols=250 Identities=34% Similarity=0.548 Sum_probs=200.5
Q ss_pred cccccccCCceEEEEEEeC-----CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 28 YSTKLGAGGFGVVYKGQFP-----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.||.|.||.||+|.+. .+..|+||.++..........+.+|+..+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999875 36889999997665666688999999999999999999999999988889999999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 103 MENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
+++|+|.+++... ...+++..++.|+.|++.||.|||+ ++++|+||+++||+++.++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999766 6789999999999999999999999 99999999999999999999999999999887433333
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
...........|+|||.+... .++.++||||||+++|||++ |+.||...... ++........
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~----------------~~~~~~~~~~ 222 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE----------------EIIEKLKQGQ 222 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH----------------HHHHHHHTTE
T ss_pred ccccccccccccccccccccc-cccccccccccccccccccccccccccccccc----------------cccccccccc
Confidence 333445578899999988775 58999999999999999999 67877543221 1112222222
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHh
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L 297 (369)
....+...+..+.+++..||..+|.+||++.+|++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2333445677899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=305.77 Aligned_cols=240 Identities=25% Similarity=0.331 Sum_probs=205.5
Q ss_pred cCHHHHHHhhhccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 017591 16 FTLEQLCSFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD 92 (369)
Q Consensus 16 ~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 92 (369)
++++++ .+.+.||.|+||.|.+++.+ +|..+|+|++.+.. .-...+...+|..+|+.+.||+++++++.+.+
T Consensus 41 ~~l~df-----e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDF-----ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhh-----hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 666665 34568999999999999885 58999999997542 33445678899999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCc
Q 017591 93 QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA 172 (369)
Q Consensus 93 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 172 (369)
.+..++||||.+||.|..++ .+.+.+++.....++.||+.||+|||+ ++|++|||||+|||+|.+|.+||+|||.|
T Consensus 116 ~~~lymvmeyv~GGElFS~L-rk~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFA 191 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYL-RKSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFA 191 (355)
T ss_pred CCeEEEEEeccCCccHHHHH-HhcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccce
Confidence 99999999999999999999 566789999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
+..... +-..+||+.|+|||+++.. .+..++|.|||||++|||+.|.+||....+. .+++.+-.++
T Consensus 192 K~v~~r-----T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~- 257 (355)
T KOG0616|consen 192 KRVSGR-----TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGK- 257 (355)
T ss_pred EEecCc-----EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCc-
Confidence 976533 3346799999999999885 7999999999999999999999999865542 1233333332
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCC
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEAR 287 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 287 (369)
-..+......+.+|+..+|+.|-.+|
T Consensus 258 ---------v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 ---------VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---------ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 23456677889999999999999999
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=320.53 Aligned_cols=253 Identities=25% Similarity=0.469 Sum_probs=208.4
Q ss_pred ccccccccCCceEEEEEEeCC------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.||+|+||.||+|.... ...|++|.+...........+.+|+.++..++||||+++++++.+....+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 456899999999999997633 26799999876555566678999999999999999999999999888999999
Q ss_pred eccCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCee
Q 017591 101 EFMENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAK 165 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 165 (369)
||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEE
Confidence 9999999999995431 458899999999999999999999 9999999999999999999999
Q ss_pred EeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchh
Q 017591 166 VADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVW 244 (369)
Q Consensus 166 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 244 (369)
|+|||++................++..|+|||++..+ .++.++|||||||++|||++ |..||......
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---------- 233 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---------- 233 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence 9999999876443333333344578899999988765 68999999999999999998 99898654321
Q ss_pred HHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 245 DEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
++...+........+...+..+.+|+.+||+.||.+||++.+|++.|++
T Consensus 234 ------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 ------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111122222233445667889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=339.16 Aligned_cols=269 Identities=31% Similarity=0.402 Sum_probs=219.6
Q ss_pred CcccCHHHHHHhhhccccccccCCceEEEEEEeCC--C---cEEEEEEccc--cccHHHHHHHHHHHHHHhccCCCceee
Q 017591 13 PVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPN--G---VKIAAKILKT--CLNKRVEAQFMAEIGTIGRTYHINLVR 85 (369)
Q Consensus 13 ~~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~ 85 (369)
|+.-..+||.-..-.+.++||+|+||.||+|+.+. + ..||+|..+. ........+|.+|.+++++++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 33344455544444566899999999999997632 2 2389998884 356677889999999999999999999
Q ss_pred EEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCee
Q 017591 86 LYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAK 165 (369)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 165 (369)
+||++.+....++|||+|.||+|.++|......++..+...++.+.|.||+|||+ ++++||||-++|+|++.++.+|
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999999997777789999999999999999999999 9999999999999999999999
Q ss_pred EeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchh
Q 017591 166 VADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVW 244 (369)
Q Consensus 166 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 244 (369)
|+|||+++.... .........-+..|+|||.+..+ .++.++|||||||++||+++ |..||.+....
T Consensus 303 ISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---------- 369 (474)
T KOG0194|consen 303 ISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---------- 369 (474)
T ss_pred eCccccccCCcc--eeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHH----------
Confidence 999999876431 11111133467899999999987 89999999999999999998 78888755432
Q ss_pred HHhhhchhhhhh-hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcCC
Q 017591 245 DEYEKGELAAKV-LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEI 303 (369)
Q Consensus 245 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~~ 303 (369)
++...+ .+......+...+..+..++.+||..+|++||+|.+|.+.|+.....
T Consensus 370 ------~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 370 ------EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred ------HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 222223 22333444556788899999999999999999999999999886443
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=314.05 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=201.9
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
++||+|+||.||+|.++ +++.+|+|.............+.+|+.+++.++|+||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999874 68999999887655556667899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCC
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 188 (369)
.+++......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99996656679999999999999999999999 999999999999999999999999999987644221111111122
Q ss_pred CCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHH
Q 017591 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE 267 (369)
Q Consensus 189 gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (369)
.+..|+|||.+..+ .++.++|||||||++|+|++ |..||...... ..............+..
T Consensus 158 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~ 220 (252)
T cd05084 158 IPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----------------QTREAIEQGVRLPCPEL 220 (252)
T ss_pred CceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHH----------------HHHHHHHcCCCCCCccc
Confidence 35579999988765 68999999999999999997 77777543221 01111111111223344
Q ss_pred HHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 268 EAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 268 ~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
.+..+.+++.+||+.+|++||++.+|.++|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 5678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=336.20 Aligned_cols=257 Identities=25% Similarity=0.425 Sum_probs=208.9
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.+.||+|.||+||+|+| ...||||+++.. ..++..+.|.+|+.++++-+|.||+-+.|+|..+.. .||+.||+|
T Consensus 395 ~l~~rIGsGsFGtV~Rg~w--hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRW--HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeeccc--ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 3457999999999999998 346999998743 455678889999999999999999999999987776 999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
-+|..+++-....|+..+.+.|+.|+++|+.|||. ++|||+|||..|||+.++++|||+|||++..-..........
T Consensus 472 sSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~ 548 (678)
T KOG0193|consen 472 SSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLE 548 (678)
T ss_pred chhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccC
Confidence 99999998888899999999999999999999999 999999999999999999999999999986543222111222
Q ss_pred cCCCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRN--YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~--~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
...|...|||||+++.. .+++..+||||||+++|||++|..||.....+...|.. ..|.+... ...
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV-------GrG~l~pd-----~s~ 616 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV-------GRGYLMPD-----LSK 616 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-------cccccCcc-----chh
Confidence 34588899999998743 37999999999999999999999999844444332221 11211100 011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.....+..+.+|+..||..++++||.+.+|+..|+...
T Consensus 617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 22345678999999999999999999999999887653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=357.82 Aligned_cols=262 Identities=29% Similarity=0.439 Sum_probs=220.9
Q ss_pred HHHHhhhccccccccCCceEEEEEEeCC--C----cEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC
Q 017591 20 QLCSFTNNYSTKLGAGGFGVVYKGQFPN--G----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ 93 (369)
Q Consensus 20 el~~~t~~f~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 93 (369)
++...+-.+.+.||+|.||.||.|...+ + ..||+|.+......+...+|.+|..+|+.++|||||+++|+|.+.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 3334444556789999999999997643 3 359999999888888899999999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEe
Q 017591 94 TKAALVYEFMENGSLDKYLFTD------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVA 167 (369)
Q Consensus 94 ~~~~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 167 (369)
...+|++|||++|+|..||.+. ...++....+.++.|||+|..||++ +++|||||.++|+||+....|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEc
Confidence 9999999999999999999766 5679999999999999999999999 999999999999999999999999
Q ss_pred ecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHH
Q 017591 168 DFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDE 246 (369)
Q Consensus 168 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 246 (369)
|||+|+.+.............-...|||||.+..+ .+|.|+|||||||+|||++| |..||......
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~------------ 911 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------------ 911 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchH------------
Confidence 99999965444443333333456789999999985 89999999999999999998 66777654432
Q ss_pred hhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
++........+-+.+...++.+.+|+..||+.+|++||++..|++.+....
T Consensus 912 ----~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 912 ----EVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred ----HHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 223333333455667778899999999999999999999999999887763
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=334.40 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=203.0
Q ss_pred hccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (369)
..+.+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.+ .|+||+++++++.+....++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 345689999999999999742 24589999998655555567789999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHhccCC--------------------------------------------------------------
Q 017591 99 VYEFMENGSLDKYLFTDT-------------------------------------------------------------- 116 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~-------------------------------------------------------------- 116 (369)
||||+++|+|.+++....
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 999999999999884321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCC
Q 017591 117 -------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG 189 (369)
Q Consensus 117 -------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 189 (369)
.++++..++.++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++................+
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 247889999999999999999999 9999999999999999999999999999976543322222223345
Q ss_pred CCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHH
Q 017591 190 TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268 (369)
Q Consensus 190 t~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (369)
+..|+|||++... .++.++|||||||++|+|++ |+.||........ .+..... ......+...
T Consensus 277 ~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~---------~~~~~~~~~~ 340 (374)
T cd05106 277 PVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKR---------GYQMSRPDFA 340 (374)
T ss_pred ccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHc---------ccCccCCCCC
Confidence 6789999988764 78999999999999999997 9999865432110 1111111 1111112223
Q ss_pred HHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 269 AERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+..+.+++.+||+.||.+||++.+|+++|+..
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 57799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=324.75 Aligned_cols=242 Identities=24% Similarity=0.288 Sum_probs=196.0
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.||+|+||.||++.+. +|..||+|++.... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999874 58999999987532 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|..++. ....+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 154 (323)
T cd05595 81 ELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence 9998884 44579999999999999999999999 9999999999999999999999999999875322211 1223
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
..||+.|+|||++.++ .++.++|||||||++|||++|+.||....... ........ ....+.
T Consensus 155 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~----------~~~~p~ 216 (323)
T cd05595 155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILME----------EIRFPR 216 (323)
T ss_pred ccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcC----------CCCCCC
Confidence 5689999999988764 78999999999999999999999996543221 01111100 011233
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 267 EEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
..+..+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 4567889999999999999998 7777763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=327.84 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=211.0
Q ss_pred cccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 28 YSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
-.+.||+|.||.||+|.+ ..++.||+|++.-...+....+++.|+.++.+++++||.++|+.+..+..++++||||.||
T Consensus 17 ~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gG 96 (467)
T KOG0201|consen 17 KLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGG 96 (467)
T ss_pred cchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCc
Confidence 347899999999999977 5699999999987777777889999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
++.+.+ +.+..+++..+..++++++.||.|||. ++.+|||||+.|||+..+|.+||+|||.+-.+...... ...
T Consensus 97 sv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~t 170 (467)
T KOG0201|consen 97 SVLDLL-KSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKT 170 (467)
T ss_pred chhhhh-ccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc--ccc
Confidence 999999 555666999999999999999999999 99999999999999999999999999999776543332 245
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
..||+.|||||++.. ..|+.|+||||||++.+||.+|.+|+....+-...+ .+-....+....
T Consensus 171 fvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----------------lIpk~~PP~L~~ 233 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----------------LIPKSAPPRLDG 233 (467)
T ss_pred ccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------------eccCCCCCcccc
Confidence 789999999999985 479999999999999999999999998766632211 111222233444
Q ss_pred HHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 267 EEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
.++..+.+++..||+.||+.||++.+++
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 6788899999999999999999999988
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=325.79 Aligned_cols=242 Identities=23% Similarity=0.282 Sum_probs=196.9
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.||+|+||.||++.++ +|+.||+|++.... .......+.+|+.++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 68999999987532 2334457888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|.+++. ....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~ 154 (323)
T cd05571 81 ELFFHLS-RERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccc
Confidence 9999984 45678999999999999999999999 9999999999999999999999999999875322111 1233
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
..||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .......+ ....+.
T Consensus 155 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~----------~~~~p~ 216 (323)
T cd05571 155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILME----------EIRFPR 216 (323)
T ss_pred eecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcC----------CCCCCC
Confidence 5699999999988764 78999999999999999999999996432210 01111110 112234
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 267 EEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
..+..+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 4567899999999999999999 7888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=318.95 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=208.6
Q ss_pred hhhccccccccCCceEEEEEEeCC------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPN------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (369)
.++.+.+.||+|+||.||+|.+.+ +..||+|.+...........+.+|+.++..+.|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 445677899999999999997633 47899999886655556778999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhccCC-------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCe
Q 017591 98 LVYEFMENGSLDKYLFTDT-------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA 164 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 164 (369)
+||||+++++|.+++...+ ..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999995432 357899999999999999999999 999999999999999999999
Q ss_pred eEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccch
Q 017591 165 KVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQV 243 (369)
Q Consensus 165 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 243 (369)
+|+|||+++...............++..|+|||++..+ .++.++|||||||++|||++ |..||....... .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~ 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------V 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------H
Confidence 99999999865433322222334467889999988765 78999999999999999998 999986443221 1
Q ss_pred hHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 244 WDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.+. .........+...+..+.+++.+||+.||.+||++.+|++.|++
T Consensus 234 ~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IEC---------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHH---------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111 11222222334566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=315.20 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=207.4
Q ss_pred hccccccccCCceEEEEEEeCC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
..+.+.||+|+||.||+|.++. ...|++|.+...........+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 3456899999999999998742 468999998765555666789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++++|.+++......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.........
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 999999999997666689999999999999999999999 99999999999999999999999999999876522222
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.......++..|+|||.+... .++.++||||||+++|+|++ |..||...... ...+.. ....
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~---------~~~~ 225 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------DVIKAV---------EDGY 225 (266)
T ss_pred eeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHH-------HHHHHH---------HcCC
Confidence 222223456789999988764 78999999999999999998 88888543221 111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
....+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1222334567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=318.24 Aligned_cols=259 Identities=19% Similarity=0.266 Sum_probs=204.5
Q ss_pred ccCHHHHHHhhhccccccccCCceEEEEEEeCCCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 017591 15 RFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD 92 (369)
Q Consensus 15 ~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 92 (369)
.+++.++...+ ...||+|++|.||+|.+ +|+.||+|.+.... .......+.+|+.++.+++||||+++++++.+
T Consensus 14 ~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 89 (283)
T PHA02988 14 CIESDDIDKYT---SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89 (283)
T ss_pred ecCHHHcCCCC---CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence 34555552221 14699999999999998 78999999987532 22334678899999999999999999999877
Q ss_pred ----CCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEee
Q 017591 93 ----QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVAD 168 (369)
Q Consensus 93 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 168 (369)
....++||||+++|+|.+++.. ...+++...+.++.+++.||.|||+. .+++||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~d 166 (283)
T PHA02988 90 IVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIIC 166 (283)
T ss_pred cccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcc
Confidence 3467899999999999999944 45789999999999999999999972 4889999999999999999999999
Q ss_pred cCCceecCCCCCccccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHh
Q 017591 169 FGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEY 247 (369)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 247 (369)
||+++...... ....++..|+|||++.+. ..++.++|||||||++|||++|+.||....... .....
T Consensus 167 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-------~~~~i 234 (283)
T PHA02988 167 HGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-------IYDLI 234 (283)
T ss_pred cchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-------HHHHH
Confidence 99987653321 224588999999988652 378999999999999999999999997543211 11111
Q ss_pred hhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 248 EKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.. .......+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 235 ~~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 235 IN--------KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred Hh--------cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 10 1111222334567899999999999999999999999999764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=318.49 Aligned_cols=249 Identities=24% Similarity=0.304 Sum_probs=199.8
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
...+.||+|+||.||++.+ .+++.||+|.+.... .......+.+|+.++..++|+|++.+++++.+.+..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 3457899999999999987 468999999886432 1223456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
++|+|..++... ...+++..+..++.|++.||+|||+ ++++||||||+|||++.++.++|+|||++........
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-- 157 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--
Confidence 999999888543 3468999999999999999999999 9999999999999999999999999999987543222
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....||..|+|||++.+. .++.++|||||||++|+|++|+.||........ ..... . .......
T Consensus 158 -~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-------~~~~~-----~-~~~~~~~ 222 (285)
T cd05631 158 -VRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-------REEVD-----R-RVKEDQE 222 (285)
T ss_pred -ecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-------HHHHH-----H-Hhhcccc
Confidence 1234689999999988764 789999999999999999999999975443211 01110 0 0111112
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCC-----hHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPP-----MSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~v~~ 295 (369)
..+...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 233445678999999999999999997 677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=334.06 Aligned_cols=245 Identities=27% Similarity=0.346 Sum_probs=208.9
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+-||.|+-|.|-+|++ .+|+..|||++.+. ........+.+|+.+|+.+.|||++.+|+++.++.++|+|.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 3457799999999999977 67999999998754 33344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++|.|.+++- ..+++.+.+..+++.||+.|+.|+|. .+|+||||||+|+||+..+++||+|||+|..-..+..
T Consensus 95 ~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl--- 167 (786)
T KOG0588|consen 95 PGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL--- 167 (786)
T ss_pred CCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCcc---
Confidence 9999999994 55679999999999999999999999 9999999999999999999999999999986443332
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
-...+|++.|.+||++.+......++||||+|||||.||+|+.||++++... +..++..+. -+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~----------------LLlKV~~G~-f~ 230 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV----------------LLLKVQRGV-FE 230 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH----------------HHHHHHcCc-cc
Confidence 2346799999999999998788999999999999999999999998554321 122222222 23
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+...+.++++|+.+|+..||.+|.|+.+|++
T Consensus 231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred CCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 34667888999999999999999999999985
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=329.26 Aligned_cols=242 Identities=25% Similarity=0.341 Sum_probs=203.2
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
++||+|+.|.||.+.. .+++.||+|.+..... ...+-+.+|+.+|+..+|+|||.+++.|...+..+.|||||+||+|
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 5899999999999976 5689999999875332 2245688999999999999999999999988999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCC
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 188 (369)
.+.+. ...+++.++..|++.+++||+|||. +||+|||||.+|||++.+|.+||+|||++..+..... ......
T Consensus 358 TDvVt--~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmV 430 (550)
T KOG0578|consen 358 TDVVT--KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMV 430 (550)
T ss_pred hhhhh--cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cccccc
Confidence 99993 3459999999999999999999999 9999999999999999999999999999987654433 234567
Q ss_pred CCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh-cCCCCCCCHH
Q 017591 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL-GCGIEENDRE 267 (369)
Q Consensus 189 gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 267 (369)
||+.|||||++... .|.+|.||||||++++||+-|.+||....+-.. .+ .... ....-..+..
T Consensus 431 GTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA---------ly------LIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 431 GTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---------LY------LIATNGTPKLKNPEK 494 (550)
T ss_pred CCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHH---------HH------HHhhcCCCCcCCccc
Confidence 99999999998885 899999999999999999999999975333211 00 1111 1111244566
Q ss_pred HHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 268 EAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 268 ~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+..+.+++.+||+.|+.+|+++.|+++
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 7889999999999999999999999984
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=322.34 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=204.4
Q ss_pred hhhccccccccCCceEEEEEEeCC-Cc----EEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPN-GV----KIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
..+...+.||+|+||.||+|.+.. +. .||+|.+..........++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 334455789999999999998643 33 48999987655555667899999999999999999999998764 5789
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
|++|+++|+|.+++......+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 999999999999997666779999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
..........++..|+|||++... .++.++|||||||++|||++ |+.||....... ......
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~--------- 225 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILE--------- 225 (316)
T ss_pred CcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHh---------
Confidence 332222223456789999988764 78999999999999999997 898886432211 111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.......+......+..++.+||+.+|.+||++.+++..|....
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111222334567899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=320.95 Aligned_cols=243 Identities=23% Similarity=0.281 Sum_probs=196.2
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 32 LGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 32 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
||+|+||.||++.+. +++.||+|++.... .......+.+|+.++..++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999885 48899999986432 233456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCC
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 188 (369)
.+++.. ...+++..+..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||+++...... .......
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 999943 4579999999999999999999999 999999999999999999999999999987542221 1223356
Q ss_pred CCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHH
Q 017591 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268 (369)
Q Consensus 189 gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (369)
||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+... ... ....+...
T Consensus 155 gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~~~---------~~~-~~~~~~~~ 216 (312)
T cd05585 155 GTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYRKI---------LQE-PLRFPDGF 216 (312)
T ss_pred CCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHHHH---------HcC-CCCCCCcC
Confidence 99999999988764 7899999999999999999999999753321 011111 111 11223445
Q ss_pred HHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 269 AERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
+..+.+++.+||+.||.+||++..+.+.|+
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 678899999999999999987655555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=319.13 Aligned_cols=264 Identities=20% Similarity=0.287 Sum_probs=200.7
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||.|+||.||+|..+ +++.||+|.+...........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 345689999999999999875 5899999998754333334567899999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+ +|.+++......+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 87 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~ 160 (288)
T cd07871 87 S-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TY 160 (288)
T ss_pred c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cc
Confidence 6 9999986666678999999999999999999999 9999999999999999999999999999976533221 12
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhc-hhhhh
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKG-ELAAK 255 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~-~~~~~ 255 (369)
....+++.|+|||.+.+...++.++|||||||++|+|++|+.||......... ..+...|...... .....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 23458899999998876557899999999999999999999999765432110 0000111111000 00000
Q ss_pred hhcCCCC----CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLGCGIE----ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... .........+.+|+.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 001123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.51 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=203.3
Q ss_pred cccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEE
Q 017591 28 YSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 100 (369)
+.++||+|+||.||+|.+. .+..||+|++...........+.+|+.++..+. ||||+++++++.+....++||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 4478999999999999752 135799999976555555678999999999996 999999999999999999999
Q ss_pred eccCCCCHHHHhccC-----------------------------------------------------------------
Q 017591 101 EFMENGSLDKYLFTD----------------------------------------------------------------- 115 (369)
Q Consensus 101 e~~~~gsL~~~l~~~----------------------------------------------------------------- 115 (369)
||+++|+|.+++..+
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 999999999988532
Q ss_pred ------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCee
Q 017591 116 ------------------------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAK 165 (369)
Q Consensus 116 ------------------------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 165 (369)
...+++..++.++.|++.||.|||+ ++++|+||||+|||++.++.+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEE
Confidence 1247888999999999999999999 9999999999999999999999
Q ss_pred EeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchh
Q 017591 166 VADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVW 244 (369)
Q Consensus 166 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 244 (369)
|+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..||........ .+
T Consensus 278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~------~~ 350 (400)
T cd05105 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST------FY 350 (400)
T ss_pred EEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH------HH
Confidence 9999999876433322222334567889999988764 68999999999999999996 8888864322110 11
Q ss_pred HHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 245 DEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
... ........+...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus 351 ~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 NKI---------KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHH---------hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 111 11111223345567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=327.15 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=214.6
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc-eEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK-AALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~ 102 (369)
|...+++|+|+||.+++++.+ ++..+++|.+.-. ...........|+.+++++.|||||.+.+.+.+++. .+|||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 445689999999999999774 4788999987643 333444578899999999999999999999998888 9999999
Q ss_pred cCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 103 MENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+||+|.+.+.... ..++++++..|+.|++.|+.|||+ +.|+|||||+.|||+++++.|+|+|||+|+.+.....
T Consensus 86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~- 161 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS- 161 (426)
T ss_pred cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCchh-
Confidence 99999999996554 689999999999999999999998 9999999999999999999999999999998875542
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......||+.|++||.+.+ .+|..|+|||||||++|||++.+++|...+... +..++.....
T Consensus 162 -~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----------------Li~ki~~~~~ 223 (426)
T KOG0589|consen 162 -LASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----------------LILKINRGLY 223 (426)
T ss_pred -hhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHH----------------HHHHHhhccC
Confidence 2345789999999998877 489999999999999999999999997655432 2334444556
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
...+..++..+..++..||+.+|..||++.+++..
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 77788899999999999999999999999999865
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=320.99 Aligned_cols=241 Identities=24% Similarity=0.256 Sum_probs=197.4
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 45688999999999999885 58999999986421 2234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++|+|.+++. ....+++..+..++.|++.||+|||+ +|++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----- 154 (291)
T cd05612 84 PGGELFSYLR-NSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----- 154 (291)
T ss_pred CCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----
Confidence 9999999994 44578999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....|++.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+.....+. ..
T Consensus 155 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~----------~~ 216 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPF-------GIYEKILAGK----------LE 216 (291)
T ss_pred cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC----------cC
Confidence 1234589999999988764 6899999999999999999999999754321 1111111111 12
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCC-----hHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPP-----MSAVV 294 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~v~ 294 (369)
.+......+.+|+.+||+.||.+||+ +.+++
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 23334667899999999999999995 67665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=316.33 Aligned_cols=255 Identities=20% Similarity=0.353 Sum_probs=205.2
Q ss_pred hhccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
.+.+.++||+|+||.||+|.+. .+..||+|++...........+.+|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3456688999999999999763 2578999999865544555678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC
Q 017591 99 VYEFMENGSLDKYLFTD---------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS 163 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 163 (369)
++||+.+++|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 99999999999998421 2358889999999999999999999 99999999999999999999
Q ss_pred eeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccc
Q 017591 164 AKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQ 242 (369)
Q Consensus 164 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 242 (369)
+||+|||+++...............+++.|+|||.+..+ .++.++|||||||++|||++ |..||......
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------- 233 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999998865433322222334467899999988765 68999999999999999998 77777543221
Q ss_pred hhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 243 VWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
+.............+...+..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 234 --------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 --------DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1112222222223344567779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=309.02 Aligned_cols=249 Identities=29% Similarity=0.460 Sum_probs=201.4
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
.+.+.||+|+||.||++.++++..+++|.+..... ...++.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 45688999999999999998888999998764322 2457889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|.+++......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||.++........ ....
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05114 85 CLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSG 160 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCC
Confidence 9999996555678999999999999999999999 99999999999999999999999999998765332221 1122
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..++..|+|||.+... .++.++||||||+++|+|++ |+.||....... .......+ .....+
T Consensus 161 ~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-------~~~~i~~~---------~~~~~~ 223 (256)
T cd05114 161 AKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-------VVEMISRG---------FRLYRP 223 (256)
T ss_pred CCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCC---------CCCCCC
Confidence 3456789999988764 78999999999999999999 888886443211 11111111 111122
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 234567899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.28 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=201.5
Q ss_pred hhccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
.+.+.+.||+|+||.||+|.+. .+..||+|.+..........++.+|+.+++.++|+||+++++++.+....++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 3455689999999999999753 2568999988654444455678999999999999999999999998899999
Q ss_pred EEeccCCCCHHHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeec
Q 017591 99 VYEFMENGSLDKYLFTDT---------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADF 169 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 169 (369)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+||
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCC
Confidence 999999999999985422 246788999999999999999999 99999999999999999999999999
Q ss_pred CCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhh
Q 017591 170 GLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYE 248 (369)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (369)
|++................++..|+|||++..+ .++.++|||||||++|||++ |..||....... ..+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~--- 232 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLR--- 232 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH---
Confidence 998765433222222223457789999988764 68999999999999999999 677875432210 111
Q ss_pred hchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
..........+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus 233 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 ------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ------HHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111222233445678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=305.94 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=203.4
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCHH
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLD 109 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 109 (369)
++||+|+||.||+|...++..+|+|.+...........+.+|+.++..++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988899999999886655555667999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCC
Q 017591 110 KYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG 189 (369)
Q Consensus 110 ~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 189 (369)
+++......+++..++.++.+++.+|.|||+ ++++|+||||+||+++.++.++|+|||++......... ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence 9996666678999999999999999999999 99999999999999999999999999998764322211 1122234
Q ss_pred CCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHH
Q 017591 190 TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268 (369)
Q Consensus 190 t~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (369)
+..|+|||++..+ .++.++||||||+++|++++ |..||....... ..... ........+...
T Consensus 157 ~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~---------~~~~~~~~~~~~ 219 (250)
T cd05085 157 PIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQV---------EKGYRMSCPQKC 219 (250)
T ss_pred cccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHH---------HcCCCCCCCCCC
Confidence 6789999988764 78999999999999999998 888886443211 01111 111111223345
Q ss_pred HHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 269 AERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
+..+.+++.+||+.+|++||++.++++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=313.98 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=204.1
Q ss_pred ccccccccCCceEEEEEEe-----CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 27 NYSTKLGAGGFGVVYKGQF-----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
.+.++||+|+||.||+|.+ ..+..+++|.+...........+.+|+.+++.++|+||+++++++......++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 87 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE 87 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence 5668999999999999974 24688999998765555556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccC----------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCee
Q 017591 102 FMENGSLDKYLFTD----------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAK 165 (369)
Q Consensus 102 ~~~~gsL~~~l~~~----------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 165 (369)
|+++++|.+++... ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+|
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcEE
Confidence 99999999998422 1347899999999999999999999 9999999999999999999999
Q ss_pred EeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchh
Q 017591 166 VADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVW 244 (369)
Q Consensus 166 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 244 (369)
|+|||++................++..|+|||++..+ .++.++|||||||++|||++ |..||......
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---------- 233 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---------- 233 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence 9999999865433322222334467789999988764 68999999999999999998 88887543221
Q ss_pred HHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 245 DEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.+............+...+..+.+++.+||+.||.+||++.+|.+.|++
T Consensus 234 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 ------EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111111222333456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=324.98 Aligned_cols=241 Identities=24% Similarity=0.273 Sum_probs=197.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||.||+|++. +++.||+|++.... .......+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 45688999999999999885 58999999987432 2233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++|+|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 172 (329)
T PTZ00263 101 VGGELFTHLR-KAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---- 172 (329)
T ss_pred CCChHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----
Confidence 9999999994 44578999999999999999999999 999999999999999999999999999998754322
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....||+.|+|||++... .++.++|||||||++|+|++|+.||...... ..++....+. ..
T Consensus 173 -~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~----------~~ 233 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAGR----------LK 233 (329)
T ss_pred -ceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCC----------cC
Confidence 224689999999988775 6799999999999999999999999643321 1112211111 11
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCC-----hHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPP-----MSAVV 294 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~v~ 294 (369)
.+...+..+.+|+.+||+.||.+||+ +.+++
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 22234567899999999999999997 46655
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=321.54 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=202.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+...++||+|+||.||+++++ ++..+|+|++...........+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 344578999999999999885 5889999998765555566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++. ....+++..+..++.|++.||.|||+. .+++||||||+|||++.++.++|+|||++....... .
T Consensus 87 ~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~ 159 (331)
T cd06649 87 GGSLDQVLK-EAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----A 159 (331)
T ss_pred CCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----c
Confidence 999999994 445689999999999999999999981 369999999999999999999999999987653321 2
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc-cccchh-------------------
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW-FPKQVW------------------- 244 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~------------------- 244 (369)
....|+..|+|||++.+. .++.++|||||||++|||++|+.||.......... +.....
T Consensus 160 ~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 160 NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred ccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence 234689999999988764 78999999999999999999999996433211000 000000
Q ss_pred -------HH---hhhchhhhhhhcCCCCC-CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 245 -------DE---YEKGELAAKVLGCGIEE-NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 245 -------~~---~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ...............+. ....++..+.+|+.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 00000001111111111 12235678999999999999999999999974
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=309.30 Aligned_cols=253 Identities=31% Similarity=0.437 Sum_probs=204.6
Q ss_pred hhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
....+.+.||+|++|.||+|.+.+++.||+|.+..... ...++.+|+.++++++|+|++++++++...+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 44566789999999999999987788999999875322 2457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
++++|.+++.... ..+++..+..++.|++.||.+||+ ++++|+||||+||+++.++.++|+|||+++........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 9999999995443 578999999999999999999999 99999999999999999999999999999876532211
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
.......+..|+|||++... .++.++||||||+++|+|++ |+.||....... ..... .....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~---------~~~~~ 222 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQV---------DQGYR 222 (261)
T ss_pred ccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHH---------HcCCC
Confidence 11222334679999987764 78999999999999999999 888886433211 11111 11111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
...+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 12233456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=308.26 Aligned_cols=249 Identities=27% Similarity=0.462 Sum_probs=202.2
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
.+.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+.++.+++||||+++++++.+.+..++||||+.++
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 56788999999999999987777899998874322 2457899999999999999999999999888999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|.+++......+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||.++....... .....
T Consensus 85 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~ 160 (256)
T cd05113 85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVG 160 (256)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCC
Confidence 9999996655679999999999999999999999 9999999999999999999999999999886543321 11222
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..++..|++||.+... .++.++|||||||++|+|++ |..||....... ..... ........+
T Consensus 161 ~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~---------~~~~~~~~~ 223 (256)
T cd05113 161 SKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKV---------SQGLRLYRP 223 (256)
T ss_pred CccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHH---------hcCCCCCCC
Confidence 3456789999988764 68999999999999999998 888886433211 11111 111111222
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 234678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=323.72 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=195.9
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.++||+|+||.||++.+. +++.||+|++...........+.+|+.+++.++|+||+++++++.+.+..++||||++++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4468999999999999874 589999999876555556678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|.+.. ...+..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++....... ....
T Consensus 158 ~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~ 227 (353)
T PLN00034 158 SLEGTH-----IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNS 227 (353)
T ss_pred cccccc-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccc
Confidence 986533 45678889999999999999999 9999999999999999999999999999987643221 1123
Q ss_pred CCCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 187 YRGTPGYSAPEFLLR----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
..||..|+|||++.. +...+.++|||||||++|||++|+.||....... |.... .........
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--------~~~~~-----~~~~~~~~~ 294 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--------WASLM-----CAICMSQPP 294 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--------HHHHH-----HHHhccCCC
Confidence 468999999998753 2234579999999999999999999997322211 11110 001111112
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.........+.+|+.+||+.||++||++.+|++
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 233455678999999999999999999999985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=316.50 Aligned_cols=264 Identities=22% Similarity=0.293 Sum_probs=198.3
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||.||+|... +++.||+|++...........+.+|+.+++.++||||+++++++.+....++||||+.
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 445689999999999999885 6899999998754333334567889999999999999999999999999999999996
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........ ..
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~ 160 (303)
T cd07869 87 -TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TY 160 (303)
T ss_pred -cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cC
Confidence 58888886666779999999999999999999999 9999999999999999999999999999875432221 12
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc---------cccchhHHhhhc-hhhh
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW---------FPKQVWDEYEKG-ELAA 254 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~~-~~~~ 254 (369)
....++..|+|||++.+...++.++|||||||++|+|++|+.||.......... .....|...... ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 334689999999988765568999999999999999999999997543210000 000000000000 0000
Q ss_pred hhhcCCCCCC------CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGIEEN------DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.......+.. .......+.+|+.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 0012356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=338.87 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=222.4
Q ss_pred cccccccCCceEEEEEEeC----CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 28 YSTKLGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.++||.|.||.||+|+.+ ....||||.++....+....+|..|..+|.+++||||+++.|+....+...||.|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 4478999999999999874 357899999998888888999999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC-cc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT-HD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 182 (369)
++|+|+.||..+.+.+++.++..+++.|+.|+.||-+ .++|||||.++|||++.+..+|++|||+++.+.++.. ..
T Consensus 713 ENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred hCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 9999999999888899999999999999999999999 9999999999999999999999999999998754432 22
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
.+..-+-+.+|.|||.+... .+|.+|||||||++|||+++ |.+|+-+.+.+ ++...+.....
T Consensus 790 tt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----------------dVIkaIe~gyR 852 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----------------DVIKAIEQGYR 852 (996)
T ss_pred cccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchH----------------HHHHHHHhccC
Confidence 22223346789999998885 89999999999999999986 88887544432 33344455555
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcCC
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEI 303 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~~ 303 (369)
-+.+.+.+..|.+|++.||++|..+||.+.+|+..|++.+..
T Consensus 853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 667788899999999999999999999999999999987543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.78 Aligned_cols=242 Identities=24% Similarity=0.293 Sum_probs=196.7
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.||+|+||.||++.+. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 58999999987532 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|..++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~ 154 (328)
T cd05593 81 ELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKT 154 (328)
T ss_pred CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cccc
Confidence 9998884 44679999999999999999999999 9999999999999999999999999999875322211 1233
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
..||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ..... .. .....+.
T Consensus 155 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-------~~~~~---------~~-~~~~~p~ 216 (328)
T cd05593 155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELI---------LM-EDIKFPR 216 (328)
T ss_pred ccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHH-------HHHHh---------cc-CCccCCC
Confidence 5699999999988764 78999999999999999999999996433211 01111 00 0112233
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 267 EEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
..+..+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 4567789999999999999997 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=323.80 Aligned_cols=241 Identities=25% Similarity=0.354 Sum_probs=205.5
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
.+.||+|+||.||+|+.+ +.+.||+|.+.+. ..+.....+.+|+++++.++||||+.++++|+...+.++|.||+.|
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 468999999999999775 5899999998754 3445567899999999999999999999999999999999999988
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|..++ ...+.++++.+..++.+++.||.|||+ ++|.|||+||.|||+++++.+|++|||+++.+..+. ...+.
T Consensus 86 ~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vlts 159 (808)
T KOG0597|consen 86 DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVLTS 159 (808)
T ss_pred hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc--eeeee
Confidence 999999 566789999999999999999999999 999999999999999999999999999999876533 34456
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
.+||+-|||||.+.+ ..++..+|+||+||++||++.|++||...+- ..+...+.. -....+.
T Consensus 160 ikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si----------------~~Lv~~I~~-d~v~~p~ 221 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSI----------------TQLVKSILK-DPVKPPS 221 (808)
T ss_pred ccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHH----------------HHHHHHHhc-CCCCCcc
Confidence 789999999998775 5899999999999999999999999953221 111122221 1133455
Q ss_pred HHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 267 EEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
..+..+..++...|..||..|.+-.+++
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 7788899999999999999999999877
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=311.21 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=201.4
Q ss_pred cccccccCCceEEEEEEeC-CCc----EEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGV----KIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.||+|+||+||+|.+. +++ .+++|.+..........++..|+..+..+.||||+++++++. ....++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence 4578999999999999874 344 477787765444455677888999999999999999999875 4557899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|.+++......+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T cd05111 90 SPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166 (279)
T ss_pred CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCccc
Confidence 99999999997767789999999999999999999999 999999999999999999999999999998764433322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......++..|++||++..+ .++.++|||||||++|||++ |+.||........ .+....+ ..
T Consensus 167 ~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~---------~~ 229 (279)
T cd05111 167 FYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKG---------ER 229 (279)
T ss_pred ccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCC---------Cc
Confidence 23345577899999988765 68999999999999999998 9988865432210 1111111 11
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
...+...+..+..++.+||..||.+||++.++++.|....
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1112223456788999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=333.53 Aligned_cols=248 Identities=21% Similarity=0.298 Sum_probs=201.0
Q ss_pred ccccccccCCceEEEEEEeC-C-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-N-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|+||.||+|... + +..||+|.+... .......+.+|+.++..++||||+++++++...+..+|||||++
T Consensus 70 ~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 34578999999999999763 3 678888876543 33445678889999999999999999999999999999999999
Q ss_pred CCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 105 NGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 105 ~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
+|+|.+++.. ...++++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999998843 24578999999999999999999999 99999999999999999999999999999876543332
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
.......||+.|+|||++... .++.++|||||||++|+|++|+.||...... .+.........
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----------------~~~~~~~~~~~ 288 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQR----------------EIMQQVLYGKY 288 (478)
T ss_pred ccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCC
Confidence 233445699999999988764 7899999999999999999999998643221 11111111222
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+...+..+.+++.+||+.||.+||++.+++.
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 2233445678999999999999999999998863
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=308.13 Aligned_cols=250 Identities=29% Similarity=0.446 Sum_probs=203.6
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
.+.++||+|+||.||+|...++..|++|.+.... .....+.+|+.+++.++|+||+++++.+.+.+..+++|||++++
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05072 9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86 (261)
T ss_pred EEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence 4568999999999999998888899999876432 23567899999999999999999999999999999999999999
Q ss_pred CHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 107 SLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 107 sL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......... ...
T Consensus 87 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 162 (261)
T cd05072 87 SLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-ARE 162 (261)
T ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccC
Confidence 999999543 4578999999999999999999999 99999999999999999999999999999876433221 122
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
...++..|+|||++..+ .++.++|||||||++|+|++ |..||....... ..... ........
T Consensus 163 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~---------~~~~~~~~ 225 (261)
T cd05072 163 GAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSAL---------QRGYRMPR 225 (261)
T ss_pred CCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHH---------HcCCCCCC
Confidence 23467789999988764 68899999999999999998 888886432211 11111 11111122
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
....+..+.+++.+||+.+|++||+++++.+.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 23456778999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=317.60 Aligned_cols=238 Identities=26% Similarity=0.307 Sum_probs=188.5
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHH-HHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIG-TIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||.||+|++. +++.||+|++.... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999884 58899999986432 2223344555654 57788999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|...+. ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 81 GELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 99998884 45678999999999999999999999 999999999999999999999999999987532211 1223
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||+.|+|||.+... .++.++|||||||++|||++|+.||...+... .++.. ... ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i---------~~~-~~~~~ 216 (321)
T cd05603 155 TFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNI---------LHK-PLQLP 216 (321)
T ss_pred cccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHH---------hcC-CCCCC
Confidence 45689999999988764 68999999999999999999999996543211 11111 111 11222
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMS 291 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~ 291 (369)
......+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 34456789999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=306.17 Aligned_cols=249 Identities=32% Similarity=0.486 Sum_probs=207.9
Q ss_pred cccccCCceEEEEEEeCC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||.||+|.+.. +..+++|.+...........+.+|+..+..++|+|++++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998753 8899999998655544577899999999999999999999999998999999999999
Q ss_pred CCHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 106 GSLDKYLFTD--------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 106 gsL~~~l~~~--------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
++|.+++... ...+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999654 4789999999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
...........++..|+|||.+... .++.++|||||||++|+|++ |..||...... ..++. .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~---------~ 220 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-------EVLEY---------L 220 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHH---------H
Confidence 4332333445678899999988775 78999999999999999998 58888754221 11111 1
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
........+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112222334445788999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=317.07 Aligned_cols=239 Identities=25% Similarity=0.298 Sum_probs=190.8
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhc-cCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGR-TYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
++||+|+||.||+|.+. +++.||+|+++... .......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 48899999987532 22233445566666664 4799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|..++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 g~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQ-SSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99999984 44579999999999999999999999 999999999999999999999999999997643222 1223
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ..... . ...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i---------~-~~~~~~~ 216 (316)
T cd05592 155 TFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSI---------L-NDRPHFP 216 (316)
T ss_pred cccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHH---------H-cCCCCCC
Confidence 45689999999988764 68999999999999999999999997543211 11111 1 1112233
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSA 292 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~ 292 (369)
...+..+.+++.+||+.||.+||++.+
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 445677899999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=317.67 Aligned_cols=264 Identities=26% Similarity=0.389 Sum_probs=209.6
Q ss_pred HHHHHhhhccccccccCCceEEEEEEeCC--------CcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeE
Q 017591 19 EQLCSFTNNYSTKLGAGGFGVVYKGQFPN--------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGF 89 (369)
Q Consensus 19 ~el~~~t~~f~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 89 (369)
.+|....+.+.+.||+|+||.||++.+.. +..|++|.+..........++.+|+.++.++ .|+||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 34555667788999999999999997521 2478999888655555667899999999999 79999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCC
Q 017591 90 CYDQTKAALVYEFMENGSLDKYLFTD---------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPA 154 (369)
Q Consensus 90 ~~~~~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~ 154 (369)
+.+.+..+++|||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccc
Confidence 99999999999999999999998542 1357889999999999999999999 99999999999
Q ss_pred ceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 017591 155 NILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSS 233 (369)
Q Consensus 155 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~ 233 (369)
||+++.++.+||+|||+++...............++..|+|||++... .++.++|||||||++|||++ |..||.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999876443222222223345679999988764 78999999999999999998 7788754332
Q ss_pred CccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 234 DTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
.. .... .........+...+..+.+++.+||+.+|.+||++.++++.|+....
T Consensus 243 ~~-------~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EE-------LFKL---------LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HH-------HHHH---------HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 1111 11111222233456679999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=312.48 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=213.5
Q ss_pred HHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 22 CSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 22 ~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
.+.++.|.+.||+|.||.|-++.. +.|+.||||.++++. +++..-.+.+|+++++.|+||||+.++++|...+..+|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 456677888999999999999976 679999999998653 44556678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||..+|.|.+|+ ...+.+++.+...+++||..|+.|+|. ++++|||||.+|||+|.++++||+|||++..+...
T Consensus 131 vMEYaS~GeLYDYi-Ser~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYI-SERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEecCCccHHHHH-HHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999999 566789999999999999999999999 99999999999999999999999999999887655
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.. -+.++|++-|.+||++.+...-.+..|-|||||+||.|+-|..||++.+...+ ...+..|...+
T Consensus 207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l-------vrQIs~GaYrE---- 272 (668)
T KOG0611|consen 207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL-------VRQISRGAYRE---- 272 (668)
T ss_pred cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH-------HHHhhcccccC----
Confidence 43 34578999999999988876678899999999999999999999987554211 12223332221
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHh
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L 297 (369)
+..+....-||.|||-.||++|.|+.+|....
T Consensus 273 -------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 -------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 22344567899999999999999999988644
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=305.25 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=200.2
Q ss_pred ccccCCceEEEEEEeC---CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 31 KLGAGGFGVVYKGQFP---NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
.||+|+||.||+|.+. ++..||+|++...........+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 356799999876655555678999999999999999999999875 457899999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc-cccc
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD-STSG 186 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~ 186 (369)
|.+++......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999996666789999999999999999999999 999999999999999999999999999997654332211 1122
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..++..|+|||.+... .++.++|||||||++|++++ |..||....... .............+
T Consensus 158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~ 220 (257)
T cd05115 158 GKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----------------VMSFIEQGKRLDCP 220 (257)
T ss_pred CCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----------------HHHHHHCCCCCCCC
Confidence 2345789999987764 68999999999999999996 999986543211 11111122222334
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
...+..+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 4556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=321.41 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=201.7
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.++||+|+||.||+|++. +++.||+|++.... .......+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 45689999999999999885 48999999987532 2234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++..... .
T Consensus 84 ~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~ 154 (333)
T cd05600 84 PGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----Y 154 (333)
T ss_pred CCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----c
Confidence 9999999994 45578999999999999999999999 9999999999999999999999999999976543 2
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+........ .........
T Consensus 155 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~--~~~~~~~~~ 224 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-------TWENLKYWKE--TLQRPVYDD 224 (333)
T ss_pred cCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHH-------HHHHHHhccc--cccCCCCCc
Confidence 2345699999999988775 78999999999999999999999997543321 1111111000 000000011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
.....+..+.+++.+||..+|.+||++.++++.
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 112456788999999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=306.14 Aligned_cols=248 Identities=28% Similarity=0.457 Sum_probs=201.1
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
.+.+.||+|+||.||++.++++..+++|++..... ....+.+|+.+++.++|+||+++++++.+.+..++||||++++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 46788999999999999988788999998864322 2346888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|.+++......+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++........ ....
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 160 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQG 160 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCC
Confidence 9999996656689999999999999999999999 99999999999999999999999999998765432211 1112
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..++..|+|||.+... .++.++||||||+++|+|++ |+.||....... .... .........+
T Consensus 161 ~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~---------~~~~~~~~~~ 223 (256)
T cd05059 161 TKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVES---------VSAGYRLYRP 223 (256)
T ss_pred CCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHHH---------HHcCCcCCCC
Confidence 2245679999988764 78999999999999999998 788886433211 1111 1111112223
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHHHh
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVKML 297 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L 297 (369)
...+..+.+++.+||+.+|++||++.+|++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 34677899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=319.04 Aligned_cols=265 Identities=23% Similarity=0.361 Sum_probs=202.4
Q ss_pred HHhhhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 22 CSFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 22 ~~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
....+.+.++||+|+||.||++.+. ++..+|+|++...........+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3444556789999999999999885 588899998876555556678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++++|.+++. ....+++..+..++.|++.||.|||+. .+++|+||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 83 EHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred ecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999994 445689999999999999999999971 47999999999999999999999999998754322
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccc---------cc---------
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP---------KQ--------- 242 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~---------~~--------- 242 (369)
......|+..|+|||++.+. .++.++|||||||++|+|++|+.||............ ..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred --ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 12234689999999988764 7899999999999999999999999754321110000 00
Q ss_pred --hhHHhh--------hchhhhhhhcCCCCCC-CHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 243 --VWDEYE--------KGELAAKVLGCGIEEN-DREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 243 --~~~~~~--------~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
....+. .............+.. .......+.+|+.+||+.||.+||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell 297 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLM 297 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHh
Confidence 000000 0000011111111111 112456789999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=318.81 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=203.3
Q ss_pred hhccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeC-Cce
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQ-TKA 96 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~ 96 (369)
.+.+.+.||+|+||.||+|... +++.||+|++...........+..|+.++.++ +|+||+++++++... ...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 3456789999999999999642 35789999987544444556788999999999 799999999988754 567
Q ss_pred EEEEeccCCCCHHHHhccCC------------------------------------------------------------
Q 017591 97 ALVYEFMENGSLDKYLFTDT------------------------------------------------------------ 116 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 116 (369)
+++|||+++++|.+++....
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 89999999999999984321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCcccc
Q 017591 117 EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAP 196 (369)
Q Consensus 117 ~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 196 (369)
..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++..+.............++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 268999999999999999999999 99999999999999999999999999999876433322223334567789999
Q ss_pred ccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHH
Q 017591 197 EFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMV 275 (369)
Q Consensus 197 E~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 275 (369)
|++.+. .++.++|||||||++|||++ |..||....... ........+ .....+......+.++
T Consensus 245 E~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~l 308 (337)
T cd05054 245 ESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEG---------TRMRAPEYATPEIYSI 308 (337)
T ss_pred HHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhcc---------CCCCCCccCCHHHHHH
Confidence 988775 78999999999999999997 988886432211 011111111 1122233456779999
Q ss_pred HHhccccCCCCCCChHHHHHHhcCCc
Q 017591 276 ALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 276 ~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
+.+||+.+|++||++.+|++.|+...
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=309.18 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=203.6
Q ss_pred ccccccccCCceEEEEEEeC-CCc----EEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGV----KIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
.+.++||+|+||+||+|.+. +++ .||+|++...........+.+|+.++..+.|+||+++++++.. ...+++|+
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEE
Confidence 45689999999999999763 444 4899998765565667789999999999999999999999875 45789999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++|+|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~ 165 (279)
T cd05109 89 LMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165 (279)
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence 999999999997666779999999999999999999999 99999999999999999999999999999876543332
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.......++..|++||.+... .++.++|||||||++|||++ |..||....... .... .....
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~---------~~~~~ 228 (279)
T cd05109 166 YHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDL---------LEKGE 228 (279)
T ss_pred eecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH---------HHCCC
Confidence 222223456789999988764 68999999999999999998 888886432211 0111 11111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
....+...+..+.+++.+||+.||.+||++.++++.|+...
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 12223345677899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=305.19 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=199.4
Q ss_pred cccccCCceEEEEEEe---CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQF---PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
++||+|+||.||+|.+ +++..+|+|++.... .......+.+|+.++..+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 3699999999999965 357899999986433 3345667999999999999999999999875 4567899999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc-c
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS-T 184 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~ 184 (369)
++|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++........... .
T Consensus 80 ~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 80 GPLNKFLQ-KNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999994 44579999999999999999999999 9999999999999999999999999999987654332211 1
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....++..|+|||.+... .++.++|||||||++|||++ |+.||....... .... ........
T Consensus 156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~---------i~~~~~~~ 218 (257)
T cd05116 156 THGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQM---------IESGERME 218 (257)
T ss_pred CCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH---------HHCCCCCC
Confidence 223346789999987654 68899999999999999998 898986432211 1111 12222223
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+...+..+.+++.+||+.||.+||++.+|+..|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 3344667899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=311.66 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=202.9
Q ss_pred ccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.||+|+||.||++... ++..+++|.+... .......+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus 8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 45688999999999999742 3456888888753 3344667999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCC------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEee
Q 017591 101 EFMENGSLDKYLFTDT------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVAD 168 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 168 (369)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||+++.++.++|+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEecc
Confidence 9999999999985332 258999999999999999999999 9999999999999999999999999
Q ss_pred cCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHh
Q 017591 169 FGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEY 247 (369)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 247 (369)
||++................++..|+|||++... .++.++|||||||++|+|++ |..||....... ..+..
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~i 235 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECI 235 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence 9999865433322222334467789999988764 78999999999999999998 888876443211 11111
Q ss_pred hhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 248 EKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.. ......+...+..+.+|+.+||+.||.+||++.+|++.|++..
T Consensus 236 ~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 TQ---------GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred Hc---------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11 1112222234567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=312.83 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=201.5
Q ss_pred hhhccccccccCCceEEEEEEeCC---------------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEe
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPN---------------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 88 (369)
-.+.+.++||+|+||.||++...+ ...||+|.+...........+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 345667899999999999997632 23589999886555555678999999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHhccCC-----------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceE
Q 017591 89 FCYDQTKAALVYEFMENGSLDKYLFTDT-----------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANIL 157 (369)
Q Consensus 89 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nil 157 (369)
++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 9999999999999999999999984321 247899999999999999999999 99999999999999
Q ss_pred ecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCc
Q 017591 158 LDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG--RRKNAQDCSSDT 235 (369)
Q Consensus 158 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt--g~~p~~~~~~~~ 235 (369)
++.++.+||+|||++................++..|+|||++..+ .++.++|||||||++|+|++ +..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999765433322222333457789999988765 68999999999999999998 445655332211
Q ss_pred cCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 236 LDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
. .... ...............+...+..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 241 ~-------~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 V-------IENT--GEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H-------HHHH--HHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0 0000 0000000000111122334578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=313.24 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=204.2
Q ss_pred ccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (369)
.+.+.||+|+||.||++... +...+++|.+..........++.+|+.++.++ +|+||+++++++.+.+..+++
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 34578999999999999763 24689999988655555567799999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCe
Q 017591 100 YEFMENGSLDKYLFTD---------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA 164 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 164 (369)
|||+++|+|..++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeE
Confidence 9999999999998532 3468999999999999999999999 999999999999999999999
Q ss_pred eEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccch
Q 017591 165 KVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQV 243 (369)
Q Consensus 165 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 243 (369)
+|+|||+++...............++..|+|||++... .++.++|||||||++|||++ |..||....... .
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~ 243 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------L 243 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-------H
Confidence 99999999876543322222223456789999987664 78999999999999999997 888876433211 1
Q ss_pred hHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 244 WDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
++.. ........+...+..+.+|+.+||+.||.+|||+.+|++.|++.
T Consensus 244 ~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 FKLL---------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHH---------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111 11111223334567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=312.27 Aligned_cols=249 Identities=24% Similarity=0.277 Sum_probs=196.5
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccccc-------------HHHHHHHHHHHHHHhccCCCceeeEEeEEEeC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-------------KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ 93 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 93 (369)
+.+.||+|.||.|-+|++. +++.||+|++.+... ....+...+|+.++++++|+|||+++++..+.
T Consensus 101 l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 101 LIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCc
Confidence 3478999999999999884 599999999864211 11225788999999999999999999998765
Q ss_pred --CceEEEEeccCCCCHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecC
Q 017591 94 --TKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFG 170 (369)
Q Consensus 94 --~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 170 (369)
+..|||+|||..|.+...= ...+ +++.+.++|+++++.||+|||. +||+||||||+|+||+.+|+|||+|||
T Consensus 181 ~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred ccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEeeccc
Confidence 5899999999988874432 3344 9999999999999999999999 999999999999999999999999999
Q ss_pred CceecCCCCC---ccccccCCCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchh
Q 017591 171 LAKLCNPENT---HDSTSGYRGTPGYSAPEFLLRN---YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVW 244 (369)
Q Consensus 171 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 244 (369)
.+..+..... ...-....||+.|+|||....+ ...+.+.||||+||+||+|+.|+.||.+....
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---------- 325 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---------- 325 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----------
Confidence 9987743321 1122335799999999987763 24578999999999999999999999753321
Q ss_pred HHhhhchhhhhhhcCC-CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHh
Q 017591 245 DEYEKGELAAKVLGCG-IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297 (369)
Q Consensus 245 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L 297 (369)
+ +.+++.+.. .-+..++..+.+.+||.+||++||+.|.+..+|....
T Consensus 326 ~------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 E------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred H------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1 112222211 1222335678899999999999999999999986443
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=308.92 Aligned_cols=251 Identities=29% Similarity=0.430 Sum_probs=200.9
Q ss_pred cccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 28 YSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.+.||+|+||.||+|.+. .+..|++|.............+.+|+.+++.++|+||+++++++.+....++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 3478999999999999874 3578899988765555556789999999999999999999999998889999999
Q ss_pred ccCCCCHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC---CeeEeecCCc
Q 017591 102 FMENGSLDKYLFTDT------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF---SAKVADFGLA 172 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~ 172 (369)
|+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCccc
Confidence 999999999995432 258999999999999999999999 9999999999999998654 5899999999
Q ss_pred eecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhch
Q 017591 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
+................+..|+|||++.+. .++.++|||||||++|+|++ |..||.......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---------------- 229 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---------------- 229 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----------------
Confidence 876332222222223345689999998765 68999999999999999997 888886433211
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
.............+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111122233445678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=306.73 Aligned_cols=251 Identities=31% Similarity=0.479 Sum_probs=205.9
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.+.++||.|+||.||+|.+.++..+++|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 34568999999999999999889999999987543 23456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 106 GSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 106 gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
++|.+++... +..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||.+......... .
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~ 161 (261)
T cd05148 87 GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--S 161 (261)
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc--c
Confidence 9999999653 4568999999999999999999999 99999999999999999999999999999765432221 1
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....++..|++||.+..+ .++.++||||||+++|+|++ |+.||...... .... .........
T Consensus 162 ~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-------~~~~---------~~~~~~~~~ 224 (261)
T cd05148 162 SDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-------EVYD---------QITAGYRMP 224 (261)
T ss_pred cCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHH---------HHHhCCcCC
Confidence 233467789999988764 78999999999999999998 78888643321 0111 111121223
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 334556789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=321.54 Aligned_cols=244 Identities=23% Similarity=0.270 Sum_probs=198.2
Q ss_pred hhccccccccCCceEEEEEEeCC--CcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPN--GVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.++||+|+||.||+|.+++ +..||+|.+.... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 34567899999999999997643 3689999886432 2334557889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++|+|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++.......
T Consensus 111 Ey~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~- 185 (340)
T PTZ00426 111 EFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT- 185 (340)
T ss_pred eCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-
Confidence 9999999999994 44579999999999999999999999 999999999999999999999999999998754321
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.....+.
T Consensus 186 ----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~--------- 244 (340)
T PTZ00426 186 ----YTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGI--------- 244 (340)
T ss_pred ----ceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCC---------
Confidence 234689999999998764 6899999999999999999999999754321 1112211111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
...+...+..+.+++.+||+.||.+|+ ++.++++
T Consensus 245 -~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 -IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 112233456788999999999999995 7887764
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=311.24 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=204.5
Q ss_pred ccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.||+|+||.||++.+. ++..+++|.+.... ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 34578999999999999742 35668888876433 334467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCee
Q 017591 101 EFMENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAK 165 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 165 (369)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||+++.++.++
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999995432 348999999999999999999999 9999999999999999999999
Q ss_pred EeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchh
Q 017591 166 VADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVW 244 (369)
Q Consensus 166 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 244 (369)
|+|||++................++..|+|||++... .++.++|||||||++|+|++ |+.||....... .+
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~ 235 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VI 235 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH
Confidence 9999999765443322223334567889999988764 78999999999999999998 999886543221 11
Q ss_pred HHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 245 DEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
+. .............+..+.+++.+||+.+|.+||++.+|+++|+...
T Consensus 236 ~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 236 EC---------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HH---------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11 1112222233345678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.17 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=202.8
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCHH
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLD 109 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 109 (369)
++||+|+||.||++.+.+++.|++|.+...........+.+|+.+++++.|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999887799999999876544445678999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCC
Q 017591 110 KYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG 189 (369)
Q Consensus 110 ~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 189 (369)
+++......+++..+..++.+++.+|.|||+ ++++||||+|+||+++.++.++|+|||++.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9996666678999999999999999999999 9999999999999999999999999999876543222222122234
Q ss_pred CCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHH
Q 017591 190 TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268 (369)
Q Consensus 190 t~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (369)
+..|+|||.+..+ .++.++|+|||||++|+|++ |..||....... .... .........+...
T Consensus 158 ~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~---------~~~~~~~~~~~~~ 220 (251)
T cd05041 158 PIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRER---------IESGYRMPAPQLC 220 (251)
T ss_pred eeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHH---------HhcCCCCCCCccC
Confidence 5679999988765 78999999999999999998 777775433211 0111 1111111223345
Q ss_pred HHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 269 AERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=316.38 Aligned_cols=242 Identities=27% Similarity=0.313 Sum_probs=194.6
Q ss_pred cccccCCceEEEEEEe----CCCcEEEEEEccccc---cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 30 TKLGAGGFGVVYKGQF----PNGVKIAAKILKTCL---NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
++||+|+||.||+++. .+++.||+|++.... .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 357899999987432 122345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++++|.+++. ....+.+..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (323)
T cd05584 82 LSGGELFMHLE-REGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-- 155 (323)
T ss_pred CCCchHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence 99999999984 45578899999999999999999999 9999999999999999999999999999875432221
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ........+ ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~~~~~----------~~ 217 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDKILKG----------KL 217 (323)
T ss_pred cccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC----------CC
Confidence 12235689999999988764 6889999999999999999999999753321 011111111 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
..+...+..+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 22334467789999999999999999 6777654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=321.16 Aligned_cols=252 Identities=21% Similarity=0.226 Sum_probs=201.5
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.++||+|+||+||++.+. +++.||+|+++... .......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 345689999999999999874 58999999987532 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~- 158 (330)
T cd05601 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV- 158 (330)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-
Confidence 99999999996666789999999999999999999999 99999999999999999999999999999876533322
Q ss_pred ccccCCCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 183 STSGYRGTPGYSAPEFLLR-----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~-----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
......||+.|+|||++.. ...++.++|||||||++|+|++|+.||....... .+....... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~-----~ 226 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNFQ-----R 226 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcCC-----C
Confidence 2233468999999998763 3467899999999999999999999997543211 011111000 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+ .....+..+.+|+..||+ +|.+||++.+++.
T Consensus 227 ~~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00011 122356778899999998 9999999999873
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=305.99 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=204.5
Q ss_pred ccccccccCCceEEEEEEeCC-C---cEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-G---VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
...+.||+|+||.||+|..+. + ..+++|.+...........+.+|+.++..++|+|++++.+++.+.+..++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 456889999999999998753 3 379999987655555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++++|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++..........
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 88 MENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 99999999997666789999999999999999999999 999999999999999999999999999998664322211
Q ss_pred c-cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 183 S-TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 183 ~-~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
. ......+..|+|||++... .++.++|||||||++|||++ |+.||...... ....... ...
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~~~~~i~---------~~~ 227 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAIN---------DGF 227 (268)
T ss_pred eeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHh---------cCC
Confidence 1 1112234579999988764 68999999999999999997 99998643221 1111111 111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
........+..+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1222334567789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=306.53 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=203.0
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||+|+||.||+|.++ .+..|++|.+.... .....+.+|+.++..++|+||+++++++...+..++||||+++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 45688999999999999874 48899999887532 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 106 GSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 106 gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
++|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++......... ..
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~ 162 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AH 162 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee-cc
Confidence 9999999543 3468999999999999999999999 99999999999999999999999999999876433221 11
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....++..|+|||.+... .++.++|||||||++|||++ |..||...... ..+... .......
T Consensus 163 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~---------~~~~~~~ 225 (263)
T cd05052 163 AGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELL---------EKGYRME 225 (263)
T ss_pred CCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHH---------HCCCCCC
Confidence 122346689999988764 78999999999999999998 88887643221 111111 1111223
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+...+..+.+++.+||+.||++||++.+++++|+..
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 3344567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=316.32 Aligned_cols=241 Identities=24% Similarity=0.299 Sum_probs=197.0
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
++||+|+||.||+|+-+ +|+.+|+|+++++. .......+..|-.+|.....+.||+++-.|.+.+.+||||||.+||
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 58999999999999764 59999999998652 3455677889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC--------
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE-------- 178 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-------- 178 (369)
++..+| .+.+.+++..+..++.+++.|+..||+ .|++||||||+|+|||..|++||+|||++.-+...
T Consensus 227 D~mTLL-~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~ 302 (550)
T KOG0605|consen 227 DMMTLL-MRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRL 302 (550)
T ss_pred cHHHHH-HhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcc
Confidence 999999 667889999999999999999999999 99999999999999999999999999998432110
Q ss_pred --------------CCc----cc-------------------cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHH
Q 017591 179 --------------NTH----DS-------------------TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221 (369)
Q Consensus 179 --------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~el 221 (369)
... .. .....|||-|+|||++.+. .++..+|.||||||+|||
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 303 DEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWWSLGCIMYEM 381 (550)
T ss_pred hhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHHHHHHHHHHH
Confidence 000 00 0112599999999999986 699999999999999999
Q ss_pred HcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 017591 222 IGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPP 289 (369)
Q Consensus 222 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 289 (369)
|.|-+||....+. ..|..+..... +..-+.......+..+||.+|+. ||.+|.-
T Consensus 382 LvGyPPF~s~tp~-------~T~rkI~nwr~------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 382 LVGYPPFCSETPQ-------ETYRKIVNWRE------TLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HhCCCCCCCCCHH-------HHHHHHHHHhh------hccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999876654 23443322221 11112222334788999999999 9999976
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=306.17 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=198.5
Q ss_pred cccccccCCceEEEEEEeCCC-c--EEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC------CceE
Q 017591 28 YSTKLGAGGFGVVYKGQFPNG-V--KIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ------TKAA 97 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~~~-~--~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 97 (369)
+.++||+|+||.||+|.+.++ . .+|+|.++... .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 457899999999999987543 2 68999886532 334467889999999999999999999987532 2468
Q ss_pred EEEeccCCCCHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCc
Q 017591 98 LVYEFMENGSLDKYLFT-----DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA 172 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 172 (369)
++|||+++|+|.+++.. ....+++..+..++.|++.||+|||+ ++++||||||+|||++.++.++|+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999998732 23458999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhch
Q 017591 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
+...............++..|++||++... .++.++|||||||++|||++ |+.||...... ..++....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~- 230 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQG- 230 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcC-
Confidence 876543322222333467789999988764 78999999999999999999 78887643221 112222211
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.....+...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus 231 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 --------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11122234556789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=320.17 Aligned_cols=239 Identities=26% Similarity=0.284 Sum_probs=193.6
Q ss_pred cccccCCceEEEEEEe----CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 30 TKLGAGGFGVVYKGQF----PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.||+|+||.||+++. .+|+.+|+|++.... .......+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999975 358999999987532 22234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+|+|.+++. ....+++..++.++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++........ ..
T Consensus 82 ~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~ 155 (318)
T cd05582 82 GGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA 155 (318)
T ss_pred CCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence 999999984 44579999999999999999999999 9999999999999999999999999999876533221 12
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....||+.|+|||.+... .++.++|||||||++|+|++|+.||....... ..... .... ...
T Consensus 156 ~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-------~~~~i---------~~~~-~~~ 217 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-------TMTMI---------LKAK-LGM 217 (318)
T ss_pred ecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHH-------HHHHH---------HcCC-CCC
Confidence 235689999999988764 67899999999999999999999997533210 01111 1111 122
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSA 292 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~ 292 (369)
+...+..+.+++.+||+.||.+||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 3345677899999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=318.17 Aligned_cols=251 Identities=21% Similarity=0.231 Sum_probs=197.5
Q ss_pred ccccccccCCceEEEEEEe----CCCcEEEEEEccccc---cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEE
Q 017591 27 NYSTKLGAGGFGVVYKGQF----PNGVKIAAKILKTCL---NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (369)
.+.++||+|+||.||+++. .+++.||+|++.... .......+..|+.++..+ +|+||+.+++++.+.+..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 4568899999999999975 258999999986432 223345678899999999 59999999999999999999
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+++|+|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus 83 v~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 83 ILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 999999999999984 44578999999999999999999999 99999999999999999999999999998765332
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
... ......||..|+|||++.+...++.++|||||||++|||++|+.||........ ...+... ...
T Consensus 159 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~---------~~~ 225 (332)
T cd05614 159 EKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRR---------ILK 225 (332)
T ss_pred CCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHH---------Hhc
Confidence 221 122356999999999987654578999999999999999999999964432211 0001111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
..+..+...+..+.+++.+||+.||++|| ++.++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 -CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11223334567789999999999999999 5666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.57 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=203.3
Q ss_pred cccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 28 YSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.+.||+|+||.||+|... ....+++|.+..........++.+|+.+++.+.||||+++++.+...+..+++||
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4578999999999999763 2357888888765544556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe
Q 017591 102 FMENGSLDKYLFTD-----------------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL 158 (369)
Q Consensus 102 ~~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill 158 (369)
|+.+++|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEE
Confidence 99999999998431 1358899999999999999999999 999999999999999
Q ss_pred cCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccC
Q 017591 159 DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLD 237 (369)
Q Consensus 159 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~ 237 (369)
+.++.++|+|||+++...............++..|+|||.+... .++.++||||||+++|+|++ |..||......
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--- 236 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--- 236 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 99999999999999765433322222334467789999987664 68999999999999999998 88888643321
Q ss_pred ccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 238 WFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.++..... ......+...+..+.+++.+||+.+|.+||++.++++.|++..
T Consensus 237 ----~~~~~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 ----RLFNLLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ----HHHHHHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11222111 1112223345678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=331.31 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=202.8
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC--------
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-------- 94 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 94 (369)
.+.+.+.||+|+||+||++++ .+++.||+|++... ........+.+|+..+..++|+|++++++.+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 444568999999999999976 46899999998643 34455667889999999999999999988775332
Q ss_pred ceEEEEeccCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCC
Q 017591 95 KAALVYEFMENGSLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 367999999999999998542 3579999999999999999999999 9999999999999999999999999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
++.+.............||+.|+|||++... .++.++|||||||++|||++|+.||...... .
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~----------------~ 252 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENME----------------E 252 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----------------H
Confidence 9876543333333446799999999988774 7899999999999999999999999643221 1
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+............+...+..+.+++.+||+.||.+||++.+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 253 VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 11112222223334456778999999999999999999999875
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=309.50 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=204.4
Q ss_pred hccccccccCCceEEEEEEeCC-----------------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN-----------------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 88 (369)
+.+.++||+|+||.||++.+.+ +..||+|.+...........+.+|+.++.+++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3566899999999999997643 25689999886665566778999999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHhccCC----------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe
Q 017591 89 FCYDQTKAALVYEFMENGSLDKYLFTDT----------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL 158 (369)
Q Consensus 89 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill 158 (369)
++...+..+++||++++++|.+++.... ..+++..++.++.|++.||+|||+ ++++|+||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili 163 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceee
Confidence 9999999999999999999999995432 268999999999999999999999 999999999999999
Q ss_pred cCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCcc
Q 017591 159 DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG--RRKNAQDCSSDTL 236 (369)
Q Consensus 159 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt--g~~p~~~~~~~~~ 236 (369)
+.++.++|+|||+++...............++..|+|||++..+ .++.++|||||||++|||++ +..||......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-- 240 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-- 240 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcChH--
Confidence 99999999999999865443332333344567889999988764 68999999999999999998 55666533221
Q ss_pred CccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 237 DWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
+.+...... ............+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 241 -----~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 -----QVIENAGHF--FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -----HHHHHHHhc--cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111100 00000000111223345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=306.64 Aligned_cols=256 Identities=26% Similarity=0.440 Sum_probs=204.5
Q ss_pred hhccccccccCCceEEEEEEeCC-C---cEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPN-G---VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.+.||+|+||.||+|.++. + ..|++|.+..........+|..|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 34677899999999999998743 2 4699999876555556678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++++|.+++......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 9999999999997666779999999999999999999999 9999999999999999999999999999876543222
Q ss_pred cccccc-C--CCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 181 HDSTSG-Y--RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 181 ~~~~~~-~--~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
...... . ..+..|+|||++... .++.++|||||||++||+++ |..||....... .....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~i--------- 224 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAI--------- 224 (269)
T ss_pred ccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHHH---------
Confidence 111111 1 124579999988764 78999999999999999886 988886433211 11111
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
........+...+..+.+++.+||+.+|.+||++.+|+..|+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111122234566789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=307.41 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=204.4
Q ss_pred hccccccccCCceEEEEEEeCC------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (369)
+.+.+.||+|+||.||+|.++. +..|++|.+...........+.+|+.++..++|+||+++++++......++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 87 (277)
T cd05032 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV 87 (277)
T ss_pred eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence 3456889999999999997642 4789999987655555567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecC
Q 017591 100 YEFMENGSLDKYLFTD---------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFG 170 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 170 (369)
|||+++++|.+++... ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCcc
Confidence 9999999999998532 2347889999999999999999999 999999999999999999999999999
Q ss_pred CceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhh
Q 017591 171 LAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEK 249 (369)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (369)
+++...............++..|+|||.+..+ .++.++|||||||++||+++ |..||....... ..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~-- 234 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFV-- 234 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHH--
Confidence 98765433322222334567899999988765 68999999999999999998 888886433211 11111
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 250 GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
........+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 235 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 -------IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111222233347789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.90 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=203.6
Q ss_pred HhhhccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 96 (369)
...+.+.++||+|+||.||+|..+ .+..||+|.+...........+.+|+.+++.+.|+||+++++++.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 344566789999999999999653 25589999887554444456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEe
Q 017591 97 ALVYEFMENGSLDKYLFTD---------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVA 167 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 167 (369)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999532 1345778899999999999999999 999999999999999999999999
Q ss_pred ecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHH
Q 017591 168 DFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDE 246 (369)
Q Consensus 168 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 246 (369)
|||+++...............++..|+|||.+..+ .++.++|||||||++|||++ |..||......
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------------ 228 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------------ 228 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 99998765433222222223456789999988765 68999999999999999998 67777543221
Q ss_pred hhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+.............+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 229 ----QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ----HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11111111111222333457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=313.18 Aligned_cols=264 Identities=21% Similarity=0.235 Sum_probs=199.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.+.||+|+||.||+++++ +++.+|+|++.... .......+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 345688999999999999885 58899999886432 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+++.+..+. .....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......... .
T Consensus 83 ~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 157 (287)
T cd07848 83 EKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-N 157 (287)
T ss_pred CCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-c
Confidence 997776554 445679999999999999999999999 99999999999999999999999999999875432221 1
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhhc-hhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKG-ELAA 254 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~-~~~~ 254 (369)
.....|+..|+|||++.+. .++.++|||||||++|||++|+.||........ ..++...++.+... ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 158 YTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred ccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 2234689999999988765 689999999999999999999999976433110 00010001100000 0000
Q ss_pred hhhcCCC------CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGI------EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... .......+..+.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0011124567999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=312.87 Aligned_cols=241 Identities=25% Similarity=0.297 Sum_probs=192.0
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHHhc-cCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGR-TYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
++||+|+||.||+|.++ +|..||+|+++.... ......+..|..++.. ..||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999885 588999999875321 2234456677777765 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|..++. ....+++..+..++.|++.||+|||+ +|++||||||+|||++.++.++|+|||+++....... ...
T Consensus 81 g~L~~~i~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05620 81 GDLMFHIQ-DKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAS 154 (316)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--cee
Confidence 99999984 34678999999999999999999999 9999999999999999999999999999875321111 223
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||..|+|||++.+. .++.++|||||||++|+|++|+.||...... ..++.... ..+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~----------~~~~~~ 216 (316)
T cd05620 155 TFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRV----------DTPHYP 216 (316)
T ss_pred ccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh----------CCCCCC
Confidence 45689999999988764 7899999999999999999999999754321 11111111 112222
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChH-HHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMS-AVV 294 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~-~v~ 294 (369)
......+.+++.+||+.||.+||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 33566789999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=310.24 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=203.8
Q ss_pred hccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (369)
..+.+.||+|+||.||++.+. .+..||+|.+...........+.+|+.+++++ +|+||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 345689999999999999641 35689999887654445566799999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 99 VYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999999995433 348999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
...........++..|+|||.+..+ .++.++|||||||++|+|++ |..||........ ..+. .
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~---------~ 257 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKL---------I 257 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHH---------H
Confidence 3222122223467789999988775 68999999999999999998 8888865432210 0111 1
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
........+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111122223456899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=312.94 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=204.6
Q ss_pred HhhhccccccccCCceEEEEEEeC--------CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeC
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQFP--------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQ 93 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 93 (369)
...+.+.+.||+|+||.||++.+. +...+|+|.+..........++.+|+.++..+ +|+||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 345566789999999999999752 23579999988654445566788999999999 799999999999999
Q ss_pred CceEEEEeccCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe
Q 017591 94 TKAALVYEFMENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL 158 (369)
Q Consensus 94 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill 158 (369)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++++|+||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 99999999999999999995432 358899999999999999999999 999999999999999
Q ss_pred cCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccC
Q 017591 159 DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLD 237 (369)
Q Consensus 159 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~ 237 (369)
+.++.++|+|||.+................++..|+|||.+.+. .++.++|||||||++|+|++ |..||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---
Confidence 99999999999998765432222222222345689999988764 68999999999999999998 77777533211
Q ss_pred ccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 238 WFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+.+.. ........+...+..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 250 ----~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 250 ----ELFKLL---------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred ----HHHHHH---------HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111 11112233344567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=311.81 Aligned_cols=262 Identities=25% Similarity=0.391 Sum_probs=207.6
Q ss_pred HHHhhhccccccccCCceEEEEEEe--------CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEE
Q 017591 21 LCSFTNNYSTKLGAGGFGVVYKGQF--------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCY 91 (369)
Q Consensus 21 l~~~t~~f~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 91 (369)
+....+.+.+.||+|+||.||+++. .++..|++|.............+.+|+.++..+ .|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3344445678999999999999964 124579999987654455567899999999999 7999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCce
Q 017591 92 DQTKAALVYEFMENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANI 156 (369)
Q Consensus 92 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Ni 156 (369)
.....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ +|++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 9999999999999999999995431 357889999999999999999999 9999999999999
Q ss_pred EecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCc
Q 017591 157 LLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDT 235 (369)
Q Consensus 157 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~ 235 (369)
+++.++.+||+|||+++...............++..|+|||++... .++.++||||||+++|+|++ |..||......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence 9999999999999999876543333223334467789999988764 68999999999999999998 67777543221
Q ss_pred cCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 236 LDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
...+.. ........+...+..+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 247 ------~~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 ------ELFKLL---------KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ------HHHHHH---------HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 111111 1111122233456789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.52 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=202.5
Q ss_pred ccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 99 (369)
.+.++||+|+||.||+|++. .+..||+|+++..........+.+|+.++.++. ||||+++++++...+..++|
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv 119 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYII 119 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEE
Confidence 34578999999999999853 356899999986544444567899999999997 99999999999999999999
Q ss_pred EeccCCCCHHHHhccCC---------------------------------------------------------------
Q 017591 100 YEFMENGSLDKYLFTDT--------------------------------------------------------------- 116 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~--------------------------------------------------------------- 116 (369)
|||+++|+|.++++...
T Consensus 120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (401)
T cd05107 120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV 199 (401)
T ss_pred EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence 99999999999985321
Q ss_pred ----------------------------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC
Q 017591 117 ----------------------------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF 162 (369)
Q Consensus 117 ----------------------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 162 (369)
..+++..++.++.|++.||.|||+ ++++||||||+|||++.++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCC
Confidence 246778899999999999999999 9999999999999999999
Q ss_pred CeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCcccc
Q 017591 163 SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPK 241 (369)
Q Consensus 163 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 241 (369)
.++|+|||+++...............++..|+|||.+... .++.++|||||||++|||++ |+.||.......
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------ 349 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------ 349 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------
Confidence 9999999999865432222222234567889999988764 68999999999999999998 888886433211
Q ss_pred chhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 242 QVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
...... ........+...+..+.+|+.+||+.+|.+||++++|++.|+..
T Consensus 350 ~~~~~~---------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 QFYNAI---------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHH---------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011111 11111222334567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=320.57 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=219.3
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
-|.++||+|-||.|.++...++..||||.++....+....+|.+|+++|.+++||||+.++++|..++..++|+|||++|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 36689999999999999987789999999998888888899999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 107 SLDKYLFTDTEV-LKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 107 sL~~~l~~~~~~-~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+|.+|+..+..+ +.-+....|+.||+.|++||.+ .++|||||.++|+|++.++++||+|||+++.+.++.......
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 999999655433 4667788899999999999999 999999999999999999999999999999887777666555
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHH--cCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII--GRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ell--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
...-+++|||+|.+.-+ ++|++||||+||+++||++ +...||.....+... + ..+.+...--......
T Consensus 698 r~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-------e--n~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-------E--NAGEFFRDQGRQVVLS 767 (807)
T ss_pred ceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-------H--hhhhhcCCCCcceecc
Confidence 66678999999998876 8999999999999999976 577888755443211 0 0111111111122344
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+..++..+.+++.+||..+-++||+++++...|...
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 5667788899999999999999999999999888753
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=304.56 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=205.5
Q ss_pred hhccccccccCCceEEEEEEeC----CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.+.||+|+||.||+|.+. .+..+++|.+...........+.+|+.++..++||||+++++++.+.+..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 3456789999999999999763 234799999876554555678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++++|.+++......+++.+++.++.|++.||.+||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 9999999999997666778999999999999999999999 9999999999999999999999999999987643322
Q ss_pred ccc-cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 181 HDS-TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 181 ~~~-~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
... .....++..|++||++... .++.++|||||||++|++++ |..||....... .......
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~--------- 224 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEE--------- 224 (267)
T ss_pred eeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhC---------
Confidence 111 1122235689999988764 68999999999999999886 999986543211 1111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
......+...+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111122234567789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=307.66 Aligned_cols=271 Identities=23% Similarity=0.354 Sum_probs=205.0
Q ss_pred hhccccccccCCceEEEEEEe-----CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAA 97 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 97 (369)
++...++||+|+||.||++.+ .++..|++|.+...........+.+|+.+++.+.|+|++++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 344557899999999999974 347899999987655555667899999999999999999999998865 5688
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||+++++|.+++......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.++|+|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 9999999999999996555678999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 178 ENTH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
.... .......++..|+|||++.+. .++.++|||||||++|+|++++.|............... .............
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT-HGQMTVTRLVRVL 239 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc-cccccHHHHHHHH
Confidence 3221 112234567789999988764 689999999999999999998776432211100000000 0000000000111
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
............+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111122334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=306.53 Aligned_cols=245 Identities=25% Similarity=0.334 Sum_probs=195.0
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 32 LGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 32 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
||+|+||+||++.+. +++.+|+|.+.... .......+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999874 58899999986432 122345678899999999999999999999999999999999999999
Q ss_pred HHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 109 DKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 109 ~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
..++.. ....+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 988743 34579999999999999999999999 99999999999999999999999999999866433221 22
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||..|+|||++.+. .++.++|||||||++|+|++|+.||........ ... ........ ....+
T Consensus 156 ~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-------~~~-----~~~~~~~~-~~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-------NKE-----LKQRILND-SVTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-------HHH-----HHHhhccc-CCCCc
Confidence 35689999999998875 789999999999999999999999975432211 000 00111111 11223
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
...+..+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 44677899999999999999999 5566653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=301.18 Aligned_cols=249 Identities=28% Similarity=0.398 Sum_probs=199.5
Q ss_pred cccccCCceEEEEEEeCC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
++||+|+||.||+|.+.. +..+++|.+..........++.+|+.+++.+.|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997632 37899999886555455678999999999999999999999875 5568999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc-c
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS-T 184 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~ 184 (369)
++|.+++... ..+++..++.++.|++.||+|||. .+++|+||||+||+++.++.++|+|||+++.......... .
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999543 478999999999999999999999 9999999999999999999999999999987643332211 1
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....++..|+|||.+... .++.++|||||||++|+|++ |..||....... ....... .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-------~~~~~~~---------~~~~~ 218 (257)
T cd05060 156 TAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLES---------GERLP 218 (257)
T ss_pred cCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHc---------CCcCC
Confidence 122245679999988664 78999999999999999998 899986543211 1111111 11122
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+...+..+.+++.+||..+|.+||++.+|++.|++.
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 3334567889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=316.01 Aligned_cols=238 Identities=24% Similarity=0.302 Sum_probs=191.6
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||.||+|+++ +++.||+|++.... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999885 58899999987532 223345677888888766 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|..++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++........ ...
T Consensus 81 g~L~~~i~-~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (320)
T cd05590 81 GDLMFHIQ-KSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTS 154 (320)
T ss_pred chHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--ccc
Confidence 99999884 44679999999999999999999999 9999999999999999999999999999875432211 123
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||+.|+|||++... .++.++|||||||++|+|++|+.||....... .+.....+. ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~----------~~~~ 216 (320)
T cd05590 155 TFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDE----------VVYP 216 (320)
T ss_pred ccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCC----------CCCC
Confidence 35699999999988764 78999999999999999999999997543211 111111111 1122
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMS 291 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~ 291 (369)
...+..+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 33567789999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=316.12 Aligned_cols=244 Identities=24% Similarity=0.266 Sum_probs=192.4
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||.||++.+. +++.||+|+++... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999874 58999999987532 223345688899999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|..++. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (329)
T cd05588 81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS 154 (329)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence 99998884 44679999999999999999999999 999999999999999999999999999987422111 1223
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--CccccchhHHhhhchhhhhhhcCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--DWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
...||..|+|||++.+. .++.++|||||||++|+|++|+.||........ .......+... .. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~-~~~~ 223 (329)
T cd05588 155 TFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI---------LE-KQIR 223 (329)
T ss_pred cccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH---------Hc-CCCC
Confidence 35689999999988764 789999999999999999999999974332211 00001111111 11 1112
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
.+...+..+.+++.+||+.||.+||++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 233456778999999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=316.00 Aligned_cols=244 Identities=23% Similarity=0.263 Sum_probs=191.9
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||.||++.++ +++.||+|++.... .......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999874 58899999987532 233445678888888776 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|..++. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (329)
T cd05618 81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS 154 (329)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence 99998884 44679999999999999999999999 9999999999999999999999999999875322111 123
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--ccccchhHHhhhchhhhhhhcCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--WFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
...||..|+|||++.+. .++.++|||||||++|+|++|+.||......... ......+... .. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i---------~~-~~~~ 223 (329)
T cd05618 155 TFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI---------LE-KQIR 223 (329)
T ss_pred cccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH---------hc-CCCC
Confidence 35689999999988764 7899999999999999999999999643222110 0001111111 11 1112
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
.+...+..+.+++.+||+.||.+||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 334456778999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=302.91 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=194.8
Q ss_pred cccccCCceEEEEEEeCC---CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFPN---GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.||+|+||.||+|.+.+ +..+++|.+...........+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997643 46789998876554455568999999999999999999999999989999999999999
Q ss_pred CHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 107 SLDKYLFTDT----EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 107 sL~~~l~~~~----~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+|.+++.... ...++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999995422 356778889999999999999999 999999999999999999999999999987543332222
Q ss_pred ccccCCCCCCcccccccccc------CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 183 STSGYRGTPGYSAPEFLLRN------YPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~------~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
......++..|+|||++... ..++.++||||||+++|||++ |+.||........ ........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~---- 226 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-------LTYTVREQ---- 226 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-------HHHHhhcc----
Confidence 23334578889999987642 135789999999999999996 9999865432211 00000000
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 256 VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
......+.........+.+++..|| .+|++||++.+|+..|.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0000111112234556888999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=306.55 Aligned_cols=257 Identities=22% Similarity=0.317 Sum_probs=206.5
Q ss_pred hhccccccccCCceEEEEEEeCC-----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe-CCceEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPN-----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD-QTKAAL 98 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 98 (369)
.+.+.+.||+|+||.||+|.+.+ +..|++|.+...........+.+|+.+++.++|+|++++++++.. +...++
T Consensus 7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 86 (280)
T cd05043 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFV 86 (280)
T ss_pred heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEE
Confidence 34456899999999999998755 789999998866666667789999999999999999999998876 467899
Q ss_pred EEeccCCCCHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCC
Q 017591 99 VYEFMENGSLDKYLFTDT-------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
+++|+++++|.+++.... ..+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 999999999999985432 468999999999999999999999 9999999999999999999999999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhc
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKG 250 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (369)
++.+.............++..|+|||++... .++.++|||||||++||+++ |+.||....... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~- 234 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAAYLKD- 234 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHc-
Confidence 9865433322222233467789999988764 68999999999999999998 999986533211 1111111
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 251 ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
..........+..+.+++.+||..||++||++.+|++.|+...
T Consensus 235 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 --------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred --------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111122334567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=305.29 Aligned_cols=246 Identities=26% Similarity=0.333 Sum_probs=194.7
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 32 LGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 32 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
||+|+||.||++..+ +|+.+|+|.+..... ......+..|++++.+++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999874 589999998864221 12234556799999999999999999999999999999999999999
Q ss_pred HHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccC
Q 017591 109 DKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187 (369)
Q Consensus 109 ~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 187 (369)
..++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence 9888543 3468999999999999999999999 9999999999999999999999999999887643322 1234
Q ss_pred CCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHH
Q 017591 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE 267 (369)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (369)
.|+..|+|||++... .++.++|||||||++|+|++|+.||........ .. .+...............
T Consensus 155 ~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-------~~-----~~~~~~~~~~~~~~~~~ 221 (277)
T cd05607 155 AGTNGYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-------KE-----ELKRRTLEDEVKFEHQN 221 (277)
T ss_pred CCCCCccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-------HH-----HHHHHhhcccccccccc
Confidence 689999999998775 589999999999999999999999865332110 00 11111111111111234
Q ss_pred HHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 268 EAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 268 ~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
++..+.+|+.+||+.||.+||++.++++.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 56778999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=315.62 Aligned_cols=241 Identities=22% Similarity=0.280 Sum_probs=193.3
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
++||+|+||.||+|+++ +++.||+|++.... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 47899999987532 223345677888888765 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|..++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05591 81 GDLMFQIQ-RSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT 154 (321)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence 99999884 44578999999999999999999999 9999999999999999999999999999875432221 123
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||..|+|||++.+. .++.++|||||||++|+|++|+.||....... .++....+. ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~~~i~~~~----------~~~p 216 (321)
T cd05591 155 TFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-------LFESILHDD----------VLYP 216 (321)
T ss_pred ccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC----------CCCC
Confidence 35689999999988764 78999999999999999999999997544221 111111111 1112
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-------ChHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARP-------PMSAVV 294 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RP-------s~~~v~ 294 (369)
...+..+.+++.+||+.||.+|| ++.+++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence 23456789999999999999999 666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=302.59 Aligned_cols=251 Identities=28% Similarity=0.436 Sum_probs=195.8
Q ss_pred cccccCCceEEEEEEeC----CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEE-eCCceEEEEeccC
Q 017591 30 TKLGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY-DQTKAALVYEFME 104 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 104 (369)
+.||+|+||.||+|.+. ++..+|+|.+...........+.+|+.+++.++|||++++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999763 246799998865444455678889999999999999999999776 4556889999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc--c
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH--D 182 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~ 182 (369)
+++|.+++......+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999996656667888899999999999999999 99999999999999999999999999998765432111 1
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCC-CCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRK-NAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......++..|+|||++... .++.++|||||||++|||++|+. ||...... +..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~----------------~~~~~~~~~~~ 220 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF----------------DITVYLLQGRR 220 (262)
T ss_pred ccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHHHhcCCC
Confidence 11233467789999988764 78999999999999999999655 44322111 01111111111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
...+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 222233456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=313.28 Aligned_cols=238 Identities=25% Similarity=0.301 Sum_probs=189.2
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHH-HHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIG-TIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||+||+|.+. +|+.||+|++.... .......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999884 68999999986432 1222344555554 56778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|..++. ....+++..+..++.|++.||.|||+ +|++||||||+|||++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (323)
T cd05575 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS 154 (323)
T ss_pred CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence 99999984 45679999999999999999999999 999999999999999999999999999987532211 1223
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..++.... .. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~---------~~-~~~~ 216 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------EMYDNILN---------KP-LRLK 216 (323)
T ss_pred cccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHH-------HHHHHHHc---------CC-CCCC
Confidence 45689999999988764 7899999999999999999999999653321 11111111 11 1122
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMS 291 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~ 291 (369)
...+..+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 23467789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=306.10 Aligned_cols=270 Identities=25% Similarity=0.368 Sum_probs=201.7
Q ss_pred hccccccccCCceEEEEEEe-----CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 98 (369)
..+.+.||+|+||.||++.. .++..|++|.+... .......+.+|+.++..++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 44568899999999999974 25789999998754 334467889999999999999999999987543 46789
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+++++|.+++......+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 999999999999996656679999999999999999999999 99999999999999999999999999999876433
Q ss_pred CCccc-cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 179 NTHDS-TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 179 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
..... .....++..|+|||++.+. .++.++|||||||++|||++|..++.......................+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 22111 1112244569999988764 789999999999999999998876543221100000000000000000111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
...........+..+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1112222334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=318.00 Aligned_cols=243 Identities=23% Similarity=0.287 Sum_probs=195.2
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.||+|+||.||++.+ .+++.||+|++.... .......+.+|+.++..++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 468999999987532 2334456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|..++. ....+++..+..++.|++.||.|||+. ++++||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (325)
T cd05594 81 ELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT 155 (325)
T ss_pred cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence 9999883 445799999999999999999999962 6999999999999999999999999999875432211 1223
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
..||..|+|||++.+. .++.++|||||||++|+|++|+.||....... ........ ....+.
T Consensus 156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~----------~~~~p~ 217 (325)
T cd05594 156 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILME----------EIRFPR 217 (325)
T ss_pred ccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcC----------CCCCCC
Confidence 4699999999988764 78999999999999999999999996533211 01111100 111223
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 267 EEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
..+..+.+++.+||+.||.+|+ ++.++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 3567789999999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=307.55 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=202.2
Q ss_pred ccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.||+|+||.||++.++ ++..+++|++..........++.+|+.+++.+.|||++++++++.+....++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence 34578999999999999863 468999999876555555678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec
Q 017591 101 EFMENGSLDKYLFTDT---------------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD 159 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~ 159 (369)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||+++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~ 164 (288)
T cd05050 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVG 164 (288)
T ss_pred ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEec
Confidence 9999999999995321 247889999999999999999999 9999999999999999
Q ss_pred CCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCc
Q 017591 160 AKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDW 238 (369)
Q Consensus 160 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~ 238 (369)
.++.++|+|||++.................+..|+|||.+... .++.++|||||||++|+|++ |..||......
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~---- 239 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE---- 239 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999998765433222222223456789999987764 78999999999999999997 77787543221
Q ss_pred cccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 239 FPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
....... .......+...+..+.+++.+||+.+|.+||++.||++.|++
T Consensus 240 ---~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ---EVIYYVR---------DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHHHHHh---------cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111111 111112223456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.97 Aligned_cols=240 Identities=24% Similarity=0.305 Sum_probs=192.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCC-ceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHI-NLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.||+|+||.||+|.+. +++.||+|++.... .......+..|..++..+.|+ +|+.+++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 46688999999999999875 47899999987532 233456678899999988764 588899999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|..++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++........
T Consensus 83 ~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 156 (324)
T cd05587 83 VNGGDLMYHIQ-QVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-- 156 (324)
T ss_pred CCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--
Confidence 99999999984 44578999999999999999999999 9999999999999999999999999999875322111
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......||..|+|||++.+. .++.++|||||||++|+|++|+.||....... ...... . ...
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~---------~-~~~ 218 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIM---------E-HNV 218 (324)
T ss_pred ceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHH---------c-CCC
Confidence 12235689999999988764 68999999999999999999999997543211 111111 1 112
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
..+...+..+.+++.+||+.||.+|++.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 2233456778999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=306.22 Aligned_cols=267 Identities=25% Similarity=0.335 Sum_probs=202.9
Q ss_pred ccccccccCCceEEEEEEe-----CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQF-----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALV 99 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 99 (369)
.+.+.||+|+||+||++.. .++..||+|.+...........+.+|+.+++.++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4567899999999988653 357899999987654445567788999999999999999999988754 357899
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 999999999999943 359999999999999999999999 999999999999999999999999999998764322
Q ss_pred Ccc-ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 180 THD-STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 180 ~~~-~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
... ......++..|+|||.+... .++.++||||||+++|+|++|..|+............ ..........+......
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG-PKQGQMTVVRLIELLER 239 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhc-ccccccchhhhhhhhhc
Confidence 211 11223356679999988764 7899999999999999999999998654322110000 00000000111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
......+...+..+.+++..||+.+|++||++++|+++|+..
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111222344567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=310.08 Aligned_cols=264 Identities=20% Similarity=0.283 Sum_probs=201.4
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+...++||+|+||.||+|+++ +++.||+|.+...........+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 445678999999999999875 5789999998754433344567889999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+ +|.+++......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 88 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~ 161 (309)
T cd07872 88 K-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TY 161 (309)
T ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--cc
Confidence 6 8888886666678999999999999999999999 9999999999999999999999999999876433221 12
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------cccchhHHhhhchhhhhh
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------FPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 256 (369)
....++..|+|||.+.+...++.++|||||||++|+|++|+.||.......... .....|..+.........
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 234578999999988765578999999999999999999999997654321100 000111111110000000
Q ss_pred hcCCC-C----CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 257 LGCGI-E----ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 257 ~~~~~-~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..... + ......+..+.+++.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 0 011234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=318.55 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=214.5
Q ss_pred ccccccCCceEEEEEEeC---C--CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 29 STKLGAGGFGVVYKGQFP---N--GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.++||.|-||.||+|.+. . .-.||||.-+.+...+..+.|..|..+++.++||||++++|+|.+. ..+||||.+
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~ 472 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELA 472 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecc
Confidence 468999999999999762 2 3568889988877777788999999999999999999999999654 589999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+.|.|..|+..+...++......+++||+.||+|||+ ...|||||..+|||+.....|||+|||+++.+.+......
T Consensus 473 ~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka 549 (974)
T KOG4257|consen 473 PLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA 549 (974)
T ss_pred cchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccchhhc
Confidence 9999999998888899999999999999999999999 9999999999999999999999999999999876655443
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
. ...-++-|||||-+... .+|.+||||-|||.+||+++ |..||.+.... ++...+.++.+.
T Consensus 550 S-~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~iEnGeRl 611 (974)
T KOG4257|consen 550 S-RGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGHIENGERL 611 (974)
T ss_pred c-ccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEEecCCCCC
Confidence 3 34567789999988774 79999999999999999985 88898764432 333344455556
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
+.++.++..|..|+.+||..+|.+||.+.++...|..
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 7778889999999999999999999999998877654
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=302.95 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=201.2
Q ss_pred cccccccCCceEEEEEEeCC----CcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc------e
Q 017591 28 YSTKLGAGGFGVVYKGQFPN----GVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK------A 96 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~ 96 (369)
+.+.||+|+||.||+|.... +..||+|.++... .......+.+|+..++.++|+||+++++++.+... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 55789999999999997632 4789999887532 33445689999999999999999999998876554 7
Q ss_pred EEEEeccCCCCHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCC
Q 017591 97 ALVYEFMENGSLDKYLFTD-----TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
+++|||+++++|..++... ...+++..++.++.|++.||.|||+ ++++|+||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999988432 2468999999999999999999999 9999999999999999999999999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhc
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKG 250 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (369)
++...............++..|+|||++... .++.++|||||||++|||++ |..||...... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------~~~~~---- 227 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------EIYDY---- 227 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHH----
Confidence 9876544332222233456789999988654 78999999999999999999 88887543321 11111
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 251 ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.........+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 228 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 -----LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111122223445667899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=304.93 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=200.4
Q ss_pred cccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 28 YSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.++||+|+||.||++... ++..+++|.+... .......+.+|+.+++.++|+||+++++++.+.+..+++||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 4578999999999999642 3568888987743 33456689999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEe
Q 017591 102 FMENGSLDKYLFTDT--------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVA 167 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 167 (369)
|+++++|.+++.... ..+++..++.++.|++.||+|||+ ++++|+||||+|||+++++.++|+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEEC
Confidence 999999999985432 358899999999999999999999 999999999999999999999999
Q ss_pred ecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHH
Q 017591 168 DFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDE 246 (369)
Q Consensus 168 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 246 (369)
|||++................++..|+|||.+... .++.++|||||||++|+|++ |..||.......
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----------- 232 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----------- 232 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-----------
Confidence 99999765433222222233457789999988764 68999999999999999998 888875433211
Q ss_pred hhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.............+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 233 -----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 -----AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -----HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 011111111122233456778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=306.84 Aligned_cols=250 Identities=26% Similarity=0.289 Sum_probs=200.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+...++||+|+||.||++.+. +++.||+|.+.... .......+.+|+.+++.++|+||+++++.+.+++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 345678999999999999874 58999999886432 222345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 103 MENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
+++|+|.+++... ...+++..+..++.|++.||.|||+ ++++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 9999999888543 3569999999999999999999999 9999999999999999999999999999987543222
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
.....|+..|+|||++.+. .++.++|||||||++|+|++|+.||........ .+.. ..... ...
T Consensus 158 --~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-------~~~~-----~~~~~-~~~ 221 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-------REEV-----ERRVK-EDQ 221 (285)
T ss_pred --cccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhH-------HHHH-----HHHhh-hcc
Confidence 1234689999999988764 789999999999999999999999975432210 1111 01111 111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
...+...+..+.+|+.+||+.||.+|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 233445677899999999999999999 7777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=314.25 Aligned_cols=239 Identities=27% Similarity=0.355 Sum_probs=189.5
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHH---hccCCCceeeEEeEEEeCCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTI---GRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.||+|+||.||+|.+. +++.||+|+++... .......+.+|+.++ +.++||||+++++++.+.+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45678999999999999874 58999999987532 222334566666554 5678999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++++|..++. ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++......
T Consensus 82 E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 82 EYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred cCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 9999999998883 3579999999999999999999999 999999999999999999999999999987532211
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||....... ....+..+
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~---------- 216 (324)
T cd05589 156 -DRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFDSIVND---------- 216 (324)
T ss_pred -CcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC----------
Confidence 122345699999999988764 78999999999999999999999997543211 11111111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
....+...+..+.+++.+||+.||.+||++
T Consensus 217 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 217 EVRYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 112233456778999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=302.82 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=193.3
Q ss_pred cccccCCceEEEEEEeCC---CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFPN---GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.||+|+||.||+|...+ ...+++|.+...........+.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999996533 45788888765555555677899999999999999999999999999999999999999
Q ss_pred CHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 107 SLDKYLFTDT----EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 107 sL~~~l~~~~----~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+|.+++.... ...++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999995532 235688899999999999999999 999999999999999999999999999986543322221
Q ss_pred ccccCCCCCCccccccccc------cCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 183 STSGYRGTPGYSAPEFLLR------NYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~------~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
......++..|+|||++.. ...++.++|||||||++|||++ |..||........ .........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~~~---- 227 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVREQD---- 227 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHhhccC----
Confidence 2233346778999998753 2356889999999999999998 6777754322100 001111100
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 256 VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
.....+......+..+.+++..|| .||++||++++|++.|.
T Consensus 228 -~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 -IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 001112223345677788889898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=312.45 Aligned_cols=241 Identities=24% Similarity=0.313 Sum_probs=191.9
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhc-cCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGR-TYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||.||+|.+. +++.||+|++.... .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 47899999987542 12234456677777775 5899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........ ...
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05619 81 GDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC 154 (316)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence 99999984 44678999999999999999999999 9999999999999999999999999999875322111 122
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||..|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+...... .+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~----------~~~~~ 216 (316)
T cd05619 155 TFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMD----------NPCYP 216 (316)
T ss_pred eecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC----------CCCCC
Confidence 35689999999988764 7899999999999999999999999754321 111111110 11222
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChH-HHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMS-AVV 294 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~-~v~ 294 (369)
......+.+++.+||+.||.+||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 33567789999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=299.39 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=204.8
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|++|.||++.++ +++.|++|.+... ........+.+|+.+++.++|||++++++++.+.+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 45688999999999999874 5899999987632 344556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+++|.+++... ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-- 157 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-- 157 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--
Confidence 99999999654 4679999999999999999999999 99999999999999999999999999998876543222
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....|+..|+|||++..+ .++.++|+|||||++|+|++|+.||...... ...........+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~ 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQG----------------ALILKIIRGVFPP 220 (256)
T ss_pred hhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcCCCCC
Confidence 2234588899999988775 6889999999999999999999998644321 1111122222333
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+...+..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 34466788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.18 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=194.5
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||+||++.+. +++.||+|++.... .......+..|..++..+ .||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 47899999987532 223345677888888877 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|..++. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++....... ...
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (318)
T cd05570 81 GDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS 154 (318)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence 99999884 44579999999999999999999999 9999999999999999999999999999875322211 122
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...|+..|+|||++.+. .++.++|||||||++|+|++|+.||....... ........ ....+
T Consensus 155 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~----------~~~~~ 216 (318)
T cd05570 155 TFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILED----------EVRYP 216 (318)
T ss_pred ceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcC----------CCCCC
Confidence 34689999999988764 78999999999999999999999996443211 11111111 11223
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCh-----HHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPM-----SAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~-----~~v~~ 295 (369)
...+..+.+|+.+||+.||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 3456788999999999999999999 77653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=327.80 Aligned_cols=256 Identities=24% Similarity=0.301 Sum_probs=205.1
Q ss_pred ccccccccCCceEEEEEEeCCC-cEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeE-EEe---C---CceE
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNG-VKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGF-CYD---Q---TKAA 97 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~---~---~~~~ 97 (369)
.+.++|.+|||+.||+|.+..+ ..||+|++... ++.....+.+|+.+|++|. |+|||.+++. ... . -.+.
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 4557899999999999988655 99999998865 7777889999999999997 9999999993 221 1 2467
Q ss_pred EEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 98 LVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
|.||||+||.|-+++..+ ...|++.++++|++++++|+++||.. +..|||||||-+||||..+|..||||||.+....
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 999999999999999643 34599999999999999999999982 3459999999999999999999999999986532
Q ss_pred CCCC-ccc------cccCCCCCCcccccccc--ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHh
Q 017591 177 PENT-HDS------TSGYRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEY 247 (369)
Q Consensus 177 ~~~~-~~~------~~~~~gt~~y~aPE~~~--~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 247 (369)
.... ... .-...-|+.|+|||.+. .+...++|+|||+|||+||-||....||+....-.+
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI----------- 266 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI----------- 266 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE-----------
Confidence 2211 100 11123688999999864 455899999999999999999999999986533211
Q ss_pred hhchhhhhhhcCCCC-CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcCCC
Q 017591 248 EKGELAAKVLGCGIE-ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIV 304 (369)
Q Consensus 248 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~~~ 304 (369)
.+..+. +..+.+...+..||..||++||.+||++-+|+..+-.+...+
T Consensus 267 ---------lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 267 ---------LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 111111 223678999999999999999999999999998887764443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=297.71 Aligned_cols=259 Identities=23% Similarity=0.267 Sum_probs=205.0
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccH-HHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNK-RVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~ 105 (369)
++|++|+||.||+|+++ +++.||+|.++-...+ .....-.+|+.+|.+.+|||||.+-++.+.. +..|+|||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 58999999999999985 5899999998754322 2223567999999999999999999988754 579999999998
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+|..++.....++...++..++.|+++||+|||. +.|+||||||+|+|++..|.+||+|||+|+.+.+... ..+
T Consensus 162 -DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--~~T 235 (419)
T KOG0663|consen 162 -DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--PYT 235 (419)
T ss_pred -hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCcc--cCc
Confidence 9999998888899999999999999999999999 9999999999999999999999999999998865533 345
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCc-c-------CccccchhHHhhhchhhhhh-
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDT-L-------DWFPKQVWDEYEKGELAAKV- 256 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~- 256 (369)
...-|..|.|||.+.+...|+++.|+||+|||+.||+++++-|.+.+.-. . ..-...+|..+.........
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~ 315 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT 315 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence 56789999999999988899999999999999999999999888765421 1 11112223332222111100
Q ss_pred -----hcCCCCCCCHH-HHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 257 -----LGCGIEENDRE-EAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 257 -----~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
.+.....+... ..+.-.+|+..+|..||.+|.|+.+.+
T Consensus 316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 11111111111 456778999999999999999999865
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=309.67 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=203.3
Q ss_pred hccccccccCCceEEEEEEeC--------CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCce
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP--------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 96 (369)
..+.++||+|+||.||++... ....+|+|.+...........+.+|+.+++.+ .||||+++++++.+.+..
T Consensus 14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (314)
T cd05099 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL 93 (314)
T ss_pred eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence 346689999999999999742 24578999988655555667889999999999 599999999999988899
Q ss_pred EEEEeccCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC
Q 017591 97 ALVYEFMENGSLDKYLFTD---------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK 161 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 161 (369)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ +|++|+||||+||+++.+
T Consensus 94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTED 170 (314)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCC
Confidence 9999999999999999542 2358999999999999999999999 999999999999999999
Q ss_pred CCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccc
Q 017591 162 FSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFP 240 (369)
Q Consensus 162 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 240 (369)
+.+||+|||+++...............++..|+|||++..+ .++.++|||||||++|+|++ |..||......
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~------ 243 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE------ 243 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHH------
Confidence 99999999999865432222111222345679999988764 78999999999999999999 78887543221
Q ss_pred cchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
....... .......+...+..+.+++.+||+.+|.+||++.++++.|+...
T Consensus 244 -~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 244 -ELFKLLR---------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred -HHHHHHH---------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111111 11112223344567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=319.12 Aligned_cols=237 Identities=26% Similarity=0.461 Sum_probs=202.1
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCHHH
Q 017591 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDK 110 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 110 (369)
-||.|+.|.||+|+. .++.||||.++. .-..+|+-|++|+|+||+.+.|+|.....+|||||||..|-|..
T Consensus 131 WlGSGaQGAVF~Grl-~netVAVKKV~e--------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRL-HNETVAVKKVRE--------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhccCcccceeeeec-cCceehhHHHhh--------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 599999999999999 678999997763 23467889999999999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCCC
Q 017591 111 YLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGT 190 (369)
Q Consensus 111 ~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 190 (369)
.| +.+.++.......|..+||.|+.|||. +.|||||||.-||||..+..|||+|||-++..... ..+-.+.||
T Consensus 202 VL-ka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGT 274 (904)
T KOG4721|consen 202 VL-KAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGT 274 (904)
T ss_pred HH-hccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhh
Confidence 99 677889999999999999999999999 99999999999999999999999999999875433 223347899
Q ss_pred CCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHH
Q 017591 191 PGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAE 270 (369)
Q Consensus 191 ~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (369)
..|||||++... +.+.|.|||||||||||||||..||.+.+...+.| .. |. +...-..+...++
T Consensus 275 VaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw------GV---Gs------NsL~LpvPstcP~ 338 (904)
T KOG4721|consen 275 VAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW------GV---GS------NSLHLPVPSTCPD 338 (904)
T ss_pred HhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEE------ec---cC------CcccccCcccCch
Confidence 999999999885 89999999999999999999999997655443321 11 10 1112344556778
Q ss_pred HHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 271 RMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 271 ~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
-+.-|+++||+..|.+||++.+++..|+-
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 89999999999999999999999988864
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=302.18 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=196.1
Q ss_pred cccccCCceEEEEEEeCC-Cc--EEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFPN-GV--KIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||.||+|.+++ +. .+++|.+...........+.+|+.++.++ .||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 56888887554555567899999999999 799999999999999999999999999
Q ss_pred CCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecC
Q 017591 106 GSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFG 170 (369)
Q Consensus 106 gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 170 (369)
++|.+++.... ..+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999985422 247899999999999999999999 999999999999999999999999999
Q ss_pred CceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhh
Q 017591 171 LAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEK 249 (369)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (369)
++...... ........+..|+|||++... .++.++|||||||++|||++ |+.||....... .....
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~-- 224 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKL-- 224 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHH--
Confidence 98532211 111122345679999988664 68999999999999999997 999986433211 11111
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 250 GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
........+...+..+.+++.+||+.||.+||++.+++..|+..
T Consensus 225 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 -------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 11111122233456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=307.02 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=200.9
Q ss_pred hccccccccCCceEEEEEEeC-----------------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-----------------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 88 (369)
+.+.++||+|+||.||++.+. +...+|+|++..........++.+|+.+++.++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 356689999999999998542 244689999886555556678999999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHhccCC----------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe
Q 017591 89 FCYDQTKAALVYEFMENGSLDKYLFTDT----------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL 158 (369)
Q Consensus 89 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill 158 (369)
++.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEE
Confidence 9999999999999999999999985432 247788999999999999999999 999999999999999
Q ss_pred cCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCcc
Q 017591 159 DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG--RRKNAQDCSSDTL 236 (369)
Q Consensus 159 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt--g~~p~~~~~~~~~ 236 (369)
+.++.++|+|||++..+.............++..|++||....+ .++.++|||||||++|||++ |..||........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999999865433322222223456789999987665 68999999999999999998 6677754332211
Q ss_pred CccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 237 DWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.... +..............+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 243 -------~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 -------IENT--GEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -------HHHH--HHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1100 00000000000111223345789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=303.49 Aligned_cols=250 Identities=27% Similarity=0.462 Sum_probs=200.0
Q ss_pred cccccCCceEEEEEEeCC-------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 30 TKLGAGGFGVVYKGQFPN-------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.||+|+||.||+|.+++ +..+++|.+...........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2578999887554445567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-----CeeEeecCC
Q 017591 103 MENGSLDKYLFTD------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-----SAKVADFGL 171 (369)
Q Consensus 103 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~ 171 (369)
+++++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999532 2357899999999999999999999 9999999999999999887 899999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhc
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKG 250 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (369)
+................++..|+|||++..+ .++.++|||||||++|+|++ |+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------------- 221 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------------- 221 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---------------
Confidence 8765433222222233467889999988775 68999999999999999998 888886432210
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 251 ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.............+...+..+.+++.+||..+|.+||++.+|++.|+.
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 222 -VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -HHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001111111122334456789999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=300.62 Aligned_cols=256 Identities=32% Similarity=0.460 Sum_probs=205.9
Q ss_pred HHHHhhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEE
Q 017591 20 QLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 20 el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (369)
++...++.+.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.+++.++|+|++++++++ ..+..+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v 78 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYII 78 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEE
Confidence 345567778899999999999999998899999998875332 245788999999999999999999986 45678999
Q ss_pred EeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 100 YEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
|||+.+++|.+++... +..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999998543 4578999999999999999999999 99999999999999999999999999999876422
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
... ......++..|+|||++... .++.++||||||+++|+|++ |+.||....... ....+.
T Consensus 156 ~~~-~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~--------- 217 (260)
T cd05067 156 EYT-AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLE--------- 217 (260)
T ss_pred Ccc-cccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHH---------
Confidence 211 11223467789999988764 68899999999999999998 999986543211 111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.......+...+..+.+++.+||+.+|++||++++++..|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111112223345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=301.40 Aligned_cols=253 Identities=30% Similarity=0.435 Sum_probs=202.5
Q ss_pred hhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
-.+.+.++||+|+||.||+|.+.++..|++|.+..... ...++.+|+.+++.++|+||+++++.+. ....++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 34567889999999999999887777899999875322 2357899999999999999999999874 45689999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
++|+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 999999999643 3468999999999999999999999 99999999999999999999999999999876533221
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......++..|+|||+.... .++.++|||||||++|+|++ |..||...... ..... ......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~---------~~~~~~ 221 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQ---------VERGYR 221 (262)
T ss_pred cccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHH---------HhcCCC
Confidence 11233467789999987664 68999999999999999999 77777543221 11111 111111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.......+..+.+++.+||+.+|.+||++.+++++|+..
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 222345677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=313.89 Aligned_cols=265 Identities=19% Similarity=0.247 Sum_probs=195.3
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----ceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-----KAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l 98 (369)
+.+.++||+|+||.||+|.+. ++..||+|.+.... ......++.+|+.+++.++||||+++++++.... ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 345688999999999999874 58999999886432 2233457889999999999999999999886432 4799
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+. ++|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 82 v~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 82 VFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 999996 58999883 44579999999999999999999999 99999999999999999999999999999764322
Q ss_pred CC-ccccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhh
Q 017591 179 NT-HDSTSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYE 248 (369)
Q Consensus 179 ~~-~~~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~ 248 (369)
.. ........||..|+|||++... ..++.++|||||||++|+|++|+.||........ ...+...+..+.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 11 1112335689999999987652 3689999999999999999999999975432110 000000011111
Q ss_pred hch---hhhhhhcCC---CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 249 KGE---LAAKVLGCG---IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 249 ~~~---~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... ......... .....+..+..+.+++.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 100 000000000 00011123466889999999999999999999884
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=289.54 Aligned_cols=259 Identities=25% Similarity=0.297 Sum_probs=205.9
Q ss_pred HhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----ce
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-----KA 96 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 96 (369)
+.++.|.+.||+|||+-||+++. .+++.+|+|.+.-.. .+.....++|++..++++|||+++++++...+. ..
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34566778999999999999975 568999999887433 466788999999999999999999999886544 38
Q ss_pred EEEEeccCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCC--eEeecCCCCceEecCCCCeeEeecCC
Q 017591 97 ALVYEFMENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQR--IIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
||+++|...|+|.+.+.. .+..+++.+++.|+.++++||.+||+ .. +.||||||.|||+.+.+.++|.|||.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~---~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE---KEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc---cCCcccccCCCcceeEecCCCceEEEeccC
Confidence 999999999999999853 35589999999999999999999999 55 99999999999999999999999999
Q ss_pred ceecCCCCCc-------cccccCCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccc
Q 017591 172 AKLCNPENTH-------DSTSGYRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQ 242 (369)
Q Consensus 172 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 242 (369)
+....-.-.. .......-|..|.|||.+.- +...+.++|||||||+||+|+.|..||...-.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence 8754321111 11122346889999998764 34679999999999999999999999973221
Q ss_pred hhHHhhhchhhhhhhcCC--CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 243 VWDEYEKGELAAKVLGCG--IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
..+.+...+.+.. .+..++ +++.+.+++.+||+.||.+||++.+++..++..
T Consensus 247 -----~GgSlaLAv~n~q~s~P~~~~-yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 -----QGGSLALAVQNAQISIPNSSR-YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----cCCeEEEeeeccccccCCCCC-ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1112222222211 122223 899999999999999999999999999988764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.84 Aligned_cols=254 Identities=21% Similarity=0.396 Sum_probs=205.5
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccc--cccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKT--CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.++||+|+||.||+|+.. +++.||+|.+.. .........+.+|+.+++.++|||++++++++.+.+..++||||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 45688999999999999874 689999998753 233455567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 104 ENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 104 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
++++|.+++.. ....+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999988842 34568999999999999999999999 9999999999999999999999999999887643322
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ... .......
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-----~~~---------~~~~~~~ 224 (267)
T cd08228 162 --AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-----SLC---------QKIEQCD 224 (267)
T ss_pred --HHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHH-----HHH---------HHHhcCC
Confidence 11234588899999988764 688999999999999999999999864332210 001 1111111
Q ss_pred CCC-CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 261 IEE-NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 261 ~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+. .....+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 122 2234667899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=307.59 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=199.5
Q ss_pred ccccccccCCceEEEEEEeCC-C--cEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-G--VKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.||+|+||.||+|.+++ + ..+++|.++..........+.+|+.++.++ +||||+++++++.+....++||||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 456789999999999998754 3 357888877544445567899999999999 799999999999998999999999
Q ss_pred cCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEe
Q 017591 103 MENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVA 167 (369)
Q Consensus 103 ~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 167 (369)
+++++|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEEC
Confidence 99999999995422 358899999999999999999999 999999999999999999999999
Q ss_pred ecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHH
Q 017591 168 DFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDE 246 (369)
Q Consensus 168 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 246 (369)
|||++....... .......+..|+|||++... .++.++|||||||++|||++ |+.||....... .+.
T Consensus 162 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~- 229 (297)
T cd05089 162 DFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYE- 229 (297)
T ss_pred CcCCCcccccee---ccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH-
Confidence 999986432111 11112235679999987764 68999999999999999997 999986543221 111
Q ss_pred hhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
..........+...+..+.+|+.+||+.+|.+||++.+|++.|+...
T Consensus 230 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 230 --------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred --------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111112223345677899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.08 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=206.8
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccc--cccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKT--CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||+|.+. +|+.|++|.++. .........+.+|+.++++++|+|++++++++.+.+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 456789999999999999886 789999998763 22334466789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 103 MENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 103 ~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
+++++|.+++.. ....+++..++.++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999998843 24568999999999999999999999 999999999999999999999999999987654332
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
.. .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||........ + ........
T Consensus 161 ~~--~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~------~~~~~~~~ 223 (267)
T cd08224 161 TA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--------S------LCKKIEKC 223 (267)
T ss_pred cc--cceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHH--------H------HHhhhhcC
Confidence 21 2234588899999988764 689999999999999999999999864432100 0 01111111
Q ss_pred CCCCCCH-HHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 260 GIEENDR-EEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 260 ~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
..+..+. ..+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1222222 5667899999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=299.31 Aligned_cols=249 Identities=29% Similarity=0.438 Sum_probs=200.9
Q ss_pred cccccCCceEEEEEEeCC--C--cEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFPN--G--VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
++||+|++|.||+|.+.+ + ..||+|.+...........+.+|+.++++++|+||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 469999999999998743 3 36899998865554667789999999999999999999999988 889999999999
Q ss_pred CCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc-cc
Q 017591 106 GSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH-DS 183 (369)
Q Consensus 106 gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~ 183 (369)
++|.+++.... ..+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++.+...... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999996554 578999999999999999999999 99999999999999999999999999999876542221 11
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....++..|+|||++... .++.++|||||||++|+|++ |..||....... ....... .....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~--------~~~~~ 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-------ILKKIDK--------EGERL 220 (257)
T ss_pred ccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHh--------cCCcC
Confidence 2234577899999988764 68999999999999999998 999986432211 0111100 01111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
..+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=313.29 Aligned_cols=258 Identities=27% Similarity=0.393 Sum_probs=200.8
Q ss_pred hhhccccccccCCceEEEEEEe------CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeC-Cc
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQ-TK 95 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~ 95 (369)
..+.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.++..+ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 3456778999999999999974 347899999997655445566788999999999 689999999988654 46
Q ss_pred eEEEEeccCCCCHHHHhccCC-----------------------------------------------------------
Q 017591 96 AALVYEFMENGSLDKYLFTDT----------------------------------------------------------- 116 (369)
Q Consensus 96 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 116 (369)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999985321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCC
Q 017591 117 -------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG 189 (369)
Q Consensus 117 -------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 189 (369)
..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 236888899999999999999999 9999999999999999999999999999976543322222223346
Q ss_pred CCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHH
Q 017591 190 TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268 (369)
Q Consensus 190 t~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (369)
+..|+|||.+... .++.++||||||+++|+|++ |..||....... ........+ .....+...
T Consensus 244 ~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~ 307 (343)
T cd05103 244 PLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEG---------TRMRAPDYT 307 (343)
T ss_pred CcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhcc---------CCCCCCCCC
Confidence 6789999988764 78999999999999999996 888886432210 011111111 111112223
Q ss_pred HHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 269 AERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+..+.+++..||+.||.+||++.+|++.|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 46789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=299.97 Aligned_cols=241 Identities=22% Similarity=0.371 Sum_probs=190.8
Q ss_pred cccccCCceEEEEEEeCC-------------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce
Q 017591 30 TKLGAGGFGVVYKGQFPN-------------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 96 (369)
+.||+|+||.||+|.... ...|++|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999997521 2358888876532 33455788899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC-------eeEeec
Q 017591 97 ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS-------AKVADF 169 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-------~kl~Df 169 (369)
++||||+++++|..++......+++..++.++.|+++||+|||+ ++++||||||+|||++.++. ++++||
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999999986666789999999999999999999999 99999999999999987664 899999
Q ss_pred CCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHH-cCCCCCCCCCCCccCccccchhHHhh
Q 017591 170 GLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII-GRRKNAQDCSSDTLDWFPKQVWDEYE 248 (369)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 248 (369)
|++...... ....++..|+|||.+..+..++.++|||||||++|||+ +|..|+........ ....
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--------~~~~ 222 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--------ERFY 222 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------HHHH
Confidence 998654321 22457889999998875557899999999999999998 57777653321110 0000
Q ss_pred hchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
... ..........+.+|+.+||+.||.+||++.+|++.|+
T Consensus 223 ~~~----------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ----------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC----------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 0011122457889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=300.22 Aligned_cols=251 Identities=31% Similarity=0.453 Sum_probs=201.3
Q ss_pred hhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.++||+|+||.||+|.++++..+++|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 3456789999999999999988888999999875332 2356899999999999999999999874 556899999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+++|.+++... ...+++..++.++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 99999999543 3468999999999999999999999 99999999999999999999999999999876433221 1
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....++..|+|||++... .++.++||||||+++|+|++ |..||....... ..+. .......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~---------~~~~~~~ 222 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQ---------VERGYRM 222 (260)
T ss_pred ccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHH---------HHcCCCC
Confidence 1223456789999987654 78999999999999999999 788886432210 1111 1111112
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
..+...+..+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2334456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=321.06 Aligned_cols=238 Identities=27% Similarity=0.356 Sum_probs=199.7
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEecc
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
|.++||+|.||+|+++..+ +++.+|||++++.. ..+.....+.|..++.... ||.++.++.+|...++.++||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 4589999999999999875 48899999998752 3445667788888887764 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
.||++.. ..+.+.+++.++..|+..|+.||+|||+ +||||||||.+|||||.+|.+||+|||+++..-. ....
T Consensus 452 ~Ggdm~~--~~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~~ 524 (694)
T KOG0694|consen 452 AGGDLMH--HIHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGDR 524 (694)
T ss_pred CCCcEEE--EEecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCC--CCCc
Confidence 9999332 3466789999999999999999999999 9999999999999999999999999999986321 1224
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
+...+||+.|||||++.+. .|+.+.|.|||||+|||||.|..||.+.+.+.. ++.+...+ ..
T Consensus 525 TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-------FdsI~~d~----------~~ 586 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-------FDSIVNDE----------VR 586 (694)
T ss_pred cccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcCC----------CC
Confidence 5668999999999999885 899999999999999999999999987665422 22222111 34
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
++...+.+...|+.++|..||++|.-+
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCC
Confidence 456678889999999999999999876
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.73 Aligned_cols=261 Identities=22% Similarity=0.286 Sum_probs=205.6
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEcc-ccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe-----CCceEEEEec
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD-----QTKAALVYEF 102 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~ 102 (369)
+.||+|+||.|+.+.+ .+|..||+|.+. .-.+.....+-.+|+.+++.++|+||+.+++++.. -+..|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 6799999999999987 468999999876 33444556788899999999999999999999875 3568999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
|+. +|.+.+ +.+..++.+.+..+++|++.||.|+|+ .+|+||||||+|+|++.+-.+||+|||+|+.........
T Consensus 108 Met-DL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~ 182 (359)
T KOG0660|consen 108 MET-DLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDG 182 (359)
T ss_pred Hhh-HHHHHH-HcCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccCccc
Confidence 965 999998 555669999999999999999999999 999999999999999999999999999999886543333
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCc-c-------CccccchhHHhhhchhhh
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDT-L-------DWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~ 254 (369)
..+....|..|.|||++.....||.+.||||.|||+.||++|++-|.+.+.-. . ..........+.......
T Consensus 183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~ 262 (359)
T KOG0660|consen 183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARP 262 (359)
T ss_pred chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHH
Confidence 44666789999999998887899999999999999999999999998766431 1 111112222222111111
Q ss_pred hhhc-CCCCC-----CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLG-CGIEE-----NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~-~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+.. ...+. ..+.......+|+.+||..||.+|+|++|.++
T Consensus 263 yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 263 YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111 11111 12234567889999999999999999999763
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=304.00 Aligned_cols=270 Identities=23% Similarity=0.361 Sum_probs=207.5
Q ss_pred hccccccccCCceEEEEEEeC-----CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe--CCceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD--QTKAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 98 (369)
..+.++||+|+||.||++.+. ++..+|+|++...........+.+|+.+++.+.|+||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345688999999999999753 3789999998865444456789999999999999999999999887 557899
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+++++|.+++......+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++......
T Consensus 86 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999996666679999999999999999999999 99999999999999999999999999999876532
Q ss_pred CCc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 179 NTH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 179 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
... .......++..|++||.+... .++.++||||||+++|||++|+.|+.............. ..............
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA-QGQMIVTRLLELLK 240 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccc-cccccHHHHHHHHH
Confidence 221 111223456679999988765 789999999999999999999998865433221100000 00000011111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.......+...+..+.+++.+||+.+|.+||++.+|+++|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111222334457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=319.29 Aligned_cols=250 Identities=24% Similarity=0.254 Sum_probs=193.5
Q ss_pred cccccccCCceEEEEEEe-CCCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 28 YSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.++||+|+||+||+|++ .+++.||+|++... ........+.+|+.++..++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 457899999999999977 45899999998643 233445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC----
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT---- 180 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 180 (369)
+|+|.+++. ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++++||+|||++..+.....
T Consensus 85 gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 85 GGDMMSLLI-RMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 999999984 44578999999999999999999999 9999999999999999999999999999754311000
Q ss_pred -----------------------------------------ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHH
Q 017591 181 -----------------------------------------HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219 (369)
Q Consensus 181 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ 219 (369)
........||+.|+|||++.+. .++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhHHH
Confidence 0001234699999999988764 6899999999999999
Q ss_pred HHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHh--ccccCCCCCCChHHHHH
Q 017591 220 EIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALW--CVQDCPEARPPMSAVVK 295 (369)
Q Consensus 220 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~RPs~~~v~~ 295 (369)
||++|+.||........ ....... ............+..+.+++.+ |+..+|..||++.+|+.
T Consensus 240 elltG~~Pf~~~~~~~~-------~~~i~~~------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 240 EMLVGQPPFLAPTPTET-------QLKVINW------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHhCCCCCcCCCHHHH-------HHHHHcc------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 99999999975433210 0000000 0000011112345667778876 56677777999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=302.15 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=204.5
Q ss_pred hhhccccccccCCceEEEEEEeCC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (369)
....+.++||+|+||.||+|.+.+ ...|++|.............+.+|+.+++.+.|+||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 345567899999999999997643 347899988766555666789999999999999999999998865 457899
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
|||+++++|.+++......+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 99999999999996656679999999999999999999999 999999999999999999999999999998765432
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
... .....++..|+|||.+... .++.++||||||+++|++++ |..||........ ......
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~--------- 223 (270)
T cd05056 162 YYK-ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------IGRIEN--------- 223 (270)
T ss_pred cee-cCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHc---------
Confidence 221 1223355689999987654 68999999999999999986 9999865432210 111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
......+...+..+.+++.+|+..+|.+||++.++++.|+..
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 224 GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.15 Aligned_cols=252 Identities=30% Similarity=0.437 Sum_probs=201.7
Q ss_pred hhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
..+.+..+||+|+||.||++.++.+..+++|.+..... ....+.+|+.+++.++|+|++++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 34566789999999999999987777899998764322 2457889999999999999999999874 55688999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
.+++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 999999999643 3458999999999999999999999 99999999999999999999999999999876433221
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......++..|+|||+.... ..+.++|||||||++|+|++ |..||....... .+... .....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~---------~~~~~ 221 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQV---------ERGYR 221 (260)
T ss_pred ccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH---------HcCCC
Confidence 11223467789999987664 68999999999999999999 888886433211 11111 11111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
...+...+..+.+++.+||+.||.+||++.+|+++|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 22234567789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=319.25 Aligned_cols=251 Identities=25% Similarity=0.311 Sum_probs=201.3
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||+||+|.+. +++.||+|++.... .......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 345689999999999999885 58999999987532 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC---
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN--- 179 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 179 (369)
+++++|.+++... ..+++..++.++.|++.||.|||+ +|++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 83 MPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999544 679999999999999999999999 999999999999999999999999999997654332
Q ss_pred ------------------------CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCc
Q 017591 180 ------------------------THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDT 235 (369)
Q Consensus 180 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~ 235 (369)
.........||+.|+|||++... .++.++|||||||++|||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 00112335699999999988775 78999999999999999999999997544211
Q ss_pred cCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCC-hHHHHH
Q 017591 236 LDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPP-MSAVVK 295 (369)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~v~~ 295 (369)
.+..... .......+ .....+..+.+++..||. ||.+||+ +.++++
T Consensus 238 -------~~~~i~~-----~~~~~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 238 -------TYNKIIN-----WKESLRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred -------HHHHHhc-----cCCcccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 0111111 00000111 111257789999999997 9999999 999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=316.16 Aligned_cols=256 Identities=22% Similarity=0.251 Sum_probs=192.6
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||+|+||.||++.+ .+++.||+|... ...+.+|+.+++.++||||+++++++......++|||++.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 44568899999999999987 458999999654 2356789999999999999999999999999999999996
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
++|..++. ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........ ...
T Consensus 167 -~~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~ 240 (391)
T PHA03212 167 -TDLYCYLA-AKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKY 240 (391)
T ss_pred -CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccc
Confidence 58888884 34578999999999999999999999 9999999999999999999999999999875332111 122
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc---------------ccc-hhHHhh
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF---------------PKQ-VWDEYE 248 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~---------------~~~-~~~~~~ 248 (369)
....||+.|+|||++... .++.++|||||||++|||++|+.||........... +.. .+....
T Consensus 241 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 241 YGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred ccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 345699999999988764 789999999999999999999988764322110000 000 000000
Q ss_pred h-chhhhhhhc--C----CCCC--CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 249 K-GELAAKVLG--C----GIEE--NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 249 ~-~~~~~~~~~--~----~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
. ......... . ..+. .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 000000000 0 0000 01234668899999999999999999999883
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=311.44 Aligned_cols=245 Identities=24% Similarity=0.249 Sum_probs=193.3
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||.||++... +++.||+|++.... .......+.+|+.++.++ +|+||+.+++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999874 57899999987532 223445688899998887 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|..++. ....+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (327)
T cd05617 81 GDLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS 154 (327)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence 99999884 44579999999999999999999999 9999999999999999999999999999875322111 123
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||...............+... .. .....+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------~~-~~~~~p 223 (327)
T cd05617 155 TFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI---------LE-KPIRIP 223 (327)
T ss_pred cccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH---------Hh-CCCCCC
Confidence 35699999999988764 78999999999999999999999997543321111111111111 11 111223
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMS 291 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~ 291 (369)
...+..+.+++.+||+.||.+|+++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 34567789999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=302.16 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=205.1
Q ss_pred hccccccccCCceEEEEEEeCC-C----cEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN-G----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
..+.+.||+|+||.||+|.+++ | ..+++|.............+.+|+.++..++|+|++++++++.. ...++||
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 3566899999999999998643 3 26899988766656667789999999999999999999999977 7889999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++|+|.+++......+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||+++.......
T Consensus 88 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 88 QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 9999999999997766779999999999999999999999 9999999999999999999999999999987653332
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
........++..|+|||.+... .++.++|+||||+++||+++ |+.||....... +.... ...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~---------~~~ 227 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLL---------EKG 227 (279)
T ss_pred ceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHH---------hCC
Confidence 2222223346689999987654 78999999999999999998 999986543211 11111 111
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.....+......+.+++.+||..+|.+||++.++++.|+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 228 ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11122223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=298.53 Aligned_cols=246 Identities=29% Similarity=0.414 Sum_probs=202.0
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
..+.+.||.|+||.||++.. .|+.|++|.+..... ...++.+|+.+++.++|+|++++++++.+.+..++||||+++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred ccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 35678999999999999988 478999999875433 467899999999999999999999999989999999999999
Q ss_pred CCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 106 GSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 106 gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
++|.+++.... ..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||.++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence 99999995443 379999999999999999999999 9999999999999999999999999999986532211
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....+..|+|||++..+ .++.++||||||+++|+|++ |+.||....... ..... .......
T Consensus 158 -~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~---------~~~~~~~ 219 (256)
T cd05039 158 -SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHV---------EKGYRME 219 (256)
T ss_pred -cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHH---------hcCCCCC
Confidence 22356789999988764 68899999999999999997 888886432211 11111 1111122
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.+...+..+.+++.+||..+|.+||++.+++++|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 233456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=307.41 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=197.8
Q ss_pred ccccccccCCceEEEEEEeC-CCc--EEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGV--KIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.||+|+||.||+|.+. ++. .+++|.............+.+|+.++.++ +|+||+++++++.+.+..++||||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 45688999999999999874 344 45777766544455567889999999999 899999999999999999999999
Q ss_pred cCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEe
Q 017591 103 MENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVA 167 (369)
Q Consensus 103 ~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 167 (369)
+++++|.+++.... ..+++..++.++.|++.||+|||+ +|++||||||+|||++.++.++|+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeC
Confidence 99999999995332 358899999999999999999999 999999999999999999999999
Q ss_pred ecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHH
Q 017591 168 DFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDE 246 (369)
Q Consensus 168 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 246 (369)
|||++..... ........++..|+|||++... .++.++|||||||++|||++ |..||....... ..+.
T Consensus 167 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~ 235 (303)
T cd05088 167 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEK 235 (303)
T ss_pred ccccCcccch---hhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HHHH
Confidence 9999863221 1111122346679999987664 68899999999999999998 999886433211 0111
Q ss_pred hhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
. ........+...+..+.+|+.+||+.+|++||++.+++..|+..
T Consensus 236 ~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 L---------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred H---------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 11111112223456789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=312.78 Aligned_cols=237 Identities=25% Similarity=0.286 Sum_probs=186.4
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc---CCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 32 LGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT---YHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 32 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
||+|+||+||+|++. +++.||+|++.... .......+..|..++... .||||+.+++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 58999999986422 122334455666666654 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|..++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.++|+|||++........ ...
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 154 (330)
T cd05586 81 GELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN 154 (330)
T ss_pred ChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence 99999884 45679999999999999999999999 9999999999999999999999999999875332221 123
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||..|+|||++.+...++.++|||||||++|+|++|+.||...... ..+.....+. .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~---------~~~~~ 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGK---------VRFPK 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCC---------CCCCC
Confidence 3569999999999876556899999999999999999999999653321 1111111111 11111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCh
Q 017591 266 REEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
...+..+.+++.+||+.||.+||++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 2346678899999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.58 Aligned_cols=252 Identities=31% Similarity=0.467 Sum_probs=203.3
Q ss_pred hhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.++||+|+||.||++.+.++..+++|.+..... ...++.+|+.+++.++|+|++++++++......++||||++
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 3456689999999999999988888999998875322 24578999999999999999999999988889999999999
Q ss_pred CCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+++|.+++.... ..+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||.+..+..... ..
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 160 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TA 160 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh-hh
Confidence 999999996543 578999999999999999999999 9999999999999999999999999999987653221 11
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....++..|+|||.+.+. .++.++||||||+++|+|++ |+.||....... ..... ......
T Consensus 161 ~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~---------~~~~~~ 223 (261)
T cd05034 161 REGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQV---------ERGYRM 223 (261)
T ss_pred hhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH---------HcCCCC
Confidence 1223356789999988764 68999999999999999998 888886433210 11111 111111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
..+...+..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 2222336789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=319.47 Aligned_cols=245 Identities=25% Similarity=0.326 Sum_probs=208.9
Q ss_pred ccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCHH
Q 017591 31 KLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLD 109 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 109 (369)
+||+|.||+||.|++.+ ...+|||-+..... +...-+..|+.+-+.|+|.|||+++|.+-+++..-|.||-++||||.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 69999999999999854 67889998875332 44556889999999999999999999998889899999999999999
Q ss_pred HHhccCCCCC--CHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec-CCCCeeEeecCCceecCCCCCcccccc
Q 017591 110 KYLFTDTEVL--KWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD-AKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 110 ~~l~~~~~~~--~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+++...=+++ .+.++-.+..||++||.|||+ +.|||||||-+|+|++ ..|.+||+|||-++.+..- ...+..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC--Cccccc
Confidence 9998777777 889999999999999999999 9999999999999996 5678999999999876432 334455
Q ss_pred CCCCCCccccccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 187 YRGTPGYSAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~-~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
+.||..|||||++..|. .|..++|||||||++.||.||++||-........+ +..| .....++.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------FkVG------myKvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FKVG------MYKVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hhhc------ceecCCCCc
Confidence 78999999999998764 79999999999999999999999998766553321 1111 122347788
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+.+.+...+|.+|+.+||.+||++++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 899999999999999999999999999874
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=297.33 Aligned_cols=249 Identities=28% Similarity=0.498 Sum_probs=201.0
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
.+.+.||+|+||.||++.+.++..+++|.+..... ...++.+|+.+++++.|||++++++++......++||||++++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 46689999999999999887788999998875322 2356889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|.+++......++++.++.++.|++.+|++||+ .+++|+||||+||+++.++.++|+|||++......... ....
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05112 85 CLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTG 160 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCC
Confidence 9999996666678999999999999999999999 99999999999999999999999999998865432211 1122
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..++.+|+|||.+..+ .++.++||||||+++|||++ |+.||....... ..+... .......+
T Consensus 161 ~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~---------~~~~~~~~ 223 (256)
T cd05112 161 TKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETIN---------AGFRLYKP 223 (256)
T ss_pred CccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHh---------CCCCCCCC
Confidence 3356789999988764 68899999999999999998 888886433211 111111 11111112
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
...+..+.+|+.+||+.+|++||++.+|++.|.
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 224577999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=313.47 Aligned_cols=242 Identities=24% Similarity=0.279 Sum_probs=190.2
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHH-HHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEI-GTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||+||++++. +++.||+|++.... .......+..|. .+++.+.|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 57889999987432 122233444454 456778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|.+++. ....+.+..+..++.|++.||.|||+ +|++||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~ 154 (325)
T cd05602 81 GELFYHLQ-RERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS 154 (325)
T ss_pred CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence 99999984 44568899999999999999999999 9999999999999999999999999999875422211 223
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .++..... .....
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~----------~~~~~ 216 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNK----------PLQLK 216 (325)
T ss_pred cccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHH-------HHHHHHhC----------CcCCC
Confidence 45699999999988764 78999999999999999999999997533211 11111111 01122
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..+.+++.+||+.||.+||++.+.+.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 345677899999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=311.04 Aligned_cols=240 Identities=24% Similarity=0.318 Sum_probs=192.2
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.||+|+||.||+|.+. +++.||+|++.... .......+..|..++..+ .|++|+.+++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 45678999999999999875 47899999987532 223334566777777766 589999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|..++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-- 156 (323)
T cd05616 83 VNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-- 156 (323)
T ss_pred CCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--
Confidence 99999999984 44578999999999999999999999 9999999999999999999999999999875432211
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......||+.|+|||++... .++.++|||||||++|||++|+.||....... ..... ... ..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-------~~~~i---------~~~-~~ 218 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSI---------MEH-NV 218 (323)
T ss_pred ccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHH-------HHHHH---------HhC-CC
Confidence 12335689999999988765 78999999999999999999999997543221 11111 111 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
..+...+..+.+++.+||+.||.+|++.
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 2233456788999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=317.33 Aligned_cols=250 Identities=21% Similarity=0.229 Sum_probs=197.5
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.++||+|+||.||+++.+ +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 44578999999999999875 58999999986421 2233455788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++|+|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......... .
T Consensus 126 ~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~ 199 (370)
T cd05596 126 PGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-R 199 (370)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-c
Confidence 99999999843 358899999999999999999999 99999999999999999999999999999875432221 1
Q ss_pred cccCCCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 184 TSGYRGTPGYSAPEFLLRN---YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~---~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.....||+.|+|||++... ..++.++|||||||++|||++|+.||....... .+....... ....
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~-----~~~~ 267 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMDHK-----NSLT 267 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------HHHHHHcCC-----CcCC
Confidence 2335699999999988653 247899999999999999999999997543210 111111100 0000
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCC--CCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEA--RPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~v~~ 295 (369)
.+ .....+..+.+++.+||+.+|.+ ||++.+++.
T Consensus 268 ~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 268 FP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 11 12235678899999999999988 999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=318.19 Aligned_cols=250 Identities=23% Similarity=0.286 Sum_probs=195.7
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||+||++++. +++.||+|++.... .......+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 34578999999999999885 58999999987532 2334456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc-
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD- 182 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 182 (369)
++|+|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++..+.......
T Consensus 84 ~~g~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 84 PGGDMMTLLM-KKDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCcHHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 9999999994 34579999999999999999999999 999999999999999999999999999987643211100
Q ss_pred -----------------------------------ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCC
Q 017591 183 -----------------------------------STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKN 227 (369)
Q Consensus 183 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p 227 (369)
......||+.|+|||++... .++.++|||||||++|||++|..|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCCC
Confidence 01124599999999988764 789999999999999999999999
Q ss_pred CCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCC---hHHHHH
Q 017591 228 AQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPP---MSAVVK 295 (369)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~v~~ 295 (369)
|....... ......... .....+ .....+..+.+++.+|+. +|.+|++ +.++++
T Consensus 239 f~~~~~~~-------~~~~i~~~~-----~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 239 FCSDNPQE-------TYRKIINWK-----ETLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCHHH-------HHHHHHcCC-----CccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 97543211 011110000 000001 111345678899999996 9999998 777764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.73 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=202.9
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||+|+||.||++.+. +++.+++|.+...........+.+|+.+++.++|+|++++++.+.+.+..++||||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 45688999999999999875 58999999886444445567888999999999999999999999999999999999999
Q ss_pred CCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 106 GSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 106 gsL~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
++|.+++.. ....+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++++|||++........ ..
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YA 157 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--cc
Confidence 999998854 34568999999999999999999999 9999999999999999999999999999976543222 12
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....++..|+|||++... .++.++|+||||+++|+|++|..||....... .............
T Consensus 158 ~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~ 220 (255)
T cd08219 158 CTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKN----------------LILKVCQGSYKPL 220 (255)
T ss_pred ccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHH----------------HHHHHhcCCCCCC
Confidence 235688899999988764 68999999999999999999999996432210 0011111222223
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
+...+..+.+++.+||+.||.+||++.+|+..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 34456778999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.85 Aligned_cols=250 Identities=23% Similarity=0.300 Sum_probs=191.3
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.++||+|+||+||++... +++.||+|++.... .......+.+|+.++..++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 4578999999999999874 58999999987532 22334578889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc---
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH--- 181 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 181 (369)
+|+|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 85 GGDMMTLLM-KKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999994 45679999999999999999999999 99999999999999999999999999998754321100
Q ss_pred ------------------------------cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 017591 182 ------------------------------DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDC 231 (369)
Q Consensus 182 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~ 231 (369)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 001234699999999998764 7899999999999999999999999754
Q ss_pred CCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccc--cCCCCCCChHHHHH
Q 017591 232 SSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQ--DCPEARPPMSAVVK 295 (369)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~~p~~RPs~~~v~~ 295 (369)
.... .+....... .....+. .......+.+++.+++. .++..||++.+|++
T Consensus 240 ~~~~-------~~~~i~~~~-----~~~~~p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 240 TPQE-------TYKKVMNWK-----ETLIFPP-EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CHHH-------HHHHHHcCc-----CcccCCC-cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 3211 111111100 0000111 11234556667766443 34456789999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=305.06 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=190.1
Q ss_pred hccccccccCCceEEEEEEeC--CCcEEEEEEcccccc-HHHHHHHHHHHHHHhcc---CCCceeeEEeEEEe-----CC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP--NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRT---YHINLVRLYGFCYD-----QT 94 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~ 94 (369)
+.+.+.||+|+||.||+|.+. ++..||+|.+..... ......+.+|+.+++.+ .||||+++++++.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 456688999999999999873 468899998764322 12233455677666655 69999999998862 34
Q ss_pred ceEEEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 95 KAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
..++||||+. ++|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999997 4999988543 3468999999999999999999999 999999999999999999999999999998
Q ss_pred ecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHH-------
Q 017591 174 LCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDE------- 246 (369)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------- 246 (369)
...... ......||..|+|||.+... .++.++|||||||++|||++|+.||........ + ..+...
T Consensus 159 ~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--~-~~i~~~~~~~~~~ 231 (290)
T cd07862 159 IYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--L-GKILDVIGLPGEE 231 (290)
T ss_pred eccCCc---ccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--H-HHHHHHhCCCChh
Confidence 754331 22345689999999988764 789999999999999999999999976543210 0 000000
Q ss_pred -hhhc-hhhhhhhcCC----CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 247 -YEKG-ELAAKVLGCG----IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 247 -~~~~-~~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+... .......... .....+..+..+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 0000000000 00111234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=297.50 Aligned_cols=255 Identities=29% Similarity=0.429 Sum_probs=205.4
Q ss_pred HHHhhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 21 LCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 21 l~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
+....+.+.++||+|+||.||++.+.++..+++|.+... ......+.+|+.+++.++|+|++++++++.+ ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 445566778999999999999998877888999988753 2335678899999999999999999999877 7789999
Q ss_pred eccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 101 EFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 101 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
||+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999543 4568999999999999999999999 999999999999999999999999999997654322
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.. ......++..|+|||++..+ .++.++|+|||||++|++++ |+.||....... ..... ..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~---------~~ 218 (260)
T cd05073 157 YT-AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRAL---------ER 218 (260)
T ss_pred cc-cccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHH---------hC
Confidence 21 12223456789999988764 68999999999999999998 888886433211 01111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
..........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 219 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122233456779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=318.20 Aligned_cols=250 Identities=24% Similarity=0.251 Sum_probs=193.4
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.++||+|+||+||++.+ .+++.||+|++.... .......+.+|+.++..+.||||+++++++.+....++||||+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 3458899999999999977 468999999886432 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc--
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH-- 181 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 181 (369)
++|+|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.++|+|||+++.+......
T Consensus 84 ~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 84 PGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999999994 45678999999999999999999999 99999999999999999999999999998643211000
Q ss_pred -------------------------------------------cccccCCCCCCccccccccccCCCCcchhhHHHHHHH
Q 017591 182 -------------------------------------------DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLL 218 (369)
Q Consensus 182 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil 218 (369)
.......||+.|+|||++.+. .++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil 238 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIM 238 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchhh
Confidence 000124699999999988764 789999999999999
Q ss_pred HHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCC---CChHHHHH
Q 017591 219 FEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEAR---PPMSAVVK 295 (369)
Q Consensus 219 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~~v~~ 295 (369)
|||++|+.||....... .+...... ......+ .....+..+.+++.+||. +|.+| +++.+++.
T Consensus 239 ~elltG~~Pf~~~~~~~-------~~~~i~~~-----~~~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 239 FECLIGWPPFCSENSHE-------TYRKIINW-----RETLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhcCCCCCCCCCHHH-------HHHHHHcc-----CCccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 99999999996543211 11111100 0000011 111345678899999997 67765 58888774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=299.01 Aligned_cols=247 Identities=24% Similarity=0.386 Sum_probs=197.0
Q ss_pred cccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 28 YSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.+.||+|+||.||+|.+ .+++.||+|.+...........+.+|+.++.+++||||+++++++...+..++||||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 457899999999999987 4689999999876544555677999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|..+. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... ...
T Consensus 85 ~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~ 152 (279)
T cd06619 85 SLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKT 152 (279)
T ss_pred ChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccC
Confidence 997653 47889999999999999999999 999999999999999999999999999997654321 223
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
..++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+......... .........
T Consensus 153 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 223 (279)
T cd06619 153 YVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD--------EDPPVLPVG 223 (279)
T ss_pred CCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc--------cCCCCCCCC
Confidence 5689999999988765 6899999999999999999999999754322111111011111000 000011122
Q ss_pred HHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 267 EEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+..+.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 34567899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=297.44 Aligned_cols=254 Identities=22% Similarity=0.423 Sum_probs=204.8
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||.||++.+ .+++.+++|.+... .......++.+|+.+++.+.|+||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 84 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence 4567899999999999986 47899999987642 23344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 104 ENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 104 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
++++|.+++.. ....+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999998853 24568999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
. .....++..|+|||.+... .++.++||||||+++|+|++|..||........ ...+. .....
T Consensus 162 ~--~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~---------~~~~~ 224 (267)
T cd08229 162 A--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCKK---------IEQCD 224 (267)
T ss_pred c--cccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHH-----HHhhh---------hhcCC
Confidence 1 1234588999999988764 688999999999999999999999864332210 00011 11111
Q ss_pred CC-CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 261 IE-ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 261 ~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+ ......+..+.+++.+||+.||.+|||+.+|++.++..
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 12234677899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=304.86 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=200.3
Q ss_pred cccccccCCceEEEEEEeC-CCc----EEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGV----KIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
..+.||+|+||.||+|.+. ++. .+++|.+...........+.+|+.+++.++|+||+++++++... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 3468999999999999763 343 57888887655555556789999999999999999999998654 46799999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|.+++......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 99999999997666679999999999999999999999 999999999999999999999999999998765433322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......++..|++||++... .++.++|||||||++|||++ |+.||....... ..+....+ ..
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~~ 229 (303)
T cd05110 167 NADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKG---------ER 229 (303)
T ss_pred ccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCC---------CC
Confidence 22334467789999988764 78999999999999999997 888886432211 01111111 11
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
...+...+..+..++..||..+|++||++.++++.|+..
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=295.10 Aligned_cols=249 Identities=31% Similarity=0.489 Sum_probs=202.8
Q ss_pred cccccccCCceEEEEEEeCC-----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 28 YSTKLGAGGFGVVYKGQFPN-----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.||.|+||.||++.+.+ +..||+|.+...........+..|+.++..++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999998754 4889999998665544677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 103 MENGSLDKYLFTDTEV-LKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~-~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
+++++|.+++...... +++..+..++.|++.||++||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999654444 9999999999999999999999 99999999999999999999999999999876544222
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
... ...++..|+|||.+.. ..++.++||||||+++++|++ |..||...... ..........
T Consensus 160 ~~~-~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~----------------~~~~~~~~~~ 221 (258)
T smart00219 160 KKK-GGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE----------------EVLEYLKKGY 221 (258)
T ss_pred ccc-cCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHhcCC
Confidence 211 2337789999998855 478999999999999999998 67776542211 1111111122
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHh
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L 297 (369)
....+...+..+.+++.+||..||.+|||+.++++.|
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 2233334677899999999999999999999998765
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=309.97 Aligned_cols=241 Identities=24% Similarity=0.285 Sum_probs=190.3
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHH-HHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIG-TIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||+|+||.||++.+. +|+.+|+|++.... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999874 58999999986432 2223345555654 46778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|..++. ....+++..+..++.|++.||.|||+ +|++||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (325)
T cd05604 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT 154 (325)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence 99998884 45679999999999999999999999 9999999999999999999999999999875322111 223
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||..|+|||++.+. .++.++|||||||++|+|++|+.||....... .+....... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~~----------~~~~ 216 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHKP----------LVLR 216 (325)
T ss_pred cccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcCC----------ccCC
Confidence 45699999999988764 78999999999999999999999997543211 111111111 1111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
+..+..+.+++.+||+.||.+||++.+.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 23456788999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=300.57 Aligned_cols=241 Identities=21% Similarity=0.348 Sum_probs=190.5
Q ss_pred cccccCCceEEEEEEeCC--------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 30 TKLGAGGFGVVYKGQFPN--------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.||+|+||.||+|.... ...+++|..... .......+.+|+.+++.+.|||++++++++...+..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 469999999999997632 234777776543 23445678889999999999999999999999899999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC--------eeEeecCCce
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS--------AKVADFGLAK 173 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~kl~Dfg~~~ 173 (369)
|+++|+|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++. ++++|||.+.
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999997666679999999999999999999999 99999999999999987765 5899999876
Q ss_pred ecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCC-CCCCCCCCccCccccchhHHhhhchh
Q 017591 174 LCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRK-NAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
..... ....++..|+|||++.....++.++|||||||++|+|++|.. |+....... . ...
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~----------~---~~~ 217 (258)
T cd05078 157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK----------K---LQF 217 (258)
T ss_pred ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH----------H---HHH
Confidence 54321 224578899999998875568999999999999999999954 443222110 0 000
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
.. . ....+......+.+++.+||+.||++||++.++++.|+
T Consensus 218 ~~--~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 218 YE--D---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HH--c---cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 01122223467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=297.20 Aligned_cols=256 Identities=22% Similarity=0.274 Sum_probs=203.5
Q ss_pred HHHHhhhccc--cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce
Q 017591 20 QLCSFTNNYS--TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 20 el~~~t~~f~--~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 96 (369)
|++.+++++. ..||+|+||.||+|.+. ++..|++|.+.... ......+.+|+.+++.++|+||+++++++..++..
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 4566777774 68999999999999864 57889999876543 34456899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-CCCeeEeecCCce
Q 017591 97 ALVYEFMENGSLDKYLFTDTEVL--KWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-KFSAKVADFGLAK 173 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~ 173 (369)
++|+||+++++|.+++......+ ++..+..++.|++.||.|||+ ++++|+||||+||+++. ++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999996554555 889999999999999999999 99999999999999976 6789999999987
Q ss_pred ecCCCCCccccccCCCCCCccccccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 174 LCNPENTHDSTSGYRGTPGYSAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
........ .....++..|+|||++.... .++.++||||||+++|+|++|+.||......... .+
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--------~~----- 222 (268)
T cd06624 158 RLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--------MF----- 222 (268)
T ss_pred ecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--------Hh-----
Confidence 65432221 22245789999999886542 4789999999999999999999998643321110 00
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........+..+......+.+++.+||+.+|.+||++.+|+.
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 223 -KVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -hhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000111112334456678999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=295.12 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=199.7
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccccc----HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN----KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
...+.||+|++|.||.+... +++.+++|.+..... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 84 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME 84 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence 34578999999999999874 589999998764321 2234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++++|.+++. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++........
T Consensus 85 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 85 YMPGGSVKDQLK-AYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred ECCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 999999999984 44568999999999999999999999 99999999999999999999999999998765432211
Q ss_pred cc-cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 182 DS-TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 182 ~~-~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.. .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... ... ........
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------~~~-----~~~~~~~~ 224 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----------AAI-----FKIATQPT 224 (263)
T ss_pred cccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchH----------HHH-----HHHhccCC
Confidence 11 1234578899999988775 6899999999999999999999998643221 000 00111111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+......+.+++.+||..+|.+||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 225 NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 22334456678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=297.78 Aligned_cols=253 Identities=25% Similarity=0.322 Sum_probs=199.2
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||.||+|.+ .+++.||+|++..... .....+.+|+.++..++|+||+++++.+...+..++||||++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 45568999999999999987 4688999998864332 234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++. ....+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........ ..
T Consensus 90 ~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~ 163 (267)
T cd06646 90 GGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KR 163 (267)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc--cc
Confidence 999999984 44578999999999999999999999 9999999999999999999999999999986643221 12
Q ss_pred ccCCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 185 SGYRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
....++..|+|||.+.. ...++.++|||||||++|+|++|+.||.......... ....... .....
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~-----~~~~~ 231 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF-----QPPKL 231 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC-----CCCCC
Confidence 23458889999998742 2357889999999999999999999986443221100 0000000 00001
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHh
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L 297 (369)
.....++..+.+++.+||+.+|++||++.+|++.|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11223467899999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.42 Aligned_cols=264 Identities=20% Similarity=0.282 Sum_probs=200.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||.|+||.||+|.++ ++..||+|.+...........+.+|+.+++.++|+||+++++++.+.+..++||||+.
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 345678999999999999875 5889999988754333334567789999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+ +|.+++......+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........ ..
T Consensus 88 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 161 (301)
T cd07873 88 K-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TY 161 (301)
T ss_pred c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cc
Confidence 5 9999986666789999999999999999999999 9999999999999999999999999999875432221 11
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhhch-hhhh
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKGE-LAAK 255 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~ 255 (369)
....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+.... .......|..+.... ....
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 2235788999999887655688999999999999999999999975543110 000011111110000 0000
Q ss_pred hhcCCC----CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLGCGI----EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...... .......+..+.+|+.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 0011223557889999999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=305.71 Aligned_cols=197 Identities=25% Similarity=0.340 Sum_probs=162.3
Q ss_pred ccccccCCceEEEEEEeC---CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe--CCceEEEEecc
Q 017591 29 STKLGAGGFGVVYKGQFP---NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD--QTKAALVYEFM 103 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~ 103 (369)
.++||+|+||+||+|+.+ +++.+|+|.+..... ...+.+|+.+++.++||||+++++++.. ....++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 368999999999999864 468899998874322 2356789999999999999999998864 35678999998
Q ss_pred CCCCHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe----cCCCCeeEeecCC
Q 017591 104 ENGSLDKYLFTD--------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL----DAKFSAKVADFGL 171 (369)
Q Consensus 104 ~~gsL~~~l~~~--------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~ 171 (369)
.+ +|..++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 75 888877421 2358999999999999999999999 999999999999999 4567899999999
Q ss_pred ceecCCCCCc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 017591 172 AKLCNPENTH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCS 232 (369)
Q Consensus 172 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~ 232 (369)
++........ .......||+.|+|||++.+...++.++|||||||++|+|++|+.||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 9876543221 122345689999999998775578999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=314.29 Aligned_cols=251 Identities=21% Similarity=0.235 Sum_probs=195.1
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.++||+|+||.||++++. +++.+|+|++... ........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence 344578999999999999885 4889999998642 1223345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 125 ~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~- 198 (370)
T cd05621 125 MPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV- 198 (370)
T ss_pred CCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCce-
Confidence 999999999843 358999999999999999999999 99999999999999999999999999999876432221
Q ss_pred ccccCCCCCCccccccccccC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 183 STSGYRGTPGYSAPEFLLRNY---PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~---~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
......||+.|+|||++.... .++.++|||||||++|+|++|+.||....... .+..+... ....
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-------~~~~i~~~-----~~~~ 266 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-------TYSKIMDH-----KNSL 266 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC-----Cccc
Confidence 123456999999999886532 37899999999999999999999997543210 01111000 0000
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCC--CCChHHHHH
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEA--RPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~v~~ 295 (369)
. .......+..+.+++..||..++.+ |+++.++++
T Consensus 267 ~-~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 267 N-FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred C-CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 0 1112235677889999999855543 889988875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.45 Aligned_cols=262 Identities=26% Similarity=0.293 Sum_probs=201.5
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCc-eeeEEeEEEeCC------ceEEE
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHIN-LVRLYGFCYDQT------KAALV 99 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------~~~lv 99 (369)
.++||+|+||+||+|+.+ +|+.||+|.+..... +.......+|+.+++.++|+| |+.+++++...+ ..++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 467999999999999874 589999999875433 334456789999999999999 999999998877 78999
Q ss_pred EeccCCCCHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 100 YEFMENGSLDKYLFTDT---EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
+||++. +|..++.... ..++...+..+++|++.||+|||+ ++|+||||||+|||++++|.+||+|||+|+...
T Consensus 96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 999987 9999996655 368889999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhh
Q 017591 177 PENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYE 248 (369)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~ 248 (369)
-.. ...+..++|..|+|||++.+...|+...||||+|||+.||++++.-|.+...... ..-....|....
T Consensus 172 ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 172 IPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred CCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 222 2245567899999999999887899999999999999999999988877655211 000111121111
Q ss_pred hchhhhhhhcCCC-----CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 249 KGELAAKVLGCGI-----EENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 249 ~~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
............. ....+.......+++.+||+.+|.+|.+++.++..
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1100000000000 00011112478899999999999999999998764
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=295.37 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=190.6
Q ss_pred cccccCCceEEEEEEeCCC---cEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFPNG---VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.||+|+||.||++...++ ..+++|.+...........+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 3566676665444455678999999999999999999999999999999999999999
Q ss_pred CHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 107 SLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 107 sL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+|.+++... ....++..+..++.|++.||+|||+ .+++|+||||+|||++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999543 2356778889999999999999999 9999999999999999999999999999764322221122
Q ss_pred cccCCCCCCcccccccccc------CCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRN------YPITQKCDVYSFGMLLFEIIGR-RKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~------~~~s~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
.....++..|+|||++... ..++.++|||||||++|||+++ ..||...... ..+.....+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~--- 227 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-------EVLNHVIKDQQV--- 227 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhhccc---
Confidence 2345678899999987531 2457899999999999999974 5566533221 111111111100
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
....+.....+...+.+++..|| .+|++||++.+|++.|.
T Consensus 228 -~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 -KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 00112222335677888999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=301.43 Aligned_cols=266 Identities=21% Similarity=0.295 Sum_probs=206.9
Q ss_pred HHHHHHHhhcCCcccCHHHHHHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCC
Q 017591 2 EKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH 80 (369)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h 80 (369)
||+++.+.+. ++++... .++.+.+.||+|+||.||+|.+ .+++.|++|.+...... ....+.+|+.+++.+.|
T Consensus 3 ~~~~~~~~~~----~~~~~~~-~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h 76 (296)
T cd06654 3 EEILEKLRSI----VSVGDPK-KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKN 76 (296)
T ss_pred HHHHHHHHhc----cccCCcc-cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCC
Confidence 4555555443 2333332 2444567899999999999987 45899999988754332 34678899999999999
Q ss_pred CceeeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC
Q 017591 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA 160 (369)
Q Consensus 81 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 160 (369)
+|++++++.+......++||||+++++|.+++. ...+++.++..++.|++.||.|||+ .+++|+||||+||+++.
T Consensus 77 ~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~ 151 (296)
T cd06654 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGM 151 (296)
T ss_pred CCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcC
Confidence 999999999999999999999999999999984 3468999999999999999999999 99999999999999999
Q ss_pred CCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccc
Q 017591 161 KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240 (369)
Q Consensus 161 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~ 240 (369)
++.++|+|||++........ ......++..|+|||.+... .++.++|||||||++|+|++|+.||........
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~---- 224 (296)
T cd06654 152 DGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---- 224 (296)
T ss_pred CCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh----
Confidence 99999999999876433221 11234588999999988764 688999999999999999999999965433110
Q ss_pred cchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..... .........+......+.+++.+||..+|.+||++.+|++
T Consensus 225 --~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 225 --LYLIA--------TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred --HHHHh--------cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 00000 0000011123445677899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=298.63 Aligned_cols=240 Identities=21% Similarity=0.336 Sum_probs=189.5
Q ss_pred ccccCCceEEEEEEeCC-------------------------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceee
Q 017591 31 KLGAGGFGVVYKGQFPN-------------------------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 85 (369)
.||+|+||.||+|.... ...|++|++.... ......+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 69999999999996411 2458888886532 234567888999999999999999
Q ss_pred EEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC---
Q 017591 86 LYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF--- 162 (369)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~--- 162 (369)
+++++.+....++||||+++|+|..++......+++..+..++.|++.||+|||+ ++++||||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999996666789999999999999999999999 9999999999999997654
Q ss_pred ----CeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHH-cCCCCCCCCCCCccC
Q 017591 163 ----SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII-GRRKNAQDCSSDTLD 237 (369)
Q Consensus 163 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ell-tg~~p~~~~~~~~~~ 237 (369)
.++++|||++...... ....++..|+|||.+.....++.++|||||||++|||+ +|+.||........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 3799999987643211 12347788999998876557899999999999999995 78888865432211
Q ss_pred ccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 238 WFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
.... .. .. ..+......+.+++.+||+.+|.+||++.+|++.|.
T Consensus 231 ------~~~~------~~--~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ------ERFY------EK--KH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ------HHHH------Hh--cc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0000 00 00 011112346889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=294.27 Aligned_cols=247 Identities=25% Similarity=0.354 Sum_probs=202.5
Q ss_pred hccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||.||+|.+.+ ++.+++|.+..... ..++.+|+.+++.++|+|++++++++.+....++++||++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 3456789999999999998865 88999999875322 6789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~ 156 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KR 156 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--cc
Confidence 999999997667789999999999999999999999 9999999999999999999999999999886643321 12
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||......... ... ..........
T Consensus 157 ~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~-------~~~~~~~~~~ 221 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMI-------PNKPPPTLSD 221 (256)
T ss_pred ccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhh-------ccCCCCCCCc
Confidence 234578899999988765 7899999999999999999999998754332110 000 0000001112
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+..+...+.+++.+||+.||.+||++.+|++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 3345678999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=306.22 Aligned_cols=253 Identities=22% Similarity=0.218 Sum_probs=195.9
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.++||+|+||.||+++++ +++.||+|++... ........+.+|..++..+.|+||+.+++++.+.+..++||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 45689999999999999875 5789999998642 12233455788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......... .
T Consensus 84 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 159 (331)
T cd05624 84 VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-Q 159 (331)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-e
Confidence 9999999996656789999999999999999999999 99999999999999999999999999999876433221 1
Q ss_pred cccCCCCCCcccccccccc----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 184 TSGYRGTPGYSAPEFLLRN----YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~----~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
.....||+.|+|||++... ..++.++|||||||++|+|++|+.||....... .+....... ...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~i~~~~-----~~~ 227 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHE-----ERF 227 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-------HHHHHHcCC-----Ccc
Confidence 2235699999999987642 257889999999999999999999996433210 111111000 001
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCC--CCChHHHHH
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEA--RPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~v~~ 295 (369)
..+......+..+.+++.+|+..++.+ |+++.++++
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 112222334677889999999865544 456777653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=297.25 Aligned_cols=253 Identities=32% Similarity=0.497 Sum_probs=198.9
Q ss_pred ccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHH-HHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVE-AQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|+||+||+++.+. ++.+|+|++......... ....+|+.++..++|+||+++++++.+....++|||++.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 466889999999999998865 678999998865433322 244569999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++. ....+++..++.++.|+++||.+||+ ++++|+||||+||+++.++.++|+|||.+..... .....
T Consensus 82 ~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~ 155 (260)
T PF00069_consen 82 GGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENF 155 (260)
T ss_dssp TEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEB
T ss_pred ccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccccc
Confidence 999999995 55678999999999999999999999 9999999999999999999999999999986521 12223
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....++..|+|||.+..+...+.++||||||+++|+|++|..||........ ................ ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~---~~ 225 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-------LEIIEKILKRPLPSSS---QQ 225 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-------HHHHHHHHHTHHHHHT---TS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhh-------hhhhhhcccccccccc---cc
Confidence 4466899999999987445899999999999999999999999975411100 0111100000000000 00
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.......+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111278999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=294.21 Aligned_cols=245 Identities=28% Similarity=0.384 Sum_probs=196.9
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEE-eCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY-DQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 104 (369)
..+.+.||+|+||.||++.. .+..+++|...... ....+.+|+.++++++|+|++++++++. +.+..++||||++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred CeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 34568899999999999987 47889999886432 2457889999999999999999999765 4467899999999
Q ss_pred CCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+++|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 999999996543 358999999999999999999999 999999999999999999999999999987643221
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
....++..|+|||++... .++.++|||||||++|+|++ |+.||....... ..... ......
T Consensus 157 -~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~---------~~~~~~ 218 (256)
T cd05082 157 -DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRV---------EKGYKM 218 (256)
T ss_pred -CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH---------hcCCCC
Confidence 223356789999988764 78999999999999999997 888876432211 01111 111112
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
......+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 2233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=315.17 Aligned_cols=250 Identities=23% Similarity=0.248 Sum_probs=192.6
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.++||+|+||.||++++. +++.||+|++.... .......+.+|+.++..+.|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 45688999999999999874 58999999986432 2233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC----
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN---- 179 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 179 (369)
++|+|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.++|+|||++..+....
T Consensus 84 ~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 84 PGGDMMSLLI-RLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 9999999994 44578999999999999999999999 999999999999999999999999999975321000
Q ss_pred -------------------------------------CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHH
Q 017591 180 -------------------------------------THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222 (369)
Q Consensus 180 -------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ell 222 (369)
.........||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyell 238 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEML 238 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeeehh
Confidence 00001234699999999988764 7899999999999999999
Q ss_pred cCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCC---ChHHHHH
Q 017591 223 GRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARP---PMSAVVK 295 (369)
Q Consensus 223 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP---s~~~v~~ 295 (369)
+|+.||........ ........ ...........+..+.+++.+|+ .+|.+|+ ++.+++.
T Consensus 239 ~G~~Pf~~~~~~~~-------~~~i~~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 239 VGQPPFLADTPAET-------QLKVINWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hCCCCCCCCCHHHH-------HHHHhccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999975443210 01100000 00001111234556777888766 5999999 7788763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=315.10 Aligned_cols=256 Identities=20% Similarity=0.232 Sum_probs=193.4
Q ss_pred cccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 28 YSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.+.||+|+||.||++.+++ ++.||+|... ...+.+|+.++++++|+||+++++++...+..++|||++. +
T Consensus 173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred EEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 34789999999999998854 7889999643 2345689999999999999999999999999999999996 5
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|..++......+++..++.|+.|++.||.|||+ +||+||||||+|||++.++.++|+|||+++.............
T Consensus 245 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 8988886656689999999999999999999999 9999999999999999999999999999987643322222234
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC-ccCccccchhHHhhhchhh------------
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSD-TLDWFPKQVWDEYEKGELA------------ 253 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~------------ 253 (369)
..||..|+|||++.+. .++.++|||||||+||||++|..++...... ........+...+......
T Consensus 322 ~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 322 IAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred cCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 5699999999998764 7899999999999999999988766533211 1111111111111111000
Q ss_pred -hh----hhcCCCCC-----C--CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 254 -AK----VLGCGIEE-----N--DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 254 -~~----~~~~~~~~-----~--~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ......+. + .......+.+|+.+||+.||.+|||+.|+++
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 00000000 0 0122347889999999999999999999985
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=311.27 Aligned_cols=240 Identities=26% Similarity=0.373 Sum_probs=202.3
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.||-|+||.||.+++ .+.+.||||...-+ .....-.++..|+..|+++.|||++.+.|||.-+...+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 4699999999999987 56889999987532 3334456899999999999999999999999999999999999976
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
|-.+++.-...++-+..+..|+.+.+.||+|||+ .+.||||||+.|||+.+.|.|||+|||.+....+. ..
T Consensus 111 SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------ns 181 (948)
T KOG0577|consen 111 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------NS 181 (948)
T ss_pred cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch------hc
Confidence 9999997778899999999999999999999999 99999999999999999999999999998765433 33
Q ss_pred CCCCCCcccccccc--ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 187 YRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 187 ~~gt~~y~aPE~~~--~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
+.||+.|||||++. ..+.|+-+.||||||++..||.-.++|++.++.-.. ..++. .+....-.
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-------LYHIA--------QNesPtLq 246 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIA--------QNESPTLQ 246 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-------HHHHH--------hcCCCCCC
Confidence 67999999999875 345899999999999999999999999876554211 11111 11111223
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
..+++..+..++..||+.-|.+|||..+++
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 678899999999999999999999988876
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=308.04 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=193.0
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 101 (369)
.++.+.||+|+||.||+|.++ +++.||+|++.... .......+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 457789999999999999874 58999999987532 2233456778888888775 5778889999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++|+|..++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||+++.......
T Consensus 82 y~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 82 YVNGGDLMYHIQ-QVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred CCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 999999999984 44579999999999999999999999 9999999999999999999999999999875432211
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ...... .. .
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~---------~~-~ 217 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-------LFQSIM---------EH-N 217 (323)
T ss_pred -cccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHH---------hC-C
Confidence 12234689999999988764 78999999999999999999999997543211 111111 11 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMS 291 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 291 (369)
...+...+..+.+++.+||+.+|.+|++..
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 122334567789999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=306.14 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=209.7
Q ss_pred HhhhccccccccCCceEEEEEEeCC-CcEEEEEEcccccc--HHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEE
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 98 (369)
...|.+.+.||+|.||.||+++.+. |+.+|+|++.+... ......+.+|+.+|+++. |||||.+++.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3345566899999999999998865 99999999975432 224578999999999998 9999999999999999999
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC----CCeeEeecCCcee
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK----FSAKVADFGLAKL 174 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~ 174 (369)
|||++.||.|.+.+... .+++.....++.|++.++.|||+ .|++||||||+|+|+... +.++++|||++..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999999655 39999999999999999999999 999999999999999533 4799999999998
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
... .......+||+.|+|||++... .++..+||||+||++|.|++|..||........ ......++.
T Consensus 189 ~~~---~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-------~~~i~~~~~-- 255 (382)
T KOG0032|consen 189 IKP---GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-------FLAILRGDF-- 255 (382)
T ss_pred ccC---CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-------HHHHHcCCC--
Confidence 765 2234457899999999998864 799999999999999999999999986554321 111222221
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+........+.+++..|+..||.+|+++.++++
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1223445667889999999999999999999999987
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=296.52 Aligned_cols=246 Identities=23% Similarity=0.312 Sum_probs=201.8
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||.|+||.||+|.+. +++.+++|.+...........+.+|+.+++.++|+|++++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 345678999999999999875 5899999998755444455678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++... .+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (274)
T cd06609 83 GGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KR 155 (274)
T ss_pred CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--cc
Confidence 99999999543 88999999999999999999999 9999999999999999999999999999987654321 22
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....++..|+|||++.+. .++.++|||||||++|+|++|+.||........ .. .......+..
T Consensus 156 ~~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-------~~---------~~~~~~~~~~ 218 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-------LF---------LIPKNNPPSL 218 (274)
T ss_pred ccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-------HH---------HhhhcCCCCC
Confidence 334688899999988775 589999999999999999999999964432110 00 1111111221
Q ss_pred CHH-HHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 265 DRE-EAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 265 ~~~-~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... ++..+.+++.+||..+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 222 5677999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.63 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=202.5
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
..++||.|+||.||+|.+. ++..||+|.+...........+.+|+.+++.+.|+||+++++++.+....++||||++++
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 4468999999999999875 588999999875544555678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|.+++. ..++++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 88 ~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~ 160 (277)
T cd06640 88 SALDLLR--AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNT 160 (277)
T ss_pred cHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--cccc
Confidence 9999984 3468999999999999999999999 9999999999999999999999999999977643321 1223
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
..++..|+|||++.+. .++.++|+|||||++|||++|..||....+... .........+....
T Consensus 161 ~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------------~~~~~~~~~~~~~~ 223 (277)
T cd06640 161 FVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRV----------------LFLIPKNNPPTLTG 223 (277)
T ss_pred ccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH----------------hhhhhcCCCCCCch
Confidence 4578899999988764 689999999999999999999999865432211 00111111233445
Q ss_pred HHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 267 EEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+..+.+++.+||+.+|.+||++.+++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 67788999999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.35 Aligned_cols=249 Identities=23% Similarity=0.245 Sum_probs=191.1
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.++||+|+||.||+|++. +++.||+|++.... .......+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 34578999999999999874 58899999987432 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC---
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT--- 180 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 180 (369)
++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 84 PGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999844 4578999999999999999999999 9999999999999999999999999999753210000
Q ss_pred ------------------------------------------ccccccCCCCCCccccccccccCCCCcchhhHHHHHHH
Q 017591 181 ------------------------------------------HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLL 218 (369)
Q Consensus 181 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil 218 (369)
........||+.|+|||++.+. .++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHHH
Confidence 0001124689999999988764 789999999999999
Q ss_pred HHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCC---hHHHH
Q 017591 219 FEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPP---MSAVV 294 (369)
Q Consensus 219 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~v~ 294 (369)
|||++|+.||........ ...... .............+..+.+++.+|+ .+|.+|++ +.+++
T Consensus 239 ~elltG~~Pf~~~~~~~~-------~~~i~~------~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 239 YEMLVGQPPFLAQTPLET-------QMKVIN------WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHhCCCCCCCCCHHHH-------HHHHHc------cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 999999999975432110 000000 0000001112234566777777765 49999998 66655
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.57 Aligned_cols=265 Identities=20% Similarity=0.218 Sum_probs=200.5
Q ss_pred HHHHHhhhccccccccCCceEEEEEEeC---CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc
Q 017591 19 EQLCSFTNNYSTKLGAGGFGVVYKGQFP---NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK 95 (369)
Q Consensus 19 ~el~~~t~~f~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 95 (369)
..+....+.+.++||+|+||.||++... .+..|++|.+... ..+.+|+.+++.++|+||+++++++.....
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 3344455667789999999999999653 3678999987643 234689999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceec
Q 017591 96 AALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 96 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
.++|||++. ++|..++ .....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++...
T Consensus 161 ~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999999996 5888888 555789999999999999999999999 99999999999999999999999999999766
Q ss_pred CCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhc-----
Q 017591 176 NPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKG----- 250 (369)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 250 (369)
.............||..|+|||++... .++.++|||||||++|||++|+.||..............+.+.....
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred CcccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 544333333446799999999988764 78999999999999999999999997655432100000000000000
Q ss_pred -----hhh---hhhhcCCCCCC-------CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 251 -----ELA---AKVLGCGIEEN-------DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 251 -----~~~---~~~~~~~~~~~-------~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+. ........+.. .......+.+++.+||..||++||++.+++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 00000000000 0123467889999999999999999999875
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.06 Aligned_cols=253 Identities=21% Similarity=0.240 Sum_probs=195.2
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
.+.+.+.||+|+||.||++.++ +++.+|+|++... ........+.+|+.++..++||||+++++.+.+.+..++|||
T Consensus 44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (371)
T cd05622 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 123 (371)
T ss_pred hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 3344589999999999999885 5889999998642 122334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 124 y~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 124 YMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred CCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 9999999999843 358899999999999999999999 99999999999999999999999999999876433221
Q ss_pred cccccCCCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 182 DSTSGYRGTPGYSAPEFLLRN---YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~---~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
......||+.|+|||++... ..++.++|||||||++|||++|+.||....... .+..+.... ..
T Consensus 199 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~-----~~ 265 (371)
T cd05622 199 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHK-----NS 265 (371)
T ss_pred -cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC-----Cc
Confidence 12345699999999988653 237899999999999999999999997543210 111111100 00
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCC--CCChHHHHHH
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEA--RPPMSAVVKM 296 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~v~~~ 296 (369)
... ......+..+.+++..||..++.+ ||++.++++.
T Consensus 266 ~~~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 LTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ccC-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 001 112345778899999999844433 6788887753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=298.17 Aligned_cols=245 Identities=25% Similarity=0.346 Sum_probs=200.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
...+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.++|+||+++++++..++..++||||+++
T Consensus 7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06642 7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCC
Confidence 34467999999999999874 57899999987554445567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|.+++. ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 87 ~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06642 87 GSALDLLK--PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred CcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhh
Confidence 99999883 3568999999999999999999999 9999999999999999999999999999876543221 122
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...++..|+|||++... .++.++|||||||++|||++|+.|+........ ... ......+...
T Consensus 160 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~---------~~~~~~~~~~ 222 (277)
T cd06642 160 TFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFL---------IPKNSPPTLE 222 (277)
T ss_pred cccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------Hhh---------hhcCCCCCCC
Confidence 34578899999988765 689999999999999999999999864432211 000 1111112223
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..+.+++.+||+.+|.+||++.+|+.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 345677899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=298.70 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=202.3
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||+|+||.||++.+. ++..||+|.+...........+.+|+.++.+++|+||+++++.+...+..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 356688999999999999885 6899999988754444556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 105 NGSLDKYLFTD--TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 105 ~gsL~~~l~~~--~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|..++... ...+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 158 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-- 158 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc--
Confidence 99999998543 34789999999999999999999961 5999999999999999999999999999876532221
Q ss_pred ccccCCCCCCccccccccccC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 183 STSGYRGTPGYSAPEFLLRNY-----PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~-----~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
....++..|+|||.+.... .++.++|||||||++|+|++|+.||....... ..... ....
T Consensus 159 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------~~~~~------~~~~ 223 (286)
T cd06622 159 --KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-------IFAQL------SAIV 223 (286)
T ss_pred --ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-------HHHHH------HHHh
Confidence 2245788999999875432 35889999999999999999999996432211 01111 1111
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.......+..+...+.+++.+||+.+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 22223344557888999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=310.26 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=196.9
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----ceEEEE
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-----KAALVY 100 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~ 100 (369)
..++||+|+||.||++.+. +++.||+|.+... .......++.+|+.+++.++|+||+++++++...+ ..++||
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 3478999999999999874 6899999988643 23334567889999999999999999999998766 789999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+.+ +|.+++ .....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........
T Consensus 84 e~~~~-~l~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 84 ELMQS-DLHKII-VSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred ecccc-CHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99975 888887 345679999999999999999999999 9999999999999999999999999999986543222
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC-cc----ccchhHHhhh--chhh
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD-WF----PKQVWDEYEK--GELA 253 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~----~~~~~~~~~~--~~~~ 253 (369)
. ......++..|+|||.+.+...++.++|||||||++|||++|+.||......... .+ .......+.. ....
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 159 K-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred c-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 1 1223457899999999877556899999999999999999999999765432100 00 0000000000 0000
Q ss_pred hhhhcCC-CC-------CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 254 AKVLGCG-IE-------ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 254 ~~~~~~~-~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... .+ ......+..+.+|+.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000000 00 111223567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=293.43 Aligned_cols=239 Identities=23% Similarity=0.358 Sum_probs=190.1
Q ss_pred cccccCCceEEEEEEeCCCc-----------EEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 30 TKLGAGGFGVVYKGQFPNGV-----------KIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46999999999999885433 5777776643222 6788999999999999999999999988 77899
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-------CeeEeecCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-------SAKVADFGL 171 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg~ 171 (369)
||||+++|+|.+++......+++..+..++.|++.||+|||+ ++++|+||||+||+++.++ .++|+|||+
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999996655589999999999999999999999 9999999999999999887 799999999
Q ss_pred ceecCCCCCccccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCccCccccchhHHhhh
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGR-RKNAQDCSSDTLDWFPKQVWDEYEK 249 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (369)
+..... .....++..|+|||++... ..++.++|||||||++|+|++| ..|+........ ...+.
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~~~- 220 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERFYQ- 220 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHHHh-
Confidence 876433 1223467789999998764 3689999999999999999994 666654332110 01110
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 250 GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
.....+ ......+.+++.+||..+|.+||++.+|++.|+
T Consensus 221 -------~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -------DQHRLP---MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------cCCCCC---CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000001 111277899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=299.15 Aligned_cols=249 Identities=26% Similarity=0.306 Sum_probs=197.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
...+.||+|+||.||++.+. +++.+|+|.+.... .......+.+|+.++++++|+|++.+++.+.+.+..++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 34578999999999999874 58999999876432 2223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 158 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI- 158 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc-
Confidence 999999988543 3469999999999999999999999 99999999999999999999999999998765432221
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
....|+..|+|||++.+. .++.++|||||||++|+|++|+.||........ +..... .... ...
T Consensus 159 --~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-------~~~~~~--~~~~----~~~ 222 (285)
T cd05630 159 --KGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-------REEVER--LVKE----VQE 222 (285)
T ss_pred --cCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccch-------HHHHHh--hhhh----hhh
Confidence 224689999999998765 689999999999999999999999975432210 000000 0000 001
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCC-----hHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPP-----MSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~v~~ 295 (369)
..+......+.+|+.+||+.||.+||+ +.++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 122334567899999999999999999 777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=291.60 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=203.8
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.+.||.|+||.||.++. .+++.+++|.+... .......++.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 45668999999999999976 45889999987643 23455667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
++++|.+++... ...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-- 156 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-- 156 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence 999999999654 4578999999999999999999999 9999999999999999999999999999987644332
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ... ........
T Consensus 157 ~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------~~~---------~~~~~~~~ 219 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLN-------LVV---------KIVQGNYT 219 (256)
T ss_pred cccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-------HHH---------HHHcCCCC
Confidence 12335689999999987764 68899999999999999999999986433210 011 11112222
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
......+..+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 3334556789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=300.92 Aligned_cols=262 Identities=25% Similarity=0.361 Sum_probs=199.7
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||+|+||.||++.+. ++..+++|.+..........++.+|+.++.+++||||+++++++.+++..++||||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 34578999999999999874 57889999887554555566789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|.+++.. ...+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~ 156 (308)
T cd06615 84 GSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----AN 156 (308)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----cc
Confidence 999999944 46789999999999999999999971 489999999999999999999999999987543221 12
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhh-----------------
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYE----------------- 248 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------------- 248 (369)
...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....................
T Consensus 157 ~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 157 SFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred cCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 3468899999998765 4689999999999999999999999864332211000000000000
Q ss_pred ---hchhhhhhhcCCCCCC-CHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 249 ---KGELAAKVLGCGIEEN-DREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 249 ---~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
..+..........+.. ....+..+.+++.+||..+|++||++.+|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000111101111 11256679999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=298.40 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=204.3
Q ss_pred hhhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
..+.+.++||+|+||+||++.+. +++.|++|++...........+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 34456689999999999999874 58899999877554455567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++++|.+++. ....+++..+..++.+++.+|.|||+. .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYK-KGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 99999999884 345799999999999999999999962 589999999999999999999999999986542211
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC-ccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD-WFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
.....|+..|+|||++..+ .++.++|||||||++|+|++|+.||......... ..+..+.+.. ........
T Consensus 159 -~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 230 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL------QQIVQEPP 230 (284)
T ss_pred -cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH------HHHhhccC
Confidence 1234689999999988764 7899999999999999999999999854432110 0000001100 11111111
Q ss_pred CCC-CHHHHHHHHHHHHhccccCCCCCCChHHHHHHh
Q 017591 262 EEN-DREEAERMSMVALWCVQDCPEARPPMSAVVKML 297 (369)
Q Consensus 262 ~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L 297 (369)
+.. ....+..+.+++.+||+.||.+||++.+|++..
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111 123567899999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=283.75 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=200.8
Q ss_pred ccccccCCceEEEEEEe-CCCcEEEEEEcccc-------ccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEE
Q 017591 29 STKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-------LNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 99 (369)
++.||+|..++|-++.. ++|+.+|+|++... ......+.-..|+.+|+++. ||+|+++.+++..+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 35799999999998865 56889999987521 12233344557999999985 99999999999999999999
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
+|.|+.|.|.+++ ...-.+++.....|++|+++|++|||. ++||||||||+|||++++.+++|+|||.+..+..+.
T Consensus 102 Fdl~prGELFDyL-ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge 177 (411)
T KOG0599|consen 102 FDLMPRGELFDYL-TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE 177 (411)
T ss_pred hhhcccchHHHHh-hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCCch
Confidence 9999999999999 556689999999999999999999999 999999999999999999999999999999877665
Q ss_pred CccccccCCCCCCcccccccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRN-----YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
+.. ..+||++|+|||.+... ..|+...|+|++||++|.||.|.+||-. . .+--...
T Consensus 178 kLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH---------------R-kQmlMLR 238 (411)
T KOG0599|consen 178 KLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH---------------R-KQMLMLR 238 (411)
T ss_pred hHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH---------------H-HHHHHHH
Confidence 543 36799999999987642 4688999999999999999999999831 1 1111222
Q ss_pred hhhcCCC---CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGI---EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+..+.. .+...+++....+|+.+||+.||.+|.|++|+++
T Consensus 239 ~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 3333333 3345567788999999999999999999999873
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=294.28 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=199.8
Q ss_pred cccccccCCceEEEEEEeCCCcEEEEEEccccc-----cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 28 YSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL-----NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
..+.||+|+||.||+|...+++.+|+|.+.... .......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 456899999999999988889999999876432 223346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC---
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN--- 179 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 179 (369)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 84 VPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999943 4568999999999999999999999 999999999999999999999999999987643211
Q ss_pred -CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 180 -THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 180 -~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.........++..|+|||++... .++.++|||||||++|+|++|+.||........ ..... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~-------~~~ 224 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-------MFYIG-------AHR 224 (265)
T ss_pred cccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHH-------HHHhh-------hcc
Confidence 11112234588999999988764 688999999999999999999999964322100 00000 000
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122334456788999999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.75 Aligned_cols=255 Identities=21% Similarity=0.210 Sum_probs=196.0
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||+++.. +++.||+|++... ........+.+|+.++..++|+||+.+++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 345688999999999999875 5899999998642 2223345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|.+++......+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 158 (331)
T cd05597 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV- 158 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-
Confidence 99999999996656789999999999999999999999 99999999999999999999999999998765433221
Q ss_pred ccccCCCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 183 STSGYRGTPGYSAPEFLLR----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
......||+.|+|||++.. ...++.++|||||||++|+|++|+.||....... .+...... ...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-------~~~~i~~~-----~~~ 226 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNH-----KEH 226 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-------HHHHHHcC-----CCc
Confidence 1123458999999998863 2357889999999999999999999996533210 01111100 000
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccc--CCCCCCChHHHHHH
Q 017591 259 CGIEENDREEAERMSMVALWCVQD--CPEARPPMSAVVKM 296 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~~v~~~ 296 (369)
...+......+..+.+++.+||.. ++..||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111222223566788888887754 33347788887643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=297.76 Aligned_cols=244 Identities=25% Similarity=0.297 Sum_probs=194.0
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
...+.||+|+||+||++.+. +++.+|+|.+.... .......+.+|+.+++.++|+|++.+++.+..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 34578999999999999874 58899999886432 2223455788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
++++|..++... ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05632 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-- 157 (285)
T ss_pred cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--
Confidence 999999888543 3479999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....|+..|+|||++.+. .++.++|+|||||++|+|++|..||........ .... ...... ...
T Consensus 158 -~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-------~~~~-----~~~~~~-~~~ 222 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-------REEV-----DRRVLE-TEE 222 (285)
T ss_pred -ccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHH-----HHhhhc-ccc
Confidence 1234689999999988764 789999999999999999999999975432110 0000 011111 011
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
......+..+.+|+..||+.||.+||++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCC
Confidence 2233456678999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=302.22 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=188.7
Q ss_pred cccccCCceEEEEEEeC---CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe--CCceEEEEeccC
Q 017591 30 TKLGAGGFGVVYKGQFP---NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD--QTKAALVYEFME 104 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 104 (369)
.+||+|+||.||+|..+ ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 57999999999999864 357899998875322 2457789999999999999999998864 456789999987
Q ss_pred CCCHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe----cCCCCeeEeecCCc
Q 017591 105 NGSLDKYLFTD--------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL----DAKFSAKVADFGLA 172 (369)
Q Consensus 105 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~ 172 (369)
+ +|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 6 787776321 2358899999999999999999999 999999999999999 56678999999999
Q ss_pred eecCCCCCc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccc-----------
Q 017591 173 KLCNPENTH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP----------- 240 (369)
Q Consensus 173 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~----------- 240 (369)
+........ .......+|..|+|||++.+...++.++|||||||++|||++|+.||...........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 876543221 12234568999999998877556899999999999999999999999754332110000
Q ss_pred ------cchhHHhhhch----hhhhhhcC---------CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 241 ------KQVWDEYEKGE----LAAKVLGC---------GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 241 ------~~~~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...|....... ........ ............+.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00111110000 00000000 000011112356888999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=300.27 Aligned_cols=254 Identities=21% Similarity=0.215 Sum_probs=195.9
Q ss_pred ccccccccCCceEEEEEEeCC-CcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.++||+|+||.||+++.+. ++.+|+|++.+. ........+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 456899999999999998754 788999998642 12233445788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++|+|.+++......+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++......... .
T Consensus 84 ~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-~ 159 (332)
T cd05623 84 VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-Q 159 (332)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc-e
Confidence 9999999996656789999999999999999999999 99999999999999999999999999998765332221 1
Q ss_pred cccCCCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 184 TSGYRGTPGYSAPEFLLR----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
.....||+.|+|||++.. ...++.++|||||||++|||++|+.||....... ........ ....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-------~~~~i~~~-----~~~~ 227 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNH-----KERF 227 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCC-----Cccc
Confidence 223569999999998863 2367899999999999999999999997543211 01111100 0011
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCC--CCCChHHHHHH
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPE--ARPPMSAVVKM 296 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~--~RPs~~~v~~~ 296 (369)
..+......+..+.+|+.+|+..++. .|+++.++++.
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 12222234567788899998865443 46788887643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=297.97 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=207.6
Q ss_pred HHHHHHHhhcCCcccCHHHHHHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCC
Q 017591 2 EKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH 80 (369)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h 80 (369)
|++++++.+. +++++.. ..+.+.++||+|+||.||++.+ .+++.||+|.+..... .....+.+|+.+++.++|
T Consensus 2 ~~~~~~~~~~----~~~~~~~-~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h 75 (297)
T cd06656 2 EEILEKLRSI----VSVGDPK-KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKN 75 (297)
T ss_pred HHHHHHHHhh----cccCChh-hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCC
Confidence 4566665332 2233332 3344568899999999999987 4699999998865333 234668899999999999
Q ss_pred CceeeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC
Q 017591 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA 160 (369)
Q Consensus 81 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 160 (369)
+|++++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.
T Consensus 76 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~ 150 (297)
T cd06656 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGM 150 (297)
T ss_pred CCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECC
Confidence 9999999999999999999999999999999843 458999999999999999999999 99999999999999999
Q ss_pred CCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccc
Q 017591 161 KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240 (369)
Q Consensus 161 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~ 240 (369)
++.++|+|||++......... .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||..........
T Consensus 151 ~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-- 225 (297)
T cd06656 151 DGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-- 225 (297)
T ss_pred CCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--
Confidence 999999999998765433221 1234588899999988764 68899999999999999999999996543321100
Q ss_pred cchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... .........+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 226 ----~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 226 ----LIA--------TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----eec--------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0000011123345677889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.46 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=200.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccccc--------HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--------KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 96 (369)
+.+...||+|+||.||+|.+. +++.+++|.+..... ......+.+|+.+++.++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 456678999999999999874 588999998753211 12335688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 97 ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
++||||+++++|.+++. ....+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||.++...
T Consensus 82 ~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHH-hccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999994 34678999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCc----cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 177 PENTH----DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 177 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
..... .......|+..|+|||.+..+ .++.++|||||||++|+|++|+.||...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~----- 221 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----------QAI----- 221 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHH----------HHH-----
Confidence 32111 111234588899999988765 6889999999999999999999999753221 000
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........+..+...+..+.+++.+||+.||.+||++.+|++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 222 -FKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -HHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011111223334456788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=302.88 Aligned_cols=265 Identities=18% Similarity=0.231 Sum_probs=196.3
Q ss_pred cccccccC--CceEEEEEEe-CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 28 YSTKLGAG--GFGVVYKGQF-PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 28 f~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.++||+| +|++||++.. .+|+.||+|.+.... .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 7899999977 568999999987542 3344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC--
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT-- 180 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 180 (369)
++|+|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999543 3468999999999999999999999 9999999999999999999999999986543321110
Q ss_pred ---ccccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC------ccccch------h
Q 017591 181 ---HDSTSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD------WFPKQV------W 244 (369)
Q Consensus 181 ---~~~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~------~~~~~~------~ 244 (369)
........++..|+|||++... ..++.++|||||||++|||++|+.||......... ..+... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0111223467789999998764 35889999999999999999999999754321100 000000 0
Q ss_pred HHh-------------hhchhhh----hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 245 DEY-------------EKGELAA----KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 245 ~~~-------------~~~~~~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+.. ..+.... .................+.+++.+||+.||++|||+.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 0000000 00000001122345668999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=297.85 Aligned_cols=263 Identities=24% Similarity=0.295 Sum_probs=197.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|++|.||+|... ++..|++|.+.... .......+.+|+.++..++|||++++++++.+++..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 45678999999999999875 58999999886432 22234578889999999999999999999999999999999998
Q ss_pred CCCHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 105 NGSLDKYLFTD--TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 105 ~gsL~~~l~~~--~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
++|.+++... +..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 5898888532 3578999999999999999999999 9999999999999999999999999999976543221
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhchhhh
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGELAA 254 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 254 (369)
......++..|+|||++.+...++.++|||||||++|+|++|+.||......... ......|..........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 1122357889999998876556789999999999999999999999754321100 00000010000000000
Q ss_pred hhhc----CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLG----CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.... ..........+..+.+++.+||+.||.+|||+.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0000111224667889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=329.35 Aligned_cols=264 Identities=22% Similarity=0.369 Sum_probs=202.5
Q ss_pred cCHHHHHHhhhccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC
Q 017591 16 FTLEQLCSFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ 93 (369)
Q Consensus 16 ~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 93 (369)
+..++..-..+.+.++||+|+||+||++.+. .+..+|+|++... ........+..|+.++..+.||||++++++|.+.
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 4445555556667789999999999999885 4788899987643 3444567889999999999999999999988654
Q ss_pred --CceEEEEeccCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhcc----CCCeEeecCCCCceEecC----
Q 017591 94 --TKAALVYEFMENGSLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEEC----NQRIIHYDIKPANILLDA---- 160 (369)
Q Consensus 94 --~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~----~~~ivH~dlkp~Nill~~---- 160 (369)
..++|||||+++++|.++|... ...+++..++.|+.||+.||.|||+.. .++|+|+||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 5689999999999999998542 357999999999999999999999832 135999999999999964
Q ss_pred -------------CCCeeEeecCCceecCCCCCccccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcCCC
Q 017591 161 -------------KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGRRK 226 (369)
Q Consensus 161 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg~~ 226 (369)
.+.+||+|||++..+..... .....||+.|+|||++... ..++.++|||||||+||+|++|+.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 23589999999986543221 2335699999999988643 358899999999999999999999
Q ss_pred CCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH--HHhc
Q 017591 227 NAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV--KMLE 298 (369)
Q Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~--~~L~ 298 (369)
||....... .+...+..+ ........+..+.+|+..||+.+|.+||++.+++ ..+.
T Consensus 242 PF~~~~~~~------qli~~lk~~----------p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 242 PFHKANNFS------QLISELKRG----------PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred CCCcCCcHH------HHHHHHhcC----------CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 996433210 111111110 0111123457789999999999999999999988 3444
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=294.30 Aligned_cols=249 Identities=26% Similarity=0.384 Sum_probs=198.3
Q ss_pred ccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.+.||+|+||.||++.+.. +..+++|.+.... ......+.+|+.+++.++|+|++++++++..++..++||||+++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 345789999999999998854 7788888876433 34456788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|..++.....++++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ ...
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--ccc
Confidence 99999886656789999999999999999999999 9999999999999999999999999999876432211 123
Q ss_pred cCCCCCCcccccccc----ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 186 GYRGTPGYSAPEFLL----RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~----~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
...++..|+|||++. .+..++.++|||||||++|+|++|+.||........ ....... ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~-------~~~~ 227 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-------LLKIAKS-------EPPT 227 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-------HHHHhhc-------CCCC
Confidence 346889999999874 233578899999999999999999999864332100 0000000 0001
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..++..+.+++.+||+.||.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123345678999999999999999999998863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=301.41 Aligned_cols=247 Identities=24% Similarity=0.394 Sum_probs=214.8
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
-|.+.+-||+|.|.+|-+++. -+|..||||++.+. .+......+..|++-|+.++|||||++|++...+..+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 345667899999999999965 58999999999753 4555677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe-cCCCCeeEeecCCceecCCCCCc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL-DAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
-++|+|.+||.++...+.++...+|+.||+.|+.|.|+ ..+|||||||+|+.+ .+-|-|||.|||++..+..+...
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence 99999999998888899999999999999999999999 999999999999877 56788999999999887665543
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
+..+|+..|-|||++.+.....++.||||||||||.|++|+.||+..+.. +..-+++.|.+
T Consensus 176 ---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLTmImDCKY 236 (864)
T KOG4717|consen 176 ---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLTMIMDCKY 236 (864)
T ss_pred ---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhhhhhcccc
Confidence 34679999999999998777789999999999999999999999855432 22234455543
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
..+...+.++.+||.+||..||.+|.+.++|+
T Consensus 237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred -cCchhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 34677889999999999999999999999987
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=278.53 Aligned_cols=243 Identities=25% Similarity=0.344 Sum_probs=204.7
Q ss_pred cccccccCCceEEEEEEe-CCCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 28 YSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.||+|-||.||.|+. +++-.||+|++.+.. ......++.+|+++-+.|+||||+++|++|.+....||++||..
T Consensus 26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~ 105 (281)
T KOG0580|consen 26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAP 105 (281)
T ss_pred ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecC
Confidence 457899999999999987 457899999987542 33455789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+|+|.+.|.. ....+++...+.++.|+|.||.|+|. ++|+||||||+|+|++..+..|++|||-+...+ ...
T Consensus 106 ~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~k 178 (281)
T KOG0580|consen 106 RGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNK 178 (281)
T ss_pred CchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC----CCC
Confidence 9999999953 45679999999999999999999999 999999999999999999999999999987543 222
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....+||.-|++||...+. ..+...|+|++|++.||++.|.+||...... ..++.+...+ -.
T Consensus 179 R~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------etYkrI~k~~----------~~ 240 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------ETYKRIRKVD----------LK 240 (281)
T ss_pred ceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhH-------HHHHHHHHcc----------cc
Confidence 3456799999999987764 7899999999999999999999999754421 1223322221 22
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+...+....++|.+|+..+|.+|.+..+|++
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 34667788999999999999999999999875
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=308.25 Aligned_cols=191 Identities=25% Similarity=0.348 Sum_probs=163.2
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.+.||+|+||.||+|.+. ++..||+|+.... ....|+.++++++|+||+++++++.+....++|||++
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 3455689999999999999885 4788999985532 2346899999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
. ++|.+++......+++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.++|+|||+++...... .
T Consensus 140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~ 212 (357)
T PHA03209 140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---A 212 (357)
T ss_pred C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc---c
Confidence 6 48988886667789999999999999999999999 999999999999999999999999999987532211 1
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQD 230 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~ 230 (369)
.....||..|+|||++.+. .++.++|||||||++|||+++..++..
T Consensus 213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 2235689999999988775 789999999999999999987766543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.64 Aligned_cols=246 Identities=23% Similarity=0.368 Sum_probs=200.5
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC---CCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY---HINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.||+|+||.||+|.+ .+++.+++|.+..........++.+|+.+++.+. |+|++++++++.+....++||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 3457899999999999987 5689999999876545555677889999999986 99999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++++|.+++.. ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06917 84 AEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-- 156 (277)
T ss_pred CCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--
Confidence 999999999843 378999999999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......|+..|+|||.+..+..++.++|||||||++|+|++|..||........ ...... ...+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~~~~~~---------~~~~ 220 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------MMLIPK---------SKPP 220 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------hhcccc---------CCCC
Confidence 123346889999999887765679999999999999999999999975432211 000000 0001
Q ss_pred CCCH-HHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDR-EEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.... ..+..+.+++.+||+.||.+||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 25567899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=317.17 Aligned_cols=257 Identities=23% Similarity=0.259 Sum_probs=188.1
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--------Cce
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--------TKA 96 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~ 96 (369)
+.+.++||+|+||.||+|.+. +++.||+|.+.... ....+|+.+++.++|+||+++++++... ...
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 344578999999999999874 58999999876432 2345799999999999999999887532 136
Q ss_pred EEEEeccCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-CeeEeecCCc
Q 017591 97 ALVYEFMENGSLDKYLF---TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-SAKVADFGLA 172 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~ 172 (369)
++||||+++ +|.+++. .....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 689999986 7777663 245679999999999999999999999 9999999999999998665 6999999999
Q ss_pred eecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC-c----cccchhHHh
Q 017591 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD-W----FPKQVWDEY 247 (369)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~----~~~~~~~~~ 247 (369)
+.+..... .....||+.|+|||++.+...++.++|||||||++|||++|..||......... . +.....+.+
T Consensus 219 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 219 KNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred hhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 86543222 223468999999998876557899999999999999999999999765432100 0 000000000
Q ss_pred hh--chhhhhhhcCCC-----CCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 248 EK--GELAAKVLGCGI-----EENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 248 ~~--~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
.. ............ ...+...+..+.+|+.+||+.||.+|||+.+++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00 000000000000 001112346789999999999999999999987
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=288.90 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=200.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC-CceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ-TKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~ 102 (369)
+.+.+.||+|++|.||++.++ +++.+++|.+... ........+.+|+.++++++|+|++++++.+... ...+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456789999999999999875 4788999988643 2334456788999999999999999999987643 457899999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 103 MENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
+++++|.+++... ...+++.+++.++.+++.||.+||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence 9999999999653 4568999999999999999999999 9999999999999999999999999999987643222
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......+++.|+|||++... .++.++||||||+++++|++|+.||....... ..........
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~----------------~~~~~~~~~~ 219 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNS----------------LVYRIIEGKL 219 (257)
T ss_pred -ccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHHhcCC
Confidence 22334588999999988764 78899999999999999999999986432110 0011112222
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+..+...+..+.+++.+||+.||.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 3344567788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=290.29 Aligned_cols=248 Identities=20% Similarity=0.344 Sum_probs=203.0
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.++||+|+||.+|++... +++.|++|.+... .......++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 346689999999999999874 5889999987642 23344568899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
++++|.+++... ...+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 157 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL- 157 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence 999999998543 3468999999999999999999999 99999999999999999999999999999865432211
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....|+..|+|||++.+. ..+.++|+|||||++++|++|+.||...... ...........+
T Consensus 158 -~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~~~~~~~ 219 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----------------NLVLKIIRGSYP 219 (256)
T ss_pred -hhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHH----------------HHHHHHhcCCCC
Confidence 1234588899999988764 6889999999999999999999998643211 111112222233
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 344556778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=294.30 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=199.3
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||.|+||.||+|.+. ++..+++|.+... .......+.+|+.+++.++|+|++++++.+..+...++||||++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 345678999999999999875 4889999998754 33446778899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|..++......+++..+..++.|++.+|.|||+ .+++||||||+||+++.++.++|+|||++....... ...
T Consensus 93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~ 167 (292)
T cd06644 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRR 167 (292)
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc--ccc
Confidence 999999886666789999999999999999999999 999999999999999999999999999987543211 112
Q ss_pred ccCCCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 185 SGYRGTPGYSAPEFLLR----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
....++..|+|||++.. ...++.++|||||||++|+|++|+.||....... ......... ..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~-------~~ 233 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSE-------PP 233 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-------HHHHHhcCC-------Cc
Confidence 23458889999998753 2356889999999999999999999986433210 001110000 00
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+...+..+.+++.+||+.+|++||++.+|++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01122345567899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=291.59 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=197.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||+|+||.||+|.+. +++.|++|+++.... .....+.+|+.+++.++||||+++++.+.+.+..++||||+++
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 45578999999999999874 589999998875433 3345688899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|.+++. ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 91 ~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 164 (267)
T cd06645 91 GSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRK 164 (267)
T ss_pred CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccc
Confidence 99999984 44579999999999999999999999 9999999999999999999999999999876543221 223
Q ss_pred cCCCCCCcccccccc--ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 186 GYRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~--~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
...|+..|+|||++. ....++.++|||||||++|+|++|+.||........ .+ ........ ... ..
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~-~~~~~~~~----~~~-~~ 232 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LF-LMTKSNFQ----PPK-LK 232 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HH-hhhccCCC----CCc-cc
Confidence 356899999999874 223578999999999999999999999865432211 00 00000000 000 00
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....++..+.+++.+||+.+|++||++.+|++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11124567889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=289.96 Aligned_cols=244 Identities=28% Similarity=0.437 Sum_probs=197.0
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.+.+.||+|+||.||++.. +++.+++|.+.... ....+.+|+.+++.++|+|++++++++... ..++||||+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 45678999999999999976 67889999886432 245788999999999999999999998654 57999999999
Q ss_pred CCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 106 GSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 106 gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 99999996543 468999999999999999999999 999999999999999999999999999987643211
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....+..|+|||++..+ .++.++|||||||++|+|++ |+.||....... ..... .......
T Consensus 155 ~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~---------~~~~~~~ 217 (254)
T cd05083 155 DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECV---------EKGYRME 217 (254)
T ss_pred CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHH---------hCCCCCC
Confidence 122346789999988764 78999999999999999997 888886443211 11111 1111122
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.....+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 233456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=290.11 Aligned_cols=247 Identities=25% Similarity=0.353 Sum_probs=200.8
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc----cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL----NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
.+.+.||+|+||.||+|.+. +++.|++|.+.... .......+.+|+.+++.++|+|++++++++.+....+++||
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 45578999999999999886 68999999876432 23456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 83 LVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred ecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999943 4568999999999999999999999 999999999999999999999999999988754332
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......++..|++||.+.....++.++|+|||||++|+|++|+.||....... ..+.. . .....
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~---~------~~~~~ 220 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKI---G------RSKEL 220 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHH---H------hcccC
Confidence 12335688999999988765348999999999999999999999986543210 00000 0 00111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+..+......+.+++.+||+.+|.+||++.+++.
T Consensus 221 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 2233445678899999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=295.67 Aligned_cols=254 Identities=23% Similarity=0.255 Sum_probs=194.5
Q ss_pred ccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----ceEEEEec
Q 017591 29 STKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-----KAALVYEF 102 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~ 102 (369)
.+++|.|+||.||+|.. .+++.||||....+.. --.+|+.+|+.+.|||||+++-+|.... ...+||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 36899999999999977 4479999998765422 3347999999999999999999887432 34589999
Q ss_pred cCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC-CCeeEeecCCceecCCC
Q 017591 103 MENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPE 178 (369)
Q Consensus 103 ~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 178 (369)
|+. +|.+++.. .+..++...+.-+..||++||.|||+ .||+||||||.|+|+|.+ |.+||+|||.|+.+..+
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 997 99999853 36778999999999999999999999 999999999999999976 88999999999987655
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc-Cc----cccchhHHhhhch--
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL-DW----FPKQVWDEYEKGE-- 251 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~-~~----~~~~~~~~~~~~~-- 251 (369)
.... ...-|..|+|||.+.+...|+.+.||||.||++.||+-|+.-|.+.+.... .. +.....+.+....
T Consensus 180 epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 180 EPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred CCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 4432 234678899999999888999999999999999999999999987654311 00 0000001111000
Q ss_pred -----hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 252 -----LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 252 -----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
........+........+.++.+|+.++|+.+|.+|.++.+++
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 0000001111113344567899999999999999999999877
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=288.46 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=202.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||.|+||.||++.+. ++..+++|++..... .....+.+|+.+++.++||||+++++++.+....+++|||++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 345688999999999999874 578899999875433 346788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++......+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~ 158 (262)
T cd06613 84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KR 158 (262)
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--cc
Confidence 999999996655789999999999999999999999 9999999999999999999999999999876543211 12
Q ss_pred ccCCCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRN--YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~--~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
....++..|+|||.+... ..++.++|||||||++|+|++|+.||........ ........ ......
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~~~~~~~-----~~~~~~ 226 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LFLISKSN-----FPPPKL 226 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcc-----CCCccc
Confidence 334688899999987653 2678899999999999999999999865432110 00000000 011111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......+..+.+++.+||..+|.+||++.+|+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 223456778999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=302.52 Aligned_cols=258 Identities=22% Similarity=0.270 Sum_probs=191.9
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC------ceE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT------KAA 97 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~ 97 (369)
+...+.||+|+||.||++.+. +|..||+|.+... ........+.+|+.+++.++||||+++++++...+ ..+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence 344588999999999999874 5899999998643 23344567889999999999999999999986443 479
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 103 lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 103 LVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred EEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 99999976 6766662 348899999999999999999999 9999999999999999999999999999975432
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEK 249 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~ 249 (369)
.. ......||..|+|||.+.+. .++.++|||||||++|+|++|+.||........ .............
T Consensus 176 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 176 NF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred Cc---cCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 21 12334689999999988764 789999999999999999999999975532110 0000000000000
Q ss_pred chhhhhhhc-CCC-----------------CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 250 GELAAKVLG-CGI-----------------EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 250 ~~~~~~~~~-~~~-----------------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........ ... ..........+.+|+.+||+.||++|||+.|++.
T Consensus 252 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 252 -TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred -HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 000 0111123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.00 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=199.8
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.++||+|+||.||+|.+. +++.||+|++.... ......++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 345689999999999999885 58999999987532 234456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCc
Q 017591 103 MENGSLDKYLFTD----------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA 172 (369)
Q Consensus 103 ~~~gsL~~~l~~~----------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 172 (369)
++|++|.+++... ...+++..++.++.|+++||+|||+ +|++||||||+||+++.++.++|+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999988431 1345677889999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCC----------------ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc
Q 017591 173 KLCNPENT----------------HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL 236 (369)
Q Consensus 173 ~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~ 236 (369)
........ ........||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 86621110 0011234699999999988764 789999999999999999999999975332211
Q ss_pred CccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCC-ChHHHHHHhcCC
Q 017591 237 DWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARP-PMSAVVKMLEGG 300 (369)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~v~~~L~~~ 300 (369)
. .. ........ .......+..+.+++.+||+.||++|| ++.++.+.|+..
T Consensus 240 ~------~~----~~i~~P~~----~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 240 S------YR----DVILSPIE----VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred h------hh----hhccChhh----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 00 00000000 011124456788999999999999996 566677777654
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=290.99 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=200.9
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||.|+||.||+|.+ .++..+|+|.............+.+|+.++..++|+||+++++++.+....++||||+++
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 3557899999999999977 468899999887554445567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|.+++. ...+++..+..++.|++.++.+||+ ++++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 87 ~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06641 87 GSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred CcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhc
Confidence 99999984 3468999999999999999999999 9999999999999999999999999999876643221 122
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...++..|+|||.+... .++.++|+|||||++|+|++|..||....... ... .......+...
T Consensus 160 ~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~---------~~~~~~~~~~~ 222 (277)
T cd06641 160 TFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLF---------LIPKNNPPTLE 222 (277)
T ss_pred cccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHH---------HHhcCCCCCCC
Confidence 34578899999988764 68899999999999999999999986432210 001 11111122233
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..+.+++.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 445677899999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=310.08 Aligned_cols=250 Identities=24% Similarity=0.299 Sum_probs=192.6
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||.||++..+ +++.||+|++.... .......+.+|+.++..++|+||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999875 58999999987432 2334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC---
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT--- 180 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 180 (369)
++|+|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.++|+|||++........
T Consensus 84 ~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 84 PGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred CCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 9999999994 45679999999999999999999999 9999999999999999999999999999865422110
Q ss_pred ------------------------------ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 017591 181 ------------------------------HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQD 230 (369)
Q Consensus 181 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~ 230 (369)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCCCC
Confidence 0001234699999999988764 789999999999999999999999975
Q ss_pred CCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 231 CSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..... .+....... .....+. ....+..+.+++.+|+. ||.+|++...+-+
T Consensus 239 ~~~~~-------~~~~i~~~~-----~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~e 289 (360)
T cd05627 239 ETPQE-------TYRKVMNWK-----ETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEE 289 (360)
T ss_pred CCHHH-------HHHHHHcCC-----CceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHH
Confidence 44321 111111100 0000111 11245678888888764 9999996543333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=292.58 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=193.5
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeC------CceEEE
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQ------TKAALV 99 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~~~lv 99 (369)
+.+.||+|+||.||+|.+. +++.+|+|.+.... .....+.+|+.++.++ +|+|++++++++... ...++|
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred HHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 3578999999999999874 58899999886432 2345788899999988 699999999998753 457899
Q ss_pred EeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 100 YEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
|||+.+++|.+++... ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 9999999999998653 3578999999999999999999999 99999999999999999999999999998865432
Q ss_pred CCccccccCCCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLR----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
.. ......|+..|+|||++.. ...++.++|||||||++|||++|+.||........ ....
T Consensus 165 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-------~~~~------- 228 (272)
T cd06637 165 VG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFLI------- 228 (272)
T ss_pred cc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-------HHHH-------
Confidence 21 2234568999999998763 23578899999999999999999999864332110 0000
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.............+..+.+|+.+||+.+|.+||++.+|++
T Consensus 229 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 -PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000111112234567899999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=293.59 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=200.7
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||.|+||.||++.+. ++..+++|++... .......+.+|+.+++.++|+|++++++.+.++...++||||++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 345578999999999999874 5899999998754 33445678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++......+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~ 160 (280)
T cd06611 86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KR 160 (280)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc--cc
Confidence 999999997666789999999999999999999999 9999999999999999999999999998865432221 12
Q ss_pred ccCCCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 185 SGYRGTPGYSAPEFLLR----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
....++..|++||.+.. ...++.++||||||+++|+|++|+.||........ ......+. ..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~-------~~ 226 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-------LLKILKSE-------PP 226 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-------HHHHhcCC-------CC
Confidence 23458999999998752 23577899999999999999999999865432110 01110000 00
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+..++..+.+++..||+.+|.+||++.+|++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 11123345677899999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=289.33 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=204.6
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||.|+||+||+|... ++..+++|++...........+.+|+..++.++|+|++++++.+.+.+..++|||+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 345688999999999999874 5789999998754444466789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 105 NGSLDKYLFTD--TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 105 ~gsL~~~l~~~--~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|.+++... ...+++..+..++.|++.||.+||+ .+++|+||+|+||++++++.++|+|||++..........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999543 2468999999999999999999999 999999999999999999999999999987665433221
Q ss_pred --ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 183 --STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 183 --~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
......|+..|++||++......+.++|+|||||++|+|++|+.||........ ..+.. .. ....
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~-~~------~~~~ 226 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTL-QN------DPPS 226 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHh-cC------CCCC
Confidence 223346889999999987755789999999999999999999999975433211 01111 00 0001
Q ss_pred CCC--CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEE--NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... .....+..+.+++.+||+.||.+||++.+|+.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111 12355678899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=288.89 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=199.1
Q ss_pred ccccccccCCceEEEEEEeCC--CcEEEEEEcccc---------ccHHHHHHHHHHHHHHhc-cCCCceeeEEeEEEeCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN--GVKIAAKILKTC---------LNKRVEAQFMAEIGTIGR-TYHINLVRLYGFCYDQT 94 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---------~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~ 94 (369)
.+.+.||+|+||.||++.++. ++.+++|.+... .......++.+|+.++.+ ++|+||+++++++.+.+
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 355789999999999998854 788999987521 123344567788888865 78999999999999999
Q ss_pred ceEEEEeccCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCC
Q 017591 95 KAALVYEFMENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
..++||||+++++|.+++.. ....+++..++.++.|++.+|.|||+. .+++|+||+|+||+++.++.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999998742 345799999999999999999999951 6899999999999999999999999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
+....... ......++..|++||.+.++ .++.++||||||+++|+|++|+.||........ ......+.
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-------~~~~~~~~ 229 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-------ATKIVEAV 229 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-------HHHHhhcc
Confidence 98755433 22345689999999988764 689999999999999999999999864322110 01111100
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
..+......+..+.+++.+||+.||++||++.+|.++++
T Consensus 230 --------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 --------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --------CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 011111234577999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.55 Aligned_cols=260 Identities=26% Similarity=0.369 Sum_probs=216.8
Q ss_pred HHHHHHhhhccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce
Q 017591 18 LEQLCSFTNNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 18 ~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 96 (369)
-+|++---....++||.|-||.||.|.|+. .-.||||.++.+.- ...+|..|..+|+.++|||+|+++|+|..+..+
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 345544444456899999999999999965 78899999987543 357899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceec
Q 017591 97 ALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
|||+|||.+|+|.+||...+ ..++...++.++.||..|+.||.. +++|||||.++|+|+.++..||++|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999997654 467888999999999999999999 99999999999999999999999999999988
Q ss_pred CCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 176 NPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
..+. ..........+-|.|||-+..+ .++.|+|||+|||+|||+.| |..|+.+.+. .++++.
T Consensus 416 tgDT-YTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqVY~L-------- 478 (1157)
T KOG4278|consen 416 TGDT-YTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYGL-------- 478 (1157)
T ss_pred cCCc-eecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHH--------
Confidence 6433 3333445577889999988875 79999999999999999998 6667654332 223333
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 255 KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+....+.+.+..+++.+.+|++.||+-+|.+||++.|+.+.++..
T Consensus 479 -LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 479 -LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred -HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 334444556667789999999999999999999999999888754
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=288.29 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=202.1
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe--CCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD--QTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 102 (369)
.+.+.||.|+||.||++.+ .+++.+++|.+... ........+.+|+.+++.++|+|++++++++.. ....+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 4567899999999999976 45889999988643 344556678899999999999999999998764 3467899999
Q ss_pred cCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhcc--CCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 103 MENGSLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEEC--NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 103 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+++++|.+++... ...+++..++.++.|++.||.|||..+ ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 9999999998543 467999999999999999999999211 18999999999999999999999999999987654
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
.... .....++..|++||.+... .++.++||||||+++|+|++|+.||...... .......
T Consensus 163 ~~~~--~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~ 223 (265)
T cd08217 163 DSSF--AKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQL----------------QLASKIK 223 (265)
T ss_pred Cccc--ccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHH----------------HHHHHHh
Confidence 3321 1234689999999988775 6889999999999999999999998754311 1111222
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+..+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 22334445567788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.27 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=199.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.+.||+|+||.||+|.++ +++.|++|++.... .......+.+|+.+++.++|+|++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 345678999999999999885 58999999876432 2223456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++|..++ .....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .
T Consensus 83 ~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 156 (286)
T cd07847 83 DHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--D 156 (286)
T ss_pred CccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc--c
Confidence 998888876 444579999999999999999999999 9999999999999999999999999999987654322 1
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc--------ccchhHHhhhchhhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF--------PKQVWDEYEKGELAAK 255 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 255 (369)
.....++..|+|||++.+...++.++||||||+++|+|++|+.||.........+. .......+........
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 12345788999999887655688999999999999999999999975543211000 0000000000000000
Q ss_pred h-hcCCC-----CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 V-LGCGI-----EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~-~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
. ..... .......+..+.+++.+||+.+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 00000 0001233577899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=284.44 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=202.7
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|.|+.|+++.. ++|+.+++|+++.. ......+++.+|+.+-+.|+||||+++.+.+.+....++|+|+|.
T Consensus 14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~ 93 (355)
T KOG0033|consen 14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 93 (355)
T ss_pred hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEeccc
Confidence 3457899999999999965 67999999998742 233457789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC---CCeeEeecCCceecCCCCCc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+.|..-|-.+ ..+++..+..++.||+++|.|.|. ++|||||+||.|+++-.. .-+||+|||++..++++.
T Consensus 94 G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~-- 167 (355)
T KOG0033|consen 94 GGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE-- 167 (355)
T ss_pred chHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCCcc--
Confidence 99997665332 568899999999999999999999 999999999999999533 348999999999887333
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......||++|||||++... +++..+|||+.||+||-||.|..||.+.+.. .+++.+.++... ..
T Consensus 168 -~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd------~~ 232 (355)
T KOG0033|consen 168 -AWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYD------YP 232 (355)
T ss_pred -ccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccC------CC
Confidence 23446799999999998886 8999999999999999999999999753321 224444433321 11
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
+...+...+...+|+.+||..||.+|.|+.|.+
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 234556778899999999999999999998876
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.31 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=195.2
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.+.||+|++|.||+|..+ +++.|++|.+...........+.+|+.+++.++|+||+++++++.+.+..++||||+.+
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT 87 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC
Confidence 45678999999999999885 58999999986533222234567899999999999999999999999999999999985
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+|.+++......+++..+..++.|+++||.|||+ ++++|+||||+||+++.++.++|+|||+++....... ...
T Consensus 88 -~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~ 161 (291)
T cd07844 88 -DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYS 161 (291)
T ss_pred -CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--ccc
Confidence 9999986666688999999999999999999999 9999999999999999999999999999875432111 112
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC---------ccccchhHHhhhc-hhhhh
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD---------WFPKQVWDEYEKG-ELAAK 255 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~~~-~~~~~ 255 (369)
...++..|+|||++.+...++.++||||||+++|+|++|+.||......... ......|...... .....
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence 2346888999998876556899999999999999999999999654311000 0000000000000 00000
Q ss_pred hhcC----CCCCC--CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLGC----GIEEN--DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~----~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.... ..... .......+.+++.+||+.+|++||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000 0011267789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.42 Aligned_cols=259 Identities=27% Similarity=0.380 Sum_probs=189.4
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccccc-HHHHHHHHHHHHHHhcc---CCCceeeEEeEEEeC-----Cc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRT---YHINLVRLYGFCYDQ-----TK 95 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~-----~~ 95 (369)
+.+.+.||+|+||+||+|.++ +++.||+|.+..... ......+.+|+.+++.+ +||||+++++++... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 345678999999999999875 589999998864321 11223455666666655 699999999988642 45
Q ss_pred eEEEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 96 AALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 96 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
.++||||+.+ +|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++..
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 7899999985 898888543 3458999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHH--------
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDE-------- 246 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 246 (369)
...... .....+|..|+|||++.+. .++.++|||||||++|+|++|+.||......... ......
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~ 230 (288)
T cd07863 158 YSCQMA---LTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGLPPEDD 230 (288)
T ss_pred ccCccc---CCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH---HHHHHHhCCCChhh
Confidence 543221 2234588999999988764 6899999999999999999999998654322100 000000
Q ss_pred hhhc-hhhhhhhc----CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 247 YEKG-ELAAKVLG----CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 247 ~~~~-~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+... ........ .......+.....+.+++.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00000000 0000111234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=297.43 Aligned_cols=262 Identities=21% Similarity=0.250 Sum_probs=197.9
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.++||+|+||.||+|.+. +|..+++|.+.... .......+.+|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 345678999999999999885 58999999886432 2223356778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
.+ +|.+++......+++..++.++.|+++||.|||+ ++++|+||||+||+++.++.++|+|||+++....... .
T Consensus 82 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (284)
T cd07839 82 DQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--C 155 (284)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--C
Confidence 75 8888886666789999999999999999999999 9999999999999999999999999999876543221 1
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC---------ccccchhHHhhhchhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD---------WFPKQVWDEYEKGELAA 254 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~ 254 (369)
.....++..|+|||.+.+...++.++|||||||++|+|++|+.|+......... ......|..... ...
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 233 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK--LPD 233 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh--ccc
Confidence 123457889999998877556799999999999999999999987543321100 000000000000 000
Q ss_pred hhhcCCC------CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGI------EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... ....+.....+.+++.+||+.||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 0111234578889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=292.33 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=201.6
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.+.||+|+||.||+|.+. +|..|++|++.... .......+.+|+.++++++|+|++++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 356688999999999999874 68999999987543 2344567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+++|.+++......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ..
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL 156 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence 999999996666789999999999999999999999 9999999999999999999999999999987654322 11
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhchhhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 255 (369)
.....++..|+|||.+.....++.++|||||||++|+|++|+.+|......... ......|.....-.....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 223468899999998876556789999999999999999997777543321000 000000000000000000
Q ss_pred hh-cCC----CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VL-GCG----IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~-~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ... ...........+.+++.+||+.+|.+||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 000 00011233578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=290.90 Aligned_cols=250 Identities=23% Similarity=0.370 Sum_probs=198.1
Q ss_pred ccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 29 STKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.||+|+||.||+|+.+ +.+.+++|.............+.+|+.++.+++|+||+++++++.+....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 468999999999999864 24679999887554444567899999999999999999999999998999999999
Q ss_pred cCCCCHHHHhccCC--------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 103 MENGSLDKYLFTDT--------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 103 ~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
+++++|.+++.... ..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++++|||++..
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccccc
Confidence 99999999995433 168999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhh
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELA 253 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (369)
....... ......++..|++||.+... ..+.++||||||+++|+|++ |..||....... .......+...
T Consensus 167 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~~~~ 237 (275)
T cd05046 167 VYNSEYY-KLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGKLE 237 (275)
T ss_pred cCccccc-ccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcCCcC
Confidence 4322111 12223467789999988764 67899999999999999998 677775432211 11111111110
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
.......+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 238 --------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 --------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1112234578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=287.41 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=193.4
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccc----cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEEE
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL----NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALVY 100 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 100 (369)
..+.||+|+||.||++.+. ++..|++|.+.... .......+.+|+.+++.++|+||+++++++.+. ...+++|
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 4578999999999999874 58999999875321 223445788999999999999999999988753 5678999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++++|.+++. ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 86 e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 86 EYMPGGSVKDQLK-AYGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred eCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999999994 34568999999999999999999999 9999999999999999999999999999876542211
Q ss_pred c-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 181 H-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 181 ~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
. .......++..|+|||++... .++.++|||||||++|+|++|+.||...... ... .......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----------~~~-----~~~~~~~ 225 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----------AAI-----FKIATQP 225 (266)
T ss_pred cCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchH----------HHH-----HHHhcCC
Confidence 1 111234588899999988764 7899999999999999999999998643221 100 0111111
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+..+......+..++ +||..+|++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 12333445566777787 688899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=293.94 Aligned_cols=264 Identities=25% Similarity=0.326 Sum_probs=199.4
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.++||+|+||.||+|.++ +++.||+|.+..... ......+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 345689999999999999885 489999998764332 234557889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++|..+. .....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 83 ~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 156 (286)
T cd07846 83 DHTVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--V 156 (286)
T ss_pred CccHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--c
Confidence 999998877 344568999999999999999999999 9999999999999999999999999999886543321 1
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhhchhhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ 255 (369)
.....++..|+|||++.+...++.++||||||+++|+|++|+.||........ ..+.......+........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 22345788999999987655678999999999999999999988864432100 0000000000000000000
Q ss_pred hhcCCC------CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLGCGI------EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...... ....+..+..+.+++.+||+.+|.+||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 0011234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=294.25 Aligned_cols=261 Identities=25% Similarity=0.297 Sum_probs=198.4
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccccc----HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN----KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
.+.+.||+|+||.||+|.+. +++.|++|.+..... ......+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 45678999999999999875 589999999875432 2334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+ +++|.+++......+++..++.++.|+++||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 157 (298)
T cd07841 83 FM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR- 157 (298)
T ss_pred cc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence 99 889999995544479999999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhchhh
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGELA 253 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 253 (369)
......++..|+|||.+.+...++.++|||||||++|+|++|..+|......... ......|.... ...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 234 (298)
T cd07841 158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT--SLP 234 (298)
T ss_pred -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc--ccc
Confidence 1222346788999998866557899999999999999999997776543321000 00000000000 000
Q ss_pred hhhhcCC-----CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 254 AKVLGCG-----IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 254 ~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... ........+..+.+++.+||+.+|.+||++.+|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000 01112334678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=294.20 Aligned_cols=246 Identities=21% Similarity=0.301 Sum_probs=197.9
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||.|+||.||++.+ .+++.|++|.+..... .....+.+|+.+++.++|+|++++++++.+.+..++||||++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 34557899999999999987 4689999998864333 235678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|..++. ...+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......... .
T Consensus 100 ~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~ 172 (296)
T cd06655 100 GGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--R 172 (296)
T ss_pred CCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--C
Confidence 999999884 3468999999999999999999999 99999999999999999999999999998765432221 2
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....++..|+|||.+... .++.++|||||||++|+|++|+.||........ ..... .........
T Consensus 173 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-------~~~~~-------~~~~~~~~~ 237 (296)
T cd06655 173 STMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIA-------TNGTPELQN 237 (296)
T ss_pred CCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHH-------hcCCcccCC
Confidence 234588899999988764 689999999999999999999999965432110 00000 000001112
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
+...+..+.+++.+||..||.+||++.+|+
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 334566788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=286.32 Aligned_cols=246 Identities=20% Similarity=0.259 Sum_probs=199.7
Q ss_pred ccccccCCceEEEEEEeCC-CcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 29 STKLGAGGFGVVYKGQFPN-GVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.||.|.-|+||+++..+ +..+|+|++.+.. ......+.+.|-++|+.++||.++.+|..+......|++||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 3689999999999998855 6999999997542 234456788899999999999999999999999999999999999
Q ss_pred CCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC-------
Q 017591 106 GSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP------- 177 (369)
Q Consensus 106 gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------- 177 (369)
|+|..+.+.+ +..+++..+..++..++.||+|||- .|||+|||||+||||.++|++.|+||.++..+..
T Consensus 162 GdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 162 GDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred ccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 9999998654 5689999999999999999999999 9999999999999999999999999998753311
Q ss_pred --------------------------CCCc---------------------cccccCCCCCCccccccccccCCCCcchh
Q 017591 178 --------------------------ENTH---------------------DSTSGYRGTPGYSAPEFLLRNYPITQKCD 210 (369)
Q Consensus 178 --------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~s~~sD 210 (369)
.... .....+.||-.|+|||++.+. ..+.+.|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GHgsAVD 317 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GHGSAVD 317 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-CCCchhh
Confidence 0000 011234689999999999876 6789999
Q ss_pred hHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc-CCCCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 017591 211 VYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG-CGIEENDREEAERMSMVALWCVQDCPEARPP 289 (369)
Q Consensus 211 vwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 289 (369)
.|+|||++||||.|..||.+.+...- +...+.. ..+++.+ ..+..+.+||.++|.+||.+|..
T Consensus 318 WWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 318 WWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhc
Confidence 99999999999999999987665311 1111111 1122222 66788999999999999999998
Q ss_pred ----hHHHH
Q 017591 290 ----MSAVV 294 (369)
Q Consensus 290 ----~~~v~ 294 (369)
+.||-
T Consensus 382 ~~rGA~eIK 390 (459)
T KOG0610|consen 382 SKRGAAEIK 390 (459)
T ss_pred cccchHHhh
Confidence 66654
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=289.88 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=197.0
Q ss_pred cccccccCCceEEEEEEeC----CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC------ce
Q 017591 28 YSTKLGAGGFGVVYKGQFP----NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT------KA 96 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 96 (369)
+.+.||+|+||.||+|.+. ++..||+|++.... ......++.+|+.+++.++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 5578999999999999753 36899999887543 3345667899999999999999999999886542 24
Q ss_pred EEEEeccCCCCHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCC
Q 017591 97 ALVYEFMENGSLDKYLFTD-----TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
+++++|+.+|+|..++... ...+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||.
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccc
Confidence 7899999999999887422 2357899999999999999999999 9999999999999999999999999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhc
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKG 250 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (369)
++...............++..|++||.+... .++.++|||||||++|+|++ |+.||....... .......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~ 231 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-------IYNYLIKG 231 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-------HHHHHHcC
Confidence 8866433322222233456789999988765 68899999999999999999 777775432211 11111111
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 251 ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.....+...+..+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 232 ---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 ---------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11112233457899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=303.94 Aligned_cols=259 Identities=20% Similarity=0.226 Sum_probs=192.3
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC------CceE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ------TKAA 97 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 97 (369)
+.+.+.||+|+||.||++.+. .++.||+|++... ........+.+|+.+++.++||||+++++++... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 344578999999999999874 5889999998643 2334456788999999999999999999987543 3579
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||+++ +|.+++. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 106 lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 106 IVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 99999976 7777773 348899999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEK 249 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~ 249 (369)
.. ......+|..|+|||++.+. .++.++|||||||++|+|++|+.||........ .......+..+..
T Consensus 179 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 179 SF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CC---cccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 22 12335689999999988764 789999999999999999999999975442110 0000000000000
Q ss_pred ch---h----------hhhhhc----CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 250 GE---L----------AAKVLG----CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 250 ~~---~----------~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. . ...... .............+.+|+.+||+.||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 0 000000 0000111123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=289.88 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=203.5
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.+.||.|+||.||++.++ +++.+++|.+..........++.+|+.+++.+.||||+++++.+...+..++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 34578999999999999885 58999999987665556677899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|.+++......+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||.+........ .
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~ 157 (265)
T cd06605 84 GSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----K 157 (265)
T ss_pred CcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----h
Confidence 99999996555789999999999999999999997 36999999999999999999999999999865432211 1
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...++..|+|||.+.+. .++.++||||||+++|+|++|+.||........ ..... .........+..+
T Consensus 158 ~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~------~~~~~~~~~~~~~ 225 (265)
T cd06605 158 TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-----GIFEL------LQYIVNEPPPRLP 225 (265)
T ss_pred cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccc-----cHHHH------HHHHhcCCCCCCC
Confidence 15688899999988765 789999999999999999999999975432111 00111 1111111112222
Q ss_pred HH-HHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 RE-EAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~-~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. .+..+.+++.+||..||.+||++.+++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 22 6778999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=304.91 Aligned_cols=207 Identities=28% Similarity=0.397 Sum_probs=176.2
Q ss_pred ccCHHHHHHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-C-----CceeeEE
Q 017591 15 RFTLEQLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-H-----INLVRLY 87 (369)
Q Consensus 15 ~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~ 87 (369)
.+-.+|....+|...+.||+|+||.|.+|.+ ++++.||||+++. .+....+-..|+.+|..++ | -|+|+++
T Consensus 177 ~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN--~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 177 QLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN--KKRFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred eEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc--ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 3445555566777789999999999999977 5699999999985 3456678888999999886 3 3799999
Q ss_pred eEEEeCCceEEEEeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC--Ce
Q 017591 88 GFCYDQTKAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF--SA 164 (369)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~--~~ 164 (369)
++|...++.|||+|.+.. +|.+++..+. ..++...+..++.||+.||.+||+ .+|||+||||+||||...+ .+
T Consensus 255 d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred eccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCce
Confidence 999999999999999976 9999995443 579999999999999999999999 9999999999999997544 69
Q ss_pred eEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 017591 165 KVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSS 233 (369)
Q Consensus 165 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~ 233 (369)
||+|||+|........ ....+..|+|||++.+. +|..+.||||||||+.||++|.+-|.+.+.
T Consensus 331 KVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred eEEecccccccCCcce-----eeeeccccccchhhccC-CCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 9999999987543222 34578899999999985 899999999999999999999777766554
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=289.06 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=197.3
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccc---------cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceE
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL---------NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (369)
..+.||+|+||.||+|... +++.+|+|.+.... .......+.+|+.+++.++|+|++++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 3468999999999999774 58999999875311 1112346788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999544 678999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccCCCCCCccccccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
...........++..|+|||.+.... .++.++|+||||+++|++++|..||....... ..++..... .
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-----~ 229 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AMFKLGNKR-----S 229 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HHHHhhccc-----c
Confidence 22222223355889999999887643 47899999999999999999999985332210 000100000 0
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
............+..+.+++.+||+.+|.+||++.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000011122345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=291.06 Aligned_cols=245 Identities=26% Similarity=0.360 Sum_probs=196.7
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.++||+|+||.||+|... +++.|++|.+... ........+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 445578999999999999874 5899999987532 2334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+.+ +|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 97 ~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 97 CLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred hCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 975 8878775556679999999999999999999999 99999999999999999999999999998764322
Q ss_pred ccccCCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 183 STSGYRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
....++..|+|||++.. ...++.++||||||+++|+|++|+.||........ .... .....
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-------~~~~--------~~~~~ 231 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHI--------AQNDS 231 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-------HHHH--------hcCCC
Confidence 22457889999998742 24688999999999999999999999864332110 0000 00000
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.......++..+.+++.+||+.+|.+||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 232 PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11112345678999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=285.93 Aligned_cols=247 Identities=21% Similarity=0.362 Sum_probs=199.9
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.+.||+|+||.||++... +++.+++|.+... ........+.+|+.+++.++|+|++++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 345678999999999999874 5889999987643 23445678999999999999999999999999899999999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-CeeEeecCCceecCCCCCc
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 181 (369)
++++|.+++... ...+++..+..++.+++.+|.|||+ ++++|+||+|+||+++.++ .++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 999999999654 3468999999999999999999999 9999999999999998654 579999999987653322
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
.....++..|+|||.+... ..+.++||||||+++|+|++|+.||........ . ........
T Consensus 158 --~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-------~---------~~~~~~~~ 218 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPAL-------V---------LKIMSGTF 218 (256)
T ss_pred --ccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHH-------H---------HHHHhcCC
Confidence 1224588899999988764 688999999999999999999999865432110 0 11111111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 2223345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=303.53 Aligned_cols=257 Identities=21% Similarity=0.235 Sum_probs=191.8
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC------CceEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ------TKAAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l 98 (369)
...+.||+|+||.||++.+. .++.||+|.+... ........+.+|+.+++.++|+||+++++++... ...++
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence 34578999999999999874 5899999988643 2334456788999999999999999999988643 24699
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+++ +|.+.+. ..+++..+..++.|+++||.|||+ +|++||||||+|||++.++.+||+|||+++.....
T Consensus 100 v~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 100 VMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred Ehhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 9999976 6777663 358899999999999999999999 99999999999999999999999999999865332
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhc
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKG 250 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~ 250 (369)
. ......||..|+|||++.+. .++.++|||||||++|+|++|+.||......... ......+.....
T Consensus 173 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 247 (355)
T cd07874 173 F---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP- 247 (355)
T ss_pred c---ccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH-
Confidence 2 12335689999999988764 7899999999999999999999999754321100 000000000000
Q ss_pred hhhhhhh----------c-----CCC---CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 251 ELAAKVL----------G-----CGI---EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 251 ~~~~~~~----------~-----~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... . ... ..........+.+|+.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0000000 0 000 0111223567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=299.83 Aligned_cols=257 Identities=21% Similarity=0.250 Sum_probs=190.7
Q ss_pred cccccccCCceEEEEEEe-CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC------CceEEE
Q 017591 28 YSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ------TKAALV 99 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv 99 (369)
..+.||+|+||+||+|.+ .+++.||+|.+.... .......+.+|+.+++.++|+||+++++++... ...+++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence 447899999999999987 458899999987432 223345677899999999999999999987543 346899
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
++++ +++|.+++. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 171 (343)
T cd07878 99 TNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE- 171 (343)
T ss_pred eecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence 9988 679988873 4569999999999999999999999 99999999999999999999999999999865432
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhhch
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKGE 251 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~ 251 (369)
.....||..|+|||++.+...++.++|||||||++|+|++|+.||........ ...............
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 22346899999999987755789999999999999999999999965432100 000000000000000
Q ss_pred hhhhhhc-CCCCC-----CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVLG-CGIEE-----NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~~-~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... ...+. ........+.+|+.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00000 00112345789999999999999999999884
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=288.81 Aligned_cols=261 Identities=23% Similarity=0.285 Sum_probs=195.5
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeC--CceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQ--TKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~ 102 (369)
.+.++||+|+||.||+|... ++..+|+|.++............+|+..+.++. |+|++++++++.+. +..++||||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45678999999999999874 589999998875433333344567888888885 99999999999987 889999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++ +|.+++......+++..++.++.|++.||.|||+ .+++|+||+|+||+++. +.++|+|||++.........
T Consensus 82 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 82 MDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred CCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 975 8888886555689999999999999999999999 99999999999999999 99999999999865433221
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc-C-------ccccchhHHhhhchhhh
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL-D-------WFPKQVWDEYEKGELAA 254 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~ 254 (369)
....++..|+|||++..+..++.++|||||||++|||++|..||...+.... . .....+...........
T Consensus 156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2245788999999876655678999999999999999999999975443110 0 00000000000000000
Q ss_pred hhhcC----CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGC----GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..... .........+..+.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000 000111245788999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=284.85 Aligned_cols=247 Identities=22% Similarity=0.271 Sum_probs=194.9
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccc----ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEEE
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC----LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALVY 100 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 100 (369)
..+.||+|+||.||.+.+. ++..|++|.+... ........+.+|+.+++.+.|+||+++++++.+. ...+++|
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 3578999999999999874 5899999987532 1223456788999999999999999999988764 4678999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++++|.+++. ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 86 e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 86 EHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EecCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 9999999999984 33568999999999999999999999 9999999999999999999999999999876532211
Q ss_pred c-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 181 H-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 181 ~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
. .......++..|+|||.+... .++.++|||||||++|+|++|+.||...... ... .......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------~~~-----~~~~~~~ 225 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----------AAI-----FKIATQP 225 (265)
T ss_pred cccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchH----------HHH-----HHHhcCC
Confidence 1 112234588899999988764 6899999999999999999999998643211 000 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+..+......+.+++.+|+. +|.+||++++|++
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 2233455667788999999995 8999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=293.45 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=200.0
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.+.||+|+||.||+|.++ +++.|++|.+.... .......+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456688999999999999885 58899999887532 3334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+++.+..+. .+...+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++......... .
T Consensus 83 ~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (288)
T cd07833 83 ERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-P 157 (288)
T ss_pred CCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-c
Confidence 987676655 445669999999999999999999999 99999999999999999999999999998876543321 1
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------cccchhHHhhh-chhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------FPKQVWDEYEK-GELAA 254 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~ 254 (369)
.....++..|+|||++.....++.++||||||+++|+|++|+.||.........+ ++......+.. .....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 2234578899999998775478999999999999999999999987543211000 00000000000 00000
Q ss_pred -hhhcCCC-----CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 -KVLGCGI-----EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 -~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... ...+...+..+.+++.+||+.+|++||++++|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 0111223678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=307.29 Aligned_cols=246 Identities=26% Similarity=0.424 Sum_probs=208.3
Q ss_pred cccccCCceEEEEEEeCC--C--cEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFPN--G--VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
++||+|.||+|++|.|+. | -.||||.+....-.....+|.+|+.+|.+|+|+|++++||+..+ ....+|||.++.
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl 194 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL 194 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence 579999999999998843 4 47899999876555578899999999999999999999999987 668899999999
Q ss_pred CCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc-
Q 017591 106 GSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS- 183 (369)
Q Consensus 106 gsL~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~- 183 (369)
|||.+.|+. ....|-...+..|+.|||.|+.||.+ +++|||||..+|+||-....|||+|||+.+.+..+.....
T Consensus 195 GSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 195 GSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred chHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 999999976 55678999999999999999999999 9999999999999999998999999999998875544333
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....-...|+|||.+... .++.+||||+|||+||||++ |..||.+... ..++..++...+-
T Consensus 272 ~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~qIL~~iD~~erL 334 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQILKNIDAGERL 334 (1039)
T ss_pred cCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HHHHHhccccccC
Confidence 3334456789999999886 89999999999999999998 5567654332 2334444444455
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
..+..+++++.+++..||..+|.+||++..|.+.
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 6677789999999999999999999999999733
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=291.44 Aligned_cols=241 Identities=25% Similarity=0.312 Sum_probs=197.0
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||.||++.+. +++.+|+|++.... .......+.+|+.+++++.||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 45688999999999999875 58999999886432 2234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++|.+++.. ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----- 154 (290)
T cd05580 84 PGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----- 154 (290)
T ss_pred CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----
Confidence 99999999944 4679999999999999999999999 99999999999999999999999999998875433
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....+++.|+|||.+... ..+.++||||||+++|+|++|+.||...... ........+ ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~----------~~~ 216 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEG----------KVR 216 (290)
T ss_pred CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcC----------Ccc
Confidence 2234588999999988764 6889999999999999999999998644311 011111111 112
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC-----ChHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARP-----PMSAVV 294 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~ 294 (369)
.+...+..+.+++.+||..||.+|+ ++.+++
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 2334467889999999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=291.56 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=200.5
Q ss_pred cCHHHHHHhhhccc--cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEE
Q 017591 16 FTLEQLCSFTNNYS--TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCY 91 (369)
Q Consensus 16 ~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 91 (369)
+++..+..++++|. +.||+|+||.||++.+. +++.+++|++.... .....+.+|+.++..+ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 45566666766664 78999999999999874 58899999876422 2235678899999998 6999999999885
Q ss_pred -----eCCceEEEEeccCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC
Q 017591 92 -----DQTKAALVYEFMENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS 163 (369)
Q Consensus 92 -----~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 163 (369)
..+..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCC
Confidence 34568999999999999998742 34578999999999999999999999 99999999999999999999
Q ss_pred eeEeecCCceecCCCCCccccccCCCCCCcccccccccc----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc
Q 017591 164 AKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN----YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF 239 (369)
Q Consensus 164 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 239 (369)
++|+|||++........ ......|+..|+|||++... ..++.++|||||||++|+|++|+.||........
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--- 237 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--- 237 (286)
T ss_pred EEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---
Confidence 99999999887643221 12234689999999987532 3578899999999999999999999875432110
Q ss_pred ccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 240 PKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
........ . .....+..+...+.+++.+||+.||++||++.+|++.
T Consensus 238 ----~~~~~~~~------~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 ----LFKIPRNP------P-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----HhhccccC------C-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000000 0 0001122245679999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=291.06 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=194.5
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.+.||+|+||.||+|... +++.|++|++...........+.+|+.+++.++|+||+++++++.+....++||||+.
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~- 86 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH- 86 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence 34578999999999999874 5899999998754333334467789999999999999999999999999999999996
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|.+++......+.+..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++....... ...
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~ 161 (291)
T cd07870 87 TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYS 161 (291)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CCC
Confidence 58877775555678899999999999999999999 9999999999999999999999999999875432211 112
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc---------cccchhHHhhhc-hhhhh
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW---------FPKQVWDEYEKG-ELAAK 255 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~~-~~~~~ 255 (369)
...++..|+|||.+.+...++.++|||||||++|+|++|+.||.......... .....+...... .....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 33578899999988765567899999999999999999999997544311000 000000000000 00000
Q ss_pred hhcCCCCC------CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLGCGIEE------NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......+. ........+.+++.+|++.||.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 00012467889999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=288.00 Aligned_cols=243 Identities=23% Similarity=0.250 Sum_probs=189.0
Q ss_pred ccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHH---hccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTI---GRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.||+|+||.||++.+. +++.+|+|.+..... ......+.+|..++ ....|+|++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 589999998864321 12222334444333 33479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|..++. ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 999999884 44579999999999999999999999 999999999999999999999999999987553222 1
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....|+..|+|||.+..+..++.++|||||||++|+|++|..||........ ...... ........
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------~~~~~~------~~~~~~~~ 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------HEIDRM------TLTVNVEL 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--------HHHHHH------hhcCCcCC
Confidence 2346899999999886555688999999999999999999999975433211 111100 00111223
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
+...+..+.+++.+||+.||.+|| +++++++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 445677899999999999999999 5888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=290.81 Aligned_cols=259 Identities=26% Similarity=0.362 Sum_probs=201.7
Q ss_pred cCHHHHHHhhhccc--cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEE
Q 017591 16 FTLEQLCSFTNNYS--TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCY 91 (369)
Q Consensus 16 ~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 91 (369)
++..++.+++++|. +.||+|+||.||++..+ +++.+++|++.... .....+.+|+.++.++ +|+|++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 55677777787775 78999999999999874 58899999886432 2245677899999988 7999999999987
Q ss_pred eC-----CceEEEEeccCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC
Q 017591 92 DQ-----TKAALVYEFMENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS 163 (369)
Q Consensus 92 ~~-----~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 163 (369)
.. +..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCC
Confidence 54 358999999999999998842 34678999999999999999999999 99999999999999999999
Q ss_pred eeEeecCCceecCCCCCccccccCCCCCCccccccccccC----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc
Q 017591 164 AKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY----PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF 239 (369)
Q Consensus 164 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 239 (369)
++|+|||++......... .....++..|+|||.+..+. .++.++|||||||++|+|++|+.||........
T Consensus 167 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--- 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--- 241 (291)
T ss_pred EEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---
Confidence 999999998765432211 12345888999999876532 368999999999999999999999865432100
Q ss_pred ccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 240 PKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......... .....+......+.+++.+||+.+|++||++.++++
T Consensus 242 ----~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 ----LFKIPRNPP-------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ----HHHHhcCCC-------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000000000 001112334567999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=292.96 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=200.2
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||.||++... .++.|++|.+..... ......+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 35578999999999999875 478999998875422 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC---
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT--- 180 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 180 (369)
++++|.+++.. ...+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||+++.......
T Consensus 84 ~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 84 EGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999943 4578999999999999999999999 9999999999999999999999999999864211100
Q ss_pred ----------ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhc
Q 017591 181 ----------HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKG 250 (369)
Q Consensus 181 ----------~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (369)
........++..|+|||++... .++.++|+|||||++|+|++|..||...... .+......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------~~~~~~~~~ 231 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFGQVISD 231 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhc
Confidence 0011124578899999988764 6899999999999999999999998643321 111111111
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 251 ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
. ...+......+..+.+++.+||+.||++||+..++.+.|+..
T Consensus 232 ~-------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 232 D-------IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred c-------cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 1 011112224567789999999999999999987777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=285.12 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=200.1
Q ss_pred cccccccCCceEEEEEEe-CCCcEEEEEEccccc-----cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 28 YSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL-----NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
..+.||+|+||.||++.+ .+++.+++|++.... .......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 447899999999999987 568999999886422 12245678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-CeeEeecCCceecCCCCC
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENT 180 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 180 (369)
|+++++|.+++. ...++++..++.++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||++........
T Consensus 84 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 84 WMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred ccCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 999999999984 44578999999999999999999999 9999999999999998776 599999999877643321
Q ss_pred c--cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 181 H--DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 181 ~--~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
. .......++..|+|||.+... .++.++||||||+++|+|++|..||........ ... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-------~~~-----~~~~~~~ 226 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-------LAL-----IFKIASA 226 (268)
T ss_pred cCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-------HHH-----HHHHhcc
Confidence 1 112234588899999988664 688999999999999999999999864322110 000 0011111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..+......+.+++.+||+.+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1223445567788999999999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=283.83 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=200.4
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+...+.||+|+||.||++... +++.|++|.+..... ......+.+|+.+++.++|+||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 345678999999999999874 689999999875433 346678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++|.+++. ....+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...........
T Consensus 82 ~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 82 SGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCcHHHHHh-hcCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999994 34568999999999999999999999 9999999999999999999999999999887654332211
Q ss_pred --cccCCCCCCccccccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 184 --TSGYRGTPGYSAPEFLLRNY--PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 184 --~~~~~gt~~y~aPE~~~~~~--~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
.....++..|++||++.... ..+.++||||||+++|++++|+.||....... ... ......
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---------~~~------~~~~~~ 222 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---------QIM------FHVGAG 222 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---------HHH------HHHhcC
Confidence 11345788999999887642 37899999999999999999999996443210 000 000001
Q ss_pred CCCCCC--HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 GIEEND--REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+..+ ......+.+++.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111 223677889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=291.24 Aligned_cols=263 Identities=21% Similarity=0.241 Sum_probs=198.0
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 102 (369)
.+.+.||.|+||.||+|.++ +++.+++|.++.... ......+.+|+.++.++.||||+++++++... ...++||||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~ 87 (293)
T cd07843 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY 87 (293)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehh
Confidence 34578999999999999885 488999998874322 22334577899999999999999999999877 889999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+.+ +|.+++......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 161 (293)
T cd07843 88 VEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-- 161 (293)
T ss_pred cCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--
Confidence 985 9999986655679999999999999999999999 9999999999999999999999999999987654321
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhchhh-
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGELA- 253 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~- 253 (369)
......++..|+|||.+.+...++.++|+||||+++|+|++|..||......... ......|..+..-...
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 1123457889999998876556789999999999999999999998754321100 0000001111000000
Q ss_pred -----hhhhcCCCCCCCHH-HHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 254 -----AKVLGCGIEENDRE-EAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 254 -----~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...........+.. ....+.+++.+||+.+|++||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000111111 3677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=286.19 Aligned_cols=255 Identities=27% Similarity=0.368 Sum_probs=198.4
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEEEeccC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALVYEFME 104 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~ 104 (369)
+.++||.|++|.||++.+. +++.+|+|.+..........++.+|+++++.++||||+++++++.+. ...++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 4578999999999999884 58999999987655545667899999999999999999999988654 46899999999
Q ss_pred CCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 105 NGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 105 ~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
+++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 9999988742 34568999999999999999999999 9999999999999999999999999999875432211
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
....++..|++||.+... .++.++|||||||++|+|++|+.||......... +.............. .. ..
T Consensus 161 ---~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~--~~-~~ 231 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG--PIELLSYIVNMPNPE--LK-DE 231 (287)
T ss_pred ---ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC--hHHHHHHHhcCCchh--hc-cC
Confidence 234578899999988764 7899999999999999999999999755331100 000111111100000 00 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.......+..+.+++.+||+.+|.+|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111235678999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=288.64 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=199.8
Q ss_pred cCHHHHHHhhhcc--ccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEE
Q 017591 16 FTLEQLCSFTNNY--STKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCY 91 (369)
Q Consensus 16 ~~~~el~~~t~~f--~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 91 (369)
.++.++......| .+.||.|+||.||+|.+ .+++.+++|++... .....++..|+.++.++ +|+|++++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 4566665666655 47899999999999987 45889999987643 23345788899999988 6999999999985
Q ss_pred e------CCceEEEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCe
Q 017591 92 D------QTKAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA 164 (369)
Q Consensus 92 ~------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 164 (369)
. ....+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCE
Confidence 3 45689999999999999998543 3468899999999999999999999 999999999999999999999
Q ss_pred eEeecCCceecCCCCCccccccCCCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccc
Q 017591 165 KVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240 (369)
Q Consensus 165 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~ 240 (369)
+|+|||++........ ......|+..|+|||.+.. ...++.++|||||||++|+|++|+.||.........
T Consensus 161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--- 235 (282)
T cd06636 161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--- 235 (282)
T ss_pred EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh---
Confidence 9999999875432211 1223568899999998753 235788999999999999999999998644321100
Q ss_pred cchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. .............++..+.+++.+||+.||.+||++.++++
T Consensus 236 ---~~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 ---FL---------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---hh---------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 00000111112345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=287.53 Aligned_cols=247 Identities=21% Similarity=0.355 Sum_probs=192.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHH-HhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGT-IGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|+||.||++.+. +|+.||+|.+..........++..|+.. ++.++|||++++++++...+..+++|||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 34578999999999999885 5999999998765443444566667665 566789999999999999999999999997
Q ss_pred CCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCC-CeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 105 NGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQ-RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 105 ~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
++|.+++.. ....+++..++.++.|++.||.|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 588887743 34579999999999999999999998 7 99999999999999999999999999987653221
Q ss_pred ccccccCCCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRN---YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~---~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
......++..|+|||.+... ..++.++|+|||||++|+|++|+.||...... ++.+. . ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~-----~-~~ 221 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---------FQQLK-----Q-VV 221 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---------HHHHH-----H-HH
Confidence 11224588899999987642 24688999999999999999999998642211 11110 0 01
Q ss_pred cCCCCCC-CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEEN-DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... ...++..+.+++.+||..+|.+||++.+|++
T Consensus 222 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 1235678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=296.06 Aligned_cols=247 Identities=21% Similarity=0.277 Sum_probs=200.1
Q ss_pred cccccccCCceEEEEEEeCCCcEEEEEEcc-ccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccCC
Q 017591 28 YSTKLGAGGFGVVYKGQFPNGVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.++||+||-+.||++...+.+.+|+|.+. ...+.+....|.+|+..|.+|+ |.+||++++|-..++..|+||||=+.
T Consensus 365 ilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~ 444 (677)
T KOG0596|consen 365 ILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI 444 (677)
T ss_pred HHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc
Confidence 347899999999999998777777776554 4456677888999999999996 99999999999999999999998755
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+|..+|.+....+..-.+..|..|++.++.++|+ +||||.||||.|+|+-+. .+||+|||+|..+..+.+.....
T Consensus 445 -DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~DTTsI~kd 519 (677)
T KOG0596|consen 445 -DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVKG-RLKLIDFGIANAIQPDTTSIVKD 519 (677)
T ss_pred -cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEee-eEEeeeechhcccCccccceeec
Confidence 9999997666555544889999999999999999 999999999999998765 89999999999988777776667
Q ss_pred cCCCCCCcccccccccc----------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 186 GYRGTPGYSAPEFLLRN----------YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~----------~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
..+||..||+||.+... -..+.++||||||||||+|+-|+.||...... |..+ ...
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---------~aKl-----~aI 585 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---------IAKL-----HAI 585 (677)
T ss_pred cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---------HHHH-----Hhh
Confidence 78899999999987642 13678999999999999999999999643221 1111 111
Q ss_pred hhc---CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLG---CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... -.++..+.... +.+++..||..||.+||+..++++
T Consensus 586 ~~P~~~Iefp~~~~~~~--li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDE--LIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cCCCccccccCCCCchH--HHHHHHHHHhcCcccCCCcHHHhc
Confidence 111 11233333333 999999999999999999999874
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=308.57 Aligned_cols=258 Identities=17% Similarity=0.218 Sum_probs=183.3
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC------CCceeeEEeEEEeC-CceE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY------HINLVRLYGFCYDQ-TKAA 97 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~-~~~~ 97 (369)
+.+.++||+|+||+||+|.+. .++.||||+++... .....+..|+.++..+. |.+++.+++++... .+.+
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 344578999999999999874 58899999986421 22334455666665554 45689999988754 5788
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC---------------
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF--------------- 162 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~--------------- 162 (369)
+||+++ +++|.+++.. ...+++..+..|+.|++.||.|||+. .||+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 999988 6689888843 46799999999999999999999971 4999999999999998765
Q ss_pred -CeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc-----
Q 017591 163 -SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL----- 236 (369)
Q Consensus 163 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~----- 236 (369)
.+||+|||.+..... ......||..|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 285 ~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 285 CRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred ceEEECCCCccccCcc-----ccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 499999998754221 12345799999999998764 789999999999999999999999976443210
Q ss_pred ---CccccchhHHhhhc---hhhhhhh---cC-----------CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 237 ---DWFPKQVWDEYEKG---ELAAKVL---GC-----------GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 237 ---~~~~~~~~~~~~~~---~~~~~~~---~~-----------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..++..+....... .+..... .. ............+.+|+.+||+.||.+|||+.|+++
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 01111111000000 0000000 00 000001112456789999999999999999999985
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=291.88 Aligned_cols=250 Identities=21% Similarity=0.236 Sum_probs=198.2
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccH--HHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNK--RVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||+||++... +++.+|+|.+...... .....+.+|+.++..++|+||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 44578999999999999875 4899999998754322 35567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
.+++|.+++... +..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999998543 3579999999999999999999999 999999999999999999999999999987543221100
Q ss_pred ---------------------------ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCc
Q 017591 183 ---------------------------STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDT 235 (369)
Q Consensus 183 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~ 235 (369)
......|+..|+|||++.+. .++.++||||||+++|+|++|..||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 11123578899999988764 68999999999999999999999997543221
Q ss_pred cCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCC----hHHHHH
Q 017591 236 LDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPP----MSAVVK 295 (369)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~~v~~ 295 (369)
. +.... ............+..+.+++.+||+.||++||+ +.+++.
T Consensus 240 ~-------~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 T-------FSNIL--------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H-------HHHHh--------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 0 11100 000001112226788999999999999999999 666554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=282.41 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=204.8
Q ss_pred ccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.+.||+|++|.||++.+.+ ++.|++|.+...........+.+|+..+..++|+|++++++++...+..++||||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 345889999999999998864 9999999987654445567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|.+++.. ...+++..++.++.|+++||.|||+. .+++|+||+|+||+++.++.++|+|||.+.......... .
T Consensus 84 ~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--~ 158 (264)
T cd06623 84 GSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--N 158 (264)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--c
Confidence 999999944 36799999999999999999999973 799999999999999999999999999998764332221 2
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...++..|+|||.+... .++.++||||||+++|+|++|+.||....... ..... ...........+
T Consensus 159 ~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~------~~~~~~~~~~~~ 224 (264)
T cd06623 159 TFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPS-------FFELM------QAICDGPPPSLP 224 (264)
T ss_pred ceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccC-------HHHHH------HHHhcCCCCCCC
Confidence 34578899999988765 78999999999999999999999987554210 00111 111111222333
Q ss_pred HH-HHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 RE-EAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~-~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ++..+.+++.+||..+|++||++.++++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 33 6788999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=286.83 Aligned_cols=263 Identities=25% Similarity=0.326 Sum_probs=198.9
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||.|++|.||+|++. ++..||+|.+...........+.+|+.++++++|+|++++++++.+.+..++||||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 45689999999999999885 58999999887544333445677899999999999999999999999999999999986
Q ss_pred CCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 106 GSLDKYLFTDT--EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 106 gsL~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .
T Consensus 83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 156 (284)
T cd07836 83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--T 156 (284)
T ss_pred -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--c
Confidence 8988885443 568999999999999999999999 9999999999999999999999999999875533221 1
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------cccchhHHhhhchhhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------FPKQVWDEYEKGELAAK 255 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 255 (369)
.....++..|++||.+.+...++.++|||||||++|+|++|+.||.......... .....|..+........
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 1224578899999988765567899999999999999999999997554321100 00000111110000000
Q ss_pred hhcC----CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLGC----GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.... ......+..+..+.+++.+||+.||.+||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 000011234577899999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=279.56 Aligned_cols=246 Identities=28% Similarity=0.436 Sum_probs=201.3
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
..+.||+|++|.||++.+. ++..+++|++..... .....+.+|+.+++.+.|+|++++++++......++++||++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 4578999999999999885 688999999876433 45678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|.+++......+++..+..++.|++.+|.+||+ ++++||||+|+||+++.++.++|+|||.+........ ...
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~ 156 (253)
T cd05122 83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNT 156 (253)
T ss_pred cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccc
Confidence 9999996655689999999999999999999999 9999999999999999999999999999877654332 233
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
..++..|++||++... ..+.++||||||+++|+|++|+.||........ ...... ..........
T Consensus 157 ~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~-------~~~~~~~~~~ 221 (253)
T cd05122 157 MVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKA-------LFKIAT-------NGPPGLRNPE 221 (253)
T ss_pred eecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHHh-------cCCCCcCccc
Confidence 5688999999988765 588999999999999999999999875432110 000000 0000011122
Q ss_pred HHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 267 EEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.++..+.+++.+||+.||.+||++.++++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 23678999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=284.55 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=195.6
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC------ceEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQT------KAAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------~~~l 98 (369)
.+.+.||+|+||.||+|.++ +++.+++|++..... ...++.+|+.+++++ .|+||+++++++.+.. ..++
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 34589999999999999885 578999998875432 346789999999998 6999999999997654 4899
Q ss_pred EEeccCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceec
Q 017591 99 VYEFMENGSLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
||||+++++|.+++... +..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 99999999999988532 4679999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccccCCCCCCcccccccccc----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 176 NPENTHDSTSGYRGTPGYSAPEFLLRN----YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
..... ......++..|+|||++... ..++.++|||||||++|+|++|+.||........ .......
T Consensus 164 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~- 233 (275)
T cd06608 164 DSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-------LFKIPRN- 233 (275)
T ss_pred ccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-------HHHhhcc-
Confidence 43221 22335688999999987532 3567899999999999999999999964322100 0000000
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..........++..+.+++.+||..||.+|||+.+|++
T Consensus 234 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 ------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00001112346678999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=282.55 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=195.8
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 32 LGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 32 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
||.|+||.||++.+. +++.+++|++.... .......+.+|+.+++.++|+||+++++.+.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999885 48999999986432 234557799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCC
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 188 (369)
.+++.. ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 999943 4568999999999999999999999 999999999999999999999999999998764332 122345
Q ss_pred CCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHH
Q 017591 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268 (369)
Q Consensus 189 gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (369)
++..|++||.+... .++.++|+||||+++|+|++|..||.....+.. ....... ........+...
T Consensus 154 ~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~--------~~~~~~~~~~~~ 219 (262)
T cd05572 154 GTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-----EIYNDIL--------KGNGKLEFPNYI 219 (262)
T ss_pred CCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-----HHHHHHh--------ccCCCCCCCccc
Confidence 88899999987664 689999999999999999999999975542110 0011100 001112223334
Q ss_pred HHHHHHHHHhccccCCCCCCC-----hHHHHH
Q 017591 269 AERMSMVALWCVQDCPEARPP-----MSAVVK 295 (369)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~RPs-----~~~v~~ 295 (369)
+..+.+++.+||+.+|.+||+ +.++++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 678999999999999999999 566553
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=288.41 Aligned_cols=246 Identities=26% Similarity=0.369 Sum_probs=197.4
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
..+.||+|+||.||++.+. ++..+++|.+... ........+.+|+.+++.++|+|++++++++.+.+..++||||+.
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 4568999999999999874 5889999987642 223445678899999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+ +|.+.+.....++++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++..... .
T Consensus 109 g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~ 178 (317)
T cd06635 109 G-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------A 178 (317)
T ss_pred C-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC------c
Confidence 5 8888776666789999999999999999999999 9999999999999999999999999999865432 1
Q ss_pred ccCCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 185 SGYRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
....++..|+|||++.. ...++.++|||||||++|+|++|+.||........ .... .......
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~--------~~~~~~~ 243 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHI--------AQNESPT 243 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-------HHHH--------HhccCCC
Confidence 23458889999998742 23688999999999999999999999864322100 0111 0111112
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
......+..+.+++.+||+.+|.+||++.+|++.+-
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 223345677999999999999999999999987544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=286.04 Aligned_cols=247 Identities=25% Similarity=0.274 Sum_probs=201.6
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.++||.|+||.||++.+. ++..+++|.+.... .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 345689999999999999885 58999999887432 224567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+.+++|.+++... ..+++..+..++.|+++||.|||+ ++++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 154 (258)
T cd05578 82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--- 154 (258)
T ss_pred CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence 9999999999443 689999999999999999999999 999999999999999999999999999987654332
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......++..|+|||.+... .++.++|+||||+++|+|++|+.||........ ..+. .. ......
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------~~~~-----~~-~~~~~~ 219 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR--------DQIR-----AK-QETADV 219 (258)
T ss_pred cccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHH--------HHHH-----HH-hccccc
Confidence 12335688899999988765 589999999999999999999999975543211 1110 00 110123
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCh--HHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPM--SAVV 294 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~~v~ 294 (369)
..+...+..+.+++.+||+.||.+||++ ++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 3344566889999999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=286.23 Aligned_cols=245 Identities=26% Similarity=0.347 Sum_probs=198.7
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
.+.||+|++|.||++.+. ++..+++|++..... ....+.+|+.+++.++|+|++++++.+...+..++|+||+++++
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 478999999999999885 589999999875433 46678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccC
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 187 (369)
|.+++......+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 102 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 176 (286)
T cd06614 102 LTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSV 176 (286)
T ss_pred HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccc
Confidence 999996554589999999999999999999999 9999999999999999999999999998865543221 12234
Q ss_pred CCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHH
Q 017591 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE 267 (369)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (369)
.++..|++||++.+. .++.++|||||||++|+|++|+.||........ ...... ...........
T Consensus 177 ~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-------~~~~~~-------~~~~~~~~~~~ 241 (286)
T cd06614 177 VGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-------LFLITT-------KGIPPLKNPEK 241 (286)
T ss_pred cCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHh-------cCCCCCcchhh
Confidence 578899999987764 689999999999999999999999864332110 000000 00000111223
Q ss_pred HHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 268 EAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 268 ~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
++..+.+++.+||+.+|.+||++.+|+.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 5678999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=291.23 Aligned_cols=266 Identities=21% Similarity=0.261 Sum_probs=196.7
Q ss_pred hccccccccCCceEEEEEEeC---CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP---NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 98 (369)
+.+.++||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++..++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 345678999999999999875 47999999987532 122335678899999999999999999999988 78999
Q ss_pred EEeccCCCCHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC----CCCeeEeecC
Q 017591 99 VYEFMENGSLDKYLFTD----TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA----KFSAKVADFG 170 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~Dfg 170 (369)
||||+++ +|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999976 777766322 2378999999999999999999999 99999999999999999 8999999999
Q ss_pred CceecCCCCC-ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccc-------
Q 017591 171 LAKLCNPENT-HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQ------- 242 (369)
Q Consensus 171 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------- 242 (369)
++........ ........++..|+|||.+.+...++.++|||||||++|+|++|+.||...........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987643322 11223456788999999887655689999999999999999999999976544321000000
Q ss_pred ----------hhHHhhhc-hhhh---hhhcCCCC-CCCH-------HHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 243 ----------VWDEYEKG-ELAA---KVLGCGIE-ENDR-------EEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 243 ----------~~~~~~~~-~~~~---~~~~~~~~-~~~~-------~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.|...... +... .......+ .... .....+.+++.+||+.||++|||+.+++.
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 0000 00000000 0000 23457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=284.87 Aligned_cols=241 Identities=25% Similarity=0.313 Sum_probs=191.0
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 32 LGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 32 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
||+|+||+||++.+. +|+.|++|.+.... .......+.+|+.+++.++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999764 58999999886432 122345667899999999999999999999999999999999999999
Q ss_pred HHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccC
Q 017591 109 DKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187 (369)
Q Consensus 109 ~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 187 (369)
.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccc
Confidence 99996543 369999999999999999999999 9999999999999999999999999999876543211 1224
Q ss_pred CCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHH
Q 017591 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE 267 (369)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (369)
.++..|++||++.++ .++.++|||||||++|+|++|+.||........ ....... .. ......+..
T Consensus 155 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~-----~~-~~~~~~~~~ 220 (277)
T cd05577 155 AGTPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-------KEELKRR-----TL-EMAVEYPDK 220 (277)
T ss_pred cCCCCcCCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-------HHHHHhc-----cc-cccccCCcc
Confidence 578899999988765 589999999999999999999999965443111 0111111 00 011122334
Q ss_pred HHHHHHHHHHhccccCCCCCCChHH
Q 017591 268 EAERMSMVALWCVQDCPEARPPMSA 292 (369)
Q Consensus 268 ~~~~l~~l~~~cl~~~p~~RPs~~~ 292 (369)
.+..+.+++.+||+.||.+||+..+
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCc
Confidence 5778899999999999999994443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=289.63 Aligned_cols=243 Identities=22% Similarity=0.343 Sum_probs=194.8
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
..||+|+||.||++... ++..||+|.+.... ......+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 46999999999999874 58899999876432 33456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCC
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 188 (369)
.+++. ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++........ ......
T Consensus 107 ~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~ 179 (292)
T cd06658 107 TDIVT--HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLV 179 (292)
T ss_pred HHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceee
Confidence 99883 3468999999999999999999999 9999999999999999999999999999875432221 122345
Q ss_pred CCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHH
Q 017591 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268 (369)
Q Consensus 189 gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (369)
++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ...... ..... ........
T Consensus 180 ~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~------~~~~~-~~~~~~~~ 244 (292)
T cd06658 180 GTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------AMRRIR------DNLPP-RVKDSHKV 244 (292)
T ss_pred cCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHH------hcCCC-cccccccc
Confidence 88999999988664 68999999999999999999999986433210 000100 00010 01112234
Q ss_pred HHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 269 AERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+..+..++.+||..||.+||++.++++
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 567889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=290.29 Aligned_cols=243 Identities=21% Similarity=0.334 Sum_probs=195.3
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
.+||+|+||.||++.+. +++.|++|.+..... .....+.+|+.++..+.|||++++++++..++..++||||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 47999999999999874 689999999864332 2345688999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCC
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 188 (369)
..++. ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........ ......
T Consensus 106 ~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~ 178 (297)
T cd06659 106 TDIVS--QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLV 178 (297)
T ss_pred HHHHh--hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccccee
Confidence 99873 3568999999999999999999999 9999999999999999999999999999875433221 122356
Q ss_pred CCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHH
Q 017591 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268 (369)
Q Consensus 189 gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (369)
++..|+|||++.+. .++.++|||||||++|||++|+.||........ ...+.... ..........
T Consensus 179 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~-------~~~~~~~~~~ 243 (297)
T cd06659 179 GTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-------MKRLRDSP-------PPKLKNAHKI 243 (297)
T ss_pred cCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhccC-------CCCccccCCC
Confidence 89999999988764 689999999999999999999999874332110 01110000 0001112234
Q ss_pred HHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 269 AERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+.+++.+||+.+|.+||++.+|++
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=278.16 Aligned_cols=249 Identities=27% Similarity=0.352 Sum_probs=203.9
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEEEecc
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALVYEFM 103 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~ 103 (369)
..+.||+|++|.||+|.+. ++..|++|++.... .......+.+|+..+++++|+||+++++.+.+. +..++||||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 4578999999999999886 68999999987543 234567889999999999999999999999988 8899999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++|.+++... ..+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+...........
T Consensus 84 ~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 84 SGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999544 389999999999999999999999 9999999999999999999999999999987765433212
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....++..|++||.+... ..+.++||||||+++++|++|+.||........ ..+. .........
T Consensus 160 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~---------~~~~~~~~~ 224 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----ALYK---------IGSSGEPPE 224 (260)
T ss_pred ccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHh---------ccccCCCcC
Confidence 2345688999999988765 589999999999999999999999975541100 0000 011112233
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 44455788999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=284.88 Aligned_cols=250 Identities=25% Similarity=0.389 Sum_probs=193.3
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
..+||+|+||.||++.+. +++.+|+|.+...........+.+|+.++.++. |+||+++++++......+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 458999999999999874 589999999875544455667899999999996 99999999999999999999999865
Q ss_pred CHHHHh---cc-CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 107 SLDKYL---FT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 107 sL~~~l---~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+|.++. .. ....+++..+..++.|++.||+|||+. .+++||||||+||+++.++.++|+|||++........
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 163 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-- 163 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc--
Confidence 665543 22 246799999999999999999999971 4999999999999999999999999999875432221
Q ss_pred ccccCCCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 183 STSGYRGTPGYSAPEFLLRN--YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~--~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.....|+..|+|||++... ..++.++|||||||++|+|++|+.||...... ........ .......
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------~~~~~~~~--~~~~~~~ 231 (288)
T cd06616 164 -KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV---------FDQLTQVV--KGDPPIL 231 (288)
T ss_pred -cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH---------HHHHhhhc--CCCCCcC
Confidence 1223588899999998765 36889999999999999999999998643210 11111000 0000000
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........+..+.+|+.+||+.+|.+||++.+|+.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122346678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=285.55 Aligned_cols=262 Identities=24% Similarity=0.288 Sum_probs=195.7
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
..+.||.|+||.||+|+++ +++.|++|.+.... .......+.+|+.++++++||||+++++++.+.+..++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 4578999999999999875 58999999886432 22334578899999999999999999999999999999999996
Q ss_pred CCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 106 GSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 106 gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (284)
T cd07860 83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TY 157 (284)
T ss_pred cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--cc
Confidence 5898888543 4578999999999999999999999 9999999999999999999999999999876543221 11
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhchhhhhh
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ 256 (369)
....++..|+|||++.+...++.++|||||||++|+|++|+.||......... ......|............
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 22346889999998876555789999999999999999999999754321100 0000000000000000000
Q ss_pred hcCCCC----CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 257 LGCGIE----ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 257 ~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...... .........+.+++.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000 011224566889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=286.27 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=198.9
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 102 (369)
.+.++||.|+||.||+|.+. +++.+++|.+.... .......+.+|+.+++.++|+|++++++++.+. +..++||||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 35678999999999999885 48999999987643 233445788999999999999999999999887 789999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++ +|.+++......+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~- 156 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA- 156 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-
Confidence 985 9999886655689999999999999999999999 99999999999999999999999999999876543321
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc-C-------ccccchhHHhhhchhhh
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL-D-------WFPKQVWDEYEKGELAA 254 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~ 254 (369)
......++..|+|||.+.+...++.++||||||+++|+|++|+.||........ . ......|..........
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 122345688899999877655689999999999999999999999875443210 0 00000000000000000
Q ss_pred hh-----hcCCCCCCCHH-HHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KV-----LGCGIEENDRE-EAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~-----~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ........... .+..+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 00000000011 2678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=283.44 Aligned_cols=243 Identities=25% Similarity=0.346 Sum_probs=206.9
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
..+||+|+||.||++..+ .|+.+|+|.+....+ ..++..|+.++.+...+++|++||.+..+..+++|||||-.|+
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD---LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD---LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecCccch---HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 368999999999999764 599999999876443 6688999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccC
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 187 (369)
..+.+.-++.++++.++..++...++||+|||. ..-+|||||+.|||++.+|.+||+|||.+-.+.+ +......+
T Consensus 115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRNTV 189 (502)
T KOG0574|consen 115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRNTV 189 (502)
T ss_pred HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhCcc
Confidence 999998889999999999999999999999999 7889999999999999999999999999865532 11223457
Q ss_pred CCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC-ccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD-WFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
.||+-|||||+++.- .|..++||||||++..||..|++|+.+..+-... .+| ......-..+.
T Consensus 190 IGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---------------T~PPPTF~KPE 253 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---------------TKPPPTFKKPE 253 (502)
T ss_pred ccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---------------CCCCCCCCChH
Confidence 899999999999874 7899999999999999999999999876653221 111 11111113367
Q ss_pred HHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 267 EEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.++..+.+++.+||-.+|++|-|+.++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 78899999999999999999999988774
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=284.67 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=199.3
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.+.||+|+||.||++... +++.|++|.+..... .....+.+|+.+++.++|||++++++.+...+..++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 4456689999999999999864 588999998864332 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++|.+++.. ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~ 171 (293)
T cd06647 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 171 (293)
T ss_pred CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence 99999999843 358899999999999999999999 9999999999999999999999999998876543322 1
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....++..|++||.+..+ .++.++|||||||++|++++|+.||.......... ..... ......
T Consensus 172 ~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~--------~~~~~~ 236 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATN--------GTPELQ 236 (293)
T ss_pred cccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcC--------CCCCCC
Confidence 2234588899999988764 68999999999999999999999997543321100 00000 000011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
.....+..+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123355678999999999999999999998843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=288.08 Aligned_cols=263 Identities=24% Similarity=0.285 Sum_probs=195.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 102 (369)
.+.+.||+|+||.||+|.+. +|+.||+|.+..... ......+.+|+.++++++|+|++++++++.+. +..++||||
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 44578999999999999874 589999998864322 22233566899999999999999999998765 468999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+.+ +|.+++......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 90 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-- 163 (309)
T cd07845 90 CEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-- 163 (309)
T ss_pred CCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCccC--
Confidence 975 8988886656789999999999999999999999 9999999999999999999999999999987654321
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------cccchhHHhhhchhhh
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------FPKQVWDEYEKGELAA 254 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 254 (369)
......++..|+|||.+.+...++.++|||||||++|+|++|+.||...+...... .....|..........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 11223457889999988765568999999999999999999999997544321100 0000010000000000
Q ss_pred hh-hc-CCC---CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KV-LG-CGI---EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~-~~-~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. .. ... .......+..+.+++.+||+.||++||++.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00 000 0001123667889999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=302.51 Aligned_cols=246 Identities=25% Similarity=0.408 Sum_probs=202.6
Q ss_pred ccccccccCCceEEEEEEeCCC-cEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNG-VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
++.-.||.|+||.||++..++. -..|.|++... ......++.-|+.+|....||+||++++.|+..+.+++..|||.|
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4445689999999999988664 44455776643 345678899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|..+..+..-+..+.+.++..+++|++.||.|||+ ++|+|||||+.|||++-+|.++|+|||.+-... .......
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRD 188 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch--hHHhhhc
Confidence 99999997888899999999999999999999999 999999999999999999999999999875421 1222345
Q ss_pred cCCCCCCcccccccccc----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 186 GYRGTPGYSAPEFLLRN----YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~----~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
.+.||+.|||||+..+. .+|..++||||||++|.||..+.+|....++- .+..++.....
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----------------RVllKiaKSeP 252 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------------RVLLKIAKSEP 252 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----------------HHHHHHhhcCC
Confidence 57899999999987643 47899999999999999999999887544331 11122222211
Q ss_pred C--CCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 262 E--ENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 262 ~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
+ -.+..+...+.+++..||..||..||++.+++
T Consensus 253 PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 253 PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 2 23567888999999999999999999999987
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=281.91 Aligned_cols=243 Identities=23% Similarity=0.262 Sum_probs=188.8
Q ss_pred ccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHH---HHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEI---GTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.||+|+||.||++.+. +++.||+|.+..... ......+..|. ..++...|||++.+++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 588999998764321 11122233333 34445679999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|..++. ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---- 152 (278)
T cd05606 81 GGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---- 152 (278)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC----
Confidence 999999884 45679999999999999999999999 9999999999999999999999999999875532221
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....|+..|+|||.+..+..++.++|||||||++|+|++|+.||......... . ... .........
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--------~-----~~~-~~~~~~~~~ 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------E-----IDR-MTLTMAVEL 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--------H-----HHH-HhhccCCCC
Confidence 23468999999999876556899999999999999999999999754322110 0 000 000111222
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 333467899999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=328.43 Aligned_cols=267 Identities=26% Similarity=0.402 Sum_probs=200.3
Q ss_pred cCHHHHHHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 017591 16 FTLEQLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT 94 (369)
Q Consensus 16 ~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 94 (369)
+++.++.... ...+.||+|+||.||+|.+ .++..||+|.+..... ....|+..+++++||||+++++++.+.+
T Consensus 683 ~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 683 ITINDILSSL-KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhHHHHHhhC-CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 4455554432 2346899999999999987 5789999998864322 1234588899999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 95 KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
..++||||+++|+|.+++. .++|..+..++.|+++||+|||..+..+++||||||+||+++.++..++. ||.+..
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 9999999999999999993 48999999999999999999996545899999999999999999888775 665443
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
... .....+|..|+|||++... .++.++|||||||++|||++|+.||....... .....+....+.......
T Consensus 832 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 832 LCT------DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDM 903 (968)
T ss_pred ccc------CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHhcCccchhh
Confidence 211 1223588999999988764 78999999999999999999999985432211 111112111111111111
Q ss_pred hhhcCC--CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 255 KVLGCG--IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 255 ~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
..+... ...........+.+++.+||+.||++||+|.+|++.|+...
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 111111 11234456678899999999999999999999999998764
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=281.65 Aligned_cols=247 Identities=21% Similarity=0.350 Sum_probs=198.2
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|+||.||++.+. +|..+++|.+... ........+.+|+.+++.++|+|++++++.+.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 45678999999999999885 4889999988643 122345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC-eeEeecCCceecCCCCCcc
Q 017591 105 NGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS-AKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 105 ~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++. ++|+|||.+........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-- 157 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence 99999998543 3468999999999999999999999 99999999999999988864 69999999876543221
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......|+..|+|||++... .++.++||||||+++|+|++|..||....... .. .........
T Consensus 158 ~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----------~~------~~~~~~~~~ 220 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ----------LV------LKICQGYFA 220 (257)
T ss_pred cccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----------HH------HHHhcccCC
Confidence 12234588999999987764 68899999999999999999999986432210 00 011111222
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......+..+.+++.+||+.+|++||++.+|++
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 333445678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=283.22 Aligned_cols=243 Identities=21% Similarity=0.340 Sum_probs=195.5
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
+.||+|++|.||++.+. +++.+++|.+... .......+.+|+.+++.+.|+|++++++++...+..++++||+++++|
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 58999999999999874 5889999987643 223355688999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCC
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 188 (369)
.+++.. ..+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||.+........ ......
T Consensus 104 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~ 176 (285)
T cd06648 104 TDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLV 176 (285)
T ss_pred HHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cccccc
Confidence 999844 578999999999999999999999 9999999999999999999999999998875433221 112345
Q ss_pred CCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHH
Q 017591 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268 (369)
Q Consensus 189 gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (369)
|+..|+|||.+.+. .++.++|||||||++|+|++|+.||....... ........ ...........
T Consensus 177 ~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-------~~~~~~~~-------~~~~~~~~~~~ 241 (285)
T cd06648 177 GTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-------AMKRIRDN-------LPPKLKNLHKV 241 (285)
T ss_pred CCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHhc-------CCCCCcccccC
Confidence 88999999988764 68999999999999999999999986433210 01111111 00011112235
Q ss_pred HHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 269 AERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+..+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 578999999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=287.61 Aligned_cols=266 Identities=23% Similarity=0.276 Sum_probs=193.8
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC--------c
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT--------K 95 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~ 95 (369)
+.+.++||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++++.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 445678999999999999874 58999999875432 2222345678999999999999999999987654 3
Q ss_pred eEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceec
Q 017591 96 AALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 96 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
.++||||+.+ +|.+++......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 4999999975 8888886555679999999999999999999999 99999999999999999999999999999866
Q ss_pred CCCCCc--cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhH
Q 017591 176 NPENTH--DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWD 245 (369)
Q Consensus 176 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~ 245 (369)
...... .......++..|+|||.+.+...++.++||||||+++|+|++|+.||......... ..+...+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 432221 11123457888999998876555789999999999999999999998754432100 00000000
Q ss_pred Hhhhchhhhhhh-cCCCC------CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 246 EYEKGELAAKVL-GCGIE------ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 246 ~~~~~~~~~~~~-~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
............ ..... .........+.+++.+||+.||.+||++.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000000 00000 000112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=279.61 Aligned_cols=245 Identities=27% Similarity=0.361 Sum_probs=203.1
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.++||+|+||.||++.+. +++.+++|.+... ........+.+|+.+++.++|+||+++++++.+....++||||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 45678999999999999764 6889999988643 234445678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 105 NGSLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 105 ~gsL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
+++|.+++... ...+++..++.++.|++.||.|||+ .|++|+||+|.||+++.++.++|+|||++......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999998542 3578999999999999999999999 99999999999999999999999999999876543
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......++..|++||.+.+. .++.++|+||||+++|+|++|+.||...... ...........
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~ 218 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----------------DLRYKVQRGKY 218 (256)
T ss_pred -CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhcCCC
Confidence 11224578899999998764 7889999999999999999999998644321 11112222333
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+..+......+.+++.+||+.+|.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 4445567888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=282.25 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=197.7
Q ss_pred cccCCceEEEEEEeCC-CcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 32 LGAGGFGVVYKGQFPN-GVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 32 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
||.|+||.||++.+.. ++.+++|.+..... ......+.+|+.++.+++|+||+++++.+...+..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998864 99999999865322 24556788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC------cc
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT------HD 182 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~ 182 (369)
.+++... ..+++..++.++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 9999543 479999999999999999999999 9999999999999999999999999999875433211 11
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......++..|++||.+... ..+.++||||||+++|+|++|..||....... .......+.. ..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--------~~ 220 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNILNGKI--------EW 220 (265)
T ss_pred cccCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCc--------CC
Confidence 22334578899999988765 58899999999999999999999986443211 1111111000 01
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
......+..+.+++.+||+.+|.+||++..|.+.|+.
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 1111136788999999999999999999777777663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=278.27 Aligned_cols=247 Identities=24% Similarity=0.407 Sum_probs=203.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||.|+||.||++.+. ++..+++|.+.... .......+.+|+++++.++|+|++++.+.+......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 35578999999999999884 58999999987532 33556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 105 NGSLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 105 ~gsL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
+++|.+++... ...+++..+..++.+++.||.+||+ ++++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD- 158 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCcc-
Confidence 99999999654 4789999999999999999999999 9999999999999999999999999999987644331
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......|++.|+|||.+... .++.++||||||+++++|++|..||...... ...........
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~ 220 (258)
T cd08215 159 -LAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLL----------------ELALKILKGQY 220 (258)
T ss_pred -eecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHH----------------HHHHHHhcCCC
Confidence 22234688899999987764 6899999999999999999999998644321 11111112222
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+...+..+.+++.+||..+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3333456678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=291.39 Aligned_cols=268 Identities=23% Similarity=0.322 Sum_probs=197.0
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----ceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-----KAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~ 100 (369)
.+.++||+|+||.||+|.+ .+|+.||+|.+...........+.+|+.+++.++|+||+++++++...+ ..++||
T Consensus 8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 87 (336)
T cd07849 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ 87 (336)
T ss_pred EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence 3458899999999999987 4689999999875434445667889999999999999999999876443 579999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+.+ +|.+++ ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 88 e~~~~-~l~~~~--~~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 88 ELMET-DLYKLI--KTQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred hhccc-CHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 99975 888877 34579999999999999999999999 9999999999999999999999999999986543222
Q ss_pred cc-ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC-----cc---ccchhHHhhhch
Q 017591 181 HD-STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD-----WF---PKQVWDEYEKGE 251 (369)
Q Consensus 181 ~~-~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~-----~~---~~~~~~~~~~~~ 251 (369)
.. ......|+..|+|||.+.....++.++|||||||++|+|++|+.||......... .+ ....+.......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence 11 1223468899999998766556899999999999999999999999653321000 00 000000000000
Q ss_pred hhhhhhcC-CCCC-----CCHHHHHHHHHHHHhccccCCCCCCChHHHHHH--hcCC
Q 017591 252 LAAKVLGC-GIEE-----NDREEAERMSMVALWCVQDCPEARPPMSAVVKM--LEGG 300 (369)
Q Consensus 252 ~~~~~~~~-~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~--L~~~ 300 (369)
........ .... ..+..+..+.+++.+||+.+|.+||++.++++. ++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000000 0000 012235678999999999999999999999864 5443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=286.74 Aligned_cols=266 Identities=24% Similarity=0.266 Sum_probs=195.6
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC--------
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-------- 94 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 94 (369)
.+.+.++||+|+||.||+|.++ +++.|++|.+.... .......+.+|+.+++.++|||++++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 3445689999999999999885 58899999986432 2233456788999999999999999999987654
Q ss_pred --ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCc
Q 017591 95 --KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA 172 (369)
Q Consensus 95 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 172 (369)
..++|+||+++ +|..++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999986 7878775555679999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC-c-------cccchh
Q 017591 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD-W-------FPKQVW 244 (369)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~-------~~~~~~ 244 (369)
......... ......++..|+|||.+......+.++|||||||++|+|++|+.||......... . .....|
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 164 RLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 866433221 1122346778999998876556789999999999999999999998753321000 0 000000
Q ss_pred HHhhhchhhhhh-----hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 245 DEYEKGELAAKV-----LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 245 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
............ ............+..+.+++..||+.||.+||++.+|+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000000 000000011123577899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=285.52 Aligned_cols=263 Identities=26% Similarity=0.324 Sum_probs=196.4
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||.|++|.||+|.+. +|..|++|++..... ......+.+|+.+++.++|+|++++++++.+.+..+++|||+.
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 34578999999999999874 699999998864322 2233568889999999999999999999999999999999995
Q ss_pred CCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++|.+++.... ..+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~ 155 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--T 155 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--c
Confidence 59999985433 468999999999999999999999 9999999999999999999999999999876532211 1
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhc-hhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKG-ELAA 254 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~-~~~~ 254 (369)
.....++..|+|||++.+...++.++||||||+++|+|++|+.||......... ......|...... +...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 122346889999998876556789999999999999999999998754321100 0000000000000 0000
Q ss_pred hhh---cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVL---GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... ...........+..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 00001112234467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=285.11 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=197.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|+||+||+|... +++.|++|.+.............+|+..+.++. |+|++++++++.+++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45678999999999999885 478999998875443333445567999999999 999999999999999999999999
Q ss_pred CCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+|+|.+++.... ..+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-- 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc--
Confidence 779999885543 578999999999999999999999 99999999999999999999999999999865432221
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------Cccccchh-HHhhhchhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVW-DEYEKGELAA 254 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~ 254 (369)
....++..|+|||++.....++.++|+||||+++++|++|+.||........ .......| +.........
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 2245788999999887665789999999999999999999999865433110 00000000 0000000000
Q ss_pred hhhcCCC----CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGI----EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... ..........+.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 0001112467999999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=326.36 Aligned_cols=248 Identities=26% Similarity=0.329 Sum_probs=208.1
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
.+||.|.||.||.|.+ .+|...|+|-++.... ........+|..++..++|||+|+++|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 5799999999999987 4588899998764322 3344568899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC--Cccccc
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN--THDSTS 185 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 185 (369)
|.+.+ ..++..++.....+-.|++.|+.|||+ .|||||||||.||+|+.+|.+|++|||.|..+..+. ....-.
T Consensus 1321 La~ll-~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1321 LASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred HHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 99999 667778888889999999999999999 999999999999999999999999999998876542 112233
Q ss_pred cCCCCCCccccccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNY--PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~--~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
...||+.|||||++.+.. ...-+.||||||||++||+||++||...+.. -.+...+..+..|.
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------------~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------------WAIMYHVAAGHKPQ 1461 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------------hHHHhHHhccCCCC
Confidence 457999999999987642 4567999999999999999999999755443 12333444445567
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
.+...+..-.+++..||+.||+.|.++.++++.
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 777789999999999999999999999887754
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=288.66 Aligned_cols=260 Identities=22% Similarity=0.262 Sum_probs=193.6
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC------Cce
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ------TKA 96 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 96 (369)
.+...+.||+|+||.||++.+. +++.||+|.+... ........+.+|+.+++.++|+||+++++++... ...
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 3444588999999999999874 6899999988642 2334455678899999999999999999988644 357
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 97 ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
++||||+.+ +|.+.+... ++...+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||+++...
T Consensus 97 ~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 97 YLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 999999975 888887332 8999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhh
Q 017591 177 PENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYE 248 (369)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~ 248 (369)
.... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+.... ...+......+.
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 TSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCC---CCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 3221 2234578899999988764 789999999999999999999999975432100 000000000000
Q ss_pred hc-------------hhhhhhhc-CCC----CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 249 KG-------------ELAAKVLG-CGI----EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 249 ~~-------------~~~~~~~~-~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ........ ... .......+..+.+++.+||+.||.+||++.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00000000 000 0112234677899999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=278.76 Aligned_cols=246 Identities=24% Similarity=0.265 Sum_probs=191.7
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHH-hccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTI-GRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.||.|+||.||+|.+. +++.||+|++.... .......+..|..++ ....|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999874 58999999986432 122233445555444 455899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|.+++. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIK-TLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999994 44578999999999999999999999 9999999999999999999999999999875432 22
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...++..|++||.+.+. .++.++||||||+++|+|++|..||...... ..+.....+... ......
T Consensus 152 ~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~------~~~~~~ 217 (260)
T cd05611 152 KFVGTPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRIN------WPEEVK 217 (260)
T ss_pred cCCCCcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccC------CCCccc
Confidence 34588899999988775 5899999999999999999999999643321 112221111110 011122
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
...+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 2456789999999999999999988777666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=298.02 Aligned_cols=245 Identities=23% Similarity=0.415 Sum_probs=201.1
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcc---ccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc--eEEEEe
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILK---TCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK--AALVYE 101 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~---~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e 101 (369)
|..+||+|+|-+||+|.+. +|..||--.++ ....+....+|..|+.+|+.|+|+||+++++.+.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 5578999999999999874 47777754332 33455667899999999999999999999999987655 778999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-CCCeeEeecCCceecCCCCC
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-KFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~ 180 (369)
.+..|+|+.|. .+.+.++...+..|++||++||.|||+.. .+|+|||||-+||||+. .|.|||+|+|+|.......
T Consensus 124 L~TSGtLr~Y~-kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 124 LFTSGTLREYR-KKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred cccCCcHHHHH-HHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 99999999999 45567899999999999999999999854 58999999999999975 4789999999998765332
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
...+.|||.|||||.+.. .|....||||||+.++||+|+..||...... +++++..-.|.......
T Consensus 201 ---aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~------AQIYKKV~SGiKP~sl~--- 266 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNP------AQIYKKVTSGIKPAALS--- 266 (632)
T ss_pred ---cceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCH------HHHHHHHHcCCCHHHhh---
Confidence 233789999999998775 6999999999999999999999999877653 45565554443322221
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......+.++|.+||.. ..+||++.|++.
T Consensus 267 -----kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 -----KVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 22256789999999999 999999999883
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=283.69 Aligned_cols=241 Identities=26% Similarity=0.403 Sum_probs=193.2
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
++||+|+||+||+|++. ++..|++|.+... ........+.+|+.+++.++|+|++++++++.+....++||||+.+
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG- 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-
Confidence 57999999999999874 5889999987642 2334446788999999999999999999999999999999999965
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|.+++.....++++..++.++.|++.+|.|||+ +|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 106 ~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~ 176 (313)
T cd06633 106 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANS 176 (313)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC------CCC
Confidence 8888886666789999999999999999999999 9999999999999999999999999998864321 223
Q ss_pred CCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 187 YRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
..|+..|+|||++.. ...++.++|||||||++|+|++|..||........ .. ... ........
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~-~~~--------~~~~~~~~ 241 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY-HIA--------QNDSPTLQ 241 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HH-HHH--------hcCCCCCC
Confidence 468899999998752 23688899999999999999999999865432110 00 000 00001111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...++..+.+++.+||+.+|.+||++.+++.
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2334567899999999999999999999884
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=282.53 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=200.9
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
..+.||+|++|.||++... +++.+++|.+..... ......+.+|+.++++++|+||+++++++.+++..++||||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 4568999999999999874 689999998865432 23456788999999999999999999999999999999999976
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+|.+++......+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 83 -~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~ 156 (283)
T cd05118 83 -DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYT 156 (283)
T ss_pred -CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--ccc
Confidence 8988886656789999999999999999999999 9999999999999999999999999999987654331 122
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhh---chhhh
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEK---GELAA 254 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~---~~~~~ 254 (369)
...++..|+|||.+......+.++||||||+++|+|++|+.||...+..... ......+..... .....
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 3457889999998876547899999999999999999999998654431100 000000000000 00000
Q ss_pred hhh--cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVL--GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... ...........+..+.+++.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00001122346788999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=283.66 Aligned_cols=243 Identities=26% Similarity=0.373 Sum_probs=194.8
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.||+|+||.||+|.+. ++..+++|.+... .......++.+|+.+++.++|+|++++++++......++||||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 467999999999999875 5788999987532 233445678899999999999999999999999999999999997
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|.+++......+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++...... .
T Consensus 99 ~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~ 169 (308)
T cd06634 99 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------N 169 (308)
T ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc------c
Confidence 58888776666779999999999999999999999 99999999999999999999999999998765422 2
Q ss_pred cCCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 186 GYRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
...++..|+|||.+.. ....+.++|||||||++|+|++|+.||........ ..... .......
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~--------~~~~~~~ 234 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIA--------QNESPAL 234 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-------HHHHh--------hcCCCCc
Confidence 2457889999998752 23578899999999999999999999864322100 00000 0111111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
....++..+.+++.+||+.+|.+||++.+|+..
T Consensus 235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 233466779999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=291.09 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=197.1
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEe----CCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD----QTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 100 (369)
.+.+.||+|+||.||+|..+ ++..|++|.+.... .......+.+|+.+++.++|+||+++++++.. ....++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 87 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM 87 (334)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence 34578999999999999874 58999999887532 22345567889999999999999999998763 34689999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+. ++|.+++. ....+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 88 e~~~-~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 88 DLME-SDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred ehhh-hhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 9996 58999884 44569999999999999999999999 9999999999999999999999999999976543221
Q ss_pred c--cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhhc
Q 017591 181 H--DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKG 250 (369)
Q Consensus 181 ~--~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~ 250 (369)
. .......++..|+|||.+.....++.++|||||||++|+|++|+.||........ ...+...+......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1 1112346889999999887655689999999999999999999999975443110 00011111111111
Q ss_pred hhhhhhhc-CCCCC-----CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 251 ELAAKVLG-CGIEE-----NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 251 ~~~~~~~~-~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+...... ..... .....+..+.+++.+||+.+|.+||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11110000 00011 11234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=276.90 Aligned_cols=248 Identities=22% Similarity=0.267 Sum_probs=196.5
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc----ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC----LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALV 99 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 99 (369)
.+.+.||+|+||.||++.+. ++..|++|.+... ........+.+|+.++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 45688999999999999874 5899999987432 1234456788999999999999999999998764 457899
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 85 VEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 999999999999843 3468999999999999999999999 999999999999999999999999999998653221
Q ss_pred Cc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 180 TH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 180 ~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.. .......++..|+|||++... .++.++|+|||||++|+|++|+.||...... .. .......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~-----~~~~~~~ 224 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAM----------AA-----IFKIATQ 224 (264)
T ss_pred ccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHH----------HH-----HHHHHcC
Confidence 11 111234588999999988764 6889999999999999999999998643211 11 1111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..+......+.+++.+||+ +|..||++.+++.
T Consensus 225 ~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 12234456677889999999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=283.39 Aligned_cols=264 Identities=19% Similarity=0.235 Sum_probs=186.4
Q ss_pred HHHHhhhccccccccCCceEEEEEEeCC----CcEEEEEEccccccHH-H---------HHHHHHHHHHHhccCCCceee
Q 017591 20 QLCSFTNNYSTKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKR-V---------EAQFMAEIGTIGRTYHINLVR 85 (369)
Q Consensus 20 el~~~t~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~---------~~~~~~E~~~l~~l~h~niv~ 85 (369)
++....+.+.++||+|+||+||+|.+.+ +..+++|+........ . ......++..+..+.|+|++.
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3344456677899999999999998744 4566677543221110 0 112233445566778999999
Q ss_pred EEeEEEeCC----ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC
Q 017591 86 LYGFCYDQT----KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK 161 (369)
Q Consensus 86 ~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 161 (369)
+++++.... ..+++++++.. ++.+.+. .....++..+..++.|++.||.|||+ ++++||||||+|||++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN 162 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence 999776543 34678887754 6766663 33456788999999999999999999 999999999999999999
Q ss_pred CCeeEeecCCceecCCCCCc-----cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc
Q 017591 162 FSAKVADFGLAKLCNPENTH-----DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL 236 (369)
Q Consensus 162 ~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~ 236 (369)
+.++|+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999876432211 112234699999999987764 789999999999999999999999986533211
Q ss_pred CccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 237 DWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
. ......+....+..... .....+..+.+++..|+..+|++||++.++.+.|+
T Consensus 242 ~-------~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 L-------IHAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred H-------HHHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 00000111111111110 11223577999999999999999999999998763
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=275.14 Aligned_cols=246 Identities=26% Similarity=0.368 Sum_probs=201.8
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|++|.||++.+. +++.+++|.+.... .......+.+|++++.++.|+|++++++++.+.+..+++|||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 45678999999999999875 57899999987542 22456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++.. ...+++..++.++.|++.+|.+||+ +|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 83 ~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~ 156 (254)
T cd06627 83 NGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--D 156 (254)
T ss_pred CCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--c
Confidence 9999999843 3679999999999999999999999 99999999999999999999999999999876543322 2
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....++..|++||.+... ..+.++||||||+++|+|++|+.||........ .+. .........
T Consensus 157 ~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~----------~~~~~~~~~ 219 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFR----------IVQDDHPPL 219 (254)
T ss_pred cccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHH----------HhccCCCCC
Confidence 234588899999988765 588999999999999999999999864332100 001 011122333
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+...+..+.+++.+||..+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 4455678999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=284.17 Aligned_cols=248 Identities=23% Similarity=0.391 Sum_probs=193.4
Q ss_pred ccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|+||.||+|.+.+ ++.||+|.+...........+..|+.++.+.. |+||+++++++.+....++||||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 456899999999999998864 89999999876544444556777877676664 9999999999999999999999986
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+ +|.+++......+++..+..++.|++.||+|||+. .+++||||+|+||+++.++.++|+|||++..+......
T Consensus 98 ~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~--- 171 (296)
T cd06618 98 T-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--- 171 (296)
T ss_pred c-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---
Confidence 5 88887755566899999999999999999999971 49999999999999999999999999998765332211
Q ss_pred ccCCCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 185 SGYRGTPGYSAPEFLLRN---YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~---~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
....++..|+|||.+... ..++.++||||||+++|+|++|+.||...... .+.+. .......
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------~~~~~------~~~~~~~ 236 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---------FEVLT------KILQEEP 236 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---------HHHHH------HHhcCCC
Confidence 223478899999988653 24788999999999999999999998642211 01100 0010000
Q ss_pred C--CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 E--ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
. .....++..+.+++.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 111134677999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=267.15 Aligned_cols=247 Identities=22% Similarity=0.352 Sum_probs=203.2
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
.-||.|+-|.||+++.. .|...|||......++....++...+.++.+-. +|+||+++|+|..+...++.||.|.. .
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence 46999999999999874 589999999998888888888888998887665 89999999999999999999999954 7
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccC
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 187 (369)
++.++..-.+++++..+-++...+++||.||-+ +++|+|||+||+|||+|..|.+||+|||++-.+-+...+ +..
T Consensus 177 ~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---trs 251 (391)
T KOG0983|consen 177 AEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---TRS 251 (391)
T ss_pred HHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc---ccc
Confidence 888886667889999999999999999999998 489999999999999999999999999999776543332 345
Q ss_pred CCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 188 RGTPGYSAPEFLLRN--YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 188 ~gt~~y~aPE~~~~~--~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
.|-+.|||||.+.-. ..|..++||||||++++||.||+.||.....+- +.+. .+.. -....++ ..
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF---------e~lt--kvln-~ePP~L~-~~ 318 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF---------EVLT--KVLN-EEPPLLP-GH 318 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH---------HHHH--HHHh-cCCCCCC-cc
Confidence 688999999987642 478899999999999999999999998766541 1110 0101 1111111 12
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..++..+.+++..||+.|+.+||...++++
T Consensus 319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 237888999999999999999999999874
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=290.98 Aligned_cols=263 Identities=23% Similarity=0.278 Sum_probs=195.4
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeC--CceEEEEe
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQ--TKAALVYE 101 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e 101 (369)
.+.+.||+|+||.||+|.+. ++..+++|.+... ........+.+|+.++.++ +|+||+++++++... ...++|||
T Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07852 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFE 89 (337)
T ss_pred HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEec
Confidence 45588999999999999875 5889999987532 2223345677899999999 999999999988654 36899999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+.+ +|..++... .+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++.........
T Consensus 90 ~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 90 YMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred cccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 9975 999988433 78999999999999999999999 99999999999999999999999999999866433221
Q ss_pred ---cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhc
Q 017591 182 ---DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKG 250 (369)
Q Consensus 182 ---~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~ 250 (369)
.......|+..|+|||.+.....++.++||||||+++|+|++|+.||......... ......+..+...
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 12233458899999998876557889999999999999999999999654322100 0000000000000
Q ss_pred ---hhhhhhhc---CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 251 ---ELAAKVLG---CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 251 ---~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........ ..........+..+.+++.+||+.||.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00000000 0001111224678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=281.14 Aligned_cols=263 Identities=23% Similarity=0.269 Sum_probs=193.6
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|++|+||+|.++ +++.|++|.+.... .......+.+|+.+++.++|+||+++++++.+....++||||++
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 45678999999999999875 58899999886432 22334578899999999999999999999999999999999996
Q ss_pred CCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-CCCeeEeecCCceecCCCCCcc
Q 017591 105 NGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-KFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 105 ~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+ +|.+++.... ..+++..++.++.|++.||+|||+ ++++|+||+|+||+++. ++.+||+|||++........
T Consensus 85 ~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-- 158 (294)
T PLN00009 85 L-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-- 158 (294)
T ss_pred c-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--
Confidence 5 8888774433 346889999999999999999999 99999999999999985 55799999999976533211
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------cccchhHHhhhchhhh
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------FPKQVWDEYEKGELAA 254 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 254 (369)
......++..|+|||++.+...++.++|||||||++|+|++|+.||.......... .....|.....-....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 11223578899999988765568999999999999999999999997543211000 0000000000000000
Q ss_pred hhhcCCCC----CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGIE----ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........ ......+..+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 011234566899999999999999999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=283.31 Aligned_cols=262 Identities=19% Similarity=0.174 Sum_probs=193.5
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
+.+|.|+++.||++.. +++.||+|++... ........+.+|+.+++.++|+||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3345555555555544 6999999998754 3445667899999999999999999999999999999999999999999
Q ss_pred HHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC-----cc
Q 017591 109 DKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT-----HD 182 (369)
Q Consensus 109 ~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~ 182 (369)
.+++... ...+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||.+........ ..
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999643 4568999999999999999999999 9999999999999999999999999998875532211 11
Q ss_pred ccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC------ccccchhH---Hhhhchh
Q 017591 183 STSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD------WFPKQVWD---EYEKGEL 252 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~------~~~~~~~~---~~~~~~~ 252 (369)
......++..|+|||++... ..++.++|||||||++|||++|..||......... ..+..... .......
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 12234577889999988753 35789999999999999999999999754322100 00000000 0000000
Q ss_pred h--------hhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 253 A--------AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 253 ~--------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
. ..................+.+++.+||+.||++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 000000112223455678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=280.89 Aligned_cols=243 Identities=22% Similarity=0.326 Sum_probs=194.8
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
.+||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 5799999999999987 468999999876432 34456799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCC
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 188 (369)
.+++. ...+++..+..++.|++.+|+|||+ +|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 105 ~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 177 (292)
T cd06657 105 TDIVT--HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 177 (292)
T ss_pred HHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence 99873 3468999999999999999999999 9999999999999999999999999999876543221 122345
Q ss_pred CCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHH
Q 017591 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268 (369)
Q Consensus 189 gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (369)
++..|++||++... .++.++|+|||||++|+|++|..||........ ...... ..... .......
T Consensus 178 ~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~------~~~~~-~~~~~~~ 242 (292)
T cd06657 178 GTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRD------NLPPK-LKNLHKV 242 (292)
T ss_pred cCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHh------hCCcc-cCCcccC
Confidence 88999999987654 688999999999999999999999864322100 000000 00000 1112234
Q ss_pred HHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 269 AERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+..+.+++.+||+.+|.+||++.+|+.
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 567889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=285.50 Aligned_cols=267 Identities=21% Similarity=0.294 Sum_probs=198.4
Q ss_pred HHHHHhhhccc--cccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe-C
Q 017591 19 EQLCSFTNNYS--TKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD-Q 93 (369)
Q Consensus 19 ~el~~~t~~f~--~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~ 93 (369)
+++...+++|. +.||+|+||.||++.++ +++.||+|.+... ........+.+|+.++..++|||++++++++.. .
T Consensus 3 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 3 GTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred cceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 45556666664 89999999999999875 6899999987542 222345678899999999999999999998875 4
Q ss_pred CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 94 TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 94 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
...++||||+. ++|.+++. ...+++..+..++.|+++||.|||+ ++++|+||+|+||+++.++.++|+|||++.
T Consensus 83 ~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 83 EDIYFVTELLG-TDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred CcEEEEeehhc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 57899999984 58988883 3468889999999999999999999 999999999999999999999999999987
Q ss_pred ecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhH
Q 017591 174 LCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWD 245 (369)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~ 245 (369)
..... .....++..|+|||.+..+..++.++|||||||++|+|++|+.||........ ...+..+..
T Consensus 157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 54321 12235788999999877655789999999999999999999999965432100 001111111
Q ss_pred HhhhchhhhhhhcCC-CCCC-----CHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 246 EYEKGELAAKVLGCG-IEEN-----DREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 246 ~~~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
............... .... ....+..+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111111111000000 0011 11245789999999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.69 Aligned_cols=250 Identities=28% Similarity=0.449 Sum_probs=214.0
Q ss_pred ccccccCCceEEEEEEe-CC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 29 STKLGAGGFGVVYKGQF-PN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.++||+|+||+||+|.| ++ ..+||+|++..........++.+|+..|..++|||+++++++|.... .-||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 36899999999999976 44 46789999988777777889999999999999999999999997665 78999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+.|+|.++++.++..+.....+.|+.||++|+.|||+ +.+|||||-++||||..-..+|+.|||+++..........
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 9999999998889999999999999999999999999 9999999999999999999999999999998876655555
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....-.+.|||-|.+... .++.++|||||||++||++| |..|+++...... .+.++.+ .+-
T Consensus 857 ~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------~dlle~g---------eRL 919 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------PDLLEKG---------ERL 919 (1177)
T ss_pred ccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------hHHHhcc---------ccC
Confidence 4555567789999988875 89999999999999999997 8889887665432 2222222 233
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
..++..+.++..++.+||..|+..||+++++...+..
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 4456677889999999999999999999998877654
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=282.96 Aligned_cols=261 Identities=23% Similarity=0.273 Sum_probs=192.6
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccccc-HHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCc-----eEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTK-----AAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~~l 98 (369)
...+.||+|+||.||+|.+. +++.||+|....... ......+.+|+.+++.+. |+||+++++++..... .++
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence 44578999999999999875 589999998764322 223356888999999995 6999999999887665 799
Q ss_pred EEeccCCCCHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-CCCeeEeecCCce
Q 017591 99 VYEFMENGSLDKYLFTD----TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-KFSAKVADFGLAK 173 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~ 173 (369)
||||+++ +|.+++... ...+++..++.++.|++.||.|||+ ++++||||+|+||+++. ++.++|+|||++.
T Consensus 84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 9999986 898888543 3468999999999999999999999 99999999999999998 8899999999988
Q ss_pred ecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------cccchhH
Q 017591 174 LCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------FPKQVWD 245 (369)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~ 245 (369)
....... ......+++.|+|||++.+...++.++||||||+++|+|++|..||.......... .....|.
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 160 AFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 6533211 11223468889999988765568999999999999999999999987543211000 0000000
Q ss_pred HhhhchhhhhhhcCC-----CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 246 EYEKGELAAKVLGCG-----IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 246 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.... ......... .....+..+..+.+++.+||+.||.+||++.+++.
T Consensus 238 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 238 GVSK--LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred chhh--ccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 000000000 00111235677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=304.05 Aligned_cols=261 Identities=18% Similarity=0.246 Sum_probs=183.0
Q ss_pred hhccccccccCCceEEEEEEeCC--CcEEEEEE--------------ccc--cccHHHHHHHHHHHHHHhccCCCceeeE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPN--GVKIAAKI--------------LKT--CLNKRVEAQFMAEIGTIGRTYHINLVRL 86 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~ 86 (369)
.+.+.++||+|+||+||++..+. +...++|. +.+ .........+.+|+.++..++|+||+++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 44556899999999999986532 22222221 110 1122345578899999999999999999
Q ss_pred EeEEEeCCceEEEEeccCCCCHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC
Q 017591 87 YGFCYDQTKAALVYEFMENGSLDKYLFTD----TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF 162 (369)
Q Consensus 87 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 162 (369)
++++.+.+..++|++++.+ +|..++... ........+..|+.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 229 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 229 EEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred eEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCC
Confidence 9999999999999999865 777776432 2234467788999999999999999 9999999999999999999
Q ss_pred CeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCC-CCCCccCcccc
Q 017591 163 SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQD-CSSDTLDWFPK 241 (369)
Q Consensus 163 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~-~~~~~~~~~~~ 241 (369)
.+||+|||++..+...... ......||..|+|||++.+. .++.++|||||||++|||++|..++.. .......
T Consensus 305 ~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~---- 378 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK---- 378 (501)
T ss_pred CEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH----
Confidence 9999999999876543222 12235699999999988765 789999999999999999998864432 2211100
Q ss_pred chhHHhhh------------chhhhhhhcCCCCC---CC------HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 242 QVWDEYEK------------GELAAKVLGCGIEE---ND------REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 242 ~~~~~~~~------------~~~~~~~~~~~~~~---~~------~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+.+.. ..+...+....... .. ...+..+.+++.+||+.||.+||++.|++.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000 00000000000000 00 012345678899999999999999999985
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=274.24 Aligned_cols=248 Identities=21% Similarity=0.260 Sum_probs=189.4
Q ss_pred CHHHHHHhhhcc--ccc--cccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEE
Q 017591 17 TLEQLCSFTNNY--STK--LGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFC 90 (369)
Q Consensus 17 ~~~el~~~t~~f--~~~--lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 90 (369)
+..++....+++ .+. ||+|+||.||++..+ ++..+++|.+....... . |+.....+ +|+|++++++.+
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~--e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I--EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h--hHHHHHHhhcCCCEEEEEEEE
Confidence 344455555543 344 599999999999874 58889999876432111 1 22222222 699999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-CeeEeec
Q 017591 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-SAKVADF 169 (369)
Q Consensus 91 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Df 169 (369)
...+..++||||+++++|.+++... ..+++..++.++.|+++||.|||+ .+++||||||+||+++.++ .++|+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 9999999999999999999999544 489999999999999999999999 9999999999999999998 9999999
Q ss_pred CCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhh
Q 017591 170 GLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEK 249 (369)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (369)
|++...... ....++..|+|||++.+. .++.++|||||||++|+|++|+.||......... ...+.
T Consensus 155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~------~~~~~- 220 (267)
T PHA03390 155 GLCKIIGTP------SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD------LESLL- 220 (267)
T ss_pred ccceecCCC------ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh------HHHHH-
Confidence 998765422 123588999999998764 6899999999999999999999999744322110 01110
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCC-hHHHH
Q 017591 250 GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPP-MSAVV 294 (369)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~v~ 294 (369)
... ..........+..+.+++.+||+.+|.+||+ +++++
T Consensus 221 ----~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 221 ----KRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred ----Hhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 001 1112223356788999999999999999996 58876
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=279.30 Aligned_cols=250 Identities=22% Similarity=0.252 Sum_probs=194.6
Q ss_pred ccccccccCCceEEEEEEe----CCCcEEEEEEccccc---cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEE
Q 017591 27 NYSTKLGAGGFGVVYKGQF----PNGVKIAAKILKTCL---NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (369)
.+.+.||+|+||.||.+.. .+|..||+|++.... .......+.+|+.++.++ +|+||+.+++++......++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 4567899999999999976 368999999986432 123346688899999999 59999999999998889999
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+++++|.+++. ....+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 83 ILDYINGGELFTHLS-QRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 999999999999994 34578999999999999999999999 99999999999999999999999999999865433
Q ss_pred CCccccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
... ......|+..|+|||.+... ..++.++||||||+++|+|++|..||........ ...+ .....
T Consensus 159 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~~~~-----~~~~~ 225 (290)
T cd05613 159 EVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-------QAEI-----SRRIL 225 (290)
T ss_pred ccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-------HHHH-----HHHhh
Confidence 221 11234588999999988653 2467899999999999999999999864322110 0000 01111
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCC-----ChHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARP-----PMSAVV 294 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~ 294 (369)
. ..+..+......+.+++.+||+.||.+|| ++.+++
T Consensus 226 ~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 226 K-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred c-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 1 11223344667889999999999999997 455554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=310.31 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=189.5
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe----------------
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD---------------- 92 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------------- 92 (369)
+.||+||||.||+++++ +|+.+|||.+...........+.+|+.++.+|+|||||+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 47999999999999885 8999999998865566778889999999999999999998743311
Q ss_pred ---------------------------------------C----------------------------------------
Q 017591 93 ---------------------------------------Q---------------------------------------- 93 (369)
Q Consensus 93 ---------------------------------------~---------------------------------------- 93 (369)
.
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence 0
Q ss_pred ------------------------CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEee
Q 017591 94 ------------------------TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149 (369)
Q Consensus 94 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~ 149 (369)
...||-||||+..+|.+++..+...-.....|.++++|++||.|+|+ +|+|||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~giIHR 721 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---QGIIHR 721 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---Cceeec
Confidence 01367899999977777774332222678999999999999999999 999999
Q ss_pred cCCCCceEecCCCCeeEeecCCceecC----------------CCCCccccccCCCCCCccccccccccC--CCCcchhh
Q 017591 150 DIKPANILLDAKFSAKVADFGLAKLCN----------------PENTHDSTSGYRGTPGYSAPEFLLRNY--PITQKCDV 211 (369)
Q Consensus 150 dlkp~Nill~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~s~~sDv 211 (369)
||||.|||++.++.|||+|||++.... ........+...||.-|+|||++.... .|+.|+|+
T Consensus 722 DLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDm 801 (1351)
T KOG1035|consen 722 DLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDM 801 (1351)
T ss_pred cCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhh
Confidence 999999999999999999999998621 011122345678999999999988765 69999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC---CHHHHHHHHHHHHhccccCCCCCC
Q 017591 212 YSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN---DREEAERMSMVALWCVQDCPEARP 288 (369)
Q Consensus 212 wSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RP 288 (369)
|||||||+||+.. |. ..++...+...+....++.. .......=..+|.+|++.||.+||
T Consensus 802 YSLGIVlFEM~yP---F~---------------TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 802 YSLGIVLFEMLYP---FG---------------TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred HHHHHHHHHHhcc---CC---------------chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCC
Confidence 9999999999943 32 12222222222223333333 445556678899999999999999
Q ss_pred ChHHHHH
Q 017591 289 PMSAVVK 295 (369)
Q Consensus 289 s~~~v~~ 295 (369)
|+.|++.
T Consensus 864 tA~eLL~ 870 (1351)
T KOG1035|consen 864 TATELLN 870 (1351)
T ss_pred CHHHHhh
Confidence 9999873
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=280.07 Aligned_cols=256 Identities=21% Similarity=0.240 Sum_probs=200.6
Q ss_pred ccccccccCCceEEEEEEe----CCCcEEEEEEccccc---cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEE
Q 017591 27 NYSTKLGAGGFGVVYKGQF----PNGVKIAAKILKTCL---NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (369)
.+.+.||+|+||.||++.. .++..|++|+++... .......+.+|+.++.++ +|+||+++++.+......++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 4567899999999999975 357889999886422 123345688999999999 59999999999998899999
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+++++|.+++.. ...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||+++.....
T Consensus 83 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 83 ILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999843 4578999999999999999999999 99999999999999999999999999998765433
Q ss_pred CCccccccCCCCCCccccccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
... ......++..|++||.+.+.. ..+.++||||||+++|+|++|..||........ ...+.. ...
T Consensus 159 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~-----~~~ 225 (288)
T cd05583 159 EEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-------QSEISR-----RIL 225 (288)
T ss_pred ccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-------HHHHHH-----HHH
Confidence 211 122345889999999876542 368899999999999999999999864322110 011111 011
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
. .....+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 226 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 226 K-SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred c-cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1 11223344567789999999999999999999998888753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=283.34 Aligned_cols=261 Identities=20% Similarity=0.249 Sum_probs=192.3
Q ss_pred ccccC--CceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 31 KLGAG--GFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 31 ~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
.||+| +||+||++.+. +++.||+|+..... .......+.+|+.+++.++||||+++++++..++..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 56666 99999999874 69999999987432 3344578899999999999999999999999999999999999999
Q ss_pred CHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc----
Q 017591 107 SLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH---- 181 (369)
Q Consensus 107 sL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---- 181 (369)
+|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++++||+.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999998543 3468999999999999999999999 99999999999999999999999999765332111100
Q ss_pred -cccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC-----ccccchhH---------
Q 017591 182 -DSTSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD-----WFPKQVWD--------- 245 (369)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~-----~~~~~~~~--------- 245 (369)
.......++..|+|||++.++ ..++.++|||||||++|+|++|+.||......... ..+...+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 011112356679999998764 35789999999999999999999999754321100 00000000
Q ss_pred Hhhh-----------chhh-----hhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 246 EYEK-----------GELA-----AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 246 ~~~~-----------~~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
.... .... ..............+...+.+|+.+||+.||.+|||+.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000 0000 00000001122345677899999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=290.83 Aligned_cols=243 Identities=22% Similarity=0.336 Sum_probs=204.2
Q ss_pred cccccccCCceEEEEEEe-CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 28 YSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.+.||+|.|++|.+++. .++..||+|++.+.. +......+.+|+.++..++|||||+++.+...+..+|+||||+.+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 457899999999999976 469999999998654 334445689999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|.+.+++..++. +.+.....++.|+.+|++|+|+ ++|+|||||++|+||+.+.++||+|||++..+..... ..
T Consensus 140 ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~---lq 212 (596)
T KOG0586|consen 140 GELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM---LQ 212 (596)
T ss_pred chhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccccc---cc
Confidence 999999965554 4558999999999999999999 9999999999999999999999999999998764433 34
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..+|++.|.|||++.+....++.+|+||+|++||.|++|..||++.....+. .....+. -..+
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------~rvl~gk----------~rIp 275 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------PRVLRGK----------YRIP 275 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------chheeee----------eccc
Confidence 5789999999999988778899999999999999999999999876554321 1111111 1122
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
.....++.+|++++|-++|.+|++++++.
T Consensus 276 ~~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 276 FYMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred ceeechhHHHHHHhhccCccccCCHHHhh
Confidence 33456688999999999999999999876
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=285.09 Aligned_cols=265 Identities=25% Similarity=0.292 Sum_probs=192.4
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC--------ce
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT--------KA 96 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~ 96 (369)
.+.++||+|+||.||+|.+. +++.+++|.+..... ......+.+|+.+++.++|+||+++++++.+.. ..
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 34578999999999999875 589999998764322 222346778999999999999999999876543 35
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 97 ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
++||||+.+ +|...+......+++..+..++.|+++||.|||+ ++++|+||||+||+++.++.++|+|||++....
T Consensus 91 ~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 91 YMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred EEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 899999976 7888776666689999999999999999999999 999999999999999999999999999997654
Q ss_pred CCCCcc---------ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------c
Q 017591 177 PENTHD---------STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------F 239 (369)
Q Consensus 177 ~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~ 239 (369)
...... ..+...++..|+|||.+.+...++.++|||||||++|+|++|+.||.......... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 322111 11233568889999988765568999999999999999999999987544321000 0
Q ss_pred ccchhHHhhhchhhh--hhh---cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 240 PKQVWDEYEKGELAA--KVL---GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 240 ~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+..+....... ... ..............+.+++.+||+.||.+|||+.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000000000000 000 00000001123367889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.67 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=197.8
Q ss_pred cccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC------CceEEEE
Q 017591 28 YSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ------TKAALVY 100 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~ 100 (369)
-.+.||+|+||.||+|++ +.|+.||||.+++.......+...+|++++++++|+|||+++++-.+. +...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 357899999999999996 569999999998766666678899999999999999999999876543 3568999
Q ss_pred eccCCCCHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec--CCC--CeeEeecCCcee
Q 017591 101 EFMENGSLDKYLFT--DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD--AKF--SAKVADFGLAKL 174 (369)
Q Consensus 101 e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~--~~kl~Dfg~~~~ 174 (369)
|||.||+|+..+.+ +...+++.+++.++.++..||.|||+ +||+||||||.||++- .+| ..||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999999964 34579999999999999999999999 9999999999999993 334 379999999998
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhh------
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYE------ 248 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 248 (369)
+.++.. -+...||..|++||.+.....++.-.|.|||||++|++.||..||.....+... ....|....
T Consensus 174 l~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~--~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 174 LDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN--KEIMWHIITKKPSGV 248 (732)
T ss_pred CCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc--chhhhhhhccCCCce
Confidence 876653 345789999999998886558999999999999999999999999866544210 000111110
Q ss_pred --------hchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCC
Q 017591 249 --------KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARP 288 (369)
Q Consensus 249 --------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 288 (369)
+|.+.....-.............+..++..+|.-+|.+|-
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1111000000011223455667788888889999999998
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=283.46 Aligned_cols=241 Identities=26% Similarity=0.323 Sum_probs=200.0
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEcccc-c-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-L-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
++||+||||.||-++. .+|+.+|.|.+.+. . ....+.-..+|-.+|.+++.+.||.+--.|...+.+++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 6899999999999976 45999999877532 1 2234455778999999999999999999999999999999999999
Q ss_pred CHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 107 SLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 107 sL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+|.-+|.+.+ ..+++.++..++.+|+.||++||+ .+||+|||||+|||||+.|+++|+|.|+|..+.......
T Consensus 271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~--- 344 (591)
T KOG0986|consen 271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR--- 344 (591)
T ss_pred ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCccc---
Confidence 9999886554 579999999999999999999999 999999999999999999999999999999887655433
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||.+|||||++..+ .|+...|.|||||+||||+.|+.||...... ....++...+. ....+.+
T Consensus 345 ~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK------------vk~eEvdrr~~-~~~~ey~ 410 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK------------VKREEVDRRTL-EDPEEYS 410 (591)
T ss_pred cccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhhhh------------hhHHHHHHHHh-cchhhcc
Confidence 24799999999999987 5999999999999999999999999643221 11122222222 2224556
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCh
Q 017591 266 REEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
..+++++.+|....|+.||.+|.--
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccC
Confidence 7889999999999999999999653
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=279.53 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=199.0
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.||+|+||.||++.+. +++.|++|++.... .......+.+|+.++.++. |+||+++++++.+.+..++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 45678999999999999875 68999999987522 2344567889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc-
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH- 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 181 (369)
+++++|.+++.. ...+++..++.++.|++.||.+||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 84 APNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999999999944 4579999999999999999999999 99999999999999999999999999998866433221
Q ss_pred -----------------cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchh
Q 017591 182 -----------------DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVW 244 (369)
Q Consensus 182 -----------------~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 244 (369)
.......++..|++||.+... ..+.++||||||++++++++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------- 228 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---------- 228 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHH----------
Confidence 122334578899999987764 6899999999999999999999998754311
Q ss_pred HHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCCh----HHHH
Q 017591 245 DEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPM----SAVV 294 (369)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~~v~ 294 (369)
.... ... ......+...+..+.+++.+||+.+|.+||++ .+++
T Consensus 229 ~~~~------~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 229 LTFQ------KIL-KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HHHH------HHH-hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 1110 000 01112233447789999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=287.09 Aligned_cols=263 Identities=21% Similarity=0.268 Sum_probs=194.8
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC-----CceEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ-----TKAALV 99 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 99 (369)
...+.||+|+||+||++.+ .+++.||+|.+... ........+.+|+.+++.++|+||+++++++... ...++|
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 87 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV 87 (337)
T ss_pred eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence 3457899999999999987 45899999987643 2223345677899999999999999999988644 347999
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
|||+. ++|.+++. ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 88 YELMD-TDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EeCCC-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 99996 58988884 45679999999999999999999999 999999999999999999999999999998654322
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhhch
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKGE 251 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~ 251 (369)
.......++..|+|||.+.....++.++|||||||++|+|++|+.||........ .......+.......
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 163 --DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred --ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 1122345788999999877644689999999999999999999999965421100 000000000000000
Q ss_pred hh---hhhhcC---CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 252 LA---AKVLGC---GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 252 ~~---~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
.. ...... .........+..+.+++.+||+.+|.+||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00 000000 0001122356778999999999999999999998854
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=275.33 Aligned_cols=247 Identities=22% Similarity=0.340 Sum_probs=194.9
Q ss_pred hccccccccCCceEEEEEEeCC-CcEEEEEEccc----cccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKT----CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
+.+.++||+|+||.||++.+.. +..+++|+.+. ........++..|+.+++.++||||+++++++.+.+..++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4567899999999999998743 44555555542 122233456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 101 EFMENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 101 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
||+++++|.+++.. ....+++..++.++.|++.||.|||+ ++++|+||+|+||+++. +.++|+|||.+.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998853 34679999999999999999999999 99999999999999975 5799999999877543
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
... ......++..|+|||.+... .++.++|+||||+++|+|++|+.||...... . ......
T Consensus 158 ~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----------~------~~~~~~ 218 (260)
T cd08222 158 SCD--LATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFL----------S------VVLRIV 218 (260)
T ss_pred Ccc--cccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------H------HHHHHH
Confidence 222 12234588899999987653 6788999999999999999999998532211 1 111112
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+..+...+..+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 219 EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 22233445567788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=283.92 Aligned_cols=273 Identities=20% Similarity=0.263 Sum_probs=197.7
Q ss_pred cCHHHHHHhhh----cc--ccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEE
Q 017591 16 FTLEQLCSFTN----NY--STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLY 87 (369)
Q Consensus 16 ~~~~el~~~t~----~f--~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~ 87 (369)
|+..|+.++++ +| .+.||+|+||.||+|.+. +|+.||+|.+.... .......+.+|+.+++.+.|+||++++
T Consensus 1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 80 (342)
T cd07879 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80 (342)
T ss_pred CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence 44556666653 33 368999999999999874 58999999886432 223345688999999999999999999
Q ss_pred eEEEeCC------ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC
Q 017591 88 GFCYDQT------KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK 161 (369)
Q Consensus 88 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 161 (369)
+++.... ..++|+||+.. +|..++ +..+++..+..++.|++.||+|||+ ++++||||||+||+++.+
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~ 153 (342)
T cd07879 81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNED 153 (342)
T ss_pred heecccccCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCC
Confidence 9987543 45899999975 777765 3468999999999999999999999 999999999999999999
Q ss_pred CCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC----
Q 017591 162 FSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD---- 237 (369)
Q Consensus 162 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~---- 237 (369)
+.++|+|||+++..... .....++..|+|||.+.+...++.++|||||||++|||++|+.||.........
T Consensus 154 ~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~ 228 (342)
T cd07879 154 CELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228 (342)
T ss_pred CCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998754321 123457889999998876556899999999999999999999999754321100
Q ss_pred ----ccccchhHHhhhchhhhhhhc-CCCC-----CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH--HhcCC
Q 017591 238 ----WFPKQVWDEYEKGELAAKVLG-CGIE-----ENDREEAERMSMVALWCVQDCPEARPPMSAVVK--MLEGG 300 (369)
Q Consensus 238 ----~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~--~L~~~ 300 (369)
.......+............. ...+ ...+.....+.+++.+||+.||.+||++.+++. .++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000000000000000000000 0000 001123466889999999999999999999983 35544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=284.47 Aligned_cols=259 Identities=20% Similarity=0.235 Sum_probs=193.0
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEccccccHH-------------HHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKR-------------VEAQFMAEIGTIGRTYHINLVRLYGFCYDQT 94 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 94 (369)
.+.||.|+||+||+|.++ +++.||+|.+....... ....+.+|+.+++.++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 457999999999999875 58999999876432111 0124778999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 95 KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
..++||||+. ++|.+++ .....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 94 ~~~lv~e~~~-~~l~~~l-~~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVV-DRKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred cEEEEEeccc-cCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccceee
Confidence 9999999997 4999988 445579999999999999999999999 9999999999999999999999999999976
Q ss_pred cCCCC------------CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccc
Q 017591 175 CNPEN------------THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQ 242 (369)
Q Consensus 175 ~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 242 (369)
..... .........++..|+|||.+.+...++.++|||||||++|+|++|..||........ ...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---~~~ 245 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ---LGR 245 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence 54111 011112234688899999887655679999999999999999999999875543210 000
Q ss_pred hhHHhh-----------hchhhhhh---hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 243 VWDEYE-----------KGELAAKV---LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 243 ~~~~~~-----------~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+..... ........ ............+..+.+++.+||+.+|++||++.+++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 000000 00000000 000000011223567889999999999999999999884
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=279.71 Aligned_cols=262 Identities=29% Similarity=0.399 Sum_probs=201.3
Q ss_pred cccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhc--cCCCceeeEEeEEEeCC----ceEEEEe
Q 017591 28 YSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR--TYHINLVRLYGFCYDQT----KAALVYE 101 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e 101 (369)
+.+.||+|+||.||+|.. +++.||||++.. +..+.|++|-++++. ++|+||+++++.-...+ .++||++
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 557899999999999998 569999999884 456788888888775 57999999999876555 7899999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc------CCCeEeecCCCCceEecCCCCeeEeecCCceec
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC------NQRIIHYDIKPANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
|.+.|+|.+|| ....++|....+++..+++||+|||+.. +.+|+|||||..||||..|+++.|+|||+|..+
T Consensus 289 fh~kGsL~dyL--~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 289 FHPKGSLCDYL--KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eccCCcHHHHH--HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 99999999999 4557999999999999999999999854 356999999999999999999999999999988
Q ss_pred CCCCCccccccCCCCCCccccccccccCCCC-----cchhhHHHHHHHHHHHcCCCCCCCCCCC--ccCcc----ccchh
Q 017591 176 NPENTHDSTSGYRGTPGYSAPEFLLRNYPIT-----QKCDVYSFGMLLFEIIGRRKNAQDCSSD--TLDWF----PKQVW 244 (369)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s-----~~sDvwSlGvil~elltg~~p~~~~~~~--~~~~~----~~~~~ 244 (369)
.........-...||.+|||||++.+..++. .+.||||+|.|||||++.-.-+.....+ ...+- .....
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 7655554445578999999999988754544 4799999999999999877655421111 11110 00011
Q ss_pred HHhhhchhhhhhhcCCCCCCCH-----HHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 245 DEYEKGELAAKVLGCGIEENDR-----EEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+.+....+. ...++..+. .....|.+.+..||+.||+.|.|+.=|-+.+...
T Consensus 447 e~mq~~VV~----kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 447 EEMQELVVR----KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred HHHHHHHHh----hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 222211111 112222222 2457789999999999999999998777766554
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=274.82 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=192.1
Q ss_pred ccccccccCCceEEEEEEeCC-CcEEEEEEcccccc-HHHHHHHHHHHHHHhcc---CCCceeeEEeEEEeCCc-----e
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLN-KRVEAQFMAEIGTIGRT---YHINLVRLYGFCYDQTK-----A 96 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----~ 96 (369)
.+.+.||+|+||.||+|.++. ++.+|+|.+..... ......+.+|+.++.++ +|+|++++++++.+.+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 356789999999999999864 89999999874322 22334566777766655 59999999999987776 8
Q ss_pred EEEEeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceec
Q 017591 97 ALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
+++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+...
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999999975 8988885433 368999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhh------
Q 017591 176 NPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEK------ 249 (369)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 249 (369)
...... ....++..|+|||++... .++.++|||||||++|+|++|..||........ + ..+.+....
T Consensus 158 ~~~~~~---~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~ 230 (287)
T cd07838 158 SFEMAL---TSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--L-DKIFDVIGLPSEEEW 230 (287)
T ss_pred cCCccc---ccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--H-HHHHHHcCCCChHhc
Confidence 433221 223478899999988765 689999999999999999999988875432210 0 000000000
Q ss_pred --chh-hhhhhcCC----CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 250 --GEL-AAKVLGCG----IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 250 --~~~-~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... ........ ...........+.+++.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 00000000 01112345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=284.56 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=200.5
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----ceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-----KAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l 98 (369)
+.+.+.||+|+||.||+|.+. +++.|++|.+..... ......+.+|+.+++.++|+||+++++++.+.. ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 346688999999999999885 489999998875432 344567899999999999999999999988765 7899
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+.+ +|.+++. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++......
T Consensus 82 v~e~~~~-~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 82 VTELMET-DLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred Eecchhh-hHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999985 8999884 44589999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhh
Q 017591 179 NTH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEK 249 (369)
Q Consensus 179 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~ 249 (369)
... .......++..|+|||.+.....++.++||||||+++|+|++|+.||........ .......+.....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 210 1122345788999999888755789999999999999999999999976543110 0000000000000
Q ss_pred chhhhhhhc-CC-----CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 250 GELAAKVLG-CG-----IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 250 ~~~~~~~~~-~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......... .. ........+..+.+++.+||+.+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000000000 00 00111224677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=278.06 Aligned_cols=262 Identities=26% Similarity=0.303 Sum_probs=198.8
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.++||+|+||.||+|... +++.+++|.+.... .......+.+|+.+++.++|+|++++++++.+....++||||+.+
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM 82 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc
Confidence 4578999999999999885 48999999987543 233446778899999999999999999999999999999999985
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+|.+++......+++..++.++.|++.||.+||+ ++++||||+|+||+++.++.++|+|||.+........ ...
T Consensus 83 -~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~ 156 (282)
T cd07829 83 -DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYT 156 (282)
T ss_pred -CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccC
Confidence 9999996554679999999999999999999999 9999999999999999999999999999886543322 112
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhhchhhhhhh
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 257 (369)
...++..|+|||.+.....++.++|||||||++|||++|+.||........ .......|.....-.......
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 234677899999887655789999999999999999999998865432110 000000011110000000000
Q ss_pred c----CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 G----CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
. .......+.....+.+++.+||+.||++||++.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000111223677999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=266.81 Aligned_cols=270 Identities=20% Similarity=0.292 Sum_probs=212.9
Q ss_pred CHHHHHHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCC
Q 017591 17 TLEQLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQT 94 (369)
Q Consensus 17 ~~~el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 94 (369)
.+.|+.+.|.. .||+|+++.|-.+.. .+|..+|||++.+. ......++.+|++++...+ |+||++++++|.+++
T Consensus 74 ~F~d~YkLt~e---~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 74 KFEDMYKLTSE---LLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred hHHHHHHhHHH---HhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 36777777754 599999999999965 78999999999875 4466788999999999885 999999999999999
Q ss_pred ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC---eeEeecCC
Q 017591 95 KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS---AKVADFGL 171 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~ 171 (369)
.+|||||.|.||+|...| .....+++.+...+..+|+.||.|||. +||.||||||+|||....+. +||+||.+
T Consensus 150 ~FYLVfEKm~GGplLshI-~~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHI-QKRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred eEEEEEecccCchHHHHH-HHhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999999999 455679999999999999999999999 99999999999999977665 79999988
Q ss_pred ceecCC-----CCCccccccCCCCCCcccccccc----ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccc
Q 017591 172 AKLCNP-----ENTHDSTSGYRGTPGYSAPEFLL----RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQ 242 (369)
Q Consensus 172 ~~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~----~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 242 (369)
..-+.. ......-....|+..|||||+.. ....|..+.|.||||||||-||+|-.||.+.-...-.|-...
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 653321 11122233467999999999754 223688999999999999999999999987765544443322
Q ss_pred hhHHhhhchhhhhhhcCCCC---CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 243 VWDEYEKGELAAKVLGCGIE---ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....- +..+.+.+..+.+. .....++.+..+++..+|..++..|-++..++.
T Consensus 306 ~Cr~C-Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVC-QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHH-HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22111 12233334433332 223456788899999999999999999988875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=269.98 Aligned_cols=237 Identities=28% Similarity=0.337 Sum_probs=193.1
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 32 LGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 32 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
||+|+||.||++... +++.+++|.+.... .......+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 48999999887532 223556889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCC
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 188 (369)
.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSK-EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 999943 3468999999999999999999999 999999999999999999999999999988754332 1223456
Q ss_pred CCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHH
Q 017591 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268 (369)
Q Consensus 189 gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (369)
++..|++||.+.+. ..+.++|+||||+++|+|++|+.||....... .... ... .....+...
T Consensus 155 ~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~---------~~~-~~~~~~~~~ 216 (250)
T cd05123 155 GTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-------IYEK---------ILK-DPLRFPEFL 216 (250)
T ss_pred CCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHH---------Hhc-CCCCCCCCC
Confidence 88899999988764 67899999999999999999999986433210 0111 111 112223334
Q ss_pred HHHHHHHHHhccccCCCCCCChHH
Q 017591 269 AERMSMVALWCVQDCPEARPPMSA 292 (369)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~RPs~~~ 292 (369)
+..+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 678899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=281.22 Aligned_cols=257 Identities=22% Similarity=0.266 Sum_probs=192.5
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC------ceEE
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT------KAAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l 98 (369)
.+.+.||+|+||.||++.+ .++..||+|.+... ........+.+|+.+++.++|+||+++++++.... ..++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07880 18 RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97 (343)
T ss_pred EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence 3457899999999999976 46899999988643 23334557889999999999999999999887543 3589
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+ +++|.+++. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 98 v~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 98 VMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred EEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 99998 679998883 3568999999999999999999999 99999999999999999999999999998765322
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhhc
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKG 250 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~ 250 (369)
.....++..|++||.+.....++.++|+|||||++|+|++|+.||........ ...+..+...+...
T Consensus 172 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 172 -----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred -----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 12345788999999887644688999999999999999999999975432100 00001111111111
Q ss_pred hhhhhhh--cCCC----CCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 251 ELAAKVL--GCGI----EENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 251 ~~~~~~~--~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
....... .... ..........+.+++.+|++.||.+||++.+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000 0000 001122345688999999999999999999988
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=271.39 Aligned_cols=238 Identities=25% Similarity=0.305 Sum_probs=199.1
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
|.++||+|.||.|.+++.+ .++.+|+|++++. ..++....-..|-++|...+||.+..+.-.|..+++.|+||||..
T Consensus 172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence 4589999999999999875 5999999999864 344555667789999999999999999989999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
||.|.-.+ ++...+++.+...+...|+.||.|||+ ++||+||||.+|.|++++|++||+|||+++.--. .....
T Consensus 252 GGeLf~HL-srer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~g~t~ 325 (516)
T KOG0690|consen 252 GGELFFHL-SRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--YGDTT 325 (516)
T ss_pred CceEeeeh-hhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc--cccee
Confidence 99998888 566789999999999999999999999 9999999999999999999999999999875211 12234
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
...+||+.|+|||++... .|..+.|.|.+||++|||++|+.||-..+...+ ++.+..++ ...
T Consensus 326 kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-------FeLIl~ed----------~kF 387 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-------FELILMED----------LKF 387 (516)
T ss_pred ccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHH-------HHHHHhhh----------ccC
Confidence 568899999999999886 899999999999999999999999975544321 12211111 234
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCC
Q 017591 265 DREEAERMSMVALWCVQDCPEARPP 289 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs 289 (369)
+.....+...|+..+|..||.+|.-
T Consensus 388 Pr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 388 PRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred CccCCHHHHHHHHHHhhcChHhhcC
Confidence 5566778889999999999999953
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=281.18 Aligned_cols=269 Identities=19% Similarity=0.257 Sum_probs=197.5
Q ss_pred cCHHHHHHhhhccc--cccccCCceEEEEEEe-CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEE
Q 017591 16 FTLEQLCSFTNNYS--TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCY 91 (369)
Q Consensus 16 ~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 91 (369)
....+|...+++|. +.||+|+||.||++.+ .+++.||+|.+.... .......+.+|+.++..++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34456666777774 6899999999999976 468999999887432 2233456888999999999999999999886
Q ss_pred eC------CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCee
Q 017591 92 DQ------TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAK 165 (369)
Q Consensus 92 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 165 (369)
.. ...+++++++ +++|.+++. ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEE
Confidence 43 3467888887 679988873 3468999999999999999999999 9999999999999999999999
Q ss_pred EeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------C
Q 017591 166 VADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------D 237 (369)
Q Consensus 166 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~ 237 (369)
|+|||++...... .....++..|+|||.+.+...++.++|||||||++|+|++|+.||........ .
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998754321 12345788999999876645688999999999999999999999865432110 0
Q ss_pred ccccchhHHhhhchhhhhhhc-CCCC-----CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 238 WFPKQVWDEYEKGELAAKVLG-CGIE-----ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+......+........... ...+ .........+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000011111110000000000 0000 001123567889999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.32 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=208.2
Q ss_pred cccccccCCceEEEEEEeC----C----CcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEE
Q 017591 28 YSTKLGAGGFGVVYKGQFP----N----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (369)
+.+.||.|.||.|++|... . ...||||..+..........+..|+++++.+ .|+|++.++|+|...+..++
T Consensus 300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~ 379 (609)
T KOG0200|consen 300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYV 379 (609)
T ss_pred ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEE
Confidence 4568999999999999642 1 4689999999777767788999999999998 59999999999999889999
Q ss_pred EEeccCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC
Q 017591 99 VYEFMENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS 163 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 163 (369)
|+||+..|+|.+++..++ ..++....+.++.|||.|++||++ .+++||||.++|||+..+..
T Consensus 380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCCE
Confidence 999999999999997655 358999999999999999999999 99999999999999999999
Q ss_pred eeEeecCCceecCCCCCcccc-ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCcccc
Q 017591 164 AKVADFGLAKLCNPENTHDST-SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPK 241 (369)
Q Consensus 164 ~kl~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 241 (369)
+||+|||+++........... +...-...|||||.+.. ..++.+||||||||+||||++ |..|+.+... ..
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~------~~ 529 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP------TE 529 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCc------HH
Confidence 999999999965443333221 11113455999999988 589999999999999999998 5566654211 11
Q ss_pred chhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 242 QVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+++. +..+.+...+.....++.++++.||+.+|++||++.++++.++..
T Consensus 530 ~l~~~---------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 ELLEF---------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHH---------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 12233 333344455566678899999999999999999999999999873
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=279.49 Aligned_cols=263 Identities=21% Similarity=0.274 Sum_probs=192.1
Q ss_pred ccccccccCCceEEEEEEeC-C--CcEEEEEEccccc-cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeC----CceE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-N--GVKIAAKILKTCL-NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQ----TKAA 97 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~~~ 97 (369)
.+.+.||+|+||.||++.+. . +..||+|.+.... .......+.+|+.++.++ .|+||+++++.+... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 45678999999999999874 3 7899999876432 223355788899999998 599999999876432 4578
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
++++|+. ++|.+++ .....+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||+++....
T Consensus 83 ~~~e~~~-~~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 83 LYEELME-ADLHQII-RSGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEeccc-CCHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 8999986 5899988 445679999999999999999999999 9999999999999999999999999999986643
Q ss_pred CCCc--cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHh
Q 017591 178 ENTH--DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEY 247 (369)
Q Consensus 178 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~ 247 (369)
.... .......|+..|+|||++.+...++.++|||||||++|+|++|..||........ ...+...+..+
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2221 1123346899999999877655689999999999999999999999875432100 00000001111
Q ss_pred hhchhhhhhh---cC---CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 248 EKGELAAKVL---GC---GIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 248 ~~~~~~~~~~---~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
.......... .. ............+.+++.+||+.||.+||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000 00 00011112356789999999999999999999976
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=279.52 Aligned_cols=263 Identities=21% Similarity=0.231 Sum_probs=191.1
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC----------
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ---------- 93 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---------- 93 (369)
++.+.+.||.|+||.||+|.+. +++.|++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 3445688999999999999874 589999998764332 3456788999999999999999999876543
Q ss_pred ----CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-CCCeeEee
Q 017591 94 ----TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-KFSAKVAD 168 (369)
Q Consensus 94 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~D 168 (369)
...++||||+++ +|.+++. ...+++..++.++.|++.||.|||+ .|++||||||+||+++. ++.++|+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYMET-DLANVLE--QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeecccc-cHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECC
Confidence 357899999975 8988883 3468999999999999999999999 99999999999999974 55789999
Q ss_pred cCCceecCCCCCcc-ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------cc
Q 017591 169 FGLAKLCNPENTHD-STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WF 239 (369)
Q Consensus 169 fg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~ 239 (369)
||++.......... ......++..|+|||.+..+..++.++|||||||++|+|++|+.||......... ..
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99998654322111 1122357889999998766557889999999999999999999999654321100 00
Q ss_pred ccchhHHhhhchhhhhhhcCCCCCC-----CHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 240 PKQVWDEYEKGELAAKVLGCGIEEN-----DREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
....+.................... .......+.+++.+||+.||.+||++.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 0000000000000000000000111 112456788999999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=280.57 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=192.6
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc------eEEE
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK------AALV 99 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv 99 (369)
+.+.||+|++|.||+|.+. +++.||+|.+... ........+.+|+.+++.+.|+|++++++++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 3478999999999999885 5889999987643 223344667889999999999999999988765544 8999
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
+||+ +++|.+++.. ..+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus 99 ~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 99 THLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred EecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 9998 5699998843 569999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhhch
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKGE 251 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~ 251 (369)
.....++..|+|||.+.....++.++|||||||++|+|++|+.||........ ...+...+..+....
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 22345788999999887654688999999999999999999999965432110 000000111111000
Q ss_pred hhhhhh---cCCCC---CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVL---GCGIE---ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~---~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...... ..... ......+..+.+++.+||+.||.+|||+.+|+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 00000 001123678999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=267.02 Aligned_cols=204 Identities=27% Similarity=0.338 Sum_probs=171.4
Q ss_pred ccccccccCCceEEEEEEeCC-----CcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEe-CCceEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-----GVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYD-QTKAALV 99 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv 99 (369)
+...+||+|.||.||+|..++ ...+|+|.++...+ ...-....+|+.+++.++|+|++.+..++.. +...+++
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 345789999999999995432 34789998875422 2333567899999999999999999999987 6788999
Q ss_pred EeccCCCCHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC----CCeeEeecCC
Q 017591 100 YEFMENGSLDKYLFTD----TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK----FSAKVADFGL 171 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~ 171 (369)
+||.+. +|...|.-+ ...++...+..|+.||+.|+.|||+ +-|+||||||.|||+..+ |+|||+|||+
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999998 898888432 3578999999999999999999999 999999999999999877 8999999999
Q ss_pred ceecCCCCCcc-ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 017591 172 AKLCNPENTHD-STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSD 234 (369)
Q Consensus 172 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~ 234 (369)
++.+...-... ....+.-|..|.|||.+.+...||.+.|||+.|||+.||++..+-|......
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k 246 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK 246 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh
Confidence 99887544333 4455678999999999998889999999999999999999998887755443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=262.14 Aligned_cols=220 Identities=21% Similarity=0.149 Sum_probs=175.4
Q ss_pred CCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCHHHHhc
Q 017591 35 GGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLF 113 (369)
Q Consensus 35 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 113 (369)
|.+|.||+++++ +++.+|+|.+.... .+.+|...+....|||++++++++.+.+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999884 58999999987532 23344555555679999999999999999999999999999999984
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCc
Q 017591 114 TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193 (369)
Q Consensus 114 ~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 193 (369)
. ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 78 ~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y 148 (237)
T cd05576 78 K-FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY 148 (237)
T ss_pred H-hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence 4 3469999999999999999999999 999999999999999999999999999876543221 123456789
Q ss_pred cccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHH
Q 017591 194 SAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMS 273 (369)
Q Consensus 194 ~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 273 (369)
+|||.+..+ .++.++||||+|+++|||++|+.|+........ . ......+...+..+.
T Consensus 149 ~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~---------~~~~~~~~~~~~~~~ 206 (237)
T cd05576 149 CAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSGIN------------T---------HTTLNIPEWVSEEAR 206 (237)
T ss_pred cCCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------c---------ccccCCcccCCHHHH
Confidence 999987654 678999999999999999999987653211100 0 000012233457789
Q ss_pred HHHHhccccCCCCCCChH
Q 017591 274 MVALWCVQDCPEARPPMS 291 (369)
Q Consensus 274 ~l~~~cl~~~p~~RPs~~ 291 (369)
+++.+||+.||.+||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=270.09 Aligned_cols=272 Identities=25% Similarity=0.322 Sum_probs=208.2
Q ss_pred hhcCCcccCHHHHHHhhhccccccccCCceEEEEEEe-CCCcEEEEEEcc--ccccH----HHHHHHHHHHHHHhccCCC
Q 017591 9 AREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILK--TCLNK----RVEAQFMAEIGTIGRTYHI 81 (369)
Q Consensus 9 ~~~~~~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~----~~~~~~~~E~~~l~~l~h~ 81 (369)
.++++-.|..+-+...+|-..+.||+|||+.||++.+ ..++.||+|+-. ++..+ .......+|..+-+.|.||
T Consensus 448 ~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHp 527 (775)
T KOG1151|consen 448 HNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHP 527 (775)
T ss_pred cccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcc
Confidence 3344455666666666666678899999999999977 458999999864 32222 2334577899999999999
Q ss_pred ceeeEEeEEE-eCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC
Q 017591 82 NLVRLYGFCY-DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA 160 (369)
Q Consensus 82 niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 160 (369)
.||++|+++. +.+.+|-|+|||+|.+|+-|| .....+++.++..|+.||+.||.||.+.. .+|+|-||||.||||..
T Consensus 528 RIVKlYDyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~ 605 (775)
T KOG1151|consen 528 RIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVN 605 (775)
T ss_pred eeeeeeeeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEec
Confidence 9999999986 556789999999999999999 56678999999999999999999999853 68999999999999954
Q ss_pred ---CCCeeEeecCCceecCCCCCcc-----ccccCCCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCC
Q 017591 161 ---KFSAKVADFGLAKLCNPENTHD-----STSGYRGTPGYSAPEFLLRN---YPITQKCDVYSFGMLLFEIIGRRKNAQ 229 (369)
Q Consensus 161 ---~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~---~~~s~~sDvwSlGvil~elltg~~p~~ 229 (369)
-|.+||+|||+++.+.+..... -+.-..||..|++||.+.-+ ...+.|.||||+|||+|.++-|+.||.
T Consensus 606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 4679999999999987543321 13446799999999987644 367999999999999999999999998
Q ss_pred CCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHH
Q 017591 230 DCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAV 293 (369)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v 293 (369)
...... +.+....+... ..-.++. -+....+...+|.+||+..-++|....++
T Consensus 686 hnqsQQ---------dILqeNTIlkA-tEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 686 HNQSQQ---------DILQENTILKA-TEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred CchhHH---------HHHhhhchhcc-eeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 655432 11111221111 1111222 23456678899999999999998766654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=261.13 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=194.5
Q ss_pred ccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
.||.|+||+|++-.. +.|+..|||.+..........++..|.++..+- +.||||+++|.+..++.+++.||.|.- ||
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-Sl 149 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SL 149 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hH
Confidence 799999999999976 569999999998766656667888888766554 699999999999999999999999965 88
Q ss_pred HHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 109 DKYLF----TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 109 ~~~l~----~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+.+.. -+...+++..+-.|....+.||.||-+. ..|+|||+||+|||++..|.+||+|||.+-.+...- ..
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---Ak 224 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---AK 224 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH---Hh
Confidence 77652 1356799999999999999999999985 899999999999999999999999999986543221 22
Q ss_pred ccCCCCCCccccccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~-~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
+.-.|-..|||||.+.... .+..+|||||||++|||+.||+.|+..-.. +++.+..-...+... -..+.
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---------vfeql~~Vv~gdpp~-l~~~~ 294 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---------VFEQLCQVVIGDPPI-LLFDK 294 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---------HHHHHHHHHcCCCCe-ecCcc
Confidence 3345788999999887544 489999999999999999999999864221 112211111000000 00122
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+...+..++..||..|-..||...++.+
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 23457888999999999999999999998764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=292.23 Aligned_cols=143 Identities=29% Similarity=0.415 Sum_probs=128.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.++||+|+||.||+|.+. +++.||+|++... ........+.+|+.++..++|+||+++++++......++||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 45689999999999999885 5899999998643 23344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
.+++|.+++.. ...+++..++.|+.||+.||.|||. ++|+||||||+|||++.++.++|+|||+++
T Consensus 87 ~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999943 4568999999999999999999999 999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=256.71 Aligned_cols=244 Identities=22% Similarity=0.249 Sum_probs=193.5
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEe----CCceEEEEecc
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYD----QTKAALVYEFM 103 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~----~~~~~lv~e~~ 103 (369)
++||-|-.|.|-.+..+ +++.+|+|++... ....+|+++-.... |+|||.+++++.. ...+.+|||.|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 68999999999999764 5999999998753 23457887777664 9999999998863 24567899999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC---CCeeEeecCCceecCCCC
Q 017591 104 ENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 104 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~ 179 (369)
+||.|.+.+.+++ ..+++.++..|+.||+.|+.|||+ .+|.||||||+|+|...+ -.+||+|||.|+......
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~ 218 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG 218 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence 9999999996654 479999999999999999999999 999999999999999654 458999999998754322
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
.....+-|+.|.|||++... .+....|+||+||++|-||+|-+||-....... ..-....+..|...
T Consensus 219 ---~L~TPc~TPyYvaPevlg~e-KydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gqy~------ 285 (400)
T KOG0604|consen 219 ---DLMTPCFTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQYE------ 285 (400)
T ss_pred ---cccCCcccccccCHHHhCch-hcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccCcc------
Confidence 22345689999999988775 699999999999999999999999976554321 11222222222211
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+.....++...++|+.+|..+|.+|.|+.++.+
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 112334556888999999999999999999999873
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=275.90 Aligned_cols=243 Identities=22% Similarity=0.315 Sum_probs=199.3
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccc-cccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKT-CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
+.||+|-||+||-|.. ++|+.||||++.+ ...+..+.++.+|+.+|..+.||.||.+.-.|+..+..+.|||.+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 7899999999999976 6799999999864 2344556899999999999999999999999999999999999998866
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC---CCeeEeecCCceecCCCCCcccc
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
|+..+.+..+.+++.....++.||+.||.|||. ++|+|+||||+|||+... -.+||+|||.|++++.... .
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---R 723 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---R 723 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh---h
Confidence 666665667789999999999999999999999 999999999999999654 3699999999999865433 2
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
..+.||+.|+|||+++.. .|...-|+||.|||+|--|+|..||..+..-. +.+.+..+.. .+..
T Consensus 724 rsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn---------dQIQNAaFMy------Pp~P 787 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN---------DQIQNAAFMY------PPNP 787 (888)
T ss_pred hhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchh---------HHhhcccccc------CCCc
Confidence 346799999999999885 79999999999999999999999997554321 1111111111 1223
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
..+......+||..+|+..-.+|-+....+
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 455667788899999999999998877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=279.36 Aligned_cols=234 Identities=24% Similarity=0.298 Sum_probs=190.1
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.|...+|.|+|+.|-.+.. .+++..++|++... ..+-.+|+.++... +|||++++.+.+.+..+.++|||.+.
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 3456799999999999976 56899999998864 23445677566554 69999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe-cCCCCeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL-DAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
|+-|.+.+..... +. ..+..|+++|+.|+.|||+ +|+|||||||+|||+ +..++++|+|||.++.....
T Consensus 400 g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----- 469 (612)
T ss_pred ccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----
Confidence 9988887743332 23 7888999999999999999 999999999999999 68999999999999876544
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....+-|..|.|||++.. ..++.++|+||||++||+||+|+.||.....+. .+...+ ..+.
T Consensus 470 ~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i------------~~~~ 530 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRI------------QMPK 530 (612)
T ss_pred hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhh------------cCCc
Confidence 122457889999999885 589999999999999999999999997554430 011111 1233
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
.....+....+|+.+||+.||.+||+|.++.
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 3467788899999999999999999999976
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=261.82 Aligned_cols=260 Identities=28% Similarity=0.375 Sum_probs=194.9
Q ss_pred cccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHh--ccCCCceeeEEeEEEeC----CceEEEEe
Q 017591 28 YSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIG--RTYHINLVRLYGFCYDQ----TKAALVYE 101 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~~~~~~~~~----~~~~lv~e 101 (369)
+.+.||+|.||.||+|+| .|+.||||++... .+..+.+|.++++ .|+|+||+.+++.-... ..++||.+
T Consensus 215 L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEEecCccccceeeccc-cCCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 347899999999999999 7899999999852 2345556555554 67999999999876543 36899999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc-----CCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC-----NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~-----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
|-+.|||.+||. ...++.+..++++..+|.||+|||.+. +..|.|||||..||||.+++.+.|+|+|+|....
T Consensus 290 YHe~GSL~DyL~--r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 290 YHEHGSLYDYLN--RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred cccCCcHHHHHh--hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 999999999993 478999999999999999999999633 3569999999999999999999999999998765
Q ss_pred CCCCc--cccccCCCCCCccccccccccCC-----CCcchhhHHHHHHHHHHHcC----------CCCCCCCCCCccCcc
Q 017591 177 PENTH--DSTSGYRGTPGYSAPEFLLRNYP-----ITQKCDVYSFGMLLFEIIGR----------RKNAQDCSSDTLDWF 239 (369)
Q Consensus 177 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-----~s~~sDvwSlGvil~elltg----------~~p~~~~~~~~~~~~ 239 (369)
..... .......||.+|||||++....+ .-..+||||||.|+||+... +.||.+..+....
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-- 445 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS-- 445 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC--
Confidence 44221 22345679999999999876432 23479999999999999842 2455433322110
Q ss_pred ccchhHHhhhchhhhhhhcCCC--CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 240 PKQVWDEYEKGELAAKVLGCGI--EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
++.+..---.++ ..+.. ..........+.+|++.||..||.-|-|+-.|-+.|.+..
T Consensus 446 ----~eeMrkVVCv~~-~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 446 ----FEEMRKVVCVQK-LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred ----HHHHhcceeecc-cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 122222111111 11111 2345567788999999999999999999988888776653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=256.44 Aligned_cols=263 Identities=23% Similarity=0.319 Sum_probs=204.8
Q ss_pred ccccccCCceEEEEEEeCC-CcEEEEEEcc-ccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--------CceEE
Q 017591 29 STKLGAGGFGVVYKGQFPN-GVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--------TKAAL 98 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~l 98 (369)
..+||+|.||.||+|+.++ |+.||+|.+- .+..........+|+.+|..++|+|++.+++.|... ...++
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 3589999999999998754 7888887543 333334445678999999999999999999988632 34899
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||.+|+. +|..++......++..++.+++.+++.||.|+|+ ..|+|||+||.|+|++.+|.+||+|||+++.+...
T Consensus 102 Vf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred eHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 9999988 9999996666789999999999999999999999 99999999999999999999999999999776533
Q ss_pred CC--ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhh
Q 017591 179 NT--HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYE 248 (369)
Q Consensus 179 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~ 248 (369)
.. ....+...-|..|++||.+.+...++++.|||.-||++.||.++.+-++....... ..+...+|....
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d 257 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD 257 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence 22 22334556799999999999888999999999999999999999998887665421 223344455444
Q ss_pred hchhhhhhhcCCCCCC----------CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 249 KGELAAKVLGCGIEEN----------DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 249 ~~~~~~~~~~~~~~~~----------~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+-.+...+.....+.. +-.......+|+..++..||.+|+++++++.
T Consensus 258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 4444443322111111 1111346789999999999999999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=252.90 Aligned_cols=237 Identities=30% Similarity=0.393 Sum_probs=192.0
Q ss_pred CceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCHHHHhcc
Q 017591 36 GFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFT 114 (369)
Q Consensus 36 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 114 (369)
+||.||+|.+. +++.+++|++...........+.+|+..+++++|+|++++++++......+++|||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999886 48999999987544333267899999999999999999999999998999999999999999999854
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCcc
Q 017591 115 DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYS 194 (369)
Q Consensus 115 ~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 194 (369)
. ..+++..++.++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..|+
T Consensus 81 ~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 R-GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred c-cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 3 338999999999999999999999 999999999999999999999999999998765432 223456888999
Q ss_pred ccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHH--HHHHH
Q 017591 195 APEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE--EAERM 272 (369)
Q Consensus 195 aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l 272 (369)
+||.+... ..+.++||||||+++++|++|..||....... ................. .+..+
T Consensus 154 ~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~ 217 (244)
T smart00220 154 APEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLL---------------ELFKKIGKPKPPFPPPEWKISPEA 217 (244)
T ss_pred CHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH---------------HHHHHHhccCCCCccccccCCHHH
Confidence 99988754 67889999999999999999999986421110 01111111111111111 56789
Q ss_pred HHHHHhccccCCCCCCChHHHHH
Q 017591 273 SMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 273 ~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+++.+||..+|.+||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=291.15 Aligned_cols=264 Identities=23% Similarity=0.270 Sum_probs=206.8
Q ss_pred CCcccCHHHHHHhhhccc--cccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeE
Q 017591 12 KPVRFTLEQLCSFTNNYS--TKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRL 86 (369)
Q Consensus 12 ~~~~~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~ 86 (369)
.|+--...+|.-....|. ++||+|+||.|..++.+ +++.+|+|++++. ........|..|-.+|..-+.+=|+.+
T Consensus 61 kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~L 140 (1317)
T KOG0612|consen 61 KPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQL 140 (1317)
T ss_pred HHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHH
Confidence 344444555555566664 89999999999999885 4899999999862 222334568888889988788889999
Q ss_pred EeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeE
Q 017591 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKV 166 (369)
Q Consensus 87 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 166 (369)
+-.|.+++++|+|||||+||+|-.++.+.. .+++..+..|+..|+.||.-||+ .|+|||||||+||||+..|++||
T Consensus 141 hyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikL 216 (1317)
T KOG0612|consen 141 HYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKL 216 (1317)
T ss_pred HHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEee
Confidence 999999999999999999999999995555 89999999999999999999999 99999999999999999999999
Q ss_pred eecCCceecCCCCCccccccCCCCCCccccccccc---c-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccc
Q 017591 167 ADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR---N-YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQ 242 (369)
Q Consensus 167 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~-~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 242 (369)
+|||.+-.+...... ......|||-|++||+++. + +.|...+|.||+||++|||+.|..||-..+.
T Consensus 217 ADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--------- 286 (1317)
T KOG0612|consen 217 ADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--------- 286 (1317)
T ss_pred ccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH---------
Confidence 999999877644333 3344679999999999873 2 4789999999999999999999999964332
Q ss_pred hhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCC---hHHHH
Q 017591 243 VWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPP---MSAVV 294 (369)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~v~ 294 (369)
-+.+ +++........+| .....++...+||...+. +|+.|-. +.++-
T Consensus 287 -veTY--~KIm~hk~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 287 -VETY--GKIMNHKESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred -HHHH--HHHhchhhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 1122 2222222222233 223478888899987665 5778877 66654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=232.82 Aligned_cols=196 Identities=26% Similarity=0.372 Sum_probs=171.5
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
.++||+|.||+||+|++. +++.||+|.++-+. ++.......+|+-+++.++|.|||++++....++..-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 368999999999999875 48899999987543 344556788999999999999999999999999999999999976
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
.|..++.+-++.++.+.+..++.|+++||.|.|+ +++.|||+||.|.|++.+|..|++|||+++.++-... ....
T Consensus 86 dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr--cysa 160 (292)
T KOG0662|consen 86 DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CYSA 160 (292)
T ss_pred HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--eeec
Confidence 9999998888999999999999999999999999 9999999999999999999999999999987654332 2233
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQD 230 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~ 230 (369)
..-|..|.+|.++.+..-+++..|+||-||++.|+..-.+|...
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 45788999999999887899999999999999999976555443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=262.65 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=199.6
Q ss_pred cCHHHHHHhhh-ccccccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHHhcc-CCCceeeEEeEE
Q 017591 16 FTLEQLCSFTN-NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRT-YHINLVRLYGFC 90 (369)
Q Consensus 16 ~~~~el~~~t~-~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 90 (369)
.+-.+...+|+ ||..+||+|+||.|-++..+ +.+.+|||+++++.- .+..+--+.|-++|... +-|.+++++.+|
T Consensus 340 ~~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 340 SSKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred CCcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence 44445555665 88899999999999999764 478999999987532 12222334566677665 467899999999
Q ss_pred EeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecC
Q 017591 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFG 170 (369)
Q Consensus 91 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 170 (369)
..-+.+|+||||+.||+|--.+ ++-+.+.+..+..++..|+-||-+||+ +||++||||.+||||+.+|++||+|||
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhi-QQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred hhhhheeeEEEEecCchhhhHH-HHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecc
Confidence 9999999999999999998777 555678999999999999999999999 999999999999999999999999999
Q ss_pred CceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhc
Q 017591 171 LAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKG 250 (369)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (369)
+++.---.. ..+...+||+.|+|||++... +|+...|.|||||+|||||.|+.||++.+.+.+ +..
T Consensus 496 mcKEni~~~--~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-------F~a---- 561 (683)
T KOG0696|consen 496 MCKENIFDG--VTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQA---- 561 (683)
T ss_pred cccccccCC--cceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHH----
Confidence 987522111 123457899999999988875 899999999999999999999999987654322 111
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 017591 251 ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPP 289 (369)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 289 (369)
+.. ..-.++...+.+...++...|...|.+|.-
T Consensus 562 -----I~e-hnvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 -----IME-HNVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -----HHH-ccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 111 113456677888999999999999999954
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=270.88 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=202.2
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEE-----eCCceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCY-----DQTKAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~l 98 (369)
..|.+.||.|.+|.||+++. ++++..|+|+.....+ ...+++.|+++++.+ .|||++.+++++. .++.++|
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 34568999999999999977 5688999999875433 245677888888877 5999999999887 3467999
Q ss_pred EEeccCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 99 VYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
|||||.+||..+++.. .+..+.|+.+..|++.++.||.+||. +.++|||||-.|||++.++.|||+|||.+..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999999943 36789999999999999999999999 9999999999999999999999999999876643
Q ss_pred CCCccccccCCCCCCccccccccccC----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNY----PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELA 253 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (369)
. ........||+.|||||++.... .++.++|+||||++..||--|.+|+.+..+...-+.
T Consensus 176 T--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-------------- 239 (953)
T KOG0587|consen 176 T--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------------- 239 (953)
T ss_pred c--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc--------------
Confidence 2 22334578999999999987542 467799999999999999999999987665321110
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
....+......+..+...+.++|..||..|-..||++.+++
T Consensus 240 IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 240 IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 00111111233678899999999999999999999999877
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=255.61 Aligned_cols=270 Identities=21% Similarity=0.289 Sum_probs=204.2
Q ss_pred cccCHHHHHHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-C-C----ceeeE
Q 017591 14 VRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-H-I----NLVRL 86 (369)
Q Consensus 14 ~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~ 86 (369)
..|..+|.....+.+...+|+|.||.|-.+.+ ..+..||+|+++.-. .......-|++++.++. + | -++.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 45667777777777788999999999999976 447999999998532 22345566888888883 2 2 27888
Q ss_pred EeEEEeCCceEEEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-----
Q 017591 87 YGFCYDQTKAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA----- 160 (369)
Q Consensus 87 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~----- 160 (369)
.++|.-.++.|||+|.+ |-|+.+++..+ -.+++...+..++.|+++++++||+ .+++|-||||+|||+..
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEE
Confidence 89999999999999998 45999999654 3589999999999999999999999 99999999999999831
Q ss_pred ---------------CCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCC
Q 017591 161 ---------------KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225 (369)
Q Consensus 161 ---------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~ 225 (369)
+..++|+|||.|.+-.... .....|..|.|||++.+- .++..+||||+||||+|+.+|.
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc-CcCCccCceeeeeEEEEeeccc
Confidence 2358999999998754433 345689999999999884 7999999999999999999999
Q ss_pred CCCCCCCCCc--------cCccccchhHHh------hhchh-----------hhhhhcCC----CCCCCHHHHHHHHHHH
Q 017591 226 KNAQDCSSDT--------LDWFPKQVWDEY------EKGEL-----------AAKVLGCG----IEENDREEAERMSMVA 276 (369)
Q Consensus 226 ~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~-----------~~~~~~~~----~~~~~~~~~~~l~~l~ 276 (369)
.-|+..+... .+.+|..+.... ..+.+ ......+. ...........|.+|+
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 9988665431 222332222211 00000 00000010 0122344567899999
Q ss_pred HhccccCCCCCCChHHHHH
Q 017591 277 LWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 277 ~~cl~~~p~~RPs~~~v~~ 295 (369)
..||..||.+|+|+.|++.
T Consensus 387 ~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHccCccccccHHHHhc
Confidence 9999999999999999873
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=251.78 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=207.3
Q ss_pred ccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe-CCceEEEEe
Q 017591 29 STKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD-QTKAALVYE 101 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 101 (369)
+..+-+|.||.||.|.|. +.+.|.+|.++.....-....+..|--++....|||+..+.+++.+ ....+.+++
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 457899999999999653 2467788888876666667788899999999999999999998875 457889999
Q ss_pred ccCCCCHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 102 FMENGSLDKYLFTD-------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 102 ~~~~gsL~~~l~~~-------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
++.-|+|..|+... ...++-.++..++.|++.|++|||. +++||.||.++|+++++..++||+|=.+++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccc
Confidence 99999999999622 2357778899999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhh
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELA 253 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (369)
+...+.+.-......+..||+||.+... .++.++|||||||+||||+| |+.|+...++.. +...+..
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~ylkd---- 513 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEHYLKD---- 513 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHHHHhc----
Confidence 7666555544555578899999999986 89999999999999999997 777876554422 1222223
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+.+...+.+.+++|..++.-||..+|++||++++++..|...
T Consensus 514 -----GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 514 -----GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -----cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 333344556788999999999999999999999999988654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=229.21 Aligned_cols=195 Identities=27% Similarity=0.422 Sum_probs=169.2
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
..||+|++|.|-+.++ .+|...|+|.+....+.+...++..|+.+..+. .+|.+|.++|....+...++.||.|.- |
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 4799999999988876 679999999999887878888999999888765 699999999999999999999999975 9
Q ss_pred HHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 108 LDKYLF---TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 108 L~~~l~---~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
|+.+-. ..+..+++..+-+|+..+.+||.|||+. ..++|||+||+|||++.+|++|++|||.+-.+.+.-. .
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA---k 205 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA---K 205 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH---H
Confidence 987763 4678899999999999999999999994 7899999999999999999999999999977643222 2
Q ss_pred ccCCCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRN---YPITQKCDVYSFGMLLFEIIGRRKNAQD 230 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~---~~~s~~sDvwSlGvil~elltg~~p~~~ 230 (369)
+...|-..|||||.+..+ ..|+.++||||||+++.||.+++.|+..
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 223477789999987643 2689999999999999999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=272.60 Aligned_cols=250 Identities=18% Similarity=0.190 Sum_probs=159.6
Q ss_pred ccccccCCceEEEEEEeC-C----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeE------EEeCCceE
Q 017591 29 STKLGAGGFGVVYKGQFP-N----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF------CYDQTKAA 97 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~~~~~~~ 97 (369)
.++||+|+||.||+|.+. + +..||+|.+...... .....+ .+....+.++..++.. .......+
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 478999999999999874 4 689999987642211 111111 1111112222221111 23556789
Q ss_pred EEEeccCCCCHHHHhccCCCCC-------------------CHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe
Q 017591 98 LVYEFMENGSLDKYLFTDTEVL-------------------KWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL 158 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~-------------------~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill 158 (369)
+||||+.+++|.+++.....+. ....+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl 288 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIF 288 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEE
Confidence 9999999999999985432211 234467899999999999999 999999999999999
Q ss_pred cC-CCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccC---------------------CCCcchhhHHHHH
Q 017591 159 DA-KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY---------------------PITQKCDVYSFGM 216 (369)
Q Consensus 159 ~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~s~~sDvwSlGv 216 (369)
+. ++.+||+|||+++.+...... ......+++.|+|||.+.... .++.++|||||||
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred eCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 86 578999999999865432221 123456899999999653221 2345679999999
Q ss_pred HHHHHHcCCCCCCCCCCCccCccccchhHHhhhch--h---hhhhhcCCCCC------CCHHHHHHHHHHHHhccccCCC
Q 017591 217 LLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE--L---AAKVLGCGIEE------NDREEAERMSMVALWCVQDCPE 285 (369)
Q Consensus 217 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~~p~ 285 (369)
+||||+++..++...... ....+.... . .........++ ..........+|+.+||+.||.
T Consensus 368 iL~el~~~~~~~~~~~~~--------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 368 IFLQMAFPNLRSDSNLIQ--------FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHhCcCCCchHHHH--------HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999876654321000 000000000 0 00000000000 0001123455899999999999
Q ss_pred CCCChHHHHH
Q 017591 286 ARPPMSAVVK 295 (369)
Q Consensus 286 ~RPs~~~v~~ 295 (369)
+|||+.++++
T Consensus 440 kR~ta~e~L~ 449 (566)
T PLN03225 440 QRISAKAALA 449 (566)
T ss_pred cCCCHHHHhC
Confidence 9999999885
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=272.47 Aligned_cols=239 Identities=26% Similarity=0.366 Sum_probs=184.8
Q ss_pred cccccCCce-EEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 30 TKLGAGGFG-VVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
+++|.|+.| .||+|.. +|+.||||.+-. .......+|+..++.- +|||||++++.-.+....||..|.|.. +
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 568999998 6799998 789999998763 3345678999999887 599999999988888999999999976 9
Q ss_pred HHHHhccCCC---CCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC---C--CCeeEeecCCceecCCCC
Q 017591 108 LDKYLFTDTE---VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA---K--FSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 108 L~~~l~~~~~---~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~--~~~kl~Dfg~~~~~~~~~ 179 (369)
|.+++..... .......+.++.|+++||++||+ .+||||||||.||||.. + .+++|+|||+++.+..+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999965311 11124567889999999999999 99999999999999976 3 468999999999886544
Q ss_pred Cc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 180 TH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGR-RKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 180 ~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
.. .......||.+|+|||++... ..+.+.|||||||++|+.++| ..||...-..... +..+..- .
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N---------Il~~~~~---L 732 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN---------ILTGNYT---L 732 (903)
T ss_pred chhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHhhhh---------hhcCccc---e
Confidence 33 234567799999999999886 567799999999999999987 7888754332110 0001000 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
... .. ..+. ...+||.+|++++|..||++.+|+
T Consensus 733 ~~L-~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 733 VHL-EP-LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred eee-cc-CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 000 01 1111 788999999999999999999997
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=261.82 Aligned_cols=236 Identities=25% Similarity=0.322 Sum_probs=197.7
Q ss_pred ccccCCceEEEEEEeCCCc-EEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 31 KLGAGGFGVVYKGQFPNGV-KIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
-||-||||.|-++...... .+|+|++++. ........+..|-.+|...+.|.||++|..|.+....|+.||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 5899999999999875433 4888988753 344556788899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccC
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 187 (369)
|...+ ...+.++..+...|+.++++|++|||+ +|||+|||||+|++++.+|-+||.|||.|+.+..+.+.- .+
T Consensus 507 lWTiL-rdRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw---TF 579 (732)
T KOG0614|consen 507 LWTIL-RDRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW---TF 579 (732)
T ss_pred hhhhh-hhcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCcee---ee
Confidence 99999 556789999999999999999999999 999999999999999999999999999999887655433 47
Q ss_pred CCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHH
Q 017591 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE 267 (369)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (369)
+||+.|.|||++... ....+.|.||||+++||||+|.+||...++-. .+..+..|- -....+..
T Consensus 580 cGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-------tYn~ILkGi--------d~i~~Pr~ 643 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMK-------TYNLILKGI--------DKIEFPRR 643 (732)
T ss_pred cCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-------HHHHHHhhh--------hhhhcccc
Confidence 899999999998875 56899999999999999999999998765421 122221111 01234566
Q ss_pred HHHHHHHHHHhccccCCCCCCC
Q 017591 268 EAERMSMVALWCVQDCPEARPP 289 (369)
Q Consensus 268 ~~~~l~~l~~~cl~~~p~~RPs 289 (369)
......+|++++...+|.+|.-
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhc
Confidence 7778889999999999999976
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=230.23 Aligned_cols=212 Identities=36% Similarity=0.596 Sum_probs=185.0
Q ss_pred cccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCHHH
Q 017591 32 LGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDK 110 (369)
Q Consensus 32 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 110 (369)
||+|.+|.||++...+ ++.+++|++...........+.+|+..++.+.|++++++++++......+++||++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998854 899999998865443345789999999999999999999999999899999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-CCCeeEeecCCceecCCCCCccccccCCC
Q 017591 111 YLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-KFSAKVADFGLAKLCNPENTHDSTSGYRG 189 (369)
Q Consensus 111 ~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 189 (369)
++......+++..++.++.+++.+|.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 995544579999999999999999999999 99999999999999999 89999999999987654321 1223457
Q ss_pred CCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHH
Q 017591 190 TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEA 269 (369)
Q Consensus 190 t~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (369)
...|++||.+......+.++|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 88999999877644678999999999999998
Q ss_pred HHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 270 ERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 270 ~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
..+.+++.+|++.+|.+||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 558899999999999999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=240.06 Aligned_cols=244 Identities=24% Similarity=0.269 Sum_probs=192.5
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
++||+|+|..|-.++. ++.+.+|+|++++.. ..+...=++.|-.+..+- +||.+|.++.+|..+..+++|.||.+|
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g 335 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG 335 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence 6899999999999987 458899999987642 222233455666666554 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|--.+ +++..++++.+..+...|+.||.|||+ +||++||||.+|+|++..|++||+|+|+++.--. ....+.
T Consensus 336 gdlmfhm-qrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~--~gd~ts 409 (593)
T KOG0695|consen 336 GDLMFHM-QRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG--PGDTTS 409 (593)
T ss_pred cceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC--CCcccc
Confidence 9997666 556789999999999999999999999 9999999999999999999999999999875321 223345
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..+||+.|+|||++.+. .|....|.|+|||+++||+.|+.||+....+..... ..+....+.-......+
T Consensus 410 tfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~n---------tedylfqvilekqirip 479 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN---------TEDYLFQVILEKQIRIP 479 (593)
T ss_pred cccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc---------hhHHHHHHHhhhccccc
Confidence 68899999999988875 899999999999999999999999985543322111 01111111111223345
Q ss_pred HHHHHHHHHHHHhccccCCCCCCC
Q 017591 266 REEAERMSMVALWCVQDCPEARPP 289 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs 289 (369)
...+.+...+++.-|+.||.+|..
T Consensus 480 rslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhcC
Confidence 566777889999999999999853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=256.62 Aligned_cols=254 Identities=19% Similarity=0.231 Sum_probs=172.5
Q ss_pred ccccccCCceEEEEEEe-----------------CCCcEEEEEEccccccHHHHHH--------------HHHHHHHHhc
Q 017591 29 STKLGAGGFGVVYKGQF-----------------PNGVKIAAKILKTCLNKRVEAQ--------------FMAEIGTIGR 77 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~~E~~~l~~ 77 (369)
.++||+|+||+||+|.+ ..++.||||.+..... ....+ ...|+..+.+
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 47899999999999964 2357899999864321 11222 3346666677
Q ss_pred cCCCce-----eeEEeEEEe--------CCceEEEEeccCCCCHHHHhccCC-----------------------CCCCH
Q 017591 78 TYHINL-----VRLYGFCYD--------QTKAALVYEFMENGSLDKYLFTDT-----------------------EVLKW 121 (369)
Q Consensus 78 l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~ 121 (369)
++|.++ ++++++|.. ....+|||||+++++|.++++... ..+++
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 765544 667777653 346799999999999999885321 13467
Q ss_pred HHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccc
Q 017591 122 EKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201 (369)
Q Consensus 122 ~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 201 (369)
..+..++.|++.+|.|||+ .+++||||||+|||++.++.+||+|||++......... ......+++.|+|||.+..
T Consensus 309 ~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred HHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhhcC
Confidence 7899999999999999999 99999999999999999999999999999765432211 1112235789999998754
Q ss_pred cC---------------------CCCcchhhHHHHHHHHHHHcCCC-CCCCCCCCccC--cc--ccchhHHhhhchhhhh
Q 017591 202 NY---------------------PITQKCDVYSFGMLLFEIIGRRK-NAQDCSSDTLD--WF--PKQVWDEYEKGELAAK 255 (369)
Q Consensus 202 ~~---------------------~~s~~sDvwSlGvil~elltg~~-p~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~ 255 (369)
.. ....+.||||+||++++|++|.. |+......... .. ....|..+.....
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~--- 461 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY--- 461 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC---
Confidence 21 11235799999999999999875 55432111000 00 0000111111100
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHhccccCC---CCCCChHHHHH
Q 017591 256 VLGCGIEENDREEAERMSMVALWCVQDCP---EARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~~v~~ 295 (369)
.+ ...........+|+.+||..+| .+|+|+.++++
T Consensus 462 ----~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 462 ----DF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ----Cc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00 1123346778899999999766 68999999874
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=251.64 Aligned_cols=201 Identities=28% Similarity=0.387 Sum_probs=170.1
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+-||-|+||.|.+++- .+...+|+|.+.+. ........+..|-.+|..-.++-||++|-.|.+.+.+|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 4699999999999954 56888999988753 23445567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecC---------C
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN---------P 177 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~---------~ 177 (369)
++-.+|. +-+-|.++....++..+.+|++++|. .|+|||||||+|||||.+|++||+|||++.-+. .
T Consensus 715 DmMSLLI-rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 715 DMMSLLI-RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred cHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 9999884 45679999999999999999999999 999999999999999999999999999975221 1
Q ss_pred CC--Cccc-----------------------------cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCC
Q 017591 178 EN--THDS-----------------------------TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRK 226 (369)
Q Consensus 178 ~~--~~~~-----------------------------~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~ 226 (369)
++ ..+. .-...||..|+|||++... .++..+|.||.|||||||+.|+.
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHHhhCCC
Confidence 00 0000 0112599999999999885 78999999999999999999999
Q ss_pred CCCCCCCCc
Q 017591 227 NAQDCSSDT 235 (369)
Q Consensus 227 p~~~~~~~~ 235 (369)
||....+..
T Consensus 870 pf~~~tp~~ 878 (1034)
T KOG0608|consen 870 PFLADTPGE 878 (1034)
T ss_pred CccCCCCCc
Confidence 998877654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=243.49 Aligned_cols=151 Identities=23% Similarity=0.292 Sum_probs=129.6
Q ss_pred HHHHHHhhcCCcccCHHHHHH-hhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-
Q 017591 3 KFLRDIAREKPVRFTLEQLCS-FTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY- 79 (369)
Q Consensus 3 ~~~~~~~~~~~~~~~~~el~~-~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~- 79 (369)
|=.++|.+..++....+|+-+ .+|-..++||+|-|++||++.+ .+.+.||+|+.+.. ....+....|+.+|+++.
T Consensus 56 E~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~ 133 (590)
T KOG1290|consen 56 EDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVRE 133 (590)
T ss_pred cChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHh
Confidence 446789999999999999988 8888889999999999999987 56899999999853 344566788999999874
Q ss_pred ----C---CceeeEEeEEEe----CCceEEEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeE
Q 017591 80 ----H---INLVRLYGFCYD----QTKAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147 (369)
Q Consensus 80 ----h---~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~iv 147 (369)
| .+||++++.|.. +.+.|+|+|+. |.+|..+|... ...++...+.+|++||+.||.|||.. .|||
T Consensus 134 ~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgII 210 (590)
T KOG1290|consen 134 GDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGII 210 (590)
T ss_pred cCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCcc
Confidence 2 369999999974 45899999999 55888888543 46799999999999999999999996 5999
Q ss_pred eecCCCCceEe
Q 017591 148 HYDIKPANILL 158 (369)
Q Consensus 148 H~dlkp~Nill 158 (369)
|-||||+|||+
T Consensus 211 HTDlKPENvLl 221 (590)
T KOG1290|consen 211 HTDLKPENVLL 221 (590)
T ss_pred ccCCCcceeee
Confidence 99999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=224.58 Aligned_cols=252 Identities=19% Similarity=0.273 Sum_probs=193.2
Q ss_pred ccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeC--CceEEEEeccC
Q 017591 29 STKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQ--TKAALVYEFME 104 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~ 104 (369)
.+++|+|.++.|+.|.. .++++++||++++ .....+.+|+.+|..|. ||||++++++..++ ....||+||+.
T Consensus 43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~ 118 (338)
T KOG0668|consen 43 VRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN 118 (338)
T ss_pred HHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence 47899999999999975 5789999999885 44568899999999997 99999999999866 46789999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-CeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+.+...+. ..++...+..++.+++.||.|+|+ .||.|||+||.|++++... .++|+|+|+|.++........
T Consensus 119 n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV 191 (338)
T KOG0668|consen 119 NTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 191 (338)
T ss_pred cccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCceeee
Confidence 98877766 568888999999999999999999 9999999999999998665 599999999998876554432
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc--c-----cchhHHhhhch-----
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF--P-----KQVWDEYEKGE----- 251 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~--~-----~~~~~~~~~~~----- 251 (369)
...+..|--||.+..-..+...-|+|||||+|..|+..+.||........+.+ . ..+..-+..-.
T Consensus 192 ---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 192 ---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred ---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 23566788899998877899999999999999999999999986655322110 0 00000000000
Q ss_pred -hhhh--------hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 252 -LAAK--------VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 252 -~~~~--------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
.... .......+...-...+..+++.+.|..|-.+|+|+.|..
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 0000 000000111112247788999999999999999999865
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=229.36 Aligned_cols=265 Identities=18% Similarity=0.251 Sum_probs=200.1
Q ss_pred cccCHHHHHHhh----hccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEE
Q 017591 14 VRFTLEQLCSFT----NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLY 87 (369)
Q Consensus 14 ~~~~~~el~~~t----~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 87 (369)
+.+...||.+.+ +++.+.||+|.||.+-++.. ..+..+++|.+.... ...++|.+|..---.| .|.||+..|
T Consensus 10 h~I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY 87 (378)
T KOG1345|consen 10 HLIPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTY 87 (378)
T ss_pred cccccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHH
Confidence 334444444332 45568899999999999987 457899999887533 3457899998766666 499999988
Q ss_pred eE-EEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec--CCCCe
Q 017591 88 GF-CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD--AKFSA 164 (369)
Q Consensus 88 ~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~ 164 (369)
+. |...+.+++++||++.|+|.+-+.. ..+.+.....++.|+++||.|||+ +++||||||.+|||+- +..++
T Consensus 88 ~vaFqt~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rv 162 (378)
T KOG1345|consen 88 EVAFQTSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRV 162 (378)
T ss_pred HHHhhcCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEE
Confidence 74 4455678899999999999998833 468899999999999999999999 9999999999999993 33479
Q ss_pred eEeecCCceecCCCCCccccccCCCCCCcccccccccc----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccc
Q 017591 165 KVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN----YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240 (369)
Q Consensus 165 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~ 240 (369)
||+|||.++..+.-... ...+..|.+||..... ....+.+|||+||+++|.+|+|..||+...... .+
T Consensus 163 KlcDFG~t~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~ 234 (378)
T KOG1345|consen 163 KLCDFGLTRKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KP 234 (378)
T ss_pred EeeecccccccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---ch
Confidence 99999998765432222 2356689999975432 246788999999999999999999999544332 34
Q ss_pred cchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.+-|..|..+... ..+.....+++.+..+..+-|..+|++|-...++.++.+.
T Consensus 235 Y~~~~~w~~rk~~------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 235 YWEWEQWLKRKNP------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred HHHHHHHhcccCc------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 4556666554432 3345555677888999999999999999666666655543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=245.94 Aligned_cols=273 Identities=19% Similarity=0.282 Sum_probs=213.4
Q ss_pred cCCcccCHHHHHHhhhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC------CCce
Q 017591 11 EKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY------HINL 83 (369)
Q Consensus 11 ~~~~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~ni 83 (369)
+.+.++-++||....|...-..|+|-|++|..|.+. .|..||||++..+ ..-...=..|+++|++|+ --|+
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 577889999999999999999999999999999874 4889999999853 333455678999999996 3479
Q ss_pred eeEEeEEEeCCceEEEEeccCCCCHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC
Q 017591 84 VRLYGFCYDQTKAALVYEFMENGSLDKYLFTD--TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK 161 (369)
Q Consensus 84 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 161 (369)
++++-.|...+++|||+|.+. .+|.++|... +..+....+..|+.|++.||..|-. .||+|.||||+|||+++.
T Consensus 497 lrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccC
Confidence 999999999999999999885 4999999554 3467888999999999999999999 999999999999999876
Q ss_pred C-CeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC---
Q 017591 162 F-SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--- 237 (369)
Q Consensus 162 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--- 237 (369)
. .+||||||.|.....+... ...-+.-|.|||++.+- .|....|+||.||+||||.||+..|.+.....+-
T Consensus 573 k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred cceeeeccCcccccccccccc----HHHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 4 5899999999876554432 23345679999988874 8999999999999999999999988876654220
Q ss_pred -----ccccchh-------HHh--------------------------hh-chhhhhhhc-CCCCCCCHHHHHHHHHHHH
Q 017591 238 -----WFPKQVW-------DEY--------------------------EK-GELAAKVLG-CGIEENDREEAERMSMVAL 277 (369)
Q Consensus 238 -----~~~~~~~-------~~~--------------------------~~-~~~~~~~~~-~~~~~~~~~~~~~l~~l~~ 277 (369)
-+|..+. .++ .. .++...+.. ...+.........|.+|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 0010000 000 00 111122221 1234555667788999999
Q ss_pred hccccCCCCCCChHHHH
Q 017591 278 WCVQDCPEARPPMSAVV 294 (369)
Q Consensus 278 ~cl~~~p~~RPs~~~v~ 294 (369)
.||..||++|.|..+.+
T Consensus 728 kml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQAL 744 (752)
T ss_pred HHhccChhhcCCHHHHh
Confidence 99999999999998865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=231.05 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=193.5
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccc-cccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----ceEEEEec
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKT-CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-----KAALVYEF 102 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~ 102 (369)
+-||-|+||+||.+.++ +|+.|++|.+.. ..+-....++.+|+.++..++|.|++..+++..-.. ..|.++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 57999999999999885 599999987653 233445678999999999999999999998775332 46788898
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
|.. +|.+.| -....++...+.-+++||++||.|||+ .+|.||||||.|.|++.+-..||+|||+++........
T Consensus 139 mQS-DLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~- 212 (449)
T KOG0664|consen 139 MQS-DLHKII-VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL- 212 (449)
T ss_pred HHh-hhhhee-ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhhhh-
Confidence 876 887777 455678999999999999999999999 99999999999999999999999999999875433322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCc-cCccc----cchhHHhh---hchhhh
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDT-LDWFP----KQVWDEYE---KGELAA 254 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~-~~~~~----~~~~~~~~---~~~~~~ 254 (369)
..+...-|..|.|||++++...|+.+.||||.||++.||+..+.-|+..++-. ...+. ....+.+. +|....
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 23334568899999999998899999999999999999998888887665531 11100 00001000 111000
Q ss_pred hhhcCCC-C--------CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHh
Q 017591 255 KVLGCGI-E--------ENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297 (369)
Q Consensus 255 ~~~~~~~-~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L 297 (369)
.+..... + ..+.........+...++..||++|.+..+.+..+
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0000000 1 11122334567788889999999999988876544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=236.09 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=195.7
Q ss_pred ccccccCCceEEEEEEeC----CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEecc
Q 017591 29 STKLGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.++||.|.|++||++.+. .++.||+|.+..... ..++.+|++.|..+. +.||+++.+++..++..++|+||+
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 378999999999999663 478999999886544 346889999999985 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-CCCeeEeecCCceecCC-----
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-KFSAKVADFGLAKLCNP----- 177 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~----- 177 (369)
+.....++. ..++...+..+++.++.||.++|. +|||||||||+|+|.+. .++-.|.|||++.....
T Consensus 118 ~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 118 EHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred CccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 999998888 347799999999999999999999 99999999999999975 56789999999872110
Q ss_pred --------CCC-----------------------------ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHH
Q 017591 178 --------ENT-----------------------------HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFE 220 (369)
Q Consensus 178 --------~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~e 220 (369)
... ........||+||.|||++..-...++++||||.|||++.
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 000 0001223599999999999987789999999999999999
Q ss_pred HHcCCCCCCCCCCCccC-----------------ccccc--hhHHhhhc----------hh-hhhhhc-----CCCCCCC
Q 017591 221 IIGRRKNAQDCSSDTLD-----------------WFPKQ--VWDEYEKG----------EL-AAKVLG-----CGIEEND 265 (369)
Q Consensus 221 lltg~~p~~~~~~~~~~-----------------~~~~~--~~~~~~~~----------~~-~~~~~~-----~~~~~~~ 265 (369)
+++++.||.....+... .++.. +|+..... .+ .+...+ .......
T Consensus 271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~ 350 (418)
T KOG1167|consen 271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS 350 (418)
T ss_pred hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence 99999999866554220 00111 11100000 00 000001 1222334
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
..++..+.+++.+|+..||.+|.++++.+
T Consensus 351 d~~~~~~~dlLdk~le~np~kRitAEeAL 379 (418)
T KOG1167|consen 351 DVFPALLLDLLDKCLELNPQKRITAEDAL 379 (418)
T ss_pred ccccHHHHHHHHHHccCChhhcccHHHHh
Confidence 44566899999999999999999999976
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=220.08 Aligned_cols=200 Identities=33% Similarity=0.490 Sum_probs=171.0
Q ss_pred ccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.+.||.|++|.||++...+ ++.+++|.+...........+.+|+..+..++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356789999999999998865 8999999988644333567899999999999999999999999988999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|.+++......+++..+..++.+++.+|.+||+ .+++|+||+|.||+++.++.++|+|||.+........ ....
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 99999995443338999999999999999999999 8999999999999999999999999999987654321 0122
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQD 230 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~ 230 (369)
...++..|++||.+.....++.++|||+||+++++|++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345788899999874334678899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=244.25 Aligned_cols=192 Identities=25% Similarity=0.320 Sum_probs=163.8
Q ss_pred cccccCCceEEEEEEeCC-CcEEEEEEcccccc-------HHHHHHHHHHHHHHhccC---CCceeeEEeEEEeCCceEE
Q 017591 30 TKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLN-------KRVEAQFMAEIGTIGRTY---HINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l 98 (369)
+.+|.|+||.|++|.++. ...|++|.+.+..- +.....+--|+.+|..++ |+||++++++|++++.++|
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 679999999999998854 67888898875311 111123456999999997 9999999999999999999
Q ss_pred EEec-cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 99 VYEF-MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 99 v~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||. -++.+|.++| .....+++.+...|+.|++.|+++||+ +||||||||-+|+.++.+|.+||+|||.+.....
T Consensus 647 ~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsaa~~ks 722 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS 722 (772)
T ss_pred EecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccchhhhcC
Confidence 9997 5567899999 556779999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQ 229 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~ 229 (369)
+.. ..++||..|.|||++.+.......-|||++|++||.++....||-
T Consensus 723 gpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 723 GPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 322 346799999999999988778899999999999999998887763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=221.93 Aligned_cols=254 Identities=22% Similarity=0.245 Sum_probs=186.7
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccc-cccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC------CceEEEEe
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKT-CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ------TKAALVYE 101 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e 101 (369)
.-+|.|.- .|..+.+ -.++.|++|.... ..+.....+..+|..++..+.|+|+++++.++.-. ...|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 34677776 5666644 3588888887542 22233346788999999999999999999998633 35799999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
+|.. +|...+. -.++-+++..++.|++.|++|||+ .||+||||||+||+++.+..+||.|||+++.-.. .
T Consensus 102 ~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~---~ 171 (369)
T KOG0665|consen 102 LMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT---D 171 (369)
T ss_pred hhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCc---c
Confidence 9976 9999885 457889999999999999999999 9999999999999999999999999999986432 2
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCc--------cCccccchhHHhhh-c--
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDT--------LDWFPKQVWDEYEK-G-- 250 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~-~-- 250 (369)
-..+....|..|.|||++.+. .+....||||+||++.||++|+--|.+...-. .........+.+.. +
T Consensus 172 ~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred cccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 345667789999999998886 59999999999999999999998877433210 00000011111100 0
Q ss_pred ------hhhhhhhcCCC--------CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 251 ------ELAAKVLGCGI--------EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 251 ------~~~~~~~~~~~--------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+.........+ .+.+......+.+++.+||-.||++|.++.++++
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00000000001 1222344567889999999999999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=257.71 Aligned_cols=196 Identities=17% Similarity=0.214 Sum_probs=138.0
Q ss_pred ccCC-CceeeEEeEE-------EeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEe
Q 017591 77 RTYH-INLVRLYGFC-------YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148 (369)
Q Consensus 77 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH 148 (369)
.++| +||+.++++| .+....++++||+. ++|.+++......+++.+++.++.||++||.|||+ +||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence 3445 5777777776 23345778899885 59999996656679999999999999999999999 99999
Q ss_pred ecCCCCceEecC-------------------CCCeeEeecCCceecCCCCC--------------ccccccCCCCCCccc
Q 017591 149 YDIKPANILLDA-------------------KFSAKVADFGLAKLCNPENT--------------HDSTSGYRGTPGYSA 195 (369)
Q Consensus 149 ~dlkp~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y~a 195 (369)
|||||+||||+. ++.+|++|||+++....... ........||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999965 34556666666653211000 000112357889999
Q ss_pred cccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHH
Q 017591 196 PEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMV 275 (369)
Q Consensus 196 PE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 275 (369)
||++.+. .++.++|||||||+||||++|..|+..... ....+. ... .+............+
T Consensus 184 PE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~~~-----~~~----~~~~~~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSSLR-----HRV----LPPQILLNWPKEASF 244 (793)
T ss_pred hhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHHHH-----Hhh----cChhhhhcCHHHHHH
Confidence 9988765 789999999999999999998877542110 001110 000 111111123345688
Q ss_pred HHhccccCCCCCCChHHHHH
Q 017591 276 ALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 276 ~~~cl~~~p~~RPs~~~v~~ 295 (369)
+.+||+.+|.+||++.+|++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 89999999999999999974
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=239.65 Aligned_cols=247 Identities=26% Similarity=0.324 Sum_probs=198.1
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
..++|.|++|.||+++++ .++..|+|+++-... ....-++.|+-+++..+|+||+.+++.+.-....++.||||.+|+
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 468999999999999985 489999999875433 346678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccC
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 187 (369)
|.+.- .-.+++++.++...++..++||+|||+ .|=+|||||-.||++++.|.+|+.|||.+-.+... ......+
T Consensus 99 lQdiy-~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~Krksf 172 (829)
T KOG0576|consen 99 LQDIY-HVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRKSF 172 (829)
T ss_pred cccee-eecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh--hhhhhcc
Confidence 98865 456789999999999999999999999 99999999999999999999999999998654322 2223457
Q ss_pred CCCCCcccccccc--ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 188 RGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 188 ~gt~~y~aPE~~~--~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
.||+.|||||+.. ..+.+...+|||++|+...|+--.+.|.....+.... ..+.... .........
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-------~LmTkS~-----~qpp~lkDk 240 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-------FLMTKSG-----FQPPTLKDK 240 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-------HHhhccC-----CCCCcccCC
Confidence 8999999999753 3347899999999999999999888887654432110 0000000 001112234
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
..+.+.+.++++.|+..+|++||++..++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 45778899999999999999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=201.70 Aligned_cols=166 Identities=22% Similarity=0.249 Sum_probs=125.7
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|.+++..++..+++..++.|+.|++.||.|||+ ++ ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------
Confidence 68999997667789999999999999999999999 66 999999999999999 99988654321
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ............ .........
T Consensus 64 -~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~------~~~~~~~~~~~~---~~~~~~~~~ 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELS------AILEILLNGMPA---DDPRDRSNL 132 (176)
T ss_pred -CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhc------HHHHHHHHHhcc---CCccccccH
Confidence 2588999999998775 78999999999999999999999986432211 001111100000 000001122
Q ss_pred HHHHH--HHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 266 REEAE--RMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 266 ~~~~~--~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
..... .+.+++.+||+.+|.+||++.++++.+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 33333 69999999999999999999999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=200.47 Aligned_cols=257 Identities=20% Similarity=0.219 Sum_probs=198.5
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEec
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+...++||+|.||+++.|++ -+++.||||.....+. ..++..|++.++.|. .++|..++-+-.++.+..||+|.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 344568999999999999975 6899999999764332 457888999998885 78999999888888899999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-----CeeEeecCCceecCC
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-----SAKVADFGLAKLCNP 177 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~~~~~~~ 177 (369)
. |-||++++.-++..|+..++..++.|++.-++++|+ +.+|+|||||+|+||...+ .+.++|||+|+.+.+
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8 569999998889999999999999999999999999 9999999999999996543 589999999998866
Q ss_pred CCCcc-----ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 178 ENTHD-----STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 178 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
..+.. +.....||.+||+-....+ .+.+.+.|+-|||=++++.|.|..||++...+.... -++.+..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~----kYeKIGe--- 253 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE----KYEKIGE--- 253 (449)
T ss_pred ccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHH----HHHHhcc---
Confidence 54332 3445669999999997666 488999999999999999999999999887764421 1222211
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
......+......++.++..-+...-..+-.+-|..+-+...+.
T Consensus 254 --~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 254 --TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred --ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 11111112223334555666666666677777777665554443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=195.64 Aligned_cols=259 Identities=20% Similarity=0.250 Sum_probs=202.7
Q ss_pred HhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCC-CceeeEEeEEEeCCceEEEE
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH-INLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 100 (369)
...+...++||.|+||.+|.|.. .+|..||+|+...... ..++..|..++..|++ ..|..+..+..+.....+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 33446679999999999999976 6799999999875433 4578889999999874 56778888888889999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC---CCeeEeecCCceecCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNP 177 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~ 177 (369)
+.. |-||++++.-....++..+++-++.|++.-++|+|. ++++||||||+|+|..-+ ..+.++|||+|+.+.+
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 998 569999997778899999999999999999999999 999999999999999644 4689999999987754
Q ss_pred CC-----CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 178 EN-----THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 178 ~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
.. ...+.....||.+|.+-....+ ...+.+.|+-|+|.+|.++..|..||++..+... ...-..+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---------~QKyEkI 236 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---------KQKYEKI 236 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhH---------HHHHHHH
Confidence 32 2233455679999999886554 4789999999999999999999999998766532 1112223
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
.++............++.++.-.+..|-..--++-|...-+.+.+.
T Consensus 237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 3333333333334445677778888898888889998766655444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-27 Score=198.53 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=194.7
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccc-cccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKT-CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+|..+|.....|..|+|+|. |..+++|+++. ....+..++|..|.-.++.+.||||+.+++.|.......++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34468999999999999995 45566677653 33445567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEe--ecCCceecCCCCCcc
Q 017591 106 GSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVA--DFGLAKLCNPENTHD 182 (369)
Q Consensus 106 gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~~~ 182 (369)
|+|.+.++... -..+-.+..+++.+++.|++|||+.. .-|.---|....++++++.+.+|+ |-..+.
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--------- 341 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------- 341 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---------
Confidence 99999997554 35788899999999999999999852 233444688899999999888775 322221
Q ss_pred ccccCCCCCCccccccccccCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYP--ITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~--~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
......-.+.|++||.++.... .-.++|+|||++++|||.|...||.+.++-.... ...+.+.
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialegl 406 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGL 406 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhccc
Confidence 1122335678999999987643 3458999999999999999999998655432211 1223445
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
....++..+..+..|+.-|+++||.+||.+..|+-.|++.
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 5667788889999999999999999999999999888753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-25 Score=201.87 Aligned_cols=258 Identities=20% Similarity=0.252 Sum_probs=189.6
Q ss_pred hhccccccccCCceEEEEEEeCCC--cEEEEEEccccccHHHHHHHHHHHHHHhccCC----CceeeEEeEE-EeCCceE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPNG--VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH----INLVRLYGFC-YDQTKAA 97 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~ 97 (369)
.+.+.++||+|+||.||.+.+... ..+|+|+.......... .+..|+.++..+.. .++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 455678999999999999987553 58899987754332222 67778888887762 5889999888 4777899
Q ss_pred EEEeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC-----CCeeEeecCC
Q 017591 98 LVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK-----FSAKVADFGL 171 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-----~~~kl~Dfg~ 171 (369)
+||+.+ |.+|.++..... ..++..+.+.++.|++.+|.+||+ .|++||||||+|+++... ..++|.|||+
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 999987 669999885444 789999999999999999999999 999999999999999765 3599999999
Q ss_pred ce--ecCCCCC----ccc--cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccch
Q 017591 172 AK--LCNPENT----HDS--TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQV 243 (369)
Q Consensus 172 ~~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 243 (369)
++ .+..... ... ....+||..|+++....+ ...+.+.|+||++.++.+++.|..||........
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~------- 245 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL------- 245 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccch-------
Confidence 98 3221111 111 234669999999996655 5899999999999999999999999965543211
Q ss_pred hHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 244 WDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
...+.. ..............+..+..+...+-..+...+|....+...|+..
T Consensus 246 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 246 KSKFEK-----DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHH-----HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 011110 0000000101122334555666656668999999999999888765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=201.31 Aligned_cols=162 Identities=22% Similarity=0.174 Sum_probs=125.8
Q ss_pred hhccccccccCCceEEEEEEeC--CCcEEEEEEcccc----ccHHHHHHHHHHHHHHhccCCCceee-EEeEEEeCCceE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP--NGVKIAAKILKTC----LNKRVEAQFMAEIGTIGRTYHINLVR-LYGFCYDQTKAA 97 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~ 97 (369)
.+.+.+.||+|+||+||+|.++ +++.+|||.+... ........+.+|+.++..+.|+|++. +++ .+..+
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~ 94 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDG 94 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcE
Confidence 3455689999999999999774 5777899986532 12334567999999999999999985 443 24689
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecC-CCCceEecCCCCeeEeecCCceecC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDI-KPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
+||||++|++|.. +... . ...++.+++++|.|||+ +||+|||| ||+|||++.++.++|+|||+++.+.
T Consensus 95 LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 95 LVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 9999999999963 2111 1 14678999999999999 99999999 9999999999999999999999775
Q ss_pred CCCCcc------ccccCCCCCCccccccccc
Q 017591 177 PENTHD------STSGYRGTPGYSAPEFLLR 201 (369)
Q Consensus 177 ~~~~~~------~~~~~~gt~~y~aPE~~~~ 201 (369)
...... .-+...++..|++||++..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 432111 1134568888999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-26 Score=222.79 Aligned_cols=254 Identities=18% Similarity=0.178 Sum_probs=189.2
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEcc----cccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILK----TCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
..++|.|.+|.|+..... ....++.|... .... ......+..|+-+-..+.|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 467999999977777542 23333333322 2222 22222367788888889999998888877766665556999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc-
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH- 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 181 (369)
|++ +|..++ .....+....+-.++.|++.|+.|+|+ .|+.|||+|++|+++..+|.+||+|||.+..+......
T Consensus 403 ~~~-Dlf~~~-~~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 403 CPY-DLFSLV-MSNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred ccH-HHHHHH-hcccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 999 999998 444679999999999999999999999 99999999999999999999999999999876544433
Q ss_pred -cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 182 -DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.......|+.+|+|||++..........||||.|+++..|++|+.||.........+ ... .... .......
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~--~~~~-~~~~~~~ 549 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTN--NYSD-QRNIFEG 549 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhh--cccc-ccccccC
Confidence 455678899999999999887666788999999999999999999997554432211 000 0000 0011111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........+...+.++.+||+.||.+|.|+.+|++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 12224456788899999999999999999999873
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-23 Score=188.68 Aligned_cols=260 Identities=30% Similarity=0.364 Sum_probs=196.6
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHH--HHHHHHHHHHHHhccCCC-ceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKR--VEAQFMAEIGTIGRTYHI-NLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~ 103 (369)
...+.||.|+||.||++.+. ..+++|.+....... ....+.+|+.++..+.|+ +++++.+.+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 34578999999999999886 888999887654433 477899999999999988 7999999997777789999999
Q ss_pred CCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-CeeEeecCCceecCCCCC
Q 017591 104 ENGSLDKYLFTDT--EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENT 180 (369)
Q Consensus 104 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 180 (369)
.++++.+++.... ..+.......++.|++.++.++|+ .+++|||+||+||+++..+ .+++.|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999997774333 279999999999999999999999 9999999999999999998 699999999986544332
Q ss_pred cc----ccccCCCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 181 HD----STSGYRGTPGYSAPEFLLRN--YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 181 ~~----~~~~~~gt~~y~aPE~~~~~--~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
.. ......|+..|++||.+... ...+...|+||+|++++++++|..||...... ......++........
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-
Confidence 21 23456799999999988763 47899999999999999999999996544321 0001111111111100
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.................+.+++..|+..+|..|.+..+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 00000000000222367889999999999999999887665
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=214.47 Aligned_cols=249 Identities=22% Similarity=0.223 Sum_probs=183.4
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccH---HHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNK---RVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||++.|=.|.+|++.+|. |+||++.+.... +...+...|++ ...+++||++++..+...++..|||-+|.
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 45688999999999999997777 888887654322 23333444454 45568999999998888888899999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceec--CCCCCc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC--NPENTH 181 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~--~~~~~~ 181 (369)
.. +|.+.+ ..+..+...+...|+.|++.||...|. .||+|||||.+|||++.-+-+.|+||...+.. ..++..
T Consensus 104 kh-nLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 104 KH-NLYDRL-STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred hh-hhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 87 999988 555678889999999999999999999 99999999999999999999999999887543 222222
Q ss_pred cc---cccCCCCCCccccccccccC----------CCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCccCccccchhHHh
Q 017591 182 DS---TSGYRGTPGYSAPEFLLRNY----------PITQKCDVYSFGMLLFEIIGR-RKNAQDCSSDTLDWFPKQVWDEY 247 (369)
Q Consensus 182 ~~---~~~~~gt~~y~aPE~~~~~~----------~~s~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~ 247 (369)
.. -.....-.+|+|||.+.... ..+++.||||+||++.||++- +++|... +... +
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----------QL~a-Y 247 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----------QLLA-Y 247 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----------HHHh-H
Confidence 21 12233556899999876521 267899999999999999975 6655421 1111 1
Q ss_pred hhc--hhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 248 EKG--ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 248 ~~~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+.+ ...+..+... + ...++.++..|++.||++|.++++.++.-.+.
T Consensus 248 r~~~~~~~e~~Le~I-e------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKI-E------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred hccCccCHHHHHHhC-c------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111 1111222111 1 12588999999999999999999999775543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=174.91 Aligned_cols=139 Identities=18% Similarity=0.155 Sum_probs=108.7
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHH-H------------------------HHHHHHHHHHHhccCCCcee
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKR-V------------------------EAQFMAEIGTIGRTYHINLV 84 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~------------------------~~~~~~E~~~l~~l~h~niv 84 (369)
..||+|+||.||+|..++|+.||+|+++...... . ......|+..+..+.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 5799999999999998889999999987542110 0 12234599999999877664
Q ss_pred eEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-hhccCCCeEeecCCCCceEecCCCC
Q 017591 85 RLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYL-HEECNQRIIHYDIKPANILLDAKFS 163 (369)
Q Consensus 85 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~L-H~~~~~~ivH~dlkp~Nill~~~~~ 163 (369)
....+. ....+|||||++++++..... ....+++..+..++.|++.+|.++ |+ .||+||||||+||+++ ++.
T Consensus 83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPIL--LKSHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEE--ecCCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCc
Confidence 333222 223489999999987765532 345789999999999999999999 68 8999999999999998 478
Q ss_pred eeEeecCCceec
Q 017591 164 AKVADFGLAKLC 175 (369)
Q Consensus 164 ~kl~Dfg~~~~~ 175 (369)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=176.33 Aligned_cols=172 Identities=15% Similarity=0.121 Sum_probs=129.9
Q ss_pred HHhhhccccccccCCceEEEEEEeCCCcEEEEEEcccccc--HHHHHH------HHHHHHHHhccCCCceeeEEeEEEeC
Q 017591 22 CSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLN--KRVEAQ------FMAEIGTIGRTYHINLVRLYGFCYDQ 93 (369)
Q Consensus 22 ~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~ 93 (369)
....+...+.+|.|+||.||+... ++..+|+|++..... +..... +.+|+..+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 334445568999999999999765 677899999975432 222222 68999999999999999999886643
Q ss_pred --------CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCee
Q 017591 94 --------TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAK 165 (369)
Q Consensus 94 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 165 (369)
+..+|||||++|.+|.++. .++. ....+++.+|..+|+ .|++|||+||+||+++.++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EE
Confidence 3578999999999998874 2232 245689999999999 9999999999999999988 99
Q ss_pred EeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHH
Q 017591 166 VADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222 (369)
Q Consensus 166 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ell 222 (369)
|+|||............ .++.. ..+..++|+|+||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~d--------------~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAKD--------------RIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhHH--------------HHHHH-hHhcccccccceeEeehHHH
Confidence 99999876542111110 02222 24668999999999987664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=179.31 Aligned_cols=229 Identities=19% Similarity=0.224 Sum_probs=150.0
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEccc--cccHHHHHHHHHHHHHHhccCC----------CceeeEEeEEEeC--
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKT--CLNKRVEAQFMAEIGTIGRTYH----------INLVRLYGFCYDQ-- 93 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~~~-- 93 (369)
...||.|+++.||.+++. +|+.+++|+... .......+++.+|......+.+ -.++-.++.....
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 367999999999999985 499999998753 2333456677777766655332 2333333333211
Q ss_pred ----------C-----ceEEEEeccCCCCHHHHhc---cCC---CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCC
Q 017591 94 ----------T-----KAALVYEFMENGSLDKYLF---TDT---EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIK 152 (369)
Q Consensus 94 ----------~-----~~~lv~e~~~~gsL~~~l~---~~~---~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlk 152 (369)
+ ..+++|+-+.+ +|..++. ... ..+....++.+..|+++.+++||. .|++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence 1 23678888865 8988763 111 234456667777999999999999 999999999
Q ss_pred CCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCcccccccccc-------CCCCcchhhHHHHHHHHHHHcCC
Q 017591 153 PANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN-------YPITQKCDVYSFGMLLFEIIGRR 225 (369)
Q Consensus 153 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~s~~sDvwSlGvil~elltg~ 225 (369)
|+|++++.+|.++|+||+.....+..... ...+..|.+||..... ..++.+.|.|+||+++|.|.|++
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999887654321111 2345779999976442 25789999999999999999999
Q ss_pred CCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCC
Q 017591 226 KNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEAR 287 (369)
Q Consensus 226 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 287 (369)
.||........... . +.... +.++.+..||..+|+.||.+|
T Consensus 248 lPf~~~~~~~~~~~---------------~-----f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW---------------D-----FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG---------------G-----GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc---------------c-----chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99986544322100 1 11222 778899999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-21 Score=162.48 Aligned_cols=188 Identities=17% Similarity=0.073 Sum_probs=140.4
Q ss_pred ccccccCCceEEEEEEeCCCcEEEEEEcccccc---HHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccC
Q 017591 29 STKLGAGGFGVVYKGQFPNGVKIAAKILKTCLN---KRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
...|++|+||+||.+.. .+.+++.+.+..... .-....+.+|++++.++. |+++++++++ +..+++|+|+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35799999999998766 678888777664322 111235889999999995 5789999886 35699999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecC-CCCceEecCCCCeeEeecCCceecCCCCCc--
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDI-KPANILLDAKFSAKVADFGLAKLCNPENTH-- 181 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 181 (369)
|.+|...+.. ....++.|++.+|.++|+ +||+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 82 GAAMYQRPPR--------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred CccHHhhhhh--------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9998754411 114578899999999999 99999999 799999999999999999999865433311
Q ss_pred --cc-------cccCCCCCCccccccccccCCCC-cchhhHHHHHHHHHHHcCCCCCCCCC
Q 017591 182 --DS-------TSGYRGTPGYSAPEFLLRNYPIT-QKCDVYSFGMLLFEIIGRRKNAQDCS 232 (369)
Q Consensus 182 --~~-------~~~~~gt~~y~aPE~~~~~~~~s-~~sDvwSlGvil~elltg~~p~~~~~ 232 (369)
.. ......++.|++|+...--...+ .+.+.++-|+-+|.++|++.+...+.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00 11123677888888543222233 57788899999999999998875444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=163.86 Aligned_cols=141 Identities=21% Similarity=0.187 Sum_probs=110.9
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccH-------------------------HHHHHHHHHHHHHhccCCCcee
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNK-------------------------RVEAQFMAEIGTIGRTYHINLV 84 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~l~h~niv 84 (369)
..||+|+||.||+|.+.+|+.||+|++...... .....+..|+..+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999878999999998754210 0012346789999999988875
Q ss_pred eEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCe
Q 017591 85 RLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA 164 (369)
Q Consensus 85 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 164 (369)
....+... ..+|||||++++++..... ....++......++.|++.++.++|+. +|++||||||+||+++ ++.+
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCCE
Confidence 44443332 3489999999876544321 235678899999999999999999973 7999999999999999 7899
Q ss_pred eEeecCCceecC
Q 017591 165 KVADFGLAKLCN 176 (369)
Q Consensus 165 kl~Dfg~~~~~~ 176 (369)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.9e-22 Score=185.49 Aligned_cols=216 Identities=25% Similarity=0.356 Sum_probs=163.4
Q ss_pred HhccCCCceeeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCC
Q 017591 75 IGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPA 154 (369)
Q Consensus 75 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~ 154 (369)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+....-.+++--...++++++.||.|||.. ....|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 3567899999999999999999999999999999999977778899999999999999999999983 23399999999
Q ss_pred ceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccC------CCCcchhhHHHHHHHHHHHcCCCCC
Q 017591 155 NILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY------PITQKCDVYSFGMLLFEIIGRRKNA 228 (369)
Q Consensus 155 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~s~~sDvwSlGvil~elltg~~p~ 228 (369)
|++++..+.+||+|||+....................-|.|||.+.... ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999987653211111112223455699999887631 2578899999999999999999999
Q ss_pred CCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC--HHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 229 QDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND--REEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
......... ..+......+ .....++... ....+.+..++..||..+|..||++..|-..++..
T Consensus 159 ~~~~~~~~~---~eii~~~~~~-----~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 159 DLRNLVEDP---DEIILRVKKG-----GSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccCCh---HHHHHHHHhc-----CCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 864443221 1111111110 0011111111 13445799999999999999999999999888765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.8e-22 Score=185.77 Aligned_cols=226 Identities=25% Similarity=0.237 Sum_probs=183.4
Q ss_pred ccccCCceEEEEEEe----CCCcEEEEEEccccccHH-HHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccC
Q 017591 31 KLGAGGFGVVYKGQF----PNGVKIAAKILKTCLNKR-VEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+|+|+||.|++++- +.|+-+++|+.++..... .......|..++...+ ||.++.+...+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998842 347888999887533211 1114555777777776 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+|.|...+ .....+++.....+...++-+++++|+ .+++|+|+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l-~~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRL-SKEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhcc-ccCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 99998888 556678899999999999999999999 9999999999999999999999999999986533222
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
.+||..|||||++.+ ...++|.||||++++||++|..||.. ++...+.. .....
T Consensus 153 --~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~-~~~~~ 206 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILK-AELEM 206 (612)
T ss_pred --cccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhh-hccCC
Confidence 279999999998772 47899999999999999999999974 11111111 12455
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
+......+.+++..++..+|.+|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 77788889999999999999999765
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=192.26 Aligned_cols=194 Identities=21% Similarity=0.206 Sum_probs=152.4
Q ss_pred hhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccC---CCceeeEEeEEEeCCceEEEE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY---HINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 100 (369)
-..-+.+.||+|+||.||.|...+|+.||+|+-+.... .+|.-=.+++.+|+ -+-|..+..++.-.+..+||+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 33345678999999999999888899999999875321 12222222333333 344666666667788899999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-------CCCeeEeecCCce
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-------KFSAKVADFGLAK 173 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------~~~~kl~Dfg~~~ 173 (369)
||.+.|+|.++++ ..+.+++..+..+..|++..+.+||. .+||||||||+|+||.. ...++|+|||.+.
T Consensus 774 ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 9999999999995 67789999999999999999999999 99999999999999942 3358999999986
Q ss_pred ecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCC
Q 017591 174 LCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRK 226 (369)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~ 226 (369)
.+.-......-...++|-.+-.+|...+ +.++..+|.|.|+-+++.||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 5532222222345678999999996655 599999999999999999999875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=157.71 Aligned_cols=132 Identities=18% Similarity=0.219 Sum_probs=103.2
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-----CCCceeeEEeEEEeCC---c-eEEEE
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-----YHINLVRLYGFCYDQT---K-AALVY 100 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv~ 100 (369)
+.||+|+||.||. ++.....+||++..... .....+.+|+..++.+ .||||+++++++.++. . ..+|+
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 5799999999996 54434346888765322 2356789999999999 5799999999998764 2 33789
Q ss_pred ec--cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHhhccCCCeEeecCCCCceEecCC----CCeeEeecCC
Q 017591 101 EF--MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGI-AYLHEECNQRIIHYDIKPANILLDAK----FSAKVADFGL 171 (369)
Q Consensus 101 e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l-~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~ 171 (369)
|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+ ++|+||||||+|||++.. ..++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 667999999943 246655 35678888888 99999 999999999999999743 3799999543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.7e-20 Score=162.70 Aligned_cols=199 Identities=23% Similarity=0.258 Sum_probs=144.1
Q ss_pred CCCceeeEEeEEEe---------------------------CCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHH
Q 017591 79 YHINLVRLYGFCYD---------------------------QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGT 131 (369)
Q Consensus 79 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l 131 (369)
.|||||++.++|.+ +...|+||..++. +|..++.. ...+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc--CCCchHHHHHHHHHH
Confidence 49999999988753 2246899998876 99999943 346777788899999
Q ss_pred HHHHHHHhhccCCCeEeecCCCCceEe--cCCCC--eeEeecCCceecCCCC----CccccccCCCCCCccccccccccC
Q 017591 132 ARGIAYLHEECNQRIIHYDIKPANILL--DAKFS--AKVADFGLAKLCNPEN----THDSTSGYRGTPGYSAPEFLLRNY 203 (369)
Q Consensus 132 ~~~l~~LH~~~~~~ivH~dlkp~Nill--~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~ 203 (369)
++|+.|||+ +||.|||+|.+|||+ ++|+. ..|+|||.+--..... ........-|...-||||+.....
T Consensus 351 LEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999 999999999999999 44443 6889999874322110 011122344888899999876431
Q ss_pred -----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHh
Q 017591 204 -----PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALW 278 (369)
Q Consensus 204 -----~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 278 (369)
-.-.|+|.|+.|.+.||+++...||-....-.... ..+. ....+..+...+..+.+++..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------r~Yq---------e~qLPalp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------RTYQ---------ESQLPALPSRVPPVARQLVFD 492 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------hhhh---------hhhCCCCcccCChHHHHHHHH
Confidence 12358999999999999999999996522211100 1111 122355566677889999999
Q ss_pred ccccCCCCCCChHHHHHHhc
Q 017591 279 CVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 279 cl~~~p~~RPs~~~v~~~L~ 298 (369)
.|+.||.+|++..-....|+
T Consensus 493 lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HhcCCccccCCccHHHhHHH
Confidence 99999999999766555544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=156.58 Aligned_cols=138 Identities=18% Similarity=0.173 Sum_probs=108.7
Q ss_pred cccccccCCceEEEEEE--eCCCcEEEEEEcccccc---------------------H--HHHHHHHHHHHHHhccCCC-
Q 017591 28 YSTKLGAGGFGVVYKGQ--FPNGVKIAAKILKTCLN---------------------K--RVEAQFMAEIGTIGRTYHI- 81 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~---------------------~--~~~~~~~~E~~~l~~l~h~- 81 (369)
+.+.||+|+||.||+|. ..+|+.||+|++..... . .....+.+|+..+.++.+.
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 45789999999999998 46899999999874321 0 0123467899999999753
Q ss_pred -ceeeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCC-eEeecCCCCceEec
Q 017591 82 -NLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR-IIHYDIKPANILLD 159 (369)
Q Consensus 82 -niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-ivH~dlkp~Nill~ 159 (369)
.+.+++++ ...++||||+.+.+|..... ....+.......++.|++.+|.+||+ +| ++|+||||+||+++
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILVH 183 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEEE
Confidence 23444442 23589999999988876552 33456677788999999999999999 89 99999999999999
Q ss_pred CCCCeeEeecCCcee
Q 017591 160 AKFSAKVADFGLAKL 174 (369)
Q Consensus 160 ~~~~~kl~Dfg~~~~ 174 (369)
++.++|+|||.+..
T Consensus 184 -~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 -DGKVVIIDVSQSVE 197 (237)
T ss_pred -CCCEEEEEChhhhc
Confidence 88999999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-19 Score=153.27 Aligned_cols=135 Identities=21% Similarity=0.292 Sum_probs=113.4
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEcccccc-------HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLN-------KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.||+|++|.||+|.+ .|..+++|+...... ......+.+|+.++..+.|+++.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4799999999999988 777888997653211 11234688899999999999988777777778889999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
++|++|.+++.... . .+..++.+++.+|.++|+ .+++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999984322 2 888999999999999999 9999999999999999 78899999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.3e-19 Score=150.38 Aligned_cols=131 Identities=21% Similarity=0.312 Sum_probs=106.8
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEccccc-------cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCL-------NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.||+|+||.||+|.+ ++..+++|...... ......++.+|+.++..+.|+++.....++.+.+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 67889999854321 1112356788999999998887655555556677789999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
+|++|.+++..... .++.+++.+|.+||+ .+++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998843211 889999999999999 9999999999999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=148.72 Aligned_cols=137 Identities=18% Similarity=0.206 Sum_probs=108.2
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccH---------------------HHHHHHHHHHHHHhccCCCc--
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNK---------------------RVEAQFMAEIGTIGRTYHIN-- 82 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~h~n-- 82 (369)
+.+.+.||+|+||.||++..++|+.||||++...... .....+..|+..+..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 4556889999999999999888999999986542210 11223677888888887763
Q ss_pred eeeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC
Q 017591 83 LVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF 162 (369)
Q Consensus 83 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 162 (369)
+...++ ....++||||+++++|..... ......++.+++.++.++|+ .|++|+||||+||+++.++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCCC
Confidence 444443 345689999999999977652 13456788999999999999 9999999999999999999
Q ss_pred CeeEeecCCceecC
Q 017591 163 SAKVADFGLAKLCN 176 (369)
Q Consensus 163 ~~kl~Dfg~~~~~~ 176 (369)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=168.39 Aligned_cols=133 Identities=17% Similarity=0.233 Sum_probs=108.8
Q ss_pred ccccccCCceEEEEEEeCCCcEEEEEEccccc------cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 29 STKLGAGGFGVVYKGQFPNGVKIAAKILKTCL------NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.||+|+||+||++.+.+...++.+...+.. .......+.+|+.++..++|++++....++.+....++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 46899999999999988554433333222211 112345688999999999999998888777777788999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
+++++|.+++. ....++.+++.+|.+||+ .+++||||||+||++ .++.++|+|||+++.
T Consensus 418 ~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 418 IGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999883 457899999999999999 999999999999999 677999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-19 Score=167.13 Aligned_cols=173 Identities=23% Similarity=0.322 Sum_probs=129.8
Q ss_pred ceEEEEeccCCCCHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCc
Q 017591 95 KAALVYEFMENGSLDKYLFT--DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA 172 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 172 (369)
..++.|++|...+|.++|.. .....++...+.++.|++.|+.| ++.+|+|+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 47899999999999999943 34568889999999999999999 59999999999999999999999999998
Q ss_pred eecCCCC----CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHh
Q 017591 173 KLCNPEN----THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEY 247 (369)
Q Consensus 173 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 247 (369)
....... .....+...||..||+||.+.+. .++.++||||||++|+|++. =...+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~------------------- 463 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQF------------------- 463 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHH-------------------
Confidence 7665433 12234557799999999999985 89999999999999999995 11111
Q ss_pred hhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHH
Q 017591 248 EKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAV 293 (369)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v 293 (369)
........+....+++.....-+.-..|+.+++.+.|.+||++.++
T Consensus 464 er~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 464 ERIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 1111111222222232222222334578999999999999954443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-18 Score=171.38 Aligned_cols=209 Identities=22% Similarity=0.316 Sum_probs=144.4
Q ss_pred hhccc--cccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 25 TNNYS--TKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 25 t~~f~--~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
..+|. +.|..|++|.||..+++. .+.+|+|+-+.+.- .+. ++....+|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li-------lRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI-------LRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccchh-------hhc--cccccCCccee-----------------
Confidence 34554 679999999999998864 77888854332111 111 22222344333
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC-
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT- 180 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 180 (369)
|+-...+ ..-++++... +.+++|||. .||+|||+||+|.+++.-|++|++|||+++...-...
T Consensus 136 ----gDc~tll-k~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ----GDCATLL-KNIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ----chhhhhc-ccCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 3444444 2333444333 678999999 9999999999999999999999999999874321100
Q ss_pred ------------ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhh
Q 017591 181 ------------HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYE 248 (369)
Q Consensus 181 ------------~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 248 (369)
......++||+.|+|||++... .|....|.|++|+|+||.+-|..||++..+..+ +...-
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeel-------fg~vi 271 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-------FGQVI 271 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-------Hhhhh
Confidence 0012345799999999998875 699999999999999999999999998766432 12111
Q ss_pred hchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
.. ....++.......++++++.++|+.+|.+|--.
T Consensus 272 sd-------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 272 SD-------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hh-------hccccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 11 111233455567789999999999999999643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=130.17 Aligned_cols=133 Identities=23% Similarity=0.171 Sum_probs=113.1
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCC--CceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH--INLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..+.+ .++++++++....+..+++|||++++.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 579999999999999844 7899998875433 4678899999999976 589999988887788999999999877
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
+..+ +......++.+++++|++||.....+++|+|++|.||+++..+.+++.|||.+..
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7543 5677788899999999999985445799999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=135.59 Aligned_cols=137 Identities=21% Similarity=0.223 Sum_probs=97.3
Q ss_pred ccccccCCceEEEEEEeCCCcEEEEEEccccccH-HHHHH----------------------HHHHHHHHhccCCC--ce
Q 017591 29 STKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNK-RVEAQ----------------------FMAEIGTIGRTYHI--NL 83 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~----------------------~~~E~~~l~~l~h~--ni 83 (369)
.+.||+|+||.||+|...+++.||+|++...... ..... ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987643211 11111 13455555555433 24
Q ss_pred eeEEeEEEeCCceEEEEeccCCCCHHH-HhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC
Q 017591 84 VRLYGFCYDQTKAALVYEFMENGSLDK-YLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF 162 (369)
Q Consensus 84 v~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 162 (369)
.+++++ ...++||||++++.+.. .+.... . ......++.+++.++.++|.. .+++|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CC
Confidence 444443 24689999999954321 111100 1 167889999999999999973 7999999999999999 88
Q ss_pred CeeEeecCCceec
Q 017591 163 SAKVADFGLAKLC 175 (369)
Q Consensus 163 ~~kl~Dfg~~~~~ 175 (369)
.++|+|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-18 Score=169.11 Aligned_cols=254 Identities=21% Similarity=0.244 Sum_probs=191.4
Q ss_pred hccccccccCCceEEEEEEeCC--CcEEEEEEccccc-cHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN--GVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 101 (369)
+++.+-||+|+|+.|-...... ...+++|.+.... ......+...|..+-..+. |.|++.+++...+.+..+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 3455679999999999886643 4555666554332 2333445556777777776 9999999999999999999999
Q ss_pred ccCCCCHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHh-hccCCCeEeecCCCCceEecCCC-CeeEeecCCceecCC-
Q 017591 102 FMENGSLDKYL-FTDTEVLKWEKLLDIAIGTARGIAYLH-EECNQRIIHYDIKPANILLDAKF-SAKVADFGLAKLCNP- 177 (369)
Q Consensus 102 ~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~l~~~l~~LH-~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~- 177 (369)
|..++++...+ .......+......++.|+..++.|+| . .++.|+|+||+|.+++..+ ..++.|||+|..+..
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999988 444447788888999999999999999 7 9999999999999999999 999999999987765
Q ss_pred CCCccccccCCC-CCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 178 ENTHDSTSGYRG-TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 178 ~~~~~~~~~~~g-t~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
...........| ++.|.|||...+........|+||.|+++..+++|..|+.........+. .|....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~---~~~~~~-------- 247 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS---SWKSNK-------- 247 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce---eecccc--------
Confidence 333333344567 99999999887744678899999999999999999999875544322110 011100
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
.................++.+++..+|..|.+.+++-
T Consensus 248 -~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 -GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0000122233455677888889999999999988754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.4e-16 Score=137.06 Aligned_cols=135 Identities=24% Similarity=0.240 Sum_probs=104.7
Q ss_pred cccc-cCCceEEEEEEeCCCcEEEEEEccccc------------cHHHHHHHHHHHHHHhccCCCce--eeEEeEEEeCC
Q 017591 30 TKLG-AGGFGVVYKGQFPNGVKIAAKILKTCL------------NKRVEAQFMAEIGTIGRTYHINL--VRLYGFCYDQT 94 (369)
Q Consensus 30 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~ 94 (369)
..|| .||.|+||.+.. ++..+++|.+.... .......+.+|+.++..+.|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 899999999987 47788888774210 11233568889999999998774 66777654332
Q ss_pred ----ceEEEEeccCC-CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeec
Q 017591 95 ----KAALVYEFMEN-GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADF 169 (369)
Q Consensus 95 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 169 (369)
..++|||+++| .+|.+++.. ..++... +.+++.+|.+||+ +||+|+||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 699988833 3455443 5689999999999 99999999999999999989999999
Q ss_pred CCcee
Q 017591 170 GLAKL 174 (369)
Q Consensus 170 g~~~~ 174 (369)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=138.81 Aligned_cols=141 Identities=18% Similarity=0.236 Sum_probs=99.0
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHH---------------------------------------HHHHH
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVE---------------------------------------AQFMA 70 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------------------------------~~~~~ 70 (369)
+.||.|++|.||+|+.++|+.||||+.+........ -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 469999999999999999999999998765322111 12444
Q ss_pred HHHHHhccC----CCceeeEEeEEE-eCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHH-HHHHHhhccCC
Q 017591 71 EIGTIGRTY----HINLVRLYGFCY-DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR-GIAYLHEECNQ 144 (369)
Q Consensus 71 E~~~l~~l~----h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~-~l~~LH~~~~~ 144 (369)
|...+.++. +.+-+.+-.++. ..+..+|||||++|++|.++........+ ...++..++. .+..+|. .
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~---~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR---D 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh---C
Confidence 555444442 222233222232 23457999999999999887643222222 3345555555 4678888 9
Q ss_pred CeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 145 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
|++|+|++|.||+++.+++++++|||++..+.
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.6e-14 Score=136.48 Aligned_cols=254 Identities=22% Similarity=0.226 Sum_probs=187.0
Q ss_pred HHHHHhhhcccccccc--CCceEEEEEEe---CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccC-CCceeeEEeEEE
Q 017591 19 EQLCSFTNNYSTKLGA--GGFGVVYKGQF---PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCY 91 (369)
Q Consensus 19 ~el~~~t~~f~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 91 (369)
.+..+.+-++.+.+|. |.+|.||.+.. .++..+|+|.-+.. ........-.+|+..-..+. |+|.++.+..+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3445555566788999 99999999977 34788888874321 12222334456666666664 999999888888
Q ss_pred eCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHH----HHHHHhhccCCCeEeecCCCCceEecCC-CCeeE
Q 017591 92 DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR----GIAYLHEECNQRIIHYDIKPANILLDAK-FSAKV 166 (369)
Q Consensus 92 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~----~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl 166 (369)
..+..++-+|++. .+|..+.......++...++.+..+..+ ||.++|. .+++|-|+||.||+...+ ...++
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccceeec
Confidence 8899999999986 5888888666667888999999999999 9999999 999999999999999999 78999
Q ss_pred eecCCceecCCCCCccc---cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccch
Q 017591 167 ADFGLAKLCNPENTHDS---TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQV 243 (369)
Q Consensus 167 ~Dfg~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 243 (369)
+|||+...+.+...... .....|...|++||.... -++..+|+|++|.++.+..++.......... .
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~ 334 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNS--------S 334 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCC--------C
Confidence 99999988876553222 122357778999997765 5899999999999999999887655432111 1
Q ss_pred hHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 244 WDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
|..+.++.+. .+........+...+..|++++|..|++...+.
T Consensus 335 W~~~r~~~ip--------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 335 WSQLRQGYIP--------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ccccccccCc--------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 2222222211 112222344556699999999999999887755
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.4e-14 Score=124.69 Aligned_cols=202 Identities=22% Similarity=0.344 Sum_probs=137.3
Q ss_pred HHHHHhccCCCceeeEEeEEEeCC-----ceEEEEeccCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhcc
Q 017591 71 EIGTIGRTYHINLVRLYGFCYDQT-----KAALVYEFMENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEEC 142 (369)
Q Consensus 71 E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~ 142 (369)
-+..+-++.|.|||+++.++.+.. ...++.|||..|+|..+|.. +...+......+|+.||+.||.|||+ |
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 344555667999999999886543 57899999999999999953 35678899999999999999999998 5
Q ss_pred CCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC---CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHH
Q 017591 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN---THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219 (369)
Q Consensus 143 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ 219 (369)
...++|+++..+.|++..+|-+|++--.- ....... .........+-++|.+||+-... +.+.++|||+||+..+
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCAL 273 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHH
Confidence 57899999999999999888888753221 1111110 11112234578899999965443 6788999999999999
Q ss_pred HHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 220 EIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 220 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
+|--+.--......... + +......+.. . .-..=+.++..|++..|..||+|.+++
T Consensus 274 emailEiq~tnseS~~~---~--------ee~ia~~i~~-l-------en~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVE---V--------EENIANVIIG-L-------ENGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHHheeccCCCcceee---h--------hhhhhhheee-c-------cCccccCcCcccccCCCCCCcchhhhh
Confidence 98865532111111100 0 0000000000 0 001123567789999999999999876
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=3e-13 Score=112.92 Aligned_cols=126 Identities=21% Similarity=0.165 Sum_probs=94.4
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCce-eeEEeEEEeCCceEEEEeccCCCCH
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL-VRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
+.|+.|.++.||++... ++.+++|+...... ....+.+|+..+..+.+.++ .+++.+. ....++||||++|.++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 45788999999999874 78899999765432 12356788888888865444 3455443 3446899999999887
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCC-----eEeecCCCCceEecCCCCeeEeecCCce
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR-----IIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
...- .....++.+++.+|+.||+ .+ ++|+|++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~~---------~~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED---------FSDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc---------ccCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5431 1113456789999999999 55 59999999999999 6689999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.8e-13 Score=131.06 Aligned_cols=138 Identities=16% Similarity=0.202 Sum_probs=92.2
Q ss_pred cccccCCceEEEEEEeCC-CcEEEEEEccccccHH---------------------------------HH------HHHH
Q 017591 30 TKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKR---------------------------------VE------AQFM 69 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---------------------------------~~------~~~~ 69 (369)
+-||+|++|.||+|+.++ |+.||||+.++...+. .. -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999987 9999999997653211 01 1233
Q ss_pred HHHHHHhccC----CCceeeEEeEEEe-CCceEEEEeccCCCCHHHHhccCCC-----CCCHHHHHHHHHHHHHHHHHHh
Q 017591 70 AEIGTIGRTY----HINLVRLYGFCYD-QTKAALVYEFMENGSLDKYLFTDTE-----VLKWEKLLDIAIGTARGIAYLH 139 (369)
Q Consensus 70 ~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~~l~~~l~~LH 139 (369)
+|...+.++. +.+.+.+=.++.+ .+..+|||||++|+.+.++..-... .+....+..++.|++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 4444444332 3333333333322 4567899999999999875321112 233333444444443
Q ss_pred hccCCCeEeecCCCCceEecCCC----CeeEeecCCceecCC
Q 017591 140 EECNQRIIHYDIKPANILLDAKF----SAKVADFGLAKLCNP 177 (369)
Q Consensus 140 ~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~ 177 (369)
. .|++|+|+||.||+++.++ ++++.|||+...++.
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 8999999999999999888 899999999887653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.6e-12 Score=122.06 Aligned_cols=166 Identities=14% Similarity=0.169 Sum_probs=128.3
Q ss_pred eCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHH
Q 017591 45 FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKL 124 (369)
Q Consensus 45 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 124 (369)
..++.+|.|...+.... .......+-+..++.++||||+++++.+...+..|||+|.+. .|..++.. +....+
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHH
Confidence 34688888888775544 555677888999999999999999999999999999999884 78777733 336677
Q ss_pred HHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCC
Q 017591 125 LDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYP 204 (369)
Q Consensus 125 ~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 204 (369)
...+.||+.||.|||. +.+++|++|..+.|+|+..|..||++|.++........ ......---.|..|+.+...
T Consensus 107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s-- 180 (690)
T KOG1243|consen 107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS-- 180 (690)
T ss_pred HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc--
Confidence 7788999999999986 38999999999999999999999999988765432221 11111222346667643322
Q ss_pred CCcchhhHHHHHHHHHHHcC
Q 017591 205 ITQKCDVYSFGMLLFEIIGR 224 (369)
Q Consensus 205 ~s~~sDvwSlGvil~elltg 224 (369)
.-..|.|-|||++++++.|
T Consensus 181 -~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 -EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -ccchhhhhHHHHHHHHhCc
Confidence 2457999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=5.8e-12 Score=106.38 Aligned_cols=136 Identities=19% Similarity=0.170 Sum_probs=99.2
Q ss_pred cccccCCceEEEEEEeCC-------CcEEEEEEcccccc---------------------HHHHHHHH----HHHHHHhc
Q 017591 30 TKLGAGGFGVVYKGQFPN-------GVKIAAKILKTCLN---------------------KRVEAQFM----AEIGTIGR 77 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~~----~E~~~l~~ 77 (369)
-.||.|--+.||.|...+ +..+|||+.+.... ......+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999997643 47999998764210 01112223 79999988
Q ss_pred cCC--CceeeEEeEEEeCCceEEEEeccCCCCHHH-HhccCCCCCCHHHHHHHHHHHHHHHHHH-hhccCCCeEeecCCC
Q 017591 78 TYH--INLVRLYGFCYDQTKAALVYEFMENGSLDK-YLFTDTEVLKWEKLLDIAIGTARGIAYL-HEECNQRIIHYDIKP 153 (369)
Q Consensus 78 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~l~~~l~~L-H~~~~~~ivH~dlkp 153 (369)
+.. -++..++++ ...+|||||+.+..+.. .+ ....++......+..+++.+|..| |+ .|++||||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 853 355666654 56789999997643321 22 122455667778889999999998 88 8999999999
Q ss_pred CceEecCCCCeeEeecCCceec
Q 017591 154 ANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 154 ~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
.||++. ++.++|+|||.+...
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeC
Confidence 999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-11 Score=101.06 Aligned_cols=131 Identities=20% Similarity=0.256 Sum_probs=99.2
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEc-cccc-c-----HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 31 KLGAGGFGVVYKGQFPNGVKIAAKIL-KTCL-N-----KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~-~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+++|+-+.+|.+.+.+ ..+++|.- .+.- . .-...+-.+|+.++.++.--.|...+=+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 57899999999997744 34666643 3221 1 122345667999998886555544444556788889999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
+|..|.+++... ...++..+-..+.-||. .||+||||.++||++..++ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999898443 25677777788889999 9999999999999998885 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=9.8e-12 Score=108.33 Aligned_cols=143 Identities=19% Similarity=0.197 Sum_probs=110.3
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCC--ceeeEEeEEEeCC---ceEEEEeccC
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHI--NLVRLYGFCYDQT---KAALVYEFME 104 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~---~~~lv~e~~~ 104 (369)
+.|+.|..+.||++...+|..+++|+............+..|+.++..+.+. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 4589999999999988667899999976543222345788999999988753 4566777765532 5689999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc------------------------------------------
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC------------------------------------------ 142 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~------------------------------------------ 142 (369)
|.++...+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888776521 45788888888889999999988531
Q ss_pred -----------CCCeEeecCCCCceEecC--CCCeeEeecCCcee
Q 017591 143 -----------NQRIIHYDIKPANILLDA--KFSAKVADFGLAKL 174 (369)
Q Consensus 143 -----------~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~ 174 (369)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2e-11 Score=99.44 Aligned_cols=141 Identities=21% Similarity=0.291 Sum_probs=105.7
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEE-cccc------ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKI-LKTC------LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
..|-+|+-+.|+++.+ .|+.++||- +.+. ...-...+..+|++.+.++.--.|.-..=++.+.....|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5688999999999998 567766664 3221 1122345677899999888655554444456677788999999
Q ss_pred cCC-CCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC---eeEeecCCcee
Q 017591 103 MEN-GSLDKYLFTDTE-VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS---AKVADFGLAKL 174 (369)
Q Consensus 103 ~~~-gsL~~~l~~~~~-~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~ 174 (369)
++| .++.+++..... ....+.....+..+-+.+.-||. ++++||||..+||++..++. +.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 987 478888865433 34444448889999999999999 99999999999999976653 58999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.3e-10 Score=106.72 Aligned_cols=211 Identities=15% Similarity=0.178 Sum_probs=148.0
Q ss_pred eEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEE----eCCceEEEEeccCC-CCHHHH
Q 017591 38 GVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY----DQTKAALVYEFMEN-GSLDKY 111 (369)
Q Consensus 38 g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~~ 111 (369)
.+.|++.. .+|..|++|+++.... .....-..-++.++++.|.|+|++.+++. .....++||+|.++ ++|.++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 57899855 5799999999953211 11122334577889999999999999886 33468899999886 467665
Q ss_pred hcc--------------CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 112 LFT--------------DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 112 l~~--------------~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
.+. .+...++..+|.++.|+..||.++|+ .|+..+-|.+.+|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 532 13457889999999999999999999 9999999999999999999999999998776543
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
+.. |.+. --.+-|.=.||.+++.|.||...-...+...
T Consensus 446 d~~----------------~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~---------------------- 483 (655)
T KOG3741|consen 446 DPT----------------EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQ---------------------- 483 (655)
T ss_pred CCC----------------cchh----HHhhhhHHHHHHHHHHHhhcccccccccchH----------------------
Confidence 321 1122 2356799999999999999965321111100
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..........++.++.+++......++++ -++.+++.
T Consensus 484 ~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 484 SSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred HHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 00011123455666777777777777775 45555553
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.1e-09 Score=98.16 Aligned_cols=259 Identities=16% Similarity=0.113 Sum_probs=160.9
Q ss_pred ccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceee----EEeEEE---eCCceEEEEe
Q 017591 29 STKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR----LYGFCY---DQTKAALVYE 101 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----~~~~~~---~~~~~~lv~e 101 (369)
..-||+|+-+.+|..-. -...+.|+...-.. ....+...| +..--.||-+.. -..... .+....+.|+
T Consensus 16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Ppp-a~~aqk~a~--la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPP-AAQAQKVAE--LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecch--hhchhheeecCCCc-hHHHHHHHH--hccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 46799999999998633 12234566653222 112222222 222234554322 111111 1223678888
Q ss_pred ccCCCC-HHHHhc-----cCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceec
Q 017591 102 FMENGS-LDKYLF-----TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 102 ~~~~gs-L~~~l~-----~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
.+++.- ...++. ++....+|.-.+..++.++.+.+-||. .|.+-||++++|+|+.+++.|.|.|-...+..
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 887742 233331 123468999999999999999999999 99999999999999999999999997766654
Q ss_pred CCCCCccccccCCCCCCcccccccc----ccCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCccCccccchhHHhhhc
Q 017591 176 NPENTHDSTSGYRGTPGYSAPEFLL----RNYPITQKCDVYSFGMLLFEIIGR-RKNAQDCSSDTLDWFPKQVWDEYEKG 250 (369)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~s~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (369)
..+... ....|...|.+||.-. .+..-+..+|.|.|||+++++|.| +.||.+.......--+.+ ..+..+
T Consensus 168 ~ng~~~---~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~Ia~g 242 (637)
T COG4248 168 ANGTLH---LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDIAHG 242 (637)
T ss_pred cCCceE---ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhhhcc
Confidence 322222 2345889999999532 123567889999999999999987 899987654322111111 111112
Q ss_pred hhhhhhh------cCCCCCCCHHHHHHHHHHHHhcccc--CCCCCCChHHHHHHhcCC
Q 017591 251 ELAAKVL------GCGIEENDREEAERMSMVALWCVQD--CPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 251 ~~~~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~~v~~~L~~~ 300 (369)
.+....+ .........-.+..+..+..+|+.. ++.-||+++..+..|...
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 1111111 1111112233466778888888876 467899998887766543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.2e-10 Score=95.45 Aligned_cols=126 Identities=25% Similarity=0.337 Sum_probs=84.2
Q ss_pred EEEEEEeCCCcEEEEEEccccc-------------------------cHHHHHHHHHHHHHHhccCCC--ceeeEEeEEE
Q 017591 39 VVYKGQFPNGVKIAAKILKTCL-------------------------NKRVEAQFMAEIGTIGRTYHI--NLVRLYGFCY 91 (369)
Q Consensus 39 ~Vy~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 91 (369)
.||.|..++|..+|+|+.+... .........+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999875321 011224466899999999755 466666542
Q ss_pred eCCceEEEEeccC--CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHH-HhhccCCCeEeecCCCCceEecCCCCeeEee
Q 017591 92 DQTKAALVYEFME--NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAY-LHEECNQRIIHYDIKPANILLDAKFSAKVAD 168 (369)
Q Consensus 92 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~-LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 168 (369)
..+|||||++ |..+..+.... ++......++.+++..+.. +|. .|++||||.+.||+++.+ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence 4689999999 65565444211 1134556677777775555 578 999999999999999988 999999
Q ss_pred cCCceec
Q 017591 169 FGLAKLC 175 (369)
Q Consensus 169 fg~~~~~ 175 (369)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.6e-10 Score=99.07 Aligned_cols=132 Identities=16% Similarity=0.057 Sum_probs=96.3
Q ss_pred EEEEEEeCCCcEEEEEEccccccHHHH----------HHHHHHHHHHhccCCCce--eeEEeEEEe-----CCceEEEEe
Q 017591 39 VVYKGQFPNGVKIAAKILKTCLNKRVE----------AQFMAEIGTIGRTYHINL--VRLYGFCYD-----QTKAALVYE 101 (369)
Q Consensus 39 ~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~ni--v~~~~~~~~-----~~~~~lv~e 101 (369)
.|.++.. +|+.++||........... ..+.+|+..+.++...+| +.++++... ....+||||
T Consensus 37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 4566665 6788999976533211111 137789888888753333 344444432 235789999
Q ss_pred ccCCC-CHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-------CCCeeEeecCCc
Q 017591 102 FMENG-SLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-------KFSAKVADFGLA 172 (369)
Q Consensus 102 ~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------~~~~kl~Dfg~~ 172 (369)
++++. +|.+++... ..+.+......++.+++..+..||. .||+|+|+++.|||++. +..+.++||+.+
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99986 899988421 3456677888999999999999999 99999999999999975 467999999987
Q ss_pred ee
Q 017591 173 KL 174 (369)
Q Consensus 173 ~~ 174 (369)
+.
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.1e-11 Score=114.50 Aligned_cols=240 Identities=19% Similarity=0.220 Sum_probs=167.9
Q ss_pred ccccccCCceEEEEEEe--CCCcEEEEEEccccccHH-HHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccC
Q 017591 29 STKLGAGGFGVVYKGQF--PNGVKIAAKILKTCLNKR-VEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
..+||.|.|+.|+.... .++..+++|...+..... ....-..|+.+...+ .|.+++.....+...+..++=-|||.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 46899999999999853 457888888776443221 122223455444444 48888887777777777889999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC-CCeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++...+ .-...+++..++.+..|++.++.++|+ ..++|+|+||+||++..+ +..+++|||....+.-.
T Consensus 350 ~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~----- 420 (524)
T KOG0601|consen 350 GGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS----- 420 (524)
T ss_pred Ccchhhhh-HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccccee-----
Confidence 99887766 333467888999999999999999999 999999999999999886 77899999987532111
Q ss_pred cccCCCCCCcc-ccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 184 TSGYRGTPGYS-APEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 184 ~~~~~gt~~y~-aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....+..++. ..|++.....+-.+.|++|||..+.+.+++..--..... |.. +.....+
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~---------i~~~~~p 481 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLT---------IRSGDTP 481 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------cee---------eeccccc
Confidence 11122344455 366666666888999999999999999887653221110 111 1111112
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHh
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L 297 (369)
..+... ..+..+...++.+++..||.+.++....
T Consensus 482 ~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 482 NLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred CCCchH-HhhhhhhhhhcCCccccchhhhhhcccc
Confidence 222223 7788889999999999999988866443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.1e-10 Score=96.56 Aligned_cols=135 Identities=23% Similarity=0.216 Sum_probs=101.5
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEcccccc---------------------HHHHHHHHHHHHHHhccCCC--ce
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLN---------------------KRVEAQFMAEIGTIGRTYHI--NL 83 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--ni 83 (369)
.+.++||-|--+.||.|..++|.++|+|+-+.... .......++|+..|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34578999999999999999999999997542110 11223467899999998654 56
Q ss_pred eeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC
Q 017591 84 VRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS 163 (369)
Q Consensus 84 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 163 (369)
.+.++ .+..++|||+++|..|...- ++.+....++..|++-+..+-. .|+||||+.+-||+++++|.
T Consensus 174 P~P~~----~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 174 PKPIA----WNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCccc----cccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCC
Confidence 66654 45678999999996664432 2445555566666666666656 89999999999999999999
Q ss_pred eeEeecCCcee
Q 017591 164 AKVADFGLAKL 174 (369)
Q Consensus 164 ~kl~Dfg~~~~ 174 (369)
+.++||..+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.6e-11 Score=117.89 Aligned_cols=242 Identities=17% Similarity=0.207 Sum_probs=161.4
Q ss_pred ccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
-+-+|.++.++.+.-. .|...+.|+.... ...........+-.++-...+|.++....-+.-....+|+++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 4667788887776432 2444444443321 111111122222222222334555544333334567889999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC----------
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP---------- 177 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---------- 177 (369)
|...++.. +..+.+-....+..+..++++||. ..+.|+|++|.|.+...++..++.|||......-
T Consensus 891 ~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~ 966 (1205)
T KOG0606|consen 891 LPSKLHNS-GCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGP 966 (1205)
T ss_pred chhhhhcC-CCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCCcccc
Confidence 99998443 467777778888889999999999 7799999999999999999999999983321100
Q ss_pred -----------C--------CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc
Q 017591 178 -----------E--------NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW 238 (369)
Q Consensus 178 -----------~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~ 238 (369)
. ..........+|+.|.+||.+.+. .....+|.|++|++++|.++|..||....+..
T Consensus 967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~--- 1042 (1205)
T KOG0606|consen 967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ--- 1042 (1205)
T ss_pred cccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCCCCCcchhh---
Confidence 0 000112345689999999988775 67789999999999999999999998655432
Q ss_pred cccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChH
Q 017591 239 FPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMS 291 (369)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 291 (369)
+++.+..++. ..+..+...+....+++...+..+|.+|-.+.
T Consensus 1043 ----~f~ni~~~~~-------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 ----IFENILNRDI-------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ----hhhccccCCC-------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 2222222221 11344555667788899999999999998776
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.2e-10 Score=109.27 Aligned_cols=152 Identities=21% Similarity=0.324 Sum_probs=107.2
Q ss_pred HHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc-------cccCCCCCCcccccccc
Q 017591 128 AIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS-------TSGYRGTPGYSAPEFLL 200 (369)
Q Consensus 128 ~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~ 200 (369)
+.+++.|+.|+|.. .++||++|.|++|.++.++..||+.|+.+........... .........|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34455999999984 8999999999999999999999999998865543221111 11123566799999988
Q ss_pred ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhcc
Q 017591 201 RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCV 280 (369)
Q Consensus 201 ~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 280 (369)
.. ..+.++|+||+||++|.+..|+.+......... ...... ..++...-......+.++.+=+.+++
T Consensus 183 ~~-~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-------~~~~~~-----~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GT-TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-------SYSFSR-----NLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cc-cccccccceeeeeEEEEEecCCcchhhccCCcc-------hhhhhh-----cccccccccccccCcHHHHHHHHHHh
Confidence 74 789999999999999999966655433222111 111111 11112222334667788999999999
Q ss_pred ccCCCCCCChHHHH
Q 017591 281 QDCPEARPPMSAVV 294 (369)
Q Consensus 281 ~~~p~~RPs~~~v~ 294 (369)
..++..||++..+.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 99999999877765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=8.7e-09 Score=88.78 Aligned_cols=106 Identities=21% Similarity=0.207 Sum_probs=83.3
Q ss_pred HHHHHHHHHHHhccCCC--ceeeEEeEEEeC----CceEEEEeccCCC-CHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q 017591 65 EAQFMAEIGTIGRTYHI--NLVRLYGFCYDQ----TKAALVYEFMENG-SLDKYLFTDTEVLKWEKLLDIAIGTARGIAY 137 (369)
Q Consensus 65 ~~~~~~E~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~ 137 (369)
.....+|...+..+... .....+++.... ...+||+|++++. +|.+++.... ..+......++.+++..++-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHH
Confidence 34677888887777533 345555555442 2458999999884 7999884322 27777889999999999999
Q ss_pred HhhccCCCeEeecCCCCceEecCCC---CeeEeecCCcee
Q 017591 138 LHEECNQRIIHYDIKPANILLDAKF---SAKVADFGLAKL 174 (369)
Q Consensus 138 LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~ 174 (369)
||+ +|++|+|+++.|||++.++ .+.++||+.++.
T Consensus 134 lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 9999999999999999887 799999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.4e-08 Score=96.48 Aligned_cols=141 Identities=16% Similarity=0.272 Sum_probs=94.3
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHH---------------------------------------HHHH
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEA---------------------------------------QFMA 70 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------------------------------------~~~~ 70 (369)
+-|+.++-|.||+|+.++|+.||||+.+++..+.... ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 4689999999999999999999999988654322221 1223
Q ss_pred HHHHHhccC-----CCceeeEEeEE-EeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCC
Q 017591 71 EIGTIGRTY-----HINLVRLYGFC-YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144 (369)
Q Consensus 71 E~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~ 144 (369)
|..-+.++. .+++ .+=.++ .-.+..+|+|||++|..+.+........++...+.....++. +..+-. .
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~---d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLR---D 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHh---c
Confidence 444333332 2222 111122 224567899999999999888643445566444444333322 222223 7
Q ss_pred CeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 145 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
|+.|.|.+|.||+++.+|++.+.|||+...+.
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999999999987654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=6.9e-08 Score=81.93 Aligned_cols=139 Identities=17% Similarity=0.086 Sum_probs=103.8
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEccccc----c-HHHHHHHHHHHHHHhccCCCc--eeeEEeEEE-e----CCceEE
Q 017591 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCL----N-KRVEAQFMAEIGTIGRTYHIN--LVRLYGFCY-D----QTKAAL 98 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~-~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~-~----~~~~~l 98 (369)
.-|+||.+.|+.... +|+.+.+|.-.... . +.....|.+|+..+..+...+ +.++. ++. . .-..+|
T Consensus 25 N~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 467799999999877 45578888754211 1 234578999999999886333 44444 232 1 124679
Q ss_pred EEeccCC-CCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC--eeEeecCCcee
Q 017591 99 VYEFMEN-GSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS--AKVADFGLAKL 174 (369)
Q Consensus 99 v~e~~~~-gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~ 174 (369)
|+|-+.+ .+|.+++.+. -.+.+......++.+++..++-||+ .|+.|+|+.+.||+++.++. +.++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9996653 5899988443 2467888889999999999999999 99999999999999987777 99999987653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.4e-07 Score=79.26 Aligned_cols=137 Identities=15% Similarity=0.254 Sum_probs=84.6
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc--eeeEEeEEEeCCceEEEEeccCCCC
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN--LVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
..||+|..+.||+. .+..+++|+...... .....+|.+++..+..-. +.+++++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 47899999999984 255678888775432 335688999998876433 4677777777777889999999963
Q ss_pred -HHHHhc--------------c-----CC---CCCCHHHHHHHH-H----------HHHH-HHHHHhhc-cCCCeEeecC
Q 017591 108 -LDKYLF--------------T-----DT---EVLKWEKLLDIA-I----------GTAR-GIAYLHEE-CNQRIIHYDI 151 (369)
Q Consensus 108 -L~~~l~--------------~-----~~---~~~~~~~~~~i~-~----------~l~~-~l~~LH~~-~~~~ivH~dl 151 (369)
+...+. . +. ..........-. . .+.. ...+|... ....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 221110 0 00 011111111000 0 0001 11122211 1245789999
Q ss_pred CCCceEecCCCCeeEeecCCce
Q 017591 152 KPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 152 kp~Nill~~~~~~kl~Dfg~~~ 173 (369)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999887 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.5e-07 Score=88.24 Aligned_cols=140 Identities=19% Similarity=0.263 Sum_probs=93.8
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHH------------------------------------HHHHHHHH
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVE------------------------------------AQFMAEIG 73 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------------------~~~~~E~~ 73 (369)
+-||..+.|.||+|+.++|+.||||+-++...+... -+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 469999999999999999999999998765432211 11223332
Q ss_pred HHhc----cCCCc------eeeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccC
Q 017591 74 TIGR----TYHIN------LVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143 (369)
Q Consensus 74 ~l~~----l~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~ 143 (369)
-..+ +.|-+ |.+++--+ .+...|+||||+|..+.+.-.-....++...+...+.+... +..-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~-----~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL-----EQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH-----HHHHh
Confidence 2222 22333 33333222 34679999999999887766545556777755554444322 21112
Q ss_pred CCeEeecCCCCceEecC----CCCeeEeecCCceecC
Q 017591 144 QRIIHYDIKPANILLDA----KFSAKVADFGLAKLCN 176 (369)
Q Consensus 144 ~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~~~~~ 176 (369)
.|.+|+|-+|.||++.. ++.+.+.|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 68999999999999984 5679999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.4e-07 Score=76.85 Aligned_cols=129 Identities=19% Similarity=0.159 Sum_probs=81.1
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHH---------HHHHHHHhccCCCc---eeeEEeEEE-----e
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQF---------MAEIGTIGRTYHIN---LVRLYGFCY-----D 92 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------~~E~~~l~~l~h~n---iv~~~~~~~-----~ 92 (369)
+.+-.....-|.+... +|..+++|....... ...+.| .+.+..+..+.... ...++-+.. -
T Consensus 37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~ 114 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRY 114 (229)
T ss_pred EeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccc
Confidence 4455555556666655 678899998775322 122222 23343333333222 222222221 2
Q ss_pred CCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCc
Q 017591 93 QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA 172 (369)
Q Consensus 93 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 172 (369)
....+++|||++|..|.++.. +++ .+...+++++.-||+ .|++|||..|+|+++..+ .+++.||+..
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iID~~~k 181 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRIIDTQGK 181 (229)
T ss_pred eeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEEECccc
Confidence 234568999999988866541 222 244567788999999 999999999999999865 5999999865
Q ss_pred e
Q 017591 173 K 173 (369)
Q Consensus 173 ~ 173 (369)
+
T Consensus 182 ~ 182 (229)
T PF06176_consen 182 R 182 (229)
T ss_pred c
Confidence 4
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1e-06 Score=76.08 Aligned_cols=136 Identities=22% Similarity=0.250 Sum_probs=91.2
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEccccccHHHH-----------------------HHHHHHHHHHhccC--CCceee
Q 017591 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVE-----------------------AQFMAEIGTIGRTY--HINLVR 85 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~E~~~l~~l~--h~niv~ 85 (369)
.|..|--+.||+|...++..+|+|+.+.....-.. .=...|+.-|+++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 46777788999998888999999998754221100 01234676666664 334455
Q ss_pred EEeEEEeCCceEEEEeccCCCCH-HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCe
Q 017591 86 LYGFCYDQTKAALVYEFMENGSL-DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA 164 (369)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 164 (369)
.+++. ...|||||+....+ .=.| ..-++..+....+..++++.+.-|-.. .++||+||..-|||+. ++.+
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeE
Confidence 55443 56899999865311 0011 112333445667777777777777652 7999999999999999 7799
Q ss_pred eEeecCCceec
Q 017591 165 KVADFGLAKLC 175 (369)
Q Consensus 165 kl~Dfg~~~~~ 175 (369)
.++|||.|...
T Consensus 206 ~iID~~QaV~~ 216 (268)
T COG1718 206 YIIDVSQAVTI 216 (268)
T ss_pred EEEECcccccc
Confidence 99999988654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.6e-06 Score=75.44 Aligned_cols=137 Identities=15% Similarity=0.064 Sum_probs=83.5
Q ss_pred cccCCc-eEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccCCCCHH
Q 017591 32 LGAGGF-GVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFMENGSLD 109 (369)
Q Consensus 32 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 109 (369)
|..|.. +.||+.... +..+++|+..... ..++.+|+.++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444555 789999764 4788889876432 335667888887774 344667777776666789999999998776
Q ss_pred HHhc-------------------cC---CCCCCH--HHHHHHHHH--------------------HHHHHHHHhhc----
Q 017591 110 KYLF-------------------TD---TEVLKW--EKLLDIAIG--------------------TARGIAYLHEE---- 141 (369)
Q Consensus 110 ~~l~-------------------~~---~~~~~~--~~~~~i~~~--------------------l~~~l~~LH~~---- 141 (369)
.... .- ..++.. ......... +...+..|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4320 00 001110 000000000 11111222110
Q ss_pred cCCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 142 ~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
....++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12458999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.3e-06 Score=73.89 Aligned_cols=140 Identities=19% Similarity=0.161 Sum_probs=83.0
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCC--ceeeEEeEEEe---CCceEEEEeccC
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHI--NLVRLYGFCYD---QTKAALVYEFME 104 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~ 104 (369)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+..++..... ....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 468889999999999866 69999987653 4456777888888877533 35566664433 234689999999
Q ss_pred CCCHHH----------------Hh---ccC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 017591 105 NGSLDK----------------YL---FTD---TEVLKWEK---------LLDI------------AIGTAR-GIAYLHE 140 (369)
Q Consensus 105 ~gsL~~----------------~l---~~~---~~~~~~~~---------~~~i------------~~~l~~-~l~~LH~ 140 (369)
|..+.. .+ +.. ...+.... .... ...+.. .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988777 11 011 01111100 0000 011122 2333332
Q ss_pred ----ccCCCeEeecCCCCceEec-CCCCeeEeecCCce
Q 017591 141 ----ECNQRIIHYDIKPANILLD-AKFSAKVADFGLAK 173 (369)
Q Consensus 141 ----~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~ 173 (369)
.....++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1246799999999999999 56666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.4e-05 Score=67.55 Aligned_cols=103 Identities=18% Similarity=0.125 Sum_probs=82.9
Q ss_pred HHHHHHHhccCC-CceeeEEeEEEeCCceEEEEeccCCCCHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhhccCCC
Q 017591 69 MAEIGTIGRTYH-INLVRLYGFCYDQTKAALVYEFMENGSLDKYLF--TDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145 (369)
Q Consensus 69 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ 145 (369)
..|..+++.+.+ +++++++|.| ..++|.||...+++...-. .+-...+|..+.+|+.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888875 6999999998 4578999998766542100 11135789999999999999999999866667
Q ss_pred eEeecCCCCceEecCCCCeeEeecCCceec
Q 017591 146 IIHYDIKPANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 146 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
+.-.|++++|+-+++++++|+.|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.2e-05 Score=68.43 Aligned_cols=131 Identities=22% Similarity=0.307 Sum_probs=92.0
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccc---------------cHHHHHHHHHHHHHHhccC------CCceeeEEe
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCL---------------NKRVEAQFMAEIGTIGRTY------HINLVRLYG 88 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~E~~~l~~l~------h~niv~~~~ 88 (369)
..||+|+.-.||. ++++...+||+..... ......+..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4699999999998 5677788899987654 1112345555655555444 788999999
Q ss_pred EEEeCCceEEEEeccCC------CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC
Q 017591 89 FCYDQTKAALVYEFMEN------GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF 162 (369)
Q Consensus 89 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 162 (369)
+..++-...+|+|.+.+ -+|.+++. ...++. ...+.+. +-..+|-+ +.|+.+|++|.||++....
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEEEecC
Confidence 99999889999998654 26788883 334555 4444444 34556666 8999999999999995432
Q ss_pred ----CeeEee-cCC
Q 017591 163 ----SAKVAD-FGL 171 (369)
Q Consensus 163 ----~~kl~D-fg~ 171 (369)
.+.|+| ||-
T Consensus 156 ~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 156 SGEFRLVLIDGLGE 169 (199)
T ss_pred CCceEEEEEeCCCC
Confidence 466776 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.32 E-value=7.9e-06 Score=84.85 Aligned_cols=79 Identities=15% Similarity=0.233 Sum_probs=57.0
Q ss_pred cccccCCceEEEEEEeCCC---cEEEEEEccccccHHHHHHHHHHHHHHhccC-CCce--eeEEeEEEeC---CceEEEE
Q 017591 30 TKLGAGGFGVVYKGQFPNG---VKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINL--VRLYGFCYDQ---TKAALVY 100 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv~ 100 (369)
+.++.|.++.+|+....++ ..+++|+............+.+|+.+++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5688999999999877553 4677777653322122357889999999885 6654 7788887664 4678999
Q ss_pred eccCCCCH
Q 017591 101 EFMENGSL 108 (369)
Q Consensus 101 e~~~~gsL 108 (369)
||++|..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99998653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.1e-07 Score=89.45 Aligned_cols=183 Identities=17% Similarity=0.101 Sum_probs=131.4
Q ss_pred cccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc-eeeEEeEEEeCCceEEEEeccCCC
Q 017591 28 YSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN-LVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
|.+.+++|+++.++|.+....+....+++... ....-++++|.+++||| .+..++-+..+...+++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 34668899999999997754555556665532 33445788999999999 666666666677889999999876
Q ss_pred -CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 107 -SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 107 -sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+-..........+..-+...+++.-+++++++|+ ..=+|+| ||+..+ +..+..||+....+.... ...
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~ 388 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR 388 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence 2222221222345556677778888899999998 4458888 666555 689999999887654332 234
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNA 228 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~ 228 (369)
...+++.++|||+...+ .+..+-|+|++|+-..++--|-.|-
T Consensus 389 t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCC
Confidence 46799999999988876 6889999999998766666665553
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.5e-05 Score=64.00 Aligned_cols=127 Identities=17% Similarity=0.228 Sum_probs=87.3
Q ss_pred ccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCcee-eEEeEEEeCCceEEEEeccCCCC
Q 017591 29 STKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV-RLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
.+.|++|++|.||+|.+ .|..+|+|+-..+.. ...+..|++++..+.--++. +++.+- ..++.|||..|-.
T Consensus 27 ~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 27 EKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhcccccEEEEeec-cCceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 36799999999999999 566899998776444 45788999999888755543 344332 2345599999988
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCC-CCceEecCCCCeeEeecCCcee
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIK-PANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlk-p~Nill~~~~~~kl~Dfg~~~~ 174 (369)
|.+..... +.+. +..++++---|-. .||-|+.|. |...++..++.+.|+||..|..
T Consensus 99 L~~~~~~~----~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG----DRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc----cHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 87766211 2233 3345555444555 899999987 4444444444999999998763
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.3e-05 Score=65.21 Aligned_cols=126 Identities=25% Similarity=0.352 Sum_probs=90.3
Q ss_pred hhhccccccccCCc-eEEEEEEeCCCcEEEEEEccc---c--------cc---H------HHHHHHHHHHHHHhccC---
Q 017591 24 FTNNYSTKLGAGGF-GVVYKGQFPNGVKIAAKILKT---C--------LN---K------RVEAQFMAEIGTIGRTY--- 79 (369)
Q Consensus 24 ~t~~f~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~--------~~---~------~~~~~~~~E~~~l~~l~--- 79 (369)
....|.+.||.|.- |.||+++. +|+.+|+|++.. . .. . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 44456789999999 99999998 788999999321 0 00 0 12235788988888875
Q ss_pred CCce--eeEEeEEEeC------------------CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh
Q 017591 80 HINL--VRLYGFCYDQ------------------TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLH 139 (369)
Q Consensus 80 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH 139 (369)
+.++ |+++||..-. ....||.||.+... .+... -+.++.+-+..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHH
Confidence 4455 9999988522 12467888876532 22323 3455667788899
Q ss_pred hccCCCeEeecCCCCceEecCCCCeeEeecCCc
Q 017591 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLA 172 (369)
Q Consensus 140 ~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 172 (369)
. .||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 K---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred H---CCeeeccCcccccc-----CCEEEecccC
Confidence 9 99999999999986 6799999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.7e-05 Score=80.03 Aligned_cols=198 Identities=16% Similarity=0.184 Sum_probs=134.3
Q ss_pred HHHHHHHHHhccCCCceeeEEeEEEeCCceE----EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc
Q 017591 67 QFMAEIGTIGRTYHINLVRLYGFCYDQTKAA----LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC 142 (369)
Q Consensus 67 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~ 142 (369)
...-|...+.+..|+|++.++.+-.+..... +..+++...++...+ ++-..++....+.+..++.+||+++|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~~~GL~~~h~-- 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKLLEGLAYLHS-- 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHHhhhHHHHHH--
Confidence 3445677777888999999999887554333 345778888888887 556778999999999999999999999
Q ss_pred CCCeEeecCCCC---ceEecCCCCeeEe--ecCCceecCCCCCccccccCCCCCCccccccccccC-CCCcchhhHHHHH
Q 017591 143 NQRIIHYDIKPA---NILLDAKFSAKVA--DFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY-PITQKCDVYSFGM 216 (369)
Q Consensus 143 ~~~ivH~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~s~~sDvwSlGv 216 (369)
....|.-+..+ +--.+..+.+.++ ||+.+........... ..-+..+.+||...... ......|+|.+|.
T Consensus 305 -~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 -LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred -hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHHH
Confidence 65555555444 3334555666666 8888876654333221 22445577777665531 3344579999999
Q ss_pred HHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHH
Q 017591 217 LLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296 (369)
Q Consensus 217 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~ 296 (369)
.+..+..|..+-..... ....+ +... ...+......|+..++++|+++.+++..
T Consensus 381 l~~~~~~~~~i~~~~~~-------------------~~~~l----~~~~---~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV-------------------PVSLL----DVLS---TSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCcccccccc-------------------hhhhh----cccc---chhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999988764321110 00111 1111 1157788889999999999999998764
Q ss_pred h
Q 017591 297 L 297 (369)
Q Consensus 297 L 297 (369)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.4e-05 Score=68.86 Aligned_cols=72 Identities=14% Similarity=0.132 Sum_probs=44.6
Q ss_pred ccccCCce-EEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCC---ceeeEEeEEEeC---CceEEEEecc
Q 017591 31 KLGAGGFG-VVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHI---NLVRLYGFCYDQ---TKAALVYEFM 103 (369)
Q Consensus 31 ~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~ 103 (369)
.|+.|+.. .||+. +..+++|+..... ....+.+|+.++..+... .+..+++..... ...+++|+++
T Consensus 4 ~~~~gG~~n~vy~~----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 4 PVDSGGTDNATFRL----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eccCCCcccceEEc----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 46666665 68985 2357778765422 244788899888877532 244444433322 2348899999
Q ss_pred CCCCHH
Q 017591 104 ENGSLD 109 (369)
Q Consensus 104 ~~gsL~ 109 (369)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00015 Score=66.17 Aligned_cols=75 Identities=9% Similarity=0.116 Sum_probs=55.5
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCC---CceeeEEeEEEeC---CceEEEEecc
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH---INLVRLYGFCYDQ---TKAALVYEFM 103 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~e~~ 103 (369)
+.||.|..+.||.....++ .+++|+.+.... ...+.+|...++.+.. -.+.++++++.+. +..+||||++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG-NPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eecCCccceeEEEEEcCCC-CEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 4699999999999977555 466777543112 3478889988888752 3678888877543 5689999999
Q ss_pred CCCCH
Q 017591 104 ENGSL 108 (369)
Q Consensus 104 ~~gsL 108 (369)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=8e-05 Score=65.43 Aligned_cols=138 Identities=17% Similarity=0.174 Sum_probs=80.5
Q ss_pred cccccCCceEEEEEEeCC--CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc-eeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFPN--GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN-LVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.|..|-.+.+|+....+ +..+++|+...... ...+..+|+.++..+...+ ..+++..+ . ..++|||++|.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~~~l~e~i~G~ 77 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATF--Q--NGLIYEFIPGR 77 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEe--C--CcEEEEeeCCC
Confidence 356778888999998764 67888997764321 1223457888888775333 34444433 2 24899999997
Q ss_pred CHHHH-------h----------ccCCC----------CCC-HHHHHHHHHHH----------------------HHHHH
Q 017591 107 SLDKY-------L----------FTDTE----------VLK-WEKLLDIAIGT----------------------ARGIA 136 (369)
Q Consensus 107 sL~~~-------l----------~~~~~----------~~~-~~~~~~i~~~l----------------------~~~l~ 136 (369)
++... + +.... ... +..+..+...+ ...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 66321 1 11011 111 22322222111 11111
Q ss_pred HH----hhc-cCCCeEeecCCCCceEecC-CCCeeEeecCCce
Q 017591 137 YL----HEE-CNQRIIHYDIKPANILLDA-KFSAKVADFGLAK 173 (369)
Q Consensus 137 ~L----H~~-~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~ 173 (369)
.| ... .+..++|+|+.+.||+++. ++.+.++||..+.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 110 1256999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.99 E-value=9.6e-05 Score=69.61 Aligned_cols=76 Identities=14% Similarity=0.174 Sum_probs=53.5
Q ss_pred cccccCCceEEEEEEeCCC-cEEEEEEccccc------cHHHHHHHHHHHHHHhccC---CCceeeEEeEEEeCCceEEE
Q 017591 30 TKLGAGGFGVVYKGQFPNG-VKIAAKILKTCL------NKRVEAQFMAEIGTIGRTY---HINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~------~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 99 (369)
+.||.|.++.||++...+| +.++||.-.... .+-...+...|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999998776 589999754211 1123456667777777653 3457777766 45668999
Q ss_pred EeccCCCC
Q 017591 100 YEFMENGS 107 (369)
Q Consensus 100 ~e~~~~gs 107 (369)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00059 Score=62.93 Aligned_cols=155 Identities=17% Similarity=0.202 Sum_probs=81.1
Q ss_pred cccCHHHHHHh--hhccc-----cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-----CC
Q 017591 14 VRFTLEQLCSF--TNNYS-----TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-----HI 81 (369)
Q Consensus 14 ~~~~~~el~~~--t~~f~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~ 81 (369)
+.++..+|.+. .+++. +.|+.|....+|.....+| .+++|+.. .... ..+..|+.++..|. .|
T Consensus 5 t~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~~---~~l~~~~~~l~~L~~~glpvP 79 (319)
T PRK05231 5 TDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-RLTA---EDLPFFLGLMQHLAARGVPVP 79 (319)
T ss_pred ccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-cCCh---HHhHHHHHHHHHHHHCCCCCC
Confidence 45566666444 33331 3466777789999876555 67888765 2222 22333444444432 33
Q ss_pred ceeeEE-e--EEEeCCceEEEEeccCCCCHH-----------HHh---ccCCC----------CCCH-HHHHH-------
Q 017591 82 NLVRLY-G--FCYDQTKAALVYEFMENGSLD-----------KYL---FTDTE----------VLKW-EKLLD------- 126 (369)
Q Consensus 82 niv~~~-~--~~~~~~~~~lv~e~~~~gsL~-----------~~l---~~~~~----------~~~~-~~~~~------- 126 (369)
.++... | +....+..+++++|++|..+. ..+ +.... .+.+ .....
T Consensus 80 ~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (319)
T PRK05231 80 APVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLA 159 (319)
T ss_pred cceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccC
Confidence 333211 0 122345678999999987431 111 11000 1111 11111
Q ss_pred -----HHHH-HHHHHHHHhhc----cCCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 127 -----IAIG-TARGIAYLHEE----CNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 127 -----i~~~-l~~~l~~LH~~----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
.+.+ +...+..+.+. .+.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 160 DEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred hhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122222211 34689999999999999976556899998764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00022 Score=63.56 Aligned_cols=137 Identities=12% Similarity=0.115 Sum_probs=78.5
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCce-eeEEeEEEeCCceEEEEeccCCCCHH
Q 017591 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL-VRLYGFCYDQTKAALVYEFMENGSLD 109 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~ 109 (369)
.+..|-.+.+|+... ++..+++|+...... ....+..+|..+++.+....+ .+++... . .++||||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCK-ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccc-cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence 355677889999874 567888887653221 111235678888887753323 3344332 2 47999999987654
Q ss_pred HH-------h----------ccC---CCCCCHH-HHHHHHHHH---------HHHHHHHhhc-----cCCCeEeecCCCC
Q 017591 110 KY-------L----------FTD---TEVLKWE-KLLDIAIGT---------ARGIAYLHEE-----CNQRIIHYDIKPA 154 (369)
Q Consensus 110 ~~-------l----------~~~---~~~~~~~-~~~~i~~~l---------~~~l~~LH~~-----~~~~ivH~dlkp~ 154 (369)
.. + +.. ..+++.. .+..+..++ ...+..+-.. .+..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 1 111 1122222 222222111 1112222211 1246899999999
Q ss_pred ceEecCCCCeeEeecCCcee
Q 017591 155 NILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 155 Nill~~~~~~kl~Dfg~~~~ 174 (369)
||+++.++ +.++||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999876 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=3.3e-05 Score=69.26 Aligned_cols=145 Identities=19% Similarity=0.176 Sum_probs=97.3
Q ss_pred ccCHHHHHHhhhc-----cccccccCCceEEEEEEeCCCcEEEEEEccccc-------cH--------------HHHHHH
Q 017591 15 RFTLEQLCSFTNN-----YSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL-------NK--------------RVEAQF 68 (369)
Q Consensus 15 ~~~~~el~~~t~~-----f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~--------------~~~~~~ 68 (369)
.+.|=-|...++. +.++||-|--+.||.+.+++|.+.++|+-.-.. .+ -..-..
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 3444455555443 347899999999999999999999999653110 00 011234
Q ss_pred HHHHHHHhccCC-Cc-eeeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCe
Q 017591 69 MAEIGTIGRTYH-IN-LVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146 (369)
Q Consensus 69 ~~E~~~l~~l~h-~n-iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~i 146 (369)
.+|+..|+.|.. .. +.+.+ +.+..++|||++.|-.|.+.-+ ..+..++. ..+..-+.-|-. +|+
T Consensus 158 ~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~----v~d~~~ly---~~lm~~Iv~la~---~Gl 223 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRH----VEDPPTLY---DDLMGLIVRLAN---HGL 223 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeee----cCChHHHH---HHHHHHHHHHHH---cCc
Confidence 568888888753 22 33444 3456789999999988866542 12223322 333333444555 999
Q ss_pred EeecCCCCceEecCCCCeeEeecCCce
Q 017591 147 IHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 147 vH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
||||..-=||++.+++.++++||....
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred eecccchheeEEecCCCEEEeechHhh
Confidence 999999999999999999999997654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00064 Score=61.94 Aligned_cols=139 Identities=18% Similarity=0.184 Sum_probs=81.2
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc--eeeEEe------EEEeCCceEEEEe
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN--LVRLYG------FCYDQTKAALVYE 101 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~------~~~~~~~~~lv~e 101 (369)
+.|..|....+|+.... +..+++|+... .. ...+..|+.++..+.+.+ +.+++. +....+..++|++
T Consensus 20 ~~i~~G~~n~~y~v~~~-~~~~vLr~~~~-~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 20 EGISAGIENTNYFVTTD-SGRYVLTLFEK-VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred ecccCccccceEEEEeC-CCcEEEEEcCC-CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 35777877899998764 45788888764 12 345666777777664332 334433 1123456689999
Q ss_pred ccCCCCHHH-----------Hh---cc--CC--------CCCCHHHHH----------HHHHHHHHHHHHHhh----ccC
Q 017591 102 FMENGSLDK-----------YL---FT--DT--------EVLKWEKLL----------DIAIGTARGIAYLHE----ECN 143 (369)
Q Consensus 102 ~~~~gsL~~-----------~l---~~--~~--------~~~~~~~~~----------~i~~~l~~~l~~LH~----~~~ 143 (369)
|++|..+.. .+ +. .. ....|.... .....+..++.++.+ ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 01 10 00 001111110 011112233444432 123
Q ss_pred CCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 144 QRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 144 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
.+++|+|+.|.||+++.++.+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 679999999999999998777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00042 Score=63.41 Aligned_cols=73 Identities=22% Similarity=0.311 Sum_probs=47.0
Q ss_pred ccccCCceEEEEEEeCC-------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc-eeeEEeEEEeCCceEEEEec
Q 017591 31 KLGAGGFGVVYKGQFPN-------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN-LVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~ 102 (369)
.+..|-...+|+....+ ++.+++|+...... ...+..+|+.++..+.... ..++++++. ..+|++|
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 45556677999997654 57899999764322 2345667777777775333 334555442 2468999
Q ss_pred cCCCCHH
Q 017591 103 MENGSLD 109 (369)
Q Consensus 103 ~~~gsL~ 109 (369)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9987664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0057 Score=56.08 Aligned_cols=140 Identities=17% Similarity=0.198 Sum_probs=77.9
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc--eeeEEeE------EEeCCceEEEEe
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN--LVRLYGF------CYDQTKAALVYE 101 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e 101 (369)
+.++.|....+|+....++ .+++|+...... ...+..|+.++..|.... +.+++.. ....+..+++++
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 3567777789999876444 677887654222 223445566665553222 3333321 112355789999
Q ss_pred ccCCCCHH-----------HHh---ccCCCC-----------CCHHHHH------------HHHHHHHHHHHHHhh----
Q 017591 102 FMENGSLD-----------KYL---FTDTEV-----------LKWEKLL------------DIAIGTARGIAYLHE---- 140 (369)
Q Consensus 102 ~~~~gsL~-----------~~l---~~~~~~-----------~~~~~~~------------~i~~~l~~~l~~LH~---- 140 (369)
|++|..+. ..+ +..... -.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99985432 111 110000 0111100 001112334444432
Q ss_pred ccCCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 141 ~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
..+.+++|+|+++.||+++.++.+.|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234789999999999999988777899998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.002 Score=58.13 Aligned_cols=31 Identities=29% Similarity=0.529 Sum_probs=25.5
Q ss_pred CCeEeecCCCCceEecCCCC-eeEeecCCcee
Q 017591 144 QRIIHYDIKPANILLDAKFS-AKVADFGLAKL 174 (369)
Q Consensus 144 ~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~ 174 (369)
..++|+|++|.||+++.+++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0022 Score=57.91 Aligned_cols=72 Identities=18% Similarity=0.250 Sum_probs=46.5
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccC---CCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY---HINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.++.|....+|+.. .+++.+.||+-... ....|..|..-|+.|. --.+.+++++....+..+|||||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 468889999999988 47788999986622 2346777887777773 456788898888777889999998876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.003 Score=57.64 Aligned_cols=133 Identities=20% Similarity=0.184 Sum_probs=80.2
Q ss_pred CCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCC--CceeeEEeEEEeCC--ceEEEEeccCCCCHHH
Q 017591 35 GGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH--INLVRLYGFCYDQT--KAALVYEFMENGSLDK 110 (369)
Q Consensus 35 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~ 110 (369)
|.-..+|..... ++.+++..-.............+|+.+++.+.- --+...+++|.++. ..+.||+|++|..+.+
T Consensus 36 G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 333455555543 777888722223334456678888888887742 23455566666555 6799999999853322
Q ss_pred HhccCCCCCCHHHHHHHH-HHHHHHHHHHhhcc-----------------------------------------------
Q 017591 111 YLFTDTEVLKWEKLLDIA-IGTARGIAYLHEEC----------------------------------------------- 142 (369)
Q Consensus 111 ~l~~~~~~~~~~~~~~i~-~~l~~~l~~LH~~~----------------------------------------------- 142 (369)
.+.. .+.. .+++ ..++..|+-||+..
T Consensus 115 ~~~~----~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 115 ALPP----ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred cCCc----ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 2200 0000 1111 13333333333311
Q ss_pred --------CCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 143 --------NQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 143 --------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
...++|||+.+.|++++.++-+=+.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 14589999999999999998899999999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0067 Score=56.21 Aligned_cols=80 Identities=18% Similarity=0.101 Sum_probs=49.8
Q ss_pred ccccCCceEEEEEEeCCC-cEEEEEEccc------cccHHHHHHHHHHHHHHhccC--CC-ceeeEEeEEEeCCceEEEE
Q 017591 31 KLGAGGFGVVYKGQFPNG-VKIAAKILKT------CLNKRVEAQFMAEIGTIGRTY--HI-NLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~------~~~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~ 100 (369)
.||.|....||++..++| +.|+||.-.. ...+-...+...|...|.... .| .+.+++. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999998654 6899986432 111222344456666665543 34 4555554 3567778999
Q ss_pred eccCCC-CHHHHh
Q 017591 101 EFMENG-SLDKYL 112 (369)
Q Consensus 101 e~~~~g-sL~~~l 112 (369)
|+++.. .|+..+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998553 343433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0052 Score=57.29 Aligned_cols=137 Identities=21% Similarity=0.285 Sum_probs=80.5
Q ss_pred ccccCCceEEEEEEeCC-----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCce-eeEEeEEEeCCceEEEEeccC
Q 017591 31 KLGAGGFGVVYKGQFPN-----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL-VRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+..|-...+|++...+ ++.+++|+...... ..-+-.+|..++..+...++ .++++.+.. ..|++|++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi~ 116 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFDRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFIH 116 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeechHHHHHHHHHHHHcCCCCceEEEECC----ceEEEeeC
Confidence 45557888999987543 36888898765432 12233678888877754443 345555422 26899998
Q ss_pred CCCHHHH-----------------hccCC----C-CCCHHHHHHHHHHH-----------------HHHHHHHhh-----
Q 017591 105 NGSLDKY-----------------LFTDT----E-VLKWEKLLDIAIGT-----------------ARGIAYLHE----- 140 (369)
Q Consensus 105 ~gsL~~~-----------------l~~~~----~-~~~~~~~~~i~~~l-----------------~~~l~~LH~----- 140 (369)
+.+|... ++... . ..-+.++..+..++ ...+..|.+
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 01111 0 11234444443222 111222211
Q ss_pred ccCCCeEeecCCCCceEecC-CCCeeEeecCCce
Q 017591 141 ECNQRIIHYDIKPANILLDA-KFSAKVADFGLAK 173 (369)
Q Consensus 141 ~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~ 173 (369)
..+..++|+|+++.||++++ ++.+.++||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11346899999999999976 4679999998765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.031 Score=52.81 Aligned_cols=73 Identities=15% Similarity=0.159 Sum_probs=48.1
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEcccccc------HHHHHHHHHHHHHHhccC---CCceeeEEeEEEeCCceEEEE
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLN------KRVEAQFMAEIGTIGRTY---HINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 100 (369)
+.||.|.-..||+...+ ++.++||.-..... +....+-..|...|..+. -.++.+++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 47899999999999874 55688887542111 112333444555555443 347888888775 5578899
Q ss_pred eccCC
Q 017591 101 EFMEN 105 (369)
Q Consensus 101 e~~~~ 105 (369)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99977
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.016 Score=53.46 Aligned_cols=136 Identities=19% Similarity=0.197 Sum_probs=90.9
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEcccccc-----------------------HHHH--HHHHHHHHHHhccCCCceee
Q 017591 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLN-----------------------KRVE--AQFMAEIGTIGRTYHINLVR 85 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~--~~~~~E~~~l~~l~h~niv~ 85 (369)
.|..|--+-||.+...+|..+|||+++.+.- ++.. .=...|++-|.++....|..
T Consensus 151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 5677888899999999999999999875420 1100 11335777777776544332
Q ss_pred EEeEEEeCCceEEEEeccCCCCHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC
Q 017591 86 LYGFCYDQTKAALVYEFMENGSLDKYLF--TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS 163 (369)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 163 (369)
.--+.. ...+|||+++-... +-. -....++...+..+-.+++.-+.-|-+. .++||.||.--|+|+.++ .
T Consensus 231 PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~LyhdG-~ 302 (520)
T KOG2270|consen 231 PEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYHDG-K 302 (520)
T ss_pred CCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEECC-E
Confidence 222221 23479999985321 111 1234567677777777787777777764 689999999999987654 8
Q ss_pred eeEeecCCcee
Q 017591 164 AKVADFGLAKL 174 (369)
Q Consensus 164 ~kl~Dfg~~~~ 174 (369)
++++|-+.+..
T Consensus 303 lyiIDVSQSVE 313 (520)
T KOG2270|consen 303 LYIIDVSQSVE 313 (520)
T ss_pred EEEEEcccccc
Confidence 99999887754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.00033 Score=74.28 Aligned_cols=157 Identities=12% Similarity=0.016 Sum_probs=109.6
Q ss_pred HHHHHHHhccCCCceeeEEeEEE--eCCceEEEEeccCCCCHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhhcc-
Q 017591 69 MAEIGTIGRTYHINLVRLYGFCY--DQTKAALVYEFMENGSLDKYLFTDT---EVLKWEKLLDIAIGTARGIAYLHEEC- 142 (369)
Q Consensus 69 ~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~l~~~l~~LH~~~- 142 (369)
..|...++...|+++.....-.. +....+.+++|+.+|.+.+.|.+.. ..++..-+.....+...+..-.|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34455555567888776655443 2345789999999999999985432 33444444444444455555555532
Q ss_pred -CCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHH
Q 017591 143 -NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221 (369)
Q Consensus 143 -~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~el 221 (369)
.+-.+|+++|+-|.++..+..++++++|+.+..... ........+++.|++|++..+ ..++.++|+|..|+-+|+.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence 234799999999999999999999999999832211 112233557888999996665 4788889999999999999
Q ss_pred HcCCCCC
Q 017591 222 IGRRKNA 228 (369)
Q Consensus 222 ltg~~p~ 228 (369)
..|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887765
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.038 Score=50.72 Aligned_cols=31 Identities=16% Similarity=0.250 Sum_probs=27.9
Q ss_pred CCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 143 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
+.+++|+|+.+.|++++.++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4689999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.02 Score=53.09 Aligned_cols=138 Identities=14% Similarity=0.210 Sum_probs=78.8
Q ss_pred cccccCCceEEEEEEeCC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCce-eeEEeEEEeCCceEEEEeccC
Q 017591 30 TKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL-VRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.|..|-...+|+....+ +..|++|+...... ..-+-.+|..+++.+...++ .++++++. + .+|.+|++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~--G~i~~fi~ 93 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFG--N--GMIQSFIN 93 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeC--C--cEeehhhc
Confidence 345557778899986533 24788888764322 12334577888877765444 34555542 2 25899998
Q ss_pred CCCHHHH-------h----------ccCC----C-CCCHHHHHHHHHHHH----------------------HHHHHHhh
Q 017591 105 NGSLDKY-------L----------FTDT----E-VLKWEKLLDIAIGTA----------------------RGIAYLHE 140 (369)
Q Consensus 105 ~gsL~~~-------l----------~~~~----~-~~~~~~~~~i~~~l~----------------------~~l~~LH~ 140 (369)
+.+|... + +... . +--+..+..+..++. .-+..+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 7665221 1 1111 1 112334433333221 11222211
Q ss_pred c-----cCCCeEeecCCCCceEecC-CCCeeEeecCCce
Q 017591 141 E-----CNQRIIHYDIKPANILLDA-KFSAKVADFGLAK 173 (369)
Q Consensus 141 ~-----~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~ 173 (369)
. .+.-.+|+|+.+.||++++ ++.++++||..|-
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 1123799999999999975 5689999998764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.013 Score=50.07 Aligned_cols=125 Identities=18% Similarity=0.206 Sum_probs=80.2
Q ss_pred HHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCC
Q 017591 65 EAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144 (369)
Q Consensus 65 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~ 144 (369)
..-|.+++.++.++. .|+++..= +.-...++.|+|..-.. . -..++..=+.+|.-+|++. .
T Consensus 102 ~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~----~~N~i~agi~~L~~fH~~~-~ 162 (308)
T PF07387_consen 102 DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------N----FSNFITAGIKDLMDFHSEN-Q 162 (308)
T ss_pred hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------c----hhHHHHHhHHHHHHhhccC-C
Confidence 445678888888763 46666621 33356789998754110 0 0122222246788889643 6
Q ss_pred CeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcC
Q 017591 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGR 224 (369)
Q Consensus 145 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg 224 (369)
+.+|||..|+||+-++.|.+||.|-+.--. .+..|.--|| ...|.++.+-+|=.-++++...
T Consensus 163 ~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~Y----~~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 163 HCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIEY----ESLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred CeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeeec----cccChHHHHHHHHHHHHHHHHH
Confidence 899999999999999999999999764211 1222333221 2467888888877777777754
Q ss_pred CC
Q 017591 225 RK 226 (369)
Q Consensus 225 ~~ 226 (369)
.+
T Consensus 225 ~~ 226 (308)
T PF07387_consen 225 QR 226 (308)
T ss_pred Hh
Confidence 43
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.041 Score=50.42 Aligned_cols=29 Identities=31% Similarity=0.352 Sum_probs=25.5
Q ss_pred CCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 144 QRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 144 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
.+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 68999999999999988 578999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.019 Score=54.01 Aligned_cols=74 Identities=14% Similarity=0.138 Sum_probs=48.4
Q ss_pred cccccCCceEEEEEEeCC-CcEEEEEEccc-----cccHHHHHHHHHHHHHHhccC--CC-ceeeEEeEEEeCCceEEEE
Q 017591 30 TKLGAGGFGVVYKGQFPN-GVKIAAKILKT-----CLNKRVEAQFMAEIGTIGRTY--HI-NLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~-----~~~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~ 100 (369)
+.||.|.-.-||++.+++ ++.|+||.-.. ...+-...+...|.+.|+... .| ++.+++. .+.....+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHHH
Confidence 578999999999998853 56788886431 111223445556666666553 34 4555664 3567778999
Q ss_pred eccCC
Q 017591 101 EFMEN 105 (369)
Q Consensus 101 e~~~~ 105 (369)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 99854
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.089 Score=48.64 Aligned_cols=92 Identities=13% Similarity=0.023 Sum_probs=52.3
Q ss_pred cccCHHHHHHhhhcccc------ccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc--eee
Q 017591 14 VRFTLEQLCSFTNNYST------KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN--LVR 85 (369)
Q Consensus 14 ~~~~~~el~~~t~~f~~------~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 85 (369)
-.+++..+.++.....= ..-.+.-..||+....++..+++|+..... ....++..|+..+..|.... ++.
T Consensus 9 ~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~ 86 (325)
T PRK11768 9 QTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVA 86 (325)
T ss_pred CCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCC
Confidence 45666766666654421 122345578999988788899999876432 12344555666665543111 111
Q ss_pred EE---e--EEEeCCceEEEEeccCCCC
Q 017591 86 LY---G--FCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 86 ~~---~--~~~~~~~~~lv~e~~~~gs 107 (369)
.. | +...++..+.++++++|..
T Consensus 87 p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 87 PLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 11 1 1222456778999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.076 Score=56.70 Aligned_cols=140 Identities=16% Similarity=0.158 Sum_probs=77.4
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhc-------cCCCceeeEEe-----EEEe-CC--
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR-------TYHINLVRLYG-----FCYD-QT-- 94 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-------l~h~niv~~~~-----~~~~-~~-- 94 (369)
+.|+ |..-.+|+....+|..+++|+.+..... .....|...+.. +.-|.+++..+ ...+ .+
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~ 106 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP 106 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence 3464 4568889998878889999999864322 223333334432 23344443221 1111 12
Q ss_pred ceEEEEeccCCCCHHHHh-----------------cc------C---CCCCCHHH-----------------HHHHHHHH
Q 017591 95 KAALVYEFMENGSLDKYL-----------------FT------D---TEVLKWEK-----------------LLDIAIGT 131 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l-----------------~~------~---~~~~~~~~-----------------~~~i~~~l 131 (369)
..+.+++|.+|..+.+.. +. . ...+.|.. ...++.++
T Consensus 107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~ 186 (1013)
T PRK06148 107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF 186 (1013)
T ss_pred EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence 457789999998775511 00 0 01122211 11222223
Q ss_pred HHHHHH----HhhccCCCeEeecCCCCceEecCCC--Cee-EeecCCce
Q 017591 132 ARGIAY----LHEECNQRIIHYDIKPANILLDAKF--SAK-VADFGLAK 173 (369)
Q Consensus 132 ~~~l~~----LH~~~~~~ivH~dlkp~Nill~~~~--~~k-l~Dfg~~~ 173 (369)
+....- .-...+.++||+|+.+.||+++.++ ++. |+|||.+.
T Consensus 187 ~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 187 LARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 222221 1112347899999999999999875 554 99999764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.054 Score=46.74 Aligned_cols=75 Identities=16% Similarity=0.228 Sum_probs=54.8
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccC---CCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY---HINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.+..|.--..|...+ +...+.||+-. .....-|..|+.-|..|. .-.+.+++..-.+.++.++||||.+-+
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 3566666667777666 56778888643 234567888888777774 355778888888889999999999987
Q ss_pred CHH
Q 017591 107 SLD 109 (369)
Q Consensus 107 sL~ 109 (369)
.++
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 775
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.034 Score=51.98 Aligned_cols=63 Identities=14% Similarity=0.157 Sum_probs=44.7
Q ss_pred ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC
Q 017591 95 KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK 161 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 161 (369)
...|+-+|++|.++..++... ..+++.+.+++.-.+.|+-.+--. .+.+|.|+.|.||++..+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEec
Confidence 456788899999999999433 334455566666555665544432 689999999999999543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.3 Score=45.09 Aligned_cols=138 Identities=21% Similarity=0.276 Sum_probs=79.3
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc------eeeEEeEE--EeC--CceEEEE
Q 017591 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN------LVRLYGFC--YDQ--TKAALVY 100 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~--~~~--~~~~lv~ 100 (369)
.|.+ .-..+|+....+|+. ++|+...... ..++..|...+..|.-.. +...=|-. .-. ...+-++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPGWT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCCCC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 4555 567899998867766 8999886522 345555666666553211 11111111 112 3677899
Q ss_pred eccCCCCHHH------------Hh---cc--------CCC---CCCHHH-------------HHHHHHHHHHHHHHHhh-
Q 017591 101 EFMENGSLDK------------YL---FT--------DTE---VLKWEK-------------LLDIAIGTARGIAYLHE- 140 (369)
Q Consensus 101 e~~~~gsL~~------------~l---~~--------~~~---~~~~~~-------------~~~i~~~l~~~l~~LH~- 140 (369)
+|++|..+.. ++ +. +.. ...|.. -.....++...+..+.+
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999988772 11 00 000 122320 01122233334444433
Q ss_pred ---ccCCC---eEeecCCCCceEecCCCC-eeEeecCCce
Q 017591 141 ---ECNQR---IIHYDIKPANILLDAKFS-AKVADFGLAK 173 (369)
Q Consensus 141 ---~~~~~---ivH~dlkp~Nill~~~~~-~kl~Dfg~~~ 173 (369)
..+.+ +||+|+.|.||+++.+.. +-+.||+-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22344 999999999999999985 8999999654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.13 Score=49.67 Aligned_cols=47 Identities=21% Similarity=0.269 Sum_probs=36.4
Q ss_pred HHHHHHHHHHhccCCCceeeEEeEEEeC-CceEEEEeccCCCCHHHHhc
Q 017591 66 AQFMAEIGTIGRTYHINLVRLYGFCYDQ-TKAALVYEFMENGSLDKYLF 113 (369)
Q Consensus 66 ~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~ 113 (369)
.++.--...++.+.|+|+-..+++.... ....+|||++. .||++.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHH
Confidence 3555666788888999999999887643 45788999985 49999883
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.075 Score=49.06 Aligned_cols=71 Identities=18% Similarity=0.196 Sum_probs=56.2
Q ss_pred ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 95 KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
..|++|++- |+++.. .....+++...++.+.+..+.-+.. +-..-|||+.-.||+++ +|++.|+||.+++.
T Consensus 300 y~yl~~kdh-gt~is~-----ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISI-----IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeee-----eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeec
Confidence 455666653 434422 2345789999999999988888876 36789999999999999 99999999999985
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.22 Score=47.07 Aligned_cols=74 Identities=15% Similarity=0.147 Sum_probs=45.0
Q ss_pred cccccCCceEEEEEEeCCC--c-----EEEEEEccccccHHHHHHHHHHHHHHhccCCCce-eeEEeEEEeCCceEEEEe
Q 017591 30 TKLGAGGFGVVYKGQFPNG--V-----KIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL-VRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~--~-----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 101 (369)
+.|..|-.+.+|++...++ . .|+++.... .....-+-.+|+.+++.+...++ .++++.+. .++|+|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~--~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST--YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccC--CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 3455688889999976443 1 244444221 11222334578888888865544 45555552 369999
Q ss_pred ccCCCCHH
Q 017591 102 FMENGSLD 109 (369)
Q Consensus 102 ~~~~gsL~ 109 (369)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99997764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.28 Score=47.30 Aligned_cols=72 Identities=8% Similarity=0.102 Sum_probs=43.8
Q ss_pred ccccCCceEEEEEEeCC---------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCce-eeEEeEEEeCCceEEEE
Q 017591 31 KLGAGGFGVVYKGQFPN---------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL-VRLYGFCYDQTKAALVY 100 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 100 (369)
.|..|-...+|++..++ ++.|++++.-.... ..-.-.+|..++..+...+| .++++.+ ..+.|.
T Consensus 112 ~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te--~lIdR~~E~~v~~~ls~~gi~P~l~~~f----~gg~I~ 185 (442)
T PTZ00296 112 QILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD--ELYNPISEFEVYKTMSKYRIAPQLLNTF----SGGRIE 185 (442)
T ss_pred EecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc--ceeCHHHHHHHHHHHHHCCCCCceEEEe----CCCEEE
Confidence 45667777889987542 45788888754332 12234557777766654343 2445544 245789
Q ss_pred eccCCCCH
Q 017591 101 EFMENGSL 108 (369)
Q Consensus 101 e~~~~gsL 108 (369)
+|++|.+|
T Consensus 186 efi~g~~l 193 (442)
T PTZ00296 186 EWLYGDPL 193 (442)
T ss_pred EeeCCccC
Confidence 99998644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 369 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-51 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-29 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-28 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-25 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-25 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-25 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-25 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-25 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-24 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-120
Identities = 125/301 (41%), Positives = 167/301 (55%), Gaps = 23/301 (7%)
Query: 13 PVRFTLEQLCSFTNNYST--KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMA 70
RF+L +L ++N+S LG GGFG VYKG+ +G +A K LK + E QF
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 71 EIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLF---TDTEVLKWEKLLDI 127
E+ I H NL+RL GFC T+ LVY +M NGS+ L L W K I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 128 AIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187
A+G+ARG+AYLH+ C+ +IIH D+K ANILLD +F A V DFGLAKL + ++TH +T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AV 195
Query: 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII-GRR-----KNAQDCSSDTLDWFPK 241
RGT G+ APE+L ++K DV+ +G++L E+I G+R + A D LDW
Sbjct: 196 RGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW--- 251
Query: 242 QVWDEYEKG---ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
V ++ L L EE E++ VAL C Q P RP MS VV+MLE
Sbjct: 252 -VKGLLKEKKLEALVDVDLQ---GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
Query: 299 G 299
G
Sbjct: 308 G 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-101
Identities = 107/304 (35%), Positives = 155/304 (50%), Gaps = 30/304 (9%)
Query: 15 RFTLEQLCSFTNNYSTK--LGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEI 72
R L L TNN+ K +G G FG VYKG +G K+A K + + +F EI
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86
Query: 73 GTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLF---TDTEVLKWEKLLDIAI 129
T+ H +LV L GFC ++ + L+Y++MENG+L ++L+ T + WE+ L+I I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 130 GTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC-NPENTHDSTSGYR 188
G ARG+ YLH IIH D+K NILLD F K+ DFG++K + TH ST +
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVK 202
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII-GRRKNAQDCSSDT-----LDWFPKQ 242
GT GY PE+ ++ +T+K DVYSFG++LFE++ R A S +W
Sbjct: 203 GTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARS--AIVQSLPREMVNLAEW---- 255
Query: 243 VWDEYEKGELAAKV---LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299
+ + G+L V L I E + A+ C+ E RP M V+ LE
Sbjct: 256 AVESHNNGQLEQIVDPNLADKI---RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
Query: 300 GVEI 303
+ +
Sbjct: 313 ALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = e-100
Identities = 112/307 (36%), Positives = 150/307 (48%), Gaps = 39/307 (12%)
Query: 15 RFTLEQLCSFTNNYST--------KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRV-- 64
F+ +L + TNN+ K+G GGFGVVYKG N +A K L ++
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 65 -EAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLF--TDTEVLKW 121
+ QF EI + + H NLV L GF D LVY +M NGSL L T L W
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 122 EKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE--N 179
IA G A GI +LHE IH DIK ANILLD F+AK++DFGLA+ + +
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARA-SEKFAQ 188
Query: 180 THDSTSGYR--GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII-GRRKNAQDCSSDT- 235
T ++ R GT Y APE LR IT K D+YSFG++L EII G A D +
Sbjct: 189 TVMTS---RIVGTTAYMAPEA-LRGE-ITPKSDIYSFGVVLLEIITGLP--AVDEHREPQ 241
Query: 236 --LDWFPKQVWDEYEK-GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSA 292
LD +++ DE + + K + + D E M VA C+ + RP +
Sbjct: 242 LLLDIK-EEIEDEEKTIEDYIDKKMN----DADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 293 VVKMLEG 299
V ++L+
Sbjct: 297 VQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-75
Identities = 76/308 (24%), Positives = 116/308 (37%), Gaps = 28/308 (9%)
Query: 14 VRFTLEQLCSFTNN--YSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAE 71
V E L + G FG V+K Q +A KI + Q E
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPI--QDKQSWQNEYE 68
Query: 72 IGTIGRTYHINLVRLYGFCYDQTKAA----LVYEFMENGSLDKYLFTDTEVLKWEKLLDI 127
+ ++ H N+++ G T L+ F E GSL +L V+ W +L I
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHI 126
Query: 128 AIGTARGIAYLHEE-------CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
A ARG+AYLHE+ I H DIK N+LL +A +ADFGLA +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 181 HDSTSGYRGTPGYSAPEFL----LRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL 236
T G GT Y APE L + D+Y+ G++L+E+ R A + +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 237 DWFPKQVWDEYEKGELAAKVLGCG----IEEN--DREEAERMSMVALWCVQDCPEARPPM 290
F +++ ++ V+ + + + C EAR
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 291 SAVVKMLE 298
V + +
Sbjct: 307 GCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 4e-65
Identities = 82/285 (28%), Positives = 139/285 (48%), Gaps = 33/285 (11%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKT-CLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
K+GAG FG V++ ++ +G +A KIL + +F+ E+ + R H N+V G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 90 CYDQTKAALVYEFMENGSLDKYLF--TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
++V E++ GSL + L E L + L +A A+G+ YLH N I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
H ++K N+L+D K++ KV DFGL++L +T S+ GTP + APE +LR+ P +
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPE-VLRDEPSNE 218
Query: 208 KCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE 267
K DVYSFG++L+E+ ++ P W ++ A V + R
Sbjct: 219 KSDVYSFGVILWELATLQQ-------------P---WGNLNPAQVVAAV----GFKCKRL 258
Query: 268 EA-----ERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVAPP 307
E +++ + C + P RP + ++ +L ++ PP
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 2e-62
Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 40/291 (13%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+G G FGVV K ++ +A K ++ ++ F+ E+ + R H N+V+LYG C
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 91 YDQTKAALVYEFMENGSLDKYLFTD--TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
+ LV E+ E GSL L + + ++G+AYLH + +IH
Sbjct: 71 LN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 149 YDIKPANILLDAKFS-AKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
D+KP N+LL A + K+ DFG A + + +G+ + APE + ++
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPE-VFEGSNYSE 182
Query: 208 KCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE 267
KCDV+S+G++L+E+I RRK P +DE + R
Sbjct: 183 KCDVFSWGIILWEVITRRK-------------P---FDEIGGPAFRIMW---AVHNGTRP 223
Query: 268 E-----AERMSMVALWCVQDCPEARPPMSAVVKMLEGG-VEIVAPPKPFRY 312
+ + + C P RP M +VK++ +P +Y
Sbjct: 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-61
Identities = 67/286 (23%), Positives = 107/286 (37%), Gaps = 42/286 (14%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
LG G FG K G + K L ++ + F+ E+ + H N+++ G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
Y + + E+++ G+L + + W + + A A G+AYLH IIH
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 150 DIKPANILLDAKFSAKVADFGLAKL------------CNPENTHDSTSGYRGTPGYSAPE 197
D+ N L+ + VADFGLA+L + G P + APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 198 FLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257
++ +K DV+SFG++L EIIGR D+ P+ +
Sbjct: 193 -MINGRSYDEKVDVFSFGIVLCEIIGRVNADP-------DYLPRTM------------DF 232
Query: 258 GCGIEENDREEA-----ERMSMVALWCVQDCPEARPPMSAVVKMLE 298
G + + + C PE RP + LE
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-60
Identities = 65/284 (22%), Positives = 114/284 (40%), Gaps = 42/284 (14%)
Query: 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKT-CLNKRVEAQFMAEIGTIGRTYHINLVR 85
N+ TKL G ++KG++ G I K+LK + R F E + H N++
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 86 LYGFCYD--QTKAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEEC 142
+ G C L+ +M GSL L T V+ + + A+ ARG+A+LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
I + + ++++D +A+++ + + G P + APE L+
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPE-ALQK 182
Query: 203 YP---ITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259
P + D++SF +LL+E++ R P + + E+ KV
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREV-------------P---FADLSNMEIGMKV--- 223
Query: 260 GIEENDREEA-----ERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E R +S + C+ + P RP +V +LE
Sbjct: 224 -ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-60
Identities = 80/286 (27%), Positives = 118/286 (41%), Gaps = 44/286 (15%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKT------CLNKRVEAQFMAEIGTIGRTYHINL 83
++G GGFG+V+KG+ + +A K L +F E+ + H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
V+LYG ++ +V EF+ G L L +KW L + + A GI Y+ N
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQN 142
Query: 144 QRIIHYDIKPANILLD-----AKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE- 197
I+H D++ NI L A AKVADFGL++ ++ H + G + APE
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGL-LGNFQWMAPET 197
Query: 198 FLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257
T+K D YSF M+L+ I+ P +DEY K +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEG-------------P---FDEYS--YGKIKFI 239
Query: 258 GCGIEENDREEA-----ERMSMVALWCVQDCPEARPPMSAVVKMLE 298
EE R R+ V C P+ RP S +VK L
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-59
Identities = 69/284 (24%), Positives = 115/284 (40%), Gaps = 44/284 (15%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKT---CLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
+G GGFG VY+ + G ++A K + + E H N++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G C + LV EF G L++ L + + + L++ A+ ARG+ YLH+E II
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 148 HYDIKPANILLDAKFS--------AKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFL 199
H D+K +NIL+ K K+ DFGLA+ E + G + APE +
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPE-V 185
Query: 200 LRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259
+R ++ DV+S+G+LL+E++ P + + +A V
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEV-------------P---FRGIDGLAVAYGVA-- 227
Query: 260 GIEENDREEA-----ERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E + + C P +RP + ++ L
Sbjct: 228 --MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-59
Identities = 75/276 (27%), Positives = 130/276 (47%), Gaps = 30/276 (10%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
++G+G FG VYKG++ V A K+L T + F E+G + +T H+N++ G+
Sbjct: 31 RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ A+V ++ E SL +L + +KL+DIA TARG+ YLH + IIH
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR--NYPITQ 207
D+K NI L + K+ DFGLA + + G+ + APE + + P +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 208 KCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE 267
+ DVY+FG++L+E++ T P + + +++G G D
Sbjct: 205 QSDVYAFGIVLYELM------------TGQL-P---YSNINNRDQIIEMVGRGSLSPDLS 248
Query: 268 EA-----ERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ +RM + C++ + RP ++ +E
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 7e-59
Identities = 68/303 (22%), Positives = 105/303 (34%), Gaps = 43/303 (14%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAE--IGTIGRTYHINLVRLYG 88
+G G +G VYKG + +A K+ F+ E I + H N+ R
Sbjct: 20 LIGRGRYGAVYKGSL-DERPVAVKVFSF----ANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 89 FCYDQTKAA-----LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE-- 141
T LV E+ NGSL KYL T W +A RG+AYLH E
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 142 ----CNQRIIHYDIKPANILLDAKFSAKVADFGLAK------LCNPENTHDSTSGYRGTP 191
I H D+ N+L+ + ++DFGL+ L P ++ GT
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 192 GYSAPEFL------LRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW---FPKQ 242
Y APE L ++ D+Y+ G++ +EI R ++ F +
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF-MRCTDLFPGESVPEYQMAFQTE 251
Query: 243 VWDEYEKGELAAKVLGCG----IEEN---DREEAERMSMVALWCVQDCPEARPPMSAVVK 295
V + ++ V E + + C EAR +
Sbjct: 252 VGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311
Query: 296 MLE 298
+
Sbjct: 312 RMA 314
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 4e-57
Identities = 69/294 (23%), Positives = 114/294 (38%), Gaps = 36/294 (12%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFM--AEIGTIGRTYHINLVRLYG 88
++G G +G V+ G++ G K+A K+ T EA + EI H N++
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 89 FCYD----QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE--- 141
T+ L+ ++ ENGSL YL + L + +L +A + G+ +LH E
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 142 --CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD--STSGYRGTPGYSAPE 197
I H D+K NIL+ + +AD GLA + + GT Y PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 198 FL-----LRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252
L ++ D+YSFG++L+E+ RR + + + V + ++
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVA-RRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 253 AAKVLGCG----IEENDREEAERMSMVALWCVQDC----PEARPPMSAVVKMLE 298
V + M L + +C P +R V K L
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKL--MTECWAHNPASRLTALRVKKTLA 327
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 8e-57
Identities = 59/292 (20%), Positives = 105/292 (35%), Gaps = 57/292 (19%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+G G FG VY G++ V A +++ N+ F E+ +T H N+V G
Sbjct: 40 LIGKGRFGQVYHGRWHGEV--AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
C A++ + +L + VL K IA +G+ YLH + I+H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 150 DIKPANILLDAKFSAKVADFGLAKL---CNPENTHDSTSGYRGTPGYSAPEFLLRNY--- 203
D+K N+ D + DFGL + D G + APE ++R
Sbjct: 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE-IIRQLSPD 212
Query: 204 ------PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257
P ++ DV++ G + +E+ +W P + + ++
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELH------------AREW-P---FKTQPAEAIIWQM- 255
Query: 258 GCGIEENDREEAERMSMVALWC-------VQDC----PEARPPMSAVVKMLE 298
+ ++ + + C E RP + ++ MLE
Sbjct: 256 ---------GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-56
Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 36/294 (12%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAE--IGTIGRTYHINLVRLYG 88
+G G FG V++G++ G ++A KI + R E + E I H N++
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 89 FCYDQTKAA----LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE--- 141
LV ++ E+GSL YL + + E ++ +A+ TA G+A+LH E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 142 --CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS--GYRGTPGYSAPE 197
I H D+K NIL+ + +AD GLA + + GT Y APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 198 FL-----LRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252
L ++++ ++ D+Y+ G++ +EI RR + D + V + E+
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIA-RRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 253 AAKVLGCG----IEENDREEAERMSMVALWCVQDC----PEARPPMSAVVKMLE 298
V I + M + +++C AR + K L
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKI--MRECWYANGAARLTALRIKKTLS 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 9e-53
Identities = 70/294 (23%), Positives = 115/294 (39%), Gaps = 36/294 (12%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAE--IGTIGRTYHINLVRLYG 88
+G G +G V++G + G +A KI + R E + E + H N++
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 89 FC----YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE--- 141
+ T+ L+ + E GSL YL L L I + A G+A+LH E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 142 --CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS--GYRGTPGYSAPE 197
I H D+K NIL+ +AD GLA + + GT Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 198 FL-----LRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252
L + + ++ D+++FG++L+E+ RR + D F V ++ ++
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVA-RRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 253 AAKVLGCG----IEENDREEAERMSMVALWCVQDC----PEARPPMSAVVKMLE 298
V I + S+ L +++C P AR + K L
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKL--MKECWYQNPSARLTALRIKKTLT 298
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 38/278 (13%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
++G G FG V+ G+ + +A K + L ++A+F+ E + + H N+VRL G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
C + +V E ++ G +L T+ L+ + LL + A G+ YL + IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHR 237
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP-GYSAPEFLLRN-YPITQ 207
D+ N L+ K K++DFG+++ + + ++ G R P ++APE L Y +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRY--SS 294
Query: 208 KCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260
+ DV+SFG+LL+E G N Q + EKG C
Sbjct: 295 ESDVWSFGILLWETFSLGASPYPNLSNQ-------------QTREFVEKGGRLPCPELC- 340
Query: 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ + + C P RP S + + L+
Sbjct: 341 --------PDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-44
Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 32/274 (11%)
Query: 31 KLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G +G VY+G + + +A K LK + E F+ E + H NLV+L G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGV 284
Query: 90 CYDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
C + ++ EFM G+L YL + + + LL +A + + YL + + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 341
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
++ N L+ KVADFGL++L +T+ + +G + ++APE L N + K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYN-KFSIK 399
Query: 209 CDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP----KQVWDEYEKGELAAKVLGCGIEEN 264
DV++FG+LL+EI + +P QV++ EK + GC
Sbjct: 400 SDVWAFGVLLWEIATYGMS----------PYPGIDLSQVYELLEKDYRMERPEGC----- 444
Query: 265 DREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E++ + C Q P RP + + + E
Sbjct: 445 ----PEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-43
Identities = 61/289 (21%), Positives = 111/289 (38%), Gaps = 39/289 (13%)
Query: 31 KLGAGGFGVVYKGQFP-----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G FG V ++ G ++A K LK A EI + YH N+V+
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 86 LYGFCYDQTKAA--LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
G C + L+ EF+ +GSL +YL + + ++ L A+ +G+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS--- 144
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPE 197
++ +H D+ N+L++++ K+ DFGL K Y + APE
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----IETDKEYYTVKDDRDSPVFWYAPE 199
Query: 198 FLL-RNYPITQKCDVYSFGMLLFEII--GRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254
L+ + DV+SFG+ L E++ ++ +
Sbjct: 200 CLMQSKF--YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR------ 251
Query: 255 KVLGCGIEENDREEA-----ERMSMVALWCVQDCPEARPPMSAVVKMLE 298
++ ++E R + + + C + P R +++ E
Sbjct: 252 -LVNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-43
Identities = 80/275 (29%), Positives = 122/275 (44%), Gaps = 36/275 (13%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLG G FG V+ G + ++A K LK F+ E + + H LV+LY
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVV 248
Query: 91 YDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
++ +V E+M GSL +L + L+ +L+D+A A G+AY+ +H
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D++ ANIL+ KVADFGLA+L +N + + G + ++APE L T K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGR-FTIKS 362
Query: 210 DVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP------KQVWDEYEKGELAAKVLGCGIEE 263
DV+SFG+LL E+ T P ++V D+ E+G C
Sbjct: 363 DVWSFGILLTELT------------TKGRVPYPGMVNREVLDQVERGYRMPCPPEC---- 406
Query: 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E + + C + PE RP + LE
Sbjct: 407 -----PESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-43
Identities = 80/275 (29%), Positives = 122/275 (44%), Gaps = 36/275 (13%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLG G FG V+ G + ++A K LK F+ E + + H LV+LY
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVV 331
Query: 91 YDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
++ +V E+M GSL +L + L+ +L+D+A A G+AY+ +H
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D++ ANIL+ KVADFGLA+L +N + + G + ++APE L T K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGR-FTIKS 445
Query: 210 DVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP------KQVWDEYEKGELAAKVLGCGIEE 263
DV+SFG+LL E+ T P ++V D+ E+G C
Sbjct: 446 DVWSFGILLTELT------------TKGRVPYPGMVNREVLDQVERGYRMPCPPEC---- 489
Query: 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E + + C + PE RP + LE
Sbjct: 490 -----PESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-42
Identities = 63/293 (21%), Positives = 111/293 (37%), Gaps = 47/293 (16%)
Query: 31 KLGAGGFGVVYKGQFP-----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
+LG G FG V ++ G +A K L+ + + F EI + H N+V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 75
Query: 86 LYGFCYDQTKAA--LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
G CY + L+ E++ GSL YL E + KLL +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT--- 132
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPE 197
+R IH D+ NIL++ + K+ DFGL K+ ++ + APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-----QDKEFFKVKEPGESPIFWYAPE 187
Query: 198 FLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257
L + + DV+SFG++L+E+ + ++ ++ + + L +
Sbjct: 188 SLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL- 245
Query: 258 GCGIEENDREEAERMS------------MVALWCVQDCPEARPPMSAVVKMLE 298
+ R+ M W + RP + ++
Sbjct: 246 ---------KNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-42
Identities = 64/294 (21%), Positives = 111/294 (37%), Gaps = 49/294 (16%)
Query: 31 KLGAGGFGVVYKGQFP-----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
+LG G FG V ++ G +A K L+ + + F EI + H N+V+
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 106
Query: 86 LYGFCYDQTKAA--LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
G CY + L+ E++ GSL YL E + KLL +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT--- 163
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPE 197
+R IH D+ NIL++ + K+ DFGL K+ Y+ + APE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-----QDKEYYKVKEPGESPIFWYAPE 218
Query: 198 FLL-RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256
L + + DV+SFG++L+E+ + ++ ++ + + L +
Sbjct: 219 SLTESKF--SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 257 LGCGIEENDREEAERMS------------MVALWCVQDCPEARPPMSAVVKMLE 298
+ R+ M W + RP + ++
Sbjct: 277 ----------KNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 318
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 77/275 (28%), Positives = 126/275 (45%), Gaps = 36/275 (13%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLGAG FG V+ + K+A K +K F+AE + H LV+L+
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVV 252
Query: 91 YDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ ++ EFM GSL +L + + KL+D + A G+A++ + + IH
Sbjct: 253 TKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 308
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D++ ANIL+ A K+ADFGLA++ +N + + G + ++APE + T K
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFG-SFTIKS 366
Query: 210 DVYSFGMLLFEII--GRRKNAQDCSSDTLDWFP----KQVWDEYEKGELAAKVLGCGIEE 263
DV+SFG+LL EI+ GR +P +V E+G + C
Sbjct: 367 DVWSFGILLMEIVTYGRI------------PYPGMSNPEVIRALERGYRMPRPENC---- 410
Query: 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E + + + C ++ PE RP + +L+
Sbjct: 411 -----PEELYNIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 67/282 (23%), Positives = 120/282 (42%), Gaps = 43/282 (15%)
Query: 31 KLGAGGFGVVYKGQFPNG-----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG+G FG VYKG + + +A K L+ + + + + E + + ++ R
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
L G C T L+ + M G L Y+ + + + LL+ + A+G+ YL + +R
Sbjct: 82 LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RR 137
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP-GYSAPE-FLLRNY 203
++H D+ N+L+ K+ DFGLAKL E G + P + A E L R Y
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-VPIKWMALESILHRIY 196
Query: 204 PITQKCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256
T + DV+S+G+ ++E++ G + + ++ EKGE +
Sbjct: 197 --THQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EISSILEKGERLPQP 241
Query: 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
C I+ + M+ C ++RP ++
Sbjct: 242 PICTID---------VYMIMRKCWMIDADSRPKFRELIIEFS 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-41
Identities = 64/286 (22%), Positives = 114/286 (39%), Gaps = 50/286 (17%)
Query: 30 TKLGAGGFGVVYKGQFPNG---VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+LG G FG V +G + + +A K+LK K + M E + + + +VRL
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G C + LV E G L K+L E + + ++ + G+ YL E +
Sbjct: 76 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 131
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPE-FL 199
+H D+ N+LL + AK++DFGL+K ++++ Y + APE
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----YTARSAGKWPLKWYAPECIN 186
Query: 200 LRNYPITQKCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGEL 252
R + + + DV+S+G+ ++E + G++ K +V E+G+
Sbjct: 187 FRKF--SSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------------EVMAFIEQGKR 231
Query: 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
C + + C E RP V + +
Sbjct: 232 MECPPEC---------PPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 38/276 (13%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
++G+G FG+V+ G + N K+A K ++ + F+ E + + H LV+LYG C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKLVQLYGVC 72
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
+Q LV EFME+G L YL T + E LL + + G+AYL E +IH D
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 129
Query: 151 IKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE-FLLRNYPITQKC 209
+ N L+ KV+DFG+ + ++ + S++G + +++PE F Y + K
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRY--SSKS 186
Query: 210 DVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262
DV+SFG+L++E+ G+ N+ +V ++ G K
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNS-------------EVVEDISTGFRLYKPRLA--- 230
Query: 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ + + C ++ PE RP S +++ L
Sbjct: 231 ------STHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 50/286 (17%)
Query: 31 KLGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+G+G G V G+ V +A K LK +R F++E +G+ H N++RL
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G A +V E+MENGSLD +L T +L+ + G G+ YL +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGY 172
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPEFLL 200
+H D+ N+L+D+ KV+DFGL+++ D T G ++APE +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRV-----LEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 201 -RNYPITQKCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGEL 252
R + + DV+SFG++++E++ G R N V E+G
Sbjct: 228 FRTF--SSASDVWSFGVVMWEVLAYGERPYWNMTNR-------------DVISSVEEGYR 272
Query: 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+GC + + L C RP S +V +L+
Sbjct: 273 LPAPMGC---------PHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 70/307 (22%), Positives = 125/307 (40%), Gaps = 50/307 (16%)
Query: 5 LRDIARE-KPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQF-----PNGVKIAAKILKT 58
++ +AR K + LG+G FG V+KG + + + K+++
Sbjct: 3 MKVLARIFKETELRKLK----------VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED 52
Query: 59 CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEV 118
++ + IG H ++VRL G C + LV +++ GSL ++
Sbjct: 53 KSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA 111
Query: 119 LKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178
L + LL+ + A+G+ YL E ++H ++ N+LL + +VADFG+A L P+
Sbjct: 112 LGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168
Query: 179 NTHDSTSGYRGTPGYSAPEFLL-RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL- 236
+ S + + A E + Y T + DV+S+G+ ++E++ T
Sbjct: 169 DKQLLYSEAKTPIKWMALESIHFGKY--THQSDVWSYGVTVWELM------------TFG 214
Query: 237 -----DWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMS 291
+V D EKGE A+ C I+ + MV + C RP
Sbjct: 215 AEPYAGLRLAEVPDLLEKGERLAQPQICTID---------VYMVMVKCWMIDENIRPTFK 265
Query: 292 AVVKMLE 298
+
Sbjct: 266 ELANEFT 272
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-40
Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 51/287 (17%)
Query: 31 KLGAGGFGVVYKGQF--PNG---VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
+GAG FG VYKG +G V +A K LK ++ F+ E G +G+ H N++R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
L G ++ E+MENG+LDK+L +L+ + G A G+ YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MN 167
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPEFL 199
+H D+ NIL+++ KV+DFGL+++ D T G ++APE +
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 200 L-RNYPITQKCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGE 251
R + T DV+SFG++++E++ G R N +V G
Sbjct: 223 SYRKF--TSASDVWSFGIVMWEVMTYGERPYWELSNH-------------EVMKAINDGF 267
Query: 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ C + + + C Q RP + +V +L+
Sbjct: 268 RLPTPMDC---------PSAIYQLMMQCWQQERARRPKFADIVSILD 305
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 74/289 (25%), Positives = 111/289 (38%), Gaps = 41/289 (14%)
Query: 31 KLGAGGFGVVYKGQFPN-----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G FG V + G +A K LK + + + EI + YH ++++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 86 LYGFCYDQTKAA--LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
G C D A+ LV E++ GSL YL + + +LL A G+AYLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHA--- 152
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR-GTPGYS-----APE 197
Q IH D+ N+LLD K+ DFGLAK + YR G S APE
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA-----VPEGHEYYRVREDGDSPVFWYAPE 207
Query: 198 FLLRNYPI-TQKCDVYSFGMLLFEII--GRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254
L DV+SFG+ L+E++ + L + EL
Sbjct: 208 CL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL-- 263
Query: 255 KVLGCGIEENDREEA-----ERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+E +R + + C + RP ++ +L+
Sbjct: 264 ------LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-40
Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 38/276 (13%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+LG+G FGVV G++ +A K++K E F E T+ + H LV+ YG C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE--FFQEAQTMMKLSHPKLVKFYGVC 72
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
+ +V E++ NG L YL + + L+ +LL++ G+A+L + IH D
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRD 129
Query: 151 IKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL-RNYPITQKC 209
+ N L+D KV+DFG+ + ++ + S+ G + +SAPE Y + K
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKY--SSKS 186
Query: 210 DVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262
DV++FG+L++E+ G+ N+ +V + +G +
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNS-------------EVVLKVSQGHRLYRPHLA--- 230
Query: 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
++ + + C + PE RP ++ +E
Sbjct: 231 ------SDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 71/307 (23%), Positives = 128/307 (41%), Gaps = 44/307 (14%)
Query: 31 KLGAGGFGVVYKGQF-----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG+G FG VYKG + + +A K L+ + + + + E + + ++ R
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
L G C T L+ + M G L Y+ + + + LL+ + A+G+ YL + +R
Sbjct: 82 LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RR 137
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP-GYSAPE-FLLRNY 203
++H D+ N+L+ K+ DFGLAKL E G + P + A E L R Y
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-VPIKWMALESILHRIY 196
Query: 204 PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL------DWFPKQVWDEYEKGELAAKVL 257
T + DV+S+G+ ++E++ T ++ EKGE +
Sbjct: 197 --THQSDVWSYGVTVWELM------------TFGSKPYDGIPASEISSILEKGERLPQPP 242
Query: 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVAPPKPFRYLYSIG 317
C I+ + M+ + C ++RP ++ ++ P+ + +
Sbjct: 243 ICTID---------VYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQRYLVIQGDE 290
Query: 318 MDALKSP 324
L SP
Sbjct: 291 RMHLPSP 297
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-39
Identities = 63/282 (22%), Positives = 117/282 (41%), Gaps = 50/282 (17%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+LG G FGVV G++ +A K++K E F+ E + H LV+LYG C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKLVQLYGVC 88
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
Q ++ E+M NG L YL + ++LL++ + YL ++ +H D
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 145
Query: 151 IKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPE-FLLRNY 203
+ N L++ + KV+DFGL++ D Y + G +S PE + +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRY-----VLDDE--YTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 204 PITQKCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256
+ K D+++FG+L++EI G+ N+ + + +G +
Sbjct: 199 --SSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------------ETAEHIAQGLRLYRP 243
Query: 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+E++ + C + + RP ++ +
Sbjct: 244 HLA---------SEKVYTIMYSCWHEKADERPTFKILLSNIL 276
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-39
Identities = 74/276 (26%), Positives = 109/276 (39%), Gaps = 42/276 (15%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+G G FG V G + G K+A K +K + F+AE + + H NLV+L G
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVI 255
Query: 91 -YDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
++ +V E+M GSL YL + VL + LL ++ + YL +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 312
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+ N+L+ AKV+DFGL K + + ++APE L + K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKK-FSTK 366
Query: 209 CDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP------KQVWDEYEKGELAAKVLGCGIE 262
DV+SFG+LL+EI + P K V EKG GC
Sbjct: 367 SDVWSFGILLWEIY------------SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC--- 411
Query: 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ V C RP + + LE
Sbjct: 412 ------PPAVYDVMKNCWHLDAATRPTFLQLREQLE 441
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-39
Identities = 61/210 (29%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 31 KLGAGGFGVVYKGQF--PNG--VKIAAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLV 84
KLG G FGVV +G++ P+G V +A K LK F+ E+ + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
RLYG +V E GSL L L A+ A G+ YL +
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 140
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPE- 197
R IH D+ N+LL + K+ DFGL + + H Y + APE
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-----YVMQEHRKVPFAWCAPES 195
Query: 198 FLLRNYPITQKCDVYSFGMLLFEII--GRR 225
R + + D + FG+ L+E+ G+
Sbjct: 196 LKTRTF--SHASDTWMFGVTLWEMFTYGQE 223
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-39
Identities = 72/286 (25%), Positives = 118/286 (41%), Gaps = 50/286 (17%)
Query: 31 KLGAGGFGVVYKGQFPNG----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+GAG FG V G+ + +A K LK ++ F+ E +G+ H N++RL
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G +V E+MENGSLD +L +L+ + G A G+ YL +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGY 168
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPE-FL 199
+H D+ NIL+++ KV+DFGL ++ D T G +++PE
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRV-----LEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 200 LRNYPITQKCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGEL 252
R + T DV+S+G++L+E++ G R N V ++G
Sbjct: 224 YRKF--TSASDVWSYGIVLWEVMSYGERPYWEMSNQ-------------DVIKAVDEGYR 268
Query: 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ C + + L C Q RP +V +L+
Sbjct: 269 LPPPMDC---------PAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 36/287 (12%)
Query: 31 KLGAGGFGVVYKGQFP-----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
+LG G FG V ++ G +A K L+ + F EI + + +V+
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQILKALHSDFIVK 88
Query: 86 LYGFCYDQTKAA--LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
G Y + + LV E++ +G L +L L +LL + +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS--- 145
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPE 197
+R +H D+ NIL++++ K+ADFGLAKL Y + APE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKL-----LPLDKDYYVVREPGQSPIFWYAPE 200
Query: 198 FLLRNYPI-TQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256
L + I +++ DV+SFG++L+E+ C E+ A
Sbjct: 201 SL--SDNIFSRQSDVWSFGVVLYELFTY------CDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 257 LGCGIEENDREEA-----ERMSMVALWCVQDCPEARPPMSAVVKMLE 298
L +EE R A + + C P+ RP SA+ L+
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 76/194 (39%), Positives = 107/194 (55%), Gaps = 11/194 (5%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+LGAG FG V+ G + K+A K LK F+AE + + H LVRLY
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVV 77
Query: 91 YDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
Q ++ E+MENGSL +L T L KLLD+A A G+A++ E + IH
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPI-TQK 208
D++ ANIL+ S K+ADFGLA+L +N + + G + ++APE + NY T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI--NYGTFTIK 190
Query: 209 CDVYSFGMLLFEII 222
DV+SFG+LL EI+
Sbjct: 191 SDVWSFGILLTEIV 204
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-38
Identities = 65/285 (22%), Positives = 110/285 (38%), Gaps = 51/285 (17%)
Query: 31 KLGAGGFGVVYKGQFPNG----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+G G FG V++G + + + +A K K C + V +F+ E T+ + H ++V+L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G + ++ E G L +L L L+ A + +AYL +R
Sbjct: 82 IGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 137
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG-----YSAPEFLL- 200
+H DI N+L+ + K+ DFGL++ Y+ + G + APE +
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINF 191
Query: 201 RNYPITQKCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGELA 253
R + T DV+ FG+ ++EI+ G + KN V E GE
Sbjct: 192 RRF--TSASDVWMFGVCMWEILMHGVKPFQGVKNN-------------DVIGRIENGERL 236
Query: 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
C + + C P RP + + L
Sbjct: 237 PMPPNC---------PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-38
Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 51/285 (17%)
Query: 31 KLGAGGFGVVYKGQF--PNGVKI--AAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
LG G FG VY+G + G KI A K K + +FM+E + H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G ++ ++ E G L YL + LK L+ ++ + +AYL
Sbjct: 79 IGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INC 134
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG-----YSAPE-FLL 200
+H DI NIL+ + K+ DFGL++ E+ Y+ + + +PE
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY------YKASVTRLPIKWMSPESINF 188
Query: 201 RNYPITQKCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGELA 253
R + T DV+ F + ++EI+ G++ +N V EKG+
Sbjct: 189 RRF--TTASDVWMFAVCMWEILSFGKQPFFWLENK-------------DVIGVLEKGDRL 233
Query: 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
K C + + C P RP + +V L
Sbjct: 234 PKPDLC---------PPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-38
Identities = 78/283 (27%), Positives = 121/283 (42%), Gaps = 50/283 (17%)
Query: 31 KLGAGGFGVVYKGQFPNG-VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G +G VY+G + + +A K LK + E F+ E + H NLV+L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGV 77
Query: 90 CYDQTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
C + ++ EFM G+L YL + + + LL +A + + YL + + IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPEFLL-R 201
D+ N L+ KVADFGL++L T Y G ++APE L
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL-----MTGDT--YTAHAGAKFPIKWTAPESLAYN 187
Query: 202 NYPITQKCDVYSFGMLLFEII--GRRKNAQDCSSDTLDWFP----KQVWDEYEKGELAAK 255
+ + K DV++FG+LL+EI G +P QV++ EK +
Sbjct: 188 KF--SIKSDVWAFGVLLWEIATYGMS------------PYPGIDLSQVYELLEKDYRMER 233
Query: 256 VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
GC E++ + C Q P RP + + + E
Sbjct: 234 PEGC---------PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-38
Identities = 63/286 (22%), Positives = 114/286 (39%), Gaps = 50/286 (17%)
Query: 30 TKLGAGGFGVVYKGQFPNG---VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+LG G FG V +G + + +A K+LK K + M E + + + +VRL
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G C + LV E G L K+L E + + ++ + G+ YL E +
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 457
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPE-FL 199
+H ++ N+LL + AK++DFGL+K ++++ Y + APE
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-----YTARSAGKWPLKWYAPECIN 512
Query: 200 LRNYPITQKCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGEL 252
R + + + DV+S+G+ ++E + G++ K +V E+G+
Sbjct: 513 FRKF--SSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------------EVMAFIEQGKR 557
Query: 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
C + + C E RP V + +
Sbjct: 558 MECPPEC---------PPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 31 KLGAGGFGVVYKGQFPNG---VKIAAKILKT-CLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+LG+G FG V KG + +A KILK + ++ + +AE + + + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G C + LV E E G L+KYL + +K + ++++ + G+ YL E
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE---SNF 138
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG------YSAPE-FL 199
+H D+ N+LL + AK++DFGL+K + + Y+ + APE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-----YKAQTHGKWPVKWYAPECIN 193
Query: 200 LRNYPITQKCDVYSFGMLLFEII--GRR 225
+ + K DV+SFG+L++E G++
Sbjct: 194 YYKF--SSKSDVWSFGVLMWEAFSYGQK 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-37
Identities = 76/277 (27%), Positives = 109/277 (39%), Gaps = 44/277 (15%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+G G FG V G + G K+A K +K N F+AE + + H NLV+L G
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 91 YDQTKAA-LVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
++ +V E+M GSL YL + VL + LL ++ + YL +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+ N+L+ AKV+DFGL K + + ++APE L + K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKK-FSTK 194
Query: 209 CDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261
DV+SFG+LL+EI GR K V EKG GC
Sbjct: 195 SDVWSFGILLWEIYSFGRVPYPRIPL-------------KDVVPRVEKGYKMDAPDGC-- 239
Query: 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ V C RP + + LE
Sbjct: 240 -------PPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-37
Identities = 67/285 (23%), Positives = 113/285 (39%), Gaps = 46/285 (16%)
Query: 31 KLGAGGFGVVYKGQFPNG----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+G G FGVVY G++ + ++ A K L + F+ E + H N++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 87 YGFCYDQTKAAL-VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
G + +M +G L +++ + + L+ + ARG+ YL E Q+
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QK 144
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG-----YSAPEFLL 200
+H D+ N +LD F+ KVADFGLA+ + S + ++A E L
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARD---ILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 201 -RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL------DWFPKQVWDEYEKGELA 253
+ T K DV+SFG+LL+E++ T P + +G
Sbjct: 202 TYRF--TTKSDVWSFGVLLWELL------------TRGAPPYRHIDPFDLTHFLAQGRRL 247
Query: 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ C + + V C + P RP +V +E
Sbjct: 248 PQPEYC---------PDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 71/285 (24%), Positives = 116/285 (40%), Gaps = 46/285 (16%)
Query: 31 KLGAGGFGVVYKGQFPNG----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+G G FG VY G + + A K L + +QF+ E + H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 87 YGFCYDQTKAAL-VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
G C + L V +M++G L ++ +T + L+ + A+G+ YL ++
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KK 148
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG-----YSAPEFLL 200
+H D+ N +LD KF+ KVADFGLA+ + S + T + A E L
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 201 -RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL------DWFPKQVWDEYEKGELA 253
+ + T K DV+SFG+LL+E++ T D + +G
Sbjct: 206 TQKF--TTKSDVWSFGVLLWELM------------TRGAPPYPDVNTFDITVYLLQGRRL 251
Query: 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ C + + V L C E RP S +V +
Sbjct: 252 LQPEYC---------PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-36
Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 46/285 (16%)
Query: 31 KLGAGGFGVVYKGQFPNG----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+G G FG VY G + + A K L + +QF+ E + H N++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 87 YGFCYDQTKAAL-VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
G C + L V +M++G L ++ +T + L+ + A+G+ +L ++
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KK 212
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG-----YSAPEFLL 200
+H D+ N +LD KF+ KVADFGLA+ + S + T + A E L
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 201 -RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL------DWFPKQVWDEYEKGELA 253
+ + T K DV+SFG+LL+E++ T D + +G
Sbjct: 270 TQKF--TTKSDVWSFGVLLWELM------------TRGAPPYPDVNTFDITVYLLQGRRL 315
Query: 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ C + + V L C E RP S +V +
Sbjct: 316 LQPEYC---------PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 65/285 (22%), Positives = 110/285 (38%), Gaps = 51/285 (17%)
Query: 31 KLGAGGFGVVYKGQFPNG----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+G G FG V++G + + + +A K K C + V +F+ E T+ + H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G + ++ E G L +L L L+ A + +AYL +R
Sbjct: 457 IGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRF 512
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG-----YSAPEFLL- 200
+H DI N+L+ + K+ DFGL++ Y+ + G + APE +
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINF 566
Query: 201 RNYPITQKCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEYEKGELA 253
R + T DV+ FG+ ++EI+ G + KN V E GE
Sbjct: 567 RRF--TSASDVWMFGVCMWEILMHGVKPFQGVKN-------------NDVIGRIENGERL 611
Query: 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
C + + C P RP + + L
Sbjct: 612 PMPPNC---------PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 59/291 (20%), Positives = 102/291 (35%), Gaps = 57/291 (19%)
Query: 31 KLGAGGFGVVYKGQF--------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN 82
LG G F ++KG + ++ K+L E+ F + + H +
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES-FFEAASMMSKLSHKH 73
Query: 83 LVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC 142
LV YG C + LV EF++ GSLD YL + + L++A A + +L E
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE-- 131
Query: 143 NQRIIHYDIKPANILLDAKFS--------AKVADFGLAKLCNPENTHDSTSGYRGTPGYS 194
+IH ++ NILL + K++D G++ + +
Sbjct: 132 -NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------LPKDILQERIPWV 184
Query: 195 APEFLLRNYPITQKCDVYSFGMLLFEII--GRR-----KNAQDCSSDTLDWFPKQVWDEY 247
PE + + D +SFG L+EI G + + + Y
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-------------RKLQFY 231
Query: 248 EKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E + A + C+ P+ RP A+++ L
Sbjct: 232 EDRHQLPAPKAAEL-------ANLI----NNCMDYEPDHRPSFRAIIRDLN 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 31/209 (14%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKIL-KTCLNKRVEAQFMAEIGTIGRTYHINL--VRLY 87
++G+GG V++ A K + + + + EI + + + +RLY
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 88 GFCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLK-WEKLLDIAIGTARGIAYLHEE 141
+ +V E N L+ +L E W+ +L + +H+
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML-------EAVHTIHQ- 145
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
I+H D+KPAN L+ K+ DFG+A P+ T GT Y PE +
Sbjct: 146 --HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 202 N----------YPITQKCDVYSFGMLLFE 220
I+ K DV+S G +L+
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYY 231
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-35
Identities = 47/211 (22%), Positives = 81/211 (38%), Gaps = 31/211 (14%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRTYHINL--VRLY 87
++G+GG V++ A K + + + + EI + + + +RLY
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 88 GFCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLK-WEKLLDIAIGTARGIAYLHEE 141
+ +V E N L+ +L E W+ +L + +H+
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML-------EAVHTIHQ- 126
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
I+H D+KPAN L+ K+ DFG+A P+ T GT Y PE +
Sbjct: 127 --HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 202 ----------NYPITQKCDVYSFGMLLFEII 222
I+ K DV+S G +L+ +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMT 214
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 70/302 (23%), Positives = 118/302 (39%), Gaps = 71/302 (23%)
Query: 31 KLGAGGFGVVYKGQFPNG---VKIAAKILKTCLNKRVEAQFMAEI---GTIGRTYHINLV 84
+G G FG V K + + A K +K +K F E+ +G H N++
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNII 89
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYL---------------FTDTEVLKWEKLLDIAI 129
L G C + L E+ +G+L +L + L ++LL A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 130 GTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG 189
ARG+ YL + ++ IH D+ NIL+ + AK+ADFGL++ Y
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVK 197
Query: 190 TPG------YSAPEFLL-RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP-- 240
+ A E L Y T DV+S+G+LL+EI+ +L P
Sbjct: 198 KTMGRLPVRWMAIESLNYSVY--TTNSDVWSYGVLLWEIV------------SLGGTPYC 243
Query: 241 ----KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKM 296
+++++ +G K L C + + + C ++ P RP + ++
Sbjct: 244 GMTCAELYEKLPQGYRLEKPLNC---------DDEVYDLMRQCWREKPYERPSFAQILVS 294
Query: 297 LE 298
L
Sbjct: 295 LN 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 21/200 (10%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G FG + +G + K I + ++ + + E+ + H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-------FTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
+ +V ++ E G L K + F + ++L W + + ++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHD- 143
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
++I+H DIK NI L + ++ DFG+A++ N +T + GTP Y +PE +
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN--STVELARACIGTPYYLSPE-ICE 198
Query: 202 NYPITQKCDVYSFGMLLFEI 221
N P K D+++ G +L+E+
Sbjct: 199 NKPYNNKSDIWALGCVLYEL 218
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 47/213 (22%), Positives = 81/213 (38%), Gaps = 35/213 (16%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRTYHINL--VRLY 87
++G+GG V++ A K + + + + EI + + + +RLY
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 88 GFCYDQTKAALVYEFME--NGSLDKYL-----FTDTEVLK-WEKLLDIAIGTARGIAYLH 139
+ +Y ME N L+ +L E W+ +L + +H
Sbjct: 123 DYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNML-------EAVHTIH 172
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFL 199
+ I+H D+KPAN L+ K+ DFG+A P+ T G Y PE +
Sbjct: 173 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 200 LR----------NYPITQKCDVYSFGMLLFEII 222
I+ K DV+S G +L+ +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 62/202 (30%), Positives = 87/202 (43%), Gaps = 15/202 (7%)
Query: 28 YSTKLGAGGFGVVYKG-QFPNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVR 85
+ ++G G F VYKG V++A L+ L K +F E + H N+VR
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 86 LYGFCYDQTKAA----LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
Y K LV E M +G+L YL +V+K + L +G+ +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 142 CNQRIIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
IIH D+K NI + S K+ D GLA L GTP + APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYE 203
Query: 201 RNYPITQKCDVYSFGMLLFEII 222
Y + DVY+FGM + E+
Sbjct: 204 EKY--DESVDVYAFGMCMLEMA 223
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 47/220 (21%), Positives = 86/220 (39%), Gaps = 39/220 (17%)
Query: 31 KLGAGGFGVVYKGQFPNG------VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
+LG FG VYKG +A K LK + +F E R H N+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYL---------------FTDTEVLKWEKLLDIAI 129
L G ++++ + +G L ++L T L+ + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 130 GTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG 189
A G+ YL ++H D+ N+L+ K + K++D GL + + Y+
Sbjct: 136 QIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREV------YAADYYKL 186
Query: 190 TPG------YSAPE-FLLRNYPITQKCDVYSFGMLLFEII 222
+ APE + + + D++S+G++L+E+
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKF--SIDSDIWSYGVVLWEVF 224
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 67/306 (21%), Positives = 110/306 (35%), Gaps = 70/306 (22%)
Query: 31 KLGAGGFGVVYKGQ------FPNGVKIAAKILKTCLNKRVEAQFMAEIG---TIGRTYHI 81
LGAG FG V + + +A K+LK + M+E+ +G H+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HM 87
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYL-----------------FTDTEVLKWEKL 124
N+V L G C ++ E+ G L +L D L E L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 125 LDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184
L + A+G+A+L + IH D+ NILL K+ DFGLA+ ++ +
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 185 SG----YRGTPGYSAPEFLL-RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF 239
+ APE + Y T + DV+S+G+ L+E+ +L
Sbjct: 205 GNARLPVKWM----APESIFNCVY--TFESDVWSYGIFLWELF------------SLGSS 246
Query: 240 P-------KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSA 292
P + + ++G M + C P RP
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHA---------PAEMYDIMKTCWDADPLKRPTFKQ 297
Query: 293 VVKMLE 298
+V+++E
Sbjct: 298 IVQLIE 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
LG GGFGVV++ + + A K ++ + + M E+ + + H +VR +
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 90 CYDQT---------KAALVY---EFMENGSLDKYLFTDTEVLKWEK--LLDIAIGTARGI 135
++ +Y + +L ++ + + E+ L I + A +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST----------S 185
+LH + ++H D+KP+NI KV DFGL + + + +
Sbjct: 132 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
G GT Y +PE + + K D++S G++LFE++
Sbjct: 189 GQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELL 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-33
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNK-RVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG VY + + +A K+L K L K VE Q E+ H N++RLYG
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
+ +D T+ L+ E+ G++ + L F + + L A ++Y H
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHS--- 127
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY 203
+R+IH DIKP N+LL + K+ADFG + P + GT Y PE ++
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLC---GTLDYLPPE-MIEGR 182
Query: 204 PITQKCDVYSFGMLLFEII 222
+K D++S G+L +E +
Sbjct: 183 MHDEKVDLWSLGVLCYEFL 201
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 75/307 (24%), Positives = 122/307 (39%), Gaps = 73/307 (23%)
Query: 31 KLGAGGFGVVYKG--------QFPNGVKIAAKILKTCLNKRVEAQFMAEIG---TIGRTY 79
LG G FG V + V +A K+LK ++ + ++E+ IG+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-- 145
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYL---------------FTDTEVLKWEKL 124
H N++ L G C ++ E+ G+L +YL E + ++ L
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 125 LDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184
+ ARG+ YL Q+ IH D+ N+L+ K+ADFGLA+ N +
Sbjct: 206 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDIN------NI 256
Query: 185 SGYRGTPG------YSAPEFLL-RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD 237
Y+ T + APE L R Y T + DV+SFG+L++EI TL
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIF------------TLG 302
Query: 238 WFP------KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMS 291
P ++++ ++G K C + M+ C P RP
Sbjct: 303 GSPYPGIPVEELFKLLKEGHRMDKPANC---------TNELYMMMRDCWHAVPSQRPTFK 353
Query: 292 AVVKMLE 298
+V+ L+
Sbjct: 354 QLVEDLD 360
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 31 KLGAGGFG-VVYKGQFPNGVKIAAK-ILKTCLNK-RVEAQFMAEIGTIGRTYHINLVRLY 87
LG G G +VY+G F + +A K IL C + E Q + E H N++R +
Sbjct: 31 VLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADREVQLLRES-----DEHPNVIRYF 84
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
D+ + E +L +Y+ + + + T G+A+LH I+
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIV 140
Query: 148 HYDIKPANILL-----DAKFSAKVADFGLAKLCNPENTHDS-TSGYRGTPGYSAPEFLLR 201
H D+KP NIL+ K A ++DFGL K S SG GT G+ APE L
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 202 NY--PITQKCDVYSFGMLLFEI 221
+ T D++S G + + +
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYV 222
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-33
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 33/214 (15%)
Query: 31 KLGAGGFGVVYKGQFPNGVK------IAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
+LG G FG+VY+G VK +A K + + R +F+ E + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYL---------FTDTEVLKWEKLLDIAIGTARGI 135
RL G ++ E M G L YL K++ +A A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYS- 194
AYL+ + +H D+ N ++ F+ K+ DFG+ + T YR
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY------ETDYYRKGGKGLL 202
Query: 195 -----APEFLL-RNYPITQKCDVYSFGMLLFEII 222
+PE L + T DV+SFG++L+EI
Sbjct: 203 PVRWMSPESLKDGVF--TTYSDVWSFGVVLWEIA 234
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 23 SFTNNYST--KLGAGGFGVVYKGQ-FPNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRT 78
S +Y +G G +G K + +G + K + + + + ++E+ +
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 79 YHINLVRLYGFCYDQTKAAL--VYEFMENGSLDKYL---------FTDTEVLKWEKLLDI 127
H N+VR Y D+T L V E+ E G L + + VL+ + +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV--MTQL 120
Query: 128 AIGTARGIAYLHE--ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185
+ + H + ++H D+KPAN+ LD K + K+ DFGLA++ N +
Sbjct: 121 TLA----LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAK 174
Query: 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
+ GTP Y +PE + +K D++S G LL+E+
Sbjct: 175 TFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYEL 209
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 52/214 (24%), Positives = 80/214 (37%), Gaps = 34/214 (15%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
LG G V++G+ G A K+ R M E + + H N+V+L+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 90 CYDQTKAA--LVYEFMENGSLDKYL--------FTDTEVLKWEKLLDIAIGTARGIAYLH 139
+ T L+ EF GSL L ++E L L D+ G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI--VLRDVV----GGMNHLR 129
Query: 140 EECNQRIIHYDIKPANILL----DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSA 195
E I+H +IKP NI+ D + K+ DFG A+ + S GT Y
Sbjct: 130 E---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLH 183
Query: 196 PEFLLRNYPI-------TQKCDVYSFGMLLFEII 222
P+ R D++S G+ +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 33/214 (15%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG GGF V + +G A K + C ++ + E H N++RL +
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRIL-CHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 90 CYDQTKAA----LVYEFMENGSLDKYL---------FTDTEVLKWEKLLDIAIGTARGIA 136
C + A L+ F + G+L + T+ ++L +G RG+
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL------LLGICRGLE 148
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG-------YRG 189
+H + H D+KP NILL + + D G + R
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 190 TPGYSAPEF--LLRNYPITQKCDVYSFGMLLFEI 221
T Y APE + + I ++ DV+S G +L+ +
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 31 KLGAGGFGVVYKGQFPNG------VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
+LG G FG V+ + N + +A K LK F E + H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIV 80
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYL---------------FTDTEVLKWEKLLDIAI 129
+ YG C D +V+E+M++G L+K+L L ++L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 130 GTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG 189
A G+ YL Q +H D+ N L+ A K+ DFG+++ ST YR
Sbjct: 141 QIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY------STDYYRV 191
Query: 190 TPG------YSAPE-FLLRNYPITQKCDVYSFGMLLFEII 222
+ PE + R + T + DV+SFG++L+EI
Sbjct: 192 GGHTMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIF 229
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 33/225 (14%)
Query: 24 FTNNYST--KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH 80
+ +++ LG G FG V K + + A K ++ + + ++E+ + H
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNH 61
Query: 81 INLVRLYGFCYDQTKAA-------------LVYEFMENGSLDKYLFTDTEVLKWEKLLDI 127
+VR Y ++ + E+ ENG+L + ++ + ++ +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 128 AIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187
++Y+H Q IIH D+KP NI +D + K+ DFGLAK +
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 188 R------------GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFE 220
GT Y A E L +K D+YS G++ FE
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 2e-32
Identities = 65/210 (30%), Positives = 88/210 (41%), Gaps = 31/210 (14%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+LG GGFG V + G ++A K + L+ + ++ EI + + H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 90 CYDQTKAA------LVYEFMENGSLDKYL--------FTDTEVLKWEKLLDIAIGTARGI 135
K A L E+ E G L KYL + + L DI+ +
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT--LLSDIS----SAL 134
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSA---KVADFGLAKLCNPENTHDSTSGYRGTPG 192
YLHE RIIH D+KP NI+L K+ D G AK + + GT
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTLQ 188
Query: 193 YSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
Y APE LL T D +SFG L FE I
Sbjct: 189 YLAPE-LLEQKKYTVTVDYWSFGTLAFECI 217
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 65/214 (30%), Positives = 88/214 (41%), Gaps = 33/214 (15%)
Query: 31 KLGAGGFGVVYKGQFPNG------VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
LG G FG VY+GQ +++A K L +++ E F+ E I + H N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEKLLDIAIGTARGIAYL 138
R G ++ E M G L +L + L LL +A A G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 139 HEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPENTHDSTSGYR-GTPGYS 194
E IH DI N LL AK+ DFG+A+ S YR G
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY------RASYYRKGGCAML 207
Query: 195 -----APE-FLLRNYPITQKCDVYSFGMLLFEII 222
PE F+ + T K D +SFG+LL+EI
Sbjct: 208 PVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIF 239
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 69/294 (23%), Positives = 114/294 (38%), Gaps = 56/294 (19%)
Query: 31 KLGAGGFGVVYKGQFPNG----VKIAAKILKT-CLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G FG V +G +K+A K +K ++R +F++E + H N++R
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 86 LYGFCYDQTKAA-----LVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGI 135
L G C + + ++ FM+ G L YL T + + + LL + A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG----YRGTP 191
YL + +H D+ N +L + VADFGL+K + + +
Sbjct: 161 EYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI- 216
Query: 192 GYSAPEFLL-RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP------KQVW 244
A E L R Y T K DV++FG+ ++EI T P +++
Sbjct: 217 ---AIESLADRVY--TSKSDVWAFGVTMWEIA------------TRGMTPYPGVQNHEMY 259
Query: 245 DEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
D G + C + + + C + P RP S + LE
Sbjct: 260 DYLLHGHRLKQPEDC---------LDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-32
Identities = 64/263 (24%), Positives = 125/263 (47%), Gaps = 12/263 (4%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+LGAG GVV+K P+G+ +A K++ + + Q + E+ + +V YG
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
Y + ++ E M+ GSLD+ + + + L ++I +G+ YL E+ I+H
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHR 156
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D+KP+NIL++++ K+ DFG++ ++ ++ + GT Y +PE L+ + +
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPE-RLQGTHYSVQS 211
Query: 210 DVYSFGMLLFEI-IGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268
D++S G+ L E+ +GR + + F QV + + + G + + +
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271
Query: 269 AERMSMVALWC--VQDCPEARPP 289
M++ L V + P P
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPS 294
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 48/233 (20%), Positives = 95/233 (40%), Gaps = 44/233 (18%)
Query: 24 FTNNYST--KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH 80
F ++ +G+GGFG V+K + +G K +K N + E+ + + H
Sbjct: 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--YNNE---KAEREVKALAKLDH 63
Query: 81 INLVRLYGFCYDQTKAA----------------LVYEFMENGSLDKYL-------FTDTE 117
+N+V G + EF + G+L++++
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 118 VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177
L+ +G+ Y+H +++I+ D+KP+NI L K+ DFGL
Sbjct: 124 ALEL------FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQD 230
+ + +GT Y +PE + + ++ D+Y+ G++L E++ A +
Sbjct: 175 DGKRTRS---KGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCDTAFE 223
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 24/202 (11%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKI--LKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
K+G G F VY+ +GV +A K + ++ + A + EI + + H N+++ Y
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 88 GFCYDQTKAALVYEFMENGSLDKYL---------FTDTEVLKWEKLLDIAIGTARGIAYL 138
+ + +V E + G L + + + V K+ + + ++
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY------FVQLCSALEHM 152
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEF 198
H +R++H DIKPAN+ + A K+ D GL + + + T + GTP Y +PE
Sbjct: 153 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE- 206
Query: 199 LLRNYPITQKCDVYSFGMLLFE 220
+ K D++S G LL+E
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYE 228
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 75/307 (24%), Positives = 121/307 (39%), Gaps = 73/307 (23%)
Query: 31 KLGAGGFGVVYKG--------QFPNGVKIAAKILKTCLNKRVEAQFMAEIG---TIGRTY 79
LG G FG V + V +A K+LK ++ + ++E+ IG+
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-- 99
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYL---------------FTDTEVLKWEKL 124
H N++ L G C ++ E+ G+L +YL E + ++ L
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 125 LDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184
+ ARG+ YL Q+ IH D+ N+L+ K+ADFGLA+ N +
Sbjct: 160 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY---- 212
Query: 185 SGYRGTPGYS------APEFLL-RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD 237
Y+ T APE L R Y T + DV+SFG+L++EI TL
Sbjct: 213 --YKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIF------------TLG 256
Query: 238 WFP------KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMS 291
P ++++ ++G K C + M+ C P RP
Sbjct: 257 GSPYPGIPVEELFKLLKEGHRMDKPANC---------TNELYMMMRDCWHAVPSQRPTFK 307
Query: 292 AVVKMLE 298
+V+ L+
Sbjct: 308 QLVEDLD 314
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-32
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 42/221 (19%)
Query: 31 KLGAGGFGVVYKG------QFPNGVKIAAKILKTCLNKRVEAQFMAEIG---TIGRTYHI 81
LGAG FG V + + +K+A K+LK+ + + M+E+ +G+ H
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ--HE 110
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYL-------------FTDTEVLKWEKLLDIA 128
N+V L G C ++ E+ G L +L LL +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 129 IGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188
A+G+A+L + IH D+ N+LL AK+ DFGLA+ + S Y
Sbjct: 171 SQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM------NDSNYI 221
Query: 189 GTPG------YSAPEFLL-RNYPITQKCDVYSFGMLLFEII 222
+ APE + Y T + DV+S+G+LL+EI
Sbjct: 222 VKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIF 260
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 52/214 (24%), Positives = 80/214 (37%), Gaps = 34/214 (15%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
LG G V++G+ G A K+ R M E + + H N+V+L+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 90 CYDQTKAA--LVYEFMENGSLDKYL--------FTDTEVLKWEKLLDIAIGTARGIAYLH 139
+ T L+ EF GSL L ++E L L D+ G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI--VLRDVV----GGMNHLR 129
Query: 140 EECNQRIIHYDIKPANILL----DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSA 195
E I+H +IKP NI+ D + K+ DFG A+ + S GT Y
Sbjct: 130 E---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLH 183
Query: 196 PEFLLRNYPI-------TQKCDVYSFGMLLFEII 222
P+ R D++S G+ +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 53/198 (26%), Positives = 78/198 (39%), Gaps = 22/198 (11%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNK-RVEAQFMAEIGTIGRTYHINLVRLYG 88
LG GGF ++ A KI+ K+ L K + EI H ++V +G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
F D +V E SL + T+ E G YLH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY------YLRQIVLGCQYLH---R 133
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN- 202
R+IH D+K N+ L+ K+ DFGLA + GTP Y APE L +
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSKKG 191
Query: 203 YPITQKCDVYSFGMLLFE 220
+ + + DV+S G +++
Sbjct: 192 H--SFEVDVWSIGCIMYT 207
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 53/200 (26%), Positives = 80/200 (40%), Gaps = 22/200 (11%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNK-RVEAQFMAEIGTIGRTYHINLVRLYG 88
LG GGF ++ A KI+ K+ L K + EI H ++V +G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
F D +V E SL + T+ E G YLH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY------YLRQIVLGCQYLH---R 159
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN- 202
R+IH D+K N+ L+ K+ DFGLA + GTP Y APE L +
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSKKG 217
Query: 203 YPITQKCDVYSFGMLLFEII 222
+ + + DV+S G +++ ++
Sbjct: 218 H--SFEVDVWSIGCIMYTLL 235
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 45/267 (16%), Positives = 86/267 (32%), Gaps = 36/267 (13%)
Query: 31 KLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQF---MAEIGTIGRTYHI 81
LG G F VY+ N K K+ K +F + + +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK----PANPWEFYIGTQLMERLKPSMQH 127
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSL----DKYLFTDTEVLKWEKLLDIAIGTARGIAY 137
++ Y Q + LV E G+L + Y T +V+ ++ A+ I
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 138 LHEECNQRIIHYDIKPANILL-----------DAKFSAKVADFGLAKLCNPENTHDSTSG 186
+H+ IIH DIKP N +L D + D G + +
Sbjct: 188 VHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDE 246
T G+ E +L N P + D + ++ ++ ++ + P+ ++
Sbjct: 245 KCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCML--FGTYMKVKNEGGECKPEGLFRR 301
Query: 247 YEKGELAAKVLGC--GIEENDREEAER 271
++ + I + +
Sbjct: 302 LPHLDMWNEFFHVMLNIPDCHHLPSLD 328
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 24/205 (11%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLY 87
+LG G +G V+K + ++ A + + + A+ +AE+G+ + H VRL
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 88 GFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
+ L E SL ++ + +V + L D +A+LH
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGY--LRDTL----LALAHLHS- 175
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
Q ++H D+KPANI L + K+ DFGL + G P Y APE L
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQG 230
Query: 202 NYPITQKCDVYSFGMLLFEIIGRRK 226
+Y DV+S G+ + E+ +
Sbjct: 231 SY--GTAADVFSLGLTILEVACNME 253
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 76/307 (24%), Positives = 122/307 (39%), Gaps = 73/307 (23%)
Query: 31 KLGAGGFGVVYKGQFPN--------GVKIAAKILKTCLNKRVEAQFMAEIG---TIGRTY 79
LG G FG V + K+A K+LK+ ++ + ++E+ IG+
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-- 133
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYL---------------FTDTEVLKWEKL 124
H N++ L G C ++ E+ G+L +YL E L + L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 125 LDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184
+ A ARG+ YL ++ IH D+ N+L+ K+ADFGLA+ +
Sbjct: 194 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH------HI 244
Query: 185 SGYRGTPG------YSAPEFLL-RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD 237
Y+ T + APE L R Y T + DV+SFG+LL+EI TL
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIF------------TLG 290
Query: 238 WFP------KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMS 291
P ++++ ++G K C + M+ C P RP
Sbjct: 291 GSPYPGVPVEELFKLLKEGHRMDKPSNC---------TNELYMMMRDCWHAVPSQRPTFK 341
Query: 292 AVVKMLE 298
+V+ L+
Sbjct: 342 QLVEDLD 348
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 23/199 (11%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNK-RVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G F VY+ + G+++A K++ K + K + + E+ + H +++ LY
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 89 FCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEKLLDIAIGTARGIAYLHEEC 142
+ D LV E NG +++YL F++ E + + G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYLHS-- 130
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
I+H D+ +N+LL + K+ADFGLA + T GTP Y +PE R+
Sbjct: 131 -HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEIATRS 187
Query: 203 -YPITQKCDVYSFGMLLFE 220
+ + DV+S G + +
Sbjct: 188 AH--GLESDVWSLGCMFYT 204
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 74/307 (24%), Positives = 110/307 (35%), Gaps = 73/307 (23%)
Query: 31 KLGAGGFGVVYKGQFPN------GVKIAAKILKTCLNKRVEAQFMAEIG---TIGRTYHI 81
LG G FG V + +A K+LK M+E+ IG H+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HL 91
Query: 82 NLVRLYGFCYDQTK-AALVYEFMENGSLDKYL---------------FTDTEVLKWEKLL 125
N+V L G C ++ EF + G+L YL + L E L+
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 126 DIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185
+ A+G+ +L ++ IH D+ NILL K K+ DFGLA+ +
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----- 203
Query: 186 GYRGTPG------YSAPEFLL-RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW 238
Y + APE + R Y T + DV+SFG+LL+EI +L
Sbjct: 204 -YVRKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIF------------SLGA 248
Query: 239 FP-------KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMS 291
P ++ ++G M L C P RP S
Sbjct: 249 SPYPGVKIDEEFCRRLKEGTRMRAPDYT---------TPEMYQTMLDCWHGEPSQRPTFS 299
Query: 292 AVVKMLE 298
+V+ L
Sbjct: 300 ELVEHLG 306
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 39/219 (17%)
Query: 31 KLGAGGFGVVYKGQFPNGVK------IAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
+LG G FG V+ + N + +A K LK ++ F E + H ++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIV 106
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYL--------------FTDTEVLKWEKLLDIAIG 130
R +G C + +V+E+M +G L+++L L +LL +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 131 TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR-G 189
A G+ YL +H D+ N L+ K+ DFG+++ + YR G
Sbjct: 167 VAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY------YRVG 217
Query: 190 TPG-----YSAPE-FLLRNYPITQKCDVYSFGMLLFEII 222
+ PE L R + T + DV+SFG++L+EI
Sbjct: 218 GRTMLPIRWMPPESILYRKF--TTESDVWSFGVVLWEIF 254
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 62/197 (31%), Positives = 92/197 (46%), Gaps = 22/197 (11%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNK-RVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG VY + N +A K+L K+ L K VE Q EI H N++R+Y
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
+ +D+ + L+ EF G L K L F + + + L A + Y HE
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL------ADALHYCHE--- 132
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY 203
+++IH DIKP N+L+ K K+ADFG + T GT Y PE ++
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--TMC--GTLDYLPPE-MIEGK 187
Query: 204 PITQKCDVYSFGMLLFE 220
+K D++ G+L +E
Sbjct: 188 THDEKVDLWCAGVLCYE 204
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 62/295 (21%), Positives = 107/295 (36%), Gaps = 57/295 (19%)
Query: 31 KLGAGGFGVVYKGQFPNG----VKIAAKILKT-CLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G FG V + Q VK+A K+LK + +F+ E + H ++ +
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 86 LYGFCYDQTKAA------LVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTARG 134
L G ++ FM++G L +L + L + L+ + A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG----YRGT 190
+ YL + IH D+ N +L + VADFGL++ + + +
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 191 PGYSAPEFLL-RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP------KQV 243
A E L Y T DV++FG+ ++EI+ T P ++
Sbjct: 207 ----ALESLADNLY--TVHSDVWAFGVTMWEIM------------TRGQTPYAGIENAEI 248
Query: 244 WDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
++ G + C E + + C P+ RP + + LE
Sbjct: 249 YNYLIGGNRLKQPPEC---------MEEVYDLMYQCWSADPKQRPSFTCLRMELE 294
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-31
Identities = 64/214 (29%), Positives = 89/214 (41%), Gaps = 33/214 (15%)
Query: 31 KLGAGGFGVVYKGQFPNG------VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
LG G FG VY+GQ +++A K L +++ E F+ E I + H N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEKLLDIAIGTARGIAYL 138
R G ++ E M G L +L + L LL +A A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 139 HEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPENTHDSTSGYR-GTPGYS 194
E IH DI N LL AK+ DFG+A+ + + YR G
Sbjct: 198 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYR-AGYYRKGGCAML 248
Query: 195 -----APE-FLLRNYPITQKCDVYSFGMLLFEII 222
PE F+ + T K D +SFG+LL+EI
Sbjct: 249 PVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIF 280
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-31
Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 51/230 (22%)
Query: 31 KLGAGGFGVVYKGQ------FPNGVKIAAKILKTCLNKRVEAQFMAEIG---TIGRTYHI 81
LG+G FG V +++A K+LK + M+E+ +G H
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HE 109
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYL----------------------FTDTEVL 119
N+V L G C L++E+ G L YL D VL
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 120 KWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179
+E LL A A+G+ +L + +H D+ N+L+ K+ DFGLA+ ++
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 180 THDSTSGYRGTPG------YSAPEFLL-RNYPITQKCDVYSFGMLLFEII 222
Y + APE L Y T K DV+S+G+LL+EI
Sbjct: 227 N------YVVRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIF 268
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 51/233 (21%), Positives = 90/233 (38%), Gaps = 40/233 (17%)
Query: 23 SFTNNYSTK--LGAGGFGVVYKGQFPNGVKIAAK-ILKTCLNK-RVEAQFMAEIGTIGRT 78
S N ++ LG G G V G +A K +L + +E + + E
Sbjct: 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-----D 66
Query: 79 YHINLVRLYGFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEKLLDIAIGTA 132
H N++R Y + E +L + + ++ K + + A
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 133 RGIAYLHEECNQRIIHYDIKPANILLDAK-------------FSAKVADFGLAKLCNPEN 179
G+A+LH +IIH D+KP NIL+ ++DFGL K +
Sbjct: 126 SGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 180 T--HDSTSGYRGTPGYSAPEFLLRNY------PITQKCDVYSFGMLLFEIIGR 224
+ + + GT G+ APE L + +T+ D++S G + + I+ +
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 54/196 (27%), Positives = 82/196 (41%), Gaps = 25/196 (12%)
Query: 32 LGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
LG G +G+VY G N V+IA K + ++ + EI H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGSF 88
Query: 91 YDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEKLLDIAIGTA---RGIAYLHEE 141
+ + E + GSL L D E I T G+ YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-------IGFYTKQILEGLKYLHD- 140
Query: 142 CNQRIIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
+I+H DIK N+L++ K++DFG +K N T + GT Y APE +
Sbjct: 141 --NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIID 196
Query: 201 RNYP-ITQKCDVYSFG 215
+ + D++S G
Sbjct: 197 KGPRGYGKAADIWSLG 212
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYG 88
+LG G +GVV K + P+G +A K ++ +N + + + + ++ RT V YG
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLD------IAIGTARGIAYLHEEC 142
+ + + E M + SLDK+ +V+ + + IA+ + + +LH +
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSK- 128
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYRGTPGYSAPE---F 198
+IH D+KP+N+L++A K+ DFG+ L + G Y APE
Sbjct: 129 -LSVIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDI-DAGCKPYMAPERINP 183
Query: 199 LLRNYPITQKCDVYSFGMLLFEI-IGR 224
L + K D++S G+ + E+ I R
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 52/215 (24%), Positives = 83/215 (38%), Gaps = 33/215 (15%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKIL-KTCLNKR---------------VEAQFMAEIGT 74
L G F + + + A K K+ L K+ F E+
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 75 IGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR- 133
I + + G + + ++YE+MEN S+ K+ VL I I +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCFIPIQVIKC 155
Query: 134 -------GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186
+Y+H E N I H D+KP+NIL+D K++DFG ++ + S
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 187 YRGTPGYSAPEFLLRNYPI-TQKCDVYSFGMLLFE 220
RGT + PEF K D++S G+ L+
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 23/229 (10%)
Query: 7 DIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVE 65
I+ E+ FT E L ++G G +G V K P+G +A K +++ ++++ +
Sbjct: 10 KISPEQHWDFTAEDLKDLG-----EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64
Query: 66 AQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKW--- 121
Q + ++ + R+ +V+ YG + + + E M + S DK+ VL
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIP 123
Query: 122 EKLL-DIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL-AKLCNPEN 179
E++L I + T + + +L E +IIH DIKP+NILLD + K+ DFG+ +L +
Sbjct: 124 EEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL---VD 178
Query: 180 THDSTSGYRGTPGYSAPE---FLLRNYPITQKCDVYSFGMLLFEI-IGR 224
+ T G Y APE + DV+S G+ L+E+ GR
Sbjct: 179 SIAKTR-DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 28/201 (13%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
++G G FG V++ + G + A K + R+E + E+ +V LYG
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 90 CYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEK-LLDIAIGTARGIAYLHEECN 143
+ + E +E GSL + + + L + L G+ YLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-------EGLEYLHT--- 168
Query: 144 QRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPENTHDSTSGY---RGTPGYSAPEFL 199
+RI+H D+K N+LL + A + DFG A P+ S GT + APE +
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-V 227
Query: 200 LRNYPITQKCDVYSFGMLLFE 220
+ P K D++S ++
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLH 248
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 72/310 (23%), Positives = 121/310 (39%), Gaps = 74/310 (23%)
Query: 31 KLGAGGFGVVYKGQ------FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
LG G FG V K +A K+LK + ++E + + H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYL-----------------------FTDTEVLKW 121
+LYG C L+ E+ + GSL +L D L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 122 EKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181
L+ A ++G+ YL E +++H D+ NIL+ K++DFGL++ E++
Sbjct: 150 GDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS- 205
Query: 182 DSTSGYRGTPG------YSAPEFLL-RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSD 234
Y + A E L Y T + DV+SFG+LL+EI+
Sbjct: 206 -----YVKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIV------------ 246
Query: 235 TLDWFP------KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARP 288
TL P +++++ + G + C +E M + L C + P+ RP
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGHRMERPDNC---------SEEMYRLMLQCWKQEPDKRP 297
Query: 289 PMSAVVKMLE 298
+ + K LE
Sbjct: 298 VFADISKDLE 307
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 12 KPVRFTLEQLCSFTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAK-ILKTCLNKRVEAQ 67
P F + + Y KLG+G +G V + V+ A K I KT ++ ++
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 68 FMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWE 122
+ E+ + H N+++LY F D+ LV E + G L + F + +
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA--- 139
Query: 123 KLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPEN 179
I G+ YLH+ I+H D+KP N+LL++K K+ DFGL+ + +
Sbjct: 140 ---VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193
Query: 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
GT Y APE L + Y +KCDV+S G++LF
Sbjct: 194 KMKERL---GTAYYIAPEVLRKKY--DEKCDVWSIGVILF 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNK--------RVEAQFMAEIGTIGRTYHI 81
KLG GG VY + +K+A K + + E +++ H
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS------HQ 71
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
N+V + + LV E++E +L +Y+ L + ++ GI + H+
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHD- 129
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
RI+H DIKP NIL+D+ + K+ DFG+AK + E + T+ GT Y +PE +
Sbjct: 130 --MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPE-QAK 185
Query: 202 NYPITQKCDVYSFGMLLFEII-GRR 225
+ D+YS G++L+E++ G
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEP 210
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 48/226 (21%), Positives = 78/226 (34%), Gaps = 46/226 (20%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLY 87
K+G+G FG V+K +G A K K E + E+ H ++VR +
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 88 GFCYDQTKAALVYEFMENGSLDKYL---------FTDTEVLKWEKLLDIAIGTARGIAYL 138
+ + E+ GSL + F + E+ LL + RG+ Y+
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL--LLQVG----RGLRYI 131
Query: 139 HEECNQRIIHYDIKPANILLD-------------------AKFSAKVADFGLAKLCNPEN 179
H ++H DIKP+NI + K K+ D G +
Sbjct: 132 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
G + A E L NY K D+++ + + G
Sbjct: 189 V------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 14/198 (7%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYG 88
++G+G G V+K +F G IA K ++ NK + + ++ + ++ +V+ +G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
T + E M +K + L + + + + YL E+ +IH
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIH 148
Query: 149 YDIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYRGTPGYSAPE----FLLRNY 203
D+KP+NILLD + K+ DFG+ +L + G Y APE
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDR-SAGCAAYMAPERIDPPDPTKP 204
Query: 204 PITQKCDVYSFGMLLFEI 221
+ DV+S G+ L E+
Sbjct: 205 DYDIRADVWSLGISLVEL 222
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 33/233 (14%)
Query: 2 EKFLRDIAREKPVRFTLEQLCSFTNNYST--KLGAGGFGVVYKG-QFPNGVKIAAKILKT 58
+KF DI ++ + + S + Y +LG+G FGVV++ + G AK + T
Sbjct: 27 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86
Query: 59 CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL------DKYL 112
EI + + +H L+ L+ D+ + L+ EF+ G L + Y
Sbjct: 87 PYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 145
Query: 113 FTDTEVLKWEKLLDIAIGTAR----GIAYLHEECNQRIIHYDIKPANILLDAKFSA--KV 166
++ E I R G+ ++HE I+H DIKP NI+ + K ++ K+
Sbjct: 146 MSEAE----------VINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKI 192
Query: 167 ADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
DFGLA NP+ T+ T ++APE + R P+ D+++ G+L +
Sbjct: 193 IDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDRE-PVGFYTDMWAIGVLGY 241
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 61/228 (26%), Positives = 98/228 (42%), Gaps = 27/228 (11%)
Query: 5 LRDIAREKPVRFTLEQLCSFTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAKILKT--C 59
+ D P F F++ Y LG G FG V + G + A K++
Sbjct: 5 MMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV 64
Query: 60 LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFT 114
K + + E+ + + H N+++LY F D+ LV E G L + F+
Sbjct: 65 KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS 124
Query: 115 DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGL 171
+ + I GI Y+H+ +I+H D+KP N+LL++K + ++ DFGL
Sbjct: 125 EVDAA------RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175
Query: 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
+ GT Y APE L Y +KCDV+S G++L+
Sbjct: 176 STHFEASKKMKDKI---GTAYYIAPEVLHGTY--DEKCDVWSTGVILY 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 37/220 (16%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR-TYHINLVRLYG 88
L GGF VY+ Q +G + A K L + + E+ + + + H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLL-SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 89 FCYD-----QTKAALVYEFME--NGSLDKYL--------FTDTEVLKWEKLLDIAIGTAR 133
T A E G L ++L + VLK I T R
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK------IFYQTCR 147
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR----- 188
+ ++H IIH D+K N+LL + + K+ DFG A + + ++ R
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 189 -----GTPGYSAPEF--LLRNYPITQKCDVYSFGMLLFEI 221
TP Y PE L N+PI +K D+++ G +L+ +
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 47/228 (20%)
Query: 31 KLGAGGFGVVYKGQFPNGVK------IAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
+G G FG V++ + P + +A K+LK + ++A F E + + N+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYL-----------------------FTDTEVLKW 121
+L G C L++E+M G L+++L L
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 122 EKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181
+ L IA A G+AYL E ++ +H D+ N L+ K+ADFGL++
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIY----- 225
Query: 182 DSTSGYRGTPGYS------APE-FLLRNYPITQKCDVYSFGMLLFEII 222
S Y+ + PE Y T + DV+++G++L+EI
Sbjct: 226 -SADYYKADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIF 270
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 28/256 (10%), Positives = 57/256 (22%), Gaps = 53/256 (20%)
Query: 2 EKFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKG-QFPNGVKIAAKIL--KT 58
E + + + + L + L G VV+ A K+
Sbjct: 50 ETTVDSLLSQGERKLKLVEP----------LRVGDRSVVFLVRDVERLEDFALKVFTMGA 99
Query: 59 CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC--------------------------YD 92
++ + R + Y
Sbjct: 100 ENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYA 159
Query: 93 QTKAALVYEFM-----ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
L+ S +++ L + R A L + ++
Sbjct: 160 VANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV 216
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFL-LRNYPIT 206
H P N+ + + D T S Y+ EFL T
Sbjct: 217 HGHFTPDNLFIMPDGRLMLGDVSALW---KVGTRGPASS--VPVTYAPREFLNASTATFT 271
Query: 207 QKCDVYSFGMLLFEII 222
+ + G+ ++ +
Sbjct: 272 HALNAWQLGLSIYRVW 287
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 26/222 (11%)
Query: 10 REKPVRFTLEQLCSFTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAK-ILKTCLNKRVE 65
R L +F Y+ LG G FG V K + + A K I K +
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 66 AQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLK 120
+ + E+ + + H N+++L+ D + +V E G L + F++ +
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA- 124
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNP 177
I GI Y+H+ I+H D+KP NILL++K K+ DFGL+
Sbjct: 125 -----RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
GT Y APE L Y +KCDV+S G++L+
Sbjct: 177 NTKMKDRI---GTAYYIAPEVLRGTY--DEKCDVWSAGVILY 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 23 SFTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRT 78
+F Y+ LG G FG V K + + A K I K + + + E+ + +
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 79 YHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDIAIGTAR 133
H N+++L+ D + +V E G L + F++ + I
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------RIIKQVFS 132
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPENTHDSTSGYRGT 190
GI Y+H+ I+H D+KP NILL++K K+ DFGL+ G T
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG---T 186
Query: 191 PGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
Y APE L Y +KCDV+S G++L+
Sbjct: 187 AYYIAPEVLRGTY--DEKCDVWSAGVILY 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 39/227 (17%)
Query: 13 PVRFTLEQLCSFTNNYS----TKLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQ 67
R + + + Y+ LG G FG V+K + G+K+AAKI+KT K E +
Sbjct: 74 DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-E 132
Query: 68 FMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL------DKYLFTDTEVLKW 121
EI + + H NL++LY + LV E+++ G L + Y T+ +
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---- 188
Query: 122 EKLLDIAIGTAR----GIAYLHEECNQRIIHYDIKPANILLDAKFSA--KVADFGLAKLC 175
I + GI ++H+ I+H D+KP NIL + + K+ DFGLA+
Sbjct: 189 ------TILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 176 NPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFG----MLL 218
P GTP + APE + ++ ++ D++S G MLL
Sbjct: 240 KPREKLKVNF---GTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLL 282
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 45/199 (22%), Positives = 74/199 (37%), Gaps = 10/199 (5%)
Query: 31 KLGAGGFGVVYKGQFPN-GVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLY 87
+G GG G VY+ + +A K++ L + + E T GR ++V ++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
F + + + L L L + + I + H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHA---AGAT 156
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
H D+KP NIL+ A A + DFG+A + GT Y APE T
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPE-RFSESHATY 214
Query: 208 KCDVYSFGMLLFEII-GRR 225
+ D+Y+ +L+E + G
Sbjct: 215 RADIYALTCVLYECLTGSP 233
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 37/231 (16%)
Query: 12 KPVRFTLEQLCSFTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAKILK----------- 57
P + ++ +Y KLG+G +G V + + A K++K
Sbjct: 22 NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81
Query: 58 -TCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKY 111
++ + EI + H N+++L+ D+ LV EF E G L +++
Sbjct: 82 DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH 141
Query: 112 LFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVAD 168
F + + +I GI YLH+ I+H DIKP NILL+ K + K+ D
Sbjct: 142 KFDECDAA------NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVD 192
Query: 169 FGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
FGL+ + + GT Y APE L + Y +KCDV+S G++++
Sbjct: 193 FGLSSFFSKDYKLRDRL---GTAYYIAPEVLKKKY--NEKCDVWSCGVIMY 238
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNK--------RVEAQFMAEIGTIGRTYHI 81
LG GG V+ + + +A K+L+ L + R EAQ A + H
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN------HP 72
Query: 82 NLVRLYGFCYDQTKAA----LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAY 137
+V +Y +T A +V E+++ +L + + ++ +++ + + +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNF 131
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK-LCNPENTHDSTSGYRGTPGYSAP 196
H+ IIH D+KPANI++ A + KV DFG+A+ + + N+ T+ GT Y +P
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 197 EFLLRNYPITQKCDVYSFGMLLFEII-GRR 225
E R + + DVYS G +L+E++ G
Sbjct: 189 E-QARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 33/233 (14%)
Query: 2 EKFLRDIAREKPVRFTLEQLCSFTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAKILKT 58
+ ++ DI ++ + + ++Y +LG G FGVV++ G AAK + T
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 59 CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL------DKYL 112
E EI T+ H LV L+ D + ++YEFM G L +
Sbjct: 193 PHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251
Query: 113 FTDTEVLKWEKLLDIAIGTAR----GIAYLHEECNQRIIHYDIKPANILLDAKFSA--KV 166
++ E A+ R G+ ++HE +H D+KP NI+ K S K+
Sbjct: 252 MSEDE----------AVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKL 298
Query: 167 ADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
DFGL +P S GT ++APE + P+ D++S G+L +
Sbjct: 299 IDFGLTAHLDP---KQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSY 347
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 33/222 (14%)
Query: 16 FTLEQLCSFTNNY---STKLGAGGFGVVYKG-QFPNGVKIAAK-ILKTCLNKRVEAQFMA 70
+ + +F N Y S +LG G F VV + G + AAK + K + A+ +
Sbjct: 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH 77
Query: 71 EIGTIGRTYHI-NLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKL 124
EI + ++ L+ + ++ L+ E+ G + + +E
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE------- 130
Query: 125 LDIAIGTAR----GIAYLHEECNQRIIHYDIKPANILLDAKFSA---KVADFGLAKLCNP 177
+ I + G+ YLH+ I+H D+KP NILL + + K+ DFG+++
Sbjct: 131 -NDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186
Query: 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
GTP Y APE L + PIT D+++ G++ +
Sbjct: 187 ACELREIM---GTPEYLAPEILNYD-PITTATDMWNIGIIAY 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 48/208 (23%), Positives = 85/208 (40%), Gaps = 34/208 (16%)
Query: 31 KLGAGGFGVVYKG--QFPNGVKIAAKILKTCLNK------RVEAQFMAEIGTIGRTYHIN 82
+ GG G +Y + NG + K L + E QF+AE+ H +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV------HPS 140
Query: 83 LVRLYGFCYDQTKAA-----LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAY 137
+V+++ F + +V E++ SL + + L + + + ++Y
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSY 197
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE 197
LH +++ D+KP NI+L + K+ D G +S GTPG+ APE
Sbjct: 198 LHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPE 247
Query: 198 FLLRNYPITQKCDVYSFGMLLFEIIGRR 225
++R P T D+Y+ G L +
Sbjct: 248 -IVRTGP-TVATDIYTVGRTLAALTLDL 273
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 42/211 (19%), Positives = 80/211 (37%), Gaps = 34/211 (16%)
Query: 24 FTNNYST--KLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH 80
Y LG G FG+V++ + + AK +K + EI + H
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARH 60
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSL------DKYLFTDTEVLKWEKLLDIAIGTAR- 133
N++ L+ + +++EF+ + + + E +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE----------IVSYVHQ 110
Query: 134 ---GIAYLHEECNQRIIHYDIKPANILLDAKFSA--KVADFGLAKLCNPENTHDSTSGYR 188
+ +LH I H+DI+P NI+ + S+ K+ +FG A+ P +
Sbjct: 111 VCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--- 164
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
P Y APE + ++ D++S G L++
Sbjct: 165 TAPEYYAPEVHQHD-VVSTATDMWSLGTLVY 194
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 23 SFTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY 79
+ + + KLG+G FG V+ + +G++ K + ++ Q AEI +
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKW--EKLLDIAIGTAR---- 133
H N+++++ D +V E E G L + + + K E +
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG---YVAELMKQMMN 135
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSA---KVADFGLAKLCNPENTHDSTSGYRGT 190
+AY H Q ++H D+KP NIL K+ DFGLA+L + + + GT
Sbjct: 136 ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GT 189
Query: 191 PGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
Y APE R+ T KCD++S G++++
Sbjct: 190 ALYMAPEVFKRDV--TFKCDIWSAGVVMY 216
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKI--LKTCLNK----RVEAQFMAEIGTIGRTYHINL 83
+G+G VV P K+A K L+ C E Q M++ H N+
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH------HPNI 75
Query: 84 VRLYGFCYDQTKAALVYEFMENGSL-DKYLFTDTEVLKWEKLLD---IAI---GTARGIA 136
V Y + + LV + + GS+ D + +LD IA G+
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYR----GTP 191
YLH IH D+K NILL S ++ADFG+ A L + + R GTP
Sbjct: 136 YLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV--RKTFVGTP 190
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
+ APE + + K D++SFG+ E+
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 38/218 (17%)
Query: 23 SFTNNYST--KLGAGGFGVVYKG-QFPNGVKIAAKI-----LKTCLNKRVEAQFMAEIGT 74
++Y +LG+G F +V K Q G + AAK L + + E+
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 75 IGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDIAI 129
+ H N++ L+ ++T L+ E + G L +K T+ E A
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE----------AT 111
Query: 130 GTAR----GIAYLHEECNQRIIHYDIKPANILLDAKFSA----KVADFGLAKLCNPENTH 181
+ G+ YLH +RI H+D+KP NI+L K K+ DFG+A N
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
+ GTP + APE + P+ + D++S G++ +
Sbjct: 169 KNIF---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 202
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 26/208 (12%)
Query: 23 SFTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY 79
Y+ +G G +G V ++ AAK + + V+ F EI +
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLD 64
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDIAIGTARG 134
H N++RLY D T LV E G L K +F +++ I
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA------RIMKDVLSA 118
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPENTHDSTSGYRGTP 191
+AY H+ + H D+KP N L K+ DFGLA P + G TP
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG---TP 172
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLF 219
Y +P+ L Y +CD +S G++++
Sbjct: 173 YYVSPQVLEGLY--GPECDEWSAGVMMY 198
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 62/270 (22%), Positives = 90/270 (33%), Gaps = 54/270 (20%)
Query: 1 MEKFLRDIAREKPVRFTLEQLCSFTNNYST--KLGAGGFGVVYKG-QFPNGVKIAAKILK 57
M + + + F L Y +G G +GVV + A KI+
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 58 T----CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLF 113
+N + + E+ + + +H N+ RLY D+ LV E G L L
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 114 TDTEVLKWEKLLDIAIGTAR---------------------------------------G 134
+ + +D+
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSA--KVADFGLAKLCNPENTHDST--SGYRGT 190
+ YLH Q I H DIKP N L S K+ DFGL+K N + + GT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 191 PGYSAPEFL-LRNYPITQKCDVYSFGMLLF 219
P + APE L N KCD +S G+LL
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 11 EKPVRFTLEQLCSFTN---NYS--TKLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRV 64
++ + L + S + Y+ K+G G G VY G ++A + + +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 65 EAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKL 124
E + EI + + N+V + +V E++ GSL T+V+ +
Sbjct: 62 E-LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-------TDVVTETCM 113
Query: 125 LDIAIG-----TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179
+ I + + +LH + ++IH DIK NILL S K+ DFG PE
Sbjct: 114 DEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
+ ST GTP + APE + R K D++S G++ E+I
Sbjct: 171 SKRST--MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMI 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 23 SFTNNYST--KLGAGGFGVVYKG-QFPNGVKIAAKI-----LKTCLNKRVEAQFMAEIGT 74
+ Y +LG+G F +V K + G++ AAK + + E+
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 75 IGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDIAI 129
+ + H N++ L+ ++T L+ E + G L K ++ E A
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE----------AT 118
Query: 130 GTAR----GIAYLHEECNQRIIHYDIKPANILLDAKFSA----KVADFGLAKLCNPENTH 181
+ G+ YLH ++I H+D+KP NI+L K K+ DFGLA
Sbjct: 119 SFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
+ GTP + APE + P+ + D++S G++ +
Sbjct: 176 KNIF---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+LG G FG VYK + G AAK+++T + +E ++ EI + H +V+L G
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGA 84
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
Y K ++ EF G++D + L ++ + + +LH ++RIIH
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHR 141
Query: 150 DIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYRGTPGYSAPE----FLLRNYP 204
D+K N+L+ + ++ADFG+ AK DS + GTP + APE +++ P
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVMCETMKDTP 198
Query: 205 ITQKCDVYSFGMLLFEII 222
K D++S G+ L E+
Sbjct: 199 YDYKADIWSLGITLIEMA 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 33/227 (14%)
Query: 9 AREKPVRFTLEQLCSFTNNYSTK--LGAGGFGVVYKG-QFPNGVKIAAK-ILKTCLNKRV 64
+ F + F++NY K LG G F VV + G++ AAK I L+ R
Sbjct: 12 QMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD 71
Query: 65 EAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVL 119
+ E + H N+VRL+ +++ LV++ + G L + +++ +
Sbjct: 72 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-- 129
Query: 120 KWEKLLDIAIGTAR----GIAYLHEECNQRIIHYDIKPANILLDAKFSA---KVADFGLA 172
A + IAY H I+H ++KP N+LL +K K+ADFGLA
Sbjct: 130 --------ASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
Query: 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
N G+ GTPGY +PE L ++ P ++ D+++ G++L+
Sbjct: 179 IEVNDSEA---WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILY 221
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 3e-26
Identities = 29/235 (12%), Positives = 66/235 (28%), Gaps = 54/235 (22%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL---------------------------KTCLNKR 63
LG + G + K +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 64 VEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM----ENGSLDKYLF---TDT 116
V +F+ + ++R+ D + + + + + L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 117 EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176
+ L L + + R +A LH + ++H ++P +I+LD + + F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 177 PENTHDSTSGYRGTPGYSAPEFLLRNY----------PITQKCDVYSFGMLLFEI 221
+ G+ PE R +T D ++ G++++ I
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 10/194 (5%)
Query: 30 TKLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
KLG G +G VYK G +A K + + ++ + + EI + + ++V+ YG
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQ-EIIKEISIMQQCDSPHVVKYYG 91
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
+ T +V E+ GS+ + + L +++ I T +G+ YLH R IH
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIH 148
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
DIK NILL+ + AK+ADFG+A +T GTP + APE +++
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPE-VIQEIGYNCV 205
Query: 209 CDVYSFGMLLFEII 222
D++S G+ E+
Sbjct: 206 ADIWSLGITAIEMA 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-26
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 23 SFTNNYSTK--LGAGGFGVVYKG-QFPNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRT 78
F++NY K LG G F VV + G++ AAK I L+ R + E +
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 79 YHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDIAIGTAR 133
H N+VRL+ +++ LV++ + G L + +++ + + +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI------LE 116
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSA---KVADFGLAKLCNPENTHDSTSGYRGT 190
IAY H I+H ++KP N+LL +K K+ADFGLA N G+ GT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
Query: 191 PGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
PGY +PE L ++ P ++ D+++ G++L+
Sbjct: 171 PGYLSPEVLKKD-PYSKPVDIWACGVILY 198
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 25/223 (11%)
Query: 11 EKPVRFTLEQLCSFTN---NYS--TKLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRV 64
+ + L + + K+G G G+V + +G ++A K++ +R
Sbjct: 27 HEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR 86
Query: 65 EAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKL 124
E E+ + H N+V +Y + ++ EF++ G+L T+++ +L
Sbjct: 87 E-LLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL-------TDIVSQVRL 138
Query: 125 --LDIAI---GTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179
IA + +AYLH Q +IH DIK +ILL K++DFG + +
Sbjct: 139 NEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195
Query: 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
+ GTP + APE + R+ + D++S G+++ E++
Sbjct: 196 PKRKS--LVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMV 235
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 23 SFTNNYST--KLGAGGFGVVYKG-QFPNGVKIAAKI-----LKTCLNKRVEAQFMAEIGT 74
+ Y +LG+G F +V K + G++ AAK + + E+
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 75 IGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDIAI 129
+ + H N++ L+ ++T L+ E + G L K ++ E A
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE----------AT 118
Query: 130 GTAR----GIAYLHEECNQRIIHYDIKPANILLDAKFSA----KVADFGLAKLCNPENTH 181
+ G+ YLH ++I H+D+KP NI+L K K+ DFGLA
Sbjct: 119 SFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
+ GTP + APE + P+ + D++S G++ +
Sbjct: 176 KNIF---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 209
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 23 SFTNNYSTK--LGAGGFGVVYKGQF-PNGVKIAAKILKT--------CLNKRVEAQFMAE 71
F NY K LG G VV + P + A KI+ + + + E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 72 IGTIGR-TYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTE---VLKWE 122
+ + + + H N+++L T LV++ M+ G L +K ++ E +++
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-- 131
Query: 123 KLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182
LL+ I LH+ I+H D+KP NILLD + K+ DFG + +P
Sbjct: 132 ALLE-------VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 179
Query: 183 STSGYRGTPGYSAPEFLLRNYPITQK-----CDVYSFGMLLF 219
GTP Y APE + + D++S G++++
Sbjct: 180 -LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 23/200 (11%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKI--LKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
K+G G FG V+KG +A KI L+ ++ + Q EI + + + + Y
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYY 86
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKL--LDIAI---GTARGIAYLHEEC 142
G TK ++ E++ GS ++L+ L IA +G+ YLH
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSA-------LDLLEPGPLDETQIATILREILKGLDYLH--- 136
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
+++ IH DIK AN+LL K+ADFG+A +T + GTP + APE +++
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPE-VIKQ 193
Query: 203 YPITQKCDVYSFGMLLFEII 222
K D++S G+ E+
Sbjct: 194 SAYDSKADIWSLGITAIELA 213
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 38/232 (16%)
Query: 5 LRDIAREKPVRFTLEQLCSFTNNYSTK--LGAGGFGVVYKG-QFPNGVKIAAKIL-KTCL 60
++ + V+ FT+ Y K +G G + V + ++ A KI+ K+
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTD 115
+ E + + G H N++ L D +V E M+ G L + F++
Sbjct: 61 DPTEEIEILLRYGQ-----HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE 115
Query: 116 TE---VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK----FSAKVAD 168
E VL I + + YLH Q ++H D+KP+NIL + S ++ D
Sbjct: 116 REASAVLF-----TIT----KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICD 163
Query: 169 FGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLF 219
FG AK EN T T + APE L R Y CD++S G+LL+
Sbjct: 164 FGFAKQLRAENGLLMTPC--YTANFVAPEVLERQGY--DAACDIWSLGVLLY 211
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 23 SFTNNYST--KLGAGGFGVVYKG-QFPNGVKIAAKI-----LKTCLNKRVEAQFMAEIGT 74
+ + Y T +LG+G F VV K + G++ AAK K+ E+
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 75 IGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDIAI 129
+ H N++ L+ ++T L+ E + G L +K T+ E A
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE----------AT 117
Query: 130 GTAR----GIAYLHEECNQRIIHYDIKPANILLDAKFSA----KVADFGLAKLCNPENTH 181
+ G+ YLH +I H+D+KP NI+L + K+ DFGLA + N
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
+ GTP + APE + P+ + D++S G++ +
Sbjct: 175 KNIF---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 208
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 29/229 (12%), Positives = 64/229 (27%), Gaps = 43/229 (18%)
Query: 32 LGAGGFGVVYKGQFPN-GVKIAAKIL---------------------------KTCLNKR 63
LG + G + K +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 64 VEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM----ENGSLDKYLF---TDT 116
V +F+ + ++R+ D + + + + + L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 117 EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176
+ L L + + R +A LH ++H ++P +I+LD + + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 177 PENTHDSTSGYRGTPGYSAPEFLL----RNYPITQKCDVYSFGMLLFEI 221
G+ P +A L +T D ++ G+ ++ I
Sbjct: 263 ASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 32/206 (15%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAE---IGTIGRTYHINLVR 85
+G GGFG VY + + K+ A K L K+ E + E + + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 86 LYGFCYDQTKAAL--VYEFMENGSLDKYL-----FTDTEVLKW--EKLLDIAIGTARGIA 136
+ + + T L + + M G L +L F++ ++ + E +L G+
Sbjct: 257 MS-YAF-HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL--------GLE 306
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAP 196
++H + +++ D+KPANILLD +++D GLA + + GT GY AP
Sbjct: 307 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAP 359
Query: 197 EFLLRNYPITQKCDVYSFGMLLFEII 222
E L + D +S G +LF+++
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 23 SFTNNYST--KLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY 79
+ + LG+G F V+ Q G A K +K ++ EI + +
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIK 64
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTE---VLKWEKLLDIAIGT 131
H N+V L T LV + + G L ++ ++T+ + V++ ++L
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ--QVLS----- 117
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKF---SAKVADFGLAKLCNPENTHDSTSGYR 188
+ YLHE I+H D+KP N+L + DFGL+K+ +
Sbjct: 118 --AVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC---- 168
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
GTPGY APE L + P ++ D +S G++ +
Sbjct: 169 GTPGYVAPEVLAQK-PYSKAVDCWSIGVITY 198
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 37/219 (16%)
Query: 23 SFTNNYST--KLGAGGFGVVYKG-QFPNGVKIAAKIL-------KTCLNKRVEAQFMAEI 72
+ + Y LG+G G V + K+A +I+ + EI
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191
Query: 73 GTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDI 127
+ + H ++++ F +D +V E ME G L + KL
Sbjct: 192 EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC----KLYFY 246
Query: 128 AIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPENTHDST 184
+ + YLHE IIH D+KP N+LL ++ K+ DFG +K+ +
Sbjct: 247 QM--LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---M 298
Query: 185 SGYRGTPGYSAPEFLL----RNYPITQKCDVYSFGMLLF 219
GTP Y APE L+ Y + D +S G++LF
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVILF 335
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 39/196 (19%), Positives = 67/196 (34%), Gaps = 20/196 (10%)
Query: 33 GAGGFGVVYKGQF-PNGVKIAAKI--LKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
G V ++ P G + + L+ C N+ V E+ H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNHPNIVPYRAT 94
Query: 90 CYDQTKAALVYEFMENGSL-DKYLFTDTEVLKWEKLLDIAI---GTARGIAYLHEECNQR 145
+ +V FM GS D + + E IA G + + Y+H
Sbjct: 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELA--IAYILQGVLKALDYIHH---MG 148
Query: 146 IIHYDIKPANILLDAKFSAKVADFG----LAKLCNPENT-HDSTSGYRGTPGYSAPEFLL 200
+H +K ++IL+ ++ + + HD + +PE L
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 201 RN-YPITQKCDVYSFG 215
+N K D+YS G
Sbjct: 209 QNLQGYDAKSDIYSVG 224
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 24 FTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRTY 79
FT Y +LG G F VV + G + AA I L+ R + E
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDIAIGTAR- 133
H N+VRL+ ++ L+++ + G L + +++ + A +
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD----------ASHCIQQ 118
Query: 134 ---GIAYLHEECNQRIIHYDIKPANILLDAKFSA---KVADFGLAKLCNPENTHDSTSGY 187
+ + H+ ++H ++KP N+LL +K K+ADFGLA E + G+
Sbjct: 119 ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGF 173
Query: 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
GTPGY +PE L ++ P + D+++ G++L+
Sbjct: 174 AGTPGYLSPEVLRKD-PYGKPVDLWACGVILY 204
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 39/200 (19%), Positives = 72/200 (36%), Gaps = 34/200 (17%)
Query: 101 EFMENGSLDKYL--FTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL 158
+ +L ++ E + L I I A + +LH ++ ++H D+KP+NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197
Query: 159 DAKFSAKVADFGLAKLCNPENTHDSTS----------GYRGTPGYSAPEFLLRNYPITQK 208
KV DFGL + + + G GT Y +PE + + K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE-QIHGNNYSHK 256
Query: 209 CDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268
D++S G++LFE+ + + E+ + V ++
Sbjct: 257 VDIFSLGLILFEL----------------LYSFS--TQMERVRIITDVRNLKFPLLFTQK 298
Query: 269 AERMSMVALWCVQDCPEARP 288
+ M+ + P RP
Sbjct: 299 YPQEHMMVQDMLSPSPTERP 318
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 39/216 (18%)
Query: 23 SFTNNY-----STKLGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIG 76
F +Y LG G F + K + A KI+ +KR+EA EI +
Sbjct: 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII----SKRMEANTQKEITALK 60
Query: 77 R-TYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTE---VLKWEKLLDI 127
H N+V+L+ +DQ LV E + G L K F++TE +++ +
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-----KL 115
Query: 128 AIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA---KVADFGLAKLCNPENTHDST 184
++++H+ ++H D+KP N+L + K+ DFG A+L P+N T
Sbjct: 116 V----SAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168
Query: 185 SGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLF 219
T Y+APE L +N Y + CD++S G++L+
Sbjct: 169 PC--FTLHYAAPELLNQNGY--DESCDLWSLGVILY 200
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 39/221 (17%)
Query: 23 SFTNNYSTK--LGAGGFGVVYKGQF-PNGVKIAAKI-------LKTCLNKRVEAQFMAEI 72
F Y K +G G VV + G + A KI L + V E
Sbjct: 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150
Query: 73 GTIGR-TYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTE---VLKWEK 123
+ + H +++ L + LV++ M G L +K ++ E +++
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR--S 208
Query: 124 LLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183
LL+ +++LH I+H D+KP NILLD +++DFG + P
Sbjct: 209 LLE-------AVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--- 255
Query: 184 TSGYRGTPGYSAPEFLLRNYPITQK-----CDVYSFGMLLF 219
GTPGY APE L + T D+++ G++LF
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 25/198 (12%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+G G F V + G ++A KI+ KT LN + E+ + H N+V+L+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYLHEE 141
+ L+ E+ G + YL +K EK AR + Y H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYL-VAHGRMK-EK-------EARSKFRQIVSAVQYCH-- 131
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
+RI+H D+K N+LLDA + K+ADFG + G P Y+APE
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC--GAPPYAAPELFQG 187
Query: 202 NYPITQKCDVYSFGMLLF 219
+ DV+S G++L+
Sbjct: 188 KKYDGPEVDVWSLGVILY 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 27/203 (13%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVE--AQFMAEIGTIGRTYHINLVRLY 87
++G G FG VY + N +A K + + E + E+ + + H N ++
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLD---IAI---GTARGIAYLHEE 141
G + A LV E+ + D +K L IA G +G+AYLH
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGLAYLH-- 171
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE--FL 199
+ +IH D+K NILL K+ DFG A + P N+ + GTP + APE
Sbjct: 172 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILA 224
Query: 200 LRNYPITQKCDVYSFGMLLFEII 222
+ K DV+S G+ E+
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELA 247
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 53/227 (23%), Positives = 84/227 (37%), Gaps = 53/227 (23%)
Query: 23 SFTNNYST--KLGAGGFGVVYKG-QFPNGVKIAAKIL-------KTCLNKRVEAQFMAEI 72
+ + Y LG+G G V + K+A KI+ + EI
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 73 GTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDI 127
+ + H ++++ F +D +V E ME G L +
Sbjct: 67 EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEAT---------- 115
Query: 128 AIGTAR--------GIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCN 176
+ + YLHE IIH D+KP N+LL ++ K+ DFG +K+
Sbjct: 116 ----CKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 177 PENTHDSTSGYRGTPGYSAPEFLL----RNYPITQKCDVYSFGMLLF 219
+ GTP Y APE L+ Y + D +S G++LF
Sbjct: 169 ETSL---MRTLCGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVILF 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 35/212 (16%)
Query: 23 SFTNNYSTK--LGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY 79
+ ++ + + LG G +VY+ + A K+LK + EIG + R
Sbjct: 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK---TVDKKIVRTEIGVLLRLS 106
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTEVLKWEKLLDIAIGTAR- 133
H N+++L T+ +LV E + G L +K +++ + A +
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD----------AADAVKQ 156
Query: 134 ---GIAYLHEECNQRIIHYDIKPANILLDAKFSA---KVADFGLAKLCNPENTHDSTSGY 187
+AYLHE I+H D+KP N+L K+ADFGL+K+ + +
Sbjct: 157 ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC-- 211
Query: 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
GTPGY APE +LR + D++S G++ +
Sbjct: 212 -GTPGYCAPE-ILRGCAYGPEVDMWSVGIITY 241
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNK--RVEAQFMAEIGTIGRTYHINLVRLY 87
LG G +G V + + A KIL K L + EA EI + R H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 88 GFCYDQTKAA--LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAY 137
Y++ K +V E+ G + + D+ K + + A G+ Y
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--ML-DSVPEK--RF---PVCQAHGYFCQLIDGLEY 124
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD--STSGYRGTPGYSA 195
LH +Q I+H DIKP N+LL + K++ G+A+ +P D TS +G+P +
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQP 179
Query: 196 PEFL--LRNYPITQKCDVYSFGMLLFEII 222
PE L + K D++S G+ L+ I
Sbjct: 180 PEIANGLDTF-SGFKVDIWSAGVTLYNIT 207
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY--HINLVRLY 87
+G G +G VYKG+ G A K++ + E + EI + + Y H N+ Y
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEI-NMLKKYSHHRNIATYY 87
Query: 88 GFCY-------DQTKAALVYEFMENGSL-DKYLFTDTEVLKWEKLLDIAIGTARGIAYLH 139
G + + LV EF GS+ D T LK E + I RG+++LH
Sbjct: 88 G-AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGL-AKLCNPENTHDSTSGYR----GTPGYS 194
+ ++IH DIK N+LL K+ DFG+ A+L D T G R GTP +
Sbjct: 147 Q---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-------DRTVGRRNTFIGTPYWM 196
Query: 195 APEFLLRNYPIT----QKCDVYSFGMLLFEII 222
APE + + K D++S G+ E+
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 24/200 (12%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G F V + + A KIL+ + + E + R H V+LY
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYLHE 140
D K + +NG L ++ D R + YLH
Sbjct: 98 TFQDDEKLYFGLSYAKNGEL----LK---YIRKIGSFDET--CTRFYTAEIVSALEYLHG 148
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
+ IIH D+KP NILL+ ++ DFG AK+ +PE+ + + GT Y +PE LL
Sbjct: 149 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LL 204
Query: 201 RNYPITQKCDVYSFGMLLFE 220
+ D+++ G ++++
Sbjct: 205 TEKSACKSSDLWALGCIIYQ 224
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 51/222 (22%), Positives = 85/222 (38%), Gaps = 38/222 (17%)
Query: 23 SFTNNYSTK---LGAGGFGVVYKG-QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR- 77
F + Y + LG G V + A KI++ E+ + +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR-VFREVEMLYQC 67
Query: 78 TYHINLVRLYGFCYDQTKAALVYEFMENGSL-----DKYLFTDTE---VLKWEKLLDIAI 129
H N++ L F ++ + LV+E M GS+ + F + E V++ D+
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-----DV-- 120
Query: 130 GTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPENTHDSTSG 186
A + +LH N+ I H D+KP NIL + K+ DF L S
Sbjct: 121 --ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 187 YR-----GTPGYSAPEFLLRNYPITQ----KCDVYSFGMLLF 219
G+ Y APE + +CD++S G++L+
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-23
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 45/229 (19%)
Query: 26 NNYSTK--LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNKRVEAQFMA----------- 70
N Y+ K +G G +GVV + A K+L K L ++
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 71 -------------EIGTIGRTYHINLVRLYGFCYDQTKAAL--VYEFMENGSLDKYLFTD 115
EI + + H N+V+L D + L V+E + G + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 116 --TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173
+E D+ G I YLH Q+IIH DIKP+N+L+ K+ADFG++
Sbjct: 133 PLSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 174 LCNPENTHDSTSGYRGTPGYSAPEFL---LRNYPITQKCDVYSFGMLLF 219
+ S + GTP + APE L + + + DV++ G+ L+
Sbjct: 186 EFKGSDALLSNTV--GTPAFMAPESLSETRKIF-SGKALDVWAMGVTLY 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-23
Identities = 54/214 (25%), Positives = 81/214 (37%), Gaps = 35/214 (16%)
Query: 23 SFTNNY---STKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT 78
+ T++Y LG G G V + G K A K+L R E +
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG---- 80
Query: 79 YHINLVRLYGFCYDQTKAA----LVYEFMENGSL-----DKYLFTDTEVLKWEKLLDIAI 129
++V + + ++ E ME G L ++ TE E + DI
Sbjct: 81 -GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG- 138
Query: 130 GTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPENTHDSTSG 186
I +LH I H D+KP N+L +K K+ DFG AK
Sbjct: 139 ---TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC-- 190
Query: 187 YRGTPGYSAPEFLLR-NYPITQKCDVYSFGMLLF 219
TP Y APE L Y + CD++S G++++
Sbjct: 191 --YTPYYVAPEVLGPEKY--DKSCDMWSLGVIMY 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-23
Identities = 50/220 (22%), Positives = 80/220 (36%), Gaps = 39/220 (17%)
Query: 23 SFTNNYSTK--LGAGGFGVVYKG-QFPNGVKIAAK-ILKTCLNKRV---EAQFMAEIGTI 75
F + Y +G G F VV + G + A K + E
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 76 GRTYHINLVRLYGFCYDQTKAALVYEFMENGSL---------DKYLFTDTEVLKWEKLLD 126
H ++V L +V+EFM+ L +++++
Sbjct: 81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--------- 131
Query: 127 IAIGTAR----GIAYLHEECNQRIIHYDIKPANILLDAKFSA---KVADFGLAKLCNPEN 179
A R + Y H+ IIH D+KP +LL +K ++ K+ FG+A
Sbjct: 132 -ASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
G GTP + APE + R P + DV+ G++LF
Sbjct: 188 --LVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILF 224
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-22
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 39/222 (17%)
Query: 22 CSFTNNYS--TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVE---AQFMAEIGTIG 76
Y K+G G +GVVYK + G +A K ++ L+ E + + EI +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR--LDAEDEGIPSTAIREISLLK 74
Query: 77 RTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEK-LLDIAI 129
+H N+V L + + LV+EFME L K L D+++ + LL
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---- 129
Query: 130 GTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN---THD-STS 185
RG+A+ H+ RI+H D+KP N+L+++ + K+ADFGLA+ TH+ T
Sbjct: 130 ---RGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 186 GYRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
YR AP+ L+ + Y + D++S G + E+I +
Sbjct: 184 WYR------APDVLMGSKKY--STSVDIWSIGCIFAEMITGK 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 66/217 (30%), Positives = 96/217 (44%), Gaps = 45/217 (20%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQ----FMA--EIGTIGRTYHINL 83
LG G F VYK + +A K K L R EA+ A EI + H N+
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIK--KIKLGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEK-LLDIAIGTARGIA 136
+ L ++ +LV++FME L+ + T + + + L +G+
Sbjct: 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL-------QGLE 126
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN---THD-STSGYRGTPG 192
YLH+ I+H D+KP N+LLD K+ADFGLAK N TH T YR
Sbjct: 127 YLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR---- 179
Query: 193 YSAPEFLL--RNY--PITQKCDVYSFGMLLFEIIGRR 225
APE L R Y + D+++ G +L E++ R
Sbjct: 180 --APELLFGARMYGVGV----DMWAVGCILAELLLRV 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-22
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 26 NNYST--KLGAGGFGVVYKGQ-FPNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRTYHI 81
Y K+G G +GVV+K + G +A K L++ + ++ + EI + + H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
NLV L + + LV+E+ ++ ++ L + + I T + + + H+
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK- 120
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN---THD-STSGYRGTPGYSAPE 197
IH D+KP NIL+ K+ DFG A+L + + +T YR +PE
Sbjct: 121 --HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR------SPE 172
Query: 198 FLL--RNY--PITQKCDVYSFGMLLFEIIGRR 225
L+ Y P+ DV++ G + E++
Sbjct: 173 LLVGDTQYGPPV----DVWAIGCVFAELLSGV 200
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-22
Identities = 56/198 (28%), Positives = 80/198 (40%), Gaps = 23/198 (11%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
LG G +G V +A KI+ E EI H N+V+ YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYLHEE 141
+ L E+ G L + D + + + A+ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---------AQRFFHQLMAGVVYLH-- 122
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
I H DIKP N+LLD + + K++DFGLA + N + GT Y APE L R
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 202 NYPITQKCDVYSFGMLLF 219
+ DV+S G++L
Sbjct: 182 REFHAEPVDVWSCGIVLT 199
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 44/219 (20%)
Query: 23 SFTNNYST---KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT 78
+ ++Y LG G G V + K A K+L+ C R E +
Sbjct: 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ---- 113
Query: 79 YHINLVRLYGFCYDQTKAA----LVYEFMENGSL-------DKYLFTDTE---VLKWEKL 124
++VR+ + +V E ++ G L FT+ E ++K
Sbjct: 114 -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---- 168
Query: 125 LDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA---KVADFGLAKLCNPENTH 181
+IG A I YLH I H D+KP N+L +K K+ DFG AK N+
Sbjct: 169 ---SIGEA--IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 220
Query: 182 DSTSGYRGTPGYSAPEFLLR-NYPITQKCDVYSFGMLLF 219
+ TP Y APE L Y + CD++S G++++
Sbjct: 221 TTPC---YTPYYVAPEVLGPEKY--DKSCDMWSLGVIMY 254
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 58/209 (27%), Positives = 86/209 (41%), Gaps = 31/209 (14%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRL-Y 87
+G G FG V Q + K+ A K + C+ + E+ + H LV L Y
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 88 GFCYDQTKAAL--VYEFMENGSLDKYL-----FTDTEVLKWEKLLDIA-IGTARGIAYLH 139
F Q + + V + + G L +L F + V + I + A + YL
Sbjct: 83 SF---QDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-----ICELVMA--LDYLQ 132
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFL 199
QRIIH D+KP NILLD + DF +A + E + + GT Y APE
Sbjct: 133 N---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMF 186
Query: 200 LRNYPI--TQKCDVYSFGMLLFE-IIGRR 225
+ D +S G+ +E + GRR
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 26/204 (12%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG GGFG V+ Q K+ A K L ++ M E + + + +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 89 FCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYL 138
+ + +TK L V M G + +++ V + A G+ +L
Sbjct: 252 YAF-ETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEP--RAIFYTAQIVSGLEHL 305
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEF 198
H+ + II+ D+KP N+LLD + +++D GLA T GY GTPG+ APE
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPE- 359
Query: 199 LLRNYPITQKCDVYSFGMLLFEII 222
LL D ++ G+ L+E+I
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMI 383
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-22
Identities = 56/198 (28%), Positives = 80/198 (40%), Gaps = 23/198 (11%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
LG G +G V +A KI+ E EI H N+V+ YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYLHEE 141
+ L E+ G L + D + + + A+ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---------AQRFFHQLMAGVVYLH-- 122
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
I H DIKP N+LLD + + K++DFGLA + N + GT Y APE L R
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 202 NYPITQKCDVYSFGMLLF 219
+ DV+S G++L
Sbjct: 182 REFHAEPVDVWSCGIVLT 199
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-21
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVE---AQFMAEIGTIGRTYHINLVRLY 87
K+G G +GVVYK Q G A K ++ L K E + + EI + H N+V+LY
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
+ + + LV+E ++ L K L L+ + GIAY H+ +R++
Sbjct: 67 DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPEN---THD-STSGYRGTPGYSAPEFLL--R 201
H D+KP N+L++ + K+ADFGLA+ TH+ T YR AP+ L+ +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR------APDVLMGSK 176
Query: 202 NYPITQKCDVYSFGMLLFEIIGRR 225
Y + D++S G + E++
Sbjct: 177 KY--STTIDIWSVGCIFAEMVNGT 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-21
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 38/213 (17%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVE---AQFMAEIGTIGRTYHINLVRL 86
K+G G +G V+K + +A K ++ L+ E + + EI + H N+VRL
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEK-LLDIAIGTARGIAYLH 139
+ + K LV+EF + L KY V + LL +G+ + H
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL-------KGLGFCH 118
Query: 140 EECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN---THD-STSGYRGTPGYSA 195
+ ++H D+KP N+L++ K+A+FGLA+ + + T YR
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR------P 169
Query: 196 PEFLL--RNYPITQKCDVYSFGMLLFEIIGRRK 226
P+ L + Y + D++S G + E+ +
Sbjct: 170 PDVLFGAKLY--STSIDMWSAGCIFAELANAGR 200
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 34/215 (15%)
Query: 27 NYST--KLGAGGFGVVYKGQ-FPNGVKIAAKILK-------TCLNKRVEAQFMAEIGTIG 76
YST LG+G FG V+ ++ K +K + + EI +
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 77 RTYHINLVRLYGFCYDQTKAALVYEFMENGS-LDKYLFTDTEVLKWEKLLDIAIGTAR-- 133
R H N++++ +Q LV E +G L ++ L E L A
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHPRLD-EPL-------ASYI 135
Query: 134 ------GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187
+ YL + IIH DIK NI++ F+ K+ DFG A +
Sbjct: 136 FRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-- 190
Query: 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
GT Y APE L+ N + +++S G+ L+ ++
Sbjct: 191 -GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 25 TNNYST--KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRV---EAQFMAEIGTIGRT 78
+ + G G FG V G+ G+ +A K K + R E Q M ++ +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--KVIQDPRFRNRELQIMQDLAVLH-- 77
Query: 79 YHINLVRLYGFCY-------DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIG- 130
H N+V+L + Y +V E++ + + I I
Sbjct: 78 -HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPILIKV 133
Query: 131 ----TARGIAYLHEECNQRIIHYDIKPANILLD-AKFSAKVADFGLAKLCNPENTHDSTS 185
R I LH + H DIKP N+L++ A + K+ DFG AK +P + + +
Sbjct: 134 FLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP--SEPNVA 190
Query: 186 GYRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
Y + Y APE + ++Y T D++S G + E++
Sbjct: 191 -YICSRYYRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLGE 229
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG GGFG V Q K+ A K L+ ++ EA + E + + +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 89 FCYDQTKAAL--VYEFMENGSL-------DKYLFTDTEVLKW--EKLLDIAIGTARGIAY 137
+ Y +TK AL V M G L + F + + + E G+
Sbjct: 251 YAY-ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC--------GLED 301
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE 197
LH +RI++ D+KP NILLD +++D GLA T G GT GY APE
Sbjct: 302 LHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355
Query: 198 FLLRNYPITQKCDVYSFGMLLFEII 222
+++N T D ++ G LL+E+I
Sbjct: 356 -VVKNERYTFSPDWWALGCLLYEMI 379
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 26/199 (13%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNK-RVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG V G+ G K+A KIL + + V + EI + H ++++LY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYLHE 140
T +V E++ G L Y+ K ++ AR + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYI------CKHGRV---EEMEARRLFQQILSAVDYCH- 128
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
++H D+KP N+LLDA +AK+ADFGL+ + + ++ G+P Y+APE +
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVIS 183
Query: 201 RNYPITQKCDVYSFGMLLF 219
+ D++S G++L+
Sbjct: 184 GRLYAGPEVDIWSCGVILY 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 26 NNYST--KLGAGGFGVVYKGQF-PNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRTYHI 81
Y +G G +G+V K + G +A K L++ +K V+ M EI + + H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
NLV L C + + LV+EF+++ ++ L L ++ + GI + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS- 142
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAK-LCNPEN--THD-STSGYRGTPGYSAPE 197
IIH DIKP NIL+ K+ DFG A+ L P + +T YR APE
Sbjct: 143 --HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR------APE 194
Query: 198 FLL--RNY--PITQKCDVYSFGMLLFEIIGRR 225
L+ Y + DV++ G L+ E+
Sbjct: 195 LLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-21
Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 42/214 (19%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNKRVEAQFMAEIGTIGR-----------T 78
LG GGFG V+ G + +++A K++ + + +++ T
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP---LSDSVTCPLEVALLWKVGAGG 95
Query: 79 YHINLVRLYGFCYDQTKAALVYEFMENGS-LDKYLFTDTEVLKWEKLLDIAIGTAR---- 133
H ++RL + Q LV E L Y+ T+ L E +R
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLG-EGP-------SRCFFG 146
Query: 134 ----GIAYLHEECNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPENTHDSTSGYR 188
I + H ++ ++H DIK NIL+D + AK+ DFG L + E D
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---- 199
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
GT YS PE++ R+ V+S G+LL++++
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 34/209 (16%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNKRVEAQFMA----EIGTIGRTYHI--NL 83
LG+GGFG VY G + + +A K + K ++ E E+ + + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 84 VRLYGFCYDQTKAALVYEFMEN-GSLDKYLFTDTEVLKWEKLLDIAIGTAR--------G 134
+RL + L+ E E L ++ T+ L+ E+L AR
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQ-EEL-------ARSFFWQVLEA 161
Query: 135 IAYLHEECNQRIIHYDIKPANILLDA-KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
+ + H N ++H DIK NIL+D + K+ DFG L D GT Y
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVY 214
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEII 222
S PE++ + + V+S G+LL++++
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 243
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 59/214 (27%), Positives = 88/214 (41%), Gaps = 40/214 (18%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRV---EAQFMAEIGTIGRTYHINLVRLY 87
+G G FGVV++ + ++A K K +KR E Q M + H N+V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIK--KVLQDKRFKNRELQIMRIVK------HPNVVDLK 98
Query: 88 GFCYDQTKAA------LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIG-----TARGIA 136
F Y LV E++ Y + + + + I R +A
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSA-KVADFGLAKLCNP--ENTHDSTSGYRGTPGY 193
Y+H + I H DIKP N+LLD K+ DFG AK+ N S Y Y
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----Y 207
Query: 194 SAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
APE + NY T D++S G ++ E++ +
Sbjct: 208 RAPELIFGATNY--TTNIDIWSTGCVMAELMQGQ 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 9e-21
Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 40/205 (19%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+G+G FGV + +A K + + ++ EI H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERG---AAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 90 CYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTAR--------GIA 136
T A++ E+ G L + + F++ E AR G++
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDE--------------ARFFFQQLLSGVS 130
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSA--KVADFGLAKLCNPENTHDSTSGYRGTPGYS 194
Y H + +I H D+K N LLD + K+ DFG +K + ST GTP Y
Sbjct: 131 YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYI 184
Query: 195 APEFLLRNYPITQKCDVYSFGMLLF 219
APE LLR + DV+S G+ L+
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLY 209
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKR--VEAQFMAEIGTIGRTYHINLVRLY 87
KLG G + VYKG+ +A K + L + E+ + H N+V L+
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALK--EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 88 GFCYDQTKAALVYEFMENGSLDKYL------FTDTEVLKWEK-LLDIAIGTARGIAYLHE 140
+ + LV+E+++ L +YL V + LL RG+AY H
Sbjct: 67 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL-------RGLAYCHR 118
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN---THD-STSGYRGTPGYSAP 196
Q+++H D+KP N+L++ + K+ADFGLA+ + ++ T YR P
Sbjct: 119 ---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR------PP 169
Query: 197 EFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
+ LL +Y + + D++ G + +E+ R
Sbjct: 170 DILLGSTDY--STQIDMWGVGCIFYEMATGR 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 26/199 (13%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNK-RVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG V G+ G K+A KIL + + V + EI + H ++++LY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYLHE 140
+ +V E++ G L Y+ K +L +R G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYI------CKNGRL---DEKESRRLFQQILSGVDYCH- 133
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
++H D+KP N+LLDA +AK+ADFGL+ + + ++ G+P Y+APE +
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVIS 188
Query: 201 RNYPITQKCDVYSFGMLLF 219
+ D++S G++L+
Sbjct: 189 GRLYAGPEVDIWSSGVILY 207
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 63/215 (29%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRV---EAQFMAEIGTIGRTYHINLVRL 86
+G G FGVVY+ + +G +A K K +KR E Q M ++ H N+VRL
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQIMRKLD------HCNIVRL 112
Query: 87 YGFCYDQTKAA------LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIG-----TARGI 135
F Y + LV +++ Y + L I + R +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSA-KVADFGLAKLCNP--ENTHDSTSGYRGTPG 192
AY+H + I H DIKP N+LLD + K+ DFG AK N S Y
Sbjct: 170 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----- 221
Query: 193 YSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
Y APE + +Y T DV+S G +L E++ +
Sbjct: 222 YRAPELIFGATDY--TSSIDVWSAGCVLAELLLGQ 254
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 61/239 (25%), Positives = 97/239 (40%), Gaps = 56/239 (23%)
Query: 20 QLCSFTNNYS--TKLGAGGFGVVYKGQFPNGVKIAA--KILKTCLNKRVEAQ-----FMA 70
C + Y K+G G FG V+K + + A K+ +E + A
Sbjct: 11 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-------LMENEKEGFPITA 63
Query: 71 --EIGTIGRTYHINLVRLYGFCYDQTKAA--------LVYEFMENGSLDKYL------FT 114
EI + H N+V L C + LV++F E+ L L FT
Sbjct: 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFT 122
Query: 115 DTEVLKWEK-LLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173
+E+ + + LL G+ Y+H +I+H D+K AN+L+ K+ADFGLA+
Sbjct: 123 LSEIKRVMQMLL-------NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 172
Query: 174 LCNPENTHDSTSGYRGTPG-----YSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
+ + + Y T Y PE LL R+Y D++ G ++ E+ R
Sbjct: 173 AFSL-AKNSQPNRY--TNRVVTLWYRPPELLLGERDY--GPPIDLWGAGCIMAEMWTRS 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 46/218 (21%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILK---------TCLNKRVEAQFMAEIGTIGRTYH 80
KLG G + VYKG GV +A K +K T + R EI + H
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI--R-------EISLMKELKH 62
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGT-----ARGI 135
N+VRLY + + K LV+EFM+N L KY+ + T L + +G+
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN---THD-STSGYRGTP 191
A+ HE +I+H D+KP N+L++ + K+ DFGLA+ + + T YR
Sbjct: 122 AFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--- 175
Query: 192 GYSAPEFLL--RNY--PITQKCDVYSFGMLLFEIIGRR 225
AP+ L+ R Y I D++S G +L E+I +
Sbjct: 176 ---APDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-20
Identities = 57/245 (23%), Positives = 100/245 (40%), Gaps = 46/245 (18%)
Query: 6 RDIAREKPVRFTLEQL--CSFTNNYS--TKLGAGGFGVVYKGQ-FPNGVKIAAKILKTCL 60
+ + P ++ + + Y TKLG G +G VYK +A K + L
Sbjct: 12 LEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK--RIRL 69
Query: 61 NKRVE---AQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYL----- 112
E + E+ + H N++ L + + L++E+ EN L KY+
Sbjct: 70 EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD 128
Query: 113 FTDTEVLKWEK-LLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA-----KV 166
+ + + L+ G+ + H +R +H D+KP N+LL ++ K+
Sbjct: 129 VSMRVIKSFLYQLI-------NGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKI 178
Query: 167 ADFGLAKLCNPEN---THD-STSGYRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFE 220
DFGLA+ TH+ T YR PE LL R+Y + D++S + E
Sbjct: 179 GDFGLARAFGIPIRQFTHEIITLWYR------PPEILLGSRHY--STSVDIWSIACIWAE 230
Query: 221 IIGRR 225
++ +
Sbjct: 231 MLMKT 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 7e-20
Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 41/221 (18%)
Query: 31 KLGAGGFGVVYKGQ---FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
K+G G +G VYK + + A K ++ + EI + H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACREIALLRELKHPNVISLQ 84
Query: 88 GFCYDQTKAA--LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTA--------RGIAY 137
L++++ E+ L + +K + + G GI Y
Sbjct: 85 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSA----KVADFGLAKLCNPEN---THDS----TSG 186
LH ++H D+KPANIL+ + K+AD G A+L N T
Sbjct: 144 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 187 YRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
YR APE LL R+Y T+ D+++ G + E++
Sbjct: 201 YR------APELLLGARHY--TKAIDIWAIGCIFAELLTSE 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 27/199 (13%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKIL-KTCLNK-RVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG V + K+A K + + L K + + EI + H ++++LY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYLHE 140
T +V E+ G L Y+ ++ +++ R I Y H
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYI------VEKKRM---TEDEGRRFFQQIICAIEYCH- 125
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
+I+H D+KP N+LLD + K+ADFGL+ + N TS G+P Y+APE +
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSC--GSPNYAAPEVIN 180
Query: 201 RNYPITQKCDVYSFGMLLF 219
+ DV+S G++L+
Sbjct: 181 GKLYAGPEVDVWSCGIVLY 199
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 60/233 (25%), Positives = 96/233 (41%), Gaps = 50/233 (21%)
Query: 22 CSFTNNYS--TKLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQF----MAEIGT 74
T+ Y ++G G +G VYK + +G +A K ++ + E+
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 75 ---IGRTYHINLVRLYGFCYDQTKAA-----LVYEFMENGSLDKYL-------FTDTEVL 119
+ H N+VRL C LV+E ++ L YL +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 120 KWEK-LLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178
+ L RG+ +LH I+H D+KP NIL+ + + K+ADFGLA++ + +
Sbjct: 124 DLMRQFL-------RGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 179 N--THD-STSGYRGTPGYSAPEFLL-RNY--PITQKCDVYSFGMLLFEIIGRR 225
T T YR APE LL Y P+ D++S G + E+ R+
Sbjct: 174 MALTPVVVTLWYR------APEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 58/207 (28%), Positives = 80/207 (38%), Gaps = 33/207 (15%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRL-Y 87
+G G FG V + N K+ A KIL L + A F E + + L Y
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 88 GFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAY 137
F Q L V ++ G L L K+E L AR I
Sbjct: 142 AF---QDDNNLYLVMDYYVGGDLLTLL------SKFEDRLPEE--MARFYLAEMVIAIDS 190
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE 197
+H +H DIKP NIL+D ++ADFG + T S+ GTP Y +PE
Sbjct: 191 VH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPE 246
Query: 198 FLLRNYPITQK----CDVYSFGMLLFE 220
L + CD +S G+ ++E
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 33/208 (15%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRV--EAQFMAEIGTIGRTYHINLVRLY 87
KLG G + V++ N K+ KILK K++ E + + + N++ L
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG-----GPNIITLA 97
Query: 88 GFCYDQT--KAALVYEFMENGSLDKYL--FTDTEV--LKWEKLLDIAIGTARGIAYLHEE 141
D ALV+E + N + TD ++ +E L + + Y H
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL--------KALDYCHS- 148
Query: 142 CNQRIIHYDIKPANILLDAKFSA-KVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
I+H D+KP N+++D + ++ D+GLA+ +P + + + + PE L+
Sbjct: 149 --MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLV 203
Query: 201 --RNYPITQKCDVYSFGMLLFEIIGRRK 226
+ Y D++S G +L +I R++
Sbjct: 204 DYQMY--DYSLDMWSLGCMLASMIFRKE 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 48/218 (22%)
Query: 30 TKLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY--------- 79
T +G+G +G V +G K+A K L + A+ R Y
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---------RAYRELLLLKHM 80
Query: 80 -HINLVRLYGFCYDQTKAA------LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIG-- 130
H N++ L + LV FM+ TD + + K + I
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---------TDLQKIMGLKFSEEKIQYL 131
Query: 131 ---TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187
+G+ Y+H + ++H D+KP N+ ++ K+ DFGLA+ + E T GY
Sbjct: 132 VYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GY 183
Query: 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
T Y APE +L Q D++S G ++ E++ +
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 50/205 (24%), Positives = 78/205 (38%), Gaps = 39/205 (19%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG V + A KIL + + + E + LV+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTAR--------GI 135
D + +V E++ G + +L F++ AR
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--------------HARFYAAQIVLTF 154
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSA 195
YLH +I+ D+KP N+L+D + +V DFG AK T GTP A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEALA 206
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFE 220
PE +L + D ++ G+L++E
Sbjct: 207 PEIILSK-GYNKAVDWWALGVLIYE 230
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 29/204 (14%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG V + + A KILK + K A + E + + H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 89 FCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYL 138
+ + QT L V E+ G L F L E++ AR + YL
Sbjct: 215 YSF-QTHDRLCFVMEYANGGEL----FFH---LSRERVFSED--RARFYGAEIVSALDYL 264
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEF 198
H E N +++ D+K N++LD K+ DFGL K + + + GTP Y APE
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEV 320
Query: 199 LLRNYPITQKCDVYSFGMLLFEII 222
L N + D + G++++E++
Sbjct: 321 LEDN-DYGRAVDWWGLGVVMYEMM 343
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 60/237 (25%)
Query: 22 CSFTNNYS--TKLGAGGFGVVYKGQ--FPNGVKIAAKILK----------TCLNKRVEAQ 67
C Y ++G G +G V+K + G +A K ++ + + R E
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI--R-EVA 63
Query: 68 FMAEIGTIGRTYHINLVRLYGFCYDQTKAA-----LVYEFMENGSLDKYL------FTDT 116
+ + T H N+VRL+ C LV+E ++ L YL T
Sbjct: 64 VLRHLET---FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 117 EVLKW--EKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174
E +K +LL RG+ +LH R++H D+KP NIL+ + K+ADFGLA++
Sbjct: 120 ETIKDMMFQLL-------RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 175 CNPEN--THD-STSGYRGTPGYSAPEFLL-RNY--PITQKCDVYSFGMLLFEIIGRR 225
+ + T T YR APE LL +Y P+ D++S G + E+ R+
Sbjct: 170 YSFQMALTSVVVTLWYR------APEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 32/204 (15%)
Query: 32 LGAGGFGVVY---KGQFPNGVKI-AAKIL-KTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
LG G FG V+ K + ++ A K+L K L R + E + H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 87 YGFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIA 136
+ + + QT+ L + +F+ G L FT L E + + +
Sbjct: 92 H-YAF-QTEGKLYLILDFLRGGDL----FTR---LSKEVMFTEE--DVKFYLAELALALD 140
Query: 137 YLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAP 196
+LH II+ D+KP NILLD + K+ DFGL+K + GT Y AP
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAP 195
Query: 197 EFLLRNYPITQKCDVYSFGMLLFE 220
E + R TQ D +SFG+L+FE
Sbjct: 196 EVVNRR-GHTQSADWWSFGVLMFE 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 56/217 (25%), Positives = 87/217 (40%), Gaps = 49/217 (22%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY----------H 80
+G+G +G V G+++A K L + A+ RTY H
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---------RTYRELRLLKHMKH 87
Query: 81 INLVRLYGFCYDQTKAA------LVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIG--- 130
N++ L LV M D ++K +KL D +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMG---------ADLNNIVKCQKLTDDHVQFLI 138
Query: 131 --TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188
RG+ Y+H + IIH D+KP+N+ ++ K+ DFGLA+ E T GY
Sbjct: 139 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-----GYV 190
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
T Y APE +L Q D++S G ++ E++ R
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 45/213 (21%), Positives = 80/213 (37%), Gaps = 28/213 (13%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAK-ILKTCLNKRVEAQFMAEIGTIGRTY---------- 79
+ +G +G V G G+ +A K + T + R R
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK-RVLREIRLLNHFH 87
Query: 80 HINLVRLYGFCYDQTKAA-----LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARG 134
H N++ L + A LV E M L + + V+ + + G
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYS 194
+ LH ++H D+ P NILL + DF LA+ + + + Y Y
Sbjct: 147 LHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYR 200
Query: 195 APEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
APE ++ + + T+ D++S G ++ E+ R+
Sbjct: 201 APELVMQFKGF--TKLVDMWSAGCVMAEMFNRK 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 7e-18
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 39/205 (19%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG V+ + + + A K+LK + + E + H ++R++G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 89 FCYDQTKAALVYEFMENGSLDKYL-----FTDTEVLKWEKLLDIAIGTAR--------GI 135
D + ++ +++E G L L F + A+ +
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP--------------VAKFYAAEVCLAL 119
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSA 195
YLH + II+ D+KP NILLD K+ DFG AK D T GTP Y A
Sbjct: 120 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIA 171
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFE 220
PE + P + D +SFG+L++E
Sbjct: 172 PEVVSTK-PYNKSIDWWSFGILIYE 195
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 45/217 (20%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY----------H 80
+G G +G+V N V++A K + + + Q RT H
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQ---------RTLREIKILLRFRH 84
Query: 81 INLVRLYGFCYDQTKAA-----LVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIG---- 130
N++ + T +V + ME TD ++LK + L + I
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLME---------TDLYKLLKTQHLSNDHICYFLY 135
Query: 131 -TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST-SGYR 188
RG+ Y+H + ++H D+KP+N+LL+ K+ DFGLA++ +P++ H + Y
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
T Y APE +L + T+ D++S G +L E++ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-18
Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 49/217 (22%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY----------H 80
+G+G +G V G K+A K L + A+ R Y H
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---------RAYRELRLLKHMRH 83
Query: 81 INLVRLYG-FCYDQTKAA-----LVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIG--- 130
N++ L F D+T LV FM TD +++K EKL + I
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMG---------TDLGKLMKHEKLGEDRIQFLV 134
Query: 131 --TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR 188
+G+ Y+H IIH D+KP N+ ++ K+ DFGLA+ + E T GY
Sbjct: 135 YQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYV 186
Query: 189 GTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
T Y APE +L TQ D++S G ++ E+I +
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 54/208 (25%), Positives = 81/208 (38%), Gaps = 33/208 (15%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKIL-KTCLNKRVE-AQFMAEIGTIGRTYHINLVRLYG 88
+G G F V + ++ A KI+ K + KR E + F E + + +L+
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 89 FCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYL 138
F + Q + L V E+ G L L K+ + + AR I +
Sbjct: 128 FAF-QDENYLYLVMEYYVGGDLLTLL------SKFGERIPAE--MARFYLAEIVMAIDSV 178
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEF 198
H +H DIKP NILLD ++ADFG + T S GTP Y +PE
Sbjct: 179 HR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEI 234
Query: 199 LLRNYPITQK------CDVYSFGMLLFE 220
L CD ++ G+ +E
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 42/221 (19%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY---------- 79
LG GG G+V+ ++A K K L +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIK--KIVLTDPQSVK---------HALREIKIIRRLD 66
Query: 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTD------TEVLKWEKLLDIAIG--- 130
H N+V+++ Y+ + VL+ LL+
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126
Query: 131 --TARGIAYLHEECNQRIIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENTHDST-SG 186
RG+ Y+H + ++H D+KPAN+ ++ + K+ DFGLA++ +P +H S
Sbjct: 127 YQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 187 YRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
T Y +P LL NY T+ D+++ G + E++ +
Sbjct: 184 GLVTKWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEMLTGK 222
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 52/203 (25%), Positives = 81/203 (39%), Gaps = 28/203 (13%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G G FG V + + K+ A K+L + + A F E + +V+L+
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYLHE 140
D +V E+M G L ++ + + AR + +H
Sbjct: 137 AFQDDRYLYMVMEYMPGGDL----VN---LMSNYDVPE---KWARFYTAEVVLALDAIHS 186
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
IH D+KP N+LLD K+ADFG N E GTP Y +PE L
Sbjct: 187 ---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLK 242
Query: 201 R---NYPITQKCDVYSFGMLLFE 220
+ ++CD +S G+ L+E
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYE 265
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 34/206 (16%)
Query: 32 LGAGGFGVVY---KGQFPNGVKI-AAKILK--TCLNKRVE-AQFMAEIGTIGRTYHINLV 84
LG GG+G V+ K N KI A K+LK + + A AE + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 85 RLYGFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------G 134
L + + QT L + E++ G L F L+ E + TA
Sbjct: 85 DLI-YAF-QTGGKLYLILEYLSGGEL----FMQ---LEREGIFMED--TACFYLAEISMA 133
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYS 194
+ +LH+ + II+ D+KP NI+L+ + K+ DFGL K + T + GT Y
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYM 188
Query: 195 APEFLLRNYPITQKCDVYSFGMLLFE 220
APE L+R+ + D +S G L+++
Sbjct: 189 APEILMRS-GHNRAVDWWSLGALMYD 213
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 50/247 (20%), Positives = 87/247 (35%), Gaps = 73/247 (29%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRV---EAQFMAEIGTIGRTYHINLVRL 86
LG G FG+V + +G + A K K + R E M + H+N+++L
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALK--KVLQDPRYKNRELDIMKVLD------HVNIIKL 65
Query: 87 YGFCYDQTKAA--------------------------------------LVYEFMENGSL 108
+ Y ++ E++
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP---D 122
Query: 109 DKYLFTDTEVLKWEKLLDIAIG-----TARGIAYLHEECNQRIIHYDIKPANILLDAK-F 162
+ + + + I R + ++H + I H DIKP N+L+++K
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDN 179
Query: 163 SAKVADFGLAKLCNP--ENTHDSTSGYRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLL 218
+ K+ DFG AK P + S + Y APE +L Y T D++S G +
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY--TPSIDLWSIGCVF 232
Query: 219 FEIIGRR 225
E+I +
Sbjct: 233 GELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 47/216 (21%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY----------H 80
+G+G G+V +A K L + A+ R Y H
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---------RAYRELVLMKCVNH 83
Query: 81 INLVRLYG-FCYDQTKAA-----LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIG---- 130
N++ L F ++ +V E M+ + + +L +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD---------ANLCQVIQMELDHERMSYLLY 134
Query: 131 -TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG 189
GI +LH + IIH D+KP+NI++ + + K+ DFGLA+ + Y
Sbjct: 135 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVV 188
Query: 190 TPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
T Y APE +L + D++S G ++ E+I
Sbjct: 189 TRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 9e-17
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 34/208 (16%)
Query: 32 LGAGGFGVVY---KGQFPNGVKI-AAKILK---TCLNKRVEAQFMAEIGTIGRTYHIN-L 83
LG G +G V+ K + K+ A K+LK + E + L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 84 VRLYGFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR-------- 133
V L+ + + QT+ L + +++ G L FT L + +
Sbjct: 122 VTLH-YAF-QTETKLHLILDYINGGEL----FT---HLSQRERFTEH--EVQIYVGEIVL 170
Query: 134 GIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
+ +LH+ II+ DIK NILLD+ + DFGL+K + + + GT Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEY 226
Query: 194 SAPEFLLRN-YPITQKCDVYSFGMLLFE 220
AP+ + + D +S G+L++E
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 49/218 (22%), Positives = 78/218 (35%), Gaps = 63/218 (28%)
Query: 23 SFTNNYST---KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT 78
+ ++Y LG G G V + K A K+L+ C R E +
Sbjct: 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ---- 69
Query: 79 YHINLVRLYGFCYDQTKAA----LVYEFMENGSL-------DKYLFTDTE---VLKWEKL 124
++VR+ + +V E ++ G L FT+ E ++K
Sbjct: 70 -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---- 124
Query: 125 LDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA---KVADFGLAKLCNPENTH 181
+IG A I YLH I H D+KP N+L +K K+ DFG
Sbjct: 125 ---SIGEA--IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF---------- 166
Query: 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
A E Y + CD++S G++++
Sbjct: 167 -------------AKETTGEKY--DKSCDMWSLGVIMY 189
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 30/204 (14%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
LG G FG V + + A KIL+ + K A + E + T H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 89 FCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAYL 138
+ + QT L V E+ G L F L E++ AR + YL
Sbjct: 72 YAF-QTHDRLCFVMEYANGGEL----FFH---LSRERVFTEE--RARFYGAEIVSALEYL 121
Query: 139 HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEF 198
H + +++ DIK N++LD K+ DFGL K + + + GTP Y APE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEV 176
Query: 199 LLRNYPITQKCDVYSFGMLLFEII 222
L N + D + G++++E++
Sbjct: 177 LEDN-DYGRAVDWWGLGVVMYEMM 199
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 50/217 (23%), Positives = 84/217 (38%), Gaps = 49/217 (22%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY----------H 80
+G+G G+V +A K L + A+ R Y H
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---------RAYRELVLMKCVNH 120
Query: 81 INLVRLYG-FCYDQTKAA-----LVYEFMENGSLDKYLFTDTEVLKWEKLLD-----IAI 129
N++ L F +T LV E M+ + + +L +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMD---------ANLCQVIQMELDHERMSYLLY 171
Query: 130 GTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG 189
GI +LH + IIH D+KP+NI++ + + K+ DFGLA+ + Y
Sbjct: 172 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVV 225
Query: 190 TPGYSAPEFLL-RNYPITQKCDVYSFGMLLFEIIGRR 225
T Y APE +L Y + D++S G ++ E++ +
Sbjct: 226 TRYYRAPEVILGMGY--KENVDIWSVGCIMGEMVRHK 260
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 31/203 (15%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAEIGTIGRTY-HINLVRLY 87
+G G FG V + A K+L+ L K+ E M+E + + H LV L+
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 88 GFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GIAY 137
F + QT L V +++ G L F L+ E+ AR + Y
Sbjct: 106 -FSF-QTADKLYFVLDYINGGEL----FYH---LQRERCFLEP--RARFYAAEIASALGY 154
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE 197
LH I++ D+KP NILLD++ + DFGL K N +TS + GTP Y APE
Sbjct: 155 LHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPE 209
Query: 198 FLLRNYPITQKCDVYSFGMLLFE 220
L + P + D + G +L+E
Sbjct: 210 VLHKQ-PYDRTVDWWCLGAVLYE 231
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 19/197 (9%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAE---IGTIGRTYHINLVR 85
LG G FG V + ++ A KILK + M E + G+ L +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--PPFLTQ 406
Query: 86 LYGFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
L+ C+ QT L V E++ G L ++ K + A A G+ +L
Sbjct: 407 LH-SCF-QTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQS--- 460
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNY 203
+ II+ D+K N++LD++ K+ADFG+ K + +T + GTP Y APE +
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQ- 517
Query: 204 PITQKCDVYSFGMLLFE 220
P + D ++FG+LL+E
Sbjct: 518 PYGKSVDWWAFGVLLYE 534
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 56/227 (24%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY---------- 79
LG G +GVV P G +A K ++ +K + A RT
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFAL---------RTLREIKILKHFK 67
Query: 80 HINLVRLYGFCYDQTKAA-----LVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIG--- 130
H N++ ++ + ++ E M+ TD V+ + L D I
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQ---------TDLHRVISTQMLSDDHIQYFI 118
Query: 131 --TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS--- 185
T R + LH N +IH D+KP+N+L+++ KV DFGLA++ + +S
Sbjct: 119 YQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 186 -----GYRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
+ T Y APE +L Y ++ DV+S G +L E+ RR
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKY--SRAMDVWSCGCILAELFLRR 220
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 34/215 (15%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTI-----------GRT 78
KLG G F V+ + N +A KI++ +K EI +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 79 YHINLVRLYG-FCYDQTKAA---LVYEFMENGSLDKYL-FTDTEVLKWEKLLDIAIGTAR 133
++++L F + +V+E + +L + + + + I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 134 GIAYLHEECNQRIIHYDIKPANILLD------AKFSAKVADFGLAKLCNPENTHDSTSGY 187
G+ Y+H C IIH DIKP N+L++ K+AD G A C + + +
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHY---TNS 195
Query: 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
T Y +PE LL P D++S L+FE+I
Sbjct: 196 IQTREYRSPEVLL-GAPWGCGADIWSTACLIFELI 229
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 61/240 (25%), Positives = 93/240 (38%), Gaps = 72/240 (30%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY---------- 79
KLG G +G+V+K G +A K + +AQ RT+
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---------RTFREIMILTELS 66
Query: 80 -HINLVRLYGFCYDQTKAA------LVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIG- 130
H N+V L + +A LV+++ME TD V++ L +
Sbjct: 67 GHENIVNLL----NVLRADNDRDVYLVFDYME---------TDLHAVIRANILEPVHKQY 113
Query: 131 ----TARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186
+ I YLH ++H D+KP+NILL+A+ KVADFGL++ +
Sbjct: 114 VVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 187 YRGTPG-------------------YSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
Y APE LL Y T+ D++S G +L EI+ +
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY--TKGIDMWSLGCILGEILCGK 228
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 60/205 (29%), Positives = 87/205 (42%), Gaps = 35/205 (17%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAE---IGTIGRTYHINLVR 85
LG G FG V+ +F + A K LK L M E + H L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--HPFLTH 82
Query: 86 LYGFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GI 135
++ + QTK L V E++ G L ++ D++ A G+
Sbjct: 83 MF-CTF-QTKENLFFVMEYLNGGDL----MYH---IQSCHKFDLS--RATFYAAEIILGL 131
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSA 195
+LH + I++ D+K NILLD K+ADFG+ K + T+ + GTP Y A
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIA 186
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFE 220
PE LL D +SFG+LL+E
Sbjct: 187 PEILLGQ-KYNHSVDWWSFGVLLYE 210
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 35/205 (17%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAE---IGTIGRTYHINLVR 85
LG G FG V + ++ A KILK + M E + G+ L +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--PPFLTQ 85
Query: 86 LYGFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GI 135
L+ C+ QT L V E++ G L ++ A G+
Sbjct: 86 LH-SCF-QTMDRLYFVMEYVNGGDL----MYH---IQQVGRFKEP--HAVFYAAEIAIGL 134
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSA 195
+L + II+ D+K N++LD++ K+ADFG+ K + +T + GTP Y A
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIA 189
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFE 220
PE + P + D ++FG+LL+E
Sbjct: 190 PEIIAYQ-PYGKSVDWWAFGVLLYE 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 30/283 (10%), Positives = 71/283 (25%), Gaps = 52/283 (18%)
Query: 31 KLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNK--RVEAQFMAEIGTIGRTYHINLVRLY 87
G ++ ++A + V + ++ + R + R+
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
+ + +V E++ GSL + + A H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHR---AGVA 151
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
P+ + V+ G L P
Sbjct: 152 LSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA--------NP 181
Query: 208 KCDVYSFGMLLFEII-GRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266
+ D+ G L+ ++ R + L + + + + I
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP----IEPADIDRDI----- 232
Query: 267 EEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVAPPKP 309
++S VA VQ R S ++ +++ + +
Sbjct: 233 --PFQISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEV 272
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 35/205 (17%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAE---IGTIGRTYHINLVR 85
LG G FG V + + A K+LK L M E + H L +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 88
Query: 86 LYGFCYDQTKAAL--VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR--------GI 135
L+ C+ QT L V EF+ G L ++ + D A AR +
Sbjct: 89 LF-CCF-QTPDRLFFVMEFVNGGDL----MFH---IQKSRRFDEA--RARFYAAEIISAL 137
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSA 195
+LH+ + II+ D+K N+LLD + K+ADFG+ K +T+ + GTP Y A
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIA 192
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFE 220
PE L D ++ G+LL+E
Sbjct: 193 PEILQEM-LYGPAVDWWAMGVLLYE 216
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAE---IGTIGRTYHINLVR 85
+G G + V + +I A +++K + E H LV
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN--HPFLVG 117
Query: 86 LYGFCYDQTKAAL--VYEFMENGSLDKYL------------FTDTEVLKWEKLLDIAIGT 131
L+ C+ QT++ L V E++ G L ++ F E+ +A+
Sbjct: 118 LH-SCF-QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS-------LALN- 167
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP 191
YLHE + II+ D+K N+LLD++ K+ D+G+ K D+TS + GTP
Sbjct: 168 -----YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTP 217
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLFE 220
Y APE L D ++ G+L+FE
Sbjct: 218 NYIAPEILRGE-DYGFSVDWWALGVLMFE 245
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 32 LGAGGFGVVYKGQFPNGVKI-AAKILK--TCLNKRVEAQFMAE---IGTIGRTYHINLVR 85
+G G + V + +I A K++K + E H LV
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN--HPFLVG 74
Query: 86 LYGFCYDQTKAAL--VYEFMENGSLDKYL------------FTDTEVLKWEKLLDIAIGT 131
L+ C+ QT++ L V E++ G L ++ F E+ +A+
Sbjct: 75 LH-SCF-QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS-------LALN- 124
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP 191
YLHE + II+ D+K N+LLD++ K+ D+G+ K D+TS + GTP
Sbjct: 125 -----YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTP 174
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLFE 220
Y APE L D ++ G+L+FE
Sbjct: 175 NYIAPEILRGE-DYGFSVDWWALGVLMFE 202
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 51/252 (20%), Positives = 85/252 (33%), Gaps = 69/252 (27%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY---------- 79
+G G +G V + +A K + ++ + R
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK---------RILREIAILNRLN 110
Query: 80 HINLVRLYGFCYDQTKAA-----LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGT--- 131
H ++V++ + +V E ++ K T L ++ I T
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTP------VYLTELHIKTLLY 163
Query: 132 --ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRG 189
G+ Y+H I+H D+KPAN L++ S KV DFGLA+ + +S
Sbjct: 164 NLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 190 TPG-------------------------YSAPEFLL--RNYPITQKCDVYSFGMLLFEII 222
Y APE +L NY T+ DV+S G + E++
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIFAELL 278
Query: 223 GRRKNAQDCSSD 234
K +D
Sbjct: 279 NMIKENVAYHAD 290
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 54/255 (21%), Positives = 87/255 (34%), Gaps = 68/255 (26%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY---------- 79
+G G +G VY +A K + ++ + R
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---------RILREITILNRLK 83
Query: 80 HINLVRLYGFCYDQTKAA-----LVYEFMENGSLDKYLFTD-TEVLKWEKLLD------I 127
++RLY +V E + +D ++ K L I
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIAD---------SDLKKLFKTPIFLTEEHIKTI 134
Query: 128 AIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187
G ++HE IIH D+KPAN LL+ S KV DFGLA+ N E + +
Sbjct: 135 LYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 188 RGTPG--------------------YSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRR 225
Y APE +L NY T+ D++S G + E++
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY--TKSIDIWSTGCIFAELLNML 249
Query: 226 KNAQDCSSDTLDWFP 240
++ + ++ FP
Sbjct: 250 QSHINDPTNRFPLFP 264
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 53/209 (25%), Positives = 79/209 (37%), Gaps = 38/209 (18%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR--------TYHI 81
+G G FG V K +A KI+K K Q E+ + Y+I
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKN--KKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIA----- 136
V L + LV+E L L+ ++L+ +++ R A
Sbjct: 119 --VHLKRHFMFRNHLCLVFE-----MLSYNLY---DLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 137 ---YLHEECNQRIIHYDIKPANILL--DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP 191
+L IIH D+KP NILL + + K+ DFG + C Y +
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRI---YQYIQSR 222
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLFE 220
Y +PE LL P D++S G +L E
Sbjct: 223 FYRSPEVLL-GMPYDLAIDMWSLGCILVE 250
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 40/209 (19%)
Query: 32 LGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR--------TYHIN 82
+G G FG V K +A K+++ KR Q EI + T ++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNV- 161
Query: 83 LVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIA------ 136
+ + + + +E L L+ E++K K ++ R A
Sbjct: 162 -IHMLENFTFRNHICMTFE-----LLSMNLY---ELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 137 --YLHEECNQRIIHYDIKPANILL--DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPG 192
LH+ RIIH D+KP NILL + KV DFG + C Y +
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRV---YTYIQSRF 264
Query: 193 YSAPEFLLRNYPITQKCDVYSFGMLLFEI 221
Y APE +L D++S G +L E+
Sbjct: 265 YRAPEVIL-GARYGMPIDMWSLGCILAEL 292
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 4/110 (3%)
Query: 113 FTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA 172
+ L E L+ + A+G+ +L ++ IH D+ NILL K K+ DFGLA
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
+ + + R + APE + + T + DV+SFG+LL+EI
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 8/90 (8%)
Query: 31 KLGAGGFGVVYKG------QFPNGVKIAAKILKTCLNKRVEAQFMAEIGT-IGRTYHINL 83
LG G FG V + + +A K+LK M+E+ I +H+N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 84 VRLYGFCYDQTKAALV-YEFMENGSLDKYL 112
V L G C +V EF + G+L YL
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 47/194 (24%), Positives = 74/194 (38%), Gaps = 42/194 (21%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNK----RVEAQFM------AEIGTIGRTY 79
K+G+GGFG++Y K A ++K + E +F I
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 80 HINLV---RLYGFCYDQTKA----ALVYEFMENG-SLDKYL-----FTDTEVLKWEKLLD 126
++ + YG + K +V E + G L K F + VL+
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQ------ 155
Query: 127 IAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKV--ADFGLAKLCNPENTH--- 181
+ I + Y+HE +H DIK AN+LL K +V AD+GL+ P H
Sbjct: 156 LGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 182 --DSTSGYRGTPGY 193
+ G+ GT +
Sbjct: 213 QENPRKGHNGTIEF 226
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 39/191 (20%), Positives = 64/191 (33%), Gaps = 33/191 (17%)
Query: 31 KLGAGGFGVVYKGQ---------FPNGVKIAAKILKTCLNKRVEAQFM------AEIGTI 75
G++Y+ P K + K+ E F ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 76 GRTYHINLV---RLYGFCYDQTK-AALVYEFMENG-SLDKYL-FTDTEVLKWEKLLDIAI 129
+ Y L+ GF Q K LV + G SL L + VL +L +A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVAC 166
Query: 130 GTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKV--ADFGLAKLCNPENTH-----D 182
+ +LHE +H ++ NI +D + ++V A +G A P H
Sbjct: 167 RLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223
Query: 183 STSGYRGTPGY 193
S S + G +
Sbjct: 224 SRSPHEGDLEF 234
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 56/273 (20%), Positives = 88/273 (32%), Gaps = 92/273 (33%)
Query: 98 LVYEFMENG-SLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPAN 155
+V+E + G L K++ + + L + I +G+ YLH +C IIH DIKP N
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPEN 177
Query: 156 ILL-------------------------------------------------DAKFSAKV 166
ILL K K+
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 167 ADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRK 226
AD G A + T D T Y + E L+ + D++S + FE+
Sbjct: 238 ADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDY 291
Query: 227 --NAQDCSSDTLDW------------FPKQVWD------EY--EKGEL--AAKVLGCGIE 262
T D P+++ E+ +KG+L K+ G+
Sbjct: 292 LFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351
Query: 263 EN-------DREEAERMSMVALWCVQDCPEARP 288
E +EEA + L ++ PE R
Sbjct: 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 40/197 (20%), Positives = 70/197 (35%), Gaps = 45/197 (22%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILK-TCLNKR------VEAQFM------AEIGTIGR 77
+G GGFG +Y + + + + E +F +I R
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 78 TYHINLV---RLYGFCYDQTKA----ALVYEFMENG-SLDKYL------FTDTEVLKWEK 123
T + + + +G ++ + G L K F+ VL+
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQ--- 156
Query: 124 LLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKV--ADFGLAKLCNPENTH 181
+++ + Y+HE +H DIK +N+LL+ K +V D+GLA PE H
Sbjct: 157 ---LSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 182 -----DSTSGYRGTPGY 193
D + GT +
Sbjct: 211 KAYAADPKRCHDGTIEF 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 2e-09
Identities = 34/212 (16%), Positives = 58/212 (27%), Gaps = 58/212 (27%)
Query: 11 EKPVRFTLEQLCSFTNNYST--KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEA-- 66
+ PV F+ C T K+G G FG V++ + +A KI+ V
Sbjct: 8 KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIADHT-PVAIKIIAIEGPDLVNGSH 63
Query: 67 --------------QFMAEIGTIGRTYHINLVRLYGFC----------------YDQTKA 96
+ ++ + + L Y+ TK
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 97 A--------------LVYEFMENG-SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
+ +V EF G L++ T++ I +A
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQM---RTKLSSLATAKSILHQLTASLAVAEAS 180
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173
H D+ N+LL K+ K
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 55/228 (24%), Positives = 84/228 (36%), Gaps = 60/228 (26%)
Query: 31 KLGAGGFGVVYKGQ--FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR--------TYH 80
LG G FG V + G +A KI+K R +EI + T+
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIA---- 136
V++ + +V+E L + + +K L + R +A
Sbjct: 79 C--VQMLEWFEHHGHICIVFE-----LLGLSTY---DFIKENGFLPFRLDHIRKMAYQIC 128
Query: 137 ----YLHEECNQRIIHYDIKPANILL-DAKFSA------------------KVADFGLAK 173
+LH ++ H D+KP NIL + ++ KV DFG A
Sbjct: 129 KSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 174 LCN-PENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFE 220
+ +T ST YR APE +L +Q CDV+S G +L E
Sbjct: 186 YDDEHHSTLVSTRHYR------APEVIL-ALGWSQPCDVWSIGCILIE 226
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 55/237 (23%), Positives = 79/237 (33%), Gaps = 78/237 (32%)
Query: 31 KLGAGGFGVVYKG--QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR--------TYH 80
LG G FG V + ++A KI++ + EI + + +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFL 83
Query: 81 INLVRLYGF-------CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTAR 133
V + + C + +E L K F E LK + R
Sbjct: 84 C--VLMSDWFNFHGHMC-------IAFE-----LLGKNTF---EFLKENNFQPYPLPHVR 126
Query: 134 GIA--------YLHEECNQRIIHYDIKPANILL-------------------DAKFSAKV 166
+A +LHE ++ H D+KP NIL S +V
Sbjct: 127 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 167 ADFGLAKLCNPENTH---DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFE 220
ADFG A H +T YR PE +L Q CDV+S G +LFE
Sbjct: 184 ADFGSA--TFDHEHHTTIVATRHYR------PPEVIL-ELGWAQPCDVWSIGCILFE 231
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 40/179 (22%), Positives = 65/179 (36%), Gaps = 27/179 (15%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKT---CLNKRVEAQFMAEI-GTIGRTYHINLVR 85
++G G FGV+++G N ++A K R E + + G G +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG------IPN 70
Query: 86 LYGFCYDQTKAALVYEFMENG-SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
+Y F + LV + + G SL+ L + + A + +HE +
Sbjct: 71 VYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---K 125
Query: 145 RIIHYDIKPANILLDAKFSAK-----VADFGLAKLCNPENTH-----DSTSGYRGTPGY 193
+++ DIKP N L+ S V DFG+ K T GT Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 41/177 (23%), Positives = 68/177 (38%), Gaps = 25/177 (14%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRV---EAQFMAEI-GTIGRTYHINLVR 85
K+G+G FG +Y G ++A K+ E++ + G G +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG------IPN 67
Query: 86 LYGFCYDQTKAALVYEFMENG-SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
+ F + LV + + G SL+ + L + +L +A + ++H +
Sbjct: 68 VRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 145 RIIHYDIKPANILLDAKFSAK---VADFGLAKLCNPENTH-----DSTSGYRGTPGY 193
+H DIKP N L+ A + DFGLAK +TH GT Y
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 41/177 (23%), Positives = 67/177 (37%), Gaps = 25/177 (14%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRV---EAQFMAEI-GTIGRTYHINLVR 85
K+G+G FG +Y G G ++A K+ E++ + G +G +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG------IPT 69
Query: 86 LYGFCYDQTKAALVYEFMENG-SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
+ + +V E + G SL+ + + +L +A I Y+H ++
Sbjct: 70 IRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 124
Query: 145 RIIHYDIKPANILLDAKFSAK---VADFGLAKLCNPENTH-----DSTSGYRGTPGY 193
IH D+KP N L+ + DFGLAK TH GT Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 44/180 (24%), Positives = 67/180 (37%), Gaps = 29/180 (16%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHI-----NLV 84
K+G G FG + G+ +A K+ K Q E R Y +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPM---KSRAPQLHLEY----RFYKQLGSGDGIP 68
Query: 85 RLYGFCYDQTKAALVYEFMENG-SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
++Y F A+V E + G SL+ + +L IAI + Y+H +
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125
Query: 144 QRIIHYDIKPANILLDAKFSAK-----VADFGLAKL-CNPE-NTH---DSTSGYRGTPGY 193
+I+ D+KP N L+ + + DF LAK +PE H GT Y
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 53/241 (21%), Positives = 78/241 (32%), Gaps = 82/241 (34%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIG---TIGRT----YHIN 82
K+G G FG V Q N A K+++ K+ E I +I
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNI- 98
Query: 83 LVRLYGF-------CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLL--------DI 127
V+ +G C L++E L L+ E++
Sbjct: 99 -VKYHGKFMYYDHMC-------LIFE-----PLGPSLY---EIITRNNYNGFHIEDIKLY 142
Query: 128 AIGTARGIAYLHEECNQRIIHYDIKPANILL-------------------------DAKF 162
I + + YL + + H D+KP NILL
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 163 SAKVADFGLAKLCNPENTHD---STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLF 219
K+ DFG A + H +T YR APE +L N D++SFG +L
Sbjct: 200 GIKLIDFGCA--TFKSDYHGSIINTRQYR------APEVIL-NLGWDVSSDMWSFGCVLA 250
Query: 220 E 220
E
Sbjct: 251 E 251
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 3e-06
Identities = 32/191 (16%), Positives = 57/191 (29%), Gaps = 35/191 (18%)
Query: 45 FPNGVKIAAKILKTC---LNKRVEAQFMAEI---GTIGRTYHINLVRLYGFCYDQTKAAL 98
FP I +L + K + ++ + + + + + Y + K L
Sbjct: 381 FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS-IYLELKVKL 439
Query: 99 VYEF-MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPA-NI 156
E+ + +D Y T + L+ + Y H I + +K +
Sbjct: 440 ENEYALHRSIVDHYNIPKT--FDSDDLIPPYL---DQYFYSH-------IGHHLKNIEHP 487
Query: 157 LLDAKFSAKVADFGL--AKLCNPENTHDSTSGYRGTPGYSAPEFL-LRNYP--ITQKCDV 211
F DF K+ HDST+ G L+ Y I
Sbjct: 488 ERMTLFRMVFLDFRFLEQKIR-----HDSTA--WNASGSILNTLQQLKFYKPYICDNDPK 540
Query: 212 YSFGMLLFEII 222
Y L+ I+
Sbjct: 541 YE--RLVNAIL 549
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 9e-05
Identities = 46/342 (13%), Positives = 95/342 (27%), Gaps = 105/342 (30%)
Query: 6 RDIAREKPV---RFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL-- 60
+++R +P R L +L G G G KT +
Sbjct: 129 YNVSRLQPYLKLRQALLELRP--AKNVLIDGVLGSG------------------KTWVAL 168
Query: 61 ----NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDT 116
+ +V+ + +I + +NL C V E ++ L
Sbjct: 169 DVCLSYKVQCKMDFKI------FWLNL----KNC---NSPETVLEMLQK------LLYQI 209
Query: 117 EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVAD-FGLAKLC 175
+ W D + I + E + + + ++L +AK + F L+ C
Sbjct: 210 D-PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS--C 266
Query: 176 NPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDT 235
+ LL T+ V + +
Sbjct: 267 ---------------------KILL----TTRFKQV-------TDFLSAATTTHISLDHH 294
Query: 236 LDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAER-----MSMVALWCVQDCPE----- 285
E L K L C ++ E +S++A ++D
Sbjct: 295 SMTL-----TPDEVKSLLLKYLDCRPQD-LPREVLTTNPRRLSIIAE-SIRDGLATWDNW 347
Query: 286 ARPPMSAVVKMLEGGVEIVAPPKPFRYLY---SIGMDALKSP 324
+ ++E + ++ P + +R ++ S+ + P
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAE-YRKMFDRLSVFPPSAHIP 388
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 369 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.28 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.86 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.64 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.62 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.53 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.49 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.11 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.98 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.77 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.72 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.58 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.55 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.33 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.33 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.32 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.92 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.17 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.37 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.12 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.05 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.1 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=435.13 Aligned_cols=265 Identities=20% Similarity=0.346 Sum_probs=220.8
Q ss_pred cCHHHHHHhhhccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeE
Q 017591 16 FTLEQLCSFTNNYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89 (369)
Q Consensus 16 ~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 89 (369)
..+.|+.-.+..|.++||+|+||+||+|.+. +++.||||+++.........+|.+|+.++++++|||||+++|+
T Consensus 18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 4445565667788899999999999999862 4689999999865555556789999999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCC
Q 017591 90 CYDQTKAALVYEFMENGSLDKYLFTD---------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPA 154 (369)
Q Consensus 90 ~~~~~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~ 154 (369)
|.+.+..+||||||++|+|.++|... ...+++..++.|+.|++.||+|||+ ++|+||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCcccc
Confidence 99999999999999999999999543 2368999999999999999999999 99999999999
Q ss_pred ceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 017591 155 NILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSS 233 (369)
Q Consensus 155 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~ 233 (369)
||||+.++.+||+|||+++...............||+.|||||++..+ .++.++|||||||+||||+| |+.||.....
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876544333334556799999999998875 79999999999999999998 8899875432
Q ss_pred CccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 234 DTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
. ++...+......+.+...+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 254 ~----------------~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 Q----------------DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H----------------HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 12222333333445556778899999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-59 Score=426.97 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=204.8
Q ss_pred cccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 28 YSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.++||+|+||+||+|++. ++..||||+++.. ......+|.+|+.++++++|||||+++++|.+.+..+||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4578999999999999864 4789999999854 44556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEe
Q 017591 102 FMENGSLDKYLFTD--------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVA 167 (369)
Q Consensus 102 ~~~~gsL~~~l~~~--------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 167 (369)
||++|+|.+++... ..++++.+++.|+.|++.||+|||+ ++|+||||||+||||+.++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEc
Confidence 99999999999543 2469999999999999999999999 999999999999999999999999
Q ss_pred ecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHH
Q 017591 168 DFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDE 246 (369)
Q Consensus 168 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 246 (369)
|||+++...............||+.|||||++.+. .++.++|||||||+||||+| |+.||...... .+.
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~~-- 270 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-------EAI-- 270 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-------HHH--
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHH-------HHH--
Confidence 99999876554444444556799999999998875 79999999999999999999 89999754321 111
Q ss_pred hhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
..+........+...+..+.+|+.+||+.||++|||+.+|++.|+....
T Consensus 271 -------~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 -------DCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -------HHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------HHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 2222222334455567889999999999999999999999999987644
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-59 Score=423.73 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=212.4
Q ss_pred ccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.++||+|+||+||+|++. ++..||||+++.. ......+|.+|+.++++++|||||+++++|.+.+..+|||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 35688999999999999863 4788999999854 4455678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEee
Q 017591 101 EFMENGSLDKYLFTD------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVAD 168 (369)
Q Consensus 101 e~~~~gsL~~~l~~~------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 168 (369)
|||++|+|.++|... ...+++.+++.|+.|++.||.|||+ ++|+||||||+||||+.++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECC
Confidence 999999999999653 2479999999999999999999999 9999999999999999999999999
Q ss_pred cCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHh
Q 017591 169 FGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEY 247 (369)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 247 (369)
||+|+...............||+.|||||++..+ .++.++|||||||++|||+| |+.||...+..
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------------- 237 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------------- 237 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------------
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------------
Confidence 9999876544433334445699999999998875 79999999999999999998 89999754321
Q ss_pred hhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 248 EKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
++...+........+...+..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 238 ---~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 238 ---EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp ---HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 112222233334445566788999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=418.56 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=204.6
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.|.++||+|+||+||+|++.+ .||||+++.. ........|.+|+.++++++|||||++++++. ++..+||||||++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCC
Confidence 456889999999999998743 5999998743 34556778999999999999999999999885 4568999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|.+++......+++.+++.|+.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+|+............
T Consensus 116 GsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~ 192 (307)
T 3omv_A 116 SSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192 (307)
T ss_dssp CBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----------
T ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeec
Confidence 99999997777789999999999999999999999 999999999999999999999999999998765443333344
Q ss_pred cCCCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRN--YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~--~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
...||+.|||||++... ..++.++|||||||+||||+||+.||....... .+......+. .....+.
T Consensus 193 ~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~-----~~p~~~~ 261 (307)
T 3omv_A 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGY-----ASPDLSK 261 (307)
T ss_dssp -CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTC-----CCCCSTT
T ss_pred ccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCC-----CCCCccc
Confidence 56799999999998642 368999999999999999999999997544321 0111111110 1111123
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3445677899999999999999999999999998765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-57 Score=414.32 Aligned_cols=248 Identities=20% Similarity=0.353 Sum_probs=202.1
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
|.+.++||+|+||+||+|+++ +|+.||||++... ........+.+|+.++++++|||||++++++.+++..|||||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 344578999999999999874 5999999998643 34455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+||+|.++|... ...+++.+++.|+.||+.||.|||+ +||+||||||+||||+.++.+||+|||+|+...... .
T Consensus 106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 180 (350)
T 4b9d_A 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--E 180 (350)
T ss_dssp TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--H
T ss_pred CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--c
Confidence 999999999654 4568999999999999999999999 999999999999999999999999999998654221 1
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......||+.|||||++.+. .++.++|||||||++|||++|+.||...+.. ++...+.....+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~----------------~~~~~i~~~~~~ 243 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMK----------------NLVLKIISGSFP 243 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHHHHHHHTCCC
T ss_pred cccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHHHHHHcCCCC
Confidence 22345799999999998774 7999999999999999999999999754321 111222222333
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+..++..+.+|+.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 444556788999999999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-57 Score=407.92 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=207.5
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||+||+|++ .+|+.||+|++.+.. .......+.+|+.+++.++|||||++++++.+++..||||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 45668999999999999987 469999999987532 223356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
|+||+|.+++. ..+.+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 114 ~~gG~L~~~i~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 114 AKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred CCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 99999999994 44679999999999999999999999 999999999999999999999999999999876554444
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....+||+.|||||++.+. .++.++|||||||++|+|++|+.||...+.. .++..+..+. .
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~----------~ 251 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEG-------LIFAKIIKLE----------Y 251 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTC----------C
T ss_pred cccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC----------C
Confidence 44567899999999998875 7899999999999999999999999754321 1122221111 1
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
..+...+..+.+|+.+||+.||.+|||+.|++
T Consensus 252 ~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 22334567899999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=397.62 Aligned_cols=245 Identities=27% Similarity=0.432 Sum_probs=197.7
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe----CCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD----QTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 100 (369)
.|.++||+|+||+||+|.+. ++..||+|++... ........|.+|+.++++++|||||++++++.+ .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 35578999999999999884 5899999998643 344556789999999999999999999999875 34579999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCC--eEeecCCCCceEecC-CCCeeEeecCCceecCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR--IIHYDIKPANILLDA-KFSAKVADFGLAKLCNP 177 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 177 (369)
|||++|+|.+++. ....+++..+..|+.|++.||+|||+ ++ |+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999994 45679999999999999999999999 77 999999999999974 78999999999985432
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
. ......||+.|||||++.+ .++.++|||||||++|||+||+.||...... ..++.....+..
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~----- 247 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVK----- 247 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCC-----
T ss_pred C----ccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCC-----
Confidence 2 2234679999999998864 5899999999999999999999999754322 111122211110
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 248 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 ---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112223457899999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-56 Score=405.35 Aligned_cols=247 Identities=21% Similarity=0.268 Sum_probs=201.8
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
.++||+|+||+||+|+++ +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..+||||||+||+
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 468999999999999884 599999999875322 2479999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-CeeEeecCCceecCCCCCc---cc
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENTH---DS 183 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~---~~ 183 (369)
|.+++. ..+.+++..+..|+.|++.||+|||+ ++|+||||||+||||+.+| .+||+|||+|+.+...... ..
T Consensus 137 L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 137 LGQLIK-QMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp HHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred HHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 999994 44679999999999999999999999 9999999999999999987 6999999999987543221 12
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||+.|||||++.+. .++.++|||||||++|||++|+.||........ ...+..+.. ....
T Consensus 213 ~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~~~-------~~~~ 277 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-------CLKIASEPP-------PIRE 277 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-------HHHHHHSCC-------GGGG
T ss_pred CCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHHcCCC-------Cchh
Confidence 2345799999999998875 799999999999999999999999976544321 112111111 0112
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+...+..+.+|+.+||+.||.+|||+.|+++.|...
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 3345677899999999999999999999999888654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=411.86 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=213.5
Q ss_pred hhccccccccCCceEEEEEEeCC------CcEEEEEEccccccHHHHHHHHHHHHHHhccCC-CceeeEEeEEEeC-Cce
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPN------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH-INLVRLYGFCYDQ-TKA 96 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~-~~~ 96 (369)
.+.+.++||+|+||+||+|.+.. ++.||||.+...........|.+|+.++.++.| ||||+++++|.+. +..
T Consensus 65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~ 144 (353)
T 4ase_A 65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 144 (353)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence 33456889999999999998632 368999999876666667889999999999965 8999999999765 568
Q ss_pred EEEEeccCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC
Q 017591 97 ALVYEFMENGSLDKYLFTD---------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK 161 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 161 (369)
+||||||++|+|.++|... ...+++..++.|+.|+++||+|||+ ++||||||||+|||++.+
T Consensus 145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK 221 (353)
T ss_dssp EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCC
Confidence 9999999999999999543 2458999999999999999999999 999999999999999999
Q ss_pred CCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccc
Q 017591 162 FSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFP 240 (369)
Q Consensus 162 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 240 (369)
+.+||+|||+|+.+.............||+.|||||++.++ .++.++|||||||+||||+| |+.||.......
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~----- 295 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 295 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 99999999999877654444444556799999999999875 79999999999999999998 899997654321
Q ss_pred cchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.+...+ ........+...+..+.+|+.+||+.||.+|||+.+|++.|+..+
T Consensus 296 -~~~~~i---------~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 296 -EFCRRL---------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp -HHHHHH---------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHH---------HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111222 222223344456778999999999999999999999999998653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=405.89 Aligned_cols=246 Identities=21% Similarity=0.307 Sum_probs=203.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||+|+||+||+|+++ +|+.||||++..... .....+.+|+.+++.++|||||++++++.+++..|||||||+|
T Consensus 77 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 77 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 34578999999999999885 699999999864322 2245688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|.+++.. ..+++..+..|+.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|+.+..... ...
T Consensus 156 g~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~ 228 (346)
T 4fih_A 156 GALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 228 (346)
T ss_dssp EEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBC
T ss_pred CcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--ccc
Confidence 999999953 469999999999999999999999 9999999999999999999999999999987654322 234
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..+||+.|||||++... .++.++|||||||++|||++|+.||....... ....+... ........
T Consensus 229 ~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~-------~~~~~~~~ 293 (346)
T 4fih_A 229 SLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-------LPPRLKNL 293 (346)
T ss_dssp CCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHS-------SCCCCSCG
T ss_pred ccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcC-------CCCCCCcc
Confidence 46799999999988764 78999999999999999999999997543211 11111110 00112233
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 456778999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=393.74 Aligned_cols=245 Identities=23% Similarity=0.380 Sum_probs=190.9
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||+||+|++. +|+.||+|++.+.. .......+.+|+.+++.++|||||++++++.+++..++||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 456689999999999999874 69999999986532 223356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+ +|+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.......
T Consensus 95 ~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~-- 167 (275)
T 3hyh_A 95 A-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-- 167 (275)
T ss_dssp C-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred C-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc--
Confidence 9 5799999844 4679999999999999999999999 9999999999999999999999999999987543322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....||+.|+|||++.+...++.++|||||||++|+|++|+.||...+.. .+......+. .
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-------~~~~~i~~~~----------~ 229 (275)
T 3hyh_A 168 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-------VLFKNISNGV----------Y 229 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTC----------C
T ss_pred -cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCC----------C
Confidence 234679999999999887645578999999999999999999999753321 1122221111 1
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 223345678899999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-55 Score=396.78 Aligned_cols=269 Identities=26% Similarity=0.316 Sum_probs=200.2
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC----ceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT----KAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 101 (369)
+-+.++||+|+||+||+|++ +|+.||||++.... .....++.|+..+.+++|||||++++++.+.+ ..+||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 34568999999999999998 68999999987532 22334456777778899999999999998654 5799999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc-----CCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC-----NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~-----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
||++|+|.+++.. ..++++.+..++.|++.||+|||+.+ ..+|+||||||+||||+.++.+||+|||+++...
T Consensus 82 y~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999999954 46899999999999999999999821 1399999999999999999999999999998765
Q ss_pred CCCCcc--ccccCCCCCCccccccccccC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccc---c-chhH
Q 017591 177 PENTHD--STSGYRGTPGYSAPEFLLRNY-----PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP---K-QVWD 245 (369)
Q Consensus 177 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~---~-~~~~ 245 (369)
...... ......||+.|||||++.+.. .++.++|||||||+||||+||+.|+.........+.. . ....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 433221 223457999999999987531 3678999999999999999999887654432221110 0 0001
Q ss_pred HhhhchhhhhhhcCCCCC--CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 246 EYEKGELAAKVLGCGIEE--NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
..... +.........+. .....+..+.+|+.+||+.||.+||||.+|++.|+.+
T Consensus 240 ~~~~~-~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 240 EMRKV-VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHH-HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH-HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11000 000001111111 1235667899999999999999999999999999865
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=406.84 Aligned_cols=246 Identities=21% Similarity=0.307 Sum_probs=203.0
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||+|+||.||+|+++ +|+.||||++..... .....+.+|+.+++.++|||||++++++.+.+..|||||||+|
T Consensus 154 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 154 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 34578999999999999884 599999999864322 2245688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|.+++.. ..+++..+..|+.||+.||+|||+ +||+||||||+||||+.+|.+||+|||+|+.+..... ...
T Consensus 233 G~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~ 305 (423)
T 4fie_A 233 GALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 305 (423)
T ss_dssp EEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBC
T ss_pred CcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--ccc
Confidence 999999943 469999999999999999999999 9999999999999999999999999999987654322 234
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..+||+.|||||++.+. .++.++|||||||++|||++|+.||....... ....+... ........
T Consensus 306 ~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~-------~~~~~~~~ 370 (423)
T 4fie_A 306 SLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-------LPPRLKNL 370 (423)
T ss_dssp CCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHS-------CCCCCSCT
T ss_pred ccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcC-------CCCCCccc
Confidence 46799999999988765 78999999999999999999999997543211 11111111 00111223
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 345678999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=387.69 Aligned_cols=247 Identities=21% Similarity=0.350 Sum_probs=189.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----------
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT----------- 94 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----------- 94 (369)
.+.+.||+|+||+||+|+++ +|+.||||++...........+.+|+.++++++|||||++++++.+.+
T Consensus 8 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~ 87 (299)
T 4g31_A 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87 (299)
T ss_dssp EEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------C
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCC
Confidence 45689999999999999874 689999999876555566678999999999999999999999987654
Q ss_pred -ceEEEEeccCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCC
Q 017591 95 -KAALVYEFMENGSLDKYLFTDT--EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 95 -~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
..++|||||++|+|.+++.... ...++..++.|+.|+++||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred cEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCcc
Confidence 3689999999999999995443 245677899999999999999999 9999999999999999999999999999
Q ss_pred ceecCCCCCc----------cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcccc
Q 017591 172 AKLCNPENTH----------DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPK 241 (369)
Q Consensus 172 ~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 241 (369)
|+.+...... ...+...||+.|||||++.+. .++.++|||||||++|||++ ||....
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--------- 231 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--------- 231 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH---------
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc---------
Confidence 9876543221 112345799999999998874 79999999999999999996 653210
Q ss_pred chhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 242 QVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..............+.........+.+|+.+||+.||.+|||+.++++
T Consensus 232 ------~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ------ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ------HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111122222233333445566788999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=395.41 Aligned_cols=241 Identities=25% Similarity=0.260 Sum_probs=191.7
Q ss_pred hccccccccCCceEEEEEEeC----CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP----NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
+.+.+.||+|+||+||+|+.. +++.||+|++.... .......+.+|+.++++++|||||++++++.+++..+|||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 456789999999999999762 47899999986432 1122346888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
|||+||+|.+++. +...+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.......
T Consensus 106 Ey~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 106 DFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp CCCTTCEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EcCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 9999999999994 44579999999999999999999999 9999999999999999999999999999986543222
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
......||+.|||||++.+. .++.++|||||||++|||++|+.||...+... +.... ....
T Consensus 182 --~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i---------~~~~ 242 (304)
T 3ubd_A 182 --KAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-------TMTMI---------LKAK 242 (304)
T ss_dssp --CCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH---------HHCC
T ss_pred --cccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-------HHHHH---------HcCC
Confidence 22346799999999998775 78999999999999999999999997543211 11111 1111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
...+...+..+.+|+.+||+.||.+|||+
T Consensus 243 -~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 -LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 22334456789999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=380.76 Aligned_cols=265 Identities=20% Similarity=0.267 Sum_probs=199.7
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC------CceE
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ------TKAA 97 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 97 (369)
+.+.++||+|+||+||+|++ .+|+.||||++... ........+.+|+.+|+.++|||||++++++... +..|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 34457899999999999988 46999999998753 3344556788999999999999999999987643 5789
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
||||||. |+|.+++ .....+++..+..|+.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 136 ivmE~~~-g~L~~~i-~~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 136 VVLDLME-SDLHQII-HSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEECCS-EEHHHHH-TSSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEeCCC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 9999996 5899999 445689999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCC--ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHh
Q 017591 178 ENT--HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEY 247 (369)
Q Consensus 178 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~ 247 (369)
... ........||+.|+|||++.+...++.++||||+||++|||++|+.||.+.+.... ...+...+...
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 221 22234568999999999988765789999999999999999999999976543210 00000001110
Q ss_pred hhchhhhhhh--cCCCCCC----CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 248 EKGELAAKVL--GCGIEEN----DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 248 ~~~~~~~~~~--~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.......... ....+.. .+..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000 0000000 1123567889999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=370.78 Aligned_cols=198 Identities=23% Similarity=0.355 Sum_probs=169.1
Q ss_pred hccccccccCCceEEEEEEeC----CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 100 (369)
+.+.++||+|+||+||+|+++ .++.||+|.+..... ..++.+|+.++..+ .||||+++++++.+.+..++||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 455689999999999999763 478999998875433 34678999999988 6999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC-CCeeEeecCCceecCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 179 (369)
||+++|+|.+++ ..+++.++..++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 100 E~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 100 PYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp ECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred eCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 999999999999 359999999999999999999999 999999999999999876 789999999998664322
Q ss_pred Cc--------------------------cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 017591 180 TH--------------------------DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSS 233 (369)
Q Consensus 180 ~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~ 233 (369)
.. ...+...||+.|+|||++.+...++.++||||+||++|||++|+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 11 1123356999999999988765789999999999999999999999975543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=365.51 Aligned_cols=284 Identities=34% Similarity=0.559 Sum_probs=229.7
Q ss_pred cccCHHHHHHhhhccc--cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEE
Q 017591 14 VRFTLEQLCSFTNNYS--TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY 91 (369)
Q Consensus 14 ~~~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 91 (369)
.++++.++...+++|. +.||+|+||.||+|.+.+++.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 3566667777777775 68999999999999998899999999875433 34668999999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEee
Q 017591 92 DQTKAALVYEFMENGSLDKYLFTDT---EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVAD 168 (369)
Q Consensus 92 ~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 168 (369)
+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999995443 359999999999999999999999 9999999999999999999999999
Q ss_pred cCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhh
Q 017591 169 FGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYE 248 (369)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 248 (369)
||++................||+.|+|||.+.++ .++.++|||||||++|+|++|+.||....+........+......
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred cccccccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 9999875543333333445689999999988765 789999999999999999999999986655433222222222222
Q ss_pred hchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
.+.+................+..+.+++.+||+.||.+||++.+|++.|+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 222222222333345678889999999999999999999999999999987643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=386.80 Aligned_cols=246 Identities=21% Similarity=0.257 Sum_probs=198.4
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc-----cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-----NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.++||+|+||.||+|+.+ +|+.||+|++.+.. ..........++.+++.++|||||++++++.+.+..||||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34589999999999999885 59999999986421 1122223344567778889999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
|||+||+|..+|. ..+.+++..+..|+.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 272 Ey~~GGdL~~~l~-~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 272 DLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp CCCCSCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred ecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 9999999999994 44679999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
....+||+.|||||++..+..++.++|+|||||++|||++|+.||........ .. +.......
T Consensus 347 ---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-------~~------i~~~i~~~- 409 (689)
T 3v5w_A 347 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------HE------IDRMTLTM- 409 (689)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-------HH------HHHHHHHC-
T ss_pred ---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-------HH------HHHhhcCC-
Confidence 23467999999999997665799999999999999999999999975332211 00 11111111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCC-----hHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPP-----MSAVV 294 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~v~ 294 (369)
....+...+..+.+|+.+||+.||.+|++ +.+|.
T Consensus 410 ~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 410 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 12234456788999999999999999998 56665
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=362.29 Aligned_cols=287 Identities=41% Similarity=0.631 Sum_probs=228.1
Q ss_pred CCcccCHHHHHHhhhccc--cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeE
Q 017591 12 KPVRFTLEQLCSFTNNYS--TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89 (369)
Q Consensus 12 ~~~~~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 89 (369)
....|++.++...+++|. +.||+|+||.||+|.+.+++.||+|++...........+.+|+.++..++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 345699999999999886 789999999999999888999999998865443334478999999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeE
Q 017591 90 CYDQTKAALVYEFMENGSLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKV 166 (369)
Q Consensus 90 ~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 166 (369)
+.+.+..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+..+++||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999643 235999999999999999999999922229999999999999999999999
Q ss_pred eecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC--ccCccccchh
Q 017591 167 ADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSD--TLDWFPKQVW 244 (369)
Q Consensus 167 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~ 244 (369)
+|||++......... ......||+.|+|||++... .++.++|||||||++|+|++|+.||...... .......+..
T Consensus 176 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 176 GDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp CCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred ccCccccccCccccc-ccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999876543332 23345699999999988765 6899999999999999999999999622111 1111111111
Q ss_pred HHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 245 DEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
........................+..+.+++.+||+.||.+|||+.+|++.|++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 11122222222223333456788899999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=386.74 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=205.9
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||+|+||+||+|.++ +|+.||+|++.... ......+.+|+.+|+.++|||||++++++.+.+..+||||||+
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 455689999999999999884 59999999987533 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC--CCeeEeecCCceecCCCCCcc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK--FSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
||+|.+++......+++..+..|+.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++.+......
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~- 313 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV- 313 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE-
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce-
Confidence 999999997667789999999999999999999999 999999999999999854 78999999999987544322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+..... ....
T Consensus 314 --~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-------~~~~i~~~~~------~~~~ 377 (573)
T 3uto_A 314 --KVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDW------NMDD 377 (573)
T ss_dssp --EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCC------CCCS
T ss_pred --eeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHhCCC------CCCc
Confidence 235699999999988875 78999999999999999999999997543321 1111111110 0011
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......+..+.+|+.+||+.||.+||++.|+++
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122345677899999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=347.76 Aligned_cols=280 Identities=38% Similarity=0.559 Sum_probs=230.0
Q ss_pred CCcccCHHHHHHhhhccc--------cccccCCceEEEEEEeCCCcEEEEEEcccc---ccHHHHHHHHHHHHHHhccCC
Q 017591 12 KPVRFTLEQLCSFTNNYS--------TKLGAGGFGVVYKGQFPNGVKIAAKILKTC---LNKRVEAQFMAEIGTIGRTYH 80 (369)
Q Consensus 12 ~~~~~~~~el~~~t~~f~--------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h 80 (369)
....|++.++.++|++|. ++||+|+||.||+|.+ +++.||+|++... ........+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 456799999999999997 4599999999999987 6889999988643 223456789999999999999
Q ss_pred CceeeEEeEEEeCCceEEEEeccCCCCHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe
Q 017591 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFT--DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL 158 (369)
Q Consensus 81 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill 158 (369)
|||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ ++++||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence 9999999999999999999999999999999953 24569999999999999999999999 999999999999999
Q ss_pred cCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc
Q 017591 159 DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW 238 (369)
Q Consensus 159 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~ 238 (369)
+.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~- 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL- 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-
Confidence 9999999999999987654443333445679999999998765 4789999999999999999999999865443211
Q ss_pred cccchhHHhhh-chhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 239 FPKQVWDEYEK-GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 239 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
..+...... ...................+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 244 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 244 --LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp --THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111111 111222233344566788899999999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=359.95 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=212.9
Q ss_pred ccccccccCCceEEEEEEeC--------CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP--------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 97 (369)
.+.+.||+|+||.||+|.+. ++..||+|+++..........+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus 84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 163 (370)
T 2psq_A 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163 (370)
T ss_dssp EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence 34578999999999999752 35689999998766666778899999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC
Q 017591 98 LVYEFMENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF 162 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 162 (369)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTC
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCCC
Confidence 9999999999999996543 358999999999999999999999 9999999999999999999
Q ss_pred CeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCcccc
Q 017591 163 SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPK 241 (369)
Q Consensus 163 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 241 (369)
.+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.......
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~------ 313 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------ 313 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 9999999999977654433334445678899999988764 79999999999999999999 999987543221
Q ss_pred chhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 242 QVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
... ..........+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 314 -~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 -LFK---------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp -HHH---------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHH---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 12222223344456678999999999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=358.51 Aligned_cols=256 Identities=26% Similarity=0.430 Sum_probs=211.2
Q ss_pred ccccccccCCceEEEEEEeC----CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.||+|+||.||+|.+. .+..||+|++...........+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 131 (325)
T 3kul_A 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY 131 (325)
T ss_dssp EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEEC
T ss_pred EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeC
Confidence 34478999999999999874 35569999998766666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc-
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH- 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 181 (369)
+++++|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (325)
T 3kul_A 132 MENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208 (325)
T ss_dssp CTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence 99999999997666789999999999999999999999 99999999999999999999999999999877543222
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.......+|+.|+|||++... .++.++|||||||++|+|++ |+.||...... ..........
T Consensus 209 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----------------~~~~~~~~~~ 271 (325)
T 3kul_A 209 YTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----------------DVISSVEEGY 271 (325)
T ss_dssp EECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----------------HHHHHHHTTC
T ss_pred eeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH----------------HHHHHHHcCC
Confidence 122334567889999988764 78999999999999999999 99998643321 1112222222
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
....+...+..+.+|+.+||+.||.+||++.+|++.|+....
T Consensus 272 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 233444567789999999999999999999999999998643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=363.97 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=210.9
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||+|+||.||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 34578999999999999985 68999999998665666667899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|.+++...+..+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++............
T Consensus 197 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~ 273 (377)
T 3cbl_A 197 GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG 273 (377)
T ss_dssp CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSS
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCC
Confidence 99999997666779999999999999999999999 999999999999999999999999999998754332222222
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
...++..|+|||.+..+ .++.++|||||||++|||++ |..||...... ..............
T Consensus 274 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 274 LRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQ----------------QTREFVEKGGRLPC 336 (377)
T ss_dssp CCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----------------HHHHHHHTTCCCCC
T ss_pred CCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCCCC
Confidence 23457789999988765 68999999999999999998 89888654321 11111222222233
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+...+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 444567899999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=350.34 Aligned_cols=256 Identities=30% Similarity=0.512 Sum_probs=201.3
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||+|+||+||+|++ ++..||+|++... ........+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118 (309)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence 4457899999999999988 6889999998653 3445567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhhccCCC--eEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 106 GSLDKYLFTDT--EVLKWEKLLDIAIGTARGIAYLHEECNQR--IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 106 gsL~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+|.+++.... ..+++..++.++.|++.||+|||+ ++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 119 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~- 194 (309)
T 3p86_A 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL- 194 (309)
T ss_dssp CBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred CcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc-
Confidence 99999995443 249999999999999999999999 89 99999999999999999999999999976433221
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||........ .. ........
T Consensus 195 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-------~~--------~~~~~~~~ 257 (309)
T 3p86_A 195 -SSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-------VA--------AVGFKCKR 257 (309)
T ss_dssp --------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------HH--------HHHHSCCC
T ss_pred -ccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HH--------HHHhcCCC
Confidence 22345699999999988765 689999999999999999999999975432110 00 01111222
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcCCC
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIV 304 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~~~ 304 (369)
...+...+..+.+|+.+||+.||.+||++.+|++.|+......
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 3334456678999999999999999999999999999875443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=351.54 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=202.8
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||+|+||+||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 345689999999999999885 6899999998754444445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++ .....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..+.........
T Consensus 89 ~~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 89 GGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp TEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCcHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 99999999 445679999999999999999999999 99999999999999999999999999999876433333333
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||........ .+..+.. .......
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~--------~~~~~~~ 230 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKE--------KKTYLNP 230 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH------HHHHHHT--------TCTTSTT
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHhc--------ccccCCc
Confidence 4567999999999988764558899999999999999999999975443211 0111111 1111111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+..+.+|+.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 2345677889999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=349.40 Aligned_cols=266 Identities=27% Similarity=0.350 Sum_probs=206.0
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC----ceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT----KAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~ 102 (369)
.+.++||+|+||+||+|++. ++.||+|++.... .....+.+|+.++..++||||+++++++.+.. ..++||||
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 34578999999999999884 8999999987532 33456677999999999999999999998754 36999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCC----------CeEeecCCCCceEecCCCCeeEeecCCc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ----------RIIHYDIKPANILLDAKFSAKVADFGLA 172 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~----------~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 172 (369)
+++|+|.+++.. ..+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 104 HEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp CTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999954 359999999999999999999999 7 9999999999999999999999999999
Q ss_pred eecCCCCCccccccCCCCCCcccccccccc----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhh
Q 017591 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLRN----YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYE 248 (369)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 248 (369)
+...............||+.|+|||++.+. ..++.++|||||||++|||++|+.||..........+.........
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 887655444344456799999999988763 2456789999999999999999999986554322111100000000
Q ss_pred hchhhhhhhcCC-CCC-----CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 249 KGELAAKVLGCG-IEE-----NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 249 ~~~~~~~~~~~~-~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
............ .+. .....+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111111111 111 1234567799999999999999999999999999865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=360.71 Aligned_cols=255 Identities=26% Similarity=0.443 Sum_probs=199.3
Q ss_pred ccccccccCCceEEEEEEeC----CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.||+|+||.||+|++. ++..||+|+++..........+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 127 (373)
T 2qol_A 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127 (373)
T ss_dssp CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeC
Confidence 34578999999999999874 57889999998766666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 128 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 204 (373)
T 2qol_A 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204 (373)
T ss_dssp CTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence 99999999997767789999999999999999999999 999999999999999999999999999998765332211
Q ss_pred -ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 183 -STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 183 -~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
......++..|+|||++... .++.++|||||||++|||++ |+.||....... .... .....
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~---------i~~~~ 267 (373)
T 2qol_A 205 YTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKA---------VDEGY 267 (373)
T ss_dssp ---------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHH---------HHTTE
T ss_pred eeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH---------HHcCC
Confidence 11223457789999988764 78999999999999999998 999986543211 1111 11111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
....+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 12223345678999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=343.15 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=208.8
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||+||+|.+. +++.||+|.+... .......+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 345689999999999999884 5899999988643 44567789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc-
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS- 183 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~- 183 (369)
+++|.+++......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 999999997767889999999999999999999999 9999999999999999999999999999987654332211
Q ss_pred -----------cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 184 -----------TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 184 -----------~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..|+............ . ... .
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-~-~~~-----~ 239 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-N-VRG-----F 239 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-C-HHH-----H
T ss_pred cccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-h-hhc-----c
Confidence 1145699999999988764 7899999999999999999999998765443221110 0 000 0
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
... ..+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 240 ~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 240 LDR-------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp HHH-------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccc-------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 01122345688999999999999999999999999876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=340.12 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=212.3
Q ss_pred HhhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
...+.+.+.||+|+||.||+|.+.++..||+|++...... ..++.+|+.++..++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3445667899999999999999988889999998754332 35689999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++++|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 160 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV- 160 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-
Confidence 99999999997666779999999999999999999999 99999999999999999999999999999876544322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......+|+.|+|||.+... .++.++||||||+++|+|++ |+.||....... ..........
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~~~~~~~~ 223 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----------------VVLKVSQGHR 223 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH----------------HHHHHHTTCC
T ss_pred cccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHH----------------HHHHHHcCCC
Confidence 22334577889999988764 68999999999999999999 999986433211 1111111112
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
...+...+..+.+++.+||+.||.+||++.++++.|+...+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 22233346679999999999999999999999999998643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=359.03 Aligned_cols=260 Identities=26% Similarity=0.386 Sum_probs=215.2
Q ss_pred hhhccccccccCCceEEEEEEeC--------CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP--------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQT 94 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 94 (369)
..+.+.++||+|+||.||+|.+. .+..||+|++...........+.+|+.+++.+ +||||+++++++.+.+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 34445678999999999999862 24689999998776667778899999999999 8999999999999999
Q ss_pred ceEEEEeccCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec
Q 017591 95 KAALVYEFMENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD 159 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~ 159 (369)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEc
Confidence 9999999999999999996543 359999999999999999999999 9999999999999999
Q ss_pred CCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCc
Q 017591 160 AKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDW 238 (369)
Q Consensus 160 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~ 238 (369)
.++.+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---- 300 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 300 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999876554433344445678899999988764 78999999999999999999 99998644321
Q ss_pred cccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcCC
Q 017591 239 FPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEI 303 (369)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~~ 303 (369)
... ...........+...+..+.+|+.+||+.||.+||++.+|++.|+.....
T Consensus 301 ---~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 301 ---ELF---------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp ---HHH---------HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHH---------HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111 11222222333344567899999999999999999999999999987443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=351.73 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=211.4
Q ss_pred ccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.||+|+||.||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 129 (343)
T 1luf_A 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 129 (343)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence 34578999999999999874 348999999987666666788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceE
Q 017591 101 EFMENGSLDKYLFTDT-----------------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANIL 157 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nil 157 (369)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+|||
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl 206 (343)
T 1luf_A 130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCL 206 (343)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEE
Confidence 9999999999996532 579999999999999999999999 99999999999999
Q ss_pred ecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 017591 158 LDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTL 236 (369)
Q Consensus 158 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~ 236 (369)
++.++.+||+|||++................+|+.|+|||.+... .++.++|||||||++|+|++ |+.||.......
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 284 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE- 284 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCCCCChHH-
Confidence 999999999999999866433322333445688999999988765 78999999999999999999 999986433211
Q ss_pred CccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 237 DWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
.. ...........+...+..+.+++.+||+.||.+||++.+|++.|+....
T Consensus 285 ------~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 285 ------VI---------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp ------HH---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ------HH---------HHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 11 1112222233344556789999999999999999999999999998744
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=349.20 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=203.6
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|+||.||+|.+ .+|+.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence 4458999999999999987 57999999998643 344556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+|+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........ .
T Consensus 98 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~ 170 (328)
T 3fe3_A 98 GGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---L 170 (328)
T ss_dssp TCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---G
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---c
Confidence 9999999944 3569999999999999999999999 9999999999999999999999999999976543322 2
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||....... .......+ . ...
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~---------~-~~~ 233 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-------LRERVLRG---------K-YRI 233 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC---------C-CCC
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC---------C-CCC
Confidence 346799999999998876445689999999999999999999997543211 11111111 1 112
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2334677899999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=349.00 Aligned_cols=276 Identities=23% Similarity=0.361 Sum_probs=211.1
Q ss_pred HHHHhhhccccccccCCceEEEEEEe-----CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC-
Q 017591 20 QLCSFTNNYSTKLGAGGFGVVYKGQF-----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ- 93 (369)
Q Consensus 20 el~~~t~~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 93 (369)
++....+.+.++||+|+||+||+|++ .+++.||+|++... .......+.+|+.++..++||||+++++++...
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 34455667778999999999999984 35899999998754 345567899999999999999999999998654
Q ss_pred -CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCc
Q 017591 94 -TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA 172 (369)
Q Consensus 94 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 172 (369)
...++||||+++++|.+++......+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 56899999999999999997766779999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCCc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 173 KLCNPENTH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 173 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
......... .......++..|+|||.+... .++.++||||||+++|+|++|..|+.......................
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 876543221 222334577889999988765 789999999999999999999998864321100000000000011112
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.............+...+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 2222333333444556678899999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=350.25 Aligned_cols=257 Identities=23% Similarity=0.378 Sum_probs=203.1
Q ss_pred hhhccccccccCCceEEEEEEeC-CCc----EEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP-NGV----KIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
..+.+.++||+|+||+||+|.+. +++ +||+|.+...........+.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 34455689999999999999864 344 458888765544455678999999999999999999999998654 789
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
|++|+.+|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 999999999999998777889999999999999999999999 99999999999999999999999999999877654
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
..........+|..|+|||++.+. .++.++|||||||++|||++ |+.||....... +.....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~~~ 233 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILE 233 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHHHH
T ss_pred cccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----------------HHHHHH
Confidence 444444445678899999988774 78999999999999999999 999997543321 111112
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.......+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 22222334445678999999999999999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=337.97 Aligned_cols=253 Identities=28% Similarity=0.491 Sum_probs=210.1
Q ss_pred hhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.+.||+|+||.||+|.+.+++.||+|++...... ..++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 34556899999999999999988999999998754332 3578999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........ ...
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 164 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HST
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-ccc
Confidence 999999997777789999999999999999999999 9999999999999999999999999999986543221 122
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....+|+.|+|||.+... .++.++||||||+++|+|++ |+.||...... .............
T Consensus 165 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----------------~~~~~~~~~~~~~ 227 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----------------EVVEDISTGFRLY 227 (269)
T ss_dssp TSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHHHHTTCCCC
T ss_pred cCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----------------HHHHHHhcCccCC
Confidence 334577889999988764 78999999999999999999 89898643321 1111112222223
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 3344567899999999999999999999999999865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=338.90 Aligned_cols=248 Identities=22% Similarity=0.304 Sum_probs=203.2
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.++||+|+||+||+|.+ .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 345568999999999999987 5689999999864332 22457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++|+|.+++... .+++..++.++.|++.||.|||+ +|++||||||+|||++.++.+||+|||++........ .
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 172 (297)
T 3fxz_A 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (297)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--c
Confidence 999999999543 69999999999999999999999 9999999999999999999999999999987654332 2
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||........ ..... ........
T Consensus 173 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~~~-------~~~~~~~~ 237 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIA-------TNGTPELQ 237 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHH-------HHCSCCCS
T ss_pred cCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHH-------hCCCCCCC
Confidence 2345799999999988775 789999999999999999999999965432110 00000 01111122
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+...+..+.+++.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 34456678999999999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=356.31 Aligned_cols=267 Identities=25% Similarity=0.365 Sum_probs=213.9
Q ss_pred ccCHHHHHHhhhc--cccccccCCceEEEEEEe------CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceee
Q 017591 15 RFTLEQLCSFTNN--YSTKLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVR 85 (369)
Q Consensus 15 ~~~~~el~~~t~~--f~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 85 (369)
.+...+..-..++ +.+.||+|+||.||+|.+ .+++.||+|++...........+.+|+.++..+ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3444444444444 458999999999999973 346899999998766666678899999999999 7999999
Q ss_pred EEeEEEeCCc-eEEEEeccCCCCHHHHhccCCC-----------------------------------------------
Q 017591 86 LYGFCYDQTK-AALVYEFMENGSLDKYLFTDTE----------------------------------------------- 117 (369)
Q Consensus 86 ~~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------- 117 (369)
+++++.+.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999954322
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 118 ------------------VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 118 ------------------~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
.+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 28999999999999999999999 999999999999999999999999999998765444
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.........||+.|+|||++.+. .++.++|||||||++|+|++ |+.||....... ...... ..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~---------~~ 311 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRL---------KE 311 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHH---------HH
T ss_pred cchhccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHH---------Hc
Confidence 44444556789999999988764 78999999999999999998 999997544321 111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
......+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 112233344567799999999999999999999999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=343.58 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=212.9
Q ss_pred hccccccccCCceEEEEEEe------CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (369)
+.+.+.||+|+||.||+|.+ .++..||+|++...........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 34457899999999999976 245899999998766666778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCce
Q 017591 100 YEFMENGSLDKYLFTDT-----------------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANI 156 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Ni 156 (369)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheE
Confidence 99999999999996532 248999999999999999999999 9999999999999
Q ss_pred EecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCc
Q 017591 157 LLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDT 235 (369)
Q Consensus 157 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~ 235 (369)
+++.++.+||+|||++................+|+.|+|||.+.+. .++.++|||||||++|+|++ |+.||.......
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999877654444344445678899999988764 68999999999999999999 999987543321
Q ss_pred cCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 236 LDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.... .........+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 261 -------~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 261 -------LFNL---------LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp -------HHHH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HHHH---------hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 112222333445667899999999999999999999999999865
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=355.93 Aligned_cols=256 Identities=28% Similarity=0.380 Sum_probs=209.2
Q ss_pred hhccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
.+.+.++||+|+||+||+|.+. ++..||||++..........++.+|+.++..++||||+++++++.+....++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 3345678999999999999842 4678999999866666677789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC---CeeEeec
Q 017591 99 VYEFMENGSLDKYLFTDT------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF---SAKVADF 169 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Df 169 (369)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999996432 469999999999999999999999 9999999999999999555 5999999
Q ss_pred CCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhh
Q 017591 170 GLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYE 248 (369)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (369)
|+++...............+|+.|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-------------- 293 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------------- 293 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------------
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------------
Confidence 999754322222223335588999999988765 78999999999999999998 98998654321
Q ss_pred hchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+............+...+..+.+|+.+||+.||.+||++.+|++.|+..
T Consensus 294 --~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 294 --EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp --HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122222222333445567799999999999999999999999999865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=342.88 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=212.8
Q ss_pred hhccccccccCCceEEEEEEe------CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 97 (369)
.+.+.+.||+|+||.||+|.+ .+++.||+|++...........+.+|+.++.++ +||||+++++++.+.+..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 445568999999999999975 347899999998766656678899999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhccCCC-----------------CCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC
Q 017591 98 LVYEFMENGSLDKYLFTDTE-----------------VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA 160 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 160 (369)
+||||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++++||||||+||+++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcC
Confidence 99999999999999965432 48999999999999999999999 99999999999999999
Q ss_pred CCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCcc
Q 017591 161 KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWF 239 (369)
Q Consensus 161 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 239 (369)
++.+||+|||++................+|+.|+|||.+... .++.++|||||||++|+|++ |+.||........
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--- 256 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH---
Confidence 999999999999877654443334445678899999988764 78999999999999999998 9999875443211
Q ss_pred ccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 240 PKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
..... ........+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 257 ---~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 257 ---FYKMI---------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp ---HHHHH---------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHh---------ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11111 11111222334567899999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=347.95 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=208.2
Q ss_pred hhccccccccCCceEEEEEEe------CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 97 (369)
.+.+.+.||+|+||.||+|.+ .++..||+|++...........+.+|+.++.++ .||||+++++++.+.+..+
T Consensus 46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 125 (344)
T 1rjb_A 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 125 (344)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccE
Confidence 344568999999999999986 246789999998655545567899999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhccCCC----------------------CCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCc
Q 017591 98 LVYEFMENGSLDKYLFTDTE----------------------VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPAN 155 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~N 155 (369)
+||||+++|+|.+++..... .+++..++.++.|++.||.|||+ +||+||||||+|
T Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~N 202 (344)
T 1rjb_A 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARN 202 (344)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGG
T ss_pred EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhh
Confidence 99999999999999965432 37999999999999999999999 999999999999
Q ss_pred eEecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 017591 156 ILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSD 234 (369)
Q Consensus 156 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~ 234 (369)
||++.++.+||+|||++................+|+.|+|||.+..+ .++.++|||||||++|+|++ |..||......
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999999999876544333333445678899999988764 78999999999999999998 99999765432
Q ss_pred ccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 235 TLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
.. ..... ........+...+..+.+|+.+||+.||.+||++.+|++.|+....
T Consensus 282 ~~------~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 282 AN------FYKLI---------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp HH------HHHHH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HH------HHHHH---------hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 11 11111 1111222334456789999999999999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=339.45 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=211.0
Q ss_pred CcccCHHHHHHhhhcc------------ccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC
Q 017591 13 PVRFTLEQLCSFTNNY------------STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY 79 (369)
Q Consensus 13 ~~~~~~~el~~~t~~f------------~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 79 (369)
...|++.++.+++... .++||+|+||.||+|++. +|+.||||++..... .....+.+|+.+++.++
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCC
Confidence 3468999999998752 358999999999999886 699999999875432 23457889999999999
Q ss_pred CCceeeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec
Q 017591 80 HINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD 159 (369)
Q Consensus 80 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~ 159 (369)
||||+++++++...+..++||||+++++|.+++. ...+++..++.++.|++.||.|||+ +|++||||||+||+++
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT 175 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence 9999999999999999999999999999999984 3469999999999999999999999 9999999999999999
Q ss_pred CCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc
Q 017591 160 AKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF 239 (369)
Q Consensus 160 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 239 (369)
.++.+||+|||++........ ......||+.|+|||++... .++.++|||||||++|+|++|+.||.......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---- 248 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---- 248 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----
T ss_pred CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 999999999999987654322 12345799999999988764 78999999999999999999999997543210
Q ss_pred ccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 240 PKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......... ..........+..+.+++.+||+.||.+||++.++++
T Consensus 249 ---~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 249 ---AMKRLRDSP-------PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ---HHHHHHHSS-------CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHhcCC-------CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111100 0001122334677899999999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=336.67 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=207.2
Q ss_pred HhhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
...+.+.+.||+|+||+||++.+.++..||+|++...... ..++.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3344556899999999999999988889999998854332 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++++|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........ .
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 176 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 176 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence 99999999996656789999999999999999999999 9999999999999999999999999999986543221 1
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......+|+.|+|||.+... .++.++||||||+++|+|++ |+.||...... ...........
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~----------------~~~~~~~~~~~ 239 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----------------ETAEHIAQGLR 239 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----------------HHHHHHHTTCC
T ss_pred cccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChh----------------HHHHHHhcccC
Confidence 22334577889999988765 78999999999999999998 99998654321 11111112222
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
...+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 223334467899999999999999999999999999765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=337.55 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=199.4
Q ss_pred hhhccccccccCCceEEEEEEeCC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (369)
..+.+.+.||+|+||.||+|.+.. +..||+|+............+.+|+.+++.++||||+++++++ ..+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEE
Confidence 344566899999999999998743 4679999988766666678899999999999999999999998 45678999
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
|||+++++|.+++......+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 99999999999997666789999999999999999999999 999999999999999999999999999998764332
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.. ......+|+.|+|||.+... .++.++|||||||++|+|++ |..||....... .... ...
T Consensus 171 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-------~~~~---------i~~ 232 (281)
T 1mp8_A 171 YY-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGR---------IEN 232 (281)
T ss_dssp ---------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHH---------HHT
T ss_pred cc-ccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-------HHHH---------HHc
Confidence 21 12234577899999988764 78999999999999999996 888987543321 1111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
......+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 233 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 222233445667899999999999999999999999999865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=342.75 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=212.8
Q ss_pred hhhccccccccCCceEEEEEEeC--------CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP--------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQT 94 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 94 (369)
..+.+.+.||+|+||.||+|.+. ++..||+|++...........+.+|+.+++.+ +||||+++++++.+.+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 34455689999999999999863 46789999998766666678899999999999 8999999999999999
Q ss_pred ceEEEEeccCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec
Q 017591 95 KAALVYEFMENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD 159 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~ 159 (369)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEc
Confidence 9999999999999999996443 248999999999999999999999 9999999999999999
Q ss_pred CCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCc
Q 017591 160 AKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDW 238 (369)
Q Consensus 160 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~ 238 (369)
.++.+||+|||++................+|+.|+|||++... .++.++|||||||++|+|++ |+.||......
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 266 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 266 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence 9999999999999877654433334445678899999988764 68999999999999999999 99998654321
Q ss_pred cccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 239 FPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
..... .........+...+..+.+++.+||+.||.+||++.+|++.|+....
T Consensus 267 ---~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 ---ELFKL---------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp ---HHHHH---------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHH---------HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111 11112223334456789999999999999999999999999998743
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=334.20 Aligned_cols=264 Identities=24% Similarity=0.271 Sum_probs=201.9
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||+||+|++.+++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 34457899999999999999889999999987432 22334678899999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+ +|.+++......+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........ ..
T Consensus 103 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~ 176 (311)
T 3niz_A 103 K-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SY 176 (311)
T ss_dssp E-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----
T ss_pred C-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc--cc
Confidence 6 8888887767789999999999999999999999 9999999999999999999999999999987653322 22
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------cccchhHHhhhchhhhhh
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------FPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 256 (369)
....||+.|+|||++.+...++.++|||||||++|+|++|+.||.......... .....|............
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 335689999999998775578999999999999999999999997654432100 000000000000000000
Q ss_pred hcCCCCC-----CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 257 LGCGIEE-----NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 257 ~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 01123467889999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=339.15 Aligned_cols=270 Identities=26% Similarity=0.448 Sum_probs=202.8
Q ss_pred ccCHHHHHHhhhccccccccCCceEEEEEEeCCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC
Q 017591 15 RFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ 93 (369)
Q Consensus 15 ~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 93 (369)
-+...|+....+.+.++||+|+||+||+|++.+ .||+|+++.. ........+.+|+.+++.++||||+++++++ ..
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 355566777777788999999999999998743 5999998743 3445567899999999999999999999965 56
Q ss_pred CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 94 TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 94 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
...++||||+++++|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecc
Confidence 67899999999999999997777789999999999999999999999 999999999999999999999999999998
Q ss_pred ecCCCCCccccccCCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 174 LCNPENTHDSTSGYRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
...............||+.|+|||.+.. +..++.++||||||+++|+|++|+.||....... ........+.
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~ 242 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGS 242 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTS
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccc
Confidence 6543333333344569999999998862 3468899999999999999999999997544321 1111111111
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
. ...........+..+.+|+.+||+.||.+||++.+|++.|+...
T Consensus 243 ~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 243 L-----SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp C-----CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred c-----CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1 11112223345678999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=346.36 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=201.0
Q ss_pred hhccccccccCCceEEEEEEeC-CCc----EEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGV----KIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (369)
.+.+.++||+|+||.||+|.+. +++ +|++|.+...........+.+|+.++..++||||+++++++.+.. .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 3445689999999999999874 344 357777665444445678999999999999999999999997654 8899
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
++|+.+|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 99999999999997777889999999999999999999999 999999999999999999999999999998765444
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.........+|+.|+|||.+.+. .++.++|||||||++|+|++ |+.||....... +......
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------~~~~~~~ 234 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEK 234 (327)
T ss_dssp --------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHHHHT
T ss_pred ccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHc
Confidence 33333445578899999988764 78999999999999999999 999997543321 1111222
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
......+...+..+.+++.+||+.||.+||++.++++.|+...
T Consensus 235 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2223334446678999999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=333.09 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=209.7
Q ss_pred cccccCCceEEEEEEeC---CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFP---NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.||+|+||.||+|.+. ++..||+|++...........+.+|+.++..++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 38999999999999763 57889999998766666778899999999999999999999999 566799999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc-cccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH-DSTS 185 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 185 (369)
+|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++......... ....
T Consensus 95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 9999997667789999999999999999999999 99999999999999999999999999999877543322 1223
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
...+|+.|+|||.+... .++.++||||||+++|+|++ |+.||....... .. ...........
T Consensus 172 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~---------~~i~~~~~~~~ 234 (287)
T 1u59_A 172 AGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VM---------AFIEQGKRMEC 234 (287)
T ss_dssp SSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HH---------HHHHTTCCCCC
T ss_pred cccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HH---------HHHhcCCcCCC
Confidence 34578899999988764 68999999999999999998 999986543321 11 11122222334
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 455678899999999999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=348.66 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=203.7
Q ss_pred hccccccccCCceEEEEEEeC-CCc----EEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGV----KIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
+.+.+.||+|+||+||+|.+. +++ +|++|.+...........+.+|+.++..++||||+++++++. .+..++||
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 345578999999999999874 344 378887754433333456788999999999999999999885 56789999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+.+|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 94 QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp ECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 9999999999997666789999999999999999999999 9999999999999999999999999999988765544
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
........+|..|+|||.+..+ .++.++|||||||++|+|++ |+.||........ .... ...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~---------~~~ 233 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------PDLL---------EKG 233 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------HHHH---------HTT
T ss_pred cccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------HHHH---------HcC
Confidence 4444556688899999998765 78999999999999999999 9999976443211 1111 111
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.....+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112223334556889999999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=339.41 Aligned_cols=282 Identities=21% Similarity=0.327 Sum_probs=216.9
Q ss_pred cccCHHHHHHhhhccccccccCCceEEEEEEe-----CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEe
Q 017591 14 VRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQF-----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88 (369)
Q Consensus 14 ~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 88 (369)
..+....+....+.+.++||+|+||.||+|++ .+++.||+|++...........+.+|+.++..++||||+++++
T Consensus 11 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (302)
T 4e5w_A 11 TEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKG 90 (302)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeee
Confidence 34455555555566778999999999999983 4689999999886544444578999999999999999999999
Q ss_pred EEEeC--CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeE
Q 017591 89 FCYDQ--TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKV 166 (369)
Q Consensus 89 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 166 (369)
++.+. +..++||||+++++|.+++......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.++|
T Consensus 91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl 167 (302)
T 4e5w_A 91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKI 167 (302)
T ss_dssp EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEE
T ss_pred EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEE
Confidence 99876 66899999999999999997767789999999999999999999999 99999999999999999999999
Q ss_pred eecCCceecCCCCCc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhH
Q 017591 167 ADFGLAKLCNPENTH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWD 245 (369)
Q Consensus 167 ~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 245 (369)
+|||++......... .......+|..|+|||.+.+. .++.++||||||+++|+|++|..|+........... .....
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~ 245 (302)
T 4e5w_A 168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI-GPTHG 245 (302)
T ss_dssp CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH-CSCCG
T ss_pred CcccccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc-CCccc
Confidence 999999887544322 223345688889999988764 688999999999999999999988642211000000 00001
Q ss_pred HhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 246 EYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
...................+...+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111122222333333444556678899999999999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=337.38 Aligned_cols=245 Identities=18% Similarity=0.267 Sum_probs=202.7
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||+|+||.||+|.+. +++.+|+|++... ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 445689999999999999885 5889999998743 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC--CCCeeEeecCCceecCCCCCcc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA--KFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|.+++......+++..++.++.|++.||.|||+ +|++||||||+|||++. ++.+||+|||++........
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~-- 159 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc--
Confidence 999999996666689999999999999999999999 99999999999999987 78999999999988754332
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+ ......
T Consensus 160 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i---------~~~~~~ 221 (321)
T 1tki_A 160 -FRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENI---------MNAEYT 221 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHH---------HHTCCC
T ss_pred -cccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHH---------HcCCCC
Confidence 2235689999999988764 68999999999999999999999997543211 11111 111111
Q ss_pred CC---CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 EN---DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ....+..+.+++.+||+.||.+|||+.++++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1134577899999999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=344.60 Aligned_cols=253 Identities=28% Similarity=0.470 Sum_probs=202.6
Q ss_pred ccccccCCceEEEEEEeCC-----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 29 STKLGAGGFGVVYKGQFPN-----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.||+|+||.||+|.+.. +..||+|++...........+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 3689999999999997643 34699999987666666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc-
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD- 182 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 182 (369)
++++|.+++......+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++..........
T Consensus 129 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 205 (333)
T 1mqb_A 129 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205 (333)
T ss_dssp TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcccccccc
Confidence 9999999997777789999999999999999999999 999999999999999999999999999998765332211
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......+|..|+|||.+... .++.++|||||||++|+|++ |+.||...... .+.........
T Consensus 206 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----------------~~~~~~~~~~~ 268 (333)
T 1mqb_A 206 TTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNH----------------EVMKAINDGFR 268 (333)
T ss_dssp -----CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHHHHTTCC
T ss_pred ccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHH----------------HHHHHHHCCCc
Confidence 12233467889999988764 78999999999999999999 99998643321 11111122222
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
...+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 269 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2333455678999999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=337.35 Aligned_cols=247 Identities=21% Similarity=0.373 Sum_probs=197.9
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc----------
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK---------- 95 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---------- 95 (369)
.+.+.||+|+||.||+|++. +++.||+|++...........+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~ 88 (332)
T 3qd2_B 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI 88 (332)
T ss_dssp EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-
T ss_pred ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhh
Confidence 45689999999999999885 6999999998755555566789999999999999999999999866542
Q ss_pred -----------------------------------------------eEEEEeccCCCCHHHHhccCC--CCCCHHHHHH
Q 017591 96 -----------------------------------------------AALVYEFMENGSLDKYLFTDT--EVLKWEKLLD 126 (369)
Q Consensus 96 -----------------------------------------------~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~ 126 (369)
.++||||+++++|.+++.... ...++..++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 168 (332)
T 3qd2_B 89 WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168 (332)
T ss_dssp -------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHH
T ss_pred hhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHH
Confidence 799999999999999996543 3467778999
Q ss_pred HHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc----------cccccCCCCCCcccc
Q 017591 127 IAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH----------DSTSGYRGTPGYSAP 196 (369)
Q Consensus 127 i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aP 196 (369)
++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++......... .......||+.|+||
T Consensus 169 i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 169 IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 99999999999999 99999999999999999999999999999877543211 122345699999999
Q ss_pred ccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHH
Q 017591 197 EFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVA 276 (369)
Q Consensus 197 E~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 276 (369)
|++.+. .++.++|||||||++|+|++|..|+.. .............+.........+.+++
T Consensus 246 E~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~li 306 (332)
T 3qd2_B 246 EQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME------------------RVRIITDVRNLKFPLLFTQKYPQEHMMV 306 (332)
T ss_dssp HHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH------------------HHHHHHHHHTTCCCHHHHHHCHHHHHHH
T ss_pred HHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH------------------HHHHHHHhhccCCCcccccCChhHHHHH
Confidence 988775 789999999999999999998665320 0111111222223333455667789999
Q ss_pred HhccccCCCCCCChHHHHH
Q 017591 277 LWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 277 ~~cl~~~p~~RPs~~~v~~ 295 (369)
.+||+.||.+||++.++++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHH
T ss_pred HHHccCCCCcCCCHHHHhh
Confidence 9999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=341.69 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=211.6
Q ss_pred hhccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
.+.+.+.||+|+||.||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 3445689999999999999764 3788999999876666667789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeec
Q 017591 99 VYEFMENGSLDKYLFTDT---------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADF 169 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 169 (369)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcC
Confidence 999999999999995421 467999999999999999999999 99999999999999999999999999
Q ss_pred CCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhh
Q 017591 170 GLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYE 248 (369)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (369)
|++................+|+.|+|||.+.+. .++.++|||||||++|+|++ |+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------------- 247 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------------- 247 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--------------
T ss_pred ccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHH--------------
Confidence 999765433322233344578899999988764 78999999999999999999 78888643321
Q ss_pred hchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
..............+...+..+.+++.+||+.||.+||++.++++.|+....
T Consensus 248 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 --QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111122222233344566789999999999999999999999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=335.72 Aligned_cols=262 Identities=23% Similarity=0.324 Sum_probs=205.2
Q ss_pred hhhccccccccCCceEEEEEEeC-CCcEEEEEEccc--cccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKT--CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
..+.+.+.||+|+||.||+|.+. ++..||+|++.. .........+.+|+.++..++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 34556789999999999999874 589999998753 234455678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++++|.+++.. ..++++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus 91 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 91 EYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999943 4579999999999999999999999 9999999999999999999999999999976543222
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||........ ........ .....
T Consensus 167 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~~~~~---- 233 (294)
T 4eqm_A 167 -TQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-VPNVT---- 233 (294)
T ss_dssp ---------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-CCCHH----
T ss_pred -cccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-CCCcc----
Confidence 122335699999999988774 789999999999999999999999975432110 00111100 00000
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCC-ChHHHHHHhcCCcCC
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARP-PMSAVVKMLEGGVEI 303 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~v~~~L~~~~~~ 303 (369)
.......+..+.+++.+||+.||.+|| ++.++.+.|+.....
T Consensus 234 -~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 234 -TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 011223457799999999999999998 899999999887543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=336.64 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=204.3
Q ss_pred hccccccccCCceEEEEEEeCC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEE-eCCceEEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY-DQTKAALVY 100 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~ 100 (369)
+.+.++||+|+||+||+|.+.+ ...+|+|.+...........+.+|+.++++++||||+++++++. ..+..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 3455899999999999998643 23689999887666667788999999999999999999999865 456789999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++|+|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 9999999999997767789999999999999999999999 9999999999999999999999999999986643221
Q ss_pred --ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCC-CCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 181 --HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRK-NAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 181 --~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
........+|+.|+|||.+... .++.++||||||+++|+|++|.. ||....... ......
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----------------~~~~~~ 246 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------------ITVYLL 246 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----------------HHHHHH
T ss_pred hccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----------------HHHHHh
Confidence 1123345678899999988764 78999999999999999999555 444332211 111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.......+...+..+.+++.+||+.||.+||++.++++.|+...
T Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 247 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11222223344677999999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=335.24 Aligned_cols=266 Identities=21% Similarity=0.216 Sum_probs=209.6
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC--ceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT--KAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 102 (369)
+.+.++||+|+||+||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++.+.. ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 455689999999999999885 489999999876444444567889999999999999999999998765 77999999
Q ss_pred cCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe----cCCCCeeEeecCCceecC
Q 017591 103 MENGSLDKYLFTDT--EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL----DAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 103 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~ 176 (369)
+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99999999995433 349999999999999999999999 999999999999999 777889999999998765
Q ss_pred CCCCccccccCCCCCCccccccccc-------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhh
Q 017591 177 PENTHDSTSGYRGTPGYSAPEFLLR-------NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEK 249 (369)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (369)
..... ....||+.|+|||++.. +..++.++|||||||++|||++|+.||......... .........
T Consensus 168 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~ 241 (319)
T 4euu_A 168 DDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKIIT 241 (319)
T ss_dssp TTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC---HHHHHHHHH
T ss_pred CCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh---HHHHHHHhc
Confidence 43322 23569999999998762 347899999999999999999999999754432110 000111100
Q ss_pred chhhh---------------hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 250 GELAA---------------KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 250 ~~~~~---------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+.... .................+.+++.+||+.||++||++.++++...+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 00000 0000111245678899999999999999999999999999888764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=356.69 Aligned_cols=253 Identities=29% Similarity=0.429 Sum_probs=207.8
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
..+.++||+|+||.||+|.+.++..||||+++.... ....+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred eEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence 344578999999999999998899999999885432 2568999999999999999999999985 6678999999999
Q ss_pred CCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 106 GSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 106 gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++....... ...
T Consensus 267 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~ 342 (454)
T 1qcf_A 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAR 342 (454)
T ss_dssp CBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTT
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-ecc
Confidence 99999995432 478999999999999999999999 9999999999999999999999999999986543211 112
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....+|..|+|||++..+ .++.++|||||||++|||++ |+.||....... +... +.......
T Consensus 343 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~---------i~~~~~~~ 405 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRA---------LERGYRMP 405 (454)
T ss_dssp CSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHH---------HHHTCCCC
T ss_pred CCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHH---------HHcCCCCC
Confidence 334577899999998765 78999999999999999999 999987543211 1111 11222223
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
.+...+..+.+|+.+||+.||.+|||+.+|++.|+....
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 344567789999999999999999999999999998744
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=334.70 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=206.6
Q ss_pred ccccccCCceEEEEEEeCC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce-EEEEecc
Q 017591 29 STKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA-ALVYEFM 103 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e~~ 103 (369)
.++||+|+||+||+|.+.+ +..||+|.+...........+.+|+.+++.++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4789999999999997632 3379999988766666778899999999999999999999999876655 9999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC--c
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT--H 181 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 181 (369)
.+++|.+++......+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++........ .
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 9999999997767789999999999999999999999 9999999999999999999999999999976543221 1
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
.......+|..|+|||.+.+. .++.++|||||||++|+|++|+.|+...... ............
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---------------~~~~~~~~~~~~ 246 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---------------FDLTHFLAQGRR 246 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---------------GGHHHHHHTTCC
T ss_pred ccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCH---------------HHHHHHhhcCCC
Confidence 122345688899999988764 7899999999999999999977665432221 111111122222
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
...+...+..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2333445678999999999999999999999999998864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=340.89 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=194.3
Q ss_pred hccccccccCCceEEEEEEeCCC----cEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce----
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNG----VKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA---- 96 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---- 96 (369)
+.+.+.||+|+||.||+|.+... ..||+|++.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 34568999999999999987543 289999987542 334567899999999999999999999999877655
Q ss_pred --EEEEeccCCCCHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeec
Q 017591 97 --ALVYEFMENGSLDKYLFTD-----TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADF 169 (369)
Q Consensus 97 --~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 169 (369)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+ +|++||||||+|||++.++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeec
Confidence 9999999999999999432 2269999999999999999999999 99999999999999999999999999
Q ss_pred CCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhh
Q 017591 170 GLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYE 248 (369)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (369)
|++................+++.|+|||.+.+. .++.++|||||||++|+|++ |+.||.......
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------------- 247 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------------- 247 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------------
T ss_pred cccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHH-------------
Confidence 999876544433333445678899999988775 78999999999999999999 889887544321
Q ss_pred hchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.............+...+..+.+|+.+||+.||.+||++.++++.|+...
T Consensus 248 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 248 ---IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp ---HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11112222223334455678999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=340.08 Aligned_cols=243 Identities=25% Similarity=0.314 Sum_probs=193.1
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.++||+|+||+||+|.+. +++.||||++... ........+..|+..+..+ .|+||+++++++.+.+..++||||
T Consensus 59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~ 138 (311)
T 3p1a_A 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEec
Confidence 444578999999999999886 6999999987643 2334445556666666555 899999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+ +++|.+++...+..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 139 ~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~-- 212 (311)
T 3p1a_A 139 C-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-- 212 (311)
T ss_dssp C-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC--
Confidence 9 569999987777789999999999999999999999 9999999999999999999999999999987643322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .+..+..+....
T Consensus 213 -~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~~~-------- 271 (311)
T 3p1a_A 213 -GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYLPP-------- 271 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCCCH--------
T ss_pred -CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCCCc--------
Confidence 234569999999998765 68999999999999999999987664211 112221111110
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......+..+.+++.+||+.||.+|||+.++++
T Consensus 272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111224577999999999999999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=341.41 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=201.4
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHH-----HHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKR-----VEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (369)
+.+.+.||+|+||+||+|.++ +|+.||+|++....... ....+.+|+.++..++||||+++++++.+.+..++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 455689999999999999885 58999999987543211 246789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC----CeeEeecCCceec
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF----SAKVADFGLAKLC 175 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~ 175 (369)
|||+++|+|.+++. ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 94 ~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 94 LELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 99999999999994 45679999999999999999999999 9999999999999998877 7999999999876
Q ss_pred CCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 176 NPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
..... .....||+.|+|||++... .++.++|||||||++|+|++|..||....... ....+
T Consensus 170 ~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-------~~~~i-------- 230 (361)
T 2yab_A 170 EDGVE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANI-------- 230 (361)
T ss_dssp CTTCC---CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHH--------
T ss_pred CCCCc---cccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHH--------
Confidence 54322 2345699999999988764 78999999999999999999999997543211 11111
Q ss_pred hhcCCCCC---CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLGCGIEE---NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... .....+..+.+|+.+||..||.+|||+.++++
T Consensus 231 -~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 231 -TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111110 01223567899999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=330.11 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=209.2
Q ss_pred hhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.+.||+|+||.||++.+.+++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 34556899999999999999988999999998864332 3578999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++....... ....
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 162 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc-cccc
Confidence 999999997777789999999999999999999999 999999999999999999999999999997654321 1122
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....++..|+|||.+... .++.++||||||+++|+|++ |+.||....... .. ..........
T Consensus 163 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~---------~~i~~~~~~~ 225 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VV---------EDISTGFRLY 225 (267)
T ss_dssp TSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH---------HHHHTTCCCC
T ss_pred ccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHH-------HH---------HHHhcCCcCC
Confidence 334578889999988764 78999999999999999999 888886433210 11 1111111222
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3334567899999999999999999999999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=359.60 Aligned_cols=259 Identities=27% Similarity=0.385 Sum_probs=213.0
Q ss_pred HHHHhhhccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 20 QLCSFTNNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 20 el~~~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
++....+.+.++||+|+||.||+|.+.. +..||||++..... ....|.+|+.++++++||||+++++++.+....++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 3334444556899999999999998865 88999999985433 24679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 99 VYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999654 4569999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
... .......++..|+|||.+..+ .++.++|||||||++|||++ |+.||....... +... +
T Consensus 371 ~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~~~---------~ 432 (495)
T 1opk_A 371 DTY-TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYEL---------L 432 (495)
T ss_dssp CCE-ECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHH---------H
T ss_pred Cce-eecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHH---------H
Confidence 322 222334577899999988765 78999999999999999999 888887544221 1111 1
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
........+...+..+.+|+.+||+.||.+||++.+|++.|+...
T Consensus 433 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 222223334456678999999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=341.18 Aligned_cols=245 Identities=24% Similarity=0.297 Sum_probs=201.0
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||.||+++.+ +|+.||+|++.... .......+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 45689999999999999885 58999999987532 2223457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++|+|..++. ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++....... .
T Consensus 88 ~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~ 161 (337)
T 1o6l_A 88 NGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 161 (337)
T ss_dssp TTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--C
T ss_pred CCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--c
Confidence 9999999984 44679999999999999999999999 9999999999999999999999999999986432221 2
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ......... ...
T Consensus 162 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~----------~~~ 223 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILME----------EIR 223 (337)
T ss_dssp BCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC----------CCC
T ss_pred ccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHH-------HHHHHHHcC----------CCC
Confidence 2345799999999988764 7899999999999999999999999653321 111111111 112
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
.+...+..+.+|+.+||+.||.+|| ++.+|++
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 2334567899999999999999999 8888864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=338.05 Aligned_cols=257 Identities=20% Similarity=0.219 Sum_probs=205.4
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+|+.+++.+ +||||+++++++.+.+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 34568999999999999987 5689999999864332 23688999999999 8999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC-----eeEeecCCceecCCC
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS-----AKVADFGLAKLCNPE 178 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~~~ 178 (369)
+++|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 889999997667789999999999999999999999 99999999999999998887 999999999876443
Q ss_pred CCcc-----ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhh
Q 017591 179 NTHD-----STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELA 253 (369)
Q Consensus 179 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (369)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ......+......
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~----~~~~~~i~~~~~~ 238 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL----KERYQKIGDTKRA 238 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH----HHHHHHHHHHHHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccH----HHHHHHHHhhhcc
Confidence 3211 12456799999999988774 789999999999999999999999987644321 0111111111110
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
... .......+ .+.+++..||+.||.+||++.+|++.|+..
T Consensus 239 ~~~-----~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TPI-----EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SCH-----HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCH-----HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000 00001123 899999999999999999999999999865
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=342.10 Aligned_cols=245 Identities=23% Similarity=0.328 Sum_probs=200.0
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||+|.+ .+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 44568999999999999987 5689999999874321 11235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+ +|+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 91 ~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~-- 163 (336)
T 3h4j_B 91 A-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-- 163 (336)
T ss_dssp C-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT--
T ss_pred C-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc--
Confidence 9 6799998844 4579999999999999999999999 9999999999999999999999999999986543322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....||+.|+|||.+.+....+.++|||||||++|+|++|+.||......... .... ....
T Consensus 164 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------~~i~----------~~~~ 225 (336)
T 3h4j_B 164 -LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------KKVN----------SCVY 225 (336)
T ss_dssp -TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------CCCC----------SSCC
T ss_pred -cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------HHHH----------cCCC
Confidence 234569999999999887544588999999999999999999999765433210 0000 0111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 223335677899999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=339.40 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=209.6
Q ss_pred hhccccccccCCceEEEEEEe------CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC-ce
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQT-KA 96 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~ 96 (369)
.+.+.+.||+|+||.||+|.+ .+++.||+|++...........+.+|+.++..+ +||||+++++++...+ ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 344568999999999999974 346899999998766666677899999999999 6999999999987655 48
Q ss_pred EEEEeccCCCCHHHHhccCCC---------------CCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC
Q 017591 97 ALVYEFMENGSLDKYLFTDTE---------------VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK 161 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 161 (369)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+ ++++||||||+||+++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCC
Confidence 999999999999999965432 28999999999999999999999 999999999999999999
Q ss_pred CCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccc
Q 017591 162 FSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFP 240 (369)
Q Consensus 162 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 240 (369)
+.+||+|||++................+|+.|+|||.+... .++.++|||||||++|+|++ |+.||.......
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----- 258 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 258 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-----
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH-----
Confidence 99999999999876544433334445688899999988764 78999999999999999998 999987544321
Q ss_pred cchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
....... .......+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 259 -~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 259 -EFCRRLK---------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp -HHHHHHH---------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHhc---------cCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111 1111222334567799999999999999999999999999865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=330.58 Aligned_cols=253 Identities=30% Similarity=0.451 Sum_probs=203.8
Q ss_pred hhhccccccccCCceEEEEEEe-CCCcEEEEEEcccccc---HHHH---HHHHHHHHHHhccCCCceeeEEeEEEeCCce
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLN---KRVE---AQFMAEIGTIGRTYHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 96 (369)
..+.+.+.||+|+||+||+|.+ .+++.||+|++..... .... ..+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 3445668999999999999988 4689999999864321 1111 67899999999999999999999985544
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCC--eEeecCCCCceEecCCCC-----eeEeec
Q 017591 97 ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR--IIHYDIKPANILLDAKFS-----AKVADF 169 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~-----~kl~Df 169 (369)
++||||+++++|.+++......+++..++.++.|++.||+|||+ ++ ++||||||+||+++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 79999999999999997777889999999999999999999999 89 999999999999988776 999999
Q ss_pred CCceecCCCCCccccccCCCCCCccccccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhh
Q 017591 170 GLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR-NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYE 248 (369)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 248 (369)
|+++.... ......||+.|+|||.+.. ...++.++|||||||++|+|++|+.||.......... ..
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-----~~--- 240 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-----IN--- 240 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-----HH---
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-----HH---
Confidence 99975332 2234569999999998843 3367899999999999999999999997544331100 00
Q ss_pred hchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 249 KGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
........+..+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 241 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 241 -----MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -----HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 0111122233444567789999999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=341.15 Aligned_cols=268 Identities=25% Similarity=0.334 Sum_probs=212.6
Q ss_pred ccccccccCCceEEEEEEeC-----CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-----NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALV 99 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 99 (369)
.+.++||+|+||+||++.+. +++.||+|++...........+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 44578999999999998652 58999999998766667778899999999999999999999999874 578999
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
|||+++++|.+++... .+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 114 ~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp ECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 9999999999999443 49999999999999999999999 999999999999999999999999999999876543
Q ss_pred Cc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 180 TH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 180 ~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.. .......+|..|+|||.+... .++.++|||||||++|+|++|+.||.......... ............+......
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCHHHHHHHHHHHHHT
T ss_pred cccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccccchhHHHHHHHHhc
Confidence 32 223345688889999988764 68899999999999999999999986432110000 0000011111222233333
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
......+...+..+.+|+.+||+.||.+||++.+|++.|+...
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 3344455566788999999999999999999999999998763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=351.62 Aligned_cols=244 Identities=28% Similarity=0.383 Sum_probs=202.6
Q ss_pred cccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC-ceEEEEeccCCC
Q 017591 28 YSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-KAALVYEFMENG 106 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g 106 (369)
+.++||+|+||.||+|.+ .++.||||+++... ....|.+|+.++++++||||+++++++.+.. ..++||||+++|
T Consensus 197 ~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred EEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 457899999999999998 47899999998643 3457999999999999999999999987765 789999999999
Q ss_pred CHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 107 SLDKYLFTDTE-VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 107 sL~~~l~~~~~-~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+|.+++...+. .+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++...... .
T Consensus 273 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~ 344 (450)
T 1k9a_A 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 344 (450)
T ss_dssp BHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----c
Confidence 99999965543 47999999999999999999999 999999999999999999999999999998643221 1
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
...++..|+|||.+... .++.++|||||||++|||++ |+.||....... +.... ........
T Consensus 345 ~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i---------~~~~~~~~ 407 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRV---------EKGYKMDA 407 (450)
T ss_dssp --CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHH---------HTTCCCCC
T ss_pred CCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH---------HcCCCCCC
Confidence 23578899999988765 79999999999999999998 999997554321 11111 12222333
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
+...+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 445678899999999999999999999999999865
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=346.82 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=196.4
Q ss_pred cccccccCCceEEEEEEeC--C--CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe-CCceEEEEec
Q 017591 28 YSTKLGAGGFGVVYKGQFP--N--GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD-QTKAALVYEF 102 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 102 (369)
+.++||+|+||.||+|.+. + +..||+|.+..........++.+|+.++++++||||+++++++.+ .+..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 4578999999999999763 2 246899998765555667889999999999999999999998764 4578999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc-
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH- 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 181 (369)
+++|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 173 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred CCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 99999999997777789999999999999999999999 99999999999999999999999999999865433211
Q ss_pred -cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 182 -DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
.......+|+.|+|||.+... .++.++|||||||++|||++ |..||........ .... ...
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-------~~~~---------~~~ 312 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------TVYL---------LQG 312 (373)
T ss_dssp --------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-------HHHH---------HTT
T ss_pred ccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-------HHHH---------HcC
Confidence 122334578899999988764 78999999999999999999 5666654433211 1111 111
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.....+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 122223345678999999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=341.29 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=208.2
Q ss_pred ccccccccCCceEEEEEEeCC------CcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (369)
.+.+.||+|+||.||+|.+.. ...||+|.+...........+.+|+.++..+ +||||+++++++.+.+..++|
T Consensus 49 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 128 (333)
T 2i1m_A 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128 (333)
T ss_dssp EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEE
Confidence 445789999999999998743 2489999998766666678899999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeE
Q 017591 100 YEFMENGSLDKYLFTD-------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKV 166 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 166 (369)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||
T Consensus 129 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEEB
T ss_pred EecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEEE
Confidence 9999999999999542 3468999999999999999999999 99999999999999999999999
Q ss_pred eecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhH
Q 017591 167 ADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWD 245 (369)
Q Consensus 167 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 245 (369)
+|||++................+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||........ ...
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------~~~ 278 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------FYK 278 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH------HHH
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH------HHH
Confidence 999999866444333333445678899999988764 78999999999999999998 8888875433211 111
Q ss_pred HhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 246 EYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.. ........+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 279 ~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 279 LV---------KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HH---------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---------hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11 11111222333467799999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=327.09 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=205.7
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||+|+||.||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence 345689999999999999885 6899999998755444556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++ .....+++..++.++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++............
T Consensus 89 ~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 89 GGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp TEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCcHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 99999998 445679999999999999999999999 99999999999999999999999999999876433322223
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....||..|+|||.+......+.++||||||+++|+|++|+.||........ .+..+... ......
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~--------~~~~~~ 230 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEK--------KTYLNP 230 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH------HHHHHHTT--------CTTSTT
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHhhhc--------ccccCc
Confidence 4456899999999887754457899999999999999999999976543211 11111111 001111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+..+.+++.+||+.||.+||++.+|++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 2345677899999999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=337.65 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=201.7
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccH-----HHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNK-----RVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
.+.+.+.||+|+||.||+|.+. +++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4556789999999999999885 5899999998653221 124678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC----CeeEeecCCcee
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF----SAKVADFGLAKL 174 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~ 174 (369)
||||+++++|.+++. ....+++..++.++.|++.||.|||+ ++++||||||+|||++.++ .+||+|||++..
T Consensus 92 v~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 92 ILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 999999999999994 45679999999999999999999999 9999999999999998887 799999999987
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
...... .....||+.|+|||++... .++.++|||||||++|+|++|+.||....... ..........
T Consensus 168 ~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~-- 234 (326)
T 2y0a_A 168 IDFGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNY-- 234 (326)
T ss_dssp CCTTSC---CCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHTCC--
T ss_pred CCCCCc---cccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHHhcCC--
Confidence 653322 2335699999999988764 78999999999999999999999996533211 0111111000
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..........+..+.+|+.+||+.||.+|||+.++++
T Consensus 235 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 ----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ----CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000001123567899999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=333.12 Aligned_cols=260 Identities=18% Similarity=0.223 Sum_probs=208.3
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEec
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+|+.++..+ .|+|++++++++.+....++||||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 345668999999999999987 5699999998864322 34678899999998 799999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC-----eeEeecCCceecCC
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS-----AKVADFGLAKLCNP 177 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~~ 177 (369)
+ +++|.+++...+..+++..++.++.|++.||.|||+ ++++||||||+||+++.++. +||+|||++.....
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9 889999997767789999999999999999999999 99999999999999987766 99999999987654
Q ss_pred CCCc-----cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 178 ENTH-----DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 178 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
.... .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||......... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~ 238 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----QKYERIGEKKQ 238 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----HHHHHHHHHHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccH----HHHHHHHhhcc
Confidence 3321 123446799999999988764 7899999999999999999999999865443211 11111111110
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
...........+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 239 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 239 -----STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp -----HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -----CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 00001111234578999999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=352.10 Aligned_cols=264 Identities=21% Similarity=0.212 Sum_probs=208.9
Q ss_pred cCHHHHHHhhhccc--cccccCCceEEEEEEeCC-CcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEE
Q 017591 16 FTLEQLCSFTNNYS--TKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFC 90 (369)
Q Consensus 16 ~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 90 (369)
+.+.++...+++|. ++||+|+||+||+|++++ ++.||+|++.+... ......+.+|+.++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34455555556664 789999999999998864 78999999875211 11123488999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecC
Q 017591 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFG 170 (369)
Q Consensus 91 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 170 (369)
.+.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999996656789999999999999999999999 999999999999999999999999999
Q ss_pred CceecCCCCCccccccCCCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHH
Q 017591 171 LAKLCNPENTHDSTSGYRGTPGYSAPEFLLR----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDE 246 (369)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 246 (369)
+++........ ......||+.|+|||++.. ...++.++|||||||++|||++|+.||....... .+..
T Consensus 221 la~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-------~~~~ 292 (437)
T 4aw2_A 221 SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGK 292 (437)
T ss_dssp TCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHH
T ss_pred hhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-------HHHh
Confidence 99876543322 2234679999999999862 3468999999999999999999999997543211 1111
Q ss_pred hhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCC--CCChHHHHH
Q 017591 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEA--RPPMSAVVK 295 (369)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~v~~ 295 (369)
+.. .......+......+..+.+|+.+||..+|++ ||++.++++
T Consensus 293 i~~-----~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 293 IMN-----HKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHT-----HHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhh-----ccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111 01111223333345678899999999888888 999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=332.07 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=196.9
Q ss_pred hhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhc--cCCCceeeEEeEEEeC----CceE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR--TYHINLVRLYGFCYDQ----TKAA 97 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~~ 97 (369)
..+.+.++||+|+||+||+|++ +++.||+|++.... ...+..|.+++.. ++||||+++++++.+. ...+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 3445668999999999999988 78999999987532 2344555555554 8999999999987643 4588
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--------hccCCCeEeecCCCCceEecCCCCeeEeec
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLH--------EECNQRIIHYDIKPANILLDAKFSAKVADF 169 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH--------~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 169 (369)
+||||+++|+|.+++ ....+++..++.++.|++.||.||| + ++++||||||+|||++.++.+||+||
T Consensus 83 lv~e~~~~g~L~~~l--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 83 LITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEECCCTTCBHHHHH--TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EehhhccCCCHHHHH--hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeC
Confidence 999999999999999 3457999999999999999999999 7 99999999999999999999999999
Q ss_pred CCceecCCCCCcc--ccccCCCCCCccccccccccC-----CCCcchhhHHHHHHHHHHHcC----------CCCCCCCC
Q 017591 170 GLAKLCNPENTHD--STSGYRGTPGYSAPEFLLRNY-----PITQKCDVYSFGMLLFEIIGR----------RKNAQDCS 232 (369)
Q Consensus 170 g~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~s~~sDvwSlGvil~elltg----------~~p~~~~~ 232 (369)
|++.......... ......||+.|+|||.+.... .++.++|||||||++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998764433221 123347999999999887642 244799999999999999999 66765433
Q ss_pred CCccCccccchhHHhhhchhhhhhhcCCCC--CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 233 SDTLDWFPKQVWDEYEKGELAAKVLGCGIE--ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
..... +.......... ......+ ......+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 238 ~~~~~------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 238 PNDPS------FEDMRKVVCVD-QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CSSCC------HHHHHHHHTTS-CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcc------hhhhhHHHhcc-CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 32111 11111100000 0000011 1234577889999999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=353.08 Aligned_cols=253 Identities=30% Similarity=0.434 Sum_probs=202.8
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
.+.++||+|+||.||+|.+.++..||||+++.... ....+.+|+.++++++||||+++++++.+ +..++||||+++|
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~g 263 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 263 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred eeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCC
Confidence 44578999999999999998888999999985432 23578999999999999999999999865 6789999999999
Q ss_pred CHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 107 SLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 107 sL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+|.+++... +..+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++....... ....
T Consensus 264 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~ 339 (452)
T 1fmk_A 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQ 339 (452)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-eccc
Confidence 999999643 3569999999999999999999999 9999999999999999999999999999987643221 1223
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
...++..|+|||.+..+ .++.++|||||||++|||++ |+.||...... ++...+........
T Consensus 340 ~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----------------~~~~~i~~~~~~~~ 402 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------------EVLDQVERGYRMPC 402 (452)
T ss_dssp ---CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTTCCCCC
T ss_pred CCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCCCC
Confidence 34578899999988765 78999999999999999999 89998654321 11111222222333
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcCC
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEI 303 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~~ 303 (369)
+...+..+.+|+.+||+.||.+|||+.+|++.|+.....
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 445677899999999999999999999999999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=342.28 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=202.5
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||++.+. +++.||+|++.... .......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 445689999999999999875 58999999986432 222346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+.+|+|..++ .....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 97 ~~gg~L~~~l-~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-- 170 (384)
T 4fr4_A 97 LLGGDLRYHL-QQNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-- 170 (384)
T ss_dssp CTTEEHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC--
T ss_pred CCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc--
Confidence 9999999999 445679999999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccCCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 183 STSGYRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.....||+.|+|||++.. +..++.++|||||||++|+|++|+.||........ ....... . ..
T Consensus 171 -~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~----~~~~~~~---------~-~~ 235 (384)
T 4fr4_A 171 -ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS----KEIVHTF---------E-TT 235 (384)
T ss_dssp -BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH----HHHHHHH---------H-HC
T ss_pred -eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH----HHHHHHH---------h-hc
Confidence 234679999999999864 23589999999999999999999999975443221 0011111 1 11
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCC-hHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPP-MSAVV 294 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~v~ 294 (369)
....+..++..+.+|+.+||+.||.+||+ +.+|.
T Consensus 236 ~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 236 VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 12233455678999999999999999998 66665
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.27 Aligned_cols=262 Identities=20% Similarity=0.239 Sum_probs=202.8
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.++||+|+||+||+|.+. +++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 345689999999999999885 5899999998643 33344577889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
.+ +|.+++......+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........ .
T Consensus 84 ~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 157 (292)
T 3o0g_A 84 DQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--C 157 (292)
T ss_dssp SE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--C
T ss_pred CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--c
Confidence 86 6767666667789999999999999999999999 9999999999999999999999999999987643322 2
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHH-----------hhhc--
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDE-----------YEKG-- 250 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~-- 250 (369)
.....||+.|+|||++.+...++.++|||||||++|+|++|+.||........ ....+... ....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhccccc
Confidence 23456899999999987765689999999999999999999988754332110 00000000 0000
Q ss_pred --hhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 251 --ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 251 --~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..................+..+.+|+.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000000111222345678899999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=344.70 Aligned_cols=249 Identities=23% Similarity=0.257 Sum_probs=195.6
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.++||+|+||.||+|+++ +++.||+|++++.. .......+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus 55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~ 134 (396)
T 4dc2_A 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence 34578999999999999885 58899999987542 223345688899999877 899999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|..++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 135 ~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~ 208 (396)
T 4dc2_A 135 VNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 208 (396)
T ss_dssp CTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--C
T ss_pred CCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCC--C
Confidence 99999999994 34679999999999999999999999 999999999999999999999999999998532221 1
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||........... .....+...+... ..
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~~~~~~~i~~~-~~ 279 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYLFQVILEK-QI 279 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHHHHHHHHHC-CC
T ss_pred ccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhHHHHHHHHhcc-cc
Confidence 23446799999999988775 789999999999999999999999975433211000 0000011111111 12
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
..+...+..+.+|+.+||+.||.+||++
T Consensus 280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 2334466789999999999999999996
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=327.68 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=193.1
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEcccccc---HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLN---KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.++||+|+||.||+|.+ .++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 45568999999999999998 589999999875322 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCC---eEeecCCCCceEecC--------CCCeeEeecCC
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR---IIHYDIKPANILLDA--------KFSAKVADFGL 171 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~---ivH~dlkp~Nill~~--------~~~~kl~Dfg~ 171 (369)
+++++|.+++ ....+++..++.++.|++.||.|||+ ++ ++||||||+||+++. ++.+||+|||+
T Consensus 88 ~~~~~L~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 88 ARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp CTTEEHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred CCCCCHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999998 34579999999999999999999999 88 999999999999986 67899999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
+........ ....||+.|+|||.+... .++.++||||||+++|+|++|+.||........ ..
T Consensus 163 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~------ 224 (271)
T 3dtc_A 163 AREWHRTTK----MSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-------AY------ 224 (271)
T ss_dssp -----------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------HH------
T ss_pred ccccccccc----cCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HH------
Confidence 986543222 234689999999988764 789999999999999999999999975432110 00
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
...........+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 225 --GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111111223334456789999999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=333.17 Aligned_cols=251 Identities=28% Similarity=0.480 Sum_probs=197.9
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.+.+.||+|+||.||++.+ .++.||+|.+... .....+.+|+.++++++||||+++++++. +..++||||+++
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred eeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 34568999999999999988 5789999998743 23567899999999999999999999875 458999999999
Q ss_pred CCHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC-eeEeecCCceecCCCCCcc
Q 017591 106 GSLDKYLFTDTE--VLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS-AKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 106 gsL~~~l~~~~~--~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~ 182 (369)
++|.+++..... .+++..++.++.|+++||.|||+...++++||||||+||+++.++. +||+|||++......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 999999965432 5889999999999999999999855568999999999999998887 799999999765322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||........ . ..........+
T Consensus 160 -~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------~------~~~~~~~~~~~ 223 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--------R------IMWAVHNGTRP 223 (307)
T ss_dssp ------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--------H------HHHHHHTTCCC
T ss_pred -cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--------H------HHHHHhcCCCC
Confidence 1234589999999988764 789999999999999999999999975433211 0 00111112223
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
......+..+.+++.+||+.||.+||++.+|++.|+....
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 3344456789999999999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=334.14 Aligned_cols=264 Identities=23% Similarity=0.285 Sum_probs=199.6
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||+||+|++.+++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 34568999999999999999889999999986432 22223578899999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+ +|.+++......+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 157 (288)
T 1ob3_A 84 Q-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KY 157 (288)
T ss_dssp E-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--cc
Confidence 6 9999997666789999999999999999999999 9999999999999999999999999999976543221 12
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------cccchhHHhhhchhhhhh
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------FPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 256 (369)
....||+.|+|||++.+...++.++|||||||++|+|++|+.||.......... .....|............
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 234689999999998765578999999999999999999999997543211000 000000000000000000
Q ss_pred hc----CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 257 LG----CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 257 ~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0000111234577899999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=328.99 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=204.1
Q ss_pred hccccccccCCceEEEEEEeCC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.+.+.||+|+||.||+|.+.+ +..||+|++...........+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 3456899999999999998643 346999999876666667889999999999999999999999754 55789999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++++|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 999999999997767789999999999999999999999 99999999999999999999999999999865433221
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
......+|..|+|||.+... .++.++||||||+++|+|++ |+.||....... ..... ....
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-------~~~~~---------~~~~ 231 (281)
T 3cc6_A 170 -KASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVL---------EKGD 231 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-------HHHHH---------HHTC
T ss_pred -ccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHH-------HHHHH---------hcCC
Confidence 12334578899999988764 78999999999999999998 999986443321 11111 1111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
....+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 1222334567799999999999999999999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=346.73 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=202.0
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.+.||+|+||+||+|.+ .+|+.+|+|++... ........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence 345568999999999999987 46899999998653 3344566799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec---CCCCeeEeecCCceecCCCC
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD---AKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~ 179 (369)
+.+|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++.......
T Consensus 92 ~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 92 VTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999999844 4679999999999999999999999 9999999999999998 46789999999998765432
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
. ......||+.|+|||++... .++.++|||||||++|+|++|..||...... ..+.....+.. .
T Consensus 168 ~--~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~------~ 231 (444)
T 3soa_A 168 Q--AWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQH-------RLYQQIKAGAY------D 231 (444)
T ss_dssp C--BCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCC------C
T ss_pred c--eeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhCCC------C
Confidence 2 22345799999999988764 7899999999999999999999999653321 11122211111 0
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.........+..+.+|+.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011112345678999999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=338.75 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=202.7
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.+.||+|+||.||+|.++ +++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 4455689999999999999874 5899999998643 3445567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC---CeeEeecCCceecCCCC
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF---SAKVADFGLAKLCNPEN 179 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~ 179 (369)
+++|+|.+++. ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||++.......
T Consensus 110 ~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 110 VTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred CCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 99999999984 45679999999999999999999999 9999999999999997654 59999999998765332
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ..+.....+...
T Consensus 186 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~------ 248 (362)
T 2bdw_A 186 A---WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYD------ 248 (362)
T ss_dssp S---CCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC------
T ss_pred c---cccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCC------
Confidence 2 2335699999999988764 7899999999999999999999999653321 111111111100
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.........+..+.+|+.+||+.||.+||++.++++
T Consensus 249 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001112345678999999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=331.48 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=194.0
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccccc-------------------------HHHHHHHHHHHHHHhccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-------------------------KRVEAQFMAEIGTIGRTY 79 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------------------~~~~~~~~~E~~~l~~l~ 79 (369)
+.+.+.||+|+||.||+|.+. +++.||+|++..... ......+.+|+.+++.++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 455689999999999999874 589999999864321 112356889999999999
Q ss_pred CCceeeEEeEEEe--CCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceE
Q 017591 80 HINLVRLYGFCYD--QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANIL 157 (369)
Q Consensus 80 h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nil 157 (369)
||||+++++++.+ .+..++||||+++++|.+++ ....+++..++.++.|++.||.|||+ ++++||||||+|||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLL 169 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEE
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEE
Confidence 9999999999986 56789999999999998876 34579999999999999999999999 99999999999999
Q ss_pred ecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCCCc
Q 017591 158 LDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYP--ITQKCDVYSFGMLLFEIIGRRKNAQDCSSDT 235 (369)
Q Consensus 158 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~s~~sDvwSlGvil~elltg~~p~~~~~~~~ 235 (369)
++.++.+||+|||++......... .....||+.|+|||.+..... .+.++|||||||++|+|++|+.||......
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~- 246 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM- 246 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred ECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH-
Confidence 999999999999999876543221 234569999999998876432 478999999999999999999999643211
Q ss_pred cCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 236 LDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......... ..........+..+.+|+.+||+.||.+||++.+|++
T Consensus 247 ------~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 ------CLHSKIKSQ--------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ------HHHHHHHHC--------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------HHHHHHhcc--------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 001111110 0011112235677999999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=336.34 Aligned_cols=249 Identities=23% Similarity=0.258 Sum_probs=198.1
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.||+|+||.||+|+++ +++.||+|++.... .......+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 45689999999999999885 58999999987542 344566788999999887 899999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|..++.. ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 92 ~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~ 165 (345)
T 3a8x_A 92 VNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 165 (345)
T ss_dssp CCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--C
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC--C
Confidence 999999999943 4579999999999999999999999 999999999999999999999999999998543221 1
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||........... .....+...+... ..
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------~~~~~~~~~i~~~-~~ 236 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYLFQVILEK-QI 236 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHHHHHHHHC-CC
T ss_pred cccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-------ccHHHHHHHHHcC-CC
Confidence 23346799999999988774 789999999999999999999999975432211000 0000011111111 12
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
..+...+..+.+|+.+||+.||.+||++
T Consensus 237 ~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 2334456789999999999999999996
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=363.51 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=203.3
Q ss_pred ccccCCceEEEEEEeC---CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 31 KLGAGGFGVVYKGQFP---NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
+||+|+||.||+|.+. ++..||||+++..........+.+|+.+++.++||||+++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999763 4678999999865554556789999999999999999999999976 56899999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc-ccccc
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH-DSTSG 186 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~ 186 (369)
|.+++......+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........ .....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 999997677789999999999999999999999 99999999999999999999999999999865433221 11222
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..+++.|+|||++..+ .++.++|||||||++|||++ |+.||....... +...+........+
T Consensus 499 ~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~p 561 (613)
T 2ozo_A 499 GKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFIEQGKRMECP 561 (613)
T ss_dssp ---CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----------------HHHHHHTTCCCCCC
T ss_pred CCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHcCCCCCCC
Confidence 3467899999998764 79999999999999999998 999997544321 11222222233344
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
...+..+.+|+.+||+.||.+||++.+|++.|+..
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 55678899999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=332.99 Aligned_cols=263 Identities=25% Similarity=0.333 Sum_probs=191.1
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||+|+||.||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 87 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC
Confidence 44578999999999999874 58999999987544333346788999999999999999999999999999999999985
Q ss_pred CCHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 106 GSLDKYLFTD-----TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 106 gsL~~~l~~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
+|.+++... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 88 -~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 88 -DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp -BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred -CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence 999988532 2469999999999999999999999 9999999999999999999999999999987643222
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhchh
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGEL 252 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~ 252 (369)
......||+.|+|||++.+...++.++|||||||++|+|++|+.||......... ......|........
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 164 --TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp --CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred --cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 1233568999999999876557899999999999999999999999754432100 000000000000000
Q ss_pred hhhhhcCCC---------CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 253 AAKVLGCGI---------EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 253 ~~~~~~~~~---------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......... +......+..+.+|+.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000 0011123567999999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=326.11 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=204.0
Q ss_pred hhccccccccCCceEEEEEEeCCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--CceEEEEe
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--TKAALVYE 101 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 101 (369)
.+.+.++||+|+||.||+|++ +++.||+|++... ........+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 345668999999999999998 5889999998753 3445567899999999999999999999999877 77899999
Q ss_pred ccCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHhhccCCC--eEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 102 FMENGSLDKYLFTDTE-VLKWEKLLDIAIGTARGIAYLHEECNQR--IIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
|+++|+|.+++..... .+++..++.++.|++.||.|||+ ++ ++||||||+||+++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 9999999999965443 69999999999999999999999 88 99999999999999999999999888653221
Q ss_pred CCccccccCCCCCCccccccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNY--PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
....||+.|+|||.+.+.. .++.++|||||||++|+|++|+.||........ .....
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~~~~~ 224 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---------------GMKVA 224 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---------------HHHHH
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---------------HHHHH
Confidence 2345899999999887642 234489999999999999999999975432110 00111
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.....+..+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 12222334445677899999999999999999999999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=339.90 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=203.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 445688999999999999885 589999999875432 345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC--CCCeeEeecCCceecCCCCCcc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA--KFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+|+|.+++......+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++.........
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~- 207 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV- 207 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE-
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcce-
Confidence 999999996666689999999999999999999999 99999999999999974 467999999999876543322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
....||+.|+|||++... .++.++|||||||++|+|++|+.||....... ......... .....
T Consensus 208 --~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~i~~~~------~~~~~ 271 (387)
T 1kob_A 208 --KVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCD------WEFDE 271 (387)
T ss_dssp --EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCC------CCCCS
T ss_pred --eeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------CCCCc
Confidence 234699999999988764 78999999999999999999999997543210 011111110 00111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......+..+.+|+.+||+.||.+||++.++++
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 222345678999999999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=338.14 Aligned_cols=250 Identities=21% Similarity=0.279 Sum_probs=194.8
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCC--CceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYH--INLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||++.+.+++.||+|++... ........+.+|+.++..+.| +||+++++++.+.+..++|||+
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~ 90 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 90 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC
Confidence 4556899999999999999988999999998643 344556789999999999976 9999999999999999999995
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
.+++|.+++.. ...+++..++.++.|++.||.|||+ ++|+||||||+|||++ ++.+||+|||++..........
T Consensus 91 -~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 91 -GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp -CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred -CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 57799999954 5679999999999999999999999 9999999999999997 5789999999998765443333
Q ss_pred ccccCCCCCCccccccccc----------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 183 STSGYRGTPGYSAPEFLLR----------NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~----------~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
......||+.|+|||++.. ...++.++|||||||++|+|++|+.||....... .. .
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------~~-----~ 230 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---------SK-----L 230 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---------HH-----H
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH---------HH-----H
Confidence 3345679999999998864 2468999999999999999999999996432210 00 0
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
............+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 0111111112222333467899999999999999999999984
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.09 Aligned_cols=246 Identities=24% Similarity=0.296 Sum_probs=197.0
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.++||+|+||.||+|+++ +++.||+|++.... .......+.+|..++..+ +||||+++++++.+.+..++||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 3455689999999999999875 58999999987532 223345678899999987 6999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++|+|..++. ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus 104 E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 104 EFVNGGDLMFHIQ-KSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp ECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred eCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 9999999999994 34679999999999999999999999 999999999999999999999999999997543222
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+..+.
T Consensus 179 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~--------- 240 (353)
T 3txo_A 179 -VTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDE--------- 240 (353)
T ss_dssp --------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC---------
T ss_pred -ccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC---------
Confidence 123345799999999988764 7899999999999999999999999754321 1112221111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCh------HHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPM------SAVV 294 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~~v~ 294 (369)
...+...+..+.+|+.+||+.||.+||++ .+|+
T Consensus 241 -~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il 279 (353)
T 3txo_A 241 -VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAIL 279 (353)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHh
Confidence 12233356778999999999999999998 6665
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=337.29 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=202.5
Q ss_pred HhhhccccccccCCceEEEEEEeCC-C-------cEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQFPN-G-------VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT 94 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 94 (369)
...+.+.+.||+|+||+||+|.+.. + ..||+|++..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3445667899999999999997743 3 5799999875432 34567999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC--------eeE
Q 017591 95 KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS--------AKV 166 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~kl 166 (369)
..++||||+++++|.+++......+++..++.++.|++.||.|||+ ++++||||||+|||++.++. +||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence 9999999999999999997766679999999999999999999999 99999999999999998887 999
Q ss_pred eecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHH
Q 017591 167 ADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDE 246 (369)
Q Consensus 167 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 246 (369)
+|||++..... .....+|..|+|||.+.....++.++|||||||++|+|++|..|+........ ....
T Consensus 163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~------~~~~ 230 (289)
T 4fvq_A 163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KLQF 230 (289)
T ss_dssp CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHH
T ss_pred ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH------HHHH
Confidence 99999864322 12235788999999988745789999999999999999997655543221100 0000
Q ss_pred hhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
. ... ...+...+..+.+|+.+||+.||.+||++.++++.|+....
T Consensus 231 ~--------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 Y--------EDR---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp H--------HTT---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred h--------hcc---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0 000 11112224568999999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=336.83 Aligned_cols=250 Identities=22% Similarity=0.276 Sum_probs=201.2
Q ss_pred HhhhccccccccCCceEEEEEEeC-CCcEEEEEEcccccc----HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceE
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN----KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (369)
...+.+.+.||+|+||+||+|.++ +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345667789999999999999874 589999999864211 112467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC---eeEeecCC
Q 017591 98 LVYEFMENGSLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS---AKVADFGL 171 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~ 171 (369)
+||||+++++|.+++... +..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998888432 3468999999999999999999999 99999999999999987654 99999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
+........ ......||+.|+|||++... .++.++|||||||++|+|++|+.||..... ..+.....+
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~- 247 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKG- 247 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHT-
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcC-
Confidence 987654322 12345699999999988765 689999999999999999999999965211 111111111
Q ss_pred hhhhhhcCCCCCCC---HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVLGCGIEEND---REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.....+ ...+..+.+|+.+||+.||.+||++.++++
T Consensus 248 --------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 --------KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111 123578899999999999999999999984
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=338.28 Aligned_cols=259 Identities=28% Similarity=0.379 Sum_probs=205.9
Q ss_pred HHhhhccccccccCCceEEEEEEe------CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc
Q 017591 22 CSFTNNYSTKLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK 95 (369)
Q Consensus 22 ~~~t~~f~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 95 (369)
....+.+.+.||+|+||.||+|.+ .++..||+|++..........++.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 344455668999999999999984 34789999999866566667789999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC---CCCeeE
Q 017591 96 AALVYEFMENGSLDKYLFTDT------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA---KFSAKV 166 (369)
Q Consensus 96 ~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl 166 (369)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999996543 458999999999999999999999 99999999999999984 446999
Q ss_pred eecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhH
Q 017591 167 ADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWD 245 (369)
Q Consensus 167 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 245 (369)
+|||++................+|+.|+|||.+... .++.++|||||||++|+|++ |+.||......
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------- 252 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----------- 252 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----------
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-----------
Confidence 999998755433332233345688999999988765 78999999999999999998 88888643321
Q ss_pred HhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 246 EYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
..............+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 253 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 253 -----EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp -----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111222222333445567899999999999999999999999999865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=333.29 Aligned_cols=242 Identities=25% Similarity=0.308 Sum_probs=200.3
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||+++.+ +|+.||+|++..... ......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 345689999999999999885 689999999875321 12345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|.+++. ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 88 IEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp CCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred CCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 99999999994 44679999999999999999999999 99999999999999999999999999999875432
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....||+.|+|||++... .++.++|||||||++|||++|+.||...... ..+..... .. .
T Consensus 160 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~---------~~-~ 220 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILN---------AE-L 220 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHH---------CC-C
T ss_pred -cccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh---------CC-C
Confidence 2335799999999988764 7899999999999999999999999653321 11111111 11 1
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCC-----ChHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARP-----PMSAVV 294 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~ 294 (369)
..+...+..+.+++.+||+.||.+|| ++.+|+
T Consensus 221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 22334567899999999999999999 888887
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.19 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=205.4
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||+|.+. +|+.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 445688999999999999885 699999999874321 12345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|.+++. ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~-- 171 (476)
T 2y94_A 98 VSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-- 171 (476)
T ss_dssp CSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC--
T ss_pred CCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc--
Confidence 99999999994 45679999999999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....||+.|+|||++.+....+.++|||||||++|+|++|+.||....... .......+. .
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~----------~ 233 (476)
T 2y94_A 172 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-------LFKKICDGI----------F 233 (476)
T ss_dssp -BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-------HHHHHHTTC----------C
T ss_pred -ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCC----------c
Confidence 2335699999999998876455889999999999999999999997543221 111111111 1
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH--HhcC
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK--MLEG 299 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~--~L~~ 299 (369)
..+...+..+.+|+.+||+.||.+|||+.+|++ +++.
T Consensus 234 ~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 122334567899999999999999999999985 4443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=338.45 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=196.4
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSL 108 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 108 (369)
+.||+|+||.||+|.+ .+|+.||+|++..... .....+.+|+.++.+++||||+++++++.+.+..++||||+++++|
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 5799999999999987 4589999999875432 4466899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe--cCCCCeeEeecCCceecCCCCCcccccc
Q 017591 109 DKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL--DAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~ 247 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKV 247 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccc
Confidence 99997666789999999999999999999999 999999999999999 5677899999999987654332 223
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
..||+.|+|||++... .++.++|||||||++|+|++|+.||....... ....+..... ........
T Consensus 248 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~------~~~~~~~~ 313 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-------TLNNILACRW------DLEDEEFQ 313 (373)
T ss_dssp CCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCC------CSCSGGGT
T ss_pred ccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccC------CCChhhhc
Confidence 4699999999988764 78999999999999999999999997543211 0111111000 00011123
Q ss_pred HHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 267 EEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+..+.+|+.+||+.||.+||++.++++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 45678999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=335.67 Aligned_cols=273 Identities=25% Similarity=0.334 Sum_probs=213.7
Q ss_pred hhhccccccccCCceEEEEEEe-----CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEE--eCCce
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQF-----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY--DQTKA 96 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 96 (369)
..+.+.++||+|+||.||+|++ .+++.||+|++... .......+.+|+.++++++|+||+++++++. +.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 3445668999999999999983 45899999998754 3455677999999999999999999999987 44568
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 97 ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
++||||+++++|.+++......+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 99999999999999997656679999999999999999999999 999999999999999999999999999998875
Q ss_pred CCCCc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 177 PENTH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 177 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
..... .......+|..|+|||.+.+. .++.++|||||||++|+|++|+.||.............. ............
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 256 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE-RDVPALSRLLEL 256 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc-cccccHHHHHHH
Confidence 43322 223345688889999988764 689999999999999999999999864322100000000 000000112222
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 256 VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
.........+...+..+.+|+.+||+.||.+||++.+|++.|+....
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 33333344455677889999999999999999999999999998743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=338.33 Aligned_cols=241 Identities=22% Similarity=0.238 Sum_probs=200.1
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||.||++++. +|+.||+|++.... .......+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 123 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 34578999999999999885 58999999986432 1123457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++|+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 124 ~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----- 194 (350)
T 1rdq_E 124 AGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----- 194 (350)
T ss_dssp TTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-----
Confidence 99999999954 3569999999999999999999999 99999999999999999999999999999876432
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+..+..+. ..
T Consensus 195 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~----------~~ 256 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGK----------VR 256 (350)
T ss_dssp BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC----------CC
T ss_pred cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHH-------HHHHHHHcCC----------CC
Confidence 2235699999999988764 7899999999999999999999999754321 1122221111 12
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCC-----hHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPP-----MSAVV 294 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~v~ 294 (369)
.+...+..+.+|+.+||+.||.+||+ +.+|+
T Consensus 257 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~ 292 (350)
T 1rdq_E 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH
Confidence 23345678999999999999999998 77776
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=330.55 Aligned_cols=273 Identities=24% Similarity=0.335 Sum_probs=200.4
Q ss_pred cccCHHHHHHhhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhc--cCCCceeeEEeEEE
Q 017591 14 VRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR--TYHINLVRLYGFCY 91 (369)
Q Consensus 14 ~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~ 91 (369)
..+...+.....+.+.++||+|+||.||+|++ .++.||+|++.... ...+.+|.+++.. ++||||+++++++.
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 44455555566667779999999999999998 48999999986432 2334445555544 48999999999998
Q ss_pred eC----CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCC--------CeEeecCCCCceEec
Q 017591 92 DQ----TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ--------RIIHYDIKPANILLD 159 (369)
Q Consensus 92 ~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~--------~ivH~dlkp~Nill~ 159 (369)
+. ...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+ + +++||||||+|||++
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEEC
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEEC
Confidence 77 678999999999999999943 369999999999999999999998 7 999999999999999
Q ss_pred CCCCeeEeecCCceecCCCCCcc--ccccCCCCCCccccccccccCCCCc------chhhHHHHHHHHHHHcCCCCCCCC
Q 017591 160 AKFSAKVADFGLAKLCNPENTHD--STSGYRGTPGYSAPEFLLRNYPITQ------KCDVYSFGMLLFEIIGRRKNAQDC 231 (369)
Q Consensus 160 ~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~s~------~sDvwSlGvil~elltg~~p~~~~ 231 (369)
.++.+||+|||++.......... ......||+.|+|||++... ..+. ++|||||||++|||++|..|+...
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 99999999999998765433221 12245799999999988764 3333 499999999999999994444322
Q ss_pred CCCccCccc----cchhHHhhhchhhhhhhcCCCCCC-----CHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 232 SSDTLDWFP----KQVWDEYEKGELAAKVLGCGIEEN-----DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 232 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
......+.. ...+....... ......+.. ....+..+.+|+.+||+.||.+||++.+|++.|+...
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIV----CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccccHhhhcCCCCchhhhHHHH----hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 111111000 00011111000 011111111 2367888999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=327.07 Aligned_cols=253 Identities=33% Similarity=0.462 Sum_probs=206.4
Q ss_pred hhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
..+.+.+.||+|+||.||+|.+.++..||+|.+..... ....+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 34556789999999999999998888999999875432 2457899999999999999999999885 55689999999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
++++|.+++.... ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-
Confidence 9999999995432 379999999999999999999999 99999999999999999999999999999876543322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......++..|+|||.+..+ .++.++||||||+++|+|++ |+.||....... ... .......
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~---------~~~~~~~ 228 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQ---------NLERGYR 228 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHH---------HHHTTCC
T ss_pred cccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHH---------HHhcccC
Confidence 22334578899999988764 68999999999999999999 888886533211 111 1111122
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
...+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 233345567899999999999999999999999999876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=335.86 Aligned_cols=245 Identities=23% Similarity=0.319 Sum_probs=179.5
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
+.||+|+||+||+|.+. +++.||+|++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 67999999999999885 5899999998743 2456788999999997 9999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC---CeeEeecCCceecCCCCCcccc
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF---SAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
|.+++.. ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||++......... .
T Consensus 93 L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~ 166 (325)
T 3kn6_A 93 LFERIKK-KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--L 166 (325)
T ss_dssp HHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--c
Confidence 9999944 5679999999999999999999999 9999999999999997765 7999999999876533222 2
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||................ ...........
T Consensus 167 ~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---------~~i~~~~~~~~ 236 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM---------KKIKKGDFSFE 236 (325)
T ss_dssp -----------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH---------HHHTTTCCCCC
T ss_pred cccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH---------HHHHcCCCCCC
Confidence 335689999999988764 78999999999999999999999997654321111111111 11222111111
Q ss_pred C---HHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 265 D---REEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 265 ~---~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
. ...+..+.+|+.+||+.||.+||++.+++
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 1 23567899999999999999999999976
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=341.56 Aligned_cols=250 Identities=20% Similarity=0.275 Sum_probs=195.0
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccC--CCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTY--HINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||++.+.+++.||||++... ........+.+|+.++..+. |+||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 3445789999999999999988999999998643 34556678999999999996 5999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+.+++|.+++.. ...+++..++.++.|++.||.|||+ ++|+||||||+|||++ ++.+||+|||+++.+.......
T Consensus 137 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 137 CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 567799999954 4578999999999999999999999 9999999999999995 5799999999998765443333
Q ss_pred ccccCCCCCCccccccccc----------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 183 STSGYRGTPGYSAPEFLLR----------NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~----------~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
......||+.|+|||++.. ...++.++|||||||++|||++|+.||....... .. +
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---------~~-----~ 277 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---------SK-----L 277 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---------HH-----H
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---------HH-----H
Confidence 3345679999999998864 1368999999999999999999999996432210 00 0
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
............+...+..+.+|+.+||+.||.+||++.+|++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 0111111111112222567899999999999999999999984
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=339.13 Aligned_cols=260 Identities=17% Similarity=0.226 Sum_probs=202.3
Q ss_pred hccccccccC--CceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 26 NNYSTKLGAG--GFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.+.++||+| +||.||+|++. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 4456899999 99999999885 69999999987542 34556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC-
Q 017591 102 FMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN- 179 (369)
Q Consensus 102 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 179 (369)
|+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||.+.......
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 99999999999654 3679999999999999999999999 999999999999999999999999999986542211
Q ss_pred ----CccccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 180 ----THDSTSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 180 ----~~~~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
.........||+.|+|||++... ..++.++|||||||++|+|++|+.||......... .. ...+....
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~-~~~~~~~~ 256 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML------LE-KLNGTVPC 256 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH------HH-C-------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH------HH-HhcCCCCc
Confidence 11112334689999999998764 36899999999999999999999999765443210 00 00000000
Q ss_pred ---------------------------h---------hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 ---------------------------K---------VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ---------------------------~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
. .............+..+.+|+.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 0000001123445678999999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=345.76 Aligned_cols=264 Identities=21% Similarity=0.195 Sum_probs=207.3
Q ss_pred ccCHHHHHHhhhccc--cccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeE
Q 017591 15 RFTLEQLCSFTNNYS--TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGF 89 (369)
Q Consensus 15 ~~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~ 89 (369)
.+.+.++....++|. ++||+|+||.||+++.+ +|+.||+|++.+... ......+.+|..++..++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 344555555566664 78999999999999885 699999999875321 1123357889999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeec
Q 017591 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADF 169 (369)
Q Consensus 90 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 169 (369)
+.+.+..++||||+++|+|.+++...+..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999997656689999999999999999999999 99999999999999999999999999
Q ss_pred CCceecCCCCCccccccCCCCCCccccccccc------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccch
Q 017591 170 GLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR------NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQV 243 (369)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 243 (369)
|+++........ ......||+.|+|||++.. ...++.++|||||||++|||++|+.||....... .
T Consensus 207 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~ 278 (412)
T 2vd5_A 207 GSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-------T 278 (412)
T ss_dssp TTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------H
T ss_pred hhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-------H
Confidence 999876543321 2234579999999999873 2368999999999999999999999997543211 1
Q ss_pred hHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCC---CChHHHHH
Q 017591 244 WDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEAR---PPMSAVVK 295 (369)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~~v~~ 295 (369)
+..+... ......+......+..+.+|+.+||. +|.+| |++.+|++
T Consensus 279 ~~~i~~~-----~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 YGKIVHY-----KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHTH-----HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHhc-----ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111110 01111222233456789999999999 99998 58888863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=337.58 Aligned_cols=264 Identities=20% Similarity=0.284 Sum_probs=195.7
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||+||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++||||+.
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 445689999999999999885 6899999998754433333356689999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+ +|.+++...+..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........ ..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~ 157 (324)
T 3mtl_A 84 K-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TY 157 (324)
T ss_dssp E-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--cc
Confidence 5 9999997777789999999999999999999999 9999999999999999999999999999986543222 12
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhch-hhhh
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGE-LAAK 255 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~-~~~~ 255 (369)
....||+.|+|||++.+...++.++|||||||++|+|++|+.||......... ......|....... ....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 23468999999999877567899999999999999999999999765432100 00000000000000 0000
Q ss_pred hhcCCCC----CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLGCGIE----ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 001223567899999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=330.78 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=212.9
Q ss_pred HHHHHhhhccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceE
Q 017591 19 EQLCSFTNNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 19 ~el~~~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (369)
.++....+.+.++||+|+||+||+|.+.. +..||+|++..... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 34445555667899999999999998854 88999999875432 3567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 98 LVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999653 4569999999999999999999999 999999999999999999999999999998665
Q ss_pred CCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 177 PENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
.... .......+|+.|+|||.+... .++.++||||||+++|+|++ |..||....... ... .
T Consensus 163 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------~~~---------~ 224 (288)
T 3kfa_A 163 GDTY-TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYE---------L 224 (288)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHH---------H
T ss_pred CCcc-ccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH---------H
Confidence 3332 222334578899999988765 78999999999999999999 888886543321 111 1
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 256 VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.........+...+..+.+|+.+||+.||.+||++.+|++.|+..
T Consensus 225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 112222333445567899999999999999999999999999865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=330.90 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=194.7
Q ss_pred cccccccCCceEEEEEEeC----CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----ceE
Q 017591 28 YSTKLGAGGFGVVYKGQFP----NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT-----KAA 97 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 97 (369)
+.+.||+|+||.||+|.+. ++..||+|++... ........+.+|+.++++++||||+++++++.+.+ ..+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 3468999999999999763 3458999998743 34455678999999999999999999999998655 359
Q ss_pred EEEeccCCCCHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCc
Q 017591 98 LVYEFMENGSLDKYLFT-----DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLA 172 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 172 (369)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecCcc
Confidence 99999999999999842 34579999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhch
Q 017591 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
................+++.|+|||.+... .++.++||||||+++|+|++ |..||....... ...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~------ 260 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------MYD------ 260 (313)
T ss_dssp ----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHH------
T ss_pred eecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------HHH------
Confidence 876544333333445678899999988764 78999999999999999999 888886543321 111
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
..........+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 261 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 261 ---YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp ---HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11222223334455678999999999999999999999999998763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=339.14 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=189.5
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.++||+|+||+||++++. +++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 3456689999999999999885 689999999875322 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC--eeEeecCCceecCCCCCc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS--AKVADFGLAKLCNPENTH 181 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 181 (369)
++|+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-- 172 (361)
T 3uc3_A 99 SGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 172 (361)
T ss_dssp CSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence 99999999943 4579999999999999999999999 99999999999999987765 9999999987533222
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC-
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG- 260 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 260 (369)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||........ ..... .......
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~~~------~~~~~~~~ 239 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD------YRKTI------QRILSVKY 239 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC------HHHHH------HHHHTTCC
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH------HHHHH------HHHhcCCC
Confidence 223356999999999987753344559999999999999999999975443211 00110 0111110
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........+..+.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 01111134577899999999999999999999984
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=333.65 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=202.3
Q ss_pred hhhccccccccCCceEEEEEEeC-CCcE--EEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP-NGVK--IAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (369)
..+.+.+.||+|+||.||+|.+. ++.. +++|.+...........+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 34456689999999999999874 4554 4889887655555567899999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCe
Q 017591 100 YEFMENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA 164 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 164 (369)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999995443 479999999999999999999999 999999999999999999999
Q ss_pred eEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccch
Q 017591 165 KVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQV 243 (369)
Q Consensus 165 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 243 (369)
||+|||++...... .......+++.|+|||.+... .++.++|||||||++|+|++ |+.||....... .
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~ 250 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------L 250 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------H
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------H
Confidence 99999998743211 112334578899999988764 68999999999999999998 999986543211 1
Q ss_pred hHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 244 WDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
... .........+...+..+.+|+.+||+.||.+||++.++++.|+...
T Consensus 251 ~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 251 YEK---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHH---------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH---------hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 1111122333445678999999999999999999999999998763
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=327.33 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=196.8
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.++||+|+||.||++.+. ++..+|+|++...........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 4556789999999999999874 589999999876544444678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe---cCCCCeeEeecCCceecCC
Q 017591 104 ENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL---DAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 104 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~ 177 (369)
++++|.+++.. ....+++..++.++.|++.||.|||+ ++++||||||+||++ +.++.+||+|||++.....
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 99999998853 24679999999999999999999999 999999999999999 4567899999999976543
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
... .....||+.|+|||.+.. .++.++|||||||++|+|++|+.||........ ...... .
T Consensus 180 ~~~---~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-------~~~~~~-------~ 240 (285)
T 3is5_A 180 DEH---STNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-------QQKATY-------K 240 (285)
T ss_dssp ----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHH-------C
T ss_pred ccc---CcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-------Hhhhcc-------C
Confidence 322 234568999999998754 689999999999999999999999975432110 000000 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...........+..+.+|+.+||+.||.+||++.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111111124567889999999999999999999974
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=337.25 Aligned_cols=271 Identities=23% Similarity=0.359 Sum_probs=209.4
Q ss_pred hhccccccccCCceEEEEEEe-----CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC--ceE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-----PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT--KAA 97 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~ 97 (369)
.+.+.++||+|+||.||++++ .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 345568999999999999983 368999999987643 345678999999999999999999999987654 789
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||+++++|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 9999999999999997777789999999999999999999999 9999999999999999999999999999988754
Q ss_pred CCCcc-ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 178 ENTHD-STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 178 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
..... ......++..|+|||.+... .++.++|||||||++|+|++|..|+.......................+....
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 43221 12334577889999988764 68999999999999999999998875321100000000000000001112222
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
........+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22222333455678899999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=327.60 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=202.8
Q ss_pred cccc-ccccCCceEEEEEEe---CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 27 NYST-KLGAGGFGVVYKGQF---PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 27 ~f~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
.+.+ .||+|+||+||+|.+ .+++.||+|++.... .......+.+|+.+++.++||||+++++++ +.+..++|||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 3445 899999999999954 347899999987542 234467899999999999999999999999 6677899999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++++|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 98 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 98 MAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp CCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred eCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 9999999999954 4569999999999999999999999 99999999999999999999999999999877544332
Q ss_pred c-ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 182 D-STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 182 ~-~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
. ......+++.|+|||.+... .++.++||||||+++|+|++ |+.||...... .+.......
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~~~~~~~ 236 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----------------EVTAMLEKG 236 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTT
T ss_pred ccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH----------------HHHHHHHcC
Confidence 2 22234467889999988764 68899999999999999999 99998754321 111112222
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.....+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 237 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22333445678899999999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=335.64 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=198.8
Q ss_pred cccccccCCceEEEEEEe-CCCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 28 YSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
..+.||+|+||+||+|++ .+++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++||||+.
T Consensus 58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 347899999999999987 56899999998643 233445679999999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 138 -g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------ 207 (348)
T 1u5q_A 138 -GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------ 207 (348)
T ss_dssp -EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------
T ss_pred -CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC------
Confidence 48888886667789999999999999999999999 99999999999999999999999999999765321
Q ss_pred ccCCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 185 SGYRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
....||+.|+|||++.. ...++.++|||||||++|||++|+.||....... . .... .......
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~-~~~~--------~~~~~~~ 272 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------A-LYHI--------AQNESPA 272 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------H-HHHH--------HHSCCCC
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------H-HHHH--------HhcCCCC
Confidence 23569999999998852 3468999999999999999999999986543211 0 0011 1111111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......+..+.+|+.+||+.||.+||++.++++
T Consensus 273 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 122345677899999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=339.79 Aligned_cols=266 Identities=15% Similarity=0.223 Sum_probs=201.0
Q ss_pred hhccccccccCCceEEEEEEeCC------CcEEEEEEccccccHH-H---------HHHHHHHHHHHhccCCCceeeEEe
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPN------GVKIAAKILKTCLNKR-V---------EAQFMAEIGTIGRTYHINLVRLYG 88 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-~---------~~~~~~E~~~l~~l~h~niv~~~~ 88 (369)
.+.+.++||+|+||.||+|.+.. ++.||+|++....... . ...+..|+..+..+.|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 44556899999999999998754 4789999986543211 0 112445667778889999999999
Q ss_pred EEEeC----CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec--CCC
Q 017591 89 FCYDQ----TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD--AKF 162 (369)
Q Consensus 89 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~ 162 (369)
++.+. ...++||||+ +++|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCCC
Confidence 99865 4589999999 899999997777889999999999999999999999 9999999999999998 889
Q ss_pred CeeEeecCCceecCCCCCcc-----ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC
Q 017591 163 SAKVADFGLAKLCNPENTHD-----STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD 237 (369)
Q Consensus 163 ~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~ 237 (369)
.+||+|||+++.+....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~- 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK- 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH-
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCHH-
Confidence 99999999998765322111 12334599999999988765 689999999999999999999999985332211
Q ss_pred ccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 238 WFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
........+ ...+......+.. ....+..+.+++..||+.||.+||++.+|++.|+...
T Consensus 270 -~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 270 -YVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp -HHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred -HHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 000000001 1111111111111 1123567899999999999999999999999998764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=323.49 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=182.6
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||.||+|.+ .+++.||+|++..... ......+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus 14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (278)
T 3cok_A 14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC 93 (278)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence 4457899999999999987 4689999999864321 122367899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 168 (278)
T 3cok_A 94 HNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-- 168 (278)
T ss_dssp TTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--
Confidence 9999999997666789999999999999999999999 99999999999999999999999999999876432221
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||+.|+|||.+... .++.++||||||+++|+|++|+.||........ ....... ...
T Consensus 169 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~----------~~~ 230 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------LNKVVLA----------DYE 230 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS----------CCC
T ss_pred ceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------HHHHhhc----------ccC
Confidence 2235689999999988764 689999999999999999999999975443211 0000000 011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+...+..+.+++.+||+.||.+||++.++++
T Consensus 231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 22334567899999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=335.16 Aligned_cols=249 Identities=24% Similarity=0.291 Sum_probs=192.4
Q ss_pred HhhhccccccccCCceEEEEEEe----CCCcEEEEEEccccc---cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQF----PNGVKIAAKILKTCL---NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK 95 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 95 (369)
...+.+.+.||+|+||.||+++. .+++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 34456678999999999999987 468999999987542 22334568899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceec
Q 017591 96 AALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 96 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
.++||||+++++|.+++. ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE-REGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999999994 34578999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 176 NPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
..... ......||+.|+|||.+... .++.++|||||||++|+|++|+.||....... .....
T Consensus 172 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i-------- 233 (327)
T 3a62_A 172 IHDGT--VTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-------TIDKI-------- 233 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHH--------
T ss_pred ccCCc--cccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-------HHHHH--------
Confidence 32221 12345699999999988764 68999999999999999999999997543210 11111
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 256 VLGCGIEENDREEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
.... ...+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 234 -~~~~-~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 234 -LKCK-LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -HHTC-CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -HhCC-CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111 122334567899999999999999999 6667664
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=338.97 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=198.9
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.+.+.||+|+||.||+|+++ +++.||+|+++... .......+..|..++..+ +||||+++++++.+.+..++|||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 345689999999999999885 58999999987532 122345677888888876 89999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 173 (345)
T 1xjd_A 99 YLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 173 (345)
T ss_dssp CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC-
Confidence 9999999999943 4579999999999999999999999 9999999999999999999999999999975432221
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+..+ .
T Consensus 174 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~----------~ 234 (345)
T 1xjd_A 174 -KTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMD----------N 234 (345)
T ss_dssp -CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC----------C
T ss_pred -cccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHhC----------C
Confidence 23346799999999988774 7899999999999999999999999754321 111111111 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChH-HHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMS-AVV 294 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~v~ 294 (369)
...+...+..+.+|+.+||+.||.+||++. +|.
T Consensus 235 ~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 222334567899999999999999999997 554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=329.86 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=202.5
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe----CCceEEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD----QTKAALV 99 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 99 (369)
.+.+.+.||+|+||.||++.+ .+++.||+|++... .......+.+|+.+++.++||||+++++++.. ....++|
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 345568999999999999987 56899999988653 34556789999999999999999999999873 3478899
Q ss_pred EeccCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 100 YEFMENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999954 45789999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCcc-------ccccCCCCCCccccccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHh
Q 017591 177 PENTHD-------STSGYRGTPGYSAPEFLLRNY--PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEY 247 (369)
Q Consensus 177 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~--~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 247 (369)
...... ......||+.|+|||.+.... .++.++|||||||++|+|++|+.||.......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------------ 253 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG------------ 253 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT------------
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc------------
Confidence 211100 011234799999999876532 36899999999999999999999985311100
Q ss_pred hhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 248 EKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
...................+..+.+++.+||+.||.+||++.+|++.|+....
T Consensus 254 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 254 --DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00111111111112233456789999999999999999999999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=329.68 Aligned_cols=264 Identities=20% Similarity=0.246 Sum_probs=198.1
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.++||+|+||+||+|.+. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 345689999999999999885 48999999876443 3344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++|..++ .....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~l~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (311)
T 4agu_A 85 DHTVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-- 158 (311)
T ss_dssp SEEHHHHHH-HTSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCchHHHHH-hhhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--
Confidence 999999887 455679999999999999999999999 99999999999999999999999999999876533221
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------cccchhHHhhhchhhhh
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------FPKQVWDEYEKGELAAK 255 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 255 (369)
.....||..|+|||.+.+...++.++|||||||++|+|++|+.||.......... ........+........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 2335689999999998775678999999999999999999999997654321100 00000000000000000
Q ss_pred hh-cCCCCC-----CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VL-GCGIEE-----NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~-~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ...... .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 000000 01234567899999999999999999999984
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=334.42 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=185.7
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 34578999999999999885 48899999987543 245688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC---CCCeeEeecCCceecCCCCCcc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA---KFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
++|.+++. ....+++..++.++.|++.||.|||+ ++++||||||+|||++. ++.+||+|||+++.......
T Consensus 133 ~~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 206 (349)
T 2w4o_A 133 GELFDRIV-EKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-- 206 (349)
T ss_dssp CBHHHHHT-TCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc--
Confidence 99999994 45679999999999999999999999 99999999999999975 88999999999986543221
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ..+..+..... ....
T Consensus 207 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~------~~~~ 272 (349)
T 2w4o_A 207 -MKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY------YFIS 272 (349)
T ss_dssp -------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC------CCCT
T ss_pred -cccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC------ccCC
Confidence 2335689999999988764 78999999999999999999999996543321 01111111110 0111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......+..+.+|+.+||+.||.+||++.++++
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222345678999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=327.44 Aligned_cols=257 Identities=23% Similarity=0.415 Sum_probs=197.4
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
.+.+.+.||+|+||.||+|.+ .+++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 345568999999999999987 46899999998742 345566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 102 FMENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 102 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
|+++++|.+++.. ....+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999853 35679999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.. ......|+..|+|||.+... .++.++||||||+++|+|++|+.||........ .... ....
T Consensus 190 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~---------~~~~ 252 (310)
T 2wqm_A 190 TT--AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCK---------KIEQ 252 (310)
T ss_dssp -----------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-----HHHH---------HHHT
T ss_pred Cc--cccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-----HHHH---------Hhhc
Confidence 22 12234689999999988764 789999999999999999999999865332110 0011 1111
Q ss_pred CCCC-CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 259 CGIE-ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 259 ~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
...+ ......+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111 112345678999999999999999999999999998864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.60 Aligned_cols=253 Identities=30% Similarity=0.432 Sum_probs=206.8
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.+.++||+|+||.||+|.+.++..||||+++.... ....|.+|+.++++++|+||+++++++.+ +..++||||+++
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~ 345 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 345 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence 344578999999999999998888999999885432 23578999999999999999999999865 678999999999
Q ss_pred CCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 106 GSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 106 gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
|+|.+++... +..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 346 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~ 421 (535)
T 2h8h_A 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTAR 421 (535)
T ss_dssp EEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTT
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecc
Confidence 9999999643 3569999999999999999999999 999999999999999999999999999997654221 1112
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....++..|+|||.+..+ .++.++|||||||+||||++ |+.||...... ++...+.......
T Consensus 422 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----------------~~~~~i~~~~~~~ 484 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------------EVLDQVERGYRMP 484 (535)
T ss_dssp CSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH----------------HHHHHHHTTCCCC
T ss_pred cCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCCC
Confidence 334577899999988765 78999999999999999999 89998654321 1111122222223
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
.+...+..+.+|+.+||+.||.+||++.+|++.|+....
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 344566789999999999999999999999999998743
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=323.80 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=196.3
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||+||+|.+. ++..||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 91 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence 34588999999999999875 478999999864322 122457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++|.+++.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++.......
T Consensus 92 ~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~---- 163 (279)
T 3fdn_A 92 PLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---- 163 (279)
T ss_dssp TTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc----
Confidence 99999999943 4579999999999999999999999 999999999999999999999999999886543222
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||....... ....... ....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~----------~~~~ 225 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISR----------VEFT 225 (279)
T ss_dssp ----CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHH----------TCCC
T ss_pred ccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHh----------CCCC
Confidence 2335689999999988764 78999999999999999999999997433211 1111111 1112
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+...+..+.+|+.+||+.||.+||++.+|++
T Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 23335677899999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.03 Aligned_cols=200 Identities=27% Similarity=0.377 Sum_probs=166.8
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC-----CceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ-----TKAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 98 (369)
+.+.+.||+|+||.||+|.+. +++.||+|++... .......++.+|+.+++.++|+||+++++++... +..++
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 445688999999999999874 5889999998753 3345567899999999999999999999999766 56899
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+.+ +|.+++ .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 108 v~e~~~~-~L~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 108 VLEIADS-DLKKLF-KTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEECCSE-EHHHHH-HSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEecCCc-CHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 9999975 999999 455679999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCc--------------------cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 017591 179 NTH--------------------DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQD 230 (369)
Q Consensus 179 ~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~ 230 (369)
... ...+...||+.|+|||++.....++.++|||||||++|||++|..||..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 211 1124567999999999876656799999999999999999987666543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=322.30 Aligned_cols=242 Identities=23% Similarity=0.345 Sum_probs=198.4
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||+||+|.+. +++.||+|++... ........+.+|+..+..+ +||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 92 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence 345689999999999999885 6999999998753 2334567888999999988 899999999999999999999999
Q ss_pred cCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC------------------
Q 017591 103 MENGSLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK------------------ 161 (369)
Q Consensus 103 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~------------------ 161 (369)
+++++|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.+
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------------
T ss_pred cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999543 2679999999999999999999999 999999999999999844
Q ss_pred -CCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccc
Q 017591 162 -FSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240 (369)
Q Consensus 162 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~ 240 (369)
..++|+|||.+....... ...||+.|+|||.+.+...++.++|||||||++|+|++|..++....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------- 235 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-------- 235 (289)
T ss_dssp CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--------
T ss_pred ceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--------
Confidence 479999999998765322 23589999999998876567789999999999999999987753211
Q ss_pred cchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+... .....+..+...+..+.+++.+||+.||.+||++.++++
T Consensus 236 --~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 --QWHEI---------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --HHHHH---------HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHH---------HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11111 122223334445678999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=332.79 Aligned_cols=239 Identities=22% Similarity=0.295 Sum_probs=197.4
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccccc-------HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLN-------KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
.+.+.||+|+||.||+|.+ .+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 27 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 106 (335)
T 3dls_A 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQL 106 (335)
T ss_dssp EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEE
Confidence 3457899999999999987 4689999999875321 1123467789999999999999999999999999999
Q ss_pred EEeccCCC-CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 99 VYEFMENG-SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 99 v~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
||||+.+| +|.+++ .....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 107 v~e~~~~g~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 107 VMEKHGSGLDLFAFI-DRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEECCTTSCBHHHHH-HTCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEeCCCCccHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 99998776 999998 455679999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
.... ....||+.|+|||++.+....+.++|||||||++|+|++|+.||....... .
T Consensus 183 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------------~ 238 (335)
T 3dls_A 183 GKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------------E 238 (335)
T ss_dssp TCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------------T
T ss_pred CCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------------h
Confidence 3322 235699999999998876445899999999999999999999996421110 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
. ....+...+..+.+|+.+||+.||.+||++.++++
T Consensus 239 ~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 239 A--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp T--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01111224567899999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=329.92 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=208.1
Q ss_pred CCcccCHHHHHHhhhccc-cccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccC-CCceeeEE
Q 017591 12 KPVRFTLEQLCSFTNNYS-TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTY-HINLVRLY 87 (369)
Q Consensus 12 ~~~~~~~~el~~~t~~f~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~ 87 (369)
.++.|...+.....+.+. +.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.++..+. ||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 456677777777777666 78999999999999885 58999999987432 2223567889999999885 69999999
Q ss_pred eEEEeCCceEEEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC---CCC
Q 017591 88 GFCYDQTKAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA---KFS 163 (369)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~ 163 (369)
+++.+.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ +|++||||||+|||++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999998543 4679999999999999999999999 99999999999999987 789
Q ss_pred eeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccch
Q 017591 164 AKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQV 243 (369)
Q Consensus 164 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 243 (369)
+||+|||++........ .....||+.|+|||++... .++.++|||||||++|+|++|+.||....... .
T Consensus 173 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~ 241 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-------T 241 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H
T ss_pred EEEeeCccccccCCccc---cccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------H
Confidence 99999999987653322 2335699999999988764 78999999999999999999999996543211 0
Q ss_pred hHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 244 WDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...... .............+..+.+++.+||+.||.+||++.++++
T Consensus 242 ~~~i~~------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 242 YLNISQ------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHH------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHh------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111111 0111112223345677999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=333.78 Aligned_cols=266 Identities=19% Similarity=0.242 Sum_probs=196.7
Q ss_pred hhhccccccccCCceEEEEEEeC----CCcEEEEEEccccccHH----------HHHHHHHHHHHHhccCCCceeeEEeE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP----NGVKIAAKILKTCLNKR----------VEAQFMAEIGTIGRTYHINLVRLYGF 89 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~ 89 (369)
..+.+.+.||+|+||.||+|.+. ++..+|+|+........ ....+.+|+..+..+.||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 34556689999999999999885 57899999887543211 11236678899999999999999999
Q ss_pred EEe----CCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC--C
Q 017591 90 CYD----QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF--S 163 (369)
Q Consensus 90 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~--~ 163 (369)
+.+ ....++||||+ +++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCc
Confidence 987 67899999999 89999999544 389999999999999999999999 9999999999999998887 9
Q ss_pred eeEeecCCceecCCCCCc-----cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc
Q 017591 164 AKVADFGLAKLCNPENTH-----DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW 238 (369)
Q Consensus 164 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~ 238 (369)
+||+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999876432111 112345799999999988764 78999999999999999999999996432221100
Q ss_pred cccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 239 FPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
....... ...+........ .....+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 271 --~~~~~~~-~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 --QTAKTNL-LDELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp --HHHHHHH-HHTTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred --HHHHHhh-cccccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 0000000 000000000000 00134567999999999999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=328.87 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=194.6
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce----E
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA----A 97 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----~ 97 (369)
.+.+.+.||+|+||.||+|.+ .+++.||+|++... ........+.+|+.++..++||||+++++++...... +
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 345668999999999999987 56899999998753 2345567899999999999999999999998866543 9
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++.....
T Consensus 93 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 99999999999999943 4579999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 178 ENTH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ .+...........
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~~- 240 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPPS- 240 (311)
T ss_dssp -------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCCHH-
T ss_pred cccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCCCcc-
Confidence 3221 222345689999999988765 789999999999999999999999975432210 0111111000000
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHH-HHHhcCC
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAV-VKMLEGG 300 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v-~~~L~~~ 300 (369)
......+..+.+++.+||+.||.+||+..++ ...|...
T Consensus 241 ------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 ------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0012245779999999999999999976654 4555443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=335.86 Aligned_cols=241 Identities=23% Similarity=0.305 Sum_probs=196.4
Q ss_pred hccccccccCCceEEEEEEeCC-CcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.+.+.||+|+||.||+|+.+. ++.||+|++.... .......+.+|..++..+ +||||+++++++.+.+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 3456899999999999998864 8899999987532 122345688899999887 79999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++|+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 102 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 176 (353)
T 2i0e_A 102 YVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV- 176 (353)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc-
Confidence 9999999999943 3579999999999999999999999 9999999999999999999999999999985432211
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......||+.|+|||++... .++.++|||||||++|||++|+.||...... ..+..+.. ..
T Consensus 177 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~---------~~- 237 (353)
T 2i0e_A 177 -TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIME---------HN- 237 (353)
T ss_dssp -CBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH---------CC-
T ss_pred -ccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHH-------HHHHHHHh---------CC-
Confidence 23346799999999988764 7899999999999999999999999753321 11111111 11
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
...+...+..+.+|+.+||+.||.+||+.
T Consensus 238 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 238 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 12234456789999999999999999964
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=321.49 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=201.4
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.++||+|+||.||+|.+. +++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 44589999999999999874 5899999998643 344556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC---eeEeecCCceecCCCCCc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS---AKVADFGLAKLCNPENTH 181 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~ 181 (369)
+++|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++. +||+|||++........
T Consensus 89 ~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~- 163 (284)
T 3kk8_A 89 GGELFEDIVA-REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 163 (284)
T ss_dssp SCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB-
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc-
Confidence 9999998843 4679999999999999999999999 99999999999999986655 99999999987654332
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
.....||+.|+|||.+... .++.++||||||+++|+|++|+.||....... .......+.. ...
T Consensus 164 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~------~~~ 227 (284)
T 3kk8_A 164 --WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAY------DYP 227 (284)
T ss_dssp --CCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC------CCC
T ss_pred --ccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccc------cCC
Confidence 2335699999999988764 78999999999999999999999996533211 1111111110 001
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.......+..+.+++.+||+.||.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112344677899999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=327.01 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=202.3
Q ss_pred hhhccccccccCCceEEEEEEeC-CCcEEEEEEccccccH-----HHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNK-----RVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (369)
..+.+.+.||+|+||.||+|.++ +|+.||+|++...... .....+.+|+.++..+.||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34566789999999999999885 5899999998653221 12467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC----CeeEeecCCce
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF----SAKVADFGLAK 173 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~ 173 (369)
+||||+++++|.+++. ....+++..++.++.|++.||.|||+ +|++||||||+||+++.++ .+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 9999999999999994 45679999999999999999999999 9999999999999999888 79999999998
Q ss_pred ecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhh
Q 017591 174 LCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELA 253 (369)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (369)
....... .....||+.|+|||.+... .++.++|||||||++|+|++|+.||....... ..........
T Consensus 168 ~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~- 235 (321)
T 2a2a_A 168 EIEDGVE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITSVSY- 235 (321)
T ss_dssp ECCTTCC---CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCC-
T ss_pred ecCcccc---ccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhccc-
Confidence 7654332 2335699999999988764 78999999999999999999999996543211 1111111000
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..........+..+.+++.+||+.||.+||++.++++
T Consensus 236 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 -----DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -----CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -----ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000001123567899999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=325.54 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=202.9
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
...+.||+|+||.||+|.+ .+++.||+|++...........+.+|+.++..+.||||+++++++.+....++||||+++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 104 (303)
T 3a7i_A 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 104 (303)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence 3457899999999999987 468999999987554444567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|.+++. ...+++..++.++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 105 ~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 177 (303)
T 3a7i_A 105 GSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRN 177 (303)
T ss_dssp EEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBC
T ss_pred CcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc--ccC
Confidence 99999994 3579999999999999999999999 9999999999999999999999999999987643321 223
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||+.|+|||.+... .++.++||||||+++|+|++|+.||....... .. ........+...
T Consensus 178 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~---------~~~~~~~~~~~~ 240 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMK-------VL---------FLIPKNNPPTLE 240 (303)
T ss_dssp CCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HH---------HHHHHSCCCCCC
T ss_pred ccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HH---------HHhhcCCCCCCc
Confidence 45689999999988764 78899999999999999999999986433210 00 111111122233
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..+.+|+.+||+.||.+||++.+|++
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 345677999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=327.99 Aligned_cols=259 Identities=19% Similarity=0.243 Sum_probs=194.8
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.++.++ .||||+++++++.+.+..++||||+++++
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 57999999999999874 689999999875432 2356788999999884 79999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC---eeEeecCCceecCCCCC----
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS---AKVADFGLAKLCNPENT---- 180 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~---- 180 (369)
|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++. +||+|||++........
T Consensus 98 L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (316)
T 2ac3_A 98 ILSHIHK-RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173 (316)
T ss_dssp HHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred HHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence 9999954 4579999999999999999999999 99999999999999988776 99999999876532211
Q ss_pred -ccccccCCCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 181 -HDSTSGYRGTPGYSAPEFLLR----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 181 -~~~~~~~~gt~~y~aPE~~~~----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
........||+.|+|||++.. ...++.++|||||||++|+|++|+.||.........+......... ...+...
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~ 252 (316)
T 2ac3_A 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC-QNMLFES 252 (316)
T ss_dssp --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH-HHHHHHH
T ss_pred cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH-HHHHHHH
Confidence 111223459999999998864 1257899999999999999999999998765433222111100000 0011111
Q ss_pred hhcCCCCCCCH----HHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLGCGIEENDR----EEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~~~~~~~~----~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...... ..+. ..+..+.+|+.+||+.||.+||++.++++
T Consensus 253 i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 253 IQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhccCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111111 1111 24577999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=339.19 Aligned_cols=267 Identities=23% Similarity=0.352 Sum_probs=206.2
Q ss_pred HHHHhhhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 20 QLCSFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 20 el~~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
++....+.+.++||+|+||.||++.+. ++..||+|++...........+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 334445556689999999999999885 6899999999876666677889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCC-CeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ-RIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.++|+|||++.....
T Consensus 109 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999943 4579999999999999999999998 6 899999999999999999999999999865422
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccc---------cch-----
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP---------KQV----- 243 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~---------~~~----- 243 (369)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............ ...
T Consensus 185 ~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 185 S----MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp H----C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred c----cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 1 12335689999999988764 7899999999999999999999999764432110000 000
Q ss_pred ---------hHHh---hhchhhhhhhcCCCC-CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 244 ---------WDEY---EKGELAAKVLGCGIE-ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 244 ---------~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.... ..............+ ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000 000111111111111 112234667999999999999999999999873
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=319.36 Aligned_cols=244 Identities=22% Similarity=0.306 Sum_probs=199.6
Q ss_pred hhccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.++||+|+||.||+|.+.. +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 34556899999999999998854 78999998875433 22567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe---cCCCCeeEeecCCceecCCCCC
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL---DAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
++++|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+||++ +.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 89 TGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 99999998843 4569999999999999999999999 999999999999999 7888999999999987654332
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||....... ....... ..
T Consensus 165 ---~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~---------~~ 223 (277)
T 3f3z_A 165 ---MRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIRE---------GT 223 (277)
T ss_dssp ---BCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHH---------CC
T ss_pred ---hhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHh---------CC
Confidence 233569999999998765 48999999999999999999999997543211 1111111 11
Q ss_pred CCCCCH----HHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDR----EEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~----~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. .+. ..+..+.+++.+||+.||.+||++.++++
T Consensus 224 ~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 FT-FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CC-CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CC-CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 111 24678999999999999999999999873
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=332.34 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=185.4
Q ss_pred HhhhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
...+.+.+.||+|+||.||+|.+. +++.||+|++...........+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 334456689999999999999874 6899999998755444556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 102 FMENGSLDKYLFT-------DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 102 ~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
|+++++|.+++.. ....+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999853 34569999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC---ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 175 CNPENT---HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 175 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
...... ........||+.|+|||.+.....++.++|||||||++|+|++|+.||........ ...... ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~-~~ 243 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTLQ-ND 243 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHT-SS
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHhc-cC
Confidence 543221 11123356899999999887644689999999999999999999999976443211 000000 00
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.................+..+.+++.+||+.||.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000000001112234567899999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=337.71 Aligned_cols=281 Identities=22% Similarity=0.249 Sum_probs=209.9
Q ss_pred HHHHHHhhcCCcccCHHHHHHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC--
Q 017591 3 KFLRDIAREKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-- 79 (369)
Q Consensus 3 ~~~~~~~~~~~~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-- 79 (369)
|-.+++.......+..+++....+.+.++||+|+||+||+|++ .+++.||+|++... ......+.+|+.+++.+.
T Consensus 16 e~~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~ 93 (397)
T 1wak_A 16 EDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNS 93 (397)
T ss_dssp ------CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHS
T ss_pred cccccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhc
Confidence 3445566666677778887777778889999999999999987 45899999998743 344567889999999885
Q ss_pred ------CCceeeEEeEEE----eCCceEEEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCC-CeE
Q 017591 80 ------HINLVRLYGFCY----DQTKAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQ-RII 147 (369)
Q Consensus 80 ------h~niv~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~iv 147 (369)
|+||+++++++. +....++||||+. ++|.+++... ...+++..++.++.|++.||.|||+ + ||+
T Consensus 94 ~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~giv 169 (397)
T 1wak_A 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRII 169 (397)
T ss_dssp CTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEE
T ss_pred CCCCCCcceeeeeecceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEe
Confidence 788999999987 4567899999995 4666666443 4679999999999999999999999 8 999
Q ss_pred eecCCCCceEecCCC-------------------------------------------------CeeEeecCCceecCCC
Q 017591 148 HYDIKPANILLDAKF-------------------------------------------------SAKVADFGLAKLCNPE 178 (369)
Q Consensus 148 H~dlkp~Nill~~~~-------------------------------------------------~~kl~Dfg~~~~~~~~ 178 (369)
||||||+|||++.++ .+||+|||++......
T Consensus 170 HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~ 249 (397)
T 1wak_A 170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH 249 (397)
T ss_dssp CCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC
T ss_pred cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc
Confidence 999999999998775 7999999999876432
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccc---hhHH--------h
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQ---VWDE--------Y 247 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~--------~ 247 (369)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.............. +... +
T Consensus 250 -----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 323 (397)
T 1wak_A 250 -----FTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323 (397)
T ss_dssp -----SCSCCSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH
T ss_pred -----CccCCCCCcccCChhhcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh
Confidence 2334689999999988875 689999999999999999999999986554321100000 0000 0
Q ss_pred hhchhhhhhh---------c-----------CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 248 EKGELAAKVL---------G-----------CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 248 ~~~~~~~~~~---------~-----------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+....... . ......+...+..+.+|+.+||+.||.+|||+.+|++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000000000 0 0001345677889999999999999999999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=331.21 Aligned_cols=259 Identities=24% Similarity=0.270 Sum_probs=198.5
Q ss_pred HHHhhh--ccccccccCCceEEEEEEe-CCCcEEEEEEccccc----cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC
Q 017591 21 LCSFTN--NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL----NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ 93 (369)
Q Consensus 21 l~~~t~--~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 93 (369)
+.+..+ .+.+.||+|+||.||+|.+ .++..||+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 344444 4468999999999999987 458899999986431 234457899999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHhccC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 017591 94 TKAALVYEFMENGSLDKYLFTD---------------------------------------TEVLKWEKLLDIAIGTARG 134 (369)
Q Consensus 94 ~~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~~l~~~ 134 (369)
+..++||||+++|+|.+++... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998421 1234678899999999999
Q ss_pred HHHHhhccCCCeEeecCCCCceEecCCC--CeeEeecCCceecCCCCC--ccccccCCCCCCcccccccccc-CCCCcch
Q 017591 135 IAYLHEECNQRIIHYDIKPANILLDAKF--SAKVADFGLAKLCNPENT--HDSTSGYRGTPGYSAPEFLLRN-YPITQKC 209 (369)
Q Consensus 135 l~~LH~~~~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~s~~s 209 (369)
|.|||+ ++++||||||+|||++.++ .+||+|||++..+..... ........||+.|+|||.+... ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999 9999999999999998776 899999999987643221 1122345699999999988652 4789999
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 017591 210 DVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPP 289 (369)
Q Consensus 210 DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 289 (369)
|||||||++|+|++|+.||........ ......... ..........+..+.+|+.+||+.||.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~-------~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT-------ISQVLNKKL------CFENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH-------HHHHHhccc------ccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999975432210 111111000 0001112235678999999999999999999
Q ss_pred hHHHHH
Q 017591 290 MSAVVK 295 (369)
Q Consensus 290 ~~~v~~ 295 (369)
+.++++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=337.14 Aligned_cols=268 Identities=21% Similarity=0.211 Sum_probs=209.6
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC--ceEEEEe
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT--KAALVYE 101 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 101 (369)
.+.+.++||+|+||+||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+ ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 3456689999999999999885 489999999876444444567889999999999999999999998765 6799999
Q ss_pred ccCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe----cCCCCeeEeecCCceec
Q 017591 102 FMENGSLDKYLFTDT--EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL----DAKFSAKVADFGLAKLC 175 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~ 175 (369)
|+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999995432 349999999999999999999999 999999999999999 77778999999999876
Q ss_pred CCCCCccccccCCCCCCcccccccccc-------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhh
Q 017591 176 NPENTHDSTSGYRGTPGYSAPEFLLRN-------YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYE 248 (369)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 248 (369)
..... .....||+.|+|||++... ..++.++|||||||++|||++|+.||......... ........
T Consensus 167 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~---~~~~~~~~ 240 (396)
T 4eut_A 167 EDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKII 240 (396)
T ss_dssp CCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC---HHHHHHHH
T ss_pred cCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch---HHHHHHHh
Confidence 54322 2345699999999987641 35788999999999999999999999754432110 00011111
Q ss_pred hchhhh---------------hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 249 KGELAA---------------KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 249 ~~~~~~---------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.+.... .................+.+++.+||+.||++||++.++++.++...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 110000 00001112345788999999999999999999999999998887653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=323.28 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=196.1
Q ss_pred hhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC-CceEEEEecc
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ-TKAALVYEFM 103 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~ 103 (369)
.+.+.+.||+|+||.||++.+ +|+.||+|++.... ....+.+|+.+++.++||||+++++++.+. +..++||||+
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 344568899999999999988 58899999987543 346789999999999999999999987655 4789999999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 104 ENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 104 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 9999999995443 248999999999999999999999 999999999999999999999999999987643321
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
....++..|+|||.+... .++.++||||||+++|+|++ |+.||....... .... ......
T Consensus 172 --~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~---------~~~~~~ 232 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPR---------VEKGYK 232 (278)
T ss_dssp ------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHH---------HTTTCC
T ss_pred --cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH---------HhcCCC
Confidence 223578899999988764 78999999999999999998 999986543211 1111 111122
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
...+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 233445567899999999999999999999999999865
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=326.67 Aligned_cols=271 Identities=24% Similarity=0.327 Sum_probs=209.6
Q ss_pred CcccCHHHHHHhhhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhc--cCCCceeeEEeEE
Q 017591 13 PVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR--TYHINLVRLYGFC 90 (369)
Q Consensus 13 ~~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~ 90 (369)
..++..++.....+.+.+.||+|+||.||+|.+ +++.||+|++.... ...+.+|++++.. ++||||+++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 455666677777778889999999999999998 68999999987432 3467778888776 7899999999999
Q ss_pred EeCC----ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--------hccCCCeEeecCCCCceEe
Q 017591 91 YDQT----KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLH--------EECNQRIIHYDIKPANILL 158 (369)
Q Consensus 91 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH--------~~~~~~ivH~dlkp~Nill 158 (369)
.... ..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| + ++++||||||+|||+
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILV 180 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEE
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEE
Confidence 8776 78999999999999999954 36899999999999999999999 7 899999999999999
Q ss_pred cCCCCeeEeecCCceecCCCCCcc--ccccCCCCCCccccccccccCC-----CCcchhhHHHHHHHHHHHcC-------
Q 017591 159 DAKFSAKVADFGLAKLCNPENTHD--STSGYRGTPGYSAPEFLLRNYP-----ITQKCDVYSFGMLLFEIIGR------- 224 (369)
Q Consensus 159 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-----~s~~sDvwSlGvil~elltg------- 224 (369)
+.++.+||+|||++.......... ......||+.|+|||.+..... ++.++|||||||++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 999999999999998765433221 2234569999999998876422 23789999999999999999
Q ss_pred ---CCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC--CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 225 ---RKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE--NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 225 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
+.||......... .......... .......+. .....+..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 261 ~~~~~p~~~~~~~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDPS--VEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCCTTTTTSCSSCC--HHHHHHHHTT-----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccCccccCcCccc--HHHHHHHHHH-----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 5666543322110 0000111100 000111111 124677889999999999999999999999999987
Q ss_pred C
Q 017591 300 G 300 (369)
Q Consensus 300 ~ 300 (369)
.
T Consensus 334 i 334 (342)
T 1b6c_B 334 L 334 (342)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=324.14 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=186.9
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHH-HHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQ-FMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.++||+|+||+||+|.+ .+++.||+|++..........+ +.++...++.+.||||+++++++.+.+..++||||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 445568999999999999988 4689999999876544333334 44555567888999999999999999999999999
Q ss_pred cCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhccCC-CeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 103 MENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEECNQ-RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 103 ~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
+++ +|.+++.. ....+++..++.++.|++.||.|||+ + |++||||||+||+++.++.+||+|||++......
T Consensus 88 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 88 MDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred hcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 985 88887743 46789999999999999999999999 8 9999999999999999999999999999865433
Q ss_pred CCccccccCCCCCCcccccccc---ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLL---RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
.. .....||+.|+|||.+. .+..++.++|||||||++|+|++|+.||....... ... ...
T Consensus 164 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~-----~~~ 226 (290)
T 3fme_A 164 VA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF---------QQL-----KQV 226 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH---------HHH-----HHH
T ss_pred cc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH---------HHH-----HHH
Confidence 22 22346999999999873 33478999999999999999999999996432211 000 011
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.............+..+.+++.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111112222345677999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=358.69 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=200.3
Q ss_pred cccccCCceEEEEEEe---CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQF---PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
++||+|+||.||+|.+ ..++.||||+++... ......++.+|+.++..++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 3699999999999965 246899999987543 2334578999999999999999999999986 4568899999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc-ccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH-DST 184 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 184 (369)
|+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+...... ...
T Consensus 454 g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999994 45679999999999999999999999 99999999999999999999999999999876543321 222
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....+|+.|+|||++... .++.++|||||||++|||++ |+.||...... ++...+.......
T Consensus 530 ~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----------------~~~~~i~~~~~~~ 592 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----------------EVTAMLEKGERMG 592 (635)
T ss_dssp -----CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTTCCCC
T ss_pred cCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCCC
Confidence 334578899999998764 79999999999999999998 99999754321 1112222222334
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+...+..+.+|+.+||+.||.+||++.+|++.|+..
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 4455678899999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=326.28 Aligned_cols=259 Identities=19% Similarity=0.211 Sum_probs=198.7
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 345689999999999999875 68999999987542 344557899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++++|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 116 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~- 190 (309)
T 2h34_A 116 INGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT- 190 (309)
T ss_dssp CCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc-
Confidence 999999999953 4579999999999999999999999 99999999999999999999999999998765433221
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......|++.|+|||.+... .++.++||||||+++|+|++|+.||...... .......... ....
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-------~~~~ 255 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI-------PRPS 255 (309)
T ss_dssp ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC-------CCGG
T ss_pred cccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC-------CCcc
Confidence 12335689999999988764 7899999999999999999999999643221 0001110000 0001
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCC-ChHHHHHHhcCCcCCC
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARP-PMSAVVKMLEGGVEIV 304 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~v~~~L~~~~~~~ 304 (369)
......+..+.+++.+||+.||.+|| ++.++++.|+......
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 12334556799999999999999999 9999999999875443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=320.63 Aligned_cols=260 Identities=20% Similarity=0.247 Sum_probs=202.8
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEE-EeCCceEEEEec
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC-YDQTKAALVYEF 102 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~ 102 (369)
.+.+.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+|+.++..+.|++++..+..+ .+.+..++||||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 345568999999999999987 568999999865432 234688899999999888766666555 567788999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe---cCCCCeeEeecCCceecCCCC
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL---DAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
+ +++|.+++......+++..++.++.|++.||.|||+ ++++||||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9 889999997667789999999999999999999999 999999999999999 788999999999998765433
Q ss_pred Cc-----cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 180 TH-----DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 180 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
.. .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||........... ...........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~ 237 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK----YERISEKKMST 237 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH----HHHHHHHHHHS
T ss_pred cCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh----hhhhhcccccc
Confidence 21 122345799999999988775 789999999999999999999999986554322111 11111111100
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 255 KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.........+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 238 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 238 -----PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -----CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -----hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 000011123567999999999999999999999999998763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=328.62 Aligned_cols=267 Identities=22% Similarity=0.282 Sum_probs=200.7
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC--------C
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ--------T 94 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~ 94 (369)
.+.+.++||+|+||.||+|++ .+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+. +
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 344568999999999999988 568999999886432 222345678999999999999999999999873 4
Q ss_pred ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 95 KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
..++||||+++ +|.+.+......+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 68999999986 8888886666789999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCc--cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------Cccccchh
Q 017591 175 CNPENTH--DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVW 244 (369)
Q Consensus 175 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~ 244 (369)
....... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||........ ...+...|
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 6532221 2223456899999999887755789999999999999999999999976443210 00001111
Q ss_pred HHhhhchhhhhhhcCCC-CCCCHH------HHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 245 DEYEKGELAAKVLGCGI-EENDRE------EAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 245 ~~~~~~~~~~~~~~~~~-~~~~~~------~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
................. ...... ....+.+|+.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11111111000000000 000000 1356889999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=341.75 Aligned_cols=194 Identities=24% Similarity=0.360 Sum_probs=153.4
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC-----CceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ-----TKAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 98 (369)
+.+.++||+|+||+||+|.+. +++.||||++... .......++.+|+.+++.++||||+++++++... ...++
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 445689999999999999874 6899999988643 3344567899999999999999999999998543 56899
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+. ++|.+++ .....+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 135 v~e~~~-~~L~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 135 VLEIAD-SDFKKLF-RTPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EECCCS-EEHHHHH-HSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEeccc-cchhhhc-ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 999985 5999998 455679999999999999999999999 99999999999999999999999999999876432
Q ss_pred CCc-------------------------cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcC
Q 017591 179 NTH-------------------------DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGR 224 (369)
Q Consensus 179 ~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg 224 (369)
... ...+...||+.|+|||++..+..++.++|||||||++|||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 211 1223456899999999876555799999999999999999994
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=330.58 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=196.5
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.+.||+|+||.||+|.++ +++.||+|++..... ...+|+.++.++ .||||+++++++.+.+..++||||+
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 445689999999999999885 589999999875432 345678888777 7999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC-C---CeeEeecCCceecCCCC
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK-F---SAKVADFGLAKLCNPEN 179 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~---~~kl~Dfg~~~~~~~~~ 179 (369)
++|+|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+|||+..+ + .+||+|||++.......
T Consensus 99 ~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 99 KGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999999994 45679999999999999999999999 999999999999998543 2 49999999998764432
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ...+...+..+...
T Consensus 175 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~~~~~------ 241 (342)
T 2qr7_A 175 G--LLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDT----PEEILARIGSGKFS------ 241 (342)
T ss_dssp C--CBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC----HHHHHHHHHHCCCC------
T ss_pred C--ceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC----HHHHHHHHccCCcc------
Confidence 2 12345689999999988764 58899999999999999999999997543221 11122222222110
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.........+..+.+|+.+||+.||.+||++.++++
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011122345678999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=318.56 Aligned_cols=259 Identities=20% Similarity=0.256 Sum_probs=203.4
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEE-EeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC-YDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~ 103 (369)
+.+.+.||+|+||.||+|++ .+++.||+|++..... ...+.+|+.++..+.|++++..+..+ .+.+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 34568999999999999987 5699999999765332 23688999999999988766555555 5667789999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe---cCCCCeeEeecCCceecCCCCC
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL---DAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
+++|.+++......+++..++.++.|++.||.|||+ ++++||||||+|||+ +.++.+||+|||++........
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 889999997667789999999999999999999999 999999999999999 4888999999999987654332
Q ss_pred cc-----ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 181 HD-----STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 181 ~~-----~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
.. ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.......... .+...........
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----KYERISEKKMSTP 238 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS----HHHHHHHHHHHSC
T ss_pred ccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh----hhhhhcccccCCc
Confidence 11 12345799999999988775 68999999999999999999999998654432211 1122111111100
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 256 VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
........+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 239 -----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 00011223567999999999999999999999999998763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=326.69 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=201.7
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||.||++.+. +++.||+|++... ........+.+|+.+++.+.|+||+++++++.+.+..++||||+
T Consensus 44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 123 (335)
T 2owb_A 44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 123 (335)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence 34578999999999999885 4889999998653 23455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++++|.+++. ....+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........ .
T Consensus 124 ~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (335)
T 2owb_A 124 RRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--R 197 (335)
T ss_dssp TTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--c
Confidence 9999999884 34679999999999999999999999 9999999999999999999999999999987643222 1
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||..|+|||.+... .++.++|||||||++|+|++|+.||....... .+....... ..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~----------~~ 259 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNE----------YS 259 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTC----------CC
T ss_pred ccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHhcCC----------CC
Confidence 2345699999999988764 68999999999999999999999996433210 111111110 11
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.+......+.+|+.+||+.||.+||++.++++
T Consensus 260 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 IPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22334567899999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=337.14 Aligned_cols=245 Identities=24% Similarity=0.297 Sum_probs=189.4
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHH-HhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGT-IGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.+.+.||+|+||.||+|+++ +++.||+|++.+.. .......+.+|..+ ++.++||||+++++++.+.+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 345689999999999999885 48899999987543 22334566777776 567899999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++|+|..++. ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 120 ~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~- 194 (373)
T 2r5t_A 120 YINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS- 194 (373)
T ss_dssp CCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC-
T ss_pred CCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCCC-
Confidence 999999999994 34579999999999999999999999 9999999999999999999999999999975322211
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+.. ..
T Consensus 195 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~---------~~- 255 (373)
T 2r5t_A 195 -TTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILN---------KP- 255 (373)
T ss_dssp -CCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-------HHHHHHHH---------SC-
T ss_pred -ccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHh---------cc-
Confidence 23346799999999988764 7899999999999999999999999643321 11111111 11
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
...+...+..+.+|+.+||+.||.+||++.+.+
T Consensus 256 ~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 256 LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 112234567789999999999999999986433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=345.57 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=190.8
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.++||+|+||.||+|.+. +|+.||+|++... ........+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus 151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 230 (446)
T 4ejn_A 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 230 (446)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence 34578999999999999874 5899999998753 23344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
++|+|..++. ....+++..+..++.|++.||+|||+. +||+||||||+|||++.++.+||+|||+++....... .
T Consensus 231 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~ 305 (446)
T 4ejn_A 231 NGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 305 (446)
T ss_dssp SSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------
T ss_pred CCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--c
Confidence 9999999994 345799999999999999999999952 6899999999999999999999999999975432221 2
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..... ... ...
T Consensus 306 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i---------~~~-~~~ 367 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELI---------LME-EIR 367 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH---------HHC-CCC
T ss_pred cccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHH---------HhC-CCC
Confidence 2346799999999988764 78999999999999999999999996543211 11111 111 112
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
.+...+..+.+|+.+||+.||.+|| ++.++++
T Consensus 368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 2334567899999999999999999 9999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=321.10 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=202.3
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||++.+. +++.||+|++... ........+.+|+.+++.+.|+||+++++++.+.+..++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 345688999999999999885 4889999998653 2345567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++++|.+++. ....+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 170 (294)
T 2rku_A 97 CRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-- 170 (294)
T ss_dssp CTTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--
Confidence 99999999884 34579999999999999999999999 9999999999999999999999999999987643222
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......||+.|+|||.+... .++.++||||||+++|+|++|+.||....... .+..... . ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~---------~-~~ 232 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKK---------N-EY 232 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHT---------T-CC
T ss_pred ccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhh---------c-cC
Confidence 12335689999999988764 68999999999999999999999996533210 0111111 1 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+...+..+.+++.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 122344567899999999999999999999885
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=342.70 Aligned_cols=256 Identities=21% Similarity=0.240 Sum_probs=201.6
Q ss_pred HHHhhhcc--ccccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc
Q 017591 21 LCSFTNNY--STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK 95 (369)
Q Consensus 21 l~~~t~~f--~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 95 (369)
+....++| .++||+|+||.||+|+++ +++.||+|++.+... ......+.+|+.++..++||||+++++++.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 33334444 478999999999999885 589999999864211 1112347899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceec
Q 017591 96 AALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 96 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
.++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 9999999999999999953 468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCccccccCCCCCCccccccccccC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 176 NPENTHDSTSGYRGTPGYSAPEFLLRNY---PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
..... .......||+.|+|||++.... .++.++|||||||++|||++|+.||...+... .+..+..+.
T Consensus 219 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~- 289 (410)
T 3v8s_A 219 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHK- 289 (410)
T ss_dssp CTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTHH-
T ss_pred ccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-------HHHHHHhcc-
Confidence 54332 1233467999999999987642 27899999999999999999999997543211 111111110
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCC--CCChHHHHH
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEA--RPPMSAVVK 295 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~v~~ 295 (369)
.....+ .....+..+.+|+.+||+.+|.+ ||++.+|++
T Consensus 290 ----~~~~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 290 ----NSLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ----HHCCCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ----ccccCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 000111 11234677899999999999988 999999984
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.71 Aligned_cols=264 Identities=23% Similarity=0.255 Sum_probs=199.2
Q ss_pred HHHHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-----CCceeeEEeEEEeC
Q 017591 20 QLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-----HINLVRLYGFCYDQ 93 (369)
Q Consensus 20 el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~ 93 (369)
++....+.+.++||+|+||+||+|++ .+++.||+|++... ......+..|+.++..+. ||||+++++++...
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 33334444568999999999999988 46899999998742 344566788999998886 99999999999999
Q ss_pred CceEEEEeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC------------
Q 017591 94 TKAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA------------ 160 (369)
Q Consensus 94 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~------------ 160 (369)
+..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhc
Confidence 9999999999 889999996543 469999999999999999999999 99999999999999975
Q ss_pred -------------CCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCC
Q 017591 161 -------------KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKN 227 (369)
Q Consensus 161 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p 227 (369)
++.+||+|||++....... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCC
Confidence 7889999999998754322 235689999999988875 799999999999999999999999
Q ss_pred CCCCCCCcc--------CccccchhHHhhhchhhhhh---------------------hcCCCCCCCHHHHHHHHHHHHh
Q 017591 228 AQDCSSDTL--------DWFPKQVWDEYEKGELAAKV---------------------LGCGIEENDREEAERMSMVALW 278 (369)
Q Consensus 228 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~l~~l~~~ 278 (369)
|........ ...+...+............ .....+.........+.+|+.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 975442210 00011100000000000000 0000000001112678899999
Q ss_pred ccccCCCCCCChHHHHH
Q 017591 279 CVQDCPEARPPMSAVVK 295 (369)
Q Consensus 279 cl~~~p~~RPs~~~v~~ 295 (369)
||+.||.+|||+.++++
T Consensus 339 ~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HCCSSGGGSCCHHHHTT
T ss_pred HhcCChhhCCCHHHHhc
Confidence 99999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=330.84 Aligned_cols=245 Identities=17% Similarity=0.156 Sum_probs=196.9
Q ss_pred ccccccccCCceEEEEEE------eCCCcEEEEEEccccccHHHHHHHHHHHHHHhccC---CCceeeEEeEEEeCCceE
Q 017591 27 NYSTKLGAGGFGVVYKGQ------FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY---HINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~ 97 (369)
.+.++||+|+||+||+|. ..+++.||+|++.... ..++..|+.++..+. |+||+.+++++...+..+
T Consensus 68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 344689999999999994 3468999999987542 335667777777776 999999999999999999
Q ss_pred EEEeccCCCCHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-----------CC
Q 017591 98 LVYEFMENGSLDKYLFT----DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-----------KF 162 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----------~~ 162 (369)
+||||+++|+|.+++.. ....+++..++.|+.|++.||+|||+ ++|+||||||+|||++. ++
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccC
Confidence 99999999999999954 35679999999999999999999999 99999999999999998 89
Q ss_pred CeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccc
Q 017591 163 SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQ 242 (369)
Q Consensus 163 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 242 (369)
.+||+|||+++.+.............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~--- 294 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--K--- 294 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--E---
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCce--e---
Confidence 9999999999876433333334556799999999988775 689999999999999999999999864322110 0
Q ss_pred hhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCC-CChHHHHHHhcCC
Q 017591 243 VWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEAR-PPMSAVVKMLEGG 300 (369)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~~v~~~L~~~ 300 (369)
........ ...+.+.+++..||+.+|.+| |++.++.+.|+..
T Consensus 295 --------------~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 295 --------------PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------------ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------------echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 00000111 125567889999999999999 5778888888765
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=321.38 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=199.5
Q ss_pred HhhhccccccccCCceEEEEEEeC-CCcEEEEEEccccccH-----HHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNK-----RVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 96 (369)
...+.+.+.||+|+||.||++.+. +++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 345667789999999999999885 5899999988643211 1256789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC----CeeEeecCCc
Q 017591 97 ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF----SAKVADFGLA 172 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~ 172 (369)
++||||+++++|.+++. ....+++..++.++.|++.||.|||+ ++++||||||+||+++.++ .+||+|||++
T Consensus 84 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 84 VLILELVSGGELFDFLA-EKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999999994 34579999999999999999999999 9999999999999998877 7999999999
Q ss_pred eecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
........ .....|++.|+|||.+... .++.++||||||+++|+|++|+.||....... ..........
T Consensus 160 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~ 228 (283)
T 3bhy_A 160 HKIEAGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAVNY 228 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC
T ss_pred eeccCCCc---ccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhccc
Confidence 87654322 2234689999999988764 78999999999999999999999997543210 1111111000
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..........+..+.+++.+||+.||.+||++.++++
T Consensus 229 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 ------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000001123567899999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=318.85 Aligned_cols=244 Identities=27% Similarity=0.434 Sum_probs=195.4
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe----CCceEEEEe
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD----QTKAALVYE 101 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e 101 (369)
+.+.||+|+||+||+|.+. ++..||+|.+... ........+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence 3467999999999999874 5889999988643 345556789999999999999999999999875 345899999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCC--eEeecCCCCceEec-CCCCeeEeecCCceecCCC
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR--IIHYDIKPANILLD-AKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 178 (369)
|+++++|.+++. ....+++..++.++.|++.||.|||+ ++ ++||||||+||+++ .++.+||+|||++......
T Consensus 110 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 110 LMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred ecCCCCHHHHHH-HccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 999999999994 34679999999999999999999999 88 99999999999997 7889999999999754332
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
. .....||+.|+|||.+.. .++.++|||||||++|+|++|+.||....... ........+..
T Consensus 186 ~----~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~------ 247 (290)
T 1t4h_A 186 F----AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVK------ 247 (290)
T ss_dssp S----BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCC------
T ss_pred c----cccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH------HHHHHHhccCC------
Confidence 2 223569999999998764 58999999999999999999999997543321 11111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........+..+.+++.+||+.||.+||++.+|++
T Consensus 248 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01112223467899999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=332.87 Aligned_cols=244 Identities=22% Similarity=0.286 Sum_probs=187.7
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHh-ccCCCceeeEEeEEEe----CCceEEEEecc
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIG-RTYHINLVRLYGFCYD----QTKAALVYEFM 103 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~----~~~~~lv~e~~ 103 (369)
+.||+|+||+||++.+. +++.||+|++... ..+.+|+.++. ..+||||+++++++.. ....++||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 57999999999999885 5899999998642 34667887764 4579999999999875 56789999999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC---CCCeeEeecCCceecCCCC
Q 017591 104 ENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA---KFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 104 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 179 (369)
++|+|.+++.... ..+++..++.|+.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 9999999996543 469999999999999999999999 99999999999999987 7889999999998764322
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
. .....||+.|+|||++... .++.++|||||||++|+|++|+.||......... ......+..+...
T Consensus 219 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~i~~~~~~------ 285 (400)
T 1nxk_A 219 S---LTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQYE------ 285 (400)
T ss_dssp -----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC---CSHHHHHHHTCCC------
T ss_pred c---cccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc---HHHHHHHHcCccc------
Confidence 2 2345689999999988764 7899999999999999999999999765433211 0111111111110
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.........+..+.+|+.+||+.||.+|||+.+|++
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001112345677999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=334.73 Aligned_cols=253 Identities=21% Similarity=0.237 Sum_probs=200.2
Q ss_pred hccccccccCCceEEEEEEe----CCCcEEEEEEccccc---cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceE
Q 017591 26 NNYSTKLGAGGFGVVYKGQF----PNGVKIAAKILKTCL---NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 97 (369)
+.+.++||+|+||.||+++. .+++.||+|+++... .......+.+|+.++..+ .||||+++++++.+.+..+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 34558899999999999987 368999999987432 112234677899999998 6999999999999999999
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 136 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred EEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999999999954 4579999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCccccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
.... ......||+.|+|||++.++ ..++.++|||||||++|+|++|+.||........ ...+. ...
T Consensus 212 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~~~-----~~~ 278 (355)
T 1vzo_A 212 DETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-------QAEIS-----RRI 278 (355)
T ss_dssp GGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-------HHHHH-----HHH
T ss_pred CCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-------HHHHH-----HHH
Confidence 2221 22345699999999998753 3578999999999999999999999975443211 01110 111
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCC-----ChHHHHHH
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARP-----PMSAVVKM 296 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~~ 296 (369)
.. ..+..+...+..+.+|+.+||+.||.+|| ++.++++.
T Consensus 279 ~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 279 LK-SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred hc-cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11 11233445567889999999999999999 88888753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=333.82 Aligned_cols=202 Identities=29% Similarity=0.409 Sum_probs=162.8
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCC--ceEEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQT--KAALV 99 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~lv 99 (369)
.+.+.++||+|+||.||+|.+ .+++.||+|++... ........+.+|+.++..+. ||||+++++++...+ ..++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 445668999999999999987 46899999988643 34455677889999999997 999999999998554 68999
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
|||+++ +|..++.. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+....
T Consensus 90 ~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 90 FDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred ecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999985 99999854 479999999999999999999999 999999999999999999999999999998764311
Q ss_pred C-------------------ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 017591 180 T-------------------HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCS 232 (369)
Q Consensus 180 ~-------------------~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~ 232 (369)
. ....+...||+.|+|||++.+...++.++|||||||++|||++|+.||...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1112345799999999998775578999999999999999999999997654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=323.36 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=202.0
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe--CCceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD--QTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 101 (369)
+.+.+.||+|+||.||++.+. +++.||+|.+... ........+.+|+.+++.++||||+++++++.+ ....++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 345689999999999999885 6899999998643 344556789999999999999999999998864 567899999
Q ss_pred ccCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhccCCC-----eEeecCCCCceEecCCCCeeEeecCCce
Q 017591 102 FMENGSLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEECNQR-----IIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 102 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
|+++++|.+++... ...+++..++.++.|++.||.|||+ ++ ++||||||+||+++.++.+||+|||++.
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999542 3459999999999999999999999 78 9999999999999999999999999997
Q ss_pred ecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhh
Q 017591 174 LCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELA 253 (369)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (369)
........ .....||..|+|||.+... .++.++||||||+++|+|++|+.||...... ....
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~-------- 226 (279)
T 2w5a_A 165 ILNHDTSF--AKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAG-------- 226 (279)
T ss_dssp HC---CHH--HHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH--------
T ss_pred eecccccc--ccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHH-------HHHH--------
Confidence 65432211 1234589999999988764 7899999999999999999999998754321 1111
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
..........+...+..+.+++.+||+.||.+||++.+|++.+..
T Consensus 227 -~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 227 -KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -HHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 112222233344566789999999999999999999999976643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=336.34 Aligned_cols=250 Identities=11% Similarity=-0.003 Sum_probs=180.2
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc--CCCceeeEE-------eEEEeC--
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT--YHINLVRLY-------GFCYDQ-- 93 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~~~-- 93 (369)
+.++||+|+||+||+|.+. +++.||+|++.... .......+.+|+.++..+ +||||++++ +++...
T Consensus 66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence 3478999999999999875 68999999987643 334456677885444444 699988755 444433
Q ss_pred ---------------CceEEEEeccCCCCHHHHhccCCCCCCHHHH------HHHHHHHHHHHHHHhhccCCCeEeecCC
Q 017591 94 ---------------TKAALVYEFMENGSLDKYLFTDTEVLKWEKL------LDIAIGTARGIAYLHEECNQRIIHYDIK 152 (369)
Q Consensus 94 ---------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~~l~~~l~~LH~~~~~~ivH~dlk 152 (369)
...++||||++ |+|.+++...+..+.+..+ +.++.|++.||+|||+ ++|+|||||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivHrDik 221 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFT 221 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCccCcCC
Confidence 23799999999 7999999665555666666 7888999999999999 999999999
Q ss_pred CCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 017591 153 PANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGRRKNAQDC 231 (369)
Q Consensus 153 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg~~p~~~~ 231 (369)
|+|||++.++.+||+|||+++...... ....+|+.|+|||++..+ ..++.++|||||||++|+|++|+.||...
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred HHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999998754221 134577999999998752 37899999999999999999999999866
Q ss_pred CCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 232 SSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
.............. ...............+..+.+|+.+||+.||.+||++.+++
T Consensus 297 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 297 TPGIKGSWKRPSLR--------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp CTTCTTCCCBCCTT--------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred Ccccccchhhhhhh--------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 54322111000000 00000011111224567899999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=334.97 Aligned_cols=252 Identities=24% Similarity=0.290 Sum_probs=189.4
Q ss_pred hhhccccccccCCceEEEEEEeC-CCcEEEEEEccccc-------cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-------NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK 95 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 95 (369)
..+.+.++||+|+||+||+|.+. +++.||+|++.... .......+.+|+.++++++||||+++++++. .+.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence 34455689999999999999874 58999999986432 1122335889999999999999999999974 556
Q ss_pred eEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC---CeeEeecCCc
Q 017591 96 AALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF---SAKVADFGLA 172 (369)
Q Consensus 96 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~ 172 (369)
.++||||+++|+|.+++. ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 214 ~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred eEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 899999999999999984 45679999999999999999999999 9999999999999997544 5999999999
Q ss_pred eecCCCCCccccccCCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhc
Q 017591 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKG 250 (369)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (369)
+...... ......||+.|+|||++.. ...++.++|||||||++|+|++|+.||........ .......+
T Consensus 290 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~------~~~~i~~~ 360 (419)
T 3i6u_A 290 KILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQITSG 360 (419)
T ss_dssp TSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC------HHHHHHTT
T ss_pred eecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH------HHHHHhcC
Confidence 8754322 2234569999999998853 34678999999999999999999999975433211 11111111
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 251 ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... ..+......+..+.+|+.+||+.||.+||++.++++
T Consensus 361 ~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 100 000011124577999999999999999999999885
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=320.26 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=193.8
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
.+.+.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3455689999999999999885 69999999986432 11234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++++|.+++.. ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 166 (276)
T 2h6d_A 92 YVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 166 (276)
T ss_dssp CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred ccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence 9999999999954 3569999999999999999999999 9999999999999999999999999999986543322
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
.....|++.|+|||.+.+....+.++||||||+++|+|++|+.||...... ........+ .
T Consensus 167 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~----------~ 227 (276)
T 2h6d_A 167 --LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGG----------V 227 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC----------C
T ss_pred --eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcC----------c
Confidence 223468999999998877544578999999999999999999999643221 111111111 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+...+..+.+++.+||+.||.+||++.+|++
T Consensus 228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1122334567899999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=319.27 Aligned_cols=244 Identities=25% Similarity=0.324 Sum_probs=200.1
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||+|.+. ++..||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 445689999999999999885 578999999864321 12245788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++++|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 168 (284)
T 2vgo_A 96 APRGELYKELQK-HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--- 168 (284)
T ss_dssp CTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc---
Confidence 999999999954 3579999999999999999999999 999999999999999999999999999997654322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....|++.|+|||.+.+. .++.++||||||+++|+|++|+.||....... ..... ... ..
T Consensus 169 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~---------~~~-~~ 229 (284)
T 2vgo_A 169 -RRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRRI---------VNV-DL 229 (284)
T ss_dssp -BCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHH---------HTT-CC
T ss_pred -cccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHHH---------hcc-cc
Confidence 2335689999999988764 68999999999999999999999996433210 01111 111 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+...+..+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 223345678899999999999999999999984
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.19 Aligned_cols=247 Identities=26% Similarity=0.283 Sum_probs=201.3
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.||+|+||.||+|+.. +|+.||+|++.... .......+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus 188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 3478999999999999885 69999999986432 12234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
||+|.+++...+ ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 268 gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~--- 341 (576)
T 2acx_A 268 GGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 341 (576)
T ss_dssp SCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCcc---
Confidence 999999995543 359999999999999999999999 9999999999999999999999999999987654332
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+... +.. ....
T Consensus 342 ~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~---~~~i~~~---------i~~-~~~~ 407 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERL---------VKE-VPEE 407 (576)
T ss_dssp EECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC---HHHHHHH---------HHH-CCCC
T ss_pred ccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchh---HHHHHHH---------hhc-cccc
Confidence 2235799999999988774 689999999999999999999999976443211 0111111 111 1122
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC-----ChHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARP-----PMSAVV 294 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~ 294 (369)
.+...+..+.+|+.+||+.||.+|| ++.+|+
T Consensus 408 ~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil 443 (576)
T 2acx_A 408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443 (576)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHH
T ss_pred CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHH
Confidence 3345567899999999999999999 677876
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=325.34 Aligned_cols=262 Identities=26% Similarity=0.311 Sum_probs=197.3
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.+.||+|+||.||+|.+. +++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 3468999999999999885 4899999987543 3344566788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
++|..++ .....+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++........ ...
T Consensus 109 ~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 182 (331)
T 4aaa_A 109 TILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYD 182 (331)
T ss_dssp EHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------------
T ss_pred chHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccC
Confidence 8888876 455679999999999999999999999 9999999999999999999999999999976543222 123
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhchhhhhh-
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGELAAKV- 256 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~- 256 (369)
...||..|+|||++.+...++.++|||||||++|+|++|+.||......... .........+.........
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence 3568999999999877657899999999999999999999999765432110 0000000001100000000
Q ss_pred hcCCCCC-----CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 257 LGCGIEE-----NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 257 ~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 01234678999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=320.20 Aligned_cols=248 Identities=22% Similarity=0.368 Sum_probs=202.2
Q ss_pred HHHhhhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe-------
Q 017591 21 LCSFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD------- 92 (369)
Q Consensus 21 l~~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------- 92 (369)
.....+.+.+.||+|+||.||+|.+. +++.||+|++.... ..+.+|+.++..++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 33444556689999999999999885 69999999987542 356789999999999999999998864
Q ss_pred ---------CCceEEEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC
Q 017591 93 ---------QTKAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF 162 (369)
Q Consensus 93 ---------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 162 (369)
....++||||+++++|.+++... ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCC
Confidence 34579999999999999999643 3679999999999999999999999 9999999999999999999
Q ss_pred CeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccc
Q 017591 163 SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQ 242 (369)
Q Consensus 163 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 242 (369)
.+||+|||++........ .....||+.|+|||.+... .++.++||||||+++|+|++|..|+... ..
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~ 226 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFET---------SK 226 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HH
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhH---------HH
Confidence 999999999987654322 2334699999999988764 7899999999999999999998876311 00
Q ss_pred hhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 243 VWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.+.. ...... +...+..+.+++.+||+.||.+||++.++++.|....
T Consensus 227 ~~~~---------~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 227 FFTD---------LRDGII---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHH---------HHTTCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHH---------hhcccc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1111 111111 2234567889999999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=322.08 Aligned_cols=266 Identities=25% Similarity=0.326 Sum_probs=193.7
Q ss_pred HHHHHhhhccccccccCCceEEEEEEe-CCCcEEEEEEcccccc----HHHHHHHHHHHHHHhcc---CCCceeeEEeEE
Q 017591 19 EQLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLN----KRVEAQFMAEIGTIGRT---YHINLVRLYGFC 90 (369)
Q Consensus 19 ~el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l---~h~niv~~~~~~ 90 (369)
+++....+.+.++||+|+||+||+|++ .+++.||+|++..... ......+.+|+.+++.+ .||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 445555667779999999999999987 4689999999863221 11123455666666655 599999999999
Q ss_pred EeCC-----ceEEEEeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCe
Q 017591 91 YDQT-----KAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA 164 (369)
Q Consensus 91 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 164 (369)
.... ..++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCE
T ss_pred eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCE
Confidence 8765 47999999975 9999995543 349999999999999999999999 999999999999999999999
Q ss_pred eEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchh
Q 017591 165 KVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVW 244 (369)
Q Consensus 165 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 244 (369)
||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ...+.
T Consensus 160 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~ 232 (308)
T 3g33_A 160 KLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIF 232 (308)
T ss_dssp EECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHH
T ss_pred EEeeCccccccCCCcc---cCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 9999999976543322 2345689999999988775 689999999999999999999999975443210 00000
Q ss_pred HHhhhc---------hhhhhhhcCCCC----CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 245 DEYEKG---------ELAAKVLGCGIE----ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 245 ~~~~~~---------~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...... ...........+ ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000000 000000000000 001234577899999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=322.24 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=197.3
Q ss_pred hhccccccccCCceEEEEEEeC--CCc--EEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP--NGV--KIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
.+.+.++||+|+||+||+|.+. ++. .||+|++.... .......+.+|+.++..++||||+++++++.+.. .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 3455689999999999999753 233 68999887532 3345678999999999999999999999997655 899
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+++++|.+++......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++......
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 999999999999997666789999999999999999999999 99999999999999999999999999999877544
Q ss_pred CCcc-ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 179 NTHD-STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 179 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
.... ......+|..|+|||.+... .++.++||||||+++|+|++ |+.||....... ......
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~-------- 238 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKID-------- 238 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHH--------
T ss_pred ccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-------HHHHHH--------
Confidence 3221 22334578889999988764 68899999999999999999 999986543211 111111
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
........+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 239 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 111112233455678999999999999999999999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=319.41 Aligned_cols=245 Identities=23% Similarity=0.300 Sum_probs=196.7
Q ss_pred ccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCCHH
Q 017591 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLD 109 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 109 (369)
.||+|+||.||+|.+ .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 899999999999987 458899999987543 344567999999999999999999999999999999999999999999
Q ss_pred HHhccCC--CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-CCCeeEeecCCceecCCCCCcccccc
Q 017591 110 KYLFTDT--EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-KFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 110 ~~l~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+++.... ..+++..++.++.|++.||.|||+ ++++|+||||+||+++. ++.+||+|||++........ ....
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 182 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTET 182 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccc
Confidence 9996543 356799999999999999999999 99999999999999987 88999999999987653322 1234
Q ss_pred CCCCCCccccccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 187 YRGTPGYSAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~-~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..||+.|+|||.+..+. .++.++||||||+++|+|++|+.||........ ... ........+..+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~------~~~~~~~~~~~~ 248 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--------AMF------KVGMFKVHPEIP 248 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--------HHH------HHHHHCCCCCCC
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--------HHH------hhcccccccccc
Confidence 56899999999887642 478999999999999999999999864322100 000 001111223334
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..+.+++.+||+.||.+||++.++++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 456678999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=326.69 Aligned_cols=261 Identities=25% Similarity=0.290 Sum_probs=198.7
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccH----HHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNK----RVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
+.+.+.||+|+||.||+|.+. +|+.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence 445689999999999999885 5899999998743221 12346889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++ +|..++......+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........
T Consensus 92 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 92 DFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp ECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99987 8999997667789999999999999999999999 9999999999999999999999999999986643322
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch---------
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE--------- 251 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 251 (369)
......||+.|+|||.+.+...++.++|||||||++|+|++|..||........ ...++.......
T Consensus 168 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 168 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTS
T ss_pred --cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChhhhhhhcc
Confidence 223456899999999987655689999999999999999999998875432110 000000000000
Q ss_pred hhhhhhcCCCCCCC-----HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVLGCGIEEND-----REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+.......+..+ ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000000001111 233578999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=321.52 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=197.6
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEe--CCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYD--QTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~ 102 (369)
.+.++||+|+||+||+|.+ .+++.||+|++.... ...+.+|+.++..+. ||||+++++++.+ ....++||||
T Consensus 39 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 39 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 3457899999999999987 568999999987432 357889999999997 9999999999987 5678999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-CeeEeecCCceecCCCCCc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 181 (369)
+.+++|.+++. .+++..++.++.|++.||.|||+ +|++||||||+|||++.++ .+||+|||++........
T Consensus 115 ~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~- 186 (330)
T 3nsz_A 115 VNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 186 (330)
T ss_dssp CCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred cCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc-
Confidence 99999999983 48999999999999999999999 9999999999999999777 899999999987654332
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC--
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC-- 259 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 259 (369)
.....||..|+|||.+.....++.++|||||||++|+|++|+.||.......... ...................
T Consensus 187 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l--~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 187 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH--HHHHHHHCHHHHHHHHHHTTC
T ss_pred --cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH--HHHHHhcCCchhhhHHHHhcc
Confidence 2335689999999998775578999999999999999999999996543321100 0000000001111100000
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 ---------------------GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ---------------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.........+..+.+|+.+||+.||.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011112225678999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=324.71 Aligned_cols=266 Identities=23% Similarity=0.286 Sum_probs=193.6
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe-----CCceEEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD-----QTKAALVY 100 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~ 100 (369)
+.+.+.||+|+||.||+|++ +++.||+|++..... .......|+..+..++|+||+++++.+.. ....++||
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred hheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 34568999999999999987 789999999874322 12222344444556899999999986642 22568999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCC---------CeEeecCCCCceEecCCCCeeEeecCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ---------RIIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~---------~ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
||+++|+|.+++... ..++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+
T Consensus 92 e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp CCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 999999999999443 35899999999999999999999 7 999999999999999999999999999
Q ss_pred ceecCCCCC------ccccccCCCCCCcccccccccc------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc
Q 017591 172 AKLCNPENT------HDSTSGYRGTPGYSAPEFLLRN------YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF 239 (369)
Q Consensus 172 ~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~------~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 239 (369)
+..+..... ........||+.|+|||++.+. ..++.++|||||||++|||++|..||...........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 987653221 1122345699999999988752 2466799999999999999999887765433211000
Q ss_pred ccchhHHhhhc----hhhhhh----hcCCCC---CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 240 PKQVWDEYEKG----ELAAKV----LGCGIE---ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 240 ~~~~~~~~~~~----~~~~~~----~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
......... ...... .....+ ......+..+.+|+.+||+.||.+|||+.+|++.|+...
T Consensus 247 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 247 --AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp --TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred --hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 000000000 000000 011111 112346778999999999999999999999999998763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=341.71 Aligned_cols=258 Identities=20% Similarity=0.284 Sum_probs=203.8
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCC-CceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH-INLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.++||+|+||.||+|.+ .+++.||||++..... ..++.+|+.++..+.| +++..+..++.+.+..+|||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 44568999999999999987 5699999998764332 2357889999999976 56666777777888899999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe---cCCCCeeEeecCCceecCCCCC
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL---DAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
+++|.+++......+++..++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 889999997667789999999999999999999999 999999999999999 6888999999999987654332
Q ss_pred c-----cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhh
Q 017591 181 H-----DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255 (369)
Q Consensus 181 ~-----~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (369)
. .......||..|+|||++.+. .++.++|||||||+||||++|+.||......... ..+..+........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~----~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK----QKYEKISEKKVATS 236 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH----HHHHHHHHHHHHSC
T ss_pred ccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHH----HHHHHHhhcccccc
Confidence 2 122356799999999988775 7899999999999999999999999875543211 11111111111100
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 256 VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
. ......++..+.+|+..||+.||.+||++.+|++.|+..
T Consensus 237 ~-----~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 237 I-----EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp H-----HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred H-----HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0 001112356899999999999999999999999998865
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=325.52 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=198.4
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccccc-------HHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEE
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN-------KRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (369)
+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.++..+ .||||+++++++...+..++
T Consensus 98 ~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 177 (365)
T 2y7j_A 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177 (365)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence 3478999999999999885 699999999864321 22345688999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+++++|.+++. ....+++..++.++.|++.||.|||+ .|++|+||||+|||++.++.++|+|||++......
T Consensus 178 v~e~~~g~~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 178 VFDLMRKGELFDYLT-EKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 999999999999994 34579999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCccccccCCCCCCcccccccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRN-----YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELA 253 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (369)
.. .....||+.|+|||++... ..++.++|||||||++|+|++|+.||...... ........
T Consensus 254 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------~~~~~i~~---- 319 (365)
T 2y7j_A 254 EK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-------LMLRMIME---- 319 (365)
T ss_dssp CC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH----
T ss_pred cc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHh----
Confidence 32 2345699999999987632 25788999999999999999999999653221 01111111
Q ss_pred hhhhcCCCCCCC---HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 254 AKVLGCGIEEND---REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 254 ~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... ...+..+.+++.+||+.||.+||++.++++
T Consensus 320 -----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 320 -----GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -----TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 123467899999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=330.05 Aligned_cols=263 Identities=20% Similarity=0.228 Sum_probs=189.9
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+.+.++||+|+||+||+|.+ .+++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence 34458999999999999987 468999999987543 2333556889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec-----CCCCeeEeecCCceecCCC
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD-----AKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~-----~~~~~kl~Dfg~~~~~~~~ 178 (369)
++ +|.+++. ....+++..++.++.|++.||.|||+ ++|+||||||+|||++ .++.+||+|||++......
T Consensus 116 ~~-~L~~~~~-~~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 116 EN-DLKKYMD-KNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp SE-EHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred CC-CHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 86 9999994 44569999999999999999999999 9999999999999994 4556999999999866432
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc--------cccchhHHhhhc
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW--------FPKQVWDEYEKG 250 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~ 250 (369)
.. ......||..|+|||++.+...++.++|||||||++|+|++|+.||.......... .....|......
T Consensus 191 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 191 IR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 22 22334689999999998876568999999999999999999999997543211000 000000000000
Q ss_pred hhhhhhhcCCCCCC-----CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 251 ELAAKVLGCGIEEN-----DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 251 ~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.............. ....+..+.+|+.+||+.||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000000000 0113467899999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=320.33 Aligned_cols=247 Identities=24% Similarity=0.333 Sum_probs=198.3
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||+|+||.||+|.+. +|+.||+|.+..... ...+.+|+.++..+.||||+++++++.+.+..++||||++
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp EEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 344578999999999999885 489999999875432 3578899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++......+++..++.++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 182 (314)
T 3com_A 108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KR 182 (314)
T ss_dssp TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CB
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--cc
Confidence 999999996567789999999999999999999999 9999999999999999999999999999987643222 22
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....||+.|+|||.+... .++.++||||||+++|+|++|+.||........ ..... .........
T Consensus 183 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~-------~~~~~~~~~ 247 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-------IFMIP-------TNPPPTFRK 247 (314)
T ss_dssp CCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHH-------HSCCCCCSS
T ss_pred CccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHh-------cCCCcccCC
Confidence 345689999999988764 689999999999999999999999974332100 00000 000011112
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+..++..+.+++.+||+.||.+||++.++++
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 3345678999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=327.86 Aligned_cols=275 Identities=21% Similarity=0.280 Sum_probs=205.8
Q ss_pred ccCHHHHHHhh--hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEE
Q 017591 15 RFTLEQLCSFT--NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY 91 (369)
Q Consensus 15 ~~~~~el~~~t--~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 91 (369)
.+.-+++.... +.+.++||+|+||.||+|.+. ++..||+|++...........+.+|+.++..++||||+++++++.
T Consensus 16 ~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 95 (364)
T 3qyz_A 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIR 95 (364)
T ss_dssp CBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred EEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEe
Confidence 34444444433 344589999999999999874 688999999986555666678999999999999999999999997
Q ss_pred eC-----CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeE
Q 017591 92 DQ-----TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKV 166 (369)
Q Consensus 92 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 166 (369)
.. ...++||||+.+ +|.+++.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 96 APTIEQMKDVYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp CSSTTTCCCEEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEE
T ss_pred cCCccccceEEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEE
Confidence 55 368999999985 99999843 469999999999999999999999 99999999999999999999999
Q ss_pred eecCCceecCCCCCcc-ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCc-------
Q 017591 167 ADFGLAKLCNPENTHD-STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDW------- 238 (369)
Q Consensus 167 ~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~------- 238 (369)
+|||++.......... ......||+.|+|||++..+..++.++|||||||++|+|++|+.||..........
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 249 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249 (364)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence 9999998765332211 12345799999999987766678999999999999999999999997654321100
Q ss_pred -cccchhHHhhhchhhhhhhcCCC-CC-----CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 239 -FPKQVWDEYEKGELAAKVLGCGI-EE-----NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.....+................. .. .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000000000000 00 01223567899999999999999999999984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=320.24 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=199.1
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.+.||+|+||.||++++. +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 4456689999999999999885 689999999875432 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe---cCCCCeeEeecCCceecCCCCC
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL---DAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
++++|.+++.. ...+++..++.++.|++.||.|||+ +|++||||||+||++ +.++.++|+|||++.......
T Consensus 89 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~- 163 (304)
T 2jam_A 89 SGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163 (304)
T ss_dssp CSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred CCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence 99999999843 4579999999999999999999999 999999999999999 788899999999987543221
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...... .....+..+.. ..
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~------~~ 226 (304)
T 2jam_A 164 ---MSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETES-------KLFEKIKEGYY------EF 226 (304)
T ss_dssp ---THHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHCCC------CC
T ss_pred ---cccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCC------CC
Confidence 1234589999999988764 7899999999999999999999999654321 11111111110 00
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........+..+.+++.+||+.||.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11222345678999999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=340.33 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=196.8
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccH------------HHHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNK------------RVEAQFMAEIGTIGRTYHINLVRLYGFCYD 92 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 92 (369)
+.+.++||+|+||+||+|.++ +++.||+|++...... .....+.+|+.+++.++||||+++++++.+
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344589999999999999885 5889999998753211 224678899999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC---CeeEeec
Q 017591 93 QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF---SAKVADF 169 (369)
Q Consensus 93 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Df 169 (369)
....++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999843 4579999999999999999999999 9999999999999998776 6999999
Q ss_pred CCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhh
Q 017591 170 GLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEK 249 (369)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (369)
|++........ .....||+.|+|||++.. .++.++|||||||++|+|++|..||....... .......
T Consensus 194 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~ 261 (504)
T 3q5i_A 194 GLSSFFSKDYK---LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIKKVEK 261 (504)
T ss_dssp TTCEECCTTSC---BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHH
T ss_pred CCCEEcCCCCc---cccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHc
Confidence 99987654322 233569999999998764 58999999999999999999999997543221 1122211
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 250 GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+..... .......+..+.+|+.+||+.||.+|||+.++++
T Consensus 262 ~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 262 GKYYFD------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCCCC------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCC------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111000 0001123577999999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=328.21 Aligned_cols=259 Identities=22% Similarity=0.286 Sum_probs=194.1
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC------ceE
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT------KAA 97 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~ 97 (369)
+.+.+.||+|+||.||+|.+ .+|+.||+|++... .......++.+|+.+++.++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 34457899999999999988 46999999998543 34455678899999999999999999999997653 469
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 107 lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 999999 7799999854 569999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEK 249 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~ 249 (369)
. .....+|+.|+|||++.+...++.++|||||||++|||++|+.||........ ...+...+..+..
T Consensus 181 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 181 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred c-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 2 23356899999999888755799999999999999999999999976543110 0000011111100
Q ss_pred chhhhhh--h----cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 250 GELAAKV--L----GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 250 ~~~~~~~--~----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....... . ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000 0 00011112334677899999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=351.51 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=205.0
Q ss_pred hccccccccCCceEEEEEEeCC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.+.+.||+|+||.||+|.+.. +..||+|.............+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E 470 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 470 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEE
Confidence 3445789999999999998742 56899999886666666788999999999999999999999984 567899999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 471 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 547 (656)
T 2j0j_A 471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547 (656)
T ss_dssp CCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence 999999999997666789999999999999999999999 99999999999999999999999999999876433222
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
......+|+.|+|||.+... .++.++|||||||++|||++ |..||...... +.........
T Consensus 548 -~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----------------~~~~~i~~~~ 609 (656)
T 2j0j_A 548 -KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----------------DVIGRIENGE 609 (656)
T ss_dssp -------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHHHHHTC
T ss_pred -eccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHHcCC
Confidence 22234577899999988764 78999999999999999997 88898654321 1111112222
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
....+...+..+.+|+.+||+.||.+||++.+|++.|+..
T Consensus 610 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2333445667899999999999999999999999999865
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=341.75 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=196.0
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.++||+|+||+||+|+++ ++..||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 3455689999999999999885 68999999987432 222346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC---CCeeEeecCCceecCCCC
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~ 179 (369)
+++|+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++.. +.+||+|||++.......
T Consensus 118 ~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 118 YKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 999999998843 4579999999999999999999999 999999999999999764 459999999998765332
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
. .....||+.|+|||++.. .++.++|||||||++|+|++|..||...... ........+...
T Consensus 194 ~---~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~------ 255 (494)
T 3lij_A 194 K---MKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------EILRKVEKGKYT------ 255 (494)
T ss_dssp C---BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC------
T ss_pred c---ccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC------
Confidence 2 234569999999998764 5899999999999999999999999754322 111221111110
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.........+..+.+|+.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 001112234677999999999999999999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=340.73 Aligned_cols=243 Identities=26% Similarity=0.339 Sum_probs=198.4
Q ss_pred ccccccCCceEEEEEEeC-CCcEEEEEEcccccc--HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 29 STKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.||+|+||.||+|+++ +|+.||+|++..... ......+.+|+.++..++||||+++++++.+.+..++||||++|
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 367999999999999885 599999999875321 12245788999999999999999999999999999999999999
Q ss_pred CCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 106 GSLDKYLFTD---TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 106 gsL~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
|+|..++... ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~- 345 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC-
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc-
Confidence 9999998543 3479999999999999999999999 99999999999999999999999999999876543321
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+... +... ..
T Consensus 346 -~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---~~~~~~~---------i~~~-~~ 410 (543)
T 3c4z_A 346 -TKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQR---------VLEQ-AV 410 (543)
T ss_dssp -BCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---HHHHHHH---------HHHC-CC
T ss_pred -cccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchh---HHHHHHH---------Hhhc-cc
Confidence 2335799999999998774 789999999999999999999999976533211 0111111 1111 12
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCh
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPM 290 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 290 (369)
..+...+..+.+|+.+||+.||.+||++
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 2334567789999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=319.18 Aligned_cols=253 Identities=25% Similarity=0.294 Sum_probs=195.6
Q ss_pred HhhhccccccccCCceEEEEEEeC-CCcEEEEEEccccc-------cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 017591 23 SFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-------NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT 94 (369)
Q Consensus 23 ~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 94 (369)
...+.+.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 345566789999999999999874 58999999986432 1122345889999999999999999999986554
Q ss_pred ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC---eeEeecCC
Q 017591 95 KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS---AKVADFGL 171 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~ 171 (369)
.++||||+++++|.+++. ....+++..++.++.|++.||.|||+ ++++||||||+||+++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 899999999999999984 45679999999999999999999999 99999999999999987664 99999999
Q ss_pred ceecCCCCCccccccCCCCCCcccccccc--ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhh
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEK 249 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (369)
+........ .....||+.|+|||++. ....++.++|||||||++|+|++|+.||........ .......
T Consensus 164 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~ 234 (322)
T 2ycf_A 164 SKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQITS 234 (322)
T ss_dssp CEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC------HHHHHHH
T ss_pred ceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH------HHHHHHh
Confidence 987643221 12345899999999874 234689999999999999999999999975443211 1111111
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 250 GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+... ..+......+..+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cccc------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1100 000011123577899999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=316.72 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=199.6
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccccc---HHHHHHHHHHHHHHhccCCCceeeEEeEEE--eCCceEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN---KRVEAQFMAEIGTIGRTYHINLVRLYGFCY--DQTKAALV 99 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv 99 (369)
+.+.+.||+|+||.||++.+. +++.||+|++..... ......+.+|+.+++.++||||+++++++. +....++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 456689999999999999884 589999999875321 234578999999999999999999999985 44578999
Q ss_pred EeccCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 100 YEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
|||+.++ |.+++.. ....+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++......
T Consensus 87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999986 7777644 35679999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCccccccCCCCCCccccccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
..........||..|+|||++.... ..+.++||||||+++|+|++|+.||...... ........+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~------ 229 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLFENIGKGS------ 229 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCC------
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------HHHHHHhcCC------
Confidence 3333334566999999999887532 3478999999999999999999999753221 1111111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH--HhcC
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK--MLEG 299 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~--~L~~ 299 (369)
...+...+..+.+++.+||+.||.+||++.++++ +++.
T Consensus 230 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 230 ----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp ----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred ----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 1122334567899999999999999999999985 4444
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=340.70 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=200.3
Q ss_pred hhhccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
..+.+.++||+|+||+||+|.+. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 34566789999999999999885 68999999986421 12234678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec---CCCCeeEeecCCceecCCC
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD---AKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~ 178 (369)
|+.+|+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++......
T Consensus 102 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999998844 4579999999999999999999999 9999999999999995 4567999999999765433
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ........+...
T Consensus 178 ~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~----- 240 (486)
T 3mwu_A 178 TK---MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYA----- 240 (486)
T ss_dssp -------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC-----
T ss_pred Cc---cCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC-----
Confidence 22 233569999999998865 5899999999999999999999999754321 111111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.........+..+.+|+.+||+.||.+|||+.++++
T Consensus 241 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 241 -FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001112345678999999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=336.93 Aligned_cols=256 Identities=21% Similarity=0.240 Sum_probs=190.0
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC------ceEEE
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT------KAALV 99 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv 99 (369)
+.++||+|+||+||+|.+. +++.||+|++... .......++.+|+.+++.++||||+++++++...+ ..++|
T Consensus 66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence 3578999999999999874 5899999998643 24455678899999999999999999999997553 56999
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
|||+++ +|.+.+. ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus 146 ~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 146 MELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp EECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred EeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 999987 5766662 348999999999999999999999 999999999999999999999999999998764322
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhhch
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKGE 251 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~ 251 (369)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.... .......+..+.. .
T Consensus 219 ---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~-~ 293 (464)
T 3ttj_A 219 ---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 293 (464)
T ss_dssp ---CC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH-H
T ss_pred ---ccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch-h
Confidence 22345799999999998875 799999999999999999999999976542110 0000000000000 0
Q ss_pred hhhhhhcC---------------CCC---CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVLGC---------------GIE---ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~~~---------------~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........ ..+ .........+.+|+.+||+.||.+|||+.++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 000 011223677999999999999999999999884
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.79 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=192.6
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe------------
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD------------ 92 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------------ 92 (369)
+.+.+.||+|+||.||+|++. +++.||+|++.. .......+.+|+.+++.++||||+++++++.+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 345689999999999999874 689999999864 23456789999999999999999999998865
Q ss_pred -CCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCC
Q 017591 93 -QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 93 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
.+..++||||+++++|.+++......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 346789999999999999997777788999999999999999999999 9999999999999999999999999999
Q ss_pred ceecCCCCC------------ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc
Q 017591 172 AKLCNPENT------------HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF 239 (369)
Q Consensus 172 ~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 239 (369)
+........ ........||..|+|||.+.+...++.++|||||||++|+|++ ||......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~----- 234 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER----- 234 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-----
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-----
Confidence 976542210 1122345689999999998765578999999999999999998 44311000
Q ss_pred ccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 240 PKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......... ......+......+..+.+++.+||+.||.+||++.++++
T Consensus 235 -~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 -VNILKKLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHhccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 000111110 0111112334455677899999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=331.16 Aligned_cols=259 Identities=18% Similarity=0.203 Sum_probs=199.7
Q ss_pred hhccccccccCCceEEEEEEeCC---------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceee----------
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPN---------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR---------- 85 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 85 (369)
.+.+.+.||+|+||.||+|.+.. ++.||+|++... ..+.+|+.++.+++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 34456899999999999998863 789999998753 36789999999999999887
Q ss_pred -----EEeEEEe-CCceEEEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe
Q 017591 86 -----LYGFCYD-QTKAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL 158 (369)
Q Consensus 86 -----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill 158 (369)
+++++.. ....++||||+ +++|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 6777776 67889999999 89999999654 4689999999999999999999999 999999999999999
Q ss_pred cCCC--CeeEeecCCceecCCCCCc-----cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 017591 159 DAKF--SAKVADFGLAKLCNPENTH-----DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDC 231 (369)
Q Consensus 159 ~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~ 231 (369)
+.++ .+||+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 8999999999866432211 112345799999999988764 7899999999999999999999999754
Q ss_pred CCCccCccccchhHHhhhchhhhhhhc-CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 232 SSDTLDWFPKQVWDEYEKGELAAKVLG-CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
..... ....... ........ ..........+..+.+|+.+||+.||.+||++.+|++.|+...
T Consensus 272 ~~~~~-----~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 272 LPNTE-----DIMKQKQ--KFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TTCHH-----HHHHHHH--HHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CcCHH-----HHHHHHH--hccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 42211 0001000 00000000 0000001123577999999999999999999999999998763
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=326.12 Aligned_cols=254 Identities=25% Similarity=0.335 Sum_probs=184.5
Q ss_pred hhhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEe--------C
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYD--------Q 93 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--------~ 93 (369)
..+.+.++||+|+||.||+|.+. +++.||+|++... .......+.+|+.++.++. ||||+++++++.. .
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 34456689999999999999874 6899999988644 3345678899999999996 9999999999952 3
Q ss_pred CceEEEEeccCCCCHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhccCCC--eEeecCCCCceEecCCCCeeEeec
Q 017591 94 TKAALVYEFMENGSLDKYLFT--DTEVLKWEKLLDIAIGTARGIAYLHEECNQR--IIHYDIKPANILLDAKFSAKVADF 169 (369)
Q Consensus 94 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Df 169 (369)
...++||||+. |+|.+++.. ....+++..++.++.|++.||.|||+ ++ ++||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 35789999997 599998854 45679999999999999999999999 88 999999999999999999999999
Q ss_pred CCceecCCCCCcc----------ccccCCCCCCcccccccc--ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC
Q 017591 170 GLAKLCNPENTHD----------STSGYRGTPGYSAPEFLL--RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD 237 (369)
Q Consensus 170 g~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~--~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~ 237 (369)
|++.......... ......||+.|+|||++. .+..++.++|||||||++|+|++|+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 9998765332211 112345899999999874 334689999999999999999999999964332110
Q ss_pred ccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 238 WFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.... .........+..+.+|+.+||+.||.+||++.++++.|+...
T Consensus 262 ----------~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 262 ----------VNGK--------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------hcCc--------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000 000111122345889999999999999999999999998763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=342.19 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=202.8
Q ss_pred hhhccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
..+.+.++||+|+||.||+|.+. +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 44566789999999999999885 68999999985431 1233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe---cCCCCeeEeecCCceecCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL---DAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~ 177 (369)
||+.+|+|.+++. ....+++..++.++.|++.||.|||+ +||+||||||+|||+ +.++.+||+|||++.....
T Consensus 106 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 106 EVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred ecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999984 45679999999999999999999999 999999999999999 5678899999999987654
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
.... ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .....+..+...
T Consensus 182 ~~~~---~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~---- 245 (484)
T 3nyv_A 182 SKKM---KDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEY-------DILKKVEKGKYT---- 245 (484)
T ss_dssp CCSH---HHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC----
T ss_pred cccc---ccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCC----
Confidence 3322 23469999999998865 5899999999999999999999999754321 111111111110
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.........+..+.+|+.+||+.||.+|||+.++++
T Consensus 246 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 --FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp --CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 001112345678999999999999999999999884
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=321.05 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=196.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 345578999999999999885 489999999875322 235678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+++|.+++......+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++...... ....
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 174 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKR 174 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cccc
Confidence 999999997667789999999999999999999999 99999999999999999999999999987532110 0111
Q ss_pred ccCCCCCCcccccccc----ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 185 SGYRGTPGYSAPEFLL----RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~----~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
....||+.|+|||++. .+..++.++||||||+++|+|++|+.||....... ........ ...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~-------~~~ 240 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKS-------DPP 240 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHS-------CCC
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------HHHHHhcc-------CCc
Confidence 2346899999999874 23478999999999999999999999987543211 00111000 001
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+..++..+.+++.+||+.||.+||++.++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11223445678999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=315.22 Aligned_cols=249 Identities=21% Similarity=0.273 Sum_probs=200.1
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--------cHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCce
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--------NKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKA 96 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 96 (369)
.+.+.||+|+||.||+|.++ +++.||+|++.... .......+.+|+.++.++. ||||+++++++.+.+..
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (298)
T 1phk_A 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99 (298)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence 34578999999999999885 58999999986432 1233467889999999995 99999999999999999
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 97 ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++....
T Consensus 100 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 100 FLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 999999999999999943 4679999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCccccccCCCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 177 PENTHDSTSGYRGTPGYSAPEFLLR-----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
.... .....|++.|+|||.+.. ...++.++||||||+++|+|++|+.||....... .......+.
T Consensus 176 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~ 245 (298)
T 1phk_A 176 PGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIMSGN 245 (298)
T ss_dssp TTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTC
T ss_pred CCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------HHHHHhcCC
Confidence 4332 233568999999998752 3367899999999999999999999996433210 111111111
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
. ..........+..+.+++.+||+.||.+||++.++++
T Consensus 246 ~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 0011122345678999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=334.98 Aligned_cols=236 Identities=14% Similarity=0.127 Sum_probs=183.7
Q ss_pred ccccccCCceEEEEEEe-CCCcEEEEEEcccc--ccHHHHHHHHHHH---HHHhccCCCceeeEE-------eEEEeCC-
Q 017591 29 STKLGAGGFGVVYKGQF-PNGVKIAAKILKTC--LNKRVEAQFMAEI---GTIGRTYHINLVRLY-------GFCYDQT- 94 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~~~~~~- 94 (369)
.+.||+|+||.||+|.+ .+|+.||||++... ........+.+|+ ..++.++||||++++ +++.+.+
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 47899999999999987 46999999998642 2334567899999 555556899999998 6666553
Q ss_pred ----------------ceEEEEeccCCCCHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCC
Q 017591 95 ----------------KAALVYEFMENGSLDKYLFTDT------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIK 152 (369)
Q Consensus 95 ----------------~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlk 152 (369)
..++||||+ +|+|.+++.... ..+++..++.|+.|++.||+|||+ ++|+|||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDik 233 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR 233 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 278999999 579999995432 233468899999999999999999 999999999
Q ss_pred CCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCcccccccccc----------CCCCcchhhHHHHHHHHHHH
Q 017591 153 PANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN----------YPITQKCDVYSFGMLLFEII 222 (369)
Q Consensus 153 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~s~~sDvwSlGvil~ell 222 (369)
|+|||++.++.+||+|||+++.... ......| +.|+|||++... ..++.++|||||||++|||+
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 9999999999999999999986432 2233457 999999988764 26899999999999999999
Q ss_pred cCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 223 GRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 223 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+|+.||......... ...... ....+..+.+|+.+||+.||.+||++.++++
T Consensus 308 tg~~Pf~~~~~~~~~----------------~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 308 CADLPITKDAALGGS----------------EWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HSSCCC------CCS----------------GGGGSS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HCCCCCcccccccch----------------hhhhhh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999754432110 001110 0123467899999999999999999999884
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=327.35 Aligned_cols=271 Identities=18% Similarity=0.262 Sum_probs=200.2
Q ss_pred ccCHHHHHHhhhccc--cccccCCceEEEEEEeCCCcEEEEEEccccc----------cHHHHHHHHHHHHHHhccCCCc
Q 017591 15 RFTLEQLCSFTNNYS--TKLGAGGFGVVYKGQFPNGVKIAAKILKTCL----------NKRVEAQFMAEIGTIGRTYHIN 82 (369)
Q Consensus 15 ~~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~n 82 (369)
+....++....++|. +.||+|+||.||+|.+.+|..||+|++.... .......+.+|+.+++.++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 344667777777764 8999999999999999889999999886422 2234478999999999999999
Q ss_pred eeeEEeEEEeC-----CceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceE
Q 017591 83 LVRLYGFCYDQ-----TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANIL 157 (369)
Q Consensus 83 iv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nil 157 (369)
|+++++++... ...++||||+.+ +|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNIL 166 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEE
Confidence 99999998643 357999999985 8888887667789999999999999999999999 99999999999999
Q ss_pred ecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC
Q 017591 158 LDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD 237 (369)
Q Consensus 158 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~ 237 (369)
++.++.+||+|||++....... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~- 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ- 242 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9999999999999997543322 223356899999999887755789999999999999999999999975432110
Q ss_pred ccccchhHHhh-----------hchhhhhhhcC--CCC-----CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 238 WFPKQVWDEYE-----------KGELAAKVLGC--GIE-----ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 238 ~~~~~~~~~~~-----------~~~~~~~~~~~--~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..... ........... ..+ ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 --LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp --HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 000000000 00000000000 000 011223567899999999999999999999984
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=318.69 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=193.0
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccC--CCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTY--HINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||++.+.+++.||+|++... ........+.+|+.++..+. |+||+++++++.+.+..++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 3445789999999999999988999999998643 34456678999999999997 5999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+.+++|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+||+++. +.+||+|||++..........
T Consensus 109 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 109 CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 557799999954 4579999999999999999999999 99999999999999964 799999999998765433322
Q ss_pred ccccCCCCCCccccccccc----------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 183 STSGYRGTPGYSAPEFLLR----------NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~----------~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
......||+.|+|||.+.. ...++.++|||||||++|+|++|+.||....... ...
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---------~~~----- 249 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---------SKL----- 249 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---------HHH-----
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---------HHH-----
Confidence 2334568999999998764 1368899999999999999999999996433210 000
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
............+...+..+.+++.+||+.||.+||++.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 250 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 0111111111222233567899999999999999999999984
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=350.07 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=199.8
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.++||+|+||.||+|+++ +++.||||+++... .......+..|..++..+ +|++|+.+++++.+.+..+|||||
T Consensus 344 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~ 423 (674)
T 3pfq_A 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 423 (674)
T ss_dssp EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEEC
T ss_pred EEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeC
Confidence 34578999999999999875 58899999987532 222345678899999887 699999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|..++.. ...+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 424 ~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~-- 497 (674)
T 3pfq_A 424 VNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-- 497 (674)
T ss_dssp CCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--
T ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--
Confidence 999999999954 3579999999999999999999999 9999999999999999999999999999986432222
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......||+.|+|||++... .++.++|||||||++|||++|+.||...+.. .++.. +... ..
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-------~~~~~---------i~~~-~~ 559 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQS---------IMEH-NV 559 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH---------HHSS-CC
T ss_pred ccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHH-------HHHHH---------HHhC-CC
Confidence 23446799999999988765 7899999999999999999999999754321 11111 1111 12
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCh-----HHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPM-----SAVV 294 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~~v~ 294 (369)
..+...+..+.+|+.+||+.||.+||++ .+|.
T Consensus 560 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 560 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 2344567889999999999999999998 6665
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=325.89 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=198.1
Q ss_pred hhccccccccCCceEEEEEEeCCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.+.||+|+||.||+|.+.+ .+++|++.... .......+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred HeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 34456899999999999998854 48999886432 2222346778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC---C
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN---T 180 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~ 180 (369)
++++|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++ ++.++|+|||++....... .
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 9999999997666689999999999999999999999 9999999999999998 6799999999987653211 1
Q ss_pred ccccccCCCCCCccccccccc--------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 181 HDSTSGYRGTPGYSAPEFLLR--------NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~--------~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
........||..|+|||.+.. ...++.++|||||||++|+|++|+.||....... .......+.
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~- 259 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMGTGM- 259 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-------HHHHHHTTC-
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHhccCC-
Confidence 112233458999999998864 2357899999999999999999999997543221 011111110
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcCC
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEI 303 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~~ 303 (369)
.........+..+.+++.+||+.||.+||++.+|++.|+.....
T Consensus 260 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 260 -------KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp -------CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred -------CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 00111113456689999999999999999999999999987443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=323.04 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=198.9
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC-----CceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ-----TKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~ 100 (369)
.+.+.||+|+||.||+|.+. +|+.||+|++...........+.+|+.+++.++||||+++++++... ...++||
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence 34588999999999999885 58999999997655666677889999999999999999999988754 6789999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+.+ +|.+++.. ..+++..++.++.|++.||.|||+ +|++||||||+|||++.++.+||+|||++........
T Consensus 94 e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 94 ELMQT-DLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp CCCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred eccCc-cHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 99985 99999854 469999999999999999999999 9999999999999999999999999999987653221
Q ss_pred cc--------ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc-------c--cch
Q 017591 181 HD--------STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF-------P--KQV 243 (369)
Q Consensus 181 ~~--------~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~-------~--~~~ 243 (369)
.. ......||+.|+|||++..+..++.++|||||||++|+|++|+.||........... + ...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 11 122346899999999887656789999999999999999999999976542100000 0 000
Q ss_pred hHHhhhchhhhhhhc-CCCC-----CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 244 WDEYEKGELAAKVLG-CGIE-----ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 244 ~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+.............. ...+ ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000000 0000 011234577899999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=328.73 Aligned_cols=259 Identities=22% Similarity=0.267 Sum_probs=180.0
Q ss_pred cccccCCceEEEEEEeC---CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe--CCceEEEEeccC
Q 017591 30 TKLGAGGFGVVYKGQFP---NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD--QTKAALVYEFME 104 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 104 (369)
++||+|+||+||+|+++ +++.||+|++..... ...+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 58999999999999865 578999999875433 2367899999999999999999999965 568899999997
Q ss_pred CCCHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe----cCCCCeeEeecCCc
Q 017591 105 NGSLDKYLFTD--------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL----DAKFSAKVADFGLA 172 (369)
Q Consensus 105 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~ 172 (369)
+ +|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 6 888877421 2359999999999999999999999 999999999999999 67789999999999
Q ss_pred eecCCCCCc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc------------
Q 017591 173 KLCNPENTH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF------------ 239 (369)
Q Consensus 173 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~------------ 239 (369)
+........ .......||+.|+|||++.+...++.++|||||||++|+|++|+.||...........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 876533211 2233467899999999988755799999999999999999999999975543211000
Q ss_pred -----ccchhHHhhhc----hhhhhhhcCCCCCCC---------HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 240 -----PKQVWDEYEKG----ELAAKVLGCGIEEND---------REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 240 -----~~~~~~~~~~~----~~~~~~~~~~~~~~~---------~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....|..+... ............... ......+.+|+.+||+.||.+|||+.++++
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001111000 000000000000000 001456889999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=321.58 Aligned_cols=258 Identities=21% Similarity=0.224 Sum_probs=189.1
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC------ceE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT------KAA 97 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~ 97 (369)
+.+.+.||+|+||.||+|.+. +++.||+|++... ........+.+|+.+++.++||||+++++++...+ ..+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 344578999999999999874 5899999998643 34455677899999999999999999999997654 679
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||+++ +|.+++. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 107 lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 99999986 7888883 358999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEK 249 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~ 249 (369)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ .......+..+..
T Consensus 180 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 180 SF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp -------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred cc---ccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 22 12335689999999988774 789999999999999999999999976543110 0000000000000
Q ss_pred chhhhhh--------------h----cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 250 GELAAKV--------------L----GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 250 ~~~~~~~--------------~----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...... . ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus 256 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 256 -TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp -HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000 0 00000112234678999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=323.66 Aligned_cols=257 Identities=20% Similarity=0.259 Sum_probs=200.6
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccH----------------HHHHHHHHHHHHHhccCCCceeeEEeE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNK----------------RVEAQFMAEIGTIGRTYHINLVRLYGF 89 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 89 (369)
+.+.+.||+|+||.||+|.+ +++.||+|++...... .....+.+|+.++..++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34557899999999999999 9999999998743211 011689999999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHH------hccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC
Q 017591 90 CYDQTKAALVYEFMENGSLDKY------LFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF 162 (369)
Q Consensus 90 ~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 162 (369)
+.+.+..++||||+++++|.++ +... ...+++..++.++.|++.||.|||+ .+|++||||||+||+++.++
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNG 189 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTTS
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCCC
Confidence 9999999999999999999998 6332 5689999999999999999999996 27999999999999999999
Q ss_pred CeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCc-chhhHHHHHHHHHHHcCCCCCCCCCCCccCcccc
Q 017591 163 SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ-KCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPK 241 (369)
Q Consensus 163 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~-~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 241 (369)
.++|+|||++...... ......||..|+|||.+.....++. ++|||||||++|+|++|+.||.......
T Consensus 190 ~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------ 259 (348)
T 2pml_X 190 RVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV------ 259 (348)
T ss_dssp CEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH------
T ss_pred cEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH------
Confidence 9999999999876433 2234569999999998877534555 9999999999999999999997654311
Q ss_pred chhHHhhhchhhhhh---------hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 242 QVWDEYEKGELAAKV---------LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 242 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........+...... ............+..+.+|+.+||+.||.+||++.++++
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111100000 000000011345678999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=317.97 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=195.7
Q ss_pred cCHHHHHHhhhcc--ccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEE
Q 017591 16 FTLEQLCSFTNNY--STKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCY 91 (369)
Q Consensus 16 ~~~~el~~~t~~f--~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 91 (369)
+++.++....+.| .+.||+|+||.||+|.+ .+++.||+|++..... ....+.+|+.++.++ .||||+++++++.
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3444444445554 47899999999999988 4689999999864322 245788999999998 7999999999998
Q ss_pred e------CCceEEEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCe
Q 017591 92 D------QTKAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA 164 (369)
Q Consensus 92 ~------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 164 (369)
. .+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+ +|++|+||||+||+++.++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCE
Confidence 6 46789999999999999999654 3579999999999999999999999 999999999999999999999
Q ss_pred eEeecCCceecCCCCCccccccCCCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccc
Q 017591 165 KVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP 240 (369)
Q Consensus 165 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~ 240 (369)
||+|||++........ ......||+.|+|||.+.. +..++.++|||||||++|+|++|+.||........
T Consensus 169 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---- 242 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---- 242 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----
T ss_pred EEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH----
Confidence 9999999876543221 1233568999999998862 34689999999999999999999999964332100
Q ss_pred cchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... .............++..+.+++.+||..||.+||++.++++
T Consensus 243 ---~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 ---LFL--------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ---HHH--------HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHH--------hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 00111111122334678999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=329.80 Aligned_cols=255 Identities=23% Similarity=0.257 Sum_probs=190.7
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC------ceEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT------KAAL 98 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l 98 (369)
+.+.+.||+|+||.||+|++. +++.||||++.... ....+|+.+++.++|+||+++++++.... ..++
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 444578999999999999885 58999999886432 12447999999999999999999986421 3678
Q ss_pred EEeccCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC-CCeeEeecCCcee
Q 017591 99 VYEFMENGSLDKYLF---TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK-FSAKVADFGLAKL 174 (369)
Q Consensus 99 v~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~ 174 (369)
||||+++ +|.+.+. .....+++..++.++.|++.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999987 6666653 345789999999999999999999999 999999999999999965 5689999999987
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhc--hh
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKG--EL 252 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 252 (369)
...... .....||+.|+|||++.+...++.++|||||||++|||++|+.||........ + ..+.+..... +.
T Consensus 207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l-~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--L-VEIIKVLGTPTREQ 280 (420)
T ss_dssp CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCSCCHHH
T ss_pred cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHhCCCCHHH
Confidence 654332 22356899999999987655789999999999999999999999976442110 0 0000000000 00
Q ss_pred hhhhhc----CCCCC---------CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 253 AAKVLG----CGIEE---------NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 253 ~~~~~~----~~~~~---------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...... ...+. .....+..+.+|+.+||+.||.+||++.++++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000000 00000 11233578999999999999999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=323.30 Aligned_cols=258 Identities=19% Similarity=0.255 Sum_probs=181.0
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC------CceEE
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ------TKAAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l 98 (369)
.+.+.||+|+||.||+|.+ .+|+.||+|++... ........+.+|+.+++.++||||+++++++... ...++
T Consensus 32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 3457899999999999987 46899999998643 3445567888999999999999999999998754 56799
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
|||++ +++|.+++.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 112 v~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 112 VTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp EEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred Eeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 99999 6799998843 579999999999999999999999 99999999999999999999999999999865422
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhc
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKG 250 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~ 250 (369)
.....||..|+|||++.+...++.++|||||||++|+|++|+.||......... ......+..+...
T Consensus 186 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 186 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred -----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 233568999999999877557899999999999999999999999765431100 0000000000000
Q ss_pred hhhhhhhc-CCCCCCC-----HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 251 ELAAKVLG-CGIEEND-----REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 251 ~~~~~~~~-~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........ ...+... ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000 0001111 123467899999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=325.56 Aligned_cols=255 Identities=20% Similarity=0.243 Sum_probs=192.1
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC----------
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ---------- 93 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---------- 93 (369)
.+.+.+.||+|+||+||+|.+ .+|+.||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 344568999999999999987 5699999998864322 234799999999999999999998543
Q ss_pred ----------------------------CceEEEEeccCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHhhcc
Q 017591 94 ----------------------------TKAALVYEFMENGSLDKYLF---TDTEVLKWEKLLDIAIGTARGIAYLHEEC 142 (369)
Q Consensus 94 ----------------------------~~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~l~~~l~~LH~~~ 142 (369)
...++||||+++ +|.+.+. ..+..+++..++.++.|++.||.|||+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-- 159 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-- 159 (383)
T ss_dssp ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--
Confidence 337899999985 8877774 346789999999999999999999999
Q ss_pred CCCeEeecCCCCceEec-CCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHH
Q 017591 143 NQRIIHYDIKPANILLD-AKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEI 221 (369)
Q Consensus 143 ~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~el 221 (369)
+||+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+...++.++|||||||++|+|
T Consensus 160 -~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 160 -LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp -TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred -CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 9999999999999997 688999999999987654332 23356899999999887765789999999999999999
Q ss_pred HcCCCCCCCCCCCccCccccchhHHhhhc---hh-------hhhhhcCCCC-----CCCHHHHHHHHHHHHhccccCCCC
Q 017591 222 IGRRKNAQDCSSDTLDWFPKQVWDEYEKG---EL-------AAKVLGCGIE-----ENDREEAERMSMVALWCVQDCPEA 286 (369)
Q Consensus 222 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~-------~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~ 286 (369)
++|+.||........ + ..+....... .. .......... ..+...+..+.+|+.+||+.||.+
T Consensus 236 l~g~~pf~~~~~~~~--~-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQ--L-VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHSSCSSCCSSHHHH--H-HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HhCCCCCCCCChHHH--H-HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999976443210 0 0000000000 00 0000000000 012234567899999999999999
Q ss_pred CCChHHHH
Q 017591 287 RPPMSAVV 294 (369)
Q Consensus 287 RPs~~~v~ 294 (369)
|||+.+++
T Consensus 313 R~t~~e~l 320 (383)
T 3eb0_A 313 RINPYEAM 320 (383)
T ss_dssp SCCHHHHH
T ss_pred CCCHHHHh
Confidence 99999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=326.15 Aligned_cols=196 Identities=23% Similarity=0.311 Sum_probs=167.9
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhcc------CCCceeeEEeEEEeCCceE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT------YHINLVRLYGFCYDQTKAA 97 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~ 97 (369)
.+.+.++||+|+||+||+|.+. +++.||||++... ......+.+|+.++..+ .|+||+++++++...+..+
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 3455689999999999999875 5899999998753 33456677788887776 5779999999999999999
Q ss_pred EEEeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC--eeEeecCCcee
Q 017591 98 LVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS--AKVADFGLAKL 174 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~ 174 (369)
+||||+. ++|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++. +||+|||++..
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999997 59999886543 469999999999999999999999 99999999999999999987 99999999976
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCS 232 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~ 232 (369)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 252 ~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 252 EHQR-----VYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCC-----CCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCc-----ccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 5432 2235689999999998875 78999999999999999999999997654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=317.94 Aligned_cols=266 Identities=23% Similarity=0.304 Sum_probs=203.0
Q ss_pred HHHHHHhhhccccccccCCceEEEEEEe--CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCC------ceeeEEeE
Q 017591 18 LEQLCSFTNNYSTKLGAGGFGVVYKGQF--PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHI------NLVRLYGF 89 (369)
Q Consensus 18 ~~el~~~t~~f~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~ 89 (369)
.+++....+.+.+.||+|+||.||+|.+ .+++.||+|++... ......+.+|+.++..+.|+ ++++++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 3444455667778999999999999987 35899999998743 34456788899999888765 49999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC--------
Q 017591 90 CYDQTKAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-------- 160 (369)
Q Consensus 90 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------- 160 (369)
+.+.+..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999 789999996544 478999999999999999999999 99999999999999987
Q ss_pred -----------CCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 017591 161 -----------KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQ 229 (369)
Q Consensus 161 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~ 229 (369)
++.+||+|||++....... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 6689999999998754322 235689999999988764 78999999999999999999999997
Q ss_pred CCCCCcc--------CccccchhHHhhhchh-----------------hhhhhc--CCCCCCCHHHHHHHHHHHHhcccc
Q 017591 230 DCSSDTL--------DWFPKQVWDEYEKGEL-----------------AAKVLG--CGIEENDREEAERMSMVALWCVQD 282 (369)
Q Consensus 230 ~~~~~~~--------~~~~~~~~~~~~~~~~-----------------~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~ 282 (369)
....... ...+...+........ ...... ..........+..+.+|+.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 6543211 0001111000000000 000000 000122345678899999999999
Q ss_pred CCCCCCChHHHHH
Q 017591 283 CPEARPPMSAVVK 295 (369)
Q Consensus 283 ~p~~RPs~~~v~~ 295 (369)
||.+|||+.+|++
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 9999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=316.92 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=178.5
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHH-HHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIG-TIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.||+|+||.||+|.+. +++.||+|++..........++..|+. +++.+.||||+++++++.+.+..++||||+.
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 34578999999999999884 689999999976555555566667766 7777899999999999999999999999998
Q ss_pred CCCHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhccCC-CeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 105 NGSLDKYLFT----DTEVLKWEKLLDIAIGTARGIAYLHEECNQ-RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 105 ~gsL~~~l~~----~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
+ +|.+++.. ....+++..+..++.|++.||.|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 6 88887742 35689999999999999999999999 8 99999999999999999999999999997654322
Q ss_pred CccccccCCCCCCcccccccc---ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 180 THDSTSGYRGTPGYSAPEFLL---RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~---~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
. .....||+.|+|||++. .+..++.++|||||||++|+|++|+.||......... ......+..
T Consensus 181 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~~---- 247 (327)
T 3aln_A 181 A---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQVVKGDP---- 247 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC----
T ss_pred c---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHHHhcCCC----
Confidence 2 22346899999999884 2346899999999999999999999999754321100 000000000
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...........+..+.+|+.+||+.||.+||++.+|++
T Consensus 248 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 -PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00001112234677999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=328.23 Aligned_cols=259 Identities=20% Similarity=0.209 Sum_probs=191.7
Q ss_pred hhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc------eEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK------AAL 98 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~l 98 (369)
.+.+.++||+|+||+||+|++.++..+|+|.+..... ...+|+.+++.++||||+++++++..... .++
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 3455688999999999999997777788887754321 22379999999999999999999975443 789
Q ss_pred EEeccCCCCHHHHh--ccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec-CCCCeeEeecCCceec
Q 017591 99 VYEFMENGSLDKYL--FTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD-AKFSAKVADFGLAKLC 175 (369)
Q Consensus 99 v~e~~~~gsL~~~l--~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~ 175 (369)
||||++++.+.... ......+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 99999885443332 1345689999999999999999999999 9999999999999999 7899999999999876
Q ss_pred CCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHh
Q 017591 176 NPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEY 247 (369)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~ 247 (369)
...... ....+|+.|+|||++.+...++.++|||||||++|||++|+.||......... ......+...
T Consensus 193 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 193 IAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 443322 23568999999999877657999999999999999999999999765432100 0000000000
Q ss_pred hhchhhhhhhcCCCC-----CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 248 EKGELAAKVLGCGIE-----ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 248 ~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ............ ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 270 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 270 NP-NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CG-GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Ch-hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 000000000000 011124568999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=311.89 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=202.3
Q ss_pred HHHHHhhhccccccccCCceEEEEEEeC-CCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce
Q 017591 19 EQLCSFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 19 ~el~~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 96 (369)
.......+.+.++||+|+||.||+|.+. +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3344456667789999999999999885 68999999986432 223356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC---CCeeEeecCCce
Q 017591 97 ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK---FSAKVADFGLAK 173 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~ 173 (369)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ +|++|+||||+||+++.+ +.+||+|||++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999998843 3579999999999999999999999 999999999999999754 469999999987
Q ss_pred ecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhh
Q 017591 174 LCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELA 253 (369)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (369)
........ ....+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||...... ........+...
T Consensus 173 ~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~ 240 (287)
T 2wei_A 173 CFQQNTKM---KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYA 240 (287)
T ss_dssp TBCCCSSC---SCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC
T ss_pred eecCCCcc---ccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCC
Confidence 65433221 22358899999998765 4899999999999999999999999754321 111111111110
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 254 AKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.........+..+.+++.+||+.||.+||++.++++
T Consensus 241 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 ------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000111234677999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=319.93 Aligned_cols=256 Identities=20% Similarity=0.265 Sum_probs=192.9
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce------EEE
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA------ALV 99 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------~lv 99 (369)
+.+.||+|+||.||+|.+. +|+.||+|++... ........+.+|+.+++.++||||+++++++...+.. ++|
T Consensus 46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence 4478999999999999874 5899999998753 3445567889999999999999999999999877654 999
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
|||+.+ +|.+++ ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 126 ~e~~~~-~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 126 MPFMQT-DLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 197 (371)
T ss_dssp EECCCE-EHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred Eccccc-cHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence 999985 888887 3349999999999999999999999 99999999999999999999999999999865432
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhch
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGE 251 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~ 251 (369)
.....||+.|+|||++.+...++.++|||||||++|+|++|+.||......... ..+...+..+....
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 233568999999999887567899999999999999999999999754421100 00000000000000
Q ss_pred ---hhhhhhcCCCC---CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 ---LAAKVLGCGIE---ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ---~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........... ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000000000 001223678999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=321.49 Aligned_cols=243 Identities=21% Similarity=0.318 Sum_probs=196.7
Q ss_pred HHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccH-----HHHHHHHHHHHHHhccC--CCceeeEEeEEEeC
Q 017591 22 CSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNK-----RVEAQFMAEIGTIGRTY--HINLVRLYGFCYDQ 93 (369)
Q Consensus 22 ~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 93 (369)
....+.+.+.||+|+||.||+|.+ .+++.||+|++...... .....+.+|+.+++++. |+||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 334445568999999999999987 46899999998653211 12245678999999986 59999999999999
Q ss_pred CceEEEEeccCC-CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec-CCCCeeEeecCC
Q 017591 94 TKAALVYEFMEN-GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD-AKFSAKVADFGL 171 (369)
Q Consensus 94 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~ 171 (369)
+..++|||++.+ ++|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+|||++ .++.+||+|||+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999986 899999944 4679999999999999999999999 9999999999999999 778999999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
+....... .....||+.|+|||++......+.++|||||||++|+|++|+.||.... ....+.
T Consensus 197 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~~~~ 259 (320)
T 3a99_A 197 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ 259 (320)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC
T ss_pred cccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------hhhccc
Confidence 98765332 2235699999999988776455789999999999999999999985321 000000
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.......+..+.+|+.+||+.||.+||++.+|++
T Consensus 260 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112234567899999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.37 Aligned_cols=263 Identities=21% Similarity=0.249 Sum_probs=190.1
Q ss_pred hccccccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEE-------------
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY------------- 91 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~------------- 91 (369)
+...+.||+|+||.||+|.+.. ++.||+|++... .......+.+|+.+++.++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 3445789999999999998854 899999988753 3455678999999999999999999999874
Q ss_pred -eCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec-CCCCeeEeec
Q 017591 92 -DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD-AKFSAKVADF 169 (369)
Q Consensus 92 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Df 169 (369)
+....++||||++ |+|.+++. ...+++..++.++.|++.||+|||+ +|++||||||+||+++ .++.+||+||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 3467899999998 59999983 4579999999999999999999999 9999999999999997 5678999999
Q ss_pred CCceecCCCCCc-cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccc
Q 017591 170 GLAKLCNPENTH-DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFP 240 (369)
Q Consensus 170 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~ 240 (369)
|++......... .......+|..|+|||.+.....++.++|||||||++|+|++|+.||......... ...
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 999876432211 11233457899999998876557899999999999999999999999765431100 000
Q ss_pred cchhHHhhhc-h-hhhhhhcCCC---CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 241 KQVWDEYEKG-E-LAAKVLGCGI---EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 241 ~~~~~~~~~~-~-~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+...... . .......... .......+..+.+++.+||+.||.+||++.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000000 0 0000000000 0011234678999999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=318.94 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=183.4
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc-------eEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK-------AAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------~~l 98 (369)
.+.+.||+|+||.||+|.+. +++.||+|++.... .....+.+++..+..++||||+++++++..... .++
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp EEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 34589999999999999884 58999999875432 112356677888888999999999999976443 789
Q ss_pred EEeccCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHh--hccCCCeEeecCCCCceEecC-CCCeeEeecCCc
Q 017591 99 VYEFMENGSLDKYLF---TDTEVLKWEKLLDIAIGTARGIAYLH--EECNQRIIHYDIKPANILLDA-KFSAKVADFGLA 172 (369)
Q Consensus 99 v~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~l~~~l~~LH--~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~ 172 (369)
||||+++ +|...+. .....+++..++.++.|++.||.||| + +||+||||||+|||++. ++.+||+|||++
T Consensus 104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 9999987 5554442 35668999999999999999999999 8 99999999999999996 889999999999
Q ss_pred eecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchh
Q 017591 173 KLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVW 244 (369)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~ 244 (369)
........ .....||+.|+|||++.+...++.++|||||||++|+|++|+.||......... ..+...+
T Consensus 180 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 180 KKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp BCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 87654332 233568999999999877656899999999999999999999999765432110 0000001
Q ss_pred HHhhhchhhhhhhc-------CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 245 DEYEKGELAAKVLG-------CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 245 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+........... ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11100000000000 0011122235678999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=312.24 Aligned_cols=248 Identities=22% Similarity=0.316 Sum_probs=179.2
Q ss_pred cccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHH-HHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQ-FMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.+.||+|+||.||+|.+. +++.||+|++..........+ +.++..+++.++||||+++++++.+.+..++||||+ +
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 29 NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred ccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-C
Confidence 3578999999999999885 689999999876544333334 445556778889999999999999999999999999 5
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCC-CeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ-RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+.+..+.......+++..++.++.|++.||.|||+ + |++|+||||+||+++.++.+||+|||++........ .
T Consensus 108 ~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~ 181 (318)
T 2dyl_A 108 TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---K 181 (318)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---c
Confidence 56666665556789999999999999999999998 6 999999999999999999999999999976543222 2
Q ss_pred ccCCCCCCcccccccc----ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 185 SGYRGTPGYSAPEFLL----RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~----~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
....||+.|+|||.+. ....++.++|||||||++|+|++|+.||....... ........+. ..
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~-------~~ 248 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF------EVLTKVLQEE-------PP 248 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHHHHSC-------CC
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH------HHHHHHhccC-------CC
Confidence 2346899999999885 23468899999999999999999999997533210 0011111110 00
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........+..+.+++.+||+.||.+||++.+|++
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01111234577899999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=316.72 Aligned_cols=261 Identities=23% Similarity=0.278 Sum_probs=197.2
Q ss_pred HHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-----------CCceeeEEeE
Q 017591 22 CSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-----------HINLVRLYGF 89 (369)
Q Consensus 22 ~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~ 89 (369)
....+.+.+.||+|+||+||+|.+ .+++.||+|++... ......+.+|+.++.++. |+||++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 344566778999999999999987 46899999998743 334567888999988876 8899999999
Q ss_pred EEeCC----ceEEEEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCC-CeEeecCCCCceEec----
Q 017591 90 CYDQT----KAALVYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQ-RIIHYDIKPANILLD---- 159 (369)
Q Consensus 90 ~~~~~----~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dlkp~Nill~---- 159 (369)
+...+ ..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+ + ||+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEET
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCC
Confidence 98654 789999999 78999999653 4569999999999999999999999 8 999999999999994
Q ss_pred --CCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC
Q 017591 160 --AKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD 237 (369)
Q Consensus 160 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~ 237 (369)
..+.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 3447999999999876432 2234689999999988775 6899999999999999999999999865432110
Q ss_pred ccccc---hhHH--------hhhchhh---------------------hhhhcCCCCCCCHHHHHHHHHHHHhccccCCC
Q 017591 238 WFPKQ---VWDE--------YEKGELA---------------------AKVLGCGIEENDREEAERMSMVALWCVQDCPE 285 (369)
Q Consensus 238 ~~~~~---~~~~--------~~~~~~~---------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~ 285 (369)
..... +... +..+... ..... .....+...+..+.+|+.+||+.||.
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT-EKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH-HTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh-hcccCCcchHHHHHHHHHHHhccCcc
Confidence 00000 0000 0000000 00000 01234567889999999999999999
Q ss_pred CCCChHHHHH
Q 017591 286 ARPPMSAVVK 295 (369)
Q Consensus 286 ~RPs~~~v~~ 295 (369)
+|||+.+|++
T Consensus 324 ~Rpt~~ell~ 333 (373)
T 1q8y_A 324 KRADAGGLVN 333 (373)
T ss_dssp TCBCHHHHHT
T ss_pred ccCCHHHHhh
Confidence 9999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=315.39 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=190.9
Q ss_pred HHHHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccH-----HHHHHHHHHHHHHhcc----CCCceeeEEeE
Q 017591 20 QLCSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNK-----RVEAQFMAEIGTIGRT----YHINLVRLYGF 89 (369)
Q Consensus 20 el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~niv~~~~~ 89 (369)
+.....+.+.+.||+|+||.||+|.+ .+++.||+|++...... .....+.+|+.++.++ .|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44445566678999999999999987 46899999998653221 1233466789998888 89999999999
Q ss_pred EEeCCceEEEEec-cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec-CCCCeeEe
Q 017591 90 CYDQTKAALVYEF-MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD-AKFSAKVA 167 (369)
Q Consensus 90 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~ 167 (369)
+.+.+..++|||+ +.+++|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+||+++ .++.+||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEE
Confidence 9999999999999 789999999954 4569999999999999999999999 9999999999999999 88899999
Q ss_pred ecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHh
Q 017591 168 DFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEY 247 (369)
Q Consensus 168 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 247 (369)
|||++....... .....||..|+|||++......+.++|||||||++|+|++|+.||.... ..
T Consensus 183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------~~ 245 (312)
T 2iwi_A 183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------EI 245 (312)
T ss_dssp CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HH
T ss_pred EcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------HH
Confidence 999998765432 2335689999999988765445669999999999999999999985311 00
Q ss_pred hhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 248 EKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... ....+...+..+.+++.+||+.||.+||++.++++
T Consensus 246 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 LEA----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHT----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhh----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01122334567899999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=313.08 Aligned_cols=196 Identities=25% Similarity=0.311 Sum_probs=165.2
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CC-----ceeeEEeEEEeCCceEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HI-----NLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~lv 99 (369)
.+.++||+|+||+||+|.+. +++.||+|++... .....++..|+.++..+. |+ +++.+++++...+..++|
T Consensus 57 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 134 (382)
T 2vx3_A 57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV 134 (382)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence 34578999999999999875 5889999998743 344567778888888774 44 599999999999999999
Q ss_pred EeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec--CCCCeeEeecCCceecC
Q 017591 100 YEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD--AKFSAKVADFGLAKLCN 176 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~ 176 (369)
|||+.+ +|.+++.... ..+++..++.++.|++.||.|||.. ..||+||||||+|||++ .++.+||+|||++....
T Consensus 135 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 135 FEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp EECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 999975 9999996543 5699999999999999999999941 17999999999999994 47789999999998764
Q ss_pred CCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 017591 177 PENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCS 232 (369)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~ 232 (369)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 213 ~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 213 QR-----IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CC-----CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc-----cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 2235689999999988775 78999999999999999999999998654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=314.83 Aligned_cols=258 Identities=20% Similarity=0.253 Sum_probs=195.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc------eE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK------AA 97 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~ 97 (369)
+.+.+.||+|+||.||+|.+. +|+.||+|++... ........+.+|+.+++.++||||+++++++..... .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 344578999999999999874 5899999998653 344456788999999999999999999999987654 49
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||+.+ +|.+++. ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.....
T Consensus 106 lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 106 LVMPFMQT-DLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEEECCSE-EGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEeccccC-CHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 99999985 8888772 359999999999999999999999 9999999999999999999999999999976432
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEK 249 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~ 249 (369)
. .....+|+.|+|||.+.+...++.++|||||||++|+|++|+.||......... ..+...+..+..
T Consensus 179 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred C-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 2 223568999999998877557899999999999999999999999764421100 000000000000
Q ss_pred ch---hhhhhh---cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 250 GE---LAAKVL---GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 250 ~~---~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ...... ...........+..+.+|+.+||+.||.+||++.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000000 00111223345778999999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.89 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=193.6
Q ss_pred hccccccccCCceEEEEEEe--CCCcEEEEEEccccccH-HHHHHHHHHHHHHhcc---CCCceeeEEeEEE-----eCC
Q 017591 26 NNYSTKLGAGGFGVVYKGQF--PNGVKIAAKILKTCLNK-RVEAQFMAEIGTIGRT---YHINLVRLYGFCY-----DQT 94 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~~ 94 (369)
+.+.+.||+|+||.||+|.+ .+++.||+|++...... .....+.+|+.+++.+ .||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 34568999999999999988 35889999998643221 1123456677776665 8999999999987 456
Q ss_pred ceEEEEeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 95 KAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
..++||||+. |+|.+++.... ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 7899999998 59999996543 459999999999999999999999 999999999999999999999999999997
Q ss_pred ecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhh-----
Q 017591 174 LCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYE----- 248 (369)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 248 (369)
...... ......||..|+|||.+... .++.++|||||||++|+|++|+.||........ ...+.....
T Consensus 169 ~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 169 IYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEE 241 (326)
T ss_dssp CCCGGG---GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCGG
T ss_pred cccCCC---CccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCcc
Confidence 654221 22345689999999988765 689999999999999999999999975442110 000000000
Q ss_pred ---hc-hhhhhh----hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 249 ---KG-ELAAKV----LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 249 ---~~-~~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.. ...... ............+..+.+|+.+||+.||.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000000 000001122335677899999999999999999999983
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=315.50 Aligned_cols=268 Identities=20% Similarity=0.270 Sum_probs=201.2
Q ss_pred ccCHHHHHHhhhccccccccCCceEEEEEEeC-CC-cEEEEEEccccccHHHHHHHHHHHHHHhccCCCc------eeeE
Q 017591 15 RFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFP-NG-VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN------LVRL 86 (369)
Q Consensus 15 ~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~ 86 (369)
....++.....+.+.+.||+|+||+||+|.+. ++ ..||+|++... ......+.+|+.+++.+.|++ ++.+
T Consensus 10 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 34445555556677789999999999999874 34 78999998743 344567888999999887665 9999
Q ss_pred EeEEEeCCceEEEEeccCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEe-------
Q 017591 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILL------- 158 (369)
Q Consensus 87 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill------- 158 (369)
++++...+..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEE
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccc
Confidence 99999999999999999 557777765443 579999999999999999999999 999999999999999
Q ss_pred ------------cCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCC
Q 017591 159 ------------DAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRK 226 (369)
Q Consensus 159 ------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~ 226 (369)
+.++.+||+|||++....... ....||+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCC
Confidence 567899999999998754322 335699999999988764 78999999999999999999999
Q ss_pred CCCCCCCCcc--------CccccchhHHhhhchh-----------------hhhhhc--CCCCCCCHHHHHHHHHHHHhc
Q 017591 227 NAQDCSSDTL--------DWFPKQVWDEYEKGEL-----------------AAKVLG--CGIEENDREEAERMSMVALWC 279 (369)
Q Consensus 227 p~~~~~~~~~--------~~~~~~~~~~~~~~~~-----------------~~~~~~--~~~~~~~~~~~~~l~~l~~~c 279 (369)
||........ ...+...+........ ...... ..........+..+.+|+.+|
T Consensus 238 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 317 (355)
T 2eu9_A 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317 (355)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence 9976543210 0001111000000000 000000 000112334567899999999
Q ss_pred cccCCCCCCChHHHH
Q 017591 280 VQDCPEARPPMSAVV 294 (369)
Q Consensus 280 l~~~p~~RPs~~~v~ 294 (369)
|+.||.+|||+.+++
T Consensus 318 L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 318 LEFDPAQRITLAEAL 332 (355)
T ss_dssp TCSSTTTSCCHHHHT
T ss_pred hcCChhhCcCHHHHh
Confidence 999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=312.93 Aligned_cols=249 Identities=20% Similarity=0.240 Sum_probs=169.9
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe----CCceEEEEeccC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD----QTKAALVYEFME 104 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~ 104 (369)
+.||+|+||+||+|.+. +++.||+|++.... .... +....+..+.||||+++++++.. ....++||||++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 46999999999999885 69999999987531 1122 22233556689999999999876 445899999999
Q ss_pred CCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC---CCCeeEeecCCceecCCCCC
Q 017591 105 NGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA---KFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 105 ~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~ 180 (369)
+|+|.+++.... ..+++..++.++.|++.||.|||+ +|++||||||+|||++. ++.+||+|||++.......
T Consensus 110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~- 185 (336)
T 3fhr_A 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185 (336)
T ss_dssp TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-
Confidence 999999996543 479999999999999999999999 99999999999999976 4459999999998654322
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.....||+.|+|||++... .++.++|||||||++|+|++|+.||.......... ........+. ...
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~------~~~ 252 (336)
T 3fhr_A 186 ---LQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQ------YGF 252 (336)
T ss_dssp ---------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC------------------------------CC
T ss_pred ---cccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccc------ccc
Confidence 2235689999999988664 68899999999999999999999997554322100 0000000000 000
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH--HhcCC
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK--MLEGG 300 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~--~L~~~ 300 (369)
........+..+.+|+.+||+.||.+|||+.++++ +++..
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 11122345678999999999999999999999996 55543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=323.03 Aligned_cols=246 Identities=22% Similarity=0.258 Sum_probs=185.1
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
...+.||+|+||+||.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++||||+.+
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g 102 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA 102 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC
Confidence 33478999999997655556899999999864322 2356899999988 799999999999999999999999975
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-----CCCeeEeecCCceecCCCCC
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-----KFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~~~~ 180 (369)
+|.+++......+.+..++.++.|++.||.|||+ ++|+||||||+|||++. ...+||+|||+++.......
T Consensus 103 -~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 103 -TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp -EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred -CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 9999997666666667778999999999999999 99999999999999953 23578999999987653321
Q ss_pred -ccccccCCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 181 -HDSTSGYRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 181 -~~~~~~~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
........||+.|+|||++.. ...++.++|||||||++|||++ |..||........ ..... .
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--------~~~~~------~ 244 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--------NILLG------A 244 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--------HHHTT------C
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--------HHHhc------c
Confidence 122344679999999999874 2367889999999999999999 8888854322110 00000 0
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
...............+.+|+.+||+.||.+||++.+|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 245 CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 00001112234566788999999999999999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=319.56 Aligned_cols=247 Identities=23% Similarity=0.293 Sum_probs=184.4
Q ss_pred ccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 29 STKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
.+.||+|+||+||.+...+|+.||||++.... ...+.+|+.++.++ +||||+++++++.+.+..++||||+. |+
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 36799999999987766789999999986532 34577899999876 89999999999999999999999996 59
Q ss_pred HHHHhccCCCC------CCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC-------------CCeeEee
Q 017591 108 LDKYLFTDTEV------LKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK-------------FSAKVAD 168 (369)
Q Consensus 108 L~~~l~~~~~~------~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-------------~~~kl~D 168 (369)
|.+++...... ..+..++.++.|++.||.|||+ ++|+||||||+|||++.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 99999543221 1333567899999999999999 999999999999999754 4799999
Q ss_pred cCCceecCCCCCcc--ccccCCCCCCccccccccc------cCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCcc
Q 017591 169 FGLAKLCNPENTHD--STSGYRGTPGYSAPEFLLR------NYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWF 239 (369)
Q Consensus 169 fg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 239 (369)
||++.......... ......||+.|+|||++.+ ...++.++|||||||++|||++ |+.||.......
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---- 247 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---- 247 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----
Confidence 99999875433221 1234569999999998865 2468999999999999999999 899986432211
Q ss_pred ccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 240 PKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.....+.. .............+..+.+|+.+||+.||.+||++.+|++
T Consensus 248 -----~~i~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -----SNIIRGIF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -----HHHHHTCC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHhcCCC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00000000 0001112234567889999999999999999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=332.55 Aligned_cols=262 Identities=25% Similarity=0.269 Sum_probs=198.9
Q ss_pred hhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe------CCce
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD------QTKA 96 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~ 96 (369)
..+.+.++||+|+||+||+|.+ .+|+.||+|++...........+.+|+.++..++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 3456778999999999999987 45899999999876666777889999999999999999999998765 6678
Q ss_pred EEEEeccCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCC---eeEeecCC
Q 017591 97 ALVYEFMENGSLDKYLFTDT--EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFS---AKVADFGL 171 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~ 171 (369)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999996533 369999999999999999999999 99999999999999997765 89999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--Cccccc-----hh
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--DWFPKQ-----VW 244 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~-----~~ 244 (369)
+........ .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||........ ...... ..
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccc---cccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 987654332 2345799999999988764 789999999999999999999999975321100 000000 00
Q ss_pred HHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHH
Q 017591 245 DEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSA 292 (369)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~ 292 (369)
.....+..................+..+.+++.+||..||.+|||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000000000001112334557889999999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=337.08 Aligned_cols=244 Identities=21% Similarity=0.294 Sum_probs=196.4
Q ss_pred HHHHHhhhccccccccCCceEEEEEEeC--CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc-
Q 017591 19 EQLCSFTNNYSTKLGAGGFGVVYKGQFP--NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK- 95 (369)
Q Consensus 19 ~el~~~t~~f~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 95 (369)
+++....+.+.++||+|+||.||+|.+. +++.||||++...........+.+|+.++.+++||||+++++++.+.+.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 3444455666789999999999999885 5899999998765555667789999999999999999999999987665
Q ss_pred ----eEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCC
Q 017591 96 ----AALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 96 ----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
.++||||+++++|.+++.. .+++..++.|+.|++.||.|||+ +||+||||||+|||++.+ .+||+|||+
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999988732 79999999999999999999999 999999999999999986 899999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
++..... ....||+.|+|||++..+ .+.++|||||||++|+|++|..||........ +
T Consensus 228 a~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---~----------- 285 (681)
T 2pzi_A 228 VSRINSF------GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---P----------- 285 (681)
T ss_dssp CEETTCC------SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---C-----------
T ss_pred chhcccC------CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccccc---c-----------
Confidence 9876432 335699999999988764 48999999999999999999888754221110 0
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCC-hHHHHHHhcCC
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPP-MSAVVKMLEGG 300 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~v~~~L~~~ 300 (369)
...........+.+|+.+||+.||.+||+ +.++...|...
T Consensus 286 ---------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ---------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00011123467899999999999999996 55566666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=301.23 Aligned_cols=241 Identities=12% Similarity=0.053 Sum_probs=190.3
Q ss_pred cccCHHH-HHHhhhccccccccCCceEEEEEEeCC-CcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeE
Q 017591 14 VRFTLEQ-LCSFTNNYSTKLGAGGFGVVYKGQFPN-GVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGF 89 (369)
Q Consensus 14 ~~~~~~e-l~~~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 89 (369)
..+..++ +....+.+.+.||+|+||.||+|.+.. ++.||+|++.... .......+.+|+..+..++||||++++++
T Consensus 20 ~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~ 99 (286)
T 3uqc_A 20 VQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDV 99 (286)
T ss_dssp CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEE
Confidence 3455555 555667778999999999999998854 8999999997543 24556789999999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeec
Q 017591 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADF 169 (369)
Q Consensus 90 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 169 (369)
+.+.+..++||||+++++|.+++.. . ....++..++.|++.||.|||+ +||+||||||+|||++.++.+||+++
T Consensus 100 ~~~~~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 100 VHTRAGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp EEETTEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSC
T ss_pred EEECCcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEec
Confidence 9999999999999999999999932 2 4666789999999999999999 99999999999999999999999854
Q ss_pred CCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhh
Q 017591 170 GLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEK 249 (369)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (369)
+ |++ .++.++|||||||++|+|++|+.||............ ......
T Consensus 174 ~----------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~ 220 (286)
T 3uqc_A 174 A----------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAG 220 (286)
T ss_dssp C----------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTTS
T ss_pred c----------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhcc
Confidence 3 222 3689999999999999999999999876543211000 000000
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 250 GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
...... ......+..+.+|+.+||+.||.+| |+.++++.|+...
T Consensus 221 ~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 221 QPIEPA-------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CBCCHH-------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred CCCChh-------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000000 0112345678999999999999999 9999999998763
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=290.19 Aligned_cols=219 Identities=21% Similarity=0.262 Sum_probs=173.6
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHH-hccCCCceeeEEeEEEe----CCceEEEEecc
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTI-GRTYHINLVRLYGFCYD----QTKAALVYEFM 103 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 103 (369)
+.||+|+||.||++.+ .+++.||+|++... ..+.+|+.++ +...||||+++++++.+ ....++||||+
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 6799999999999988 46899999998642 3566788887 55689999999999986 66789999999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC---CCCeeEeecCCceecCCCC
Q 017591 104 ENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA---KFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 104 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 179 (369)
++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++. ++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 9999999996543 479999999999999999999999 99999999999999998 7889999999986532
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
+..++.++|||||||++|+|++|+.||........... ..... ...
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~---------~~~ 217 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRI---------RMG 217 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCCSS---------CTT
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHHHH---------hhc
Confidence 12567899999999999999999999975443211000 00000 000
Q ss_pred CCCCCC----HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 GIEEND----REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
. ...+ ...+..+.+++.+||+.||.+||++.++++
T Consensus 218 ~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 218 Q-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp C-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 0111 224677999999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=306.56 Aligned_cols=235 Identities=14% Similarity=0.122 Sum_probs=175.5
Q ss_pred ccccccCCceEEEEEEe-CCCcEEEEEEccccccH--HHHHHHHHHHHHHhccCC-Cce---------ee----------
Q 017591 29 STKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNK--RVEAQFMAEIGTIGRTYH-INL---------VR---------- 85 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h-~ni---------v~---------- 85 (369)
.+.||+|+||+||+|.+ .+|+.||||++...... .....+.+|+.++..+.| +|. +.
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 36799999999999986 46999999998743222 225678999999999976 211 11
Q ss_pred --EEeEEEe-----CCceEEEEeccCCCCHHHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCC
Q 017591 86 --LYGFCYD-----QTKAALVYEFMENGSLDKYLF------TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIK 152 (369)
Q Consensus 86 --~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlk 152 (369)
+..++.. ....+++|+++ +++|.+++. .....+++..++.++.|++.||.|||+ ++|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcc
Confidence 1111111 12457788876 469999883 234568899999999999999999999 999999999
Q ss_pred CCceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCcccccccc---------ccCCCCcchhhHHHHHHHHHHHc
Q 017591 153 PANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL---------RNYPITQKCDVYSFGMLLFEIIG 223 (369)
Q Consensus 153 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~s~~sDvwSlGvil~ellt 223 (369)
|+|||++.++.+||+|||+++..... .....| +.|+|||++. .+..++.++|||||||++|||++
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999865432 233567 9999999883 33468889999999999999999
Q ss_pred CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 224 RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 224 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
|+.||........ ........ . ..+..+.+|+.+||+.||.+||++.+++
T Consensus 313 g~~Pf~~~~~~~~----------------~~~~~~~~-~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 313 ADLPNTDDAALGG----------------SEWIFRSC-K----NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SSCCCCTTGGGSC----------------SGGGGSSC-C----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCCcchhhh----------------HHHHHhhc-c----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999975433211 00111100 1 2246799999999999999999987765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=295.78 Aligned_cols=240 Identities=14% Similarity=0.113 Sum_probs=180.8
Q ss_pred hhhccccccccCCceEEEEEEeCCCcEEEEEEccccc-------cHHHHHHHHHHHHHHhccC---------CCceeeEE
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL-------NKRVEAQFMAEIGTIGRTY---------HINLVRLY 87 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---------h~niv~~~ 87 (369)
..+.+.++||+|+||+||+|++ +|+.||+|++.... .......+.+|+.+++.++ |+||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 3445678999999999999998 78999999987542 1222356788888887775 77777777
Q ss_pred eEEE------------------------------eCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q 017591 88 GFCY------------------------------DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAY 137 (369)
Q Consensus 88 ~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~ 137 (369)
+++. +.+..++||||+++|++.+.+. ...+++..++.++.|++.||.|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHHHH
Confidence 7643 2678999999999997766662 2568999999999999999999
Q ss_pred Hh-hccCCCeEeecCCCCceEecCCC--------------------CeeEeecCCceecCCCCCccccccCCCCCCcccc
Q 017591 138 LH-EECNQRIIHYDIKPANILLDAKF--------------------SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAP 196 (369)
Q Consensus 138 LH-~~~~~~ivH~dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 196 (369)
|| + ++|+||||||+|||++.++ .+||+|||+++..... ...||+.|+||
T Consensus 177 lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP 246 (336)
T 2vuw_A 177 AEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE 246 (336)
T ss_dssp HHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred HHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence 99 8 9999999999999999887 8999999999876432 24699999999
Q ss_pred ccccccCCCCcchhhHHHHHH-HHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhc--CCCCCCCHHHHHHHH
Q 017591 197 EFLLRNYPITQKCDVYSFGML-LFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG--CGIEENDREEAERMS 273 (369)
Q Consensus 197 E~~~~~~~~s~~sDvwSlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~ 273 (369)
|++.+. . +.++||||||++ .+++++|..||.. ..|.......+...... ..........+..+.
T Consensus 247 E~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 247 DLFTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp GGGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred hhhcCC-C-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHhhhhhhccCcccchhhhhhcCHHHH
Confidence 988864 3 899999998777 7778888888731 01111111111111011 111122446788999
Q ss_pred HHHHhccccCCCCCCChHHHH
Q 017591 274 MVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 274 ~l~~~cl~~~p~~RPs~~~v~ 294 (369)
+|+.+||+.| |+.+++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-33 Score=276.31 Aligned_cols=186 Identities=18% Similarity=0.118 Sum_probs=130.4
Q ss_pred ccccCCceEEEEEEe-CCCcEEEEEEccccc---------cHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEE
Q 017591 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCL---------NKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (369)
..+.|++|.+..++. --|+.+++|++.... ......+|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 355666666655432 248889999986431 234456799999999999 699999999999999999999
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
|||++|++|.++|. ..++++.. +|+.||+.||+|+|+ +|||||||||+|||++.+|.+||+|||+++......
T Consensus 321 MEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999994 45667765 478999999999999 999999999999999999999999999998765432
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCC
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKN 227 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p 227 (369)
. ......||++|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 394 ~--~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 S--WPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C--CSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred c--cccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 2 2234579999999998875 467889999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=241.52 Aligned_cols=184 Identities=17% Similarity=0.195 Sum_probs=144.3
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccc-------cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCL-------NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.||+|+||.||++.. .+..+++|...... ......++.+|+.++++++||||+.+..++.+.+..++||||
T Consensus 342 ~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 342 HLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp ------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 5899999999999965 57788888754211 112245689999999999999999666666678888999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++++|.+++.. +..++.|+++||.|||+ ++|+||||||+|||++. .+||+|||+++.........
T Consensus 421 ~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 421 INGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 999999999943 67899999999999999 99999999999999999 99999999999875432111
Q ss_pred -----ccccCCCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHcCCCCC
Q 017591 183 -----STSGYRGTPGYSAPEFLLRN-YPITQKCDVYSFGMLLFEIIGRRKNA 228 (369)
Q Consensus 183 -----~~~~~~gt~~y~aPE~~~~~-~~~s~~sDvwSlGvil~elltg~~p~ 228 (369)
......||+.|+|||++... ..|+...|+|+..+-.++-+.++.++
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11345799999999998752 15788899999999988888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-25 Score=200.02 Aligned_cols=142 Identities=15% Similarity=0.102 Sum_probs=115.3
Q ss_pred ccccccCCceEEEEEEeCCCcEEEEEEccccccH-----------------HHHHHHHHHHHHHhccCCCceeeEEeEEE
Q 017591 29 STKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNK-----------------RVEAQFMAEIGTIGRTYHINLVRLYGFCY 91 (369)
Q Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 91 (369)
.+.||+|+||.||+|.+.+|+.||+|++...... .....+.+|+.+++.++ | +++.+++
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~- 170 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY- 170 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE-
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE-
Confidence 3789999999999999977999999998643211 23567899999999998 4 5666654
Q ss_pred eCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCC
Q 017591 92 DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 92 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
+.+..++||||++|++|.+ +.. .....++.|++.||.|||+ +||+||||||+|||++ ++.+||+|||+
T Consensus 171 ~~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 171 AWEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp EEETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 3456799999999999988 511 2345799999999999999 9999999999999999 99999999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccc
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 201 (369)
+.. +..+.|||++..
T Consensus 239 a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 239 SVE---------------VGEEGWREILER 253 (282)
T ss_dssp CEE---------------TTSTTHHHHHHH
T ss_pred CeE---------------CCCCCHHHHHHH
Confidence 863 345789997753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.6e-21 Score=169.28 Aligned_cols=135 Identities=20% Similarity=0.207 Sum_probs=105.9
Q ss_pred cccccccCCceEEEEEEe-CCCcE--EEEEEcccccc-----------------------HHHHHHHHHHHHHHhccCCC
Q 017591 28 YSTKLGAGGFGVVYKGQF-PNGVK--IAAKILKTCLN-----------------------KRVEAQFMAEIGTIGRTYHI 81 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~h~ 81 (369)
+.+.||+|+||.||+|.+ .+|+. ||||+++.... ......+.+|+..+..+.|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999988 67888 99998754311 11224688999999999877
Q ss_pred ce--eeEEeEEEeCCceEEEEeccCC-C----CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh-hccCCCeEeecCCC
Q 017591 82 NL--VRLYGFCYDQTKAALVYEFMEN-G----SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLH-EECNQRIIHYDIKP 153 (369)
Q Consensus 82 ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH-~~~~~~ivH~dlkp 153 (369)
++ ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.+|.||| + .||+||||||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~givHrDlkp 199 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQE---AELVHADLSE 199 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSCST
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCH
Confidence 53 444432 367899999942 3 67776522 235567899999999999999 8 9999999999
Q ss_pred CceEecCCCCeeEeecCCceec
Q 017591 154 ANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 154 ~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
+|||++. .++|+|||++...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2.9e-18 Score=158.70 Aligned_cols=135 Identities=13% Similarity=0.097 Sum_probs=98.6
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEcccccc----------------HH-----HHHHHHHHHHHHhccCCCce--
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLN----------------KR-----VEAQFMAEIGTIGRTYHINL-- 83 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------~~-----~~~~~~~E~~~l~~l~h~ni-- 83 (369)
.+..+||.|+||.||+|.+++|+.||||+++.... .. ......+|...+.++.+.++
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 34578999999999999999999999998753210 00 01112356677777654443
Q ss_pred eeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-
Q 017591 84 VRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF- 162 (369)
Q Consensus 84 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~- 162 (369)
...+++ ...+|||||++|++|.++.. ......++.|++.+|.+||+ .|||||||||.|||++.++
T Consensus 178 p~p~~~----~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 178 PEPIAQ----SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCEEEE----ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEEC
T ss_pred Ceeeec----cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCC
Confidence 222222 23479999999988876542 12345678999999999999 9999999999999998876
Q ss_pred ---------CeeEeecCCceec
Q 017591 163 ---------SAKVADFGLAKLC 175 (369)
Q Consensus 163 ---------~~kl~Dfg~~~~~ 175 (369)
.+.|+||+.+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.9e-12 Score=114.71 Aligned_cols=139 Identities=12% Similarity=0.003 Sum_probs=107.6
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+...++.|+.+.||++.. +++.+++|+...... .....+.+|+.+++.+. +..+.++++++.+.+..++||||++|
T Consensus 17 ~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 17 RCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp EEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred eeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 3456788888899999976 468999999874211 11236888999998884 67788999999888899999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc-------------------------------------------
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC------------------------------------------- 142 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~------------------------------------------- 142 (369)
.+|.+.+. +......++.+++++|..||+..
T Consensus 95 ~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 95 VLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp EEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred eehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 99987641 12233577889999999999821
Q ss_pred -------------CCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 143 -------------NQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 143 -------------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
+..++|||++|.||+++.++.+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=5e-12 Score=111.56 Aligned_cols=130 Identities=12% Similarity=0.014 Sum_probs=97.1
Q ss_pred ccc-cCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc--eeeEEeEEEeCCceEEEEeccCCCC
Q 017591 31 KLG-AGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN--LVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 31 ~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
.++ .|..+.||++...+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++++..+.+..++||||++|.+
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 344 56669999998777888999997643 1245778888888885444 5668888887778999999999988
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc---------------------------------------------
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC--------------------------------------------- 142 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~--------------------------------------------- 142 (369)
|. . . ..+ ...++.+++..|..||+..
T Consensus 102 l~--~-~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 102 LL--S-S---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp TT--T-S---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cC--c-C---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 84 2 1 112 2356778888888888732
Q ss_pred ----------CCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 143 ----------NQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 143 ----------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
+..++|+|++|.||+++.++.+.|+||+.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.28 E-value=2.4e-11 Score=112.71 Aligned_cols=141 Identities=18% Similarity=0.196 Sum_probs=106.3
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEcc--ccccHHHHHHHHHHHHHHhccC--CCceeeEEeEEEeC---CceEEEEec
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILK--TCLNKRVEAQFMAEIGTIGRTY--HINLVRLYGFCYDQ---TKAALVYEF 102 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e~ 102 (369)
+.|+.|.++.||+.... +..+++|+.. ..........+.+|+.+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 57899999999999875 4678888776 4322223457889999999886 45578889888766 348999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc----------------------------------------
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC---------------------------------------- 142 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~---------------------------------------- 142 (369)
++|..+.+.. -..++......++.+++..|..||+..
T Consensus 123 v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 123 VSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred cCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 9998774422 234788889999999999999999731
Q ss_pred ---------------CCCeEeecCCCCceEecCCCC--eeEeecCCcee
Q 017591 143 ---------------NQRIIHYDIKPANILLDAKFS--AKVADFGLAKL 174 (369)
Q Consensus 143 ---------------~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~ 174 (369)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=8.4e-11 Score=106.45 Aligned_cols=186 Identities=18% Similarity=0.173 Sum_probs=121.7
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCc--eeeEEeEEEeCC---ceEEEEecc
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HIN--LVRLYGFCYDQT---KAALVYEFM 103 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~ 103 (369)
+.++.|..+.||+.. ..+++|+.... .....+.+|+.+++.+. +.. +..++......+ ..++||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458899999999863 45888886532 34567889999998773 332 344554433332 358899999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc-----------------------------------------
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC----------------------------------------- 142 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~----------------------------------------- 142 (369)
+|.+|..... ..++..+...++.+++..|+.||+..
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988865432 34677888888999999999988621
Q ss_pred --------------CCCeEeecCCCCceEecC--CCCeeEeecCCceecCCCCCccccccCCCCCCccccccccc----c
Q 017591 143 --------------NQRIIHYDIKPANILLDA--KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR----N 202 (369)
Q Consensus 143 --------------~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~ 202 (369)
...++|+|++|.||+++. +..+.|+||+.+.......-.... .....-..|+.... .
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~---~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISL---MEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTT---CCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHH---HhhccccCHHHHHHHHHHc
Confidence 135899999999999998 456789999998764321100000 00000022221110 0
Q ss_pred CC---------CCcchhhHHHHHHHHHHHcCCCCC
Q 017591 203 YP---------ITQKCDVYSFGMLLFEIIGRRKNA 228 (369)
Q Consensus 203 ~~---------~s~~sDvwSlGvil~elltg~~p~ 228 (369)
.. .....+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 122368999999999999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3e-07 Score=83.06 Aligned_cols=135 Identities=18% Similarity=0.138 Sum_probs=95.5
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCC---ceeeEEeEEE-eCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHI---NLVRLYGFCY-DQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~ 105 (369)
+.++.|....||+. +..+++|+... ......+.+|+.++..+.+. .+.+++.+.. ..+..++||+|++|
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 45788888999998 56678887532 24456889999999988642 3566666664 34567899999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc-------------------------------------------
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC------------------------------------------- 142 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~------------------------------------------- 142 (369)
.+|..... ..++......++.+++..|+.||+..
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88876321 12355555666666666666666421
Q ss_pred --------------CCCeEeecCCCCceEecC---CCC-eeEeecCCcee
Q 017591 143 --------------NQRIIHYDIKPANILLDA---KFS-AKVADFGLAKL 174 (369)
Q Consensus 143 --------------~~~ivH~dlkp~Nill~~---~~~-~kl~Dfg~~~~ 174 (369)
...++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 235699999999999987 455 48999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.4e-07 Score=81.89 Aligned_cols=135 Identities=17% Similarity=0.092 Sum_probs=96.9
Q ss_pred ccccCCce-EEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 31 KLGAGGFG-VVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 31 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
.+..|..| .||+.... ++..+++|+... .....+.+|...++.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 44445554 68988764 467788998653 23457888999888774 3346788888988999999999999988
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc---------------------------------------------
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC--------------------------------------------- 142 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~--------------------------------------------- 142 (369)
+.+..... ......+..+++..|..||+..
T Consensus 107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 87765221 1233456666777777777521
Q ss_pred ----------CCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 143 ----------NQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 143 ----------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
...++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01279999999999999877677999997753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.4e-07 Score=87.09 Aligned_cols=80 Identities=8% Similarity=-0.033 Sum_probs=54.2
Q ss_pred ccc-ccCCceEEEEEEeC-------CCcEEEEEEcccccc--HHHHHHHHHHHHHHhccC-C--CceeeEEeEEEeC---
Q 017591 30 TKL-GAGGFGVVYKGQFP-------NGVKIAAKILKTCLN--KRVEAQFMAEIGTIGRTY-H--INLVRLYGFCYDQ--- 93 (369)
Q Consensus 30 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~--- 93 (369)
+.| +.|..+.+|+.... +++.+++|+...... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 88888999998764 267888998654320 000135677888877774 2 3467788777655
Q ss_pred CceEEEEeccCCCCHH
Q 017591 94 TKAALVYEFMENGSLD 109 (369)
Q Consensus 94 ~~~~lv~e~~~~gsL~ 109 (369)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.8e-06 Score=79.53 Aligned_cols=75 Identities=15% Similarity=0.069 Sum_probs=48.2
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEcccccc---H---HHHHHHHHHHHHHhccCC--C-ceeeEEeEEEeCCceEEE
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLN---K---RVEAQFMAEIGTIGRTYH--I-NLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~---~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~lv 99 (369)
+.||.|..+.||++... +++.+++|....... . ....++..|..++..+.. + .+.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 47899999999999764 468899997653211 0 112346678888876632 3 34556643 45567899
Q ss_pred EeccCCC
Q 017591 100 YEFMENG 106 (369)
Q Consensus 100 ~e~~~~g 106 (369)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=8.7e-06 Score=74.23 Aligned_cols=137 Identities=16% Similarity=0.152 Sum_probs=77.0
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-----CCceeeEE-e--EEEeCCceEEEEec
Q 017591 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-----HINLVRLY-G--FCYDQTKAALVYEF 102 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e~ 102 (369)
.|+.|..+.||+....+| .+++|+.... . ..+..|+.++..+. .|.++... + +....+..+++|+|
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP--E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC--H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC--H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 466677899999987554 5888888752 1 22334444444332 34443311 1 12345678999999
Q ss_pred cCCCCHH-----------HHh---cc--CCC--C---------CCHHHH-------------------------------
Q 017591 103 MENGSLD-----------KYL---FT--DTE--V---------LKWEKL------------------------------- 124 (369)
Q Consensus 103 ~~~gsL~-----------~~l---~~--~~~--~---------~~~~~~------------------------------- 124 (369)
++|..+. ..+ +. ... + ..|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 111 11 100 0 122211
Q ss_pred HHHHHHHHHHHHHHhh----------ccCCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 125 LDIAIGTARGIAYLHE----------ECNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 125 ~~i~~~l~~~l~~LH~----------~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
..+...+..++.+|++ ..+..++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223345666653 124789999999999999888899999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.7e-05 Score=71.55 Aligned_cols=135 Identities=17% Similarity=0.162 Sum_probs=89.6
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccC---CCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY---HINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.|+.|....+|+... ++..+++|+.... ....+..|+..++.+. ...+.+++.+....+..++||||+++.
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 4689999999999986 5678888986642 2456788988888774 356888888888788899999999987
Q ss_pred CHH--------HHh---ccCCC---------------------CCCHHHHHH---HH----------------HHHHHHH
Q 017591 107 SLD--------KYL---FTDTE---------------------VLKWEKLLD---IA----------------IGTARGI 135 (369)
Q Consensus 107 sL~--------~~l---~~~~~---------------------~~~~~~~~~---i~----------------~~l~~~l 135 (369)
.+. ..+ +.... .-+|..... +. ..++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 652 111 11111 013443210 11 1122222
Q ss_pred -HHHhh-ccCCCeEeecCCCCceEecCCCCeeEeecC
Q 017591 136 -AYLHE-ECNQRIIHYDIKPANILLDAKFSAKVADFG 170 (369)
Q Consensus 136 -~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 170 (369)
..|.. .....++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1236799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.8e-05 Score=72.34 Aligned_cols=78 Identities=12% Similarity=0.048 Sum_probs=47.6
Q ss_pred CCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccccCC--CCCCccccccccccC--CCCcchhhHHHHHHH
Q 017591 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYR--GTPGYSAPEFLLRNY--PITQKCDVYSFGMLL 218 (369)
Q Consensus 143 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~--~~s~~sDvwSlGvil 218 (369)
...++|||++|.|||++.++ ++++||+.+..-.... .-.... -...|++|+...... ......++..+...+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 37899999999999998876 9999999887532110 000000 112456665443110 112345566778888
Q ss_pred HHHHcC
Q 017591 219 FEIIGR 224 (369)
Q Consensus 219 ~elltg 224 (369)
|+.+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.98 E-value=3.3e-05 Score=64.88 Aligned_cols=101 Identities=13% Similarity=0.098 Sum_probs=68.3
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
..+|.+.|...+.+++++++|.++.|.+.+|.-+-.. +.-..+=+-|..|++..+|.|.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 3589999988899999999999999999998776210 1111223346899999999888774 2111
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGR 224 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg 224 (369)
.....+.+||.... ..+.+.=|||||+++|.-+--
T Consensus 98 ---~~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ---AGEPPPVAGKLGYS--QCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ------------CCSSS--SSCHHHHHHHHHHHHHHHHTT
T ss_pred ---ccccCCCChhhccc--cchHHHHHHHHHHHHHHHhhc
Confidence 12335678886542 568899999999999988843
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.77 E-value=8.1e-05 Score=66.25 Aligned_cols=74 Identities=15% Similarity=0.187 Sum_probs=52.7
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCC---CceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH---INLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.+|.|..+.||+.+..+|+.+++|+...... .....|..|+..|+.+.. --+.+++++. ..++||||++++
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~ 95 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER 95 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence 56899999999999998999999998654322 112357789888887742 2245555432 358999999876
Q ss_pred CH
Q 017591 107 SL 108 (369)
Q Consensus 107 sL 108 (369)
..
T Consensus 96 ~~ 97 (288)
T 3f7w_A 96 PP 97 (288)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.77 E-value=6.7e-05 Score=67.79 Aligned_cols=156 Identities=16% Similarity=0.163 Sum_probs=84.5
Q ss_pred cccCHHHHHHhhhccc-------cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc--ee
Q 017591 14 VRFTLEQLCSFTNNYS-------TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN--LV 84 (369)
Q Consensus 14 ~~~~~~el~~~t~~f~-------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv 84 (369)
..++..+|...-..|. +.|+.|....+|+....+| .+++|+...... ...+..|+.++..+.... +.
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCC
Confidence 3456666665554432 3467788899999987555 677888765211 224455666665553211 22
Q ss_pred eEEe------EEEeCCceEEEEeccCCCCHHH-----------H---hccC--C--CC----CC---HHHHHHH------
Q 017591 85 RLYG------FCYDQTKAALVYEFMENGSLDK-----------Y---LFTD--T--EV----LK---WEKLLDI------ 127 (369)
Q Consensus 85 ~~~~------~~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~--~--~~----~~---~~~~~~i------ 127 (369)
+++. +....+..+++|+|++|..+.. . ++.. . .+ .. |...+.-
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 2221 1123456789999999865321 0 1110 0 00 11 2211100
Q ss_pred ------HHHHHHHHHHHhhc----cCCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 128 ------AIGTARGIAYLHEE----CNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 128 ------~~~l~~~l~~LH~~----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
...+...+..+++. .+.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01133445555532 13579999999999999887656899998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.72 E-value=7.7e-05 Score=66.85 Aligned_cols=135 Identities=11% Similarity=0.080 Sum_probs=73.6
Q ss_pred cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCce-eeEEeEEEeCCceEEEEecc-CCCC
Q 017591 30 TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL-VRLYGFCYDQTKAALVYEFM-ENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gs 107 (369)
+.|+.|..+.+|+. +.+++|+...... ......+|+.++..+....+ .+++++ +.+..++|+||+ +|.+
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eEcCCcccccccee-----eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 56888999999998 5578887764311 11223457766666542222 455543 455568999999 6654
Q ss_pred HHHH--------h----------ccCCCC----CC-HHHHHHHHHH--------------HHHHHHHHh----h-ccCCC
Q 017591 108 LDKY--------L----------FTDTEV----LK-WEKLLDIAIG--------------TARGIAYLH----E-ECNQR 145 (369)
Q Consensus 108 L~~~--------l----------~~~~~~----~~-~~~~~~i~~~--------------l~~~l~~LH----~-~~~~~ 145 (369)
|... . +..... ++ +..+..+... +...+..+. . ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4310 0 111110 11 1111111111 111111111 0 11245
Q ss_pred eEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 146 IIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 146 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5566889999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00014 Score=66.03 Aligned_cols=140 Identities=18% Similarity=0.102 Sum_probs=72.1
Q ss_pred cccccCCceE-EEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCC--CceeeEEeEEEeCCceEEEEeccCCC
Q 017591 30 TKLGAGGFGV-VYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH--INLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 30 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
+.|+.|.... +|+....+++.+++|....... ..+..|+.++..+.. -.+.+++.+.. ...+++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCc
Confidence 3465554444 6677654467788876543210 233445555555532 23456666532 3337899999876
Q ss_pred CHHHHhccC-------------------------CCCCCHHHHH-------HHH-------------HHHHHHHHHHh--
Q 017591 107 SLDKYLFTD-------------------------TEVLKWEKLL-------DIA-------------IGTARGIAYLH-- 139 (369)
Q Consensus 107 sL~~~l~~~-------------------------~~~~~~~~~~-------~i~-------------~~l~~~l~~LH-- 139 (369)
.+.+++... -..++..... .+. ..+...+..+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 665433110 0112221110 000 01111222221
Q ss_pred -hccCCCeEeecCCCCceEecCC----CCeeEeecCCceec
Q 017591 140 -EECNQRIIHYDIKPANILLDAK----FSAKVADFGLAKLC 175 (369)
Q Consensus 140 -~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~~ 175 (369)
......++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123689999999999999874 67899999988753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00018 Score=66.61 Aligned_cols=139 Identities=14% Similarity=0.176 Sum_probs=83.0
Q ss_pred cccccCCceEEEEEEeCC--------CcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEE
Q 017591 30 TKLGAGGFGVVYKGQFPN--------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 100 (369)
+.|..|-...+|++..++ ++.+++|+.-... .....+.+|..+++.+. +.-..++++++.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 457778888999998752 5789999864321 12345668888888774 2223566665532 3999
Q ss_pred eccCCCCHHHH----------h-------ccC----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 017591 101 EFMENGSLDKY----------L-------FTD----TEVLK--WEKLLDIAIGTAR-------------------GIAYL 138 (369)
Q Consensus 101 e~~~~gsL~~~----------l-------~~~----~~~~~--~~~~~~i~~~l~~-------------------~l~~L 138 (369)
||++|.+|..- + +.. ..... +.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998655311 0 111 11222 4566666654422 23333
Q ss_pred hh-----ccCCCeEeecCCCCceEecCC----CCeeEeecCCcee
Q 017591 139 HE-----ECNQRIIHYDIKPANILLDAK----FSAKVADFGLAKL 174 (369)
Q Consensus 139 H~-----~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~ 174 (369)
.+ ..+..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 123569999999999999876 6899999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00025 Score=66.88 Aligned_cols=72 Identities=15% Similarity=0.235 Sum_probs=48.2
Q ss_pred cccccCCceEEEEEEeCC--------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCce-eeEEeEEEeCCceEEEE
Q 017591 30 TKLGAGGFGVVYKGQFPN--------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL-VRLYGFCYDQTKAALVY 100 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 100 (369)
+.|+.|....+|++..++ ++.+++|+...... ...+.+|+.++..+...++ .++++.+. + .+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 467888889999998753 57899998743111 1345578888887753333 56666543 2 4899
Q ss_pred eccCCCCH
Q 017591 101 EFMENGSL 108 (369)
Q Consensus 101 e~~~~gsL 108 (369)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0005 Score=62.14 Aligned_cols=156 Identities=15% Similarity=0.082 Sum_probs=86.7
Q ss_pred cccCHHHHHHhhhccc-------cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc--ee
Q 017591 14 VRFTLEQLCSFTNNYS-------TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN--LV 84 (369)
Q Consensus 14 ~~~~~~el~~~t~~f~-------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv 84 (369)
..++..+|..+-..+. ..++ |....||+....+|+.+++|+...... ....+..|..++..+.... ++
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeec
Confidence 4456666655544331 2356 778899998776777899999863211 1235556777766653212 33
Q ss_pred eEEeE-----EEeCCceEEEEeccCCCCHH-----H------Hh---cc--C------CCCCCHHHH----HHHH-----
Q 017591 85 RLYGF-----CYDQTKAALVYEFMENGSLD-----K------YL---FT--D------TEVLKWEKL----LDIA----- 128 (369)
Q Consensus 85 ~~~~~-----~~~~~~~~lv~e~~~~gsL~-----~------~l---~~--~------~~~~~~~~~----~~i~----- 128 (369)
+++.. ....+..+++|++++|..+. . .+ +. . ....++... ..++
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 165 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 165 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence 33332 12345567899999885432 1 11 10 0 011222211 0011
Q ss_pred ----------HHHHHHHHHHhhc----cCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 129 ----------IGTARGIAYLHEE----CNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 129 ----------~~l~~~l~~LH~~----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
..+-..+..+.+. .+..++|||+++.||+++ + .+.|+||+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1111122333221 236789999999999999 4 899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00045 Score=63.69 Aligned_cols=73 Identities=8% Similarity=0.121 Sum_probs=43.3
Q ss_pred cccccCCceEEEEEEeCC---------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc-eeeEEeEEEeCCceEEE
Q 017591 30 TKLGAGGFGVVYKGQFPN---------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN-LVRLYGFCYDQTKAALV 99 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv 99 (369)
+.|+.|....+|+....+ ++.+++|+....... ..+...|..++..+...+ ..++++.. . .++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 467788889999998754 268889987643211 112356777777664333 34566543 2 4789
Q ss_pred EeccCCCCH
Q 017591 100 YEFMENGSL 108 (369)
Q Consensus 100 ~e~~~~gsL 108 (369)
|+|++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0007 Score=64.31 Aligned_cols=73 Identities=16% Similarity=0.161 Sum_probs=46.8
Q ss_pred cccccCCceEEEEEEeCC-CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCce-eeEEeEEEeCCceEEEEeccCCCC
Q 017591 30 TKLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL-VRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
+.|+.|-...+|++...+ +..+++|+....... ..+..+|..++..+...++ .++++++ .+ .+||||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 468888889999998855 478889886532210 1122578888888764444 5677665 22 46999999855
Q ss_pred H
Q 017591 108 L 108 (369)
Q Consensus 108 L 108 (369)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0013 Score=59.85 Aligned_cols=31 Identities=26% Similarity=0.346 Sum_probs=28.0
Q ss_pred CCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 144 QRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 144 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5799999999999999888899999988765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.011 Score=55.26 Aligned_cols=138 Identities=12% Similarity=0.135 Sum_probs=82.8
Q ss_pred cccccCCceEEEEEEeCC--------CcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEE
Q 017591 30 TKLGAGGFGVVYKGQFPN--------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 100 (369)
+.+..|-...+|+....+ ++.+++++..... ....+..+|..+++.+. +.-..++++.+ . .++||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 457778888999998753 5889999865422 11123456777777664 22234555433 2 37899
Q ss_pred eccCCCCHHH-------H-------h---cc----C-------C-CCCCHHHHHHHHHHHH-------------------
Q 017591 101 EFMENGSLDK-------Y-------L---FT----D-------T-EVLKWEKLLDIAIGTA------------------- 132 (369)
Q Consensus 101 e~~~~gsL~~-------~-------l---~~----~-------~-~~~~~~~~~~i~~~l~------------------- 132 (369)
+|++|.+|.. . + +. . . .+.-+.++..+..++-
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865421 0 0 00 0 1 1112455555543322
Q ss_pred HHHHHHhh---------------------ccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 133 RGIAYLHE---------------------ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 133 ~~l~~LH~---------------------~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
..+..|.+ ..+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11346899999999999 7788899999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.37 E-value=0.0041 Score=58.01 Aligned_cols=29 Identities=31% Similarity=0.428 Sum_probs=24.5
Q ss_pred eEeecCCCCceEe------cCCCCeeEeecCCcee
Q 017591 146 IIHYDIKPANILL------DAKFSAKVADFGLAKL 174 (369)
Q Consensus 146 ivH~dlkp~Nill------~~~~~~kl~Dfg~~~~ 174 (369)
++|+|+.+.||++ +.+..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4466799999988753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.12 E-value=0.69 Score=38.59 Aligned_cols=115 Identities=8% Similarity=0.129 Sum_probs=80.6
Q ss_pred CCCceeeEEeEEEeCCceEEEEeccC-CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceE
Q 017591 79 YHINLVRLYGFCYDQTKAALVYEFME-NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANIL 157 (369)
Q Consensus 79 ~h~niv~~~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nil 157 (369)
.||+++.. .+-.+.+...+.++.-+ +-++.. + ..++...++.++.+|+....+++ .-+|--|.|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence 58888876 56666676667676544 223333 2 46788999999999998775554 3588899999999
Q ss_pred ecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 017591 158 LDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQ 229 (369)
Q Consensus 158 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~ 229 (369)
++.++.+++.-.|+-.. ++|. ..+...=.-.+=+++..+++++..|.
T Consensus 112 f~~~~~p~i~~RGik~~-------------------l~P~------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNV-------------------VDPL------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTT-------------------BSCC------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccC-------------------CCCC------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999998775321 1222 12233334457889999999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.05 E-value=0.86 Score=38.15 Aligned_cols=114 Identities=7% Similarity=0.066 Sum_probs=78.9
Q ss_pred CCCceeeEEeEEEeCCceEEEEeccCCC-CHHHHhccCCCCCCHHHHHHHHHHHHHHHH-HHhhccCCCeEeecCCCCce
Q 017591 79 YHINLVRLYGFCYDQTKAALVYEFMENG-SLDKYLFTDTEVLKWEKLLDIAIGTARGIA-YLHEECNQRIIHYDIKPANI 156 (369)
Q Consensus 79 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~-~LH~~~~~~ivH~dlkp~Ni 156 (369)
.||++ -..+-.+++...+.++.-+++ ++. .+ ..++...+++++.+++.... +++ .-+|--|.|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence 47888 344446777777878775433 443 33 36788999999999888666 444 468889999999
Q ss_pred EecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 017591 157 LLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQ 229 (369)
Q Consensus 157 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~ 229 (369)
+++.++.+++.-.|+-. -++|. ..+...=+-++=+++..++.++..|.
T Consensus 116 ~f~~~~~p~i~hRGi~~-------------------~lpP~------e~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKE-------------------SLPPD------EWDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETT-------------------TBSSC------SCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcc-------------------cCCCC------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999877532 22333 12222233457788899998887664
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.10 E-value=0.062 Score=50.92 Aligned_cols=62 Identities=3% Similarity=0.011 Sum_probs=18.7
Q ss_pred ccccccccCCceEEEEEEeCC-CcEEEE------EEccc-cccHHHHHHHHHHHHHHhccCCCceeeEEeEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-GVKIAA------KILKT-CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCY 91 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 91 (369)
.+.++|| ||.||+|.+.. ..+||+ |..+. ....+....+.+|..++..++|+|+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4456786 99999998843 357777 65553 223333456888999999999999999988775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 369 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-71 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 4e-71
Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 20/271 (7%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
++G+G FG VYKG++ V A K+L T + F E+G + +T H+N++ G+
Sbjct: 15 RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ A+V ++ E SL +L + KL+DIA TA+G+ YLH + IIH
Sbjct: 73 S-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL--RNYPITQ 207
D+K NI L + K+ DFGLA + + + G+ + APE + P +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 208 KCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE 267
+ DVY+FG++L+E++ + + ++ D V Y +L+ C
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDLSKVRSNC-------- 238
Query: 268 EAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ M + C++ + RP ++ +E
Sbjct: 239 -PKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-63
Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 22/268 (8%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
++G+G FG+V+ G + N K+A K ++ E F+ E + + H LV+LYG C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
+Q LV+EFME+G L YL T + E LL + + G + +IH D
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACVIHRD 126
Query: 151 IKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCD 210
+ N L+ KV+DFG+ + + ++G + +++PE + + K D
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFS-RYSSKSD 184
Query: 211 VYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAE 270
V+SFG+L++E+ K ++ E+ + R +
Sbjct: 185 VWSFGVLMWEVFSEG---------------KIPYENRSNSEVVEDISTGFRLYKPRLAST 229
Query: 271 RMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ + C ++ PE RP S +++ L
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 4e-63
Identities = 63/268 (23%), Positives = 119/268 (44%), Gaps = 22/268 (8%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+LG G FGVV G++ +A K++K E +F+ E + H LV+LYG C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYD 150
Q ++ E+M NG L YL + ++LL++ + YL +++ +H D
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 125
Query: 151 IKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCD 210
+ N L++ + KV+DFGL++ + S+ G + +S PE L+ + + K D
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS-KFSSKSD 183
Query: 211 VYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAE 270
+++FG+L++EI K ++ + E A + +E
Sbjct: 184 IWAFGVLMWEIYSLG---------------KMPYERFTNSETAEHIAQGLRLYRPHLASE 228
Query: 271 RMSMVALWCVQDCPEARPPMSAVVKMLE 298
++ + C + + RP ++ +
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-62
Identities = 69/290 (23%), Positives = 118/290 (40%), Gaps = 28/290 (9%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+G G FG V++G++ G ++A KI + + AEI H N++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 91 YDQ----TKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC---- 142
T+ LV ++ E+GSL YL + + E ++ +A+ TA G+A+LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 143 -NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP--ENTHDSTSGYRGTPGYSAPEFL 199
I H D+K NIL+ + +AD GLA + + + + GT Y APE L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 200 -----LRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254
++++ ++ D+Y+ G++ +EI R D + V + E+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 255 KVLGCGI------EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
V + E M+ + C AR + K L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (507), Expect = 3e-62
Identities = 67/301 (22%), Positives = 124/301 (41%), Gaps = 37/301 (12%)
Query: 16 FTLEQLCSFTNNYST-----------KLGAGGFGVVYKGQFP----NGVKIAAKILKTCL 60
FT E ++ +GAG FG V G + +A K LK+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 61 NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLK 120
++ F++E +G+ H N++ L G T ++ EFMENGSLD +L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 121 WEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180
+L+ + G A G+ YL + +H D+ NIL+++ KV+DFGL++ + +
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 181 HD---STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD 237
S G + ++APE ++ T DV+S+G++++E++ +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEA-IQYRKFTSASDVWSYGIVMWEVMSYGERP--------- 233
Query: 238 WFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKML 297
+ + ++ + + + + L C Q RP +V L
Sbjct: 234 ------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 298 E 298
+
Sbjct: 288 D 288
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-60
Identities = 82/269 (30%), Positives = 125/269 (46%), Gaps = 24/269 (8%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+LGAG FG V+ G + K+A K LK F+AE + + H LVRLY
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDTEV-LKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ ++ E+MENGSL +L T + + L KLLD+A A G+A++ E IH
Sbjct: 78 TQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D++ ANIL+ S K+ADFGLA+L +N + + G + ++APE + T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEA-INYGTFTIKS 191
Query: 210 DVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEA 269
DV+SFG+LL EI+ + + E+ +
Sbjct: 192 DVWSFGILLTEIVTHGRIP---------------YPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 270 ERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E + + C ++ PE RP + +LE
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-60
Identities = 59/273 (21%), Positives = 113/273 (41%), Gaps = 24/273 (8%)
Query: 30 TKLGAGGFGVVYKGQF---PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+LG G FG V +G + + +A K+LK K + M E + + + +VRL
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G C + LV E G L K+L E + + ++ + G+ YL +
Sbjct: 75 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNF 130
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS-TSGYRGTPGYSAPEFLLRNYPI 205
+H D+ N+LL + AK++DFGL+K ++++ + S + + AP +
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP-ECINFRKF 189
Query: 206 TQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265
+ + DV+S+G+ ++E + ++ + + + E+ A + E
Sbjct: 190 SSRSDVWSYGVTMWEALSYG---------------QKPYKKMKGPEVMAFIEQGKRMECP 234
Query: 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E + + C E RP V + +
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-59
Identities = 67/294 (22%), Positives = 125/294 (42%), Gaps = 26/294 (8%)
Query: 12 KPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQ 67
+ V+ + S +++ +G G FG VY G + + A K L + +Q
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 74
Query: 68 FMAEIGTIGRTYHINLVRLYGFCYD-QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLD 126
F+ E + H N++ L G C + +V +M++G L ++ +T + L+
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 127 IAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE--NTHDST 184
+ A+G + +++ +H D+ N +LD KF+ KVADFGLA+ + ++ +
Sbjct: 135 FGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVW 244
+G + + A E L+ T K DV+SFG+LL+E++ R +
Sbjct: 192 TGAKLPVKWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAPP---------------Y 235
Query: 245 DEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ ++ +L + + V L C E RP S +V +
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 3e-59
Identities = 61/297 (20%), Positives = 111/297 (37%), Gaps = 48/297 (16%)
Query: 31 KLGAGGFGVVYKGQFPN------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
+G G FG V++ + P +A K+LK + ++A F E + + N+V
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYLF-----------------------TDTEVLKW 121
+L G C L++E+M G L+++L L
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 122 EKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181
+ L IA A G+AYL E ++ +H D+ N L+ K+ADFGL++ + +
Sbjct: 140 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPK 241
+ + PE + T + DV+++G++L+EI
Sbjct: 197 KADGNDAIPIRWMPPES-IFYNRYTTESDVWAYGVVLWEIFSYGLQP------------- 242
Query: 242 QVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ E+ V I + + C P RP ++ ++L+
Sbjct: 243 --YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 6e-59
Identities = 78/269 (28%), Positives = 121/269 (44%), Gaps = 24/269 (8%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
KLG G FG V+ G + ++A K LK F+ E + + H LV+LY
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 91 YDQTKAALVYEFMENGSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
++ +V E+M GSL +L +T + L+ +L+D+A A G+AY+ +H
Sbjct: 82 SEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D++ ANIL+ KVADFGLA+L + G + ++APE L T K
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG-RFTIKS 195
Query: 210 DVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEA 269
DV+SFG+LL E+ + + ++V D+ E+G E
Sbjct: 196 DVWSFGILLTELTTKGRVPYP------GMVNREVLDQVERGYR---------MPCPPECP 240
Query: 270 ERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E + + C + PE RP + LE
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-57
Identities = 67/298 (22%), Positives = 110/298 (36%), Gaps = 49/298 (16%)
Query: 31 KLGAGGFGVVYKGQFPN------GVKIAAKILKTCLNKRVEAQFMAEIGTIGR-TYHINL 83
LG+G FG V +++A K+LK + M+E+ + + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYLFT----------------------DTEVLKW 121
V L G C L++E+ G L YL + D VL +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 122 EKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181
E LL A A+G+ +L + +H D+ N+L+ K+ DFGLA+ ++ +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPK 241
R + APE L T K DV+S+G+LL+EI N
Sbjct: 221 VVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP------------- 266
Query: 242 QVWDEYEKGELAAKVLGCGIE-ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ K++ G + + E + ++ C RP + L
Sbjct: 267 --YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-57
Identities = 71/302 (23%), Positives = 132/302 (43%), Gaps = 29/302 (9%)
Query: 25 TNNYST--KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHI 81
+++ +LGAG GVV+K P+G+ +A K++ + + Q + E+ +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
+V YG Y + ++ E M+ GSLD+ L + + L ++I +G+ YL E+
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
+I+H D+KP+NIL++++ K+ DFG++ + + GT Y +PE L+
Sbjct: 124 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPE-RLQ 176
Query: 202 NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261
+ + D++S G+ L E+ R + L+ + GC +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL-----------------MFGCQV 219
Query: 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVAPPKPFRYLYSIGMDAL 321
E + E R ++RPPM A+ ++L+ V P P D +
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLPSGVFSLEFQDFV 278
Query: 322 KS 323
Sbjct: 279 NK 280
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-57
Identities = 72/286 (25%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 32 LGAGGFGVVYKGQFPNG-----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+GAG FG VYKG V +A K LK ++ F+ E G +G+ H N++RL
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G ++ E+MENG+LDK+L +L+ + G A G+ YL N
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNY 131
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST-SGYRGTPGYSAPEFLLRNYPI 205
+H D+ NIL+++ KV+DFGL+++ + T SG + ++APE +
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA-ISYRKF 190
Query: 206 TQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265
T DV+SFG++++E++ ++ + E E+ +
Sbjct: 191 TSASDVWSFGIVMWEVMTYG---------------ERPYWELSNHEVMKAINDGFRLPTP 235
Query: 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVAPPKPFR 311
+ + + + C Q RP + +V +L+ +++ P +
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILD---KLIRAPDSLK 278
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-57
Identities = 63/299 (21%), Positives = 123/299 (41%), Gaps = 28/299 (9%)
Query: 31 KLGAGGFGVVYKGQFPN-----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG+G FG VYKG + + +A K L+ + + + + E + + ++ R
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
L G C T L+ + M G L Y+ + + + LL+ + A+G+ YL ++R
Sbjct: 76 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 131
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPI 205
++H D+ N+L+ K+ DFGLAKL E G + + A E +L
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IY 190
Query: 206 TQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265
T + DV+S+G+ ++E++ + +D E+++ +
Sbjct: 191 THQSDVWSYGVTVWELMTFG---------------SKPYDGIPASEISSILEKGERLPQP 235
Query: 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVAPPKPFRYLYSIGMDALKSP 324
+ M+ + C ++RP ++ ++ P+ + + L SP
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQRYLVIQGDERMHLPSP 291
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 8e-57
Identities = 75/270 (27%), Positives = 109/270 (40%), Gaps = 30/270 (11%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
+G G FG V G + G K+A K +K N F+AE + + H NLV+L G
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 91 YDQ-TKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
++ +V E+M GSL YL + VL + LL ++ + YL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 126
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+ N+L+ AKV+DFGL K + + ++APE LR + K
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEA-LREKKFSTK 180
Query: 209 CDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268
DV+SFG+LL+EI + K V EKG GC
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKGYKMDAPDGC--------- 225
Query: 269 AERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ V C RP + + LE
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-56
Identities = 66/293 (22%), Positives = 109/293 (37%), Gaps = 42/293 (14%)
Query: 31 KLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR-TYHINL 83
LGAG FG V + + +A K+LK + M+E+ + H+N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 84 VRLYGFCYDQTKAALVYEFMENGSLDKYLF-----------------TDTEVLKWEKLLD 126
V L G C ++ E+ G L +L D L E LL
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 127 IAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186
+ A+G+A+L + IH D+ NILL K+ DFGLA+ ++ +
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDE 246
R + APE + N T + DV+S+G+ L+E+ + F K + +
Sbjct: 207 ARLPVKWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSS-PYPGMPVDSKFYKMIKEG 264
Query: 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299
+ + M + C P RP +V+++E
Sbjct: 265 FR-------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-56
Identities = 69/275 (25%), Positives = 103/275 (37%), Gaps = 26/275 (9%)
Query: 31 KLGAGGFGVVYKGQFP----NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLV 84
KLG G FGVV +G++ V +A K LK + F+ E+ + H NL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
RLYG +V E GSL L L A+ A G+ YL +
Sbjct: 75 RLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 130
Query: 145 RIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYP 204
R IH D+ N+LL + K+ DFGL + + H +R P L+
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 205 ITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE-E 263
+ D + FG+ L+E+ T P W ++ K+ G
Sbjct: 191 FSHASDTWMFGVTLWEMF------------TYGQEP---WIGLNGSQILHKIDKEGERLP 235
Query: 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ + + V + C PE RP A+ L
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 3e-56
Identities = 61/274 (22%), Positives = 114/274 (41%), Gaps = 28/274 (10%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKIL-KTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G G +G K + +G + K L + + + ++E+ + H N+VR Y
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 89 FCYDQTKAAL--VYEFMENGSLDKYLFTDT---EVLKWEKLLDIAIGTARGIAYLHE--E 141
D+T L V E+ E G L + T + L E +L + + H +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 142 CNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
++H D+KPAN+ LD K + K+ DFGLA++ N + + + GTP Y +PE +
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPE-QMN 187
Query: 202 NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261
+K D++S G LL+E+ + + + ELA K+
Sbjct: 188 RMSYNEKSDIWSLGCLLYEL----------------CALMPPFTAFSQKELAGKIREGKF 231
Query: 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295
++ ++ + + RP + +++
Sbjct: 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-56
Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 26/273 (9%)
Query: 31 KLGAGGFGVVYKGQFPN---GVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+LG+G FG V KG + +A KILK + ++ + +AE + + + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G C ++ LV E E G L+KYL + +K + ++++ + G+ YL
Sbjct: 74 IGICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNF 128
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS-GYRGTPGYSAPEFLLRNYPI 205
+H D+ N+LL + AK++DFGL+K + + + + APE + Y
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI-NYYKF 187
Query: 206 TQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265
+ K DV+SFG+L++E + +V EKGE GC
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVTAMLEKGERMGCPAGC------ 235
Query: 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
M + C E RP +AV L
Sbjct: 236 ---PREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-55
Identities = 68/275 (24%), Positives = 104/275 (37%), Gaps = 29/275 (10%)
Query: 28 YSTKLGAGGFGVVYKGQFP-NGVKIAAKIL-KTCLNKRVEAQFMAEIGTIGRTYHINLVR 85
+ ++G G F VYKG V++A L L K +F E + H N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 86 LYGFCYDQTKA----ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
Y K LV E M +G+L YL +V+K + L +G+ +LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT- 130
Query: 142 CNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
IIH D+K NI + S K+ D GLA L GTP + APE
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYE 186
Query: 201 RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260
Y + DVY+FGM + E+ + Q++ G A
Sbjct: 187 EKY--DESVDVYAFGMCMLEMATSEYPYSE------CQNAAQIYRRVTSGVKPASF---- 234
Query: 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295
D+ + + C++ + R + ++
Sbjct: 235 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (457), Expect = 5e-55
Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 24/270 (8%)
Query: 31 KLGAGGFGVVYKGQFPN-GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G +G VY+G + + +A K LK + +F+ E + H NLV+L G
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 90 CYDQTKAALVYEFMENGSLDKYLF-TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
C + ++ EFM G+L YL + + + LL +A + + YL + + IH
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 138
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+ N L+ KVADFGL++L + + +G + ++APE L + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPES-LAYNKFSIK 196
Query: 209 CDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREE 268
DV++FG+LL+EI + + ++ + E
Sbjct: 197 SDVWAFGVLLWEIATYG---------------MSPYPGIDLSQVYELLEKDYRMERPEGC 241
Query: 269 AERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E++ + C Q P RP + + + E
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-53
Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 25/270 (9%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+LG G FG VYK Q V AAK++ T + +E +M EI + H N+V+L
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDA 77
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
Y + ++ EF G++D + L ++ + T + YLH+ +IIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHR 134
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL----RNYPI 205
D+K NIL K+ADFG++ + + GTP + APE ++ ++ P
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPY 192
Query: 206 TQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265
K DV+S G+ L E+ + + P +V + K E N
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELN-------PMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295
++ C++ +AR S +++
Sbjct: 246 KD-------FLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (448), Expect = 3e-53
Identities = 62/270 (22%), Positives = 105/270 (38%), Gaps = 30/270 (11%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
++G G FG VY + N +A K + + + E+ + + H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G + A LV E+ + D + L+ ++ + G +G+AYLH +I
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMI 137
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL--RNYPI 205
H D+K NILL K+ DFG A + P N+ + GTP + APE +L
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMDEGQY 191
Query: 206 TQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265
K DV+S G+ E+ R+ + ++ + L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSA---------------LYHIAQNESPALQS 236
Query: 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295
+E C+Q P+ RP ++K
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 4e-53
Identities = 68/287 (23%), Positives = 117/287 (40%), Gaps = 41/287 (14%)
Query: 31 KLGAGGFGVVYKGQFPNG---VKIAAKILKTCLNKRVEAQFMAEIGTIGR-TYHINLVRL 86
+G G FG V K + + A K +K +K F E+ + + +H N++ L
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLF---------------TDTEVLKWEKLLDIAIGT 131
G C + L E+ +G+L +L + L ++LL A
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP 191
ARG+ YL + ++ IH D+ NIL+ + AK+ADFGL++ + + R
Sbjct: 137 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMGRLPV 190
Query: 192 GYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251
+ A E L + T DV+S+G+LL+EI+ +L P + E
Sbjct: 191 RWMAIESLNYS-VYTTNSDVWSYGVLLWEIV------------SLGGTP---YCGMTCAE 234
Query: 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
L K+ E + + + C ++ P RP + ++ L
Sbjct: 235 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-52
Identities = 60/272 (22%), Positives = 105/272 (38%), Gaps = 25/272 (9%)
Query: 31 KLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRL 86
+G G FG V++G + + + +A K K C + V +F+ E T+ + H ++V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
G + ++ E G L +L L L+ A + +AYL +R
Sbjct: 74 IGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 129
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPIT 206
+H DI N+L+ + K+ DFGL++ + ++ G + + APE + T
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPES-INFRRFT 187
Query: 207 QKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266
DV+ FG+ ++EI+ V E GE C
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVK------NNDVIGRIENGERLPMPPNC------- 234
Query: 267 EEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ + C P RP + + L
Sbjct: 235 --PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 1e-51
Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 29/268 (10%)
Query: 31 KLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLY 87
LG G FG VY + + +A K+L VE Q E+ H N++RLY
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G+ +D T+ L+ E+ G++ + L ++ A ++Y H +R+I
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHS---KRVI 128
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
H DIKP N+LL + K+ADFG + GT Y PE ++ +
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPE-MIEGRMHDE 183
Query: 208 KCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDRE 267
K D++S G+L +E + + + + ++ + + E + E
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKRISRVEFT-------FPDFVTE 229
Query: 268 EAERMSMVALWCVQDCPEARPPMSAVVK 295
A + ++ P RP + V++
Sbjct: 230 GARD---LISRLLKHNPSQRPMLREVLE 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-51
Identities = 61/275 (22%), Positives = 95/275 (34%), Gaps = 21/275 (7%)
Query: 24 FTNNYS--TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH 80
F ++ LG G +G V +A KI+ EI H
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHE 140
N+V+ YG + L E+ G L + D + G+ YLH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHG 121
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
I H DIKP N+LLD + + K++DFGLA + N + GT Y APE L
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 201 RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260
R + DV+S G++L ++ S ++ + Y
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----------- 227
Query: 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295
+ + + + P AR + + K
Sbjct: 228 PWKKIDSAPLAL---LHKILVENPSARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-51
Identities = 59/287 (20%), Positives = 114/287 (39%), Gaps = 34/287 (11%)
Query: 31 KLGAGGFGVVYKG------QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLV 84
+LG G FG+VY+G + ++A K + + R +F+ E + ++V
Sbjct: 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYLFTD---------TEVLKWEKLLDIAIGTARGI 135
RL G ++ E M G L YL + K++ +A A G+
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 136 AYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSA 195
AYL + +H D+ N ++ F+ K+ DFG+ + + + + +
Sbjct: 147 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 196 PEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAK 255
PE L++ T DV+SFG++L+EI +Q + ++
Sbjct: 204 PES-LKDGVFTTYSDVWSFGVVLWEIA---------------TLAEQPYQGLSNEQVLRF 247
Query: 256 VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302
V+ G+ + + + + C Q P+ RP ++ ++ +E
Sbjct: 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-51
Identities = 71/299 (23%), Positives = 116/299 (38%), Gaps = 46/299 (15%)
Query: 31 KLGAGGFGVVYKGQFP--------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGR-TYHI 81
LG G FG V + K+A K+LK+ ++ + ++E+ + H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 82 NLVRLYGFCYDQTKAALVYEFMENGSLDKYLF---------------TDTEVLKWEKLLD 126
N++ L G C ++ E+ G+L +YL E L + L+
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 127 IAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186
A ARG+ YL ++ IH D+ N+L+ K+ADFGLA+ + + + T+
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDE 246
R + APE L T + DV+SFG+LL+EI +
Sbjct: 197 GRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLG---------------GSPYPG 240
Query: 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVEIVA 305
EL + + + M+ C P RP +V+ L+ IVA
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD---RIVA 296
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 6e-48
Identities = 72/292 (24%), Positives = 112/292 (38%), Gaps = 43/292 (14%)
Query: 31 KLGAGGFGVVYKG------QFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINL 83
LG G FG V + + +A K+LK M+E+ + +H+N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 84 VRLYGFCY-DQTKAALVYEFMENGSLDKYLFTD---------------TEVLKWEKLLDI 127
V L G C ++ EF + G+L YL + + L E L+
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 128 AIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187
+ A+G+ +L ++ IH D+ NILL K K+ DFGLA+ + +
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEY 247
R + APE + T + DV+SFG+LL+EI +L P +
Sbjct: 197 RLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIF------------SLGASP---YPGV 240
Query: 248 EKGELAAKVLGCGIE-ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
+ E + L G M L C P RP S +V+ L
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 157 bits (398), Expect = 1e-45
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+LG G FGVV++ G AAK + T E EI T+ H LV L+
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDA 91
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
D + ++YEFM G L + + + + ++ ++ +G+ ++HE +H
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHL 148
Query: 150 DIKPANILLDAKFS--AKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
D+KP NI+ K S K+ DFGL +P+ + T+G ++APE + P+
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT---AEFAAPE-VAEGKPVGY 204
Query: 208 KCDVYSFGMLLFEIIGRR 225
D++S G+L + ++
Sbjct: 205 YTDMWSVGVLSYILLSGL 222
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 1e-45
Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 10/196 (5%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
K+G G G VY G ++A + + + E + EI + + N+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIVNYLDS 85
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ +V E++ GSL + ++ + + + +LH ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHS---NQVIHR 140
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
DIK NILL S K+ DFG PE + ST GTP + APE + R K
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK-AYGPKV 197
Query: 210 DVYSFGMLLFEIIGRR 225
D++S G++ E+I
Sbjct: 198 DIWSLGIMAIEMIEGE 213
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-45
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 18/216 (8%)
Query: 10 REKPVRFTLEQLCSFTNNYSTKLGAGGFGVVYKGQ-FPNGVKIAAKILK--TCLNKRVEA 66
+++P F + LG G F V + + A KIL+ + +
Sbjct: 4 KKRPEDFKFGK----------ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 53
Query: 67 QFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLD 126
E + R H V+LY D K + +NG L KY+
Sbjct: 54 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRF 112
Query: 127 IAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186
+ YLH + IIH D+KP NILL+ ++ DFG AK+ +PE+ +
Sbjct: 113 YTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169
Query: 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEII 222
+ GT Y +PE LL + D+++ G ++++++
Sbjct: 170 FVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLV 204
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (387), Expect = 6e-44
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 16/232 (6%)
Query: 26 NNYST--KLGAGGFGVVYKGQFP-NGVKIAAKIL--KTCLNKRVEAQFMAE---IGTIGR 77
N++S +G GGFG VY + G A K L K K+ E + E + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 78 TYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAY 137
+V + + K + + + M G L +L V + A G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEH 122
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE 197
+H + +++ D+KPANILLD +++D GLA + + H S GT GY APE
Sbjct: 123 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 175
Query: 198 FLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEK 249
L + D +S G +LF+++ + + + +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 148 bits (375), Expect = 3e-42
Identities = 56/229 (24%), Positives = 106/229 (46%), Gaps = 13/229 (5%)
Query: 2 EKFLRDIAREKPVRFTLEQLCSFTNNYS--TKLGAGGFGVVYKGQF-PNGVKIAAKILKT 58
+KF DI ++ + + S + Y +LG+G FGVV++ G AK + T
Sbjct: 5 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 64
Query: 59 CLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEV 118
+ EI + + +H L+ L+ D+ + L+ EF+ G L + +
Sbjct: 65 PYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 123
Query: 119 LKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSA--KVADFGLAKLCN 176
+ ++++ G+ ++HE I+H DIKP NI+ + K ++ K+ DFGLA N
Sbjct: 124 MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180
Query: 177 PENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
P+ T ++APE ++ P+ D+++ G+L + ++
Sbjct: 181 PDEIVKV---TTATAEFAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-42
Identities = 42/195 (21%), Positives = 86/195 (44%), Gaps = 12/195 (6%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
LG G FG+V++ + AK +K + + EI + H N++ L+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ +++EF+ + + + T L +++ + +LH I H+
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 150 DIKPANILLDAKFSA--KVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
DI+P NI+ + S+ K+ +FG A+ P + P Y APE + ++ ++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEYYAPE-VHQHDVVST 182
Query: 208 KCDVYSFGMLLFEII 222
D++S G L++ ++
Sbjct: 183 ATDMWSLGTLVYVLL 197
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-41
Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 9/212 (4%)
Query: 20 QLCSFTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIG 76
Q+ Y+ +G G +G+V N V++A K + ++ + + EI +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 77 RTYHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFT--DTEVLKWEKLLDIAIGTARG 134
R H N++ + T + ++ + L+ T+ L + + RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST-SGYRGTPGY 193
+ Y+H ++H D+KP+N+LL+ K+ DFGLA++ +P++ H + Y T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
APE +L + T+ D++S G +L E++ R
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 142 bits (360), Expect = 8e-41
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 24/219 (10%)
Query: 24 FTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--------NKRVEAQFMAEI 72
F NY LG G VV + P + A KI+ + + + E+
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 73 GTIGRT-YHINLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGT 131
+ + H N+++L T LV++ M+ G L YL T+ L ++ I
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRAL 119
Query: 132 ARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTP 191
I LH+ I+H D+KP NILLD + K+ DFG + +P + GTP
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTP 173
Query: 192 GYSAPEFLL-----RNYPITQKCDVYSFGMLLFEIIGRR 225
Y APE + + ++ D++S G++++ ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-40
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 31 KLGAGGFGVVYKGQFPN-GVKIAAKILK----TCLNKRVEAQFMAEIGTIGRTYHINLVR 85
LG G F VYK + N +A K +K + + + EI + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 86 LYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
L ++ +LV++FME + ++ VL + + T +G+ YLH+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 120
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPI 205
I+H D+KP N+LLD K+ADFGLAK + + + + T Y APE L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 206 TQKCDVYSFGMLLFEIIGRR 225
D+++ G +L E++ R
Sbjct: 179 GVGVDMWAVGCILAELLLRV 198
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 2e-39
Identities = 41/193 (21%), Positives = 71/193 (36%), Gaps = 6/193 (3%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
LG G F V + +A K + + E EI + + H N+V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
L+ + + G L + + + + YLH+
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 134
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
LD ++DFGL+K+ +P + S GTPGY AP +L P ++
Sbjct: 135 PENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAP-EVLAQKPYSKAV 190
Query: 210 DVYSFGMLLFEII 222
D +S G++ + ++
Sbjct: 191 DCWSIGVIAYILL 203
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 2e-39
Identities = 60/279 (21%), Positives = 106/279 (37%), Gaps = 19/279 (6%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G +GVVYK + G +A K ++ + V + + EI + H N+V+L
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
+ + K LV+EF+ + + + +G+A+ H ++H
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLH 125
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+KP N+L++ + + K+ADFGLA+ + T Y APE LL +
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLGCKYYSTA 183
Query: 209 CDVYSFGMLLFEIIGRRKNAQDCSS--------DTLDWFPKQVWDEYEKGELAAKVLGCG 260
D++S G + E++ RR S TL + VW
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 261 IEENDREEAERMSMVALWCVQDC----PEARPPMSAVVK 295
++ + + + P R A +
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (350), Expect = 3e-39
Identities = 58/277 (20%), Positives = 110/277 (39%), Gaps = 27/277 (9%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLY 87
LG GG V+ + +A K+L+ L + +F E H +V +Y
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 88 GFCYDQTKAA----LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECN 143
+T A +V E+++ +L + + ++ +++ + + + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQ--- 129
Query: 144 QRIIHYDIKPANILLDAKFSAKVADFGLAK-LCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
IIH D+KPANI++ A + KV DFG+A+ + + N+ T+ GT Y +PE R
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARG 188
Query: 203 YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262
+ + DVYS G +L+E++ + + V ++
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTG--DSPVSVAYQHVREDPIP-----------PS 235
Query: 263 ENDREEAERMSMVALWCVQDCPEARPP-MSAVVKMLE 298
+ + V L + PE R + + L
Sbjct: 236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-39
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 20/218 (9%)
Query: 21 LCSFTNNYS--TKLGAGGFGVVYKGQF--PNGVKIAAKILK-TCLNKRVEAQFMAEIG-- 73
LC Y ++G G +G V+K + G +A K ++ + + + E+
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 74 -TIGRTYHINLVRLYGFCYD-----QTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDI 127
+ H N+VRL+ C +TK LV+E ++ + E + D+
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 128 AIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGY 187
RG+ +LH R++H D+KP NIL+ + K+ADFGLA++ + + S
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---V 175
Query: 188 RGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR 225
T Y AP +L D++S G + E+ R+
Sbjct: 176 VVTLWYRAP-EVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 137 bits (346), Expect = 9e-39
Identities = 60/278 (21%), Positives = 111/278 (39%), Gaps = 19/278 (6%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
K+G G +GVVYK Q G A K ++ ++ + + + EI + H N+V+LY
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
+ + + LV+E + + L K L L+ + GIAY H+ +R++H
Sbjct: 69 IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHR 124
Query: 150 DIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKC 209
D+KP N+L++ + K+ADFGLA+ + T Y AP+ L+ + +
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYSTTI 182
Query: 210 DVYSFGMLLFEII-GRRKNAQDCSSDTLD-------WFPKQVWDEYEKGELAAKVLGCGI 261
D++S G + E++ G +D L + W +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 262 EENDREEAERMSMVAL----WCVQDCPEARPPMSAVVK 295
+ + + ++ P R ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-38
Identities = 65/304 (21%), Positives = 107/304 (35%), Gaps = 33/304 (10%)
Query: 21 LCSFTNNYST--KLGAGGFGVVYKGQF-PNGVKIAAKIL-KTCLNKRVEAQFMAEIGTIG 76
C + Y K+G G FG V+K + G K+A K + + + EI +
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 77 RTYHINLVRLYGFCYDQTKAA--------LVYEFMENGSLDKYLFTDTEVLKWEKLLDIA 128
H N+V L C + LV++F E+ + ++ +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 123
Query: 129 IGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT--HDSTSG 186
G L+ +I+H D+K AN+L+ K+ADFGLA+ + + +
Sbjct: 124 QMLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR--------KNAQDCSSDTLDW 238
T Y PE LL D++ G ++ E+ R ++ S
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 239 FPKQVWDEYEKGELAAK---VLGCGIEENDREEAERMSMVALWCVQDC----PEARPPMS 291
+VW + EL K V G + DR +A AL + P R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 292 AVVK 295
+
Sbjct: 301 DALN 304
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-38
Identities = 55/196 (28%), Positives = 83/196 (42%), Gaps = 11/196 (5%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILK--TCLNKRVEAQFMAEIGTIGRTY-HINLVRL 86
LG G FG V+ +F A K LK L M E + + H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 87 YGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRI 146
+ + V E++ G L ++ + A G+ +LH + I
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHS---KGI 124
Query: 147 IHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPIT 206
++ D+K NILLD K+ADFG+ K + +T + GTP Y APE LL
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQ-KYN 181
Query: 207 QKCDVYSFGMLLFEII 222
D +SFG+LL+E++
Sbjct: 182 HSVDWWSFGVLLYEML 197
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (343), Expect = 3e-38
Identities = 51/277 (18%), Positives = 93/277 (33%), Gaps = 25/277 (9%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
K+G+G FG +Y G G ++A K+ K Q E + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHY 149
C + ++ + SL+ + + +L +A I Y+H + IH
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHR 127
Query: 150 DIKPANIL---LDAKFSAKVADFGLAKLCNPENTHD-----STSGYRGTPGYSAPEFLLR 201
D+KP N L + DFGLAK TH GT Y++
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN-THL 186
Query: 202 NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261
+++ D+ S G +L Q + T +++ + K + I
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---------KKMSTPI 237
Query: 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E + + +C + +P S + ++
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 7e-38
Identities = 55/274 (20%), Positives = 100/274 (36%), Gaps = 39/274 (14%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVE-----AQFMAEIGTIGR--TYHIN 82
LG+GGFG VY G + + +A K ++ + E+ + + +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 83 LVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC 142
++RL + L+ E E T+ L+ E + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128
Query: 143 NQRIIHYDIKPANILLDA-KFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLR 201
++H DIK NIL+D + K+ DFG L D + GT YS PE++
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEWIRY 183
Query: 202 NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261
+ + V+S G+LL++++ P + +E +G++
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGD-------------IPFEHDEEIIRGQVF-------F 223
Query: 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295
+ E + + WC+ P RP +
Sbjct: 224 RQRVSSECQH---LIRWCLALRPSDRPTFEEIQN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (335), Expect = 5e-37
Identities = 45/280 (16%), Positives = 87/280 (31%), Gaps = 29/280 (10%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN-LVRLYG 88
++G G FGV+++G N ++A K + Q E T + +Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP---RRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
F + LV + + D L + + A + +HE + +++
Sbjct: 69 FGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 149 YDIKPANILLDAKF-----SAKVADFGLAKLCNPENTHD-----STSGYRGTPGYSAPEF 198
DIKP N L+ V DFG+ K T GT Y +
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN- 183
Query: 199 LLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258
+++ D+ + G + + Q + T +++ ++ + L G
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298
E + +A P + +
Sbjct: 244 FPEE---------FYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-36
Identities = 64/280 (22%), Positives = 102/280 (36%), Gaps = 33/280 (11%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
+G G FGVVY+ + +G +A K + + + E+ + + H N+VRL F
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 90 CY------DQTKAALVYEFMENGSLD--KYLFTDTEVLKWEKLLDIAIGTARGIAYLHEE 141
Y D+ LV +++ ++ + L + R +AY+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS- 140
Query: 142 CNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
I H DIKP N+LLD K+ DFG AK + S Y + Y APE +
Sbjct: 141 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPELIF 195
Query: 201 RNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSS--------DTLDWFPKQVWDEYEKGEL 252
T DV+S G +L E++ + S L ++ E
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 253 AAKVLGCGIEENDREEAERMSMVAL----WCVQDCPEARP 288
K + R A+ ++ P AR
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (334), Expect = 1e-36
Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILK--TCLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
LG G FG V+ + NG A K+LK + + E + H ++R++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
G D + ++ +++E G L L A L ++ II
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV----AKFYAAEVCLALEYLHSKDII 126
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
+ D+KP NILLD K+ DFG AK D T GTP Y APE ++ P +
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE-VVSTKPYNK 180
Query: 208 KCDVYSFGMLLFEIIGRRK 226
D +SFG+L++E++
Sbjct: 181 SIDWWSFGILIYEMLAGYT 199
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-36
Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 21/203 (10%)
Query: 32 LGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFC 90
LG G G V + K A K+L+ C R E + ++VR+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ-----CPHIVRIVDVY 74
Query: 91 YD----QTKAALVYEFMENGSLDKYLFT-DTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
+ + +V E ++ G L + + + +I I YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 131
Query: 146 IIHYDIKPANILLDAKF---SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
I H D+KP N+L +K K+ DFG AK N+ + TP Y APE +L
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPE-VLGP 187
Query: 203 YPITQKCDVYSFGMLLFEIIGRR 225
+ CD++S G++++ ++
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-34
Identities = 48/280 (17%), Positives = 99/280 (35%), Gaps = 21/280 (7%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILK-TCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
K+G G +G V+K + +A K ++ ++ V + + EI + H N+VRL+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 89 FCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIH 148
+ K LV+EF + + + + + + L ++ ++H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRNVLH 124
Query: 149 YDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQK 208
D+KP N+L++ K+A+FGLA+ S T Y P+ L +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTS 182
Query: 209 CDVYSFGMLLFEIIGRRKNAQDCSSD---------TLDWFPKQVWDEYEKGELAAKVLGC 259
D++S G + E+ + + L ++ W K
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 260 GIEENDREEAERMSMVAL----WCVQDCPEARPPMSAVVK 295
+ +++ ++ P R ++
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-34
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVE-----AQFMAEIGTIGRTYHINLV 84
+LG+G F VV K + G++ AAK +K K E+ + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 85 RLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQ 144
L+ ++T L+ E + G L + + E L E+ + G ++ +
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNG---VYYLHSL 132
Query: 145 RIIHYDIKPANILLD----AKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
+I H+D+KP NI+L K K+ DFGLA + N GTP + APE ++
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPE-IV 188
Query: 201 RNYPITQKCDVYSFGMLLFEII 222
P+ + D++S G++ + ++
Sbjct: 189 NYEPLGLEADMWSIGVITYILL 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 9e-34
Identities = 48/205 (23%), Positives = 80/205 (39%), Gaps = 12/205 (5%)
Query: 26 NNYS--TKLGAGGFGVVYKGQF-PNGVKIAAKILK--TCLNKRVEAQFMAEIGTIGRTYH 80
N++ LG G FG V + G A KIL+ + K A + E + T H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHE 140
L L + V E+ G L +L + V E+ L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA---LEY 120
Query: 141 ECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLL 200
++ +++ DIK N++LD K+ DFGL K + + GTP Y +L
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY-LAPEVL 177
Query: 201 RNYPITQKCDVYSFGMLLFEIIGRR 225
+ + D + G++++E++ R
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 4e-33
Identities = 45/201 (22%), Positives = 84/201 (41%), Gaps = 21/201 (10%)
Query: 31 KLGAGGFGVVYKGQ-FPNGVKIAAKILKTCLNKRV--EAQFMAEIGTIGRTYHINLVRLY 87
KLG G + V++ N K+ KILK K++ E + + + N++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR-----GGPNIITLA 96
Query: 88 GFCYDQTK--AALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
D ALV+E + N + + L + + + Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MG 149
Query: 146 IIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYP 204
I+H D+KP N+++D + ++ D+GLA+ +P + + + + PE L+
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQM 206
Query: 205 ITQKCDVYSFGMLLFEIIGRR 225
D++S G +L +I R+
Sbjct: 207 YDYSLDMWSLGCMLASMIFRK 227
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-32
Identities = 49/200 (24%), Positives = 83/200 (41%), Gaps = 13/200 (6%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKIL-KTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G+G +G V G K+A K L + ++ + E+ + H N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 89 FCYDQTKAALVYEF---MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
+F M D E L +++ + +G+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPI 205
IIH D+KP N+ ++ K+ DFGLA+ +GY T Y APE +L
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRY 196
Query: 206 TQKCDVYSFGMLLFEIIGRR 225
TQ D++S G ++ E+I +
Sbjct: 197 TQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (302), Expect = 7e-32
Identities = 51/227 (22%), Positives = 83/227 (36%), Gaps = 21/227 (9%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKT--CLNKRVEAQFMAEIGTIGRTYHINLVRLY 87
LG G FG V + +G A KIL + + + E + LV+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 88 GFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRII 147
D + +V E++ G + +L A YLH +I
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 148 HYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQ 207
+ D+KP N+L+D + +V DFG AK GTP APE ++ + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPE-IILSKGYNK 217
Query: 208 KCDVYSFGMLLFEII-GRRKNAQDCSSDTLDW-------FPKQVWDE 246
D ++ G+L++E+ G D + FP +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD 264
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 7e-30
Identities = 44/203 (21%), Positives = 75/203 (36%), Gaps = 12/203 (5%)
Query: 31 KLGAGGFGVVYKGQ----FPNGVKIAAKILKTCL---NKRVEAQFMAEIGTIGRTYHI-N 82
LG G +G V+ + G A K+LK + E +
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 83 LVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC 142
LV L+ +TK L+ +++ G L +L + E + I + L
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----VQIYVGEIVLALEHLH 146
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
II+ DIK NILLD+ + DFGL+K + T + + +
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206
Query: 203 YPITQKCDVYSFGMLLFEIIGRR 225
+ D +S G+L++E++
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-28
Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 19/203 (9%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKIL-KTCLNKRVEAQFMAEIGTIGRTYHINLVRLYG 88
+G+G G+V +A K L + N+ + E+ + H N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 89 FCYDQTKA------ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC 142
Q LV E M+ E++ + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD----HERMSYLLYQMLCGIKHLHSAG 139
Query: 143 NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRN 202
IH D+KP+NI++ + + K+ DFGLA+ + Y T Y APE +
Sbjct: 140 I---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEV-ILG 192
Query: 203 YPITQKCDVYSFGMLLFEIIGRR 225
+ D++S G ++ E++ +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 3e-27
Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 13/200 (6%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEA-QFMAEIGTIGRTYHINLVRLYG 88
+G+G +G V G+++A K L + A + E+ + H N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 89 FCYDQTKAA---LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR 145
VY D + L + + + RG+ Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141
Query: 146 IIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPI 205
IIH D+KP+N+ ++ K+ DFGLA+ + E T Y T Y APE +L
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-----YVATRWYRAPEIMLNWMHY 196
Query: 206 TQKCDVYSFGMLLFEIIGRR 225
Q D++S G ++ E++ R
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (248), Expect = 3e-24
Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 22/209 (10%)
Query: 31 KLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGF 89
KLG G F V+ + N +A KI++ +K EI + R + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 90 CY---------------DQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARG 134
+ +V+E + L + + + I+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 135 IAYLHEECNQRIIHYDIKPANILLDAK-FSAKVADFGLAKLCNPENTHDSTSGYRGTPGY 193
+ Y+H C IIH DIKP N+L++ + +A L N + + T Y
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 194 SAPEFLLRNYPITQKCDVYSFGMLLFEII 222
+PE LL P D++S L+FE+I
Sbjct: 196 RSPEVLLGA-PWGCGADIWSTACLIFELI 223
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.3 bits (218), Expect = 2e-21
Identities = 28/203 (13%), Positives = 57/203 (28%), Gaps = 31/203 (15%)
Query: 31 KLGAGGFGVVYKGQFPNGVKIAAKILKT---------CLNKRVEAQFMAEIGTIGRTYHI 81
+G G V+ + K K + F R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 82 NLVRLYGFC----YDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAY 137
L +L G Y A++ E ++ L + + E ++ +A
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAK 118
Query: 138 LHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPE 197
+ I+H D+ N+L+ + + DF + E + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWRE----ILERDVRNIIT 170
Query: 198 FLLRNYPITQKCDVYSFGMLLFE 220
+ R Y + D+ S + +
Sbjct: 171 YFSRTYRT--EKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 369 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.23 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.91 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.09 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-57 Score=408.68 Aligned_cols=266 Identities=26% Similarity=0.452 Sum_probs=210.7
Q ss_pred cCHHHHHHhhhccc-----------cccccCCceEEEEEEeCC-C---cEEEEEEccccccHHHHHHHHHHHHHHhccCC
Q 017591 16 FTLEQLCSFTNNYS-----------TKLGAGGFGVVYKGQFPN-G---VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH 80 (369)
Q Consensus 16 ~~~~el~~~t~~f~-----------~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h 80 (369)
++|.++..++.+|. ++||+|+||+||+|.++. + ..||||.+...........|.+|+.++++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 56677777777664 579999999999998743 2 36889998776666677889999999999999
Q ss_pred CceeeEEeEEEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC
Q 017591 81 INLVRLYGFCYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA 160 (369)
Q Consensus 81 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 160 (369)
||||++++++.+.+..++|||||++|+|.+++......+++.+++.++.|+++||.|||+ ++|+||||||+||||+.
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~ 163 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNS 163 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECT
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECC
Confidence 999999999999999999999999999999997777789999999999999999999999 99999999999999999
Q ss_pred CCCeeEeecCCceecCCCCCcc---ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 017591 161 KFSAKVADFGLAKLCNPENTHD---STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTL 236 (369)
Q Consensus 161 ~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~ 236 (369)
++.+||+|||+++......... ......||+.|+|||.+..+ .++.++|||||||++|||+| |+.||......
T Consensus 164 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-- 240 (299)
T d1jpaa_ 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-- 240 (299)
T ss_dssp TCCEEECCC-----------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred CCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHH--
Confidence 9999999999998765433221 12234589999999988775 79999999999999999998 89998654321
Q ss_pred CccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 237 DWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
++...+........+...+..+.+|+.+||+.||.+|||+.+|++.|+..+
T Consensus 241 --------------~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 241 --------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp --------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------------HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 111222223333445566788999999999999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=399.93 Aligned_cols=251 Identities=23% Similarity=0.273 Sum_probs=204.0
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
.+.++||+|+||+||+|+++ +|+.||+|++...........+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence 44589999999999999884 68999999987654444556799999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
|+|.+++ .....+++.+++.++.|+++||+|||+ +||+||||||+|||++.++.+||+|||+|+............
T Consensus 88 g~L~~~l-~~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 88 GELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp EEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CcHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 9999999 455689999999999999999999999 999999999999999999999999999999875444433445
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
...||+.|+|||++.+...++.++|||||||++|||++|+.||........ .+.... .........
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~~~~~--------~~~~~~~~~ 229 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWK--------EKKTYLNPW 229 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH------HHHHHH--------TTCTTSTTG
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH------HHHHHh--------cCCCCCCcc
Confidence 577999999999988764557889999999999999999999975443211 011111 111111222
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+..+.+|+.+||+.||.+|||+.++++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 345677889999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=397.02 Aligned_cols=252 Identities=29% Similarity=0.500 Sum_probs=200.9
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
.+.++||+|+||+||+|.+.+++.||||+++..... ..+|.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 566899999999999999988999999998754332 357999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 86 ~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~ 161 (263)
T d1sm2a_ 86 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTG 161 (263)
T ss_dssp BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce-eecc
Confidence 9999997777889999999999999999999999 99999999999999999999999999999876543322 2234
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCCH
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDR 266 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (369)
..||+.|+|||++..+ .++.++|||||||++|||+|++.|+...... .++...+........+.
T Consensus 162 ~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---------------~~~~~~i~~~~~~~~p~ 225 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---------------SEVVEDISTGFRLYKPR 225 (263)
T ss_dssp ---CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---------------HHHHHHHHHTCCCCCCT
T ss_pred eecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCH---------------HHHHHHHHhcCCCCCcc
Confidence 5689999999998875 7999999999999999999966555432211 11111222222233344
Q ss_pred HHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 267 EEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
..+..+.+|+.+||+.||.+|||+++|++.|++.
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 5567899999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-56 Score=398.10 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=204.1
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||+||+|++. ..||||+++.. ........|.+|+.++++++|||||++++++. .+..++|||||+
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCC
Confidence 345689999999999999874 36999998643 33455678999999999999999999999875 456899999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+|+|.+++......+++..+..++.|+++||+|||+ ++|+||||||+||||+.++.+||+|||+|+...........
T Consensus 87 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 999999997777789999999999999999999999 99999999999999999999999999999876544433344
Q ss_pred ccCCCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRN--YPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~--~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
....||+.|+|||++... ..++.++|||||||++|||+||+.||....... ........+.. .....
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~-----~p~~~ 232 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYL-----SPDLS 232 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSC-----CCCGG
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCC-----CCcch
Confidence 556799999999998643 257999999999999999999999997654321 11111111110 11111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
..+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 223445678999999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=394.06 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=210.5
Q ss_pred ccccCCceEEEEEEeC---CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 31 KLGAGGFGVVYKGQFP---NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 31 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
+||+|+||+||+|.+. ++..||||+++.........+|.+|+.++++++|||||++++++.+ +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 5999999999999763 3557999999877666777889999999999999999999999864 56899999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc-ccccc
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH-DSTSG 186 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~ 186 (369)
|.+++......+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+...... .....
T Consensus 95 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 171 (285)
T d1u59a_ 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171 (285)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccccccc
Confidence 999987677789999999999999999999999 99999999999999999999999999999987654332 22334
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..||+.|+|||++..+ .++.++|||||||++|||+| |+.||...... ++...+.....+..+
T Consensus 172 ~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~p 234 (285)
T d1u59a_ 172 GKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------------EVMAFIEQGKRMECP 234 (285)
T ss_dssp SCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----------------HHHHHHHTTCCCCCC
T ss_pred cccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCCCCC
Confidence 5689999999998875 78999999999999999998 89999754332 111222233334445
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
...+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 56678899999999999999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=393.95 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=207.3
Q ss_pred ccccccccCCceEEEEEEeCCC-----cEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEe
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNG-----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
.+.+.||+|+||+||+|.+.++ ..||||.+..........+|.+|+.++++++|||||++++++.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 4567899999999999987532 47999999876666667789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+.++++.+++......+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 999999999987777889999999999999999999999 99999999999999999999999999999876543222
Q ss_pred -cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 182 -DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.......||+.|+|||++..+ .++.++|||||||++|||++++.|+...... .++...+....
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---------------~~~~~~i~~~~ 230 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSN---------------HEVMKAINDGF 230 (283)
T ss_dssp -------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------------HHHHHHHHTTC
T ss_pred ceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCH---------------HHHHHHHhccC
Confidence 223345689999999988775 7999999999999999999977776533221 11222233333
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
.+..+...+..+.+|+.+||+.||++||++.+|++.|+....
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 344555667889999999999999999999999999987643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=391.69 Aligned_cols=252 Identities=33% Similarity=0.472 Sum_probs=207.0
Q ss_pred hhccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
.+.+.++||+|+||+||+|.++++..||||++...... ...|.+|+.++++++|||||++++++. ++..++||||++
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 34556889999999999999988899999998754332 357999999999999999999999875 456799999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 105 NGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 105 ~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+|+|.+++... ...+++..++.|+.|+++||.|||+ ++|+||||||+||||+.++.+||+|||+|+........ .
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-A 166 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-C
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc-c
Confidence 99999988433 3469999999999999999999999 99999999999999999999999999999987543322 2
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||+.|+|||++..+ .++.++|||||||++|||+||+.|+...... .++...+.......
T Consensus 167 ~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~---------------~~~~~~i~~~~~~~ 230 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLERGYRMV 230 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------------HHHHHHHHTTCCCC
T ss_pred ccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCH---------------HHHHHHHHhcCCCC
Confidence 3446799999999998875 7899999999999999999977766433221 11112222233334
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.+...+..+.+|+.+||+.||++|||+++|++.|+.
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 445567789999999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=384.10 Aligned_cols=250 Identities=25% Similarity=0.440 Sum_probs=212.6
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMENG 106 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 106 (369)
.|.++||+|+||+||+|++++++.||||+++..... ..+|.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 466899999999999999988899999998754332 357999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccccc
Q 017591 107 SLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTSG 186 (369)
Q Consensus 107 sL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 186 (369)
+|..++......+++..++.++.|+++||.|||+ +||+||||||+|||++.++.+||+|||+++........ ....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~ 160 (258)
T d1k2pa_ 85 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVG 160 (258)
T ss_dssp EHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCC
T ss_pred cHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecc
Confidence 9999987777889999999999999999999999 99999999999999999999999999999876544332 2344
Q ss_pred CCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCCC
Q 017591 187 YRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEND 265 (369)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (369)
..||+.|+|||.+... .++.++|||||||++|||+| |+.||...... ++...+........+
T Consensus 161 ~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~p 223 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----------------ETAEHIAQGLRLYRP 223 (258)
T ss_dssp SCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----------------HHHHHHHTTCCCCCC
T ss_pred cCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHH----------------HHHHHHHhCCCCCCc
Confidence 6799999999988875 78999999999999999998 78888654432 111222222333444
Q ss_pred HHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 266 REEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
...+..+.+|+.+||+.||.+|||+.+|++.|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 5566789999999999999999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-55 Score=394.03 Aligned_cols=259 Identities=27% Similarity=0.369 Sum_probs=213.3
Q ss_pred HHHHhhhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 20 QLCSFTNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 20 el~~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
|+......+.++||+|+||+||+|.+. +++.||||+++.+.. ..++|.+|+.++++++|||||++++++.+.+..++
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 333334456689999999999999885 588999999875433 24579999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 99 VYEFMENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
|||||++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999643 5689999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
.... ......|++.|+|||++.++ .++.++|||||||++|||++|+.|+...... ..+...+.
T Consensus 168 ~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---------------~~~~~~i~ 230 (287)
T d1opja_ 168 DTYT-AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------SQVYELLE 230 (287)
T ss_dssp SSSE-EETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------------HHHHHHHH
T ss_pred CCce-eeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchH---------------HHHHHHHh
Confidence 3322 23345689999999998875 7899999999999999999988776533221 11112222
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
....+..+...+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2233444555678899999999999999999999999999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=389.08 Aligned_cols=248 Identities=27% Similarity=0.393 Sum_probs=202.2
Q ss_pred cccccCCceEEEEEEeC---CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 30 TKLGAGGFGVVYKGQFP---NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
++||+|+||+||+|.+. .++.||||+++.. .......+|.+|+.++++++|||||+++++|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999763 3578999998643 334456789999999999999999999999854 567899999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc-cc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD-ST 184 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~ 184 (369)
|+|.+++. ....+++..++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+....... ..
T Consensus 92 g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999994 45679999999999999999999999 999999999999999999999999999999876543332 23
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....||+.|+|||.+..+ .++.++|||||||++|||++ |+.||...... ++...+.....+.
T Consensus 168 ~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----------------~~~~~i~~~~~~~ 230 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----------------EVTAMLEKGERMG 230 (277)
T ss_dssp ---CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTTCCCC
T ss_pred cccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHH----------------HHHHHHHcCCCCC
Confidence 345799999999988775 78999999999999999998 89998754321 1112222233344
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
.+...+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 455567889999999999999999999999988864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-55 Score=386.45 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=203.6
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||+||+|+++ +++.||+|++.... .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 345689999999999999885 58999999986432 222346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
|++|+|.+++. ....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--- 160 (263)
T d2j4za1 88 APLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 160 (263)
T ss_dssp CTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred cCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence 99999999994 44579999999999999999999999 999999999999999999999999999997654332
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.. ..+....... .
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~----------~ 221 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRVE----------F 221 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTC----------C
T ss_pred -ccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC----------C
Confidence 2345799999999998875 7899999999999999999999999654321 1122211111 1
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+...+..+.+|+.+||+.||.+|||+.||++
T Consensus 222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 223345678999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-55 Score=398.50 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=205.8
Q ss_pred ccccccccCCceEEEEEEeCC------CcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (369)
.+.++||+|+||+||+|++.. ...||+|.+...........+.+|+.++.++ +|||||++++++.+.+..++|
T Consensus 40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (325)
T d1rjba_ 40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119 (325)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEE
Confidence 456899999999999998743 2379999987655555567899999999988 899999999999999999999
Q ss_pred EeccCCCCHHHHhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceE
Q 017591 100 YEFMENGSLDKYLFTDT----------------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANIL 157 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nil 157 (369)
||||++|+|.+++.... ..+++..++.|+.|+++||+|||+ ++|+||||||+|||
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVL 196 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEE
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhccc
Confidence 99999999999995432 358999999999999999999999 99999999999999
Q ss_pred ecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 017591 158 LDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTL 236 (369)
Q Consensus 158 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~ 236 (369)
++.++.+||+|||+|+...............||+.|+|||++.++ .++.++|||||||++|||+| |+.||........
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876554444344456689999999998875 79999999999999999997 8999976543311
Q ss_pred CccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhc
Q 017591 237 DWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLE 298 (369)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~ 298 (369)
+.... ........+...+..+.+|+.+||+.||++|||+++|++.|.
T Consensus 276 ------~~~~~---------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 276 ------FYKLI---------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ------HHHHH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ------HHHHH---------hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11111 122223344556778999999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-55 Score=387.59 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=193.5
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe--CCceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD--QTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 101 (369)
+.+.+.||+|+||+||+|+++ +|+.||+|++... ..+.....+.+|+.++++++||||+++++++.+ .+..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 345689999999999999874 5899999998654 344556779999999999999999999999975 356899999
Q ss_pred ccCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhcc--CCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 102 FMENGSLDKYLFT---DTEVLKWEKLLDIAIGTARGIAYLHEEC--NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 102 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
||++|+|.+++.. ....+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 9999999999853 3567999999999999999999999821 1239999999999999999999999999998765
Q ss_pred CCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 177 PENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.. .+. ..+
T Consensus 166 ~~~~--~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-------~~~---------~~i 226 (269)
T d2java1 166 HDTS--FAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELA---------GKI 226 (269)
T ss_dssp ------------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHH---------HHH
T ss_pred cCCC--ccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-------HHH---------HHH
Confidence 3322 22346799999999998764 7899999999999999999999999653321 111 122
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........+..++..+.+|+.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 222333344556778999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=385.69 Aligned_cols=247 Identities=22% Similarity=0.311 Sum_probs=204.0
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||+||+|.+ .+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+++..++|||||+
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 45568899999999999987 46999999998754322 24678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+|+|.+++.. ..+++..++.|+.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 101 gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~ 173 (293)
T d1yhwa1 101 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 173 (293)
T ss_dssp TCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CB
T ss_pred CCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--cc
Confidence 9999998843 469999999999999999999999 9999999999999999999999999999998754332 22
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....||+.|+|||++.++ .++.++|||||||++|+|++|+.||....... ....... ........
T Consensus 174 ~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~--------~~~~~~~~ 238 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIAT--------NGTPELQN 238 (293)
T ss_dssp CCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH--------HCSCCCSS
T ss_pred cccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHh--------CCCCCCCC
Confidence 346799999999998875 78999999999999999999999996543211 0011100 11111223
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 4456788999999999999999999999863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=387.77 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=205.4
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||+||+|++. +++.||+|++..... .....+.+|+.++++++|||||++++++.+++..++|||||+
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 345678999999999999884 689999999875433 335678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+|+|.+++......+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|...... ....
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~ 167 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 167 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHH
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC--cccc
Confidence 999999986667789999999999999999999999 99999999999999999999999999999764321 1122
Q ss_pred ccCCCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 185 SGYRGTPGYSAPEFLLR----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
....||+.|+|||++.. +..++.++|||||||++|||++|+.||....... .......+. ..
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------~~~~i~~~~-------~~ 233 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSE-------PP 233 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHHSC-------CC
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCC-------CC
Confidence 34679999999998752 3468999999999999999999999997544321 111111111 11
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12233456778999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=380.09 Aligned_cols=245 Identities=27% Similarity=0.432 Sum_probs=197.7
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe----CCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD----QTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 100 (369)
.|.++||+|+||+||+|.+. ++..||+|.+... ........+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 46678999999999999885 5889999988643 344556789999999999999999999999875 34578999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCC--eEeecCCCCceEec-CCCCeeEeecCCceecCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQR--IIHYDIKPANILLD-AKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 177 (369)
||+++|+|.+++. ....+++..++.++.|+++||+|||+ ++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHh-ccccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999994 44679999999999999999999999 78 99999999999996 578999999999986432
Q ss_pred CCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
.. .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ..++.....+..
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~----- 230 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVK----- 230 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCC-----
T ss_pred Cc----cCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCC-----
Confidence 22 234579999999998865 5899999999999999999999999754322 111222211111
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 ---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 01112223456899999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=388.63 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=201.5
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||+||+|+++ +|+.||||++.... .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 456789999999999999884 68999999986432 222346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+++|+|.+++. ..+.+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 90 ~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 90 AKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 99999999984 44679999999999999999999999 999999999999999999999999999999876544444
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.. .+.... .... .
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i---------~~~~-~ 227 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------LIFQKI---------IKLE-Y 227 (288)
T ss_dssp ----CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHH---------HTTC-C
T ss_pred ccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHH-------HHHHHH---------HcCC-C
Confidence 44456799999999998875 7899999999999999999999999754321 111111 1111 1
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVV 294 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~ 294 (369)
..+...+..+.+|+.+||+.||.+|||+.|++
T Consensus 228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 22334567899999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=396.13 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=203.4
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||+||+|++. +|+.||+|+++.........++.+|+.+++.++|||||+++++|.+++..++||||++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 344589999999999999874 6899999998766555666789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
+|+|.+++.+ ...+++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 88 gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~ 160 (322)
T d1s9ja_ 88 GGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 160 (322)
T ss_dssp TEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC
T ss_pred CCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----cc
Confidence 9999999954 45799999999999999999999971 48999999999999999999999999999865321 12
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc-ccchh-------------------
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF-PKQVW------------------- 244 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~-~~~~~------------------- 244 (369)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||........... .....
T Consensus 161 ~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp ---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred ccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 345799999999999875 799999999999999999999999976543211000 00000
Q ss_pred ---HHhh---hchhhhhhhcCCCCC-CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 245 ---DEYE---KGELAAKVLGCGIEE-NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 245 ---~~~~---~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.... ..+..........+. .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000 000000111111111 11223567899999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-53 Score=387.95 Aligned_cols=250 Identities=21% Similarity=0.312 Sum_probs=189.5
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.+.||+|+||+||+|+++ +++.||||++...........+.+|+.+++.++||||+++++++.+++..++|||||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 3566789999999999999885 589999999876544444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec---CCCCeeEeecCCceecCCCCC
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD---AKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
+||+|.+++ .....+++..+..++.|++.||+|||+ ++|+||||||+|||+. .++.+||+|||+++.......
T Consensus 90 ~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 90 SGGELFDRI-VEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp CSCBHHHHH-HTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred CCCcHHHhh-hcccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 999999999 455689999999999999999999999 9999999999999994 578999999999986543322
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.....+.. ..
T Consensus 166 ---~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~------~~ 228 (307)
T d1a06a_ 166 ---LSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEY------EF 228 (307)
T ss_dssp ----------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCC------CC
T ss_pred ---eeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCC------CC
Confidence 2335699999999998875 78999999999999999999999997533211 1111111110 01
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11223455678999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=382.03 Aligned_cols=254 Identities=30% Similarity=0.435 Sum_probs=203.2
Q ss_pred hccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
..+.+.||+|+||.||+|+++++..||||++...... ...|.+|+.++++++|||||++++++. .+..++||||+++
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 95 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence 4566899999999999999988889999998754332 367999999999999999999999985 4568999999999
Q ss_pred CCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 106 GSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 106 gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
|+|..++... ...+++.+++.++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~ 171 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TAR 171 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-eee
Confidence 9999998643 3569999999999999999999999 9999999999999999999999999999987653332 223
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEEN 264 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (369)
....||+.|+|||++..+ .++.++|||||||++|||++|..|+...... . ++...+......+.
T Consensus 172 ~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~---------~~~~~i~~~~~~~~ 235 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN------R---------EVLDQVERGYRMPC 235 (285)
T ss_dssp ----CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------H---------HHHHHHHTTCCCCC
T ss_pred ccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------H---------HHHHHHHhcCCCCC
Confidence 345699999999999875 7899999999999999999987776543321 1 11112222223344
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 265 DREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
+...++.+.+|+.+||+.||++||++++|+++|+....
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 55567789999999999999999999999999998643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-53 Score=387.62 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=212.2
Q ss_pred hhcc--ccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCce
Q 017591 25 TNNY--STKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 25 t~~f--~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 96 (369)
+++| .++||+|+||+||+|+++ ++..||||++..........+|.+|+.+++.++||||+++++++.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 4445 589999999999999864 35789999998766667778899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCC
Q 017591 97 ALVYEFMENGSLDKYLFTD-----------------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKP 153 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp 153 (369)
++||||+++|+|.+++... ...+++..++.|+.|++.||+|||+ ++++||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcc
Confidence 9999999999999999532 1248999999999999999999999 9999999999
Q ss_pred CceEecCCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCC-CCCCCC
Q 017591 154 ANILLDAKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRK-NAQDCS 232 (369)
Q Consensus 154 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~-p~~~~~ 232 (369)
+|||++.++.+||+|||+++...............||+.|+|||.+... .++.++|||||||++|||++|.. ||....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999876544444444456789999999998875 79999999999999999999965 554332
Q ss_pred CCccCccccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 233 SDTLDWFPKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.. ++...+.....+..+...+..+.+|+.+||+.||++||||.+|+++|+.+.
T Consensus 248 ~~----------------e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HE----------------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HH----------------HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 21 111222233334445566778999999999999999999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-53 Score=385.42 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=201.2
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+...++||+|+||+||+|++ .+|+.||||++.... .......+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 34457899999999999987 468999999986532 344556799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
|.+|+|..++ .....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 97 CLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp CSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred cCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 9999997766 445689999999999999999999999 9999999999999999999999999999986432
Q ss_pred ccccCCCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 183 STSGYRGTPGYSAPEFLLR--NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~--~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.....||+.|+|||++.. ...++.++|||||||++|||++|+.||....... ..... .....
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-------~~~~i--------~~~~~ 231 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHI--------AQNES 231 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHH--------HHSCC
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-------HHHHH--------HhCCC
Confidence 233569999999999864 2358999999999999999999999997543211 01111 11111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
........++.+.+|+.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11223345678999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=383.62 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=212.1
Q ss_pred hhccccccccCCceEEEEEEeCCC----cEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC-CceEEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPNG----VKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ-TKAALV 99 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv 99 (369)
+.+|.++||+|+||+||+|++.++ ..||||.++.........+|.+|+.++++++||||+++++++.+. ...++|
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 446678999999999999987442 368999988666667778899999999999999999999998764 578999
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
||||++|+|.+++......+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999999997777789999999999999999999999 999999999999999999999999999998765433
Q ss_pred Cc--cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhh
Q 017591 180 TH--DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 180 ~~--~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (369)
.. .......||..|+|||.+..+ .++.++||||||+++|||++|+.||....... ++.....
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---------------~~~~~i~ 248 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---------------DITVYLL 248 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC---------------------CHHHHH
T ss_pred cccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---------------HHHHHHH
Confidence 22 223345789999999988875 78999999999999999999988876433221 1111122
Q ss_pred cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 258 GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
....+..+...+..+.+|+.+||+.||++||++.||++.|+...
T Consensus 249 ~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22233334455678999999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-52 Score=387.15 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=208.7
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
+.+.++||+|+||+||+|.+ .+|+.||+|++..... .....+.+|+.++++++||||+++++++.+++..++|||||+
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 45668999999999999987 4699999999875433 345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec--CCCCeeEeecCCceecCCCCCcc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD--AKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+|+|.+++...+..+++..++.|+.||+.||.|||+ +||+||||||+||||+ .++.+||+|||++..+......
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~- 185 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV- 185 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE-
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCce-
Confidence 999999886667789999999999999999999999 9999999999999997 6789999999999987654332
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .......+.. ....
T Consensus 186 --~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~------~~~~ 249 (352)
T d1koba_ 186 --KVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDW------EFDE 249 (352)
T ss_dssp --EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCC------CCCS
T ss_pred --eeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC------CCCc
Confidence 335699999999988775 78999999999999999999999997543211 1111111110 1112
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH--HhcC
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPPMSAVVK--MLEG 299 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~--~L~~ 299 (369)
......+..+.+|+.+||+.||.+|||+.|+++ ++++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 223456678999999999999999999999986 3544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-53 Score=376.29 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=201.2
Q ss_pred hhccccccccCCceEEEEEEeCC----CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFPN----GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.+.||+|+||.||+|.+.. +..||+|.+...........+.+|+.++++++||||+++++++. .+..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 34566899999999999998743 35789999876666677788999999999999999999999985 56789999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++|+|.+++......+++..++.++.|+++||.|||+ ++++||||||+||+++.++.+||+|||+++.......
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 9999999999987777889999999999999999999999 9999999999999999999999999999987653322
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
. ......||+.|+|||++..+ .++.++|||||||++|||++ |..||....... +.. .+...
T Consensus 164 ~-~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~---------~i~~~ 225 (273)
T d1mp8a_ 164 Y-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIG---------RIENG 225 (273)
T ss_dssp --------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHH---------HHHTT
T ss_pred e-eccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHH---------HHHcC
Confidence 2 23345689999999998875 78999999999999999998 788886544321 122 22222
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.....+...+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 226 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 23344556678899999999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-53 Score=384.97 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=203.5
Q ss_pred hccccccccCCceEEEEEEeC-CCc----EEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGV----KIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
+.+.++||+|+||+||+|.+. +|+ +||+|.+..........+|.+|+.++++++|||||+++++|.++ ..+++|
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 345689999999999999874 343 68888887555545567899999999999999999999999765 567889
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
+++.+|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999999998765544
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
........||+.|+|||++.++ .++.++|||||||++|||+| |+.||....... +.. .+...
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~---------~i~~~ 229 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISS---------ILEKG 229 (317)
T ss_dssp --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHH---------HHHHT
T ss_pred cccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------HHH---------HHHcC
Confidence 4444455689999999998875 79999999999999999998 677776443221 112 22222
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 260 GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.....+...+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 230 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 33344455677899999999999999999999999988764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.7e-52 Score=384.89 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=206.4
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.++||+|+||+||+|++. +|+.||||++.... ......+.+|+.++++++|||||++++++.+++..++|||||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 3566789999999999999884 68999999987543 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec--CCCCeeEeecCCceecCCCCCc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD--AKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
++|+|.+++......+++..+..|+.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.+......
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 9999999997667789999999999999999999999 9999999999999995 4578999999999987544332
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.. ..+..+..+.. ...
T Consensus 183 ---~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~------~~~ 245 (350)
T d1koaa2 183 ---KVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDW------NMD 245 (350)
T ss_dssp ---EEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCC------CSC
T ss_pred ---ceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------CCC
Confidence 335699999999998775 7899999999999999999999999754321 11111111110 001
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.......+..+.+|+.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122345678999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=379.27 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=215.0
Q ss_pred hhhccccccccCCceEEEEEEe------CCCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCce
Q 017591 24 FTNNYSTKLGAGGFGVVYKGQF------PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 24 ~t~~f~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 96 (369)
....|.++||+|+||.||+|++ .+++.||||+++..........+.+|+.++..+ +|||||++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 3445678999999999999975 346799999998766666777899999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHhccCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEec
Q 017591 97 ALVYEFMENGSLDKYLFTDT-----------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLD 159 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~ 159 (369)
++|||||++|+|.+++.... ..+++..+..++.|++.||+|||+ ++++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 99999999999999995432 368999999999999999999999 9999999999999999
Q ss_pred CCCCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc
Q 017591 160 AKFSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF 239 (369)
Q Consensus 160 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 239 (369)
.++.+|++|||+++...............||+.|+|||++..+ .++.++|||||||++|||+|++.|+.......
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~---- 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---- 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999987655555555667899999999998875 78999999999999999999665554332221
Q ss_pred ccchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 240 PKQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
..++. .+.....+..+...+..+.+|+.+||+.||.+|||+.+|+++|++.
T Consensus 255 -~~~~~---------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 255 -SKFYK---------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp -HHHHH---------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHH---------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 01111 1222223344445678899999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=376.19 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=202.7
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEcccccc-----HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLN-----KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAAL 98 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (369)
.+.+.++||+|+||+||+|++ .+|+.||||++..... ......+.+|+.++++++|||||++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 455678999999999999988 4699999999864321 1235679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC----CeeEeecCCcee
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF----SAKVADFGLAKL 174 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~ 174 (369)
|||||++|+|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||++..
T Consensus 91 v~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999943 4579999999999999999999999 9999999999999998776 499999999988
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.....+...
T Consensus 167 ~~~~~~---~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~- 234 (293)
T d1jksa_ 167 IDFGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYE- 234 (293)
T ss_dssp CTTSCB---CSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCCC-
T ss_pred cCCCcc---ccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcCCC-
Confidence 754332 2345699999999998874 78999999999999999999999997543221 11111111100
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.........+..+.+|+.+||+.||.+|||+.++++
T Consensus 235 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111224567899999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=370.00 Aligned_cols=245 Identities=28% Similarity=0.397 Sum_probs=197.8
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC-CceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ-TKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~ 105 (369)
.|.++||+|+||.||+|++ .|..||||+++... ..+.+.+|+.++++++||||+++++++.+. +..++||||+++
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 4568899999999999998 57899999997543 245789999999999999999999998654 568999999999
Q ss_pred CCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 106 GSLDKYLFTDT-EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 106 gsL~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
|+|.+++..+. ..+++..++.|+.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----- 157 (262)
T d1byga_ 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 157 (262)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-----
Confidence 99999996543 469999999999999999999999 999999999999999999999999999998654322
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
....+|..|+|||++.++ .++.++|||||||++|||+| |+.||...... ++...+.....++
T Consensus 158 ~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----------------~~~~~i~~~~~~~ 220 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPRVEKGYKMD 220 (262)
T ss_dssp ----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----------------GHHHHHTTTCCCC
T ss_pred ccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----------------HHHHHHHcCCCCC
Confidence 234588999999998875 79999999999999999998 56666543221 1222233334445
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 264 NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+...+..+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 5556678899999999999999999999999999764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-52 Score=374.90 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=208.7
Q ss_pred hccccccccCCceEEEEEEeCC--------CcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCce
Q 017591 26 NNYSTKLGAGGFGVVYKGQFPN--------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKA 96 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 96 (369)
+.+.+.||+|+||.||+|+... +..||||+++.........++.+|+..+.++ +|||||+++++|.+++..
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence 3456899999999999997632 3479999998777767778899999999888 799999999999999999
Q ss_pred EEEEeccCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC
Q 017591 97 ALVYEFMENGSLDKYLFTDT---------------EVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK 161 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 161 (369)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.+
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTED 171 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTT
T ss_pred EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCC
Confidence 99999999999999995432 358999999999999999999999 999999999999999999
Q ss_pred CCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccc
Q 017591 162 FSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFP 240 (369)
Q Consensus 162 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 240 (369)
+.+||+|||+++...............+|+.|+|||.+..+ .++.++|||||||++|||++ |+.||......
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~------ 244 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ 244 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHH------
Confidence 99999999999877655444445556799999999998875 79999999999999999998 57777543321
Q ss_pred cchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
.++. .+.....+..+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 245 -~~~~---------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 -ELFK---------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -HHHH---------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHH---------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1122 22223334444556678999999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-52 Score=375.34 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=199.4
Q ss_pred hhccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeC-Cce
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQ-TKA 96 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~ 96 (369)
.+.+.++||+|+||.||+|.+. +++.||||+++..........+.+|...+.++ +|+||+.+++++.+. ...
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 3456689999999999999763 24689999998766666677888888888777 689999999988765 468
Q ss_pred EEEEeccCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC
Q 017591 97 ALVYEFMENGSLDKYLFTD---------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK 161 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 161 (369)
++|||||++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+||||+.+
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCC
Confidence 9999999999999999543 2358999999999999999999999 999999999999999999
Q ss_pred CCeeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCC-CCCCCCCCccCccc
Q 017591 162 FSAKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRK-NAQDCSSDTLDWFP 240 (369)
Q Consensus 162 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~-p~~~~~~~~~~~~~ 240 (369)
+.+||+|||+|+...............||+.|+|||++.++ .++.++|||||||++|||++|.. ||.......
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~----- 244 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 244 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-----
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 99999999999876655444444556799999999998875 78999999999999999999754 565433221
Q ss_pred cchhHHhhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 241 KQVWDEYEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.+.... .....+..+...+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 245 -~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 -EFCRRL---------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp -HHHHHH---------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHH---------hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111111 12222334445567899999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-52 Score=377.20 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=202.3
Q ss_pred ccccccccCCceEEEEEEeCC-Cc--EEEEEEccccccHHHHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFPN-GV--KIAAKILKTCLNKRVEAQFMAEIGTIGRT-YHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.|.++||+|+||+||+|.+++ |. .||||.+...........+.+|+.++.++ +||||+++++++.+++..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 356899999999999998754 44 46778776554555567899999999998 699999999999999999999999
Q ss_pred cCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEe
Q 017591 103 MENGSLDKYLFTD---------------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVA 167 (369)
Q Consensus 103 ~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 167 (369)
+++|+|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEc
Confidence 9999999999543 3579999999999999999999999 999999999999999999999999
Q ss_pred ecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCC-CCCCCCCCccCccccchhHH
Q 017591 168 DFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRK-NAQDCSSDTLDWFPKQVWDE 246 (369)
Q Consensus 168 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~ 246 (369)
|||+++...... ......||..|+|||.+..+ .++.++|||||||++|||++|.. ||......
T Consensus 170 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~------------ 233 (309)
T d1fvra_ 170 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------------ 233 (309)
T ss_dssp CTTCEESSCEEC---CC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------------
T ss_pred cccccccccccc---cccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHH------------
Confidence 999998654222 22335689999999999875 78999999999999999999776 45432211
Q ss_pred hhhchhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCc
Q 017591 247 YEKGELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGV 301 (369)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~ 301 (369)
++...+.....+..+...+..+.+|+.+||+.||++|||+.+|++.|++..
T Consensus 234 ----~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 234 ----ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp ----HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111222223334445566788999999999999999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=376.27 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=213.8
Q ss_pred ccccccccCCceEEEEEEeC------CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP------NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.++||+|+||+||+|.+. ++..||||+++..........|.+|+.++++++||||+++++++...+..++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 45688999999999999763 367899999987666666778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCC
Q 017591 101 EFMENGSLDKYLFTD---------TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGL 171 (369)
Q Consensus 101 e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 171 (369)
||+++|+|.+++... ...+++..+..++.|+++||.|||+ ++|+||||||+|||++.++++||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeeccc
Confidence 999999999998532 2357999999999999999999999 9999999999999999999999999999
Q ss_pred ceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCC-CCCCCCCCCccCccccchhHHhhhc
Q 017591 172 AKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRR-KNAQDCSSDTLDWFPKQVWDEYEKG 250 (369)
Q Consensus 172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (369)
++...............||+.|+|||.+.++ .++.++|||||||++|||+||+ .||......
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---------------- 242 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---------------- 242 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----------------
T ss_pred ceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHH----------------
Confidence 9876554444444556799999999998875 7899999999999999999986 555432211
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCCcC
Q 017591 251 ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGGVE 302 (369)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~~~ 302 (369)
+....+........+...+..+.+|+.+||+.||.+|||+.+|++.|+...+
T Consensus 243 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1112222333444455567889999999999999999999999999987643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=378.04 Aligned_cols=246 Identities=24% Similarity=0.290 Sum_probs=203.6
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.+.||+|+||.||+|++ .+|+.||+|++.+.. .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 34568999999999999988 469999999987532 222356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
|++|+|.+++. ....+++..++.++.|++.||+|||+ +||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 87 ~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-- 160 (337)
T d1o6la_ 87 ANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-- 160 (337)
T ss_dssp CTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--
T ss_pred cCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc--
Confidence 99999999984 45679999999999999999999999 9999999999999999999999999999986543222
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+... +......+ ..
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~----------~~ 222 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILME----------EI 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC----------CC
T ss_pred ccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcC----------CC
Confidence 23346799999999988875 78999999999999999999999997644321 11111111 12
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCC-----hHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARPP-----MSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~v~~ 295 (369)
..+...+..+.+|+.+||+.||.+||+ +.++++
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 233456678899999999999999995 677764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=370.51 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=197.4
Q ss_pred ccccccccCCceEEEEEEeC--CC--cEEEEEEcccc--ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP--NG--VKIAAKILKTC--LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.||+|+||.||+|++. ++ ..||||++... .......+|.+|+.++++++||||+++++++.+ ...++||
T Consensus 11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~ 89 (273)
T d1u46a_ 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT 89 (273)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence 45689999999999999763 22 47899988753 233455789999999999999999999999965 4678999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
||+++|+|.+++..+...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 90 ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp ECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 9999999999987777789999999999999999999999 9999999999999999999999999999998754433
Q ss_pred cc-ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCccCccccchhHHhhhchhhhhhhc
Q 017591 181 HD-STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIG-RRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLG 258 (369)
Q Consensus 181 ~~-~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (369)
.. ......|+..|+|||.+.+. .++.++|||||||++|||+| |+.||...+.... .... ...
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-------~~~i--------~~~ 230 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------LHKI--------DKE 230 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHH--------HTS
T ss_pred cceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-------HHHH--------HhC
Confidence 22 23345688899999998875 78999999999999999998 8999865432210 1111 112
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcC
Q 017591 259 CGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEG 299 (369)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~ 299 (369)
...++.+...+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 22234445566789999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-51 Score=373.21 Aligned_cols=242 Identities=25% Similarity=0.328 Sum_probs=201.7
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
.+.+.||+|+||+||+|++ .+|+.||||++.... .......+.+|+.+++.++||||+++++++.+.+..++|||||
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 86 (316)
T d1fota_ 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 86 (316)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeec
Confidence 4568999999999999988 459999999987432 2223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
+||+|..++ .....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~gg~l~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----- 157 (316)
T d1fota_ 87 EGGELFSLL-RKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----- 157 (316)
T ss_dssp CSCBHHHHH-HHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----
T ss_pred CCccccccc-cccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc-----
Confidence 999999988 455678999999999999999999999 99999999999999999999999999999886532
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCCC
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIEE 263 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (369)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+... ..... .... ..
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i---------~~~~-~~ 219 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKI---------LNAE-LR 219 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHH---------HHCC-CC
T ss_pred cccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHH-------HHHHH---------HcCC-CC
Confidence 2346799999999988764 68999999999999999999999997543211 11111 1111 12
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 264 NDREEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
.+...+..+.+++.+||+.||.+|+ ++.++++
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 2334567799999999999999996 8888874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=369.65 Aligned_cols=249 Identities=18% Similarity=0.267 Sum_probs=203.8
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
|.+.+.||+|+||+||+|.++ +++.||+|++..... ....+.+|+.+++.++||||+++++++.+++..++|||||+
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 355689999999999999885 589999999975432 34568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC--CCeeEeecCCceecCCCCCcc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK--FSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
||+|.+++...+..+++.+++.|+.||+.||.|||+ +||+||||||+|||++.+ ..+||+|||++........
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~-- 159 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc--
Confidence 999999996666689999999999999999999999 999999999999999854 4799999999987654332
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
.....+|+.|+|||.+.+. .++.++|||||||++|+|++|..||....... .+..+ ......
T Consensus 160 -~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-------~~~~i---------~~~~~~ 221 (321)
T d1tkia_ 160 -FRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENI---------MNAEYT 221 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHH---------HHTCCC
T ss_pred -ccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-------HHHHH---------HhCCCC
Confidence 2235689999999987764 78999999999999999999999997543221 11111 111111
Q ss_pred CC---CHHHHHHHHHHHHhccccCCCCCCChHHHHH--HhcC
Q 017591 263 EN---DREEAERMSMVALWCVQDCPEARPPMSAVVK--MLEG 299 (369)
Q Consensus 263 ~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~--~L~~ 299 (369)
.. ....+..+.+|+.+||+.||.+|||+.|+++ +++.
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 10 1124567899999999999999999999986 4543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-50 Score=376.17 Aligned_cols=246 Identities=21% Similarity=0.245 Sum_probs=198.7
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEccccc-----cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL-----NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (369)
.+.+.||+|+||.||+|++. +|+.||+|++.... .........+++.+++.++||||+++++++.+.+..++||
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm 86 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 86 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence 45689999999999999885 59999999986421 1112223344577888889999999999999999999999
Q ss_pred eccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCC
Q 017591 101 EFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENT 180 (369)
Q Consensus 101 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 180 (369)
|||++|+|.+++. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 87 E~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 87 DLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp CCCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EecCCCcHHHHHH-hcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 9999999999994 44678999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCC
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCG 260 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (369)
.....||+.|+|||++..+..++.++|||||||++|||++|+.||........ .. +.. .....
T Consensus 162 ---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~------~~~-~~~~~ 224 (364)
T d1omwa3 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------HE------IDR-MTLTM 224 (364)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-------HH------HHH-HSSSC
T ss_pred ---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-------HH------HHH-hcccC
Confidence 23457999999999988766789999999999999999999999976543321 00 001 11111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCC-----hHHHH
Q 017591 261 IEENDREEAERMSMVALWCVQDCPEARPP-----MSAVV 294 (369)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~v~ 294 (369)
....+...+..+.+|+.+||+.||.+||| +.+++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil 263 (364)
T d1omwa3 225 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263 (364)
T ss_dssp CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHH
Confidence 12233445678999999999999999999 57776
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.5e-51 Score=363.69 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=203.2
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEccccc--------cHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCce
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--------NKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKA 96 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 96 (369)
.+.+.||+|+||+||+|++ .+|+.||||++.... .......+.+|+.+++++. ||||+++++++.+++..
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 85 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 85 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence 4568999999999999988 468999999986432 1233456889999999997 99999999999999999
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecC
Q 017591 97 ALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCN 176 (369)
Q Consensus 97 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 176 (369)
+||||||++|+|.+++.. ...+++..++.++.||++||+|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999999999954 5579999999999999999999999 999999999999999999999999999999875
Q ss_pred CCCCccccccCCCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhch
Q 017591 177 PENTHDSTSGYRGTPGYSAPEFLLR-----NYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGE 251 (369)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (369)
.... .....||..|+|||++.. ...++.++||||+||++|+|++|+.||....... .......+.
T Consensus 162 ~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~~~~ 231 (277)
T d1phka_ 162 PGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIMSGN 231 (277)
T ss_dssp TTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTC
T ss_pred CCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHHhCC
Confidence 4332 234569999999998863 2356889999999999999999999997543211 111111111
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
. ..........++.+.+|+.+||+.||.+||++.+|++
T Consensus 232 ~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 232 Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 0112223456778999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5e-51 Score=365.83 Aligned_cols=257 Identities=21% Similarity=0.332 Sum_probs=199.3
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCc----eE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTK----AA 97 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~ 97 (369)
.|.+.+.||+|+||+||+|.+ .+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.+. .+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 355678999999999999987 469999999987532 34556789999999999999999999999986543 78
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||++|++|.+++. ....+++.+++.++.|++.||.|||+ +||+||||||+|||++.++..+++|||.+.....
T Consensus 88 lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 9999999999999884 44579999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC-ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 178 ENT-HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 178 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .............
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~~-- 234 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPP-- 234 (277)
T ss_dssp ---------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCG--
T ss_pred ccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCCCC--
Confidence 322 2233446799999999998764 78999999999999999999999997543221 0111111111100
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCC-ChHHHHHHhcC
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARP-PMSAVVKMLEG 299 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~v~~~L~~ 299 (369)
.......+..+.+++.+||+.||.+|| +++++++.|.+
T Consensus 235 -----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 -----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 111234567899999999999999999 89999888764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=367.03 Aligned_cols=268 Identities=26% Similarity=0.318 Sum_probs=199.5
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC----ceEEEEec
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT----KAALVYEF 102 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~ 102 (369)
-+.++||+|+||+||+|++ +|+.||||++.... ......+.|+..+..++||||+++++++.+.+ ..++||||
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 4568899999999999997 78999999987532 22233445667777889999999999998654 57899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc-----CCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC-----NQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~-----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
|++|+|.+++.+ ..+++..++.++.|++.||.|||+.. .+||+||||||+||||+.++.+||+|||+++....
T Consensus 83 ~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 83 HEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 999999999954 36999999999999999999999621 26999999999999999999999999999987754
Q ss_pred CCCcc--ccccCCCCCCccccccccccC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcccc----chhHH
Q 017591 178 ENTHD--STSGYRGTPGYSAPEFLLRNY-----PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPK----QVWDE 246 (369)
Q Consensus 178 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~----~~~~~ 246 (369)
..... ......||+.|+|||++.... .++.++|||||||+||||+||..|+.........+... .....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 33221 234467999999999877531 25779999999999999999998876544332211100 00011
Q ss_pred hhhchhhhhhhcCCCCC--CCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 247 YEKGELAAKVLGCGIEE--NDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 247 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.... ..........+. ........+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 241 ~~~~-~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 241 MRKV-VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHH-HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1100 000000111111 1334567799999999999999999999999999764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-50 Score=372.52 Aligned_cols=243 Identities=21% Similarity=0.226 Sum_probs=201.6
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEec
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (369)
+.+.++||+|+||.||+|+++ +|+.||||++.... .......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 344589999999999999884 69999999986432 222345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcc
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHD 182 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 182 (369)
+.+|+|..++.. ...+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 123 ~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--- 195 (350)
T d1rdqe_ 123 VAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--- 195 (350)
T ss_dssp CTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---
T ss_pred ccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc---
Confidence 999999999944 4579999999999999999999999 999999999999999999999999999998765322
Q ss_pred ccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCCC
Q 017591 183 STSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGIE 262 (369)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (369)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ........+ ..
T Consensus 196 --~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i~~~----------~~ 255 (350)
T d1rdqe_ 196 --WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSG----------KV 255 (350)
T ss_dssp --CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC----------CC
T ss_pred --ccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHH-------HHHHHHhcC----------CC
Confidence 235699999999998874 7899999999999999999999999754321 111111111 12
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCC-----ChHHHHH
Q 017591 263 ENDREEAERMSMVALWCVQDCPEARP-----PMSAVVK 295 (369)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~v~~ 295 (369)
..+...+..+.+|+.+||+.||.+|+ ++.++++
T Consensus 256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 22344567899999999999999994 8899875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=368.27 Aligned_cols=257 Identities=25% Similarity=0.274 Sum_probs=195.5
Q ss_pred cccccCCceEEEEEEeC-CCcEEEEEEccccccH----HHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccC
Q 017591 30 TKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNK----RVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFME 104 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (369)
++||+|+||+||+|+++ +|+.||||+++..... .....+.+|+.+++.++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 57999999999999984 5899999998743221 123468899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCcccc
Q 017591 105 NGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDST 184 (369)
Q Consensus 105 ~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 184 (369)
++++..+. .....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++........ .
T Consensus 84 ~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~ 157 (299)
T d1ua2a_ 84 TDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--Y 157 (299)
T ss_dssp EEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--C
T ss_pred chHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc--c
Confidence 87666555 566789999999999999999999999 99999999999999999999999999999866543322 2
Q ss_pred ccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhh---------chhhhh
Q 017591 185 SGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEK---------GELAAK 255 (369)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 255 (369)
....||+.|+|||++..+..++.++|||||||++|||++|..||......... ..+.+.... ......
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhccchh
Confidence 33569999999999877667899999999999999999999998754321100 000000000 000000
Q ss_pred hhcCCCCCCC-----HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 VLGCGIEEND-----REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 ~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
......+..+ ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000001111 123567899999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=370.84 Aligned_cols=245 Identities=24% Similarity=0.302 Sum_probs=200.2
Q ss_pred hccccccccCCceEEEEEEeC-CCcEEEEEEccccc--cHHHHHHHHHHHHHHh-ccCCCceeeEEeEEEeCCceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCL--NKRVEAQFMAEIGTIG-RTYHINLVRLYGFCYDQTKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e 101 (369)
+.+.++||+|+||+||+|+++ +|+.||||++.+.. .......+..|..++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 456789999999999999885 59999999987532 1222345667776665 6899999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
|+++|+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 y~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~- 158 (320)
T d1xjda_ 84 YLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 158 (320)
T ss_dssp CCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred ecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccccc-
Confidence 999999999994 45679999999999999999999999 9999999999999999999999999999986543322
Q ss_pred cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcCCC
Q 017591 182 DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGCGI 261 (369)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (369)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.. .++.....+ .
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~----------~ 219 (320)
T d1xjda_ 159 -KTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMD----------N 219 (320)
T ss_dssp -CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC----------C
T ss_pred -cccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC----------C
Confidence 23446799999999999875 7899999999999999999999999754332 112222111 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCChH-HHH
Q 017591 262 EENDREEAERMSMVALWCVQDCPEARPPMS-AVV 294 (369)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~v~ 294 (369)
+..+...+..+.+|+.+||+.||.+||++. +|+
T Consensus 220 ~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 220 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 233344567899999999999999999995 665
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=362.88 Aligned_cols=263 Identities=23% Similarity=0.260 Sum_probs=197.9
Q ss_pred cccccccCCceEEEEEEe-CCCcEEEEEEcccccc-HHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 28 YSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLN-KRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 28 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
+.++||+|+||+||+|.+ .+|+.||+|+++.... .....++.+|+.++++++||||+++++++.+.+..++||||+.+
T Consensus 6 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC
Confidence 457999999999999988 5699999999865432 22356789999999999999999999999999999999999987
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+.+..........+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||.++....... ...
T Consensus 86 ~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~ 160 (298)
T d1gz8a_ 86 DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT 160 (298)
T ss_dssp EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTT
T ss_pred chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc--cce
Confidence 54444434456779999999999999999999999 9999999999999999999999999999987654332 233
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhchhhhhhh
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGELAAKVL 257 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 257 (369)
...||+.|+|||.+.....++.++|||||||++|+|++|+.||...+..... ......+.......-.....
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence 4579999999998887667799999999999999999999999754321100 00000000000000000000
Q ss_pred cCCCCC----CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 258 GCGIEE----NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 258 ~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...... .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000 01123467899999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=365.93 Aligned_cols=243 Identities=22% Similarity=0.298 Sum_probs=193.0
Q ss_pred cccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhc-cCCCceeeEEeEEEe----CCceEEEEecc
Q 017591 30 TKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGR-TYHINLVRLYGFCYD----QTKAALVYEFM 103 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~~lv~e~~ 103 (369)
+.||+|+||+||+|++ .+++.||||++... ..+.+|+.++.+ .+||||+++++++.+ ....++|||||
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 4699999999999987 56899999998642 356789988655 479999999999875 35689999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC---CCCeeEeecCCceecCCCC
Q 017591 104 ENGSLDKYLFTD-TEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA---KFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 104 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 179 (369)
+||+|.+++... ...+++.+++.|+.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++......
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccCCC
Confidence 999999999654 3579999999999999999999999 99999999999999975 4579999999998765433
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhhhcC
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKVLGC 259 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (369)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... .+......+. .
T Consensus 169 ~---~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~-------~ 234 (335)
T d2ozaa1 169 S---LTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQ-------Y 234 (335)
T ss_dssp C---CCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS-------S
T ss_pred c---cccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCC-------C
Confidence 2 2345799999999988764 78999999999999999999999997654322100 0000000000 0
Q ss_pred CCC-CCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 260 GIE-ENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 260 ~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..+ ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 011 112345678999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-49 Score=358.21 Aligned_cols=263 Identities=22% Similarity=0.257 Sum_probs=199.7
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEccccc-cHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEeccCC
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCL-NKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFMEN 105 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (369)
...++||+|+||+||+|++++|+.||||++.... ......++.+|+.++++++||||+++++++.+.+..+++||++.+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence 4558899999999999999999999999986532 223356899999999999999999999999999999999999988
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccccc
Q 017591 106 GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDSTS 185 (369)
Q Consensus 106 gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 185 (369)
+.+..+. .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.+........ ...
T Consensus 85 ~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~ 158 (286)
T d1ob3a_ 85 DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYT 158 (286)
T ss_dssp EHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred hhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccc
Confidence 6665555 666789999999999999999999999 9999999999999999999999999999987653322 223
Q ss_pred cCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhchhhhh--
Q 017591 186 GYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGELAAK-- 255 (369)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-- 255 (369)
...+++.|+|||.+.....++.++|||||||++|||++|+.||......... ......|...........
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 3468999999999887667899999999999999999999999754321100 000000000000000000
Q ss_pred --hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 256 --VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 256 --~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.............+..+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001112334567899999999999999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=358.06 Aligned_cols=240 Identities=22% Similarity=0.331 Sum_probs=194.7
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEcccccc-----HHHHHHHHHHHHHHhccC--CCceeeEEeEEEeCCce
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLN-----KRVEAQFMAEIGTIGRTY--HINLVRLYGFCYDQTKA 96 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~ 96 (369)
.+.+.+.||+|+||+||+|++ .+|+.||||++..... .....++.+|+.++++++ ||||+++++++.+++..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 355678999999999999988 4689999999864311 111234678999999886 89999999999999999
Q ss_pred EEEEeccCC-CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCC-CCeeEeecCCcee
Q 017591 97 ALVYEFMEN-GSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAK-FSAKVADFGLAKL 174 (369)
Q Consensus 97 ~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~ 174 (369)
++||||+.+ +++.+++ .....+++..++.++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|||++..
T Consensus 85 ~lv~e~~~~~~~l~~~~-~~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEECCSSEEEHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeccCcchHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccccee
Confidence 999999976 5777777 345679999999999999999999999 999999999999999854 7899999999987
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
..... .+...||+.|+|||++.....++.++|||||||++|||++|+.||.... ....+.
T Consensus 161 ~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~--- 220 (273)
T d1xwsa_ 161 LKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ--- 220 (273)
T ss_dssp CCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC---
T ss_pred ccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhcc---
Confidence 54332 2345799999999998876556788999999999999999999996321 111111
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 255 KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 221 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 -------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1112234577899999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=352.78 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=193.4
Q ss_pred hccccccccCCceEEEEEEe-CC-CcEEEEEEcccccc-HHHHHHHHHHHHHHhcc---CCCceeeEEeEEEe-----CC
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PN-GVKIAAKILKTCLN-KRVEAQFMAEIGTIGRT---YHINLVRLYGFCYD-----QT 94 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~ 94 (369)
+.+.++||+|+||+||+|++ ++ ++.||||++..... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 44568999999999999987 34 66799999864322 12223456777776655 79999999999863 24
Q ss_pred ceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 95 KAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 95 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
..+++|||+.++.+..........+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 6799999999977766665667789999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHH
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDE 246 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~ 246 (369)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..... ......|..
T Consensus 166 ~~~~---~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 166 YSFQ---MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCGG---GGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hccc---ccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 4322 233456799999999988775 7999999999999999999999999755422100 000000000
Q ss_pred hhh--chhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 247 YEK--GELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 247 ~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... ...................+..+.+|+.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000000000011122334567889999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=342.31 Aligned_cols=264 Identities=19% Similarity=0.221 Sum_probs=205.0
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCCceEEEEecc
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQTKAALVYEFM 103 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (369)
+...++||+|+||+||+|++ .+++.||||+++.. .......++.+|+.+++.++||||+++++++.+....++||+++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 34558999999999999988 46899999998643 33455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCccc
Q 017591 104 ENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTHDS 183 (369)
Q Consensus 104 ~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 183 (369)
.+++|..++ .....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||.++........
T Consensus 84 ~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-- 157 (292)
T d1unla_ 84 DQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-- 157 (292)
T ss_dssp SEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--
T ss_pred ccccccccc-ccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc--
Confidence 998888877 566789999999999999999999999 99999999999999999999999999999887543332
Q ss_pred cccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc---------ccchhHHhh----hc
Q 017591 184 TSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF---------PKQVWDEYE----KG 250 (369)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~---------~~~~~~~~~----~~ 250 (369)
.....++..|+|||.+.....++.++|||||||++|||++|+.||........... ....+.... ..
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 23345788999999888766689999999999999999999999865433211000 000000000 00
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 251 ELAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.....................+.+|+.+||+.||.+|||++||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000011112223344567899999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=353.82 Aligned_cols=264 Identities=22% Similarity=0.286 Sum_probs=196.2
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC----ceEEEEe
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT----KAALVYE 101 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 101 (369)
...++||+|+||+||+|.+ .+|+.||||++..........++.+|+.+++.++||||+++++++.... ..+++++
T Consensus 11 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~ 90 (345)
T d1pmea_ 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT 90 (345)
T ss_dssp EEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE
Confidence 3458999999999999987 5799999999986556666778999999999999999999999997553 2345555
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCCCc
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPENTH 181 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 181 (369)
++.+|+|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus 91 ~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 91 HLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp ECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred eecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 6678899999943 369999999999999999999999 99999999999999999999999999999876543222
Q ss_pred -cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCcc-------ccc-hhHHhhhchh
Q 017591 182 -DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWF-------PKQ-VWDEYEKGEL 252 (369)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~-------~~~-~~~~~~~~~~ 252 (369)
.......||+.|+|||++..+..++.++||||+||++|+|++|+.||........... +.. ..........
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence 1234467999999999987766789999999999999999999999975443111000 000 0000000000
Q ss_pred hhhh--hcCCCCC----CCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 253 AAKV--LGCGIEE----NDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 253 ~~~~--~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.... ....... .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000000 01123457889999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=355.13 Aligned_cols=259 Identities=22% Similarity=0.226 Sum_probs=193.4
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC------CceE
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ------TKAA 97 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 97 (369)
+++..++||+|+||+||+|++. +|+.||||++..... .+.+|+.++++++|+||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 4556688999999999999984 699999999875322 234799999999999999999998643 2478
Q ss_pred EEEeccCCCCHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-CeeEeecCCcee
Q 017591 98 LVYEFMENGSLDKYLF--TDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-SAKVADFGLAKL 174 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~ 174 (369)
+|||||+++.+..+.. .....+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999998764443332 345689999999999999999999999 9999999999999999775 899999999987
Q ss_pred cCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHH
Q 017591 175 CNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDE 246 (369)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~ 246 (369)
....... ....||..|+|||.+.....++.++|||||||++|||++|+.||......... ......+..
T Consensus 173 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 6543322 33569999999998877668999999999999999999999999755432100 000000100
Q ss_pred hhhchhhhhhhcC-----CCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 247 YEKGELAAKVLGC-----GIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 247 ~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
..... ....... .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNY-TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccch-hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000000 000112234567899999999999999999999984
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=351.13 Aligned_cols=258 Identities=23% Similarity=0.287 Sum_probs=192.8
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeCC------ceEE
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQT------KAAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l 98 (369)
...++||+|+||+||+|.+ .+|+.||||+++.. ........+.+|+.+++.++|||||+++++|...+ ..++
T Consensus 21 ~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 100 (346)
T d1cm8a_ 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 100 (346)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEE
Confidence 3347899999999999987 45999999998753 34455678999999999999999999999997654 4699
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+ +.+|..++. ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+|++|||+++.....
T Consensus 101 v~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 101 VMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp EEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccCCc
Confidence 99999 557887773 3469999999999999999999999 99999999999999999999999999999876433
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCcc--------CccccchhHHhhhc
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTL--------DWFPKQVWDEYEKG 250 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~ 250 (369)
. +...||+.|+|||.+.+...++.++|||||||++|+|++|+.||........ ...+...+......
T Consensus 175 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 175 M-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp C-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 2 3456999999999988766789999999999999999999999976542211 00001111111000
Q ss_pred hhh--hhhh----cCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 251 ELA--AKVL----GCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 251 ~~~--~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... .... ...........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000 00001112234567889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=344.53 Aligned_cols=266 Identities=21% Similarity=0.257 Sum_probs=193.5
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEe--------CCc
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYD--------QTK 95 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~ 95 (369)
+.+.++||+|+||+||+|++ .+|+.||||++... .......++.+|+.+++.++|||++++++++.. .+.
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence 34558999999999999988 46999999998643 222334678899999999999999999998864 346
Q ss_pred eEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceec
Q 017591 96 AALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLC 175 (369)
Q Consensus 96 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 175 (369)
.++||||+.++.+.... .....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++...
T Consensus 92 ~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp EEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 89999999886665444 566789999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCc--cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhH
Q 017591 176 NPENTH--DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWD 245 (369)
Q Consensus 176 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~ 245 (369)
...... .......||+.|+|||.+.....++.++|||||||++|||++|+.||......... ......+.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 543322 12233569999999999887667899999999999999999999999754321100 00000000
Q ss_pred HhhhchhhhhhhcCCCCCCC-------HHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 246 EYEKGELAAKVLGCGIEEND-------REEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
.................... ......+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00000000000000000110 111346778999999999999999999884
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-46 Score=339.37 Aligned_cols=259 Identities=20% Similarity=0.217 Sum_probs=198.4
Q ss_pred hhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc-eeeEEeEEEeCCceEEEEec
Q 017591 25 TNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN-LVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.++||+|+||+||+|++ .+|+.||||++..... ..++..|+++++.++|+| |+.+.++..+.+..++||||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 356678999999999999987 4589999998765332 235788999999998666 55556666788889999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC---CCCeeEeecCCceecCCCC
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA---KFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 179 (369)
+. ++|...+......+++..+..++.|++.||+|||+ +||+||||||+|||++. +..++|+|||+|+.+....
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 LG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred cC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 95 57877776777889999999999999999999999 99999999999999853 5579999999999875433
Q ss_pred Cc-----cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhh
Q 017591 180 TH-----DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAA 254 (369)
Q Consensus 180 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (369)
.. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||............ .......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~----~~~~~~~--- 232 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----ERISEKK--- 232 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H----HHHHHHH---
T ss_pred cccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH----HHhhccc---
Confidence 22 223456799999999988764 7899999999999999999999999866544321111 1111100
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 255 KVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
.....+......+..+.+++.+||+.||++||++.++.+.|+..
T Consensus 233 --~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 233 --MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp --HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred --CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00000111123457789999999999999999999998888764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.5e-47 Score=340.36 Aligned_cols=259 Identities=18% Similarity=0.212 Sum_probs=204.1
Q ss_pred hhccccccccCCceEEEEEEeC-CCcEEEEEEccccccHHHHHHHHHHHHHHhccCC-CceeeEEeEEEeCCceEEEEec
Q 017591 25 TNNYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH-INLVRLYGFCYDQTKAALVYEF 102 (369)
Q Consensus 25 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~ 102 (369)
.+.+.++||+|+||+||+|++. +|+.||||++..... ...+.+|++.+..+.| +|++.+++++.+....++||||
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 3456789999999999999874 589999998864332 2356788888888865 8999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecC-----CCCeeEeecCCceecCC
Q 017591 103 MENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDA-----KFSAKVADFGLAKLCNP 177 (369)
Q Consensus 103 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~ 177 (369)
+ +++|.+++...+..+++.++..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|+....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9 679999997777889999999999999999999999 99999999999999964 56899999999998654
Q ss_pred CCCc-----cccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchh
Q 017591 178 ENTH-----DSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGEL 252 (369)
Q Consensus 178 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (369)
.... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~----~~~~i~~~~- 232 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ----KYERIGEKK- 232 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH----HHHHHHHHH-
T ss_pred CccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH----HHHHHHhcc-
Confidence 3221 123446799999999988774 79999999999999999999999998655432211 011111111
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHHHhcCC
Q 017591 253 AAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVKMLEGG 300 (369)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~~L~~~ 300 (369)
............++.+.+++..|+..+|++||+++.+.+.|+..
T Consensus 233 ----~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 233 ----QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp ----HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ----CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00000111122346789999999999999999999988888765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-46 Score=342.46 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=195.9
Q ss_pred hccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeC--CceEEEEe
Q 017591 26 NNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQ--TKAALVYE 101 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 101 (369)
+.+.++||+|+||+||+|++ .+|+.||+|+++... ..++.+|+.++..+. ||||+++++++... ...++|||
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 34558999999999999988 469999999987532 356889999999995 99999999999854 56899999
Q ss_pred ccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCC-CeeEeecCCceecCCCCC
Q 017591 102 FMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKF-SAKVADFGLAKLCNPENT 180 (369)
Q Consensus 102 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 180 (369)
|+.+++|..+. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 113 ~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 113 HVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp CCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred ecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 99999997764 469999999999999999999999 9999999999999998765 589999999987654332
Q ss_pred ccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccc-------cchhHHhhhchh-
Q 017591 181 HDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFP-------KQVWDEYEKGEL- 252 (369)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~- 252 (369)
.....+|+.|+|||.+.....++.++|||||||++|+|++|+.||............ ...+........
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 186 ---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp ---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred ---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 234568999999999887667899999999999999999999999765432110000 000000000000
Q ss_pred ----hhh---------hhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 253 ----AAK---------VLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 253 ----~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
... .............+..+.+|+.+||+.||.+|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000011122334567899999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=345.38 Aligned_cols=252 Identities=21% Similarity=0.227 Sum_probs=200.9
Q ss_pred hccccccccCCceEEEEEEeC----CCcEEEEEEccccc---cHHHHHHHHHHHHHHhccCC-CceeeEEeEEEeCCceE
Q 017591 26 NNYSTKLGAGGFGVVYKGQFP----NGVKIAAKILKTCL---NKRVEAQFMAEIGTIGRTYH-INLVRLYGFCYDQTKAA 97 (369)
Q Consensus 26 ~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 97 (369)
+.+.++||+|+||+||+|+.. +|+.||||+++... .......+.+|+.++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 445689999999999999762 47899999986432 22234568899999999976 89999999999999999
Q ss_pred EEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCC
Q 017591 98 LVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNP 177 (369)
Q Consensus 98 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 177 (369)
+||||+.+|+|.+++. ....+.+..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 106 ~v~e~~~~~~L~~~i~-~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 106 LILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEECCCCSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeecccccHHHHHHH-hcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 9999999999999994 44567899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCccccccCCCCCCccccccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccCccccchhHHhhhchhhhhh
Q 017591 178 ENTHDSTSGYRGTPGYSAPEFLLRNY-PITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLDWFPKQVWDEYEKGELAAKV 256 (369)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (369)
..... .....|++.|++||.+.... .++.++|||||||+||+|++|+.||........ ...+..+..
T Consensus 182 ~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-------~~~i~~~~~---- 249 (322)
T d1vzoa_ 182 DETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-------QAEISRRIL---- 249 (322)
T ss_dssp GGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-------HHHHHHHHH----
T ss_pred ccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHhcc----
Confidence 33322 23457999999999887543 578899999999999999999999986654322 111111111
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----hHHHHH
Q 017591 257 LGCGIEENDREEAERMSMVALWCVQDCPEARPP-----MSAVVK 295 (369)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~v~~ 295 (369)
......+...+..+.+|+.+||+.||.+||+ ++|+++
T Consensus 250 --~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 --KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1112334456788999999999999999995 678774
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=339.38 Aligned_cols=258 Identities=21% Similarity=0.230 Sum_probs=186.8
Q ss_pred ccccccccCCceEEEEEEeC-CCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC------CceEE
Q 017591 27 NYSTKLGAGGFGVVYKGQFP-NGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ------TKAAL 98 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l 98 (369)
.+.++||+|+||+||+|.+. +|+.||||++... .......++.+|+.++++++||||+++++++... +..|+
T Consensus 20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i 99 (355)
T d2b1pa1 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99 (355)
T ss_dssp EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence 34479999999999999985 5999999998753 3345556799999999999999999999999643 67899
Q ss_pred EEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCC
Q 017591 99 VYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPE 178 (369)
Q Consensus 99 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 178 (369)
||||+.++.+ +.+ ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.++++|||+++.....
T Consensus 100 v~Ey~~~~l~-~~~---~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 100 VMELMDANLC-QVI---QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEECCSEEHH-HHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeccchHHH-Hhh---hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhccccc
Confidence 9999987544 444 2458999999999999999999999 99999999999999999999999999998865433
Q ss_pred CCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhh-
Q 017591 179 NTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEK- 249 (369)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~- 249 (369)
. ......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||...+..... ......+.....
T Consensus 173 ~---~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 173 F---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp -----------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred c---ccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 2 23445699999999998774 7899999999999999999999999755422100 000000000000
Q ss_pred ------c-------h---hhhhhhcCCCCCCCHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 250 ------G-------E---LAAKVLGCGIEENDREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 250 ------~-------~---~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
. . .................+..+.+|+.+||+.||++|||++||++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0 00000001111123446778999999999999999999999973
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=337.39 Aligned_cols=259 Identities=18% Similarity=0.223 Sum_probs=192.3
Q ss_pred ccccccccCCceEEEEEEe-CCCcEEEEEEcccc-ccHHHHHHHHHHHHHHhccCCCceeeEEeEEEeC-----CceEEE
Q 017591 27 NYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTC-LNKRVEAQFMAEIGTIGRTYHINLVRLYGFCYDQ-----TKAALV 99 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 99 (369)
...++||+|+||+||+|++ .+|+.||||++... .......++.+|+.+++.++|||++++++++... ...+++
T Consensus 21 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i 100 (348)
T d2gfsa1 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100 (348)
T ss_dssp EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence 3447899999999999987 56999999998753 3344556789999999999999999999998643 344667
Q ss_pred EeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeecCCceecCCCC
Q 017591 100 YEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKLCNPEN 179 (369)
Q Consensus 100 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 179 (369)
|+++.+|+|.+++. ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+|++|||++.....
T Consensus 101 ~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 101 VTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp EEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred EEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCc--
Confidence 77788999999983 3569999999999999999999999 9999999999999999999999999999875432
Q ss_pred CccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCccC--------ccccchhHHhhhch
Q 017591 180 THDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDCSSDTLD--------WFPKQVWDEYEKGE 251 (369)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~ 251 (369)
......||+.|+|||.+.+...++.++|||||||++|+|++|+.||...+..... ..............
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 2234568999999998777657899999999999999999999999754422110 00000000000000
Q ss_pred hhhhhh-cCCCCCC-----CHHHHHHHHHHHHhccccCCCCCCChHHHHH
Q 017591 252 LAAKVL-GCGIEEN-----DREEAERMSMVALWCVQDCPEARPPMSAVVK 295 (369)
Q Consensus 252 ~~~~~~-~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~v~~ 295 (369)
...... ....+.. ....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000 0000111 1123567889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-40 Score=309.53 Aligned_cols=271 Identities=21% Similarity=0.211 Sum_probs=191.7
Q ss_pred ccCHHHH-HHhhhccccccccCCceEEEEEEe-CCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-----------CC
Q 017591 15 RFTLEQL-CSFTNNYSTKLGAGGFGVVYKGQF-PNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-----------HI 81 (369)
Q Consensus 15 ~~~~~el-~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ 81 (369)
++..+|. .+..|.+.++||+|+||+||+|++ .+|+.||||+++.. ......+.+|+.+++.+. |+
T Consensus 3 p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 3 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp CCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 3444553 234577889999999999999988 46999999999753 233456788888887775 57
Q ss_pred ceeeEEeEEEeC--CceEEEEeccCCCCH-HHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceE
Q 017591 82 NLVRLYGFCYDQ--TKAALVYEFMENGSL-DKYL-FTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANIL 157 (369)
Q Consensus 82 niv~~~~~~~~~--~~~~lv~e~~~~gsL-~~~l-~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nil 157 (369)
||+++++++... ...+++|+++..+.. .... ......+++..+..++.|++.||+|||+. .||+||||||+|||
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIl 158 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVL 158 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEE
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHee
Confidence 899999988643 456666666554433 2222 23456899999999999999999999962 78999999999999
Q ss_pred ecCCCC------eeEeecCCceecCCCCCccccccCCCCCCccccccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 017591 158 LDAKFS------AKVADFGLAKLCNPENTHDSTSGYRGTPGYSAPEFLLRNYPITQKCDVYSFGMLLFEIIGRRKNAQDC 231 (369)
Q Consensus 158 l~~~~~------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~s~~sDvwSlGvil~elltg~~p~~~~ 231 (369)
++.++. ++++|||.+...... .....||+.|+|||++... .++.++||||+||++++|++|+.||...
T Consensus 159 l~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 159 MEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeccCcccccceeeEeecccccccccc-----cccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCC
Confidence 987654 899999999865432 2345699999999988865 7899999999999999999999999754
Q ss_pred CCCccCccccchh-----------HHhhhchhhhhhh--------------------cCCCCCCCHHHHHHHHHHHHhcc
Q 017591 232 SSDTLDWFPKQVW-----------DEYEKGELAAKVL--------------------GCGIEENDREEAERMSMVALWCV 280 (369)
Q Consensus 232 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~l~~l~~~cl 280 (369)
............. ............. ...........+..+.+|+.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 4321100000000 0000000000000 00012345677889999999999
Q ss_pred ccCCCCCCChHHHHH
Q 017591 281 QDCPEARPPMSAVVK 295 (369)
Q Consensus 281 ~~~p~~RPs~~~v~~ 295 (369)
+.||.+|||++|+++
T Consensus 313 ~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVN 327 (362)
T ss_dssp CSSTTTCBCHHHHHT
T ss_pred CCChhHCcCHHHHhc
Confidence 999999999999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.7e-25 Score=187.86 Aligned_cols=164 Identities=13% Similarity=0.122 Sum_probs=121.9
Q ss_pred ccccccccCCceEEEEEEeCCCcEEEEEEcccccc-----------------HHHHHHHHHHHHHHhccCCCceeeEEeE
Q 017591 27 NYSTKLGAGGFGVVYKGQFPNGVKIAAKILKTCLN-----------------KRVEAQFMAEIGTIGRTYHINLVRLYGF 89 (369)
Q Consensus 27 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~E~~~l~~l~h~niv~~~~~ 89 (369)
.+.++||+|+||+||+|.+.+|+.||||+++.... ........+|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45679999999999999998999999998653211 1122345678899999999999988765
Q ss_pred EEeCCceEEEEeccCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhccCCCeEeecCCCCceEecCCCCeeEeec
Q 017591 90 CYDQTKAALVYEFMENGSLDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEECNQRIIHYDIKPANILLDAKFSAKVADF 169 (369)
Q Consensus 90 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 169 (369)
. ..+++|||+++..+.+ ++......++.|++.+|+|||+ +||+||||||+|||++++ .++|+||
T Consensus 83 ~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp E----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred c----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence 3 3479999998855433 3445567899999999999999 999999999999999965 5899999
Q ss_pred CCceecCCCCCccccccCCCCCCccc------cccccccCCCCcchhhHHHHHHH
Q 017591 170 GLAKLCNPENTHDSTSGYRGTPGYSA------PEFLLRNYPITQKCDVYSFGMLL 218 (369)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~s~~sDvwSlGvil 218 (369)
|+|.....+... .|+. .+.+. ..++.++|+||..--+
T Consensus 147 G~a~~~~~~~~~----------~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR----------EILERDVRNIITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH----------HHHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH----------HHHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence 999765422211 1111 12222 3578999999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.57 E-value=2.1e-07 Score=79.67 Aligned_cols=135 Identities=13% Similarity=0.015 Sum_probs=89.3
Q ss_pred cccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccC-CCceeeEEeEEEeCCceEEEEeccCCCCHHH
Q 017591 32 LGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTY-HINLVRLYGFCYDQTKAALVYEFMENGSLDK 110 (369)
Q Consensus 32 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 110 (369)
.+.++.+.||+... +++.+++|+...... .....+.+|...+..+. +--+.+++.+..+++..++||++++|.++..
T Consensus 22 ~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 22 TEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp SCCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred CCCCCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence 33444578999875 566677787654322 12335677877776663 3336777888888888999999999988866
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc------------------------------------------------
Q 017591 111 YLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC------------------------------------------------ 142 (369)
Q Consensus 111 ~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~------------------------------------------------ 142 (369)
..... .....++.+++..++.||+..
T Consensus 100 ~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 100 EYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp HTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred ccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 54211 112334455555566666421
Q ss_pred --------CCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 143 --------NQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 143 --------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
...++|+|+.|.||+++.++.+-|+||+.+..
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 01279999999999999876667999987653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.23 E-value=2.1e-06 Score=72.88 Aligned_cols=130 Identities=12% Similarity=0.022 Sum_probs=84.4
Q ss_pred ccccCC-ceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCC--CceeeEEeEEEeCCceEEEEeccCCCC
Q 017591 31 KLGAGG-FGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYH--INLVRLYGFCYDQTKAALVYEFMENGS 107 (369)
Q Consensus 31 ~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs 107 (369)
.+..|. .+.||+....++..+++|....... ..+..|...++.+.. -.+.+++.+..+++..++||++++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 344444 4689999888888899998764322 245667777766532 236777888888888999999999866
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcc---------------------------------------------
Q 017591 108 LDKYLFTDTEVLKWEKLLDIAIGTARGIAYLHEEC--------------------------------------------- 142 (369)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~--------------------------------------------- 142 (369)
+.... .... ..+.++...|+.||+..
T Consensus 93 ~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 93 LLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 53311 1111 11223333333333210
Q ss_pred ----------CCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 143 ----------NQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 143 ----------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
...++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1237999999999999987667899998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.91 E-value=1.1e-05 Score=73.03 Aligned_cols=76 Identities=14% Similarity=0.036 Sum_probs=47.9
Q ss_pred cccccCCceEEEEEEeCC-CcEEEEEEccccc------cHHHHHHHHHHHHHHhccC---CCceeeEEeEEEeCCceEEE
Q 017591 30 TKLGAGGFGVVYKGQFPN-GVKIAAKILKTCL------NKRVEAQFMAEIGTIGRTY---HINLVRLYGFCYDQTKAALV 99 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 99 (369)
+.||.|....||+....+ ++.+++|.-.... .+....+...|+..+..+. ...+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 478999999999998754 6788998643211 1111234456777776552 2346666654 56677899
Q ss_pred EeccCCCC
Q 017591 100 YEFMENGS 107 (369)
Q Consensus 100 ~e~~~~gs 107 (369)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.28 E-value=0.00079 Score=58.78 Aligned_cols=157 Identities=13% Similarity=0.065 Sum_probs=87.8
Q ss_pred CcccCHHHHHHhhhccc-----cc--cccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCce--
Q 017591 13 PVRFTLEQLCSFTNNYS-----TK--LGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHINL-- 83 (369)
Q Consensus 13 ~~~~~~~el~~~t~~f~-----~~--lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-- 83 (369)
+..+++..+..+...+. .. | .+.-..||++..++|..+++|+...... ...++..|...+..|....+
T Consensus 5 f~~L~pd~i~~al~~~g~~~~~~~~~L-~s~EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv 81 (325)
T d1zyla1 5 FQTLHPDTIMDALFEHGIRVDSGLTPL-NSYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPV 81 (325)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEE-CCSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSB
T ss_pred ccccCHHHHHHHHHHcCCCCCcCcccc-ccccceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCC
Confidence 45567777766654432 11 2 2334689999998999999999875422 23456677777766642222
Q ss_pred ---eeEE--eEEEeCCceEEEEeccCCCCHH-----H------Hh---cc--------CCCCCCHH--------------
Q 017591 84 ---VRLY--GFCYDQTKAALVYEFMENGSLD-----K------YL---FT--------DTEVLKWE-------------- 122 (369)
Q Consensus 84 ---v~~~--~~~~~~~~~~lv~e~~~~gsL~-----~------~l---~~--------~~~~~~~~-------------- 122 (369)
+..- ..+......+.+++++.|..+. . .+ +. .....+..
T Consensus 82 ~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~ 161 (325)
T d1zyla1 82 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 161 (325)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred CCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcC
Confidence 1110 1223455678899998874331 1 11 00 01112211
Q ss_pred --------HHHHHHHHHHHHHHHH-hhccCCCeEeecCCCCceEecCCCCeeEeecCCcee
Q 017591 123 --------KLLDIAIGTARGIAYL-HEECNQRIIHYDIKPANILLDAKFSAKVADFGLAKL 174 (369)
Q Consensus 123 --------~~~~i~~~l~~~l~~L-H~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 174 (369)
.....+..+...+.-. .+..+.+++|+|+.+.|||++.+ ..++||+-+..
T Consensus 162 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 162 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 1222222233222222 12224679999999999999743 46899997754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.17 E-value=0.0011 Score=59.50 Aligned_cols=72 Identities=14% Similarity=0.204 Sum_probs=48.6
Q ss_pred cccccCCceEEEEEEeCC--------CcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc-eeeEEeEEEeCCceEEEE
Q 017591 30 TKLGAGGFGVVYKGQFPN--------GVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN-LVRLYGFCYDQTKAALVY 100 (369)
Q Consensus 30 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 100 (369)
+.|+.|-...+|++..++ .+.|++++.-.... .....+|..+++.+.-.+ ..++++++. -.+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence 578888889999998654 35677776542212 234567888888775333 457777763 37899
Q ss_pred eccCCCCH
Q 017591 101 EFMENGSL 108 (369)
Q Consensus 101 e~~~~gsL 108 (369)
||++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99988544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.09 E-value=0.0028 Score=54.72 Aligned_cols=155 Identities=14% Similarity=0.110 Sum_probs=79.3
Q ss_pred ccCHHHHHHhhhccc-------cccccCCceEEEEEEeCCCcEEEEEEccccccHHHHHHHHHHHHHHhccCCCc-----
Q 017591 15 RFTLEQLCSFTNNYS-------TKLGAGGFGVVYKGQFPNGVKIAAKILKTCLNKRVEAQFMAEIGTIGRTYHIN----- 82 (369)
Q Consensus 15 ~~~~~el~~~t~~f~-------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n----- 82 (369)
.++..||......|. +.|..|--.+.|+....+| .+++|+...... ..++..|+.++..+...+
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccc
Confidence 456677777666552 2356677789999987555 478888764322 234445555665553222
Q ss_pred eeeEEe---EEEeCCceEEEEeccCCCCHHH-----------Hh---cc--C--C----CCC------------------
Q 017591 83 LVRLYG---FCYDQTKAALVYEFMENGSLDK-----------YL---FT--D--T----EVL------------------ 119 (369)
Q Consensus 83 iv~~~~---~~~~~~~~~lv~e~~~~gsL~~-----------~l---~~--~--~----~~~------------------ 119 (369)
.+...+ +.........++.+..+..... .+ +. . . ...
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 111110 1122344566666666532210 00 00 0 0 000
Q ss_pred CHHHHHHHHHHHHHHHHHHhh-ccCCCeEeecCCCCceEecCCCCeeEeecCCce
Q 017591 120 KWEKLLDIAIGTARGIAYLHE-ECNQRIIHYDIKPANILLDAKFSAKVADFGLAK 173 (369)
Q Consensus 120 ~~~~~~~i~~~l~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 173 (369)
........+......+...+. ..+.|++|+|+.++||+++.+...-|.||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001111222222222222221 235789999999999999988777899999764
|